Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.8411212989906475,-1.792085789437906,0.0,1.0,0.82,3/25,4.54%,CYP1A2;ELOVL6;LTC4S
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.8129266343644636,1.7784099781685028,0.0,0.20413028996178254,0.18,5/40,5.60%,SERF1A;CALB1;HSPG2;H3-3A;MFGE8
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.9633615965025731,-1.75584261848517,0.0,1.0,0.91,2/9,1.38%,PLEKHH2;F2RL1
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.7057639984800222,-1.746176627673263,0.0,1.0,0.94,7/77,0.98%,GEM;SPRED2;GPC4;CAMK1G;TRPC7;NPNT;KCNIP1
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.9524735021201534,-1.7400237387866084,0.0,1.0,0.94,1/11,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.811942903079667,-1.7262156627397305,0.0,1.0,0.95,1/24,0.03%,PLEKHH2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.8975582816770403,-1.711222514923786,0.0,1.0,0.97,1/11,0.14%,PER2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.8975582816770403,-1.711222514923786,0.0,1.0,0.97,1/11,0.14%,PER2
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.7959971737388336,-1.7105570956141494,0.0,1.0,0.97,3/21,3.53%,CYP1A2;RBP4;IGF1
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.6210462711480749,-1.71005591108066,0.0,1.0,0.97,18/165,5.47%,PLEKHH2;ITGB5;GOLIM4;TRIB2;LAMB2;IQGAP2;SRGAP1;CDH13;RND3;UNC13B;PROS1;KITLG;NFIB;WWTR1;EHD4;RASSF8;COL4A3;NPHS1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.7206513094777571,-1.7089942563902918,0.030303030303030304,1.0,0.98,6/60,4.54%,CYP1A2;DECR2;ABHD1;ELOVL6;MLYCD;LTC4S
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.9545146759850967,-1.696668405261864,0.0,1.0,0.99,1/6,0.45%,PKD1L1
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.9263189416459163,-1.6896458742371288,0.03571428571428571,1.0,0.99,3/8,3.08%,LAMB2;LAMB3;NTNG1
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.9479661564242574,-1.6789208203891433,0.046511627906976744,1.0,1.0,1/9,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.9479661564242574,-1.6789208203891433,0.046511627906976744,1.0,1.0,1/9,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.9479661564242574,-1.6789208203891433,0.046511627906976744,1.0,1.0,1/9,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.8030288600703823,-1.6752005863023713,0.0,1.0,1.0,1/14,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.6577699576028037,-1.669127044777896,0.03225806451612903,1.0,1.0,12/105,8.13%,CYP1A2;PER2;LDHC;AOAH;IGF1;ACOT1;ACOT11;ALDH1A2;ALDH1A3;ACSF3;MTHFS;CROT
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.7037495813918607,-1.668311442112459,0.0,1.0,1.0,3/28,3.32%,STAC;EPHB2;LRRC55
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.7295243154379161,-1.6631232075764864,0.0,1.0,1.0,1/57,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.9942606934114302,-1.6561791129332155,0.0,1.0,1.0,1/6,0.03%,PLEKHH2
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),-0.977847455479164,-1.6546715127998355,0.0,0.9956137667091292,1.0,1/5,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.9085783410656942,1.6494039229817086,0.029850746268656716,1.0,0.94,1/11,0.21%,APOLD1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.9836255561463023,-1.6491043800025142,0.0,1.0,1.0,3/8,0.69%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.8953314830400619,-1.6466596107302838,0.0,0.9845203610180424,1.0,4/11,8.13%,GLYATL2;ABHD1;CYP4Z1;CROT
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.8717301191696806,-1.6455111858691012,0.0,0.9523456057007126,1.0,2/14,0.52%,TRPC3;TRPC7
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.6588688288443725,-1.6429779792503532,0.0,0.9397309294809392,1.0,6/45,6.85%,STAC;EPHA3;PTPN9;EPHB2;ZDHHC5;RANGRF
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),-0.9142635022694784,-1.641913599219394,0.05405405405405406,0.91463608234762,1.0,1/7,0.58%,NPNT
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),-0.9715646623859977,-1.6411209482448355,0.0,0.888162022074253,1.0,2/5,0.89%,GLYATL2;ABHD1
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.9326051086922379,-1.6390395476415511,0.0,0.8711620458704878,1.0,1/10,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.7850575273457991,-1.6369651413355835,0.0,0.8600719839838658,1.0,6/16,13.46%,LEF1;RRP1B;TFAP4;TAF11;SMARCA4;SMARCB1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.929268709524929,-1.6330125796447763,0.0,0.8697049050530223,1.0,3/8,0.69%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.8440209427045859,-1.62669319417395,0.02702702702702703,0.9028901120572382,1.0,3/8,11.11%,RAB7B;GRAMD4;PTPRS
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.9570911610655739,-1.6233010412384077,0.0,0.9047283254156769,1.0,1/10,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.9030584667973354,-1.6198917685661096,0.05263157894736842,0.8853048832164774,1.0,1/5,1.32%,PEX7
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.9030584667973354,-1.6198917685661096,0.05263157894736842,0.8853048832164774,1.0,1/5,1.32%,PEX7
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.8011829185219886,-1.6167101099186743,0.03125,0.8878448213520836,1.0,2/12,0.75%,TCHH;PKP2
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.8341631968134213,-1.6150099316322624,0.0,0.8777538733780702,1.0,2/15,2.59%,HRH1;NFATC1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.8823843107899022,-1.6105461508877978,0.0,0.8921752541841323,1.0,2/18,0.36%,CYP1A2;GLYATL2
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.9661542837862974,-1.6101703651665387,0.0,0.8703403499207892,1.0,1/8,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),-0.9410058128277115,-1.6092566683218836,0.0,0.8544289452743172,1.0,3/7,4.93%,DUSP4;DUSP5;DUSP2
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.8292338119762663,-1.6078698796887763,0.0,0.8443090222343367,1.0,3/12,3.03%,EPHA3;EPHB2;AMIGO1
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.9010863268422636,-1.6071526371389155,0.0,0.8103487199170779,1.0,2/6,6.81%,MAPK7;APOA1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.9010863268422636,-1.6071526371389155,0.0,0.8103487199170779,1.0,2/6,6.81%,MAPK7;APOA1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),-0.888258992749122,-1.6037166730581833,0.023255813953488372,0.815611577829234,1.0,2/7,1.92%,LEF1;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.7251777065563316,-1.6022334587501688,0.023255813953488372,0.8095647294958069,1.0,1/29,0.03%,PLEKHH2
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.6042773636765498,-1.6008596210468853,0.0,0.8085049907194684,1.0,16/127,7.92%,DUSP4;DUSP5;UBASH3B;PTPN3;PTPRT;EYA4;PTPRB;PTPN9;CDC14B;PPP2R3B;DUSP2;PPEF1;PPM1G;DUSP12;PTPRH;PGP
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.8962174348697367,-1.6000782108119107,0.027777777777777776,0.795273066029191,1.0,1/6,0.63%,KDR
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.9385682142709963,-1.5966022183675925,0.022727272727272728,0.801471739600516,1.0,1/6,0.14%,PER2
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.8906428363013158,-1.5947986076305476,0.05263157894736842,0.7985652087146139,1.0,1/8,0.58%,NPNT
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.8333025449057493,-1.593923274857427,0.02702702702702703,0.7899147626808989,1.0,2/12,2.18%,CYP1A2;RBP4
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.7193345717052012,-1.587365142567024,0.05,0.8198290565009151,1.0,2/27,2.83%,PER2;ASCL1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.9143265426060876,-1.5865582953305462,0.025,0.8106111102203429,1.0,1/7,0.91%,PTPRT
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.886824437882566,-1.5849158899035034,0.02564102564102564,0.808713153693392,1.0,2/11,0.35%,ITGB5;KIT
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),-0.898630403188112,-1.5796062323341402,0.0,0.8328089998258753,1.0,1/5,0.75%,PKP2
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),-0.9594878597974128,-1.5745716064458888,0.0,0.854162069666723,1.0,1/6,0.78%,HRH1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.7667812868794752,1.574259329386103,0.014925373134328358,1.0,1.0,3/28,6.67%,SHCBP1L;LMAN1;PPARGC1A
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.9053120539198427,-1.5696423104137651,0.07894736842105263,0.8870013557954058,1.0,2/6,6.66%,BCL6;FOXP1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.7554031838024555,-1.566205691773238,0.0,0.8994870791079563,1.0,6/33,1.48%,DUSP4;DUSP5;UBASH3B;PTPRT;PTPRB;PTPN9
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.969587859481428,1.565423869795607,0.0,1.0,1.0,1/13,0.03%,NPY
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.9357657850058344,1.5644304524230919,0.0,1.0,1.0,3/8,2.91%,ENPP2;PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.8038432009127944,-1.5594144002696382,0.02857142857142857,0.9450599016133847,1.0,2/12,1.08%,SELP;ITGA4
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.8306715591682565,1.5573960578784678,0.014492753623188406,1.0,1.0,4/16,9.96%,MYLK;RCSD1;YBX3;LRRC8D
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.7987577259686798,-1.5518486647081216,0.02857142857142857,1.0,1.0,2/13,1.08%,SELP;ITGA4
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.6548509645320139,-1.5516421365527016,0.0,0.9898678637969508,1.0,9/51,14.00%,NRK;KIT;EFS;CDC42BPB;NRP1;PARVA;PHACTR1;THSD7A;PTPN1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.7799542178169044,1.550802263116408,0.05,1.0,1.0,3/24,7.33%,LAMA2;TJP3;F11R
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.8520137315556735,-1.5498864029648087,0.06666666666666667,0.9943945264332905,1.0,3/9,10.00%,PAH;SLC22A2;SLC6A4
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.8201393483008351,-1.5492795268182824,0.027777777777777776,0.9830069880073359,1.0,5/17,7.30%,RUNX1;IFIH1;MAPK7;APOA1;CBFB
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.6488008263918543,-1.5453570974475137,0.03571428571428571,0.9995851709120964,1.0,9/67,7.36%,CYP1A2;GLYATL2;ELOVL6;CYP4Z1;LTC4S;ACOT1;CYP2D6;SLC27A3;ACOT8
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),-0.8592927092030127,-1.5446946275859748,0.10810810810810811,0.9884767504603181,1.0,1/8,1.24%,RUBCNL
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.7247928377459059,1.5432469136709186,0.01694915254237288,1.0,1.0,8/32,17.43%,CENPO;CENPI;KNL1;CENPK;CENPU;CENPL;HELLS;OIP5
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.7289182297644532,-1.5416146402509856,0.0625,0.9966452885888399,1.0,3/21,10.76%,KDR;SFRP1;NRP1
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.7654536211322983,-1.5413594774673316,0.05,0.9841945407110315,1.0,3/17,6.81%,KDR;IGF1;APOA1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.7394107018427466,1.5410618114964452,0.017857142857142856,1.0,1.0,9/33,17.52%,CENPO;CENPI;H3-3A;KNL1;CENPK;CENPU;CENPL;OIP5;HAT1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.6550425290130023,-1.5407975676181362,0.0,0.974013478895493,1.0,7/45,6.85%,STAC;EPHA3;PTPN9;EPHB2;ZDHHC5;NUMA1;RANGRF
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.8661518529668406,1.5404013789819129,0.0,1.0,1.0,2/13,1.33%,CSRP3;CAV3
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.8632858256309878,-1.5400393009570301,0.03125,0.9678646214432298,1.0,3/9,8.04%,DBF4B;INO80;WIZ
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.7839977278150936,-1.5380819574212354,0.08888888888888889,0.9716312929906981,1.0,4/11,15.00%,EREG;C5AR1;TFCP2;HSF1
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.9865080602498384,-1.5354132771382154,0.0,0.981986203074624,1.0,2/5,0.65%,CCL28;SELP
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.7654494217509101,-1.5324051077090173,0.0,0.993651087240706,1.0,2/17,7.07%,EPHA3;MCTP1
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.6615585469337434,-1.5315031489128004,0.1,0.9870443211427751,1.0,5/30,7.79%,NTNG1;CLDN4;WTIP;PDPN;ZMYM6
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.805634274122715,1.5304015928073675,0.0,1.0,1.0,1/30,0.02%,SERF1A
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),-0.9651386688763577,-1.530084756364716,0.0,0.9886006569924154,1.0,1/5,0.89%,ABHD1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.7213384287151425,-1.5295491550753078,0.030303030303030304,0.9798487821869266,1.0,4/20,7.32%,DUSP4;DUSP5;DUSP2;PPM1G
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.7378168729998686,1.5284271632330428,0.017241379310344827,1.0,1.0,8/28,17.43%,CENPO;CENPI;KNL1;CENPK;CENPU;CENPL;HELLS;OIP5
prerank,PanglaoDB_Augmented_2021__Platelets,0.6136608909599364,1.5267612079035584,0.014925373134328358,1.0,1.0,17/110,7.53%,TUBB1;C3AR1;NOX5;CCL5;FGL2;HCK;CD300LF;PREX1;ACKR3;P2RY12;SLC26A4;THEMIS2;CDKN2D;ALOX12;GMFG;F11R;HLA-A
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.6481193016870899,-1.5253358014123335,0.0,1.0,1.0,7/48,6.80%,NRG1;BTC;PRAG1;EREG;IGBP1;ETS1;PDPN
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.7515383386130834,1.52198796898341,0.017241379310344827,1.0,1.0,6/26,12.71%,CENPO;CENPI;KNL1;CENPK;CENPU;CENPL
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.7515383386130834,1.52198796898341,0.017241379310344827,1.0,1.0,6/26,12.71%,CENPO;CENPI;KNL1;CENPK;CENPU;CENPL
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),-0.9645182018358087,-1.5208463592438393,0.0,1.0,1.0,3/6,0.69%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),0.9183539156335717,1.5205159170554232,0.0,1.0,1.0,2/8,4.31%,ENPP2;CYP1B1
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.7678001023449403,-1.5197392534396672,0.09302325581395349,1.0,1.0,2/14,2.93%,TRPC3;TYMS
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.6755309406094935,-1.518921170204288,0.023809523809523808,1.0,1.0,5/26,7.36%,PER2;F2RL1;ECE1;SERPINF2;ACE2
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.9006299356344629,1.5152041359114918,0.03076923076923077,1.0,1.0,2/10,0.56%,CA12;SLC12A7
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.9006299356344629,1.5152041359114918,0.03076923076923077,1.0,1.0,2/10,0.56%,CA12;SLC12A7
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.8393517841713652,1.5145969818497136,0.03278688524590164,1.0,1.0,1/12,0.16%,GNLY
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),-0.9170197741215839,-1.5136351648888753,0.06666666666666667,1.0,1.0,1/5,0.84%,BMP7
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.9773154314778699,1.512770572441856,0.0,1.0,1.0,2/7,1.47%,ENPP2;RREB1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.8316133400690596,-1.5104629658004811,0.06976744186046512,1.0,1.0,3/10,9.28%,FGFR4;NR1H4;AKR1C3
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.9022575889349612,-1.5103724249782648,0.0,1.0,1.0,2/7,3.84%,STAC;CACNA2D1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),-0.8560216999919726,-1.5081756312537562,0.0851063829787234,1.0,1.0,2/8,0.84%,NPNT;BMP7
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.770955042016117,1.5065826784344525,0.029850746268656716,1.0,1.0,5/22,13.98%,NES;NOTCH1;ATP5IF1;TMBIM1;PLN
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.8228260970315631,-1.5057357742854243,0.07692307692307693,1.0,1.0,2/9,3.28%,MYRFL;KLK6
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),-0.9111275785212868,-1.5057194560464524,0.0,1.0,1.0,1/6,0.81%,SULF2
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.7319951131533323,-1.5046121740036211,0.022222222222222223,1.0,1.0,2/20,3.75%,RAB32;BLOC1S4
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.7540495790035242,-1.503140416133919,0.0625,1.0,1.0,2/13,6.34%,KDR;RHOJ
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.6996387129230603,-1.5015324477557492,0.09375,1.0,1.0,5/23,6.81%,P2RY10;F2RL1;PRAG1;RTN4R;APOA1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.6763604333625943,-1.5012013093927161,0.0,1.0,1.0,6/29,12.69%,SELP;CDH13;CDH6;CDHR3;PCDHB4;CDH20
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.9080812837575315,1.5008733870017221,0.01694915254237288,1.0,1.0,2/10,1.47%,ENPP2;RREB1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.8763954210417395,-1.4972875800514167,0.0,1.0,1.0,3/10,7.64%,GCH1;TPP1;SHANK1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.7724163121073602,-1.496588559401338,0.07142857142857142,1.0,1.0,3/16,0.69%,SPRED2;SPRED3;SPRED1
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.5940264441256153,-1.493466220955241,0.0,1.0,1.0,6/105,2.18%,CYP1A2;F11;PAH;FGFR4;RND3;RBP4
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.9162297642644349,1.4920672578983931,0.014705882352941176,1.0,1.0,2/7,1.33%,CSRP3;CAV3
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.7713280546063019,-1.4907954509299104,0.06666666666666667,1.0,1.0,3/15,11.77%,METTL8;TRMT10C;TRMT61A
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.6754165298646035,1.490367549192212,0.0,1.0,1.0,4/53,3.75%,ENPP2;PLA2G10;PLA2G7;LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.867620629846456,-1.4893022723743286,0.02631578947368421,1.0,1.0,2/7,6.29%,KDR;RIN2
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.8770200977467735,-1.4886120275907648,0.02857142857142857,1.0,1.0,1/6,0.35%,KIT
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.9655141508405136,1.4883536712204994,0.0,1.0,1.0,1/5,0.03%,NPY
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.9600605078871551,-1.4882793953272575,0.020833333333333332,1.0,1.0,1/6,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.8597018742850386,-1.4876216082618212,0.05,1.0,1.0,2/8,7.16%,RAB7B;RAB7A
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.8666240725970472,-1.4870305754976672,0.046511627906976744,1.0,1.0,2/6,9.64%,APOA1;APOE
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),-0.8671398700703423,-1.4861961718256522,0.041666666666666664,1.0,1.0,5/6,11.80%,SLC22A2;SLC22A3;SLC29A4;SLC6A2;SLC22A1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.7171002206842606,-1.485934281550934,0.05714285714285714,1.0,1.0,8/36,12.36%,ALK;BMP7;MARK1;KNDC1;VLDLR;LRP8;NSMF;COBL
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.780433570381148,-1.4855163304876038,0.06060606060606061,1.0,1.0,3/27,3.05%,CYP1A2;CYB5A;ST3GAL1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.8649445235131045,1.4850797405749054,0.06666666666666667,1.0,1.0,2/11,5.91%,CHMP4B;HSPA5
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.8875485291474933,1.483626218000706,0.0,1.0,1.0,4/12,7.05%,MYLK;ADAMTS9;PDGFRB;TBX1
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.8385859760355848,-1.483624286280788,0.061224489795918366,1.0,1.0,1/8,5.20%,SLC25A33
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.8385859760355848,-1.483624286280788,0.061224489795918366,1.0,1.0,1/8,5.20%,SLC25A33
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.7757942752036512,1.4832265861126688,0.045454545454545456,1.0,1.0,2/19,1.07%,LRP4;CHRNB1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),-0.8931756732963578,-1.482694214509386,0.06666666666666667,1.0,1.0,2/5,1.92%,LEF1;RUNX1
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.7092040380457219,1.48253423760255,0.0273972602739726,1.0,1.0,10/41,8.00%,STEAP4;ALDH1A1;SMIM22;VWA2;SYT2;AHR;TFCP2L1;SCEL;B3GNT3;MUC4
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.732974183367894,-1.4824356620736647,0.0,1.0,1.0,4/18,3.53%,LMCD1;HOMER2;FHL2;IGF1
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.7401367691305237,-1.4819218301909824,0.12903225806451613,1.0,1.0,8/14,15.92%,GREM1;SFRP1;PTCH1;DSCAML1;NOG;NBL1;ACVR1;FBXL15
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.6952992096865537,1.481710576999784,0.03125,1.0,1.0,19/39,17.87%,C3AR1;MS4A6A;FGL2;HCK;CD300LF;CD14;SIGLEC1;MYO1F;C1QA;SLC7A7;AQP9;ADGRE1;IGSF6;TBXAS1;SLC40A1;LY86;WDFY4;TLR2;NCF2
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.7310918383591283,-1.4813165496313794,0.027777777777777776,1.0,1.0,3/20,4.60%,STAC;CBARP;DRD4
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.7940312781356933,1.4809572754917162,0.03125,1.0,1.0,4/21,12.15%,RFC5;POLE2;RPA3;PCNA
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.7657665463420129,1.4807809370011182,0.02857142857142857,1.0,1.0,3/20,2.91%,ENPP2;PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.9372536980947924,-1.4806803505540431,0.0,1.0,1.0,1/6,1.29%,BUD23
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.9885015251324296,1.4798141827256766,0.0,1.0,1.0,1/5,0.55%,MYLK
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),0.8918655437717875,1.4777077947786466,0.0625,1.0,1.0,3/6,8.28%,AMN;CBLIF;TCN2
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.8297125184858775,-1.4771022549000394,0.11627906976744186,1.0,1.0,2/9,0.84%,NPNT;BMP7
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.8001231756619863,-1.475908535463849,0.05714285714285714,1.0,1.0,2/16,1.85%,KDR;GREM1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.8006969181934859,-1.4754191066203506,0.058823529411764705,1.0,1.0,4/15,6.66%,KIT;ALAS1;LYAR;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.8748710063603867,-1.4735840623509402,0.07317073170731707,1.0,1.0,2/8,3.53%,LMCD1;IGF1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.8748710063603867,-1.4735840623509402,0.07317073170731707,1.0,1.0,2/8,3.53%,LMCD1;IGF1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.6883415861082675,-1.47326883963059,0.024390243902439025,1.0,1.0,6/23,12.29%,PRELID2;TRIAP1;PITPNC1;SCARB1;PITPNA;PITPNM1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),-0.9534882844551853,-1.4721586632102537,0.0,1.0,1.0,2/5,1.08%,NPNT;ITGA4
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.9172392107628383,1.4721435424372382,0.018867924528301886,1.0,1.0,1/6,2.56%,ACTA2
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.7094421358484159,-1.4720125765211547,0.05405405405405406,1.0,1.0,4/23,9.37%,PER2;LEF1;TFAP4;IFI16
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.7855605947312476,-1.4716369615438154,0.09302325581395349,1.0,1.0,5/10,9.61%,SFRP1;HDAC1;FOXP1;ZBTB7A;SMARCA4
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.8784432428771259,-1.4714324781987007,0.045454545454545456,1.0,1.0,3/8,7.87%,RGS14;TCIM;INO80
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.8760365955378997,1.4704862189676562,0.015625,1.0,1.0,1/12,2.98%,SLC30A8
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.6031887166459853,-1.4693308168185735,0.043478260869565216,1.0,1.0,10/50,11.35%,NRG1;EREG;AHNAK2;IGF1;CFLAR;TGFB2;PDGFRA;SCARB1;DYSF;NOG
prerank,GO_Biological_Process_2021__norepinephrine transport (GO:0015874),-0.882295719844358,-1.4687325306536518,0.043478260869565216,1.0,1.0,5/5,11.80%,SLC22A2;SLC22A3;SLC29A4;SLC6A2;SLC22A1
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),-0.882295719844358,-1.4687325306536518,0.043478260869565216,1.0,1.0,5/5,11.80%,SLC22A2;SLC22A3;SLC29A4;SLC6A2;SLC22A1
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),-0.9791234129367569,-1.4680167255004402,0.0,1.0,1.0,1/5,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.7645698597643883,-1.467036119148781,0.05263157894736842,1.0,1.0,4/19,4.31%,NRG1;GREM1;IGF1;MAML1
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),-0.8201639742554738,-1.466825336433296,0.08108108108108109,1.0,1.0,4/10,10.37%,ALK;PLIN5;CIDEA;SORL1
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.8618480681038936,-1.4665835591211454,0.02631578947368421,1.0,1.0,3/7,1.80%,KDR;F2RL1;CDH13
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.740636603513393,-1.4652536308804391,0.0,1.0,1.0,3/14,12.31%,KDR;HSPB1;SMOC2
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.8716533246109159,-1.463636020763817,0.16666666666666666,1.0,1.0,1/6,0.35%,KIT
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.7634928581081171,-1.4635666234534757,0.06976744186046512,1.0,1.0,4/13,12.90%,COL15A1;SIPA1L3;COL18A1;RILPL1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.7537985115403768,-1.4632844949913166,0.12121212121212122,1.0,1.0,4/11,20.80%,NPHS1;SHANK1;MPP4;BSN
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.5845110927645114,-1.462811703540704,0.05263157894736842,1.0,1.0,12/90,8.08%,PM20D1;CPXM2;ST3GAL1;MLYCD;SLC19A1;MTHFD2;ACOT1;ACOT11;ACOT8;DHFR;MTHFS;SMPD3
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),-0.8764198058380506,-1.4621932348460167,0.045454545454545456,0.9986981748941772,1.0,2/6,4.51%,TACR1;GRK5
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),-0.964572989951863,-1.46189350257857,0.0,0.9927452351783569,1.0,3/5,0.69%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),-0.982238318254099,-1.461713970514855,0.0,0.9868831800383507,1.0,1/5,0.35%,KIT
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.8960897332105466,1.461630733455613,0.016129032258064516,1.0,1.0,2/8,2.91%,PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.8828686247227603,-1.4616254577292516,0.0,0.9802583681132024,1.0,1/7,0.04%,PM20D1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.6590474941810718,1.4607445213925312,0.015151515151515152,1.0,1.0,10/64,14.17%,NOX5;ROPN1B;RASA1;CHMP4B;SEPTIN14;ANLN;RHOB;ECT2;RACGAP1;SEPTIN1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.7681070227817737,-1.46068337643267,0.08823529411764706,0.9800250206919893,1.0,3/16,5.04%,ITGA4;APLN;COL4A3
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.7442599830953884,-1.460468016594337,0.06818181818181818,0.9748551690749941,1.0,3/20,7.06%,BUD23;MTERF4;FBLL1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.8393825155149879,-1.4600185575514084,0.06818181818181818,0.97050204287072,1.0,3/11,11.83%,SELP;ETS1;MDK
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.8581468204342743,-1.4589400113791442,0.13636363636363635,0.9726414956582687,1.0,2/7,11.71%,SLC16A2;SIRT2
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.7766807649279908,-1.4580448792273932,0.030303030303030304,0.9711030649203294,1.0,2/18,1.85%,KDR;GREM1
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.7167756549660642,-1.457998904043646,0.07142857142857142,0.9646091200340409,1.0,8/23,14.24%,CACNG4;CACNG3;CACNG5;GSG1L;CNIH3;SHANK1;CNIH2;NLGN3
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.7345098468372112,-1.4576816449070058,0.07142857142857142,0.9591071584148515,1.0,4/23,13.49%,MDGA1;ABHD17A;GRIPAP1;CTNNA2
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.5361267044622883,-1.4576666738993682,0.043478260869565216,0.9524348184038228,1.0,13/160,4.42%,CYP1A2;F11;PAPSS2;CA2;RBP4;PROS1;IL1R1;CYB5A;ATOH8;IGF1;SLC35B1;GCH1;ALAS1
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.7053780539732202,-1.456522012758764,0.09302325581395349,0.9544493804371751,1.0,2/16,3.10%,NMNAT3;PNP
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.678898787571191,1.4554633776695445,0.06153846153846154,1.0,1.0,10/49,11.23%,CCNG2;CCND2;CDKN2D;CCNE1;CCNB3;CDKN1B;CCNE2;CDC25A;CDC6;CDK5R1
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.6765328200402849,-1.4538587550145239,0.07894736842105263,0.96980490865445,1.0,4/35,0.84%,SPRED2;SPRED3;SPRED1;BMP7
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.8037872555520499,-1.4520133892471667,0.06818181818181818,0.9786571144676358,1.0,1/11,0.14%,PER2
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.7912506480515145,-1.451989407272586,0.06976744186046512,0.9721210882234597,1.0,2/10,6.66%,F2RL1;FOXP1
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.8798144866654034,-1.4514731295046748,0.08163265306122448,0.9698097614095488,1.0,3/6,9.14%,ST6GALNAC2;ST3GAL1;ST3GAL2
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.7166680395656203,-1.4507074014963208,0.06451612903225806,0.9692410251595844,1.0,5/20,6.79%,TSPAN12;VASH1;SFRP1;ETS1;VASH2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.8405912614491682,-1.4503324648913078,0.022727272727272728,0.9662160569223601,1.0,5/7,14.99%,PTPRT;PTPRB;DUSP10;PTPN1;PTPRO
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.8219037741535912,-1.4502875970350788,0.058823529411764705,0.9600251316305987,1.0,3/8,13.71%,SLC16A2;SLC22A9;SLCO1C1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.8060120206637555,1.4496264279581763,0.08823529411764706,1.0,1.0,2/12,3.75%,PLA2G10;LPCAT3
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.7599305608773009,-1.4493684253670427,0.0784313725490196,0.9602879312494104,1.0,4/16,9.64%,SELP;CELA2A;PDGFRA;APOE
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.852199402129342,1.4481915979291826,0.03278688524590164,1.0,1.0,5/12,12.24%,RP1;GNAT2;CNGB1;CACNA2D4;PDE6B
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.820947287494312,1.4474520957511405,0.029411764705882353,1.0,1.0,1/15,0.26%,ENPP2
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.5775931801218811,-1.4470828906246214,0.06896551724137931,0.9706223148112093,1.0,18/124,9.64%,PLEKHH2;KCNIP1;PCDH19;CACNG4;RND3;ASCL1;ID4;RHBDL3;POU3F4;RGS8;ZNF536;MAPK4;ADGRA1;NYAP1;ARX;DLX5;PHF21B;APOE
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.6935396072840473,-1.4459719922684515,0.06451612903225806,0.9722175876153447,1.0,5/18,21.32%,FBXW8;LRP8;DBNL;RELN;CUX1
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.8302734906211557,1.4448824107864704,0.029850746268656716,1.0,1.0,3/15,2.29%,PTGES;PTGIS;HPGDS
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.924276496239073,-1.4442468042985603,0.03636363636363636,0.9797902504206468,1.0,1/5,0.14%,TRPC3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.9059737091059672,-1.4440205801696036,0.0,0.975019043350632,1.0,2/7,2.59%,KIT;NFATC1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.5974163992867995,-1.443701844861708,0.0625,0.9712019270399007,1.0,1/66,0.03%,PLEKHH2
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.9119434147670658,-1.443426674615885,0.0,0.9677563807057056,1.0,1/7,3.66%,NOP9
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),-0.7877465217844146,-1.4432694380084712,0.08888888888888889,0.9629939424437302,1.0,2/14,5.40%,PER2;HDAC1
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.8139865039526958,1.442913277757232,0.014084507042253521,1.0,1.0,2/10,10.07%,WNT8A;RIPPLY2
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.7236326833961548,-1.442057461835382,0.03333333333333333,0.9683953687538708,1.0,2/15,2.42%,CPSF1;TRPT1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.7315153432897356,-1.4411267340177014,0.0,0.9709616995079355,1.0,3/14,3.08%,LAMB2;LAMB3;NTNG1
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),0.9086852175655217,1.441002765066244,0.047619047619047616,1.0,1.0,1/6,0.16%,WEE2
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.5931076123359871,-1.4404623399494765,0.0,0.9701180105498547,1.0,11/51,12.03%,P2RY10;F2RL1;PRAG1;IGF1;RASGRP1;RTN4R;RASGRF1;APOA1;MMD2;NGF;GPR35
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.5459787320398579,-1.4401226696210503,0.0,0.9660063008644524,1.0,16/80,14.11%,ALK;ROR2;BMP7;EPHA3;ITGA6;ARSB;TOX;VLDLR;LRP8;APOE;STMN2;MDK;COBL;P3H1;PLPPR5;GPC2
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.7860837524962087,-1.4400455669768624,0.06521739130434782,0.9606268718372405,1.0,2/9,4.60%,HRH1;DRD4
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.7015959643597436,1.4397477996734616,0.04918032786885246,1.0,1.0,10/34,17.43%,CENPO;CENPI;KNL1;CENPK;SPTY2D1;CENPU;CENPL;ACTR6;SRCAP;OIP5
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.7139764298730829,1.4395567853401925,0.016129032258064516,1.0,1.0,2/28,0.20%,C3AR1;C4BPB
prerank,GO_Biological_Process_2021__negative regulation of hematopoietic progenitor cell differentiation (GO:1901533),-0.8864657082194063,-1.4394128905618853,0.07692307692307693,0.9580893618330504,1.0,1/5,0.83%,MYB
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.7531629801338905,1.4386684076260747,0.046153846153846156,1.0,1.0,4/18,13.33%,ENC1;PSMB6;PSMA3;PSMB8
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.6151053018823178,-1.4384198988919317,0.07894736842105263,0.9592609584847408,1.0,9/39,17.95%,NRG1;EPHA3;MCTP1;RAB7A;DYSF;CTTNBP2NL;PPM1F;FER1L5;NR1H2
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.8771473690841991,-1.4382679808563592,0.05128205128205128,0.9483148135692818,1.0,1/5,0.35%,KIT
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.8771473690841991,-1.4382679808563592,0.05128205128205128,0.9483148135692818,1.0,1/5,0.35%,KIT
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.7847880691829362,-1.4381924910612758,0.10869565217391304,0.9429782718741481,1.0,2/9,3.64%,GREM1;SRGN
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.8622873557610067,-1.4372908665489899,0.07142857142857142,0.9457828628401854,1.0,1/6,0.75%,PKP2
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.627462395908451,-1.4369720449829388,0.06451612903225806,0.9421604887623053,1.0,8/30,18.60%,KIT;HPS6;BORCS6;PLEKHM2;S100A13;PIP4P1;NR4A3;FAM98A
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.74561582926339,1.4365443179722577,0.045454545454545456,1.0,1.0,7/23,15.47%,CSRP3;SCN4B;MYBPC3;CAMK2D;KCNQ1;TTN;ATP1B1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.7428127298638689,-1.4357757757908036,0.046511627906976744,0.9445672081839797,1.0,2/12,7.75%,ADAM19;NCSTN
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.8029935113100122,-1.434973028249787,0.046511627906976744,0.9456966354159748,1.0,7/11,15.99%,TYMS;MTHFD2;DHFR;MTHFS;MTHFD2L;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.7744799137447385,-1.4330199697799433,0.07317073170731707,0.949005316119147,1.0,5/15,12.91%,ITGB5;PDLIM1;KCTD13;FHDC1;PHACTR1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.7744799137447385,-1.4330199697799433,0.07317073170731707,0.949005316119147,1.0,5/15,12.91%,ITGB5;PDLIM1;KCTD13;FHDC1;PHACTR1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.5884304053287847,-1.4329845483262125,0.0,0.943736322010402,1.0,7/35,11.43%,CDK2AP2;EPHA3;TRIM36;IGBP1;AURKA;TRAF3IP1;MAP10
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.7379868818103081,-1.4309670935139127,0.06818181818181818,0.953099299226988,1.0,5/14,17.95%,PLIN5;APOA1;SCARB1;PNPLA2;NR1H2
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),0.9636556650980337,1.4294930973480031,0.01694915254237288,1.0,1.0,1/5,1.33%,CAV3
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.7937716028004658,-1.4284392712140708,0.10526315789473684,0.9610032930252644,1.0,2/9,6.74%,MYLIP;VLDLR
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.7937716028004658,-1.4284392712140708,0.10526315789473684,0.9610032930252644,1.0,2/9,6.74%,MYLIP;VLDLR
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.7153865261019315,-1.428241833721163,0.08823529411764706,0.9573379888888814,1.0,6/23,8.37%,NMB;HCRT;PTPN23;CLSTN2;KCTD13;NMU
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.7416028373038619,1.4277475854027983,0.047619047619047616,1.0,1.0,3/20,1.84%,GNLY;ITK;KLRG1
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),-0.839042626432593,-1.427500832795287,0.1388888888888889,0.9576432364415787,1.0,2/6,12.93%,PRKCD;SLC30A10
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.5814374212434619,-1.4274901146649028,0.0,0.9524328248238649,1.0,4/53,3.27%,CYP1A2;GPC4;RBP4;SDC4
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.8537933997557847,-1.4271013579854421,0.06666666666666667,0.9450138987462193,1.0,3/10,4.64%,ALKBH2;ALKBH3;MGMT
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.8537933997557847,-1.4271013579854421,0.06666666666666667,0.9450138987462193,1.0,3/10,4.64%,ALKBH2;ALKBH3;MGMT
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.7832730259512743,-1.4253793132060213,0.13513513513513514,0.9508015396853448,1.0,3/7,18.41%,IGF1;FKTN;NECAB2
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.9189025276543339,1.4251187745199023,0.017543859649122806,1.0,1.0,1/7,4.41%,INHBA
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.752677923940286,-1.424634788664768,0.058823529411764705,0.9514754162195563,1.0,3/16,10.76%,KDR;SFRP1;NRP1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.8298292610871288,1.4232025902998653,0.03333333333333333,1.0,1.0,1/15,0.11%,C3AR1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.5630701258503013,-1.4229270595720285,0.06451612903225806,0.9584547364571677,1.0,5/61,7.41%,MYB;RUNX1;KITLG;CBFB;PDCD2
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.7333152376240861,-1.4224206207551346,0.08333333333333333,0.9561094173103052,1.0,5/16,5.83%,APRT;TYMS;PNP;GMPR;POLL
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.7989634049150366,-1.4214700348237106,0.027777777777777776,0.9580868748202198,1.0,2/12,4.11%,ITGA4;APLN
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.6808524212373922,-1.421352348475607,0.03333333333333333,0.9536313181867115,1.0,7/25,10.76%,BTC;GREM1;EPHB2;EREG;HDAC1;TAF1;NRP1
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.7827547015858908,-1.4211124492161353,0.1282051282051282,0.9500868159836687,1.0,2/8,11.82%,F2RL1;CSF1R
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.7857789879715903,-1.4209788999272128,0.15384615384615385,0.9459850703863788,1.0,2/7,12.79%,DNAJB12;CLU
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.7984055487822671,-1.4187216696130045,0.15384615384615385,0.9588205697843378,1.0,1/6,3.64%,SRGN
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.9552837983859543,1.4175990639031897,0.016129032258064516,1.0,1.0,1/5,2.65%,TCP1
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.9552837983859543,1.4175990639031897,0.016129032258064516,1.0,1.0,1/5,2.65%,TCP1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.7802824835495094,1.417402201362021,0.1111111111111111,1.0,1.0,3/13,1.95%,TRIM22;TRIML2;TRIM5
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.7557459898486708,1.417276755082839,0.07575757575757576,1.0,1.0,3/19,5.26%,PLA2G10;LPCAT3;SERINC1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),-0.8477880199550794,-1.4161103374214603,0.046511627906976744,0.9734180198410992,1.0,2/7,0.73%,MDGA1;SOX13
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.8298442636856879,1.4160548104609267,0.0,1.0,1.0,1/11,0.86%,LRP4
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.8616720746710014,1.4159120129272826,0.08064516129032258,1.0,1.0,2/7,6.43%,CCL5;IDO1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.6485718644124276,-1.4154641322551205,0.08888888888888889,0.9734221068104825,1.0,1/19,0.25%,STAC
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.7326404659082361,-1.415444555343731,0.11363636363636363,0.9685078967071682,1.0,1/15,1.08%,NRG1
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.661984400730507,1.414642456847642,0.11428571428571428,1.0,1.0,5/25,8.81%,NPY;GLI3;RARRES2;CCDC39;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.8877750019880556,1.4140137124798307,0.0,1.0,1.0,1/7,1.54%,AGER
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.7485950214400832,-1.4140035019748982,0.06060606060606061,0.9741383376614826,1.0,8/17,21.17%,NEDD1;CEP83;PCM1;PIBF1;NUDCD3;HOOK3;GOLGB1;CCDC14
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.8427608834391717,-1.4135741334686138,0.0,0.972345263733839,1.0,1/7,1.77%,PID1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.7331165605989639,1.4126248353341255,0.014925373134328358,1.0,1.0,3/20,5.20%,SPDYA;CCND2;PSRC1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.6827119719408158,-1.412506232644407,0.08333333333333333,0.9748399515563402,1.0,5/18,15.31%,MT1E;FOS;AKR1C3;HSF1;EGFR
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.7005457874455361,-1.4115841425049194,0.043478260869565216,0.9754073158828634,1.0,3/14,7.64%,EPHB2;DOCK10;SHANK1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.8846023800843776,1.4115618246169277,0.0,1.0,1.0,3/9,2.29%,PTGES;PTGIS;HPGDS
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),-0.8266167935237761,-1.411506829013302,0.125,0.9708594944421041,1.0,1/6,1.65%,SLC16A2
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.6364094716403919,1.4108019987160043,0.03076923076923077,1.0,1.0,19/68,15.89%,CSRP3;TRPV6;WFS1;GCM2;CCL5;CALCB;ELANE;VAPB;TMEM203;SLC24A4;FAM20A;SLC24A2;SLC24A1;DRD3;HTR2B;ATP1B1;NPTN;TRDN;CHRNA7
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.9208722209303472,1.4107007177017625,0.03773584905660377,1.0,1.0,2/5,7.72%,AGER;WAS
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.7872164330051643,-1.4089781050062187,0.05128205128205128,0.9828639713500723,1.0,3/10,6.69%,MELTF;RUNX1;SERPINF2
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.9270005717156877,-1.408810091594243,0.045454545454545456,0.9791361804446868,1.0,1/6,3.40%,ZNHIT6
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),0.9192412552483585,1.408773809623926,0.0,1.0,1.0,1/6,1.72%,CD4
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),0.9192412552483585,1.408773809623926,0.0,1.0,1.0,1/6,1.72%,CD4
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.8208214958093253,1.4087694135151358,0.07936507936507936,1.0,1.0,1/9,1.31%,PLA2G10
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.9107486225652358,-1.4084730871568485,0.05555555555555555,0.9763775550036897,1.0,2/8,6.66%,KIT;FOXP1
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.9135514821299644,1.4081876280801264,0.04918032786885246,1.0,1.0,1/6,0.48%,NOX5
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.8887156715255614,1.4081057523049438,0.034482758620689655,1.0,1.0,1/8,2.07%,ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.7474821837179514,1.4077759733832167,0.046153846153846156,1.0,1.0,3/17,5.20%,SPDYA;CCND2;PSRC1
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.809213258517774,-1.407316065988124,0.13043478260869565,0.9797056401446381,1.0,6/9,15.99%,TYMS;MTHFD2;MTHFS;MTHFD2L;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.9789527146701452,1.4069576339999648,0.0,1.0,1.0,1/5,0.55%,MYLK
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.7620756152032035,1.4069142614699428,0.07575757575757576,1.0,1.0,4/16,8.76%,TDRD1;TDRD9;HENMT1;BTBD18
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.6443844349042291,1.406688090659395,0.05970149253731343,1.0,1.0,18/48,18.81%,C3AR1;MS4A6A;FGL2;HCK;CD300LF;CD14;SIGLEC1;MYO1F;AQP9;IGSF6;PTAFR;LY86;WDFY4;TLR2;TRIM25;NCF2;KLHDC4;HK3
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.7360201064287496,1.4064270797554546,0.0967741935483871,1.0,1.0,4/19,11.91%,RGPD3;RGPD4;RGPD1;RGPD2
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.8628502979477471,-1.4061617321031505,0.05128205128205128,0.9789169970780259,1.0,1/5,0.75%,PKP2
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),-0.8628502979477471,-1.4061617321031505,0.05128205128205128,0.9789169970780259,1.0,1/5,0.75%,PKP2
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.8807309451503937,-1.4055597339798775,0.0784313725490196,0.9785893718522093,1.0,3/5,9.14%,ST6GALNAC2;ST3GAL1;ST3GAL2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.5678593846310368,-1.405368441099336,0.10714285714285714,0.9756578377804149,1.0,10/57,11.94%,KDR;ITGA4;CDH13;APLN;VASH2;VIP;NRP1;HMGB2;MDK;SCG2
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.8599367869655912,-1.4051698462444353,0.11363636363636363,0.9725736164276414,1.0,1/5,2.53%,ALKBH3
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.8504557991564468,1.4045839845983035,0.03125,1.0,1.0,1/9,3.75%,LPCAT3
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.7382065256231298,1.4041819448980344,0.04477611940298507,1.0,1.0,5/20,12.19%,RAB6C;ATF5;CHMP4B;CHMP2B;CHMP1A
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.835192181232607,1.4039284371582725,0.07017543859649122,1.0,1.0,1/9,0.41%,STEAP4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.835192181232607,1.4039284371582725,0.07017543859649122,1.0,1.0,1/9,0.41%,STEAP4
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.7031329534766372,1.4039040645865195,0.04838709677419355,1.0,1.0,2/29,0.20%,C3AR1;C4BPB
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.8930575590590308,-1.4038582173904743,0.021739130434782608,0.9769648805012984,1.0,1/8,0.10%,F11
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.6901738860713023,-1.4035126761142518,0.13953488372093023,0.9741429582572635,1.0,3/20,6.35%,CD38;EPHB2;BCL2
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.823549345261376,1.4025297941648718,0.07272727272727272,1.0,1.0,2/8,8.94%,PRELP;OGN
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.7839749899494897,-1.4022414217548593,0.02857142857142857,0.9794365298784908,1.0,1/9,1.32%,PEX7
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),-0.7962396304492616,-1.4019899233236177,0.07894736842105263,0.9765704484717805,1.0,3/10,7.92%,DGKB;GAL3ST1;PGP
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.6954241050384332,1.4018101148036815,0.10606060606060606,1.0,1.0,5/27,12.19%,RAB6C;C10ORF90;CHMP4B;CHMP2B;CHMP1A
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.6605892691555035,-1.4017406471066025,0.05263157894736842,0.9734368353227884,1.0,1/34,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.8736741662094201,-1.401658843661094,0.0625,0.969394446452347,1.0,3/6,8.04%,DBF4B;INO80;WIZ
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),-0.8693110133996231,-1.4010813716759662,0.07142857142857142,0.9689500074057441,1.0,1/7,0.81%,SULF2
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.7351157907358526,1.4009401956492777,0.07547169811320754,1.0,1.0,5/22,6.55%,TRIM22;TRIML2;CD4;TRIM5;CIITA
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.6668434332528541,-1.4006198254474311,0.08333333333333333,0.9674059548141193,1.0,7/30,8.37%,NMB;HCRT;PTPN23;ECE1;CLSTN2;KCTD13;NMU
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.7151455989921247,1.4005881966753604,0.05,1.0,1.0,2/27,0.20%,C3AR1;C4BPB
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.8469780433827223,1.400459874118965,0.01639344262295082,1.0,1.0,3/11,7.05%,ADAMTS9;PDGFRB;TBX1
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.5868066728102518,-1.4003619230686906,0.07407407407407407,0.9645462688945712,1.0,2/69,0.84%,PM20D1;BMP7
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.7786571488562348,-1.4001884255941248,0.1,0.9615978263619738,1.0,5/11,13.31%,LTBP1;GREM1;NOG;CHRDL1;NBL1
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),-0.8595294885991033,-1.4000210107545243,0.1702127659574468,0.9588483114457588,1.0,1/5,5.34%,KNDC1
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.8023528665095823,-1.400019246859491,0.17073170731707318,0.9501315086144339,1.0,4/8,16.22%,SPHK2;PRKCD;SMPD3;NSMAF
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.8023528665095823,-1.400019246859491,0.17073170731707318,0.9501315086144339,1.0,4/8,16.22%,SPHK2;PRKCD;SMPD3;NSMAF
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.9136082192116797,-1.3999189583330216,0.0,0.946623478702585,1.0,1/5,3.42%,AGBL1
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.7273694188598924,-1.3995225300063727,0.06818181818181818,0.944609819507604,1.0,3/19,7.06%,BUD23;MTERF4;FBLL1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.8808069261099227,1.3991772432952456,0.07692307692307693,1.0,1.0,2/7,4.08%,PTGIS;BOK
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5674557902402693,-1.3988137165168042,0.12903225806451613,0.9454146187886806,1.0,5/42,7.66%,KDR;RHOJ;ETS1;MAP2K3;HSPB1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.8570622053017616,-1.3987949020953203,0.0967741935483871,0.941305533690833,1.0,1/6,0.74%,FBXL7
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.7448678333472877,1.3985187512674455,0.1016949152542373,1.0,1.0,2/13,2.56%,MYLK;ACTA2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.8650395049538291,1.3984612528705849,0.0,1.0,1.0,1/8,1.54%,AGER
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.6232282378496152,-1.3976300441595542,0.0967741935483871,0.9447268408551068,1.0,5/44,8.43%,PM20D1;SPTSSB;CERS4;SPTLC1;SGMS2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.9271737971169496,1.3968100612795948,0.0,1.0,1.0,2/7,4.69%,CCL5;DOCK8
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.9437658623074379,1.396658437459178,0.029850746268656716,1.0,1.0,2/5,4.00%,TIMP3;TIMP2
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.8496153560024011,1.3965518259519671,0.07692307692307693,1.0,1.0,2/11,1.29%,PTGES;PTGIS
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.8570555501784526,-1.3963309005714892,0.09090909090909091,0.9493889546109121,1.0,3/7,10.76%,EPHB2;NFIB;NRP1
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.7930620542162845,1.3950302547504807,0.08333333333333333,1.0,1.0,3/12,3.75%,LRRC19;NOTCH1;LPCAT3
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.5844053274929752,-1.3946072720927734,0.058823529411764705,0.9572012133964207,1.0,7/43,7.66%,SPRED2;SPRED3;SPRED1;RABL3;PUM3;ATG10;HSPB1
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.8545143355740327,1.3945518838837354,0.031746031746031744,1.0,1.0,1/9,0.86%,LRP4
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.758924270726297,1.3943181062339882,0.1346153846153846,1.0,1.0,2/12,16.37%,BRCA1;YTHDC1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.8079361436145182,-1.3915742384749432,0.05263157894736842,0.9729975639031381,1.0,2/9,6.29%,KDR;RIN2
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.6504767713739893,1.3912618841588995,0.08333333333333333,1.0,1.0,8/36,8.66%,TIMP3;TIMP2;SERPINF1;AGT;SERPINA10;KNG1;SERPINI2;SPOCK3
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.4795696672434527,-1.3906672414363022,0.0,0.9742027179626961,1.0,22/257,7.88%,NRK;SHC3;KIT;DUSP5;KDR;SPRED1;PTPN3;NRG1;FGFR4;BTC;PRKG2;EREG;KITLG;IGF1;RASGRP1;MAP3K20;PDE6D;RASGRF1;APOA1;RASA2;FNTB;FGF13
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.7871279338264878,1.390419518646662,0.05970149253731343,1.0,1.0,4/15,5.93%,PTGES;TRPA1;OPRK1;SCN9A
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.820946061254559,1.3902842877331105,0.04918032786885246,1.0,1.0,1/12,3.75%,LPCAT3
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.6230805017621034,-1.3902842440031913,0.1388888888888889,0.9727908299656487,1.0,3/33,1.32%,TRPC3;TRPC7;MELTF
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.7980134815647004,-1.390089644248435,0.058823529411764705,0.9699313218743926,1.0,2/15,1.38%,RAB7B;F2RL1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.8575661291693288,1.389030501792112,0.05,1.0,1.0,2/9,10.48%,FAS;PLAUR
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.846388427746751,-1.3887618536181636,0.05,0.9704504240121411,1.0,3/8,3.92%,CACNG4;CACNG3;CACNG5
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.846388427746751,-1.3887618536181636,0.05,0.9704504240121411,1.0,3/8,3.92%,CACNG4;CACNG3;CACNG5
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.9186231673976188,1.3884626806144975,0.03333333333333333,1.0,1.0,1/5,4.82%,P2RY12
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.7412694210901924,-1.3884518816581615,0.10526315789473684,0.9684915799601754,1.0,6/10,20.42%,MCUB;MICU1;MICU2;MCUR1;MCU;SLC25A23
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.704006042680858,-1.3881078557714335,0.14285714285714285,0.9672934788282089,1.0,3/23,2.25%,KIT;CDH13;ARFIP2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.610663312477315,1.3872369468865937,0.04411764705882353,1.0,1.0,12/75,11.23%,CCNG2;SPDYA;CCND2;CDKN2D;PSRC1;CCNE1;CCNB3;CDKN1B;CCNE2;CDC25A;CDC6;CDK5R1
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.8715716615301315,1.3863064961236313,0.08928571428571429,1.0,1.0,3/6,12.32%,WAS;EPS8;BRK1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.6074468467348727,-1.386251300624195,0.08823529411764706,0.9739381040127932,1.0,6/34,6.29%,CCL28;KDR;CDH13;UTRN;SFRP1;RIN2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.870160292231835,-1.3850517564888354,0.06666666666666667,0.979261868721347,1.0,2/7,6.69%,ADAM19;SERPINF2
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.6779587242559382,-1.3850182379562317,0.0625,0.9754621914183688,1.0,2/16,2.42%,CPSF1;TRPT1
prerank,PanglaoDB_Augmented_2021__Macrophages,0.5831033547224195,1.3846476273685309,0.04411764705882353,1.0,1.0,27/97,12.50%,C3AR1;MS4A6A;CHIT1;SLCO2B1;CCL5;FGL2;HPGDS;STAB1;HCK;CD300LF;PIK3R5;AHR;PTPRC;FMNL1;CPM;NCEH1;TAGAP;CD14;SIGLEC1;MYO1F;SCIMP;CTSK;SLC7A7;AQP9;ADGRE1;IGSF6;RGS1
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.7856587696433087,1.3846226496460543,0.06060606060606061,1.0,1.0,2/9,2.99%,SDS;BAAT
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7287158487561889,1.3844424521652854,0.1016949152542373,1.0,1.0,7/17,22.77%,FKBP1B;CAMK2D;ATP1B1;CALM3;ATP2A2;RYR2;SLC9A1
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.5683721589368149,1.3842631534918777,0.043478260869565216,1.0,1.0,34/101,20.51%,NR1I3;ANKS4B;SPON2;SLC23A1;ABCC2;NR5A2;SOX10;ACSL5;GPX2;GBA3;KLF5;TRPM6;GIPC2;CA1;KHK;ALDOB;NKD2;ABCG2;SLC28A2;UGT2B7;DEGS2;TMC4;SLC52A1;PDZK1;SLC40A1;RBP2;DPP4;MTTP;PPARG;SLC51A;MAOA;SLC2A5;CPS1;ABCG5
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.714442056981126,-1.3839296956185478,0.125,0.9791672742445573,1.0,2/13,4.42%,KIT;TICAM1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.8566494857485651,1.3833016490693564,0.06060606060606061,1.0,1.0,5/11,7.05%,MYLK;NOTCH1;ZFPM1;ACTC1;TBX1
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.8820554611562381,1.3825789187430757,0.046153846153846156,1.0,1.0,2/10,2.25%,TICRR;GMNN
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6921441440887095,-1.3820499132120607,0.18421052631578946,0.9864843334241917,1.0,2/16,3.53%,TRPC3;IGF1
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.83031317169304,1.3815777017639574,0.015873015873015872,1.0,1.0,1/10,0.86%,LRP4
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.804000624305914,-1.3809079089220915,0.13157894736842105,0.9894392111577718,1.0,2/9,11.35%,KNDC1;NOG
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.6775890071183936,-1.3806046889392283,0.06060606060606061,0.9881892053841781,1.0,4/23,3.53%,SULF2;CHST8;HS3ST4;IGF1
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.8250400441294417,-1.3805561390425445,0.06382978723404255,0.9843281762004641,1.0,5/9,12.36%,ALK;BMP7;VLDLR;LRP8;COBL
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.7784888894405543,1.3803281618906955,0.11475409836065574,1.0,1.0,1/9,2.77%,ACOT4
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.9013833290975606,-1.3800064130185539,0.09523809523809523,0.9842354908042623,1.0,1/5,1.38%,F2RL1
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),-0.882295719844358,-1.3795874964117611,0.06818181818181818,0.9789244634687693,1.0,5/5,11.80%,SLC22A2;SLC22A3;SLC29A4;SLC6A4;SLC22A1
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),-0.882295719844358,-1.3795874964117611,0.06818181818181818,0.9789244634687693,1.0,5/5,11.80%,SLC22A2;SLC22A3;SLC29A4;SLC6A4;SLC22A1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.8826177934532689,1.3795731325462501,0.0,1.0,1.0,1/7,1.33%,CAV3
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.7479348720061538,1.379517042533682,0.10606060606060606,1.0,1.0,2/13,4.82%,POLE3;LOXL2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.741437131295312,1.378963269183012,0.12280701754385964,1.0,1.0,3/18,1.95%,TRIM22;TRIML2;TRIM5
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.7761410869393905,-1.3788740534737098,0.2,0.9796132697545579,1.0,2/6,10.18%,CRH;RORA
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.6631111109897377,-1.3788552133683245,0.10256410256410256,0.9758143022769438,1.0,3/28,2.80%,NRG1;BTC;EREG
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.785562571540501,1.3781802087229365,0.016129032258064516,1.0,1.0,3/16,9.21%,CALCR;CASQ1;GPER1
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.7283245438235846,-1.378178156827546,0.13636363636363635,0.9769615043640939,1.0,4/8,19.81%,STAT3;LEP;NR4A3;GCK
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.745354333768419,-1.378172011740123,0.09302325581395349,0.9731036174603793,1.0,1/9,1.77%,PID1
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.8503746229446435,-1.3778792837825489,0.06976744186046512,0.9710678333354794,1.0,1/8,0.81%,SULF2
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.6860276620118748,-1.377546353825098,0.05263157894736842,0.9690482062274438,1.0,5/27,9.12%,PM20D1;GCH1;SPHK2;SPTLC1;GCHFR
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),-0.8333873920755174,-1.3774085366759035,0.15217391304347827,0.9664521439928906,1.0,3/6,9.23%,XRCC4;MGMT;XRCC6
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.7356286930511394,-1.376978319900941,0.10526315789473684,0.9651550044504239,1.0,3/9,10.30%,KDR;BCL2;ABCD1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.8039506137768118,-1.3763206778292991,0.11538461538461539,0.9658272194824737,1.0,2/9,8.75%,KIT;COL11A1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.8262039688388338,-1.3763170564528802,0.022727272727272728,0.9620544569063704,1.0,5/10,11.68%,PRKG2;GCH1;DHFR;GCHFR;PTS
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.7422630254214373,1.3758505049754775,0.11538461538461539,1.0,1.0,7/19,16.07%,TEX101;TDRD5;SYCP3;CAPN1;NOTCH3;SYCP2;SLC25A31
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.8234992023969094,1.3757194638760637,0.09836065573770492,1.0,1.0,2/10,5.16%,PLA2G10;AGT
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.7424791985075834,1.3747894638987999,0.06349206349206349,1.0,1.0,7/18,18.47%,HSD17B2;CYP19A1;HSD17B6;TSPOAP1;DHCR7;HSD17B11;AKR1B1
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.7433137078436125,-1.374571544451636,0.125,0.9690026934779107,1.0,4/11,20.36%,SMYD2;KMT5A;EHMT1;SETD2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.7325843112335175,-1.3744657692187907,0.10810810810810811,0.9655857390421356,1.0,5/10,19.68%,APOA1;ABCD1;SLC45A3;NR1H2;ABCD2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.7146502000479964,1.3743619415472412,0.03225806451612903,1.0,1.0,2/29,1.47%,ENPP2;RREB1
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.6750907815193203,-1.3742619082650955,0.11904761904761904,0.9635936397550042,1.0,3/19,6.81%,NAXE;ABCA13;APOA1
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.6823809702430371,-1.37415608642176,0.08571428571428572,0.9609443377774051,1.0,5/19,15.31%,MT1E;FOS;AKR1C3;HSF1;EGFR
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.6416824425327414,-1.3740398647877992,0.0625,0.9584110440788328,1.0,4/22,7.97%,RUNX1;NUMA1;CBFB;MACROH2A2
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.8234697454933531,-1.3740185871953785,0.0975609756097561,0.9551343539391554,1.0,1/7,0.63%,KDR
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),-0.7913807321929477,-1.37390341672413,0.12195121951219512,0.9522624988099827,1.0,5/8,11.80%,SLC22A2;SLC22A3;SLC29A4;SLC6A4;SLC22A1
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),0.9113489092187876,1.3737269234058107,0.08196721311475409,1.0,1.0,3/5,8.07%,ALDH1A1;KHK;ALDOB
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),0.9113489092187876,1.3737269234058107,0.08196721311475409,1.0,1.0,3/5,8.07%,ALDH1A1;KHK;ALDOB
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),0.846346731156409,1.3729492171443023,0.05,1.0,1.0,2/7,6.43%,CCL5;IDO1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.6775854457516514,-1.3728256720554406,0.09302325581395349,0.9555153600763683,1.0,10/21,22.86%,GRIN3A;SHANK1;DLG5;APOE;PTPRS;FOXO6;NEURL1;KIF1A;PSEN1;SRGAP2C
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7416625171306223,1.3725688144682395,0.1111111111111111,1.0,1.0,3/13,15.76%,TJP3;F11R;MPP7
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.8131112047163019,1.3723202494544318,0.14035087719298245,1.0,1.0,2/8,5.66%,NOTCH1;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.7342431708507642,1.3720498361092979,0.14516129032258066,1.0,1.0,4/17,7.87%,CCL5;P2RY12;RARRES2;CMKLR1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),0.6101024899154335,1.3717816033998986,0.04411764705882353,1.0,1.0,17/63,20.15%,TRIM22;TRIM5;CCL5;HCK;CIITA;HLA-A;STAT1;IRF1;CAMK2D;PTAFR;EPRS1;TLR2;TRIM25;B2M;GBP6;SP100;GBP5
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.8332972739172309,-1.3714857647307335,0.14285714285714285,0.9599219524308772,1.0,3/8,12.79%,C5AR1;SORL1;CLU
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),-0.8562464498067457,-1.3713855816906357,0.09615384615384616,0.9570644881546961,1.0,2/6,5.68%,PNP;SAMHD1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.750168942666627,-1.3712889094048986,0.13043478260869565,0.9542752063016902,1.0,4/10,18.15%,BRCA2;MACROH2A2;LRWD1;MACROH2A1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),0.9062831752429668,1.370783253854673,0.0,1.0,1.0,3/7,6.90%,GNAT2;CNGB1;CACNA2D4
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),0.9062831752429668,1.370783253854673,0.0,1.0,1.0,3/7,6.90%,GNAT2;CNGB1;CACNA2D4
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.7424256705892724,-1.3698362911225974,0.08823529411764706,0.9605944519061946,1.0,6/15,21.17%,NEDD1;CEP83;PCM1;PIBF1;HOOK3;CCDC14
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.7834773680051634,-1.3693716435552796,0.14583333333333334,0.9597164321937341,1.0,2/8,5.15%,APOBEC3H;ADARB2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.6107356640654783,1.3684208032779155,0.047619047619047616,1.0,1.0,5/70,3.56%,TUBB1;TRIM58;GYPB;RGS10;DOCK2
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.7866083908364072,1.3682625697640733,0.08064516129032258,1.0,1.0,2/11,4.82%,NOX5;LOXL2
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.6499410548812007,1.3680309308396794,0.06666666666666667,1.0,1.0,24/52,19.01%,MS4A6A;FGL2;HCK;CD300LF;HLA-DMA;PIK3R5;AHR;HLA-DMB;PTPRC;TAGAP;CIITA;SIGLEC1;MYO1F;C1QA;IGSF6;EPCAM;PTAFR;LY86;CD74;WDFY4;TLR2;NCF2;HK3;CD80
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),-0.7934668871300568,-1.3679821526443023,0.12244897959183673,0.9652748393033038,1.0,4/7,13.31%,GREM1;NOG;CHRDL1;NBL1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.6405892595908094,-1.3677801097301099,0.06818181818181818,0.9627729576232719,1.0,6/27,4.93%,DUSP4;ITGB5;DUSP5;ITGA4;LAMB3;DUSP2
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.5101358512443243,-1.3669253703540165,0.0625,0.9640547729839182,1.0,30/135,15.81%,DUSP4;DUSP5;PTPN3;PTPRT;PTPRB;PTPN9;CDC14B;PPP2R3B;DUSP2;PPEF1;THNSL2;PPM1G;PNKP;DUSP12;PTPRH;PGP;TIMM50;PTPRS;DUSP10;DUSP15;PPP1CA;PPP2R1B;PLPPR5;PTPN1;SGPP2;SSH1;DUSP6;PTPRO;PPM1M;CTTNBP2NL
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.7225602296658559,-1.3652368769406784,0.1935483870967742,0.9726472144212887,1.0,3/12,7.09%,LTBP1;SERPINF2;TGFB2
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.5544310672650925,-1.3643502381420631,0.125,0.974658549292456,1.0,14/61,14.69%,SPRED2;SPRED1;FGFR4;FIBP;POLR2G;FGFRL1;NOG;GTF2F1;TRIM71;POLR2C;POLR2L;PTBP1;FGFR3;FLRT2
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.8392150534195394,1.3638877412006485,0.09523809523809523,1.0,1.0,2/9,5.43%,PTGES;OSMR
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.68640855489896,-1.3635857279053893,0.08571428571428572,0.9758377435033329,1.0,2/12,3.83%,IQGAP2;ARPC3
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.6187541259113369,-1.3623856148260807,0.11538461538461539,0.980266595898733,1.0,3/50,4.14%,KDR;EPHA3;SFRP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.6724082472485531,1.362320972589493,0.07142857142857142,1.0,1.0,3/31,6.33%,AEN;BOK;HINT1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.6087860867685535,-1.3616901251542528,0.0625,0.9804701519068235,1.0,4/27,10.70%,EPHB2;MCTP1;APOE;NSMF
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.7447588979017156,-1.3605620879637288,0.16666666666666666,0.9843562788490441,1.0,3/9,10.63%,PTCH1;TGFB2;MYH3
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),-0.830935074442957,-1.3599600163143268,0.14583333333333334,0.984275119926744,1.0,4/7,14.35%,PLIN5;APOA1;SORL1;PNPLA2
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.6431233544788795,1.3596229918371625,0.14754098360655737,1.0,1.0,11/36,15.92%,SLC7A11;SLC38A11;SLC23A1;SLC38A8;ABCB1;SLC36A1;SLC38A2;SLC7A7;SLC38A5;SLC16A1;SLC38A4
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.7388024286652525,1.3595455208368548,0.08333333333333333,1.0,1.0,6/21,10.21%,ZNF703;EID2;NREP;SMAD7;SOX11;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.6275081339241317,1.3591975107675158,0.06756756756756757,1.0,1.0,10/40,10.41%,CCL5;IL15;DOCK8;HLA-DMB;PTPRC;PDCD1LG2;HLA-A;IL7;CD6;RHOH
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.6486779448867106,-1.3584821046106856,0.11428571428571428,0.9907070680380716,1.0,2/27,0.63%,NPNT;KDR
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.7782975729609934,1.3581527492883125,0.05084745762711865,1.0,1.0,2/13,5.91%,WFS1;HSPA5
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.8008147322203517,-1.3576140362903855,0.13333333333333333,0.9922928952695133,1.0,4/7,16.28%,GREM1;SFRP1;MDK;LEP
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.6416986417850308,1.3575711369697332,0.14754098360655737,1.0,1.0,3/34,3.56%,TDRD1;TDRD9;HENMT1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.83979665912436,1.3573413558446779,0.11666666666666667,1.0,1.0,5/9,11.98%,PLA2G7;ALOX12;PPARGC1A;ADIPOR2;ACOX1
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.8775368125375812,1.3570232791996415,0.06557377049180328,1.0,1.0,3/7,8.07%,ALDH1A1;KHK;ALDOB
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.8195244293000522,1.3567776425985212,0.046875,1.0,1.0,2/11,4.73%,ZBTB7B;ING2
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.5040812467783358,-1.356696094909157,0.045454545454545456,0.9936460255270544,1.0,24/118,14.86%,ETV5;SHC3;KCNIP1;ASCL1;NTM;VCAN;TNR;SLC6A1;ZNF536;MAPK4;ADGRA1;NYAP1;LHFPL3;MMD2;PDGFRA;STMN2;LRRTM3;SYNDIG1;ELAVL3;GRIA2;SLCO1C1;ARNT2;BRINP2;BRINP1
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.8780333946425866,1.3561772933693046,0.046875,1.0,1.0,1/7,5.01%,TRUB1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6978542802427177,1.3559542665252813,0.14285714285714285,1.0,1.0,2/19,5.59%,PPP1R1B;FKBP1B
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.7049613442319491,1.3559146743882255,0.07407407407407407,1.0,1.0,8/24,13.49%,SLC13A4;MGST1;SLC26A4;SLC26A7;SLC36A1;LRRC8D;ABCG2;RACGAP1
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.6346001405359908,1.3558643822652625,0.045454545454545456,1.0,1.0,4/38,4.84%,CAV3;LDLRAP1;ACKR3;ARR3
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.5517986387536123,-1.3551603824947156,0.03125,0.9985202724429646,1.0,11/72,7.75%,MYRFL;ADAM19;PRSS12;ADAMTS3;CPXM2;TYSND1;KLK6;SRGN;PTCH1;ECE1;NCSTN
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),-0.8074986012322166,-1.3548217275879106,0.13513513513513514,0.9968514359001641,1.0,2/5,14.41%,SDC4;TSG101
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.5886796842900391,1.3547466601878926,0.057971014492753624,1.0,1.0,22/75,20.52%,CSRP3;GCM2;CCL5;CALCB;ELANE;VAPB;TMEM203;SLC24A4;ATP12A;SLC24A2;SLC24A1;DRD3;HTR2B;ATP1B1;NPTN;TRDN;CHRNA7;ATP1A1;CALR;LETM1;SLC24A5;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.5791444827161273,-1.354567877223499,0.08571428571428572,0.9947998964351419,1.0,5/39,2.80%,PTPN3;BTC;RNF126;VPS25;EREG
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.8031860126423893,-1.3539088477019265,0.1,0.9951645838682948,1.0,4/7,17.67%,CRH;CFAP20;NR4A3;SGIP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.7316710014218297,1.3536260542697762,0.06153846153846154,1.0,1.0,1/19,0.58%,AEN
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.7913742768271378,-1.3535195605627877,0.19047619047619047,0.9939600678222095,1.0,2/8,5.82%,LEF1;SPHK2
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.7647812507130183,1.3531678105792153,0.15873015873015872,1.0,1.0,2/14,3.60%,CCL5;ACKR3
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.8065613470913842,1.3523644259193084,0.017543859649122806,1.0,1.0,3/9,4.89%,CD4;CCL5;THEMIS2
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.8408470867326479,1.3520894983439682,0.08928571428571429,1.0,1.0,2/7,8.03%,ODAD4;CCDC39
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.8898213855357213,1.3515052788845499,0.0847457627118644,1.0,1.0,1/8,1.54%,AGER
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.8067966128904163,-1.3512403806087157,0.12195121951219512,1.0,1.0,1/5,2.33%,RABL3
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.6083350640633529,-1.3505036996132354,0.05714285714285714,1.0,1.0,5/33,2.18%,F11;RIMBP2;SLC39A11;PAH;RBP4
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),-0.9114576590340624,-1.3499468879365684,0.043478260869565216,1.0,1.0,1/5,0.24%,HTR1F
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.8701150875225606,-1.3490410892447153,0.1111111111111111,1.0,1.0,2/6,5.58%,EPHB2;AMH
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.8686183214013936,1.3489926413862587,0.07142857142857142,1.0,1.0,1/6,8.81%,FGFR2
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.7677631725097698,-1.348895457192203,0.17777777777777778,1.0,1.0,3/5,22.09%,OPALIN;SLC45A3;TNFRSF21
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.6707914492159738,-1.3474435569819982,0.18181818181818182,1.0,1.0,5/19,5.01%,LAMB2;LAMB3;NTNG1;MYH11;TNXB
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.8191440694707893,-1.347330220306787,0.09090909090909091,1.0,1.0,1/6,9.64%,APOE
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.7539836351953884,1.346704012222319,0.05454545454545454,1.0,1.0,6/16,18.56%,MCM2;MCMDC2;RECQL;RECQL4;PURA;MCM6
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.5521849531705765,1.3466113135308186,0.02631578947368421,1.0,1.0,20/116,9.21%,OLFML1;CALB1;LAMA2;ALPL;TIMP3;LRP4;HSPG2;ACTA2;PDGFRB;POSTN;ITGA5;ANGPTL2;OSMR;IGFBP5;BMP1;SFRP4;RUNX2;FGFR2;EFEMP1;GPER1
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.7957078527683519,1.3454222499299255,0.0625,1.0,1.0,2/13,4.69%,CCL5;DOCK8
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.6538378288591506,-1.3451434571431589,0.08823529411764706,1.0,1.0,2/17,3.83%,IQGAP2;ARPC3
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.8238929318477574,-1.3450858898265734,0.17777777777777778,1.0,1.0,1/6,1.28%,LEF1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.5968696225292072,-1.3450600971887166,0.125,1.0,1.0,1/25,0.14%,PER2
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.6566480129516651,-1.3449030613177333,0.08108108108108109,1.0,1.0,1/23,0.14%,PER2
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.6930944607208572,-1.3445892891880626,0.17073170731707318,1.0,1.0,4/14,19.36%,TPR;EMD;BAG3;ANP32B
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),0.7500703449101527,1.3444684263435367,0.12280701754385964,1.0,1.0,7/15,16.07%,TDRD9;ING2;SYCP3;BTBD18;MEIOC;HSF2BP;SLC25A31
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.8328601102776345,-1.3441286237482433,0.1388888888888889,1.0,1.0,2/8,9.14%,ST3GAL1;ST3GAL2
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),-0.8293529571285103,-1.3437796453146549,0.22727272727272727,1.0,1.0,1/5,6.09%,CRH
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),-0.8519461672089932,-1.3436712040498595,0.045454545454545456,1.0,1.0,2/6,3.51%,NRG1;HDAC5
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),0.7909860409366609,1.3431181523974192,0.11666666666666667,1.0,1.0,2/12,3.75%,WFS1;LPCAT3
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),-0.7963138679031799,-1.3423524313683888,0.075,1.0,1.0,1/6,1.38%,F2RL1
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.7584277108517833,-1.3420031973450208,0.1590909090909091,1.0,1.0,3/9,10.85%,LAMB3;ITGA6;LAMA3
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.7123297392754718,-1.3419272571123895,0.1794871794871795,1.0,1.0,2/10,7.16%,RAB7B;RAB7A
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),-0.8102789322683279,-1.3417215571889725,0.25,1.0,1.0,1/5,7.20%,MTMR9
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.7177981885864557,1.3415876238699849,0.11864406779661017,1.0,1.0,10/21,21.99%,PTGES;PTGIS;HPGDS;PTGR1;ACOX1;TBXAS1;CD74;PLAA;GSTP1;PLA2G4A
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.8514154050766132,-1.3414104706653645,0.12195121951219512,1.0,1.0,1/5,0.39%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.9065918058965847,-1.3411259686997403,0.10869565217391304,0.9992633772909074,1.0,1/5,0.65%,SELP
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.6725252691665248,-1.340438354722435,0.15384615384615385,0.999788574757584,1.0,2/16,2.06%,UBASH3B;LRRC17
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.8725462778835213,1.3404055027551531,0.03076923076923077,1.0,1.0,2/6,8.29%,FADD;CASP8
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.7064148101118842,1.340030408992494,0.09230769230769231,1.0,1.0,6/21,7.28%,BTN2A2;AGER;FADD;PDCD1LG2;IDO1;HHLA2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.5847939780030164,1.3392204088732733,0.029850746268656716,1.0,1.0,18/77,15.89%,CSRP3;GCM2;CCL5;CALCB;SLC30A8;ELANE;VAPB;SLC39A12;TMEM203;SLC24A4;SLC24A2;SLC24A1;DRD3;HTR2B;ATP1B1;NPTN;TRDN;CHRNA7
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.9087129728185819,1.3388052372402925,0.03076923076923077,1.0,1.0,1/7,0.20%,C4BPB
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",0.9087129728185819,1.3388052372402925,0.03076923076923077,1.0,1.0,1/7,0.20%,C4BPB
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.9087129728185819,1.3388052372402925,0.03076923076923077,1.0,1.0,1/7,0.20%,C4BPB
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.6378005882939077,1.3387960004945938,0.11475409836065574,1.0,1.0,8/33,17.99%,LMAN1;ARIH2;HSPA1L;ATP5IF1;RHOU;UBL5;PINK1;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.6248927504948801,-1.338493173140285,0.09090909090909091,1.0,1.0,10/21,22.34%,LYAR;NCL;UBTF;SMARCA4;SMARCB1;DDX11;WDR75;MTOR;MARS1;ERBB2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.6887500916895146,1.3383401022793016,0.14516129032258066,1.0,1.0,6/19,22.15%,FKBP1B;CASQ1;CAMK2D;TRDN;CALM3;RYR2
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.8292805539949548,1.338329282814583,0.08620689655172414,1.0,1.0,2/5,9.64%,P2RY12;VWF
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.8520012998255146,1.338246138680757,0.11864406779661017,1.0,1.0,2/7,2.72%,CALCR;PDGFRB
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.5741109169845886,1.3381047946597315,0.0410958904109589,1.0,1.0,5/107,4.73%,NPY;ROPN1B;AGER;PLP1;UNC5A
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.7757645206009435,-1.338097368660281,0.18181818181818182,1.0,1.0,1/6,5.82%,SRM
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),0.6327196277471112,1.337842929338208,0.07352941176470588,1.0,1.0,11/42,17.89%,TRIM22;TRIM5;HCK;CIITA;HLA-A;STAT1;IRF1;CAMK2D;PTAFR;TRIM25;B2M
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.7140746111958594,1.3377565010958758,0.12121212121212122,1.0,1.0,2/19,5.16%,PLA2G10;AGT
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.7364582008436982,-1.337389732115938,0.13953488372093023,1.0,1.0,3/8,16.33%,APOBEC3H;HMGA2;SETDB1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",-0.8666068057046555,-1.337267717527384,0.1320754716981132,1.0,1.0,1/5,5.78%,ZDHHC3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.627510347527563,-1.336794422059561,0.1111111111111111,1.0,1.0,7/20,18.86%,ERCC2;GTF2H2;CUL4A;DDB2;GTF2H5;XPC;ERCC3
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.7618497599590188,1.3363375385967922,0.13793103448275862,1.0,1.0,3/13,5.89%,CSRP3;PDGFRB;ACTC1
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),-0.7409422861930478,-1.3355434437706146,0.08333333333333333,1.0,1.0,2/10,3.03%,EPHB2;AMIGO1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.6891587027111683,-1.335248398009521,0.15151515151515152,1.0,1.0,5/11,20.86%,MAPRE1;STMN2;TBCD;TUBB4A;CLIP3
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.555737372244436,1.335026313410349,0.0625,1.0,1.0,22/131,7.35%,OLFML1;STEAP4;LAMA2;PTGES;TIMP3;ACTA2;PDGFRB;AOX1;POSTN;NQO1;CYP1B1;SERPINF1;FBLN5;ECM2;ANGPTL2;AGT;PLSCR4;RARRES2;PPARGC1A;ADRB1;TBX1;F10
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),0.8554591560014315,1.334937085851064,0.12,1.0,1.0,1/5,3.61%,ITGA5
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.8209100942425451,1.334892961100668,0.11864406779661017,1.0,1.0,2/8,10.21%,NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.7140546051778351,-1.3348278501854973,0.14634146341463414,1.0,1.0,3/12,9.90%,AASS;OGDH;HYKK
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.7140546051778351,-1.3348278501854973,0.14634146341463414,1.0,1.0,3/12,9.90%,AASS;OGDH;HYKK
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.7792874625120826,1.3344348687595546,0.17391304347826086,1.0,1.0,3/8,15.89%,CHRNB1;LGMN;CHRNA7
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.7026618636833307,1.333886070767226,0.06349206349206349,1.0,1.0,7/27,10.21%,ZNF703;EID2;NREP;SFRP4;SMAD7;SOX11;TGFB1
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.7407653145903503,-1.3337412511719964,0.11627906976744186,1.0,1.0,3/11,3.82%,APRT;PNP;GMPR
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.6296257417496853,1.3335525596313824,0.10606060606060606,1.0,1.0,8/34,17.99%,TRPV6;SYT2;SYT4;DOC2A;SYT9;SYT15;SYT13;LRRK2
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.8187945993002933,1.3332157891713632,0.045454545454545456,1.0,1.0,1/6,3.56%,DOCK2
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.6980500548187819,-1.3330776389687773,0.09090909090909091,1.0,1.0,2/13,3.10%,NMNAT3;PNP
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7790930862597969,1.3321654396229583,0.109375,1.0,1.0,2/11,8.45%,LRP4;CNTN2
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.595074851001084,1.3320399601100148,0.07936507936507936,1.0,1.0,15/61,9.29%,RDH10;TYR;WFS1;CRYBB1;CRYBG3;RABGGTB;GNAT2;CNGB1;ARR3;CABP4;CACNA2D4;GPR179;GUCY2F;EFEMP1;SLC24A1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.813187232566068,1.3320116726060902,0.11290322580645161,1.0,1.0,4/8,10.17%,AMBP;SLCO2B1;ABCC2;ABCG2
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.813187232566068,1.3320116726060902,0.11290322580645161,1.0,1.0,4/8,10.17%,AMBP;SLCO2B1;ABCC2;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),-0.7987283553454716,-1.331536127545075,0.175,1.0,1.0,2/5,16.69%,MAML1;ATP11A
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.6616983530491691,-1.3313844983668766,0.11428571428571428,1.0,1.0,9/19,19.82%,FOS;TEX15;DMAP1;BEND3;DNMT1;EHMT2;DNMT3B;GATAD2A;EHMT1
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.8244850026674662,1.3312810281326326,0.06779661016949153,1.0,1.0,3/10,9.36%,TBX1;FGFR2;STAT1
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.8082027848362796,-1.3311065769149704,0.10909090909090909,1.0,1.0,2/6,7.81%,TPR;IWS1
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.8082027848362796,-1.3311065769149704,0.10909090909090909,1.0,1.0,2/6,7.81%,TPR;IWS1
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),-0.848822980694833,-1.3309828536264299,0.15384615384615385,1.0,1.0,3/7,12.93%,CA2;PRKCD;SLC30A10
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.8236958801800579,1.330896708474199,0.0847457627118644,1.0,1.0,1/7,5.91%,HSPA5
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.5945884615276636,-1.3305690630739697,0.0975609756097561,1.0,1.0,5/26,20.30%,ARL13B;PCNT;ACBD5;SQSTM1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.818423739070582,-1.3302921825847063,0.15555555555555556,1.0,1.0,3/5,12.80%,SLC25A37;SLC6A9;ABCB10
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),0.7343976147939311,1.3294429703513915,0.11290322580645161,1.0,1.0,2/16,8.00%,WEE2;BUB1B
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.62111998954388,-1.3290996237555093,0.09090909090909091,1.0,1.0,3/26,2.25%,KIT;CDH13;ARFIP2
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.7887512808669483,1.3290349727167885,0.09375,1.0,1.0,3/12,7.05%,HESX1;GCM2;TBX1
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.8092531270386971,1.328800935916884,0.10144927536231885,1.0,1.0,2/10,3.75%,PLA2G10;LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),-0.9186248736919533,-1.3286727544751316,0.03333333333333333,1.0,1.0,2/5,7.66%,KDR;HSPB1
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.9077260826517465,1.3285641797833334,0.03636363636363636,1.0,1.0,1/5,2.02%,EIF5A2
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5827955782564489,1.3284932912169458,0.09090909090909091,1.0,1.0,14/60,9.29%,RDH10;TYR;WFS1;CRYBB1;CRYBG3;RABGGTB;GNAT2;CNGB1;ARR3;CABP4;GPR179;GUCY2F;EFEMP1;SLC24A1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.6715731032656195,1.3284503599136903,0.07462686567164178,1.0,1.0,8/27,10.17%,SLC13A4;SLCO2B1;SLC26A4;SLC22A25;SLC17A8;SLC26A7;LRRC8D;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.6992621878646232,-1.3281156388189028,0.1388888888888889,1.0,1.0,3/14,8.65%,UNC13B;HCRT;TENM4
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.5852784446665523,-1.327917794460946,0.06060606060606061,1.0,1.0,4/42,1.85%,KDR;NAXE;CDH13;GREM1
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),0.8816213431491406,1.3273935512308177,0.09433962264150944,1.0,1.0,2/6,10.23%,SLC12A7;RHD
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),-0.8995096899551365,-1.3271026656424165,0.047619047619047616,1.0,1.0,2/5,8.04%,FGFR4;NR1H4
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.8030665909227139,1.326958137548642,0.125,1.0,1.0,1/8,1.33%,CAV3
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),-0.8015099290480603,-1.3269523427424252,0.11627906976744186,1.0,1.0,3/5,16.28%,ABCC4;SLCO3A1;LEP
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.7824636923638318,1.3269247535447162,0.13114754098360656,1.0,1.0,2/10,15.18%,AGT;RFK
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.6485244922474236,1.3263720894902116,0.0625,1.0,1.0,7/30,18.55%,ROPN1B;ODAD4;FSIP2;ARL6;TUB;TULP3;NPHP4
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.7381454370380112,-1.3261285765225574,0.15384615384615385,1.0,1.0,5/10,16.89%,AZU1;FOXP1;DYSF;SPACA3;FER1L5
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.8951549135863128,-1.3260860226764717,0.11627906976744186,1.0,1.0,2/5,5.72%,SLC6A11;SLC6A1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.8042474201284036,1.3259086043018398,0.09615384615384616,1.0,1.0,2/10,7.12%,NOTCH1;REST
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.6743603199575661,-1.32588714089015,0.1,1.0,1.0,2/17,5.94%,ATP6V0D2;CLN6
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.7533618386614064,1.3257789430690547,0.11864406779661017,1.0,1.0,4/15,7.53%,AGER;PTPRC;FADD;HLA-A
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.8453361257785994,-1.3255366339611814,0.13333333333333333,0.9999605696321807,1.0,2/6,7.93%,ERCC2;SDF4
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.7175281987533272,-1.3251317720401374,0.14893617021276595,0.9994409388839723,1.0,3/12,9.23%,XRCC4;BRCC3;XRCC6
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.660599792072852,-1.324836642443759,0.11904761904761904,0.9982611997276776,1.0,8/17,15.99%,SLC19A1;MTHFD2;DHFR;MTHFS;MTHFD2L;MTHFD1L;PM20D2;MTHFR
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.850888299710096,1.3247363394577545,0.11290322580645161,1.0,1.0,2/5,9.76%,NOTCH1;SOX11
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.5325157956685742,-1.3244119478020726,0.1,0.9970516655710219,1.0,2/71,2.98%,PM20D1;FOS
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.783937943652243,1.3239741668442626,0.13793103448275862,1.0,1.0,3/10,8.29%,CD4;IL15;CASP8
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.7177042321300929,-1.3234002587339062,0.14285714285714285,0.9999880669906582,1.0,3/12,10.55%,ALG8;ALG12;MPDU1
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.7266595403869137,-1.3233638791727864,0.13333333333333333,0.9972102045542577,1.0,3/11,7.30%,GFI1B;RUNX1;CBFB
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.7409509003657546,1.3232029249556745,0.09090909090909091,1.0,1.0,1/12,2.19%,LMAN1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.7510577217576525,1.322978960432567,0.15,1.0,1.0,2/10,10.44%,RND1;C1QA
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.700354122324744,-1.322386073939387,0.14634146341463414,0.9998741284494908,1.0,3/10,17.95%,PLIN5;SCARB1;NR1H2
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.8050604929783071,-1.32203260886403,0.13333333333333333,0.9988918148699202,1.0,3/8,8.04%,DBF4B;INO80;WIZ
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.7409814465303594,1.3219121744385136,0.1016949152542373,1.0,1.0,4/17,9.14%,NES;CYP1B1;LAMA1;EFEMP1
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.8638545571591216,1.3217069222656885,0.10714285714285714,1.0,1.0,4/7,12.25%,ALDH1A1;SULT2A1;ALDH2;ADH5
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.7877746669528232,1.321629367703652,0.09090909090909091,1.0,1.0,3/8,17.21%,NOTCH1;TGFB1;DPP4
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.6863830836139863,-1.3213660379498158,0.1111111111111111,0.999797713191222,1.0,9/18,17.39%,SFSWAP;PTBP3;RBMX;U2AF2;SRSF7;PTBP1;RPS26;PTBP2;PCBP4
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.5223279809357978,-1.321347184293917,0.05555555555555555,0.996980319675845,1.0,11/74,6.10%,DUSP4;SPRED2;SPRED3;SPRED1;BMP7;SPRY4;RGS14;EPHB2;PRDM15;IGBP1;PRKCD
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.7992300548692416,1.3213396620487308,0.171875,1.0,1.0,4/5,19.18%,STAT1;TGFB1;PPARG;SOAT1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.7992300548692416,1.3213396620487308,0.171875,1.0,1.0,4/5,19.18%,STAT1;TGFB1;PPARG;SOAT1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.5429415979044034,-1.3212185295888044,0.09375,0.9950070174891292,1.0,10/46,14.83%,PER2;SVBP;LIMK1;TAF1;CHP1;U2AF2;SH3RF2;USP4;SIRT7;IVNS1ABP
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.6498926034175077,-1.3209891549048574,0.0625,0.9933680676308395,1.0,1/21,1.19%,EPHA3
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.5195338730740516,-1.3206724962974583,0.10714285714285714,0.9920248086814317,1.0,21/106,13.53%,ETV1;RIMBP2;PTPRT;UNC5B;KCNIP1;RBP4;SLC6A1;SST;MAPK4;ADGRA1;TMEM196;RAB3C;GAD2;POU3F1;LCORL;STMN2;KCNB2;SCG2;NPTX2;RGS7BP;GRIA2
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.7326560776763007,1.3204570631741148,0.12903225806451613,1.0,1.0,2/10,7.33%,TJP3;F11R
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.7264729004086775,1.32042064826477,0.14754098360655737,1.0,1.0,2/18,1.54%,GADD45B;AGER
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.7094585339717498,1.3201060678963294,0.1506849315068493,1.0,1.0,1/17,0.86%,LRP4
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.8149237509263794,1.3196036938014284,0.07936507936507936,1.0,1.0,3/9,9.36%,TBX1;FGFR2;STAT1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.7713638960748121,-1.319355843511616,0.2,0.9930263441516898,1.0,1/8,2.59%,NFATC1
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.7713638960748121,-1.319355843511616,0.2,0.9930263441516898,1.0,1/8,2.59%,NFATC1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.636200111122176,-1.3191512983161653,0.12195121951219512,0.9912342340109949,1.0,4/18,12.37%,ADAM19;NCSTN;RBMX;HM13
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.6900324792674487,-1.3177277972827652,0.15,0.9963871119542198,1.0,4/16,8.64%,STING1;IFIH1;TICAM1;COLEC12
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),-0.8502570353634966,-1.3173258999286108,0.10256410256410256,0.9955835251148545,1.0,1/5,6.67%,LYPLA2
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.7885305085436034,-1.316857244310225,0.11627906976744186,0.9957695748103356,1.0,8/12,18.15%,WTIP;SHANK2;MAP2K3;DLG5;WWC3;VGLL4;WWC1;MARK3
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),-0.8544226514309768,-1.3166826468608348,0.15217391304347827,0.9941653132709927,1.0,2/5,8.82%,COL15A1;COL18A1
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),0.9378867809941873,1.316581448830685,0.03225806451612903,1.0,1.0,1/5,0.61%,TICRR
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.6732313053753809,1.3164873668851453,0.17142857142857143,1.0,1.0,4/19,9.67%,CCL5;RARRES2;CMKLR1;STAP1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.719491413174538,1.3162496294155028,0.17857142857142858,1.0,1.0,3/13,12.75%,PHKG1;PHKA1;AGL
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),0.8717890919754776,1.31580047552136,0.10909090909090909,1.0,1.0,1/7,0.26%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),-0.892116358472316,-1.3156235936919611,0.10638297872340426,0.9969781962861076,1.0,2/5,7.13%,KIT;OLFM2
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.7632670214736301,1.3153907392908606,0.15254237288135594,1.0,1.0,2/14,7.87%,C3AR1;CMKLR1
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.6674478915813935,-1.3150441626232994,0.1951219512195122,0.9971587911763996,1.0,1/14,1.77%,PID1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.7843659616898182,-1.3139411191323267,0.21052631578947367,1.0,1.0,3/7,3.90%,SLC16A9;PNP;SLC2A9
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.49963868980558773,-1.3133327361302944,0.045454545454545456,1.0,1.0,16/139,7.08%,SPRED2;SPRED3;SPRED1;PKP2;TRIB2;MYB;BMP7;SINHCAF;GREM1;ASCL1;DTX1;SFRP1;WWTR1;PTCH1;PTHLH;ID2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.8195291474050858,1.313121870394644,0.1,1.0,1.0,1/8,1.33%,CAV3
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.707867417356644,1.3128927206827574,0.12121212121212122,1.0,1.0,4/18,16.76%,KCNE2;REST;KCNQ1;CRHBP
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.740834148564457,1.3127549494159667,0.08955223880597014,1.0,1.0,2/19,3.75%,PLA2G10;LPCAT3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.8504787313228142,-1.312562538356547,0.13043478260869565,1.0,1.0,1/6,4.53%,NBDY
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.8272151583262558,1.3124907784544912,0.08955223880597014,1.0,1.0,1/6,0.55%,MYLK
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.6128131625175387,-1.3124744040603986,0.17647058823529413,1.0,1.0,6/40,2.20%,DUSP4;SPRED2;SPRED3;SPRED1;RGS14;EPHB2
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.6357165301794311,-1.3120446747747458,0.1,1.0,1.0,6/13,27.12%,BTG1;RIPOR2;AKIRIN1;IGFBP3;HIF1AN;BOC
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.6705670736959252,1.3119489938969402,0.15625,1.0,1.0,6/22,14.22%,NCAPH2;NCAPG;PHF13;SMC2;CHMP1A;TTN
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.8339945416104395,1.311917028410399,0.10416666666666667,1.0,1.0,2/5,5.11%,ALPL;CDKN2D
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),-0.840741693169526,-1.311912036217151,0.16666666666666666,0.9988048364742225,1.0,2/6,3.32%,UNC13B;UNC13C
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.79573595016576,1.3116440602198647,0.125,1.0,1.0,1/8,2.25%,GMNN
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.7279578874093402,1.311500255083729,0.13333333333333333,1.0,1.0,3/17,2.91%,AGER;CCL5;PLA2G7
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.750866244315882,1.3114076248804383,0.140625,1.0,1.0,5/18,17.33%,SULT2A1;DAO;PPA1;MTARC2;TPST2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.7562416014339793,-1.3113249459845338,0.18421052631578946,0.9991138376914228,1.0,2/7,6.80%,MELTF;PDPN
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.837419699450429,-1.3110912481072166,0.16279069767441862,0.9949282631048494,1.0,1/5,1.06%,RAB32
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.837419699450429,-1.3110912481072166,0.16279069767441862,0.9949282631048494,1.0,1/5,1.06%,RAB32
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.8201718200531779,-1.3110568961498406,0.06976744186046512,0.992462231001434,1.0,1/7,0.62%,NMNAT3
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.7997893870047742,1.3110366475087898,0.06666666666666667,1.0,1.0,2/11,4.73%,ZBTB7B;ING2
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.830169155002726,1.3108059349850887,0.13559322033898305,1.0,1.0,1/7,0.69%,ALDH1A1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.7065051134817089,-1.3108009360991497,0.16666666666666666,0.9911265369808793,1.0,1/9,3.85%,TPR
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),-0.8304948833350226,-1.3107347048468403,0.10638297872340426,0.9887853781899966,1.0,3/5,7.72%,GCH1;DHFR;MTHFS
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.8145614691529709,1.3102021146133906,0.11666666666666667,1.0,1.0,2/8,8.76%,MSX1;RPS7
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),-0.7398727458002339,-1.309597135169292,0.21621621621621623,0.9927185620044228,1.0,1/5,1.28%,LEF1
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.8341033758470608,1.309279472093659,0.09615384615384616,1.0,1.0,2/5,10.92%,RAD54L;FANCM
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.8288891304208966,1.3091211483476,0.08771929824561403,1.0,1.0,1/7,5.24%,SYT4
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.5680059617096099,-1.3091144618349044,0.13157894736842105,0.9931052589818923,1.0,13/40,12.81%,KIT;CCL28;LEF1;AZU1;PRKCD;PDGFRA;ACKR2;NRP1;HMGB2;ABCC1;CXCR5;PARVA;ELMO2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.6678090774511223,1.3088797006317692,0.10344827586206896,1.0,1.0,2/27,1.79%,CAV3;TMEM35A
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",-0.8467496722147794,-1.3088481552750748,0.13157894736842105,0.9923848887145262,1.0,1/5,2.44%,CDH26
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.854891723709347,1.3083329840777855,0.09836065573770492,1.0,1.0,2/6,10.37%,GLI3;SIX4
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.5262104974879123,-1.3078656461879883,0.0967741935483871,0.9953084398107842,1.0,15/56,14.70%,CACNG4;CACNG3;CACNG5;GSG1L;CRH;CNIH3;SHANK1;GRIA4;GRIA1;NPTXR;GRIN2A;NPTX2;CNIH2;GRIA2;DLGAP4
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.6496210848422801,-1.3067643471369401,0.17647058823529413,0.9981164804070454,1.0,3/18,0.69%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.7803718839067385,1.3060705456523325,0.1774193548387097,1.0,1.0,2/8,8.29%,YBX3;CASP8
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",0.7732919839308051,1.3055251560343504,0.1267605633802817,1.0,1.0,4/11,12.24%,RP1;CNGB1;CNGA1;PDE6B
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.631860378060324,-1.305403662772986,0.17142857142857143,1.0,1.0,7/15,22.18%,TRPT1;POP1;SARS1;FARS2;ADAT1;YARS2;POP5
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.7164061719899958,1.3050916677217996,0.09836065573770492,1.0,1.0,1/16,1.09%,WNT8A
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.6208786443746885,-1.3049032769150566,0.11428571428571428,1.0,1.0,4/21,4.14%,SPRED2;SPRED3;SPRED1;SFRP1
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),-0.8195685315893142,-1.3048880290174492,0.12903225806451613,1.0,1.0,3/7,7.09%,PAH;GCH1;TGFB2
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),0.8366471380279363,1.3046657910452562,0.14035087719298245,1.0,1.0,1/5,3.71%,NOTCH1
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.7659180922175228,-1.3046031368221582,0.13043478260869565,0.9991163657125033,1.0,1/8,0.24%,HTR1F
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.71810574703113,-1.304561358132156,0.2702702702702703,0.9966514513084628,1.0,5/13,26.24%,SYNDIG1;TMEM230;DNM2;RAB27A;KIF5C
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.5866130958646498,-1.3044759270519328,0.15,0.9946256365067019,1.0,8/37,9.21%,BMP7;BMP3;GREM1;INHA;PMEPA1;BMP6;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.7684462692095606,-1.3042410799004214,0.15217391304347827,0.9905731325177365,1.0,2/8,1.99%,HOMER2;FHL2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.7684462692095606,-1.3042410799004214,0.15217391304347827,0.9905731325177365,1.0,2/8,1.99%,HOMER2;FHL2
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.827043158794132,1.304134342286127,0.20833333333333334,1.0,1.0,3/6,14.08%,SFXN3;SLC38A2;SLC38A5
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.6778466475035548,1.3039528379680645,0.140625,1.0,1.0,1/28,0.23%,RAB6C
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.9348720684890762,1.3035450400195376,0.09433962264150944,1.0,1.0,1/5,3.71%,NOTCH1
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.8424076640488681,-1.3033226370082185,0.12195121951219512,0.9931000129392027,1.0,1/6,1.96%,RAD21L1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),-0.49334995857360714,-1.3030552754101232,0.04,0.9915910848234356,1.0,12/107,7.79%,TSPAN12;PID1;LZTS3;VASH1;CLDN4;SFRP1;WTIP;BCL6;KNDC1;ETS1;VASH2;ZMYM6
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.9012110249517064,1.3025937245389305,0.10416666666666667,1.0,1.0,1/5,5.00%,WASF1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.5239062884853856,-1.3024707736097543,0.06666666666666667,0.9920961052030765,1.0,11/57,7.09%,SPRED2;SPRED3;SPRED1;EPHA3;LEF1;GREM1;SFRP1;WWTR1;PDPN;GCNT2;TGFB2
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.5224199662142418,1.3022923295689877,0.0410958904109589,1.0,1.0,14/166,11.24%,TRIM58;GYPB;GYPE;SLC7A11;TYR;UROD;LAMP2;CA1;SLC2A1;CLCN3;IGSF3;ABCG2;RHD;MOSPD1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6894663254981291,-1.3016529981005955,0.16666666666666666,0.9944703687571232,1.0,1/13,0.35%,KIT
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.6255838220430617,1.3016266496356852,0.12903225806451613,1.0,1.0,11/27,17.53%,NSDHL;HMGCR;G6PD;HMGCS1;SQLE;MSMO1;INSIG2;DHCR7;DHCR24;INSIG1;ACAA2
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.5782341087605792,-1.3004264877859761,0.11538461538461539,0.999117894532321,1.0,2/47,0.17%,CD38;P2RY10
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.718957777967894,1.299999908529664,0.12698412698412698,1.0,1.0,3/17,4.69%,CCL5;ACKR3;DOCK8
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.6543948338694969,-1.2999265376692013,0.24324324324324326,0.9987648786390346,1.0,3/15,8.64%,STING1;IFIH1;COLEC12
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.7926361402433177,-1.2997241135191107,0.28125,0.9971967203130321,1.0,2/7,4.14%,GREM1;SFRP1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.612709891712664,-1.2997205102140301,0.08333333333333333,0.9946463450692646,1.0,5/27,11.71%,PER2;ASCL1;TENM4;HMGB2;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.5927141195866678,-1.2994687339642832,0.15384615384615385,0.9934471724907401,1.0,2/37,2.20%,CD38;EPHB2
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.6813051538056681,-1.2988572829363048,0.1388888888888889,0.9917644876409251,1.0,9/17,19.82%,FOS;TEX15;DMAP1;BEND3;DNMT1;EHMT2;DNMT3B;GATAD2A;EHMT1
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.6813051538056681,-1.2988572829363048,0.1388888888888889,0.9917644876409251,1.0,9/17,19.82%,FOS;TEX15;DMAP1;BEND3;DNMT1;EHMT2;DNMT3B;GATAD2A;EHMT1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.7874470378891304,1.29871920001005,0.12903225806451613,1.0,1.0,3/11,12.89%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.7874470378891304,1.29871920001005,0.12903225806451613,1.0,1.0,3/11,12.89%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.8195648858302789,1.2983822528923807,0.16666666666666666,1.0,1.0,2/7,6.53%,OSMR;PTGER3
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.8126437118425907,1.2983230018601275,0.11320754716981132,1.0,1.0,2/8,13.25%,ACTA2;HTR2B
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.818011636237102,1.2981533412571862,0.11475409836065574,1.0,1.0,3/10,7.55%,CLEC2A;CORO1A;TUBB
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.7827476869289731,-1.2977718662118938,0.20833333333333334,0.9957673480714453,1.0,1/8,0.35%,KIT
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),0.781650752321429,1.2974199132068116,0.09090909090909091,1.0,1.0,4/5,20.72%,CCL5;PODXL;CXCL13;SKAP1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.7325370955872079,1.2970391752643462,0.07462686567164178,1.0,1.0,5/15,13.98%,CAV3;TCAF2;HECW1;CAMK2D;PLN
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.8362014253397773,1.2968163059249624,0.11363636363636363,1.0,1.0,3/5,8.09%,HLA-DMA;HLA-DMB;TAPBPL
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.8429871324091465,-1.296458754923236,0.1590909090909091,0.9996869123460767,1.0,1/5,4.14%,SFRP1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.759750566383277,1.2964386897012246,0.15625,1.0,1.0,4/12,14.99%,TCP1;CCT6A;CCT8;GNL3
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.7762184851168847,1.296311756503661,0.12903225806451613,1.0,1.0,4/10,18.08%,NOTCH1;FGFR2;PIM1;ZFPM2
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.6141057237596322,1.2961891258484552,0.16923076923076924,1.0,1.0,13/30,20.00%,NSDHL;HMGCR;G6PD;HMGCS1;SQLE;MSMO1;INSIG2;DHCR7;FAXDC2;DHCR24;INSIG1;ACAA2;PRKAG2
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.8049282570361347,1.2961052325923064,0.11475409836065574,1.0,1.0,1/8,3.14%,PRDX4
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.879082038159219,-1.296075074663662,0.15789473684210525,0.9990564332372078,1.0,2/6,6.66%,UBASH3B;FOXP1
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.7809710408186987,-1.2958868796363494,0.125,0.9977073512494523,1.0,2/9,5.05%,VCAN;ARSB
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6975283637238822,-1.2957293340305875,0.09375,0.9964902423888075,1.0,1/10,0.75%,PKP2
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.5958550290038709,-1.2956118076298007,0.20588235294117646,0.9949045257194035,1.0,2/25,1.52%,F11;PRSS12
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.5483224233796116,-1.2956081634575682,0.13793103448275862,0.9924857602110528,1.0,9/44,11.11%,PTPN9;MYLIP;PRAG1;RTN4R;SPOCK1;SPRY3;APOE;STMN2;PTPRS
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.7093612400167786,-1.2949605442644831,0.23076923076923078,0.9933723530240237,1.0,2/10,11.83%,ETS1;MDK
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),0.8364253979153337,1.2949573655612154,0.1,1.0,1.0,3/5,15.41%,HSD17B2;CYP19A1;HSD17B11
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.5975380079652257,-1.2947557387832385,0.15789473684210525,0.9921470894617228,1.0,1/24,0.14%,PER2
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.8334454213967991,1.2946491268933444,0.1774193548387097,1.0,1.0,1/7,9.02%,RHOB
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7193120425822322,1.2945376683976246,0.15254237288135594,1.0,1.0,4/14,22.15%,FKBP1B;CAMK2D;CALM3;RYR2
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.45282574061396375,-1.2945088894392183,0.043478260869565216,0.9910824680264061,1.0,30/148,19.78%,STK32B;CAMK1G;NEK6;SGK1;MARK1;PRKCD;PLK2;AURKA;TAF1;SBK1;CSNK1G2;MAP3K10;MAST2;PRKCE;TLK2;MAPK12;TGFBR1;ATM;LATS1;MAST4;ULK3;MARK3;PRKCB;VRK1;DMPK;PKN2;MTOR;MKNK2;STK38;LATS2
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.6140891449110603,1.2944742854170983,0.14492753623188406,1.0,1.0,12/51,12.19%,ENPP2;PLA2G10;PLA2G7;ERAP2;ELANE;TST;LVRN;SIAH1;ENPEP;IL4I1;NAALADL1;CLPX
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.44911310289083445,-1.2944262337216172,0.0,0.9890979352078998,1.0,31/158,19.78%,STK32B;CAMK1G;NEK6;SGK1;MARK1;PARP2;PRKCD;PLK2;AURKA;TAF1;SBK1;CSNK1G2;MAP3K10;MAST2;PRKCE;TLK2;MAPK12;TGFBR1;ATM;LATS1;MAST4;ULK3;MARK3;PRKCB;VRK1;DMPK;PKN2;MTOR;MKNK2;STK38;LATS2
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.625568799247876,1.2943387773344253,0.16393442622950818,1.0,1.0,11/28,17.53%,NSDHL;HMGCR;G6PD;HMGCS1;SQLE;MSMO1;INSIG2;DHCR7;DHCR24;INSIG1;ACAA2
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.8461019465189944,1.2940155519934131,0.16981132075471697,1.0,1.0,1/5,7.37%,YBX3
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.7382996550623633,1.2936786265505014,0.2033898305084746,1.0,1.0,3/9,9.36%,TBXA2R;AVPR1A;SMTNL1
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.6980327166799872,1.2928569994830321,0.10344827586206896,1.0,1.0,6/19,15.63%,DNAH3;CFAP54;CCDC39;DNAH8;DNAH7;DNAI3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.6919449589966997,-1.2927509949995544,0.125,0.9933516657359188,1.0,4/14,6.58%,UNC5B;EYA4;BCL2;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.6919449589966997,-1.2927509949995544,0.125,0.9933516657359188,1.0,4/14,6.58%,UNC5B;EYA4;BCL2;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.8381267322157375,1.2926934105374606,0.13725490196078433,1.0,1.0,3/5,11.87%,NOTCH1;DRD3;DAAM2
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.7418398857400333,-1.2924170011354383,0.20512820512820512,0.992478202585111,1.0,3/10,9.89%,DGKB;DGKD;DGKH
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),-0.8176683068150311,-1.2922337553698031,0.15555555555555556,0.9909677261804103,1.0,4/6,11.39%,SLC22A2;SLC7A1;SLC25A29;SLC7A2
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),0.7256852558312203,1.2921540954484148,0.14925373134328357,1.0,1.0,3/14,11.98%,PRDX4;NOX1;ACOX1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),-0.5739042656792104,-1.2921259875257407,0.0625,0.989099063462501,1.0,6/44,9.34%,PER2;PRDM5;HDAC5;HDAC1;TBL1Y;SIN3B
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.6563194665168495,-1.2920719048811324,0.15789473684210525,0.9870267727066059,1.0,2/14,5.46%,BMP7;PTCH1
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),-0.763218574725153,-1.2920251446302125,0.28125,0.9849039116221695,1.0,2/7,8.04%,FGFR4;NR1H4
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.6880332916976133,-1.2917436384648064,0.13513513513513514,0.9838800281305753,1.0,3/14,6.80%,FGFR4;MELTF;PDPN
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),0.8094495211611308,1.291490374217637,0.13793103448275862,1.0,1.0,2/9,8.00%,WEE2;BUB1B
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.6023847889821405,-1.2914685552763445,0.1,0.9827705852952058,1.0,4/33,3.65%,PER2;G6PC3;RBP4;SLC37A4
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.7472412649752842,-1.2905064788523009,0.2608695652173913,0.9853080872221411,1.0,4/7,19.50%,NVL;POLR1A;NMD3;BYSL
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.5064217533481166,-1.2896862584052102,0.07142857142857142,0.9864523083512803,1.0,22/128,11.11%,GPC4;SELP;PTPRT;IGSF11;CDH13;CDH26;CDH6;AMIGO1;NTNG1;CLDN4;CNTN6;SDK1;LRFN4;DSCAML1;TGFB2;CDHR3;ADGRL1;TENM4;FGFRL1;PCDHB4;CDH1;PTPRS
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.7247761262586973,1.2895056371186302,0.21311475409836064,1.0,1.0,1/8,0.21%,APOLD1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.5563544643316063,1.289491254946686,0.13432835820895522,1.0,1.0,16/125,9.34%,NPY;LRP4;PPP1R1B;CD82;CTHRC1;PLP1;CHST1;SCN4B;TST;SOX10;AGT;IGFBP5;CPE;CNTN2;TMEM178A;SCN7A
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.5816931703263207,-1.2892223298376937,0.16216216216216217,0.9863031268066035,1.0,7/24,9.61%,ATOH8;FOS;APLN;ETS1;TGFB2;STAT3;SMARCA4
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.6748533912919872,-1.2889938587973317,0.2222222222222222,0.9851088642041507,1.0,3/10,3.34%,KIT;KDR;KITLG
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.8372994770420277,1.2889761340632704,0.13043478260869565,1.0,1.0,1/6,1.33%,CAV3
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.834964197364153,-1.2887303010556321,0.08333333333333333,0.9837414508966678,1.0,2/7,3.52%,CDK2AP2;PRDM15
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.593826737049155,-1.2887023625633294,0.13953488372093023,0.9816668474562443,1.0,2/28,2.20%,CD38;EPHB2
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.7733276234601487,-1.2878723417142663,0.24444444444444444,0.9836961362509007,1.0,2/6,11.56%,ADARB2;ADAT2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.7799136987851316,1.2878453234077447,0.09836065573770492,1.0,1.0,3/11,12.89%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.622695232707339,1.2877616448256948,0.11267605633802817,1.0,1.0,8/34,8.66%,TIMP3;TIMP2;SERPINF1;AGT;SERPINA10;KNG1;SERPINI2;SPOCK3
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.755119179521657,1.2869903100787656,0.18032786885245902,1.0,1.0,2/11,4.69%,CCL5;DOCK8
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.8601138275010979,1.286523002119086,0.10909090909090909,1.0,1.0,3/6,12.25%,ALDH1A1;ALDH2;ADH5
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.5872059556481191,-1.2863733123034329,0.15151515151515152,0.9893265965894716,1.0,4/36,2.80%,PTPN3;BTC;RNF126;EREG
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.6693564581080292,-1.2863447258539324,0.21951219512195122,0.987076343016698,1.0,3/16,3.70%,BMP7;ASCL1;DTX1
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.6637942145272945,1.2862155464697498,0.21666666666666667,1.0,1.0,5/22,11.52%,IL15;STAT4;STAT1;STAT6;STAT5A
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.6033552220733451,1.2860857410840743,0.13846153846153847,1.0,1.0,8/39,15.76%,MARVELD2;CTNNA1;MARVELD3;F11R;CLDN10;ECT2;CLDN20;MPP7
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.7294143045796067,-1.286051173147012,0.14285714285714285,0.9863390121027733,1.0,4/9,19.46%,SMPD3;SGMS2;SMPD4;SGMS1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.5975867681067192,-1.2858738280622608,0.18421052631578946,0.9850761721300022,1.0,6/30,9.53%,FGFR4;XRCC4;CHTOP;APOA1;NCSTN;B3GAT3
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.7513295350774943,-1.2857024116738252,0.22727272727272727,0.9837606235259512,1.0,3/6,12.80%,SLC25A37;SLC6A9;ABCB10
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.8688941575741463,1.2855382285472232,0.1746031746031746,1.0,1.0,2/5,10.18%,GLI3;FAS
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.8556303196694621,-1.2855200586267905,0.11764705882352941,0.9803016985538238,1.0,1/7,1.38%,F2RL1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.8556303196694621,-1.2855200586267905,0.11764705882352941,0.9803016985538238,1.0,1/7,1.38%,F2RL1
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),-0.7506697798216808,-1.2852212300446444,0.23809523809523808,0.9794140707364493,1.0,2/6,14.50%,C5AR1;TFCP2
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7204245157304889,1.284706730883812,0.15,1.0,1.0,2/12,4.92%,PDGFRB;PTPRC
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.6018072394083277,-1.2846412481223957,0.10638297872340426,0.9800990552240685,1.0,6/23,18.01%,ECRG4;PRKCD;ID2;HMGA2;PML;ULK3
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.6219740569838476,-1.2846338800325938,0.1935483870967742,0.9778250434950103,1.0,4/20,5.82%,F2RL1;RBP4;EPHB2;SPHK2
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.8356311544384792,1.2845628075439315,0.15384615384615385,1.0,1.0,1/6,4.92%,PTPRC
prerank,PanglaoDB_Augmented_2021__Basophils,0.5648375620396383,1.2844842692374216,0.0958904109589041,1.0,1.0,17/81,12.63%,C3AR1;MS4A6A;P2RY1;CD4;FGL2;STAB1;HCK;CD300LF;NFIL3;CD14;DNASE2B;SIGLEC1;HGF;MYO1F;AQP9;FADS2;GPR183
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.62405020604537,1.2844229504145546,0.16071428571428573,1.0,1.0,9/38,7.55%,MS4A6A;FGL2;HCK;CD300LF;PTPRC;MXD1;CD14;NREP;TUBB
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.5187474971611524,-1.2843772932867947,0.11764705882352941,0.9768047551367418,1.0,12/76,10.37%,ADAM19;ADAMTS3;CPXM2;LMF2;TYSND1;SRGN;PTCH1;ECE1;LMF1;NCSTN;MME;SORL1
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),-0.7952002680201324,-1.2836272167607445,0.20930232558139536,0.9777217779375716,1.0,2/6,15.14%,PUSL1;RPUSD4
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.7577485350633543,-1.2833757192092083,0.20454545454545456,0.9771668819692588,1.0,2/7,7.61%,PPP1R3B;PPP1R3E
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.7904702847730086,1.2833450916046625,0.11475409836065574,1.0,1.0,3/10,12.89%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.735416981981508,1.2833439422765833,0.1774193548387097,1.0,1.0,3/7,21.25%,ACMSD;TGFB1;CLTC
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.7177069421324538,1.2833145625408282,0.1509433962264151,1.0,1.0,3/13,12.75%,PHKG1;PHKA1;AGL
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),0.8419814603095166,1.2830775309076592,0.13793103448275862,1.0,1.0,2/5,10.26%,HMGCR;LRPAP1
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.5465744696175892,-1.282941078571479,0.17142857142857143,0.9770739313961259,1.0,5/58,6.01%,SHC3;NRG1;BTC;EREG;DGKD
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.4847315949784402,-1.282684029219639,0.12121212121212122,0.9761506650581284,1.0,11/92,9.21%,ITGB5;FOS;ZMIZ2;SFRP1;PDE3A;MAPK7;GCNT2;APOA1;TGFB2;CILP;TGFB3
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.5017822907092913,-1.2826705824714713,0.16129032258064516,0.9739454914045297,1.0,12/65,12.85%,GLYATL2;ABHD1;EHHADH;NUDT7;ACOT8;CROT;MECR;ABCD1;ACADVL;HADHA;SLC27A2;SLC25A17
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),-0.7719610113326216,-1.2826618467233923,0.1875,0.9695937336653434,1.0,2/5,16.86%,DRD1;NR4A3
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),-0.7719610113326216,-1.2826618467233923,0.1875,0.9695937336653434,1.0,2/5,16.86%,DRD1;NR4A3
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.8708810108956961,-1.2817804483371391,0.19444444444444445,0.9720170067364978,1.0,3/6,4.14%,UBASH3B;GREM1;SFRP1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),-0.7655821112190999,-1.2815399197146728,0.21951219512195122,0.9708891032757481,1.0,4/6,19.90%,SGPP2;NR4A3;NR4A1;NUPR1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.8592426351179434,1.2810578840295994,0.10344827586206896,1.0,1.0,1/6,5.21%,ACSL5
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.5648655396852189,-1.2809309887558717,0.15151515151515152,0.971066144645204,1.0,11/38,14.10%,STAC;KCNJ16;AMIGO1;KCNN3;ACE2;KCNE1;KCNN2;NOS1AP;KCNJ6;GABBR2;KCNJ2
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.7327334877027425,-1.2805026362789547,0.23076923076923078,0.9706785141152302,1.0,2/9,6.90%,KIT;IL11
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7374062180922275,1.2804079689123635,0.15254237288135594,1.0,1.0,1/12,2.44%,STK26
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7374062180922275,1.2804079689123635,0.15254237288135594,1.0,1.0,1/12,2.44%,STK26
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.711335965346519,-1.2803278620521703,0.28205128205128205,0.9696175065100535,1.0,4/11,26.24%,TMEM230;DNM2;RAB27A;KIF5C
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.7473857148695654,1.2802803800858338,0.140625,1.0,1.0,1/9,1.97%,CCL5
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.7215172037568299,-1.280105774312653,0.21052631578947367,0.9686174013140479,1.0,3/9,8.51%,SRM;SLC22A3;SLC29A4
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.6144957393802688,-1.2798172150305909,0.1875,0.9677618008323229,1.0,4/22,8.59%,NMNAT3;PNP;ENPP3;CTPS2
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.6504966342212652,1.2798058022129837,0.14516129032258066,1.0,1.0,3/22,9.60%,NOX5;ATP12A;SLC36A1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.6382116551763486,-1.2792288129048333,0.16666666666666666,0.9687541569002649,1.0,9/21,15.62%,SULF2;HS3ST4;HS3ST3B1;EXT1;B3GAT3;HS3ST5;EXT2;SGSH;XYLT2
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.8280848176269404,-1.2789255032328462,0.20454545454545456,0.9680135866844304,1.0,3/6,9.23%,ERCC8;ZBTB7A;XRCC6
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.7908055543190726,-1.2786353484776838,0.2727272727272727,0.9629868415406456,1.0,1/5,1.12%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.7908055543190726,-1.2786353484776838,0.2727272727272727,0.9629868415406456,1.0,1/5,1.12%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.7908055543190726,-1.2786353484776838,0.2727272727272727,0.9629868415406456,1.0,1/5,1.12%,TACR1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.5790026878954587,1.2785499633538162,0.17391304347826086,1.0,1.0,2/53,1.31%,ENPP2;PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.7386749043644447,1.2784988443114191,0.15,1.0,1.0,2/11,4.33%,TRIM5;TRIM32
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.6253828328258767,-1.2778401763296425,0.18181818181818182,0.9641722100599148,1.0,4/14,16.29%,TIMELESS;MTR;SPIDR;DDX11
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.5464108873300036,-1.277516420869305,0.1388888888888889,0.9638910686583986,1.0,4/48,4.28%,NRK;BMP7;NYAP2;SGK1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.8385527746684021,1.2770577548581528,0.21818181818181817,1.0,1.0,1/5,1.38%,LDLRAP1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.7174002630156846,-1.276890864802394,0.15517241379310345,0.9649591814994785,1.0,4/12,16.84%,ZC3H12B;POP1;ZC3H12C;LACTB2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.8335578236598112,1.2766904597574253,0.17307692307692307,1.0,1.0,1/7,1.31%,PLA2G10
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),-0.8399754764993729,-1.275513795868363,0.24444444444444444,0.9698930581509141,1.0,3/5,11.39%,SLC7A1;SLC25A29;SLC7A2
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.7544578894116725,-1.2754612134962535,0.175,0.9680399983399564,1.0,1/6,6.10%,PRKCD
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.691785538655718,1.2753202123911855,0.203125,1.0,1.0,1/14,1.31%,PLA2G10
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.7935734734688984,1.2750700624756064,0.2033898305084746,1.0,1.0,3/6,9.36%,IL21R;STAT4;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.7935734734688984,1.2750700624756064,0.2033898305084746,1.0,1.0,3/6,9.36%,IL21R;STAT4;STAT1
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.7060701768424068,-1.27424509310967,0.2916666666666667,0.9722349629356717,1.0,3/7,15.54%,PLIN5;CIDEA;OSBPL11
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.7563583556298269,-1.2742222069155615,0.17073170731707318,0.9682435426307642,1.0,2/11,1.84%,MELTF;SPRY4
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.7563583556298269,-1.2742222069155615,0.17073170731707318,0.9682435426307642,1.0,2/11,1.84%,MELTF;SPRY4
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.5896350809237919,1.2738635662350317,0.14705882352941177,1.0,1.0,9/37,9.82%,AGER;CCL5;IL15;HLA-DMB;PTPRC;FADD;PDCD1LG2;HHLA2;CD6
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.7707116340602649,-1.2735303862639014,0.175,0.9700485090483068,1.0,2/8,7.64%,TPP1;SHANK1
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.831654476084478,-1.2734047238014239,0.20408163265306123,0.96862160221932,1.0,1/5,0.56%,UBASH3B
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.5258835779953914,-1.2733465889810602,0.12903225806451613,0.9667412918843938,1.0,11/59,12.03%,P2RY10;F2RL1;PRAG1;HEG1;RTN4R;APOA1;KCTD13;APOE;RIPOR2;NRP1;GPR35
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.686154470848684,-1.2730610815288543,0.17142857142857143,0.9661099889548652,1.0,1/10,0.83%,MYB
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.7669788377825566,1.2729866804030734,0.1896551724137931,1.0,1.0,2/10,3.71%,CAV3;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),-0.7416860355240692,-1.272948419411764,0.1794871794871795,0.9646738783805014,1.0,2/9,2.80%,NFATC1;EREG
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.7847875663466205,-1.272531952157436,0.2682926829268293,0.9645869315543519,1.0,3/6,19.42%,JADE2;MEAF6;KAT7
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.620144836412657,-1.2723867353652927,0.21428571428571427,0.9632942634064396,1.0,1/9,2.23%,MT1E
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.7418734789070324,-1.2723112149690512,0.18421052631578946,0.961552471281854,1.0,4/14,9.22%,PNP;ITPA;SAMHD1;DNPH1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.6557492063149151,1.2722516530033996,0.1,1.0,1.0,2/28,1.47%,MYLK;RREB1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.8227991846684213,-1.2720369332960906,0.12195121951219512,0.9606721246576586,1.0,3/5,16.47%,TGFB2;ACVR1;TGFBR1
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.5183220199501342,1.2713254636818985,0.07462686567164178,1.0,1.0,26/125,12.38%,ITK;CD4;CCL5;STAB1;CD8A;ELANE;IL15;HLA-DMA;INHBA;CCND2;HLA-DMB;PTPRC;FYB1;STAT4;HLA-A;WAS;MAP4K1;IL7;STAT1;GCNT1;FAS;TGFB1;BRCA1;RPL9;RIPK2;IGSF6
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.6548769036687266,1.2710215763424915,0.15254237288135594,1.0,1.0,1/28,0.03%,NPY
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.8210010507564498,1.2708385677537706,0.10344827586206896,1.0,1.0,2/7,3.71%,CAV3;NOTCH1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.5997121430976324,-1.2703013166968684,0.21052631578947367,0.9673852696056231,1.0,7/27,21.89%,ARL13B;PCM1;RPGRIP1L;PIBF1;TBC1D32;TMEM216;CEP89
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.7808255425910341,1.2702632522774127,0.2222222222222222,1.0,1.0,1/10,1.72%,CD4
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.736783924031429,1.270034649090475,0.12698412698412698,1.0,1.0,4/14,8.05%,P2RY12;PTPRC;ITGA11;VEGFC
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.8276925391401091,1.2699920698392637,0.16363636363636364,1.0,1.0,3/5,15.18%,SLC52A2;SLC52A1;RFK
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.8276925391401091,1.2699920698392637,0.16363636363636364,1.0,1.0,3/5,15.18%,SLC52A2;SLC52A1;RFK
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.6600425932587327,-1.2698308645807013,0.13157894736842105,0.9676920887782754,1.0,2/17,4.52%,NRG1;MYH11
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.5987180104151083,1.269792323159552,0.13043478260869565,1.0,1.0,15/41,18.94%,TLL1;MMP15;ADAMTS4;ELANE;TIMP2;BMP1;CAPN1;CTSK;KIF9;A2M;FURIN;MMP16;MMP19;SCUBE3;TLL2
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.7599193641941583,-1.2695354733750703,0.21428571428571427,0.9669899372101823,1.0,1/8,0.14%,PER2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.7254416301292557,1.2693659841254719,0.18032786885245902,1.0,1.0,1/16,1.38%,LDLRAP1
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.5227844875772445,-1.2692939258931084,0.047619047619047616,0.966026146910695,1.0,12/93,4.62%,RNF150;FBXL7;PDE10A;SLC16A2;LAMA4;PCDH18;ZNF462;CACNA2D1;SFRP1;WWTR1;NTM;RASSF8
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.6008870156976304,1.2689177950281476,0.15625,1.0,1.0,5/41,1.97%,MYLK;CAV3;CD4;WFS1;CCL5
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.800763327249264,1.2685345355072348,0.18333333333333332,1.0,1.0,1/8,0.55%,MYLK
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.812500587994072,-1.2681986815231086,0.22,0.9672200359260167,1.0,2/5,14.21%,VPS25;SNF8
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.812500587994072,-1.2681986815231086,0.22,0.9672200359260167,1.0,2/5,14.21%,VPS25;SNF8
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.7913877365293353,-1.2680660979770964,0.29545454545454547,0.9655781972746594,1.0,2/5,8.06%,APIP;MRI1
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.8125234186552763,1.2680113216646218,0.16393442622950818,1.0,1.0,2/7,7.87%,C3AR1;CMKLR1
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5855718477454591,-1.2679916714385588,0.08333333333333333,0.9639432571050305,1.0,3/24,5.22%,RTP5;CYB5A;EMD
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.48946104889799324,-1.2679195366072655,0.125,0.9621580678991892,1.0,16/135,6.10%,SPRED2;SPRED3;UBASH3B;SPRED1;TRIB2;RASSF2;PID1;PRR5L;GREM1;EPHB2;PRKRIP1;PMEPA1;SFRP1;WWTR1;ZBED3;PRKCD
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.6730257441732437,-1.2678676806696667,0.20512820512820512,0.9603280896170735,1.0,4/14,7.09%,BMP7;NRG1;RBP4;TGFB2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),-0.7972276771507463,-1.2674758962102481,0.23809523809523808,0.9607221011545297,1.0,1/6,3.53%,IGF1
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.6138759614202038,1.26699525240562,0.18055555555555555,1.0,1.0,4/32,7.34%,SLC12A7;TRPV6;WFS1;FAM20A
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.5519576183238614,1.2667768200520377,0.14492753623188406,1.0,1.0,14/76,8.07%,ENPP2;MYLK;ANKS4B;SLC38A11;TRPA1;SSTR1;ANGPTL2;AGT;GABRA2;GIPC2;PPARGC1A;CNTN3;SLC17A8;ALDOB
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.7033394397329022,-1.266733871177821,0.175,0.9620772247316434,1.0,2/11,2.70%,NOX4;SGCD
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),0.8947851084647148,1.266614384931968,0.06349206349206349,1.0,1.0,1/5,0.48%,NOX5
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.8127011525500643,-1.2664328951425234,0.21951219512195122,0.9614532767739419,1.0,3/6,9.96%,RUNX1;CBFB;TARM1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.8270403785560724,1.2663986180930786,0.12727272727272726,1.0,1.0,3/7,12.63%,CCL5;EPS8;GPR183
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),0.715345516253874,1.2663927252653198,0.24,1.0,1.0,1/11,3.54%,KNL1
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.8224763016309072,1.2662427297686827,0.1896551724137931,1.0,1.0,2/5,12.63%,CCL5;GPR183
prerank,PanglaoDB_Augmented_2021__Microglia,0.5489474942502486,1.2651184112695937,0.09859154929577464,1.0,1.0,21/79,12.63%,C3AR1;MS4A6A;IL21R;SLCO2B1;CD4;FGL2;HPGDS;HCK;CD300LF;PIK3R5;P2RY12;PTPRC;TAGAP;CD14;SIGLEC1;MAFB;MYO1F;C1QA;AQP9;IGSF6;GPR183
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.5251796644371484,-1.2649838668494524,0.1111111111111111,0.9661439605074775,1.0,11/60,12.59%,CPSF1;TRPT1;LCMT2;TRDMT1;TRMT10C;WDR4;POP1;SARS1;ADAT2;TRMT61A;FARS2
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.7812536797878569,-1.2649570944389876,0.2653061224489796,0.9642470974706954,1.0,2/6,13.13%,LIN28B;DIS3L2
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.8160627520859132,-1.2646845898169288,0.23255813953488372,0.9595799115228743,1.0,3/5,12.49%,XYLB;SORD;DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.8160627520859132,-1.2646845898169288,0.23255813953488372,0.9595799115228743,1.0,3/5,12.49%,XYLB;SORD;DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.8160627520859132,-1.2646845898169288,0.23255813953488372,0.9595799115228743,1.0,3/5,12.49%,XYLB;SORD;DCXR
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.6464835182680135,-1.2646019670755282,0.1875,0.9579172779082994,1.0,2/16,1.59%,TSPAN12;ADAMTS3
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.8795276618892183,1.264222250766814,0.10909090909090909,1.0,1.0,2/5,9.76%,NOTCH1;SOX11
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),0.7817406629946155,1.264101759851911,0.22950819672131148,1.0,1.0,3/6,18.00%,IL18R1;IL18BP;IL18
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),0.7817406629946155,1.264101759851911,0.22950819672131148,1.0,1.0,3/6,18.00%,IL18R1;IL18BP;IL18
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.5987709337578251,1.2635372198450525,0.14925373134328357,1.0,1.0,15/41,18.94%,TLL1;MMP15;ADAMTS4;ELANE;TIMP2;BMP1;CAPN1;CTSK;KIF9;A2M;FURIN;MMP16;MMP19;SCUBE3;TLL2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.8004250901722576,1.2634371576019559,0.22807017543859648,1.0,1.0,1/6,1.33%,CAV3
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.552004703272019,1.2632177117571106,0.14473684210526316,1.0,1.0,9/66,10.56%,AEN;TICRR;NHEJ1;FIGNL1;RAD9B;EYA1;INIP;RHOB;BRCA1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.7616020773748575,1.2627121928733416,0.19047619047619047,1.0,1.0,5/10,15.01%,B3GALT1;B3GNT4;B3GNT3;B3GALNT1;B4GAT1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.6975047197621698,-1.2623378902460185,0.18604651162790697,0.9667037321397908,1.0,6/13,17.39%,SFSWAP;RBMX;U2AF2;SRSF7;PTBP1;PCBP4
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.6576892364217952,-1.262274322284842,0.14705882352941177,0.9651099549299574,1.0,2/15,9.09%,NTNG1;SPRY3
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5947879372594821,-1.2621218387227378,0.15151515151515152,0.9638030657144288,1.0,4/23,3.50%,SPRED2;SPRED3;SPRED1;SMYD2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.8275205807731493,1.2619353195382168,0.13432835820895522,1.0,1.0,2/7,10.18%,CASP8;FAS
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.718393074981294,-1.2615623759598829,0.17073170731707318,0.9637479339770398,1.0,4/11,15.06%,FBLL1;EXOSC10;EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.5461244122792228,-1.2613977340710363,0.16216216216216217,0.9625506685686771,1.0,7/32,10.10%,SPRY4;EPHB2;HEG1;TGFB2;KCTD13;SPRY3;RIPOR2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),0.816904765627915,1.2613334545899342,0.125,1.0,1.0,2/5,9.70%,CAV3;SMAD7
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.767763963637173,1.2610667437550807,0.21311475409836064,1.0,1.0,2/7,3.38%,CHIT1;CTBS
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.7855633452691959,1.2609731387986933,0.1774193548387097,1.0,1.0,5/9,15.01%,B3GALT1;B3GNT4;B3GNT3;B3GALNT1;B4GAT1
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.8360564612301384,1.2607786153849136,0.125,1.0,1.0,2/5,7.08%,PTGIS;LMO3
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.7432140200716573,1.2602862527137155,0.125,1.0,1.0,1/9,3.71%,NOTCH1
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.6003317367396338,-1.2602638751690056,0.16666666666666666,0.9656904146071162,1.0,1/19,0.23%,NOX4
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.5247296731990434,-1.2599102018519348,0.1388888888888889,0.9651767039921605,1.0,17/70,15.17%,BMP7;BCL2L11;NRG1;SDC4;TRABD2A;TPR;RAB7A;ERCC1;SMPD3;LIMK1;CLU;SPIDR;SH3GLB1;FAF1;SNF8;TSG101;SYNPO2L
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.5653733728907965,-1.2598803377589787,0.15384615384615385,0.9634539389455474,1.0,6/34,10.88%,CDK2AP2;EPHA3;TRIM36;MAPRE1;TRAF3IP1;STMN2
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.9033844140526331,-1.2596224418076751,0.19047619047619047,0.9626194557040414,1.0,1/5,0.39%,RAB7B
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.6937504429235827,-1.2595589271314591,0.21052631578947367,0.9608836383434363,1.0,2/11,11.82%,F2RL1;CSF1R
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.7881039233404888,1.2594434251351356,0.13432835820895522,1.0,1.0,1/10,0.20%,C4BPB
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.6760955467312633,-1.2593577300163463,0.125,0.9599071884281801,1.0,4/13,11.66%,RAD21L1;DSCC1;SMC1A;MAU2
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.5630530159881946,1.2590945936661588,0.16176470588235295,1.0,1.0,10/40,20.77%,CHMP4B;PSRC1;KIF14;CHMP2B;CHMP1A;EML3;RAB11A;CHMP2A;CDCA8;VPS4A
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.6455051483467439,-1.2589948713208658,0.1590909090909091,0.9595603925424151,1.0,3/13,17.95%,PLIN5;SCARB1;NR1H2
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.7674919075924388,1.25866031065898,0.19672131147540983,1.0,1.0,1/8,1.97%,CCL5
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.7674919075924388,1.25866031065898,0.19672131147540983,1.0,1.0,1/8,1.97%,CCL5
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),0.747471246364089,1.2585027388285919,0.25,1.0,1.0,1/9,3.54%,KNL1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.6359716151128222,1.2583033888026145,0.1864406779661017,1.0,1.0,10/25,22.77%,CAV3;SMAD7;KCNQ1;PLN;ATP1B1;CALM3;HCN4;ATP2A2;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.7238152979146477,-1.2580043935919456,0.18181818181818182,0.962487305790273,1.0,2/6,19.81%,PGP;GCK
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.6299321188184718,1.2578989953911552,0.2153846153846154,1.0,1.0,8/34,12.03%,FADD;BNIP3;F11R;CASP8;TMEM150C;FAS;IRF1;PIEZO2
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.6933363855390396,1.2578454587187196,0.20634920634920634,1.0,1.0,3/14,7.87%,CCL5;RARRES2;CMKLR1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.6555493741453657,1.2578042813623107,0.16417910447761194,1.0,1.0,3/24,7.05%,CHRNB1;TMEM204;TBX1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.6338825988491832,-1.257632816308692,0.1568627450980392,0.9627350571237884,1.0,6/18,14.55%,PRKG2;GCH1;SPHK2;GCHFR;PTS;SGPP2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),-0.7334936267783481,-1.257273200176111,0.2916666666666667,0.96211102011486,1.0,2/7,10.42%,PNP;PRTFDC1
prerank,PanglaoDB_Augmented_2021__Monocytes,0.5698287442037346,1.2570990002167255,0.10606060606060606,1.0,1.0,28/78,19.54%,C3AR1;MS4A6A;FGL2;HCK;CD300LF;PTPRC;IDO1;TAGAP;CD14;IFIT3;CMKLR1;MYO1F;AQP9;ADGRE1;IGSF6;RGS1;FN1;PTAFR;LY86;PSAP;PLSCR1;TLR2;NCF2;CX3CR1;IFIT1;HK3;IFITM3;NFKBIZ
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.7553773004721837,-1.2565634326229895,0.2926829268292683,0.963947691136,1.0,1/7,5.82%,SPHK2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.5000039268199229,-1.25608809031577,0.2,0.9638689131857721,1.0,8/43,8.46%,RAB7B;F2RL1;IFIH1;EREG;SPHK2;TLR1;STAT3;POU2F2
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.7761292654709583,1.2558044676494526,0.14035087719298245,1.0,1.0,2/8,10.32%,HENMT1;MRPL44
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.7970895488032047,1.2556494800910687,0.18461538461538463,1.0,1.0,5/8,18.53%,PLA2G10;SERPINA10;SPINK13;GLRA1;CACNA1H
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),-0.7583290822852358,-1.2547125330832156,0.21739130434782608,0.9678465336896215,1.0,4/6,10.05%,SLC22A3;SLC29A4;SLC6A4;SLC6A2
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),-0.8478559291568315,-1.2542780884955258,0.21951219512195122,0.9684268125202296,1.0,2/5,6.86%,PTPN23;BMP6
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),0.8470554507315862,1.2542444728165483,0.16666666666666666,1.0,1.0,2/5,10.09%,SFRP4;TMEM79
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.7267994564554376,1.2540518299030456,0.2,1.0,1.0,2/11,11.73%,GMNN;ZNF304
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.8571308563423232,1.2533210250476368,0.18181818181818182,1.0,1.0,1/5,1.33%,CAV3
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.6283760764945168,-1.2528468511663275,0.16666666666666666,0.9733405044612372,1.0,1/13,1.38%,F2RL1
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.6190962588128912,-1.2525783517714753,0.1935483870967742,0.9728750643494822,1.0,3/21,2.79%,RASSF2;GREM1;PDGFD
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.7725125076291747,1.2524814942348472,0.2,1.0,1.0,7/10,21.24%,AMBP;FADD;GPER1;SPINK5;CD200;FCRLB;LYN
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.4950267497679486,-1.252127774329913,0.1,0.9728776727062863,1.0,18/110,10.88%,ETV1;RIMBP2;PTPRT;PCDH19;NFIB;ID4;SLC6A1;UNC5C;SST;SERTM1;MAPK4;ADGRA1;ARX;CMTM8;TMEM196;FGF14;PCDHB4;STMN2
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.8332089437116996,1.2521215819682765,0.1694915254237288,1.0,1.0,2/5,11.89%,AHR;IL4I1
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.47386793829941504,-1.2521051421295173,0.08823529411764706,0.9711170079962984,1.0,20/114,9.91%,CNGA3;RNF150;RIMBP2;PENK;PCDH18;SGCD;CACNA2D1;NTM;SEZ6L2;ZNF385D;SST;ZNF536;GRIA4;TMEM196;GRIA1;RAB3C;COL11A1;PDGFRA;GAD2;FGF14
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.6215209959643867,-1.2513479364450413,0.09302325581395349,0.9722718128816822,1.0,6/17,13.65%,GCH1;S100A1;DHFR;APOE;SCARB1;NOS1AP
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.5273751388572149,1.2512296735425392,0.0958904109589041,1.0,1.0,22/80,12.26%,ADAM28;MS4A6A;ALDH1A1;SLCO2B1;CLIC6;FGL2;CD302;CP;OMG;HLA-DMB;TEX26;CPM;CD14;FAM20A;ANKUB1;SOD2;SLC31A1;C1QA;L3MBTL4;APOBEC4;ALDH2;AQP9
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.6527330029605007,-1.2511400124881502,0.21052631578947367,0.9713486084374149,1.0,3/14,3.85%,NEK6;PTTG1;TPR
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.6847654877265782,-1.2510352194882355,0.2564102564102564,0.969771646470988,1.0,1/11,3.42%,AGBL1
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.619496909268415,1.2508512306182606,0.23076923076923078,1.0,1.0,2/20,5.59%,PPP1R1B;FKBP1B
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.6365300423815229,-1.2506387876600906,0.2,0.9697559680528095,1.0,3/12,8.51%,SLC22A2;SLC22A3;SLC29A4
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.74201992341395,-1.2500964938388222,0.15789473684210525,0.9705164144244753,1.0,1/9,0.63%,KDR
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),-0.8424379055539699,-1.2500293670177052,0.2857142857142857,0.9690228486115727,1.0,2/5,5.55%,ASCL1;TOX
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),0.7824210223128538,1.2497831659361618,0.17857142857142858,1.0,1.0,1/6,5.47%,GBA3
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),0.7824210223128538,1.2497831659361618,0.17857142857142858,1.0,1.0,1/6,5.47%,GBA3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.8290068742265659,1.249358932173635,0.2641509433962264,1.0,1.0,4/5,16.60%,NOTCH1;AGT;TGFB1;RGCC
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.5570196072960389,1.249174486713545,0.14492753623188406,1.0,1.0,20/65,18.82%,TMEM97;NSDHL;ATF5;FASN;NFIL3;AVPR1A;HMGCR;SCD;HMGCS1;PLAUR;ANTXR2;SQLE;FADS2;LGMN;DHCR7;STARD4;GLDC;PLSCR1;PPARG;PNRC1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.5147013182386423,-1.2491345585537066,0.11428571428571428,0.9708447311106202,1.0,5/54,3.33%,SPRED2;SPRED3;SPRED1;LTBP1;PMEPA1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.6608902874775259,1.2488883500878465,0.22950819672131148,1.0,1.0,7/18,19.54%,PLA2G10;SPHK1;CD74;PJA2;GPR137B;CD200;LBP
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.7784382629243183,1.2488766382049812,0.08771929824561403,1.0,1.0,3/13,4.31%,RDH10;BCO1;CYP1B1
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.7220389175498909,-1.2488335345103767,0.3,0.9703207598003363,1.0,2/5,6.72%,TPR;NUMA1
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.7011014822794769,-1.248794341997518,0.17073170731707318,0.9687158788812403,1.0,1/9,0.23%,NOX4
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.6435114008051146,1.2481842918176294,0.21875,1.0,1.0,6/29,12.53%,SEMA3D;ELANE;NOTCH1;ANGPT2;SEMA3F;SEMA3A
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.5052685552267819,1.2480526003022048,0.11428571428571428,1.0,1.0,30/131,14.20%,C3AR1;IL18R1;NDP;CCL5;KCNA3;STAB1;CD82;ITGA5;OPRK1;IL15;INHBA;PIK3R5;AHR;OSMR;NAMPT;MXD1;CD14;CMKLR1;SLC31A1;PLAUR;SLC28A2;IRF1;RIPK2;AQP9;ADGRE1;RGS1;GPR183;RNF144B;PCDH7;SPHK1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6865715519569942,1.2476490418668698,0.16923076923076924,1.0,1.0,3/14,5.11%,ACKR3;TRIM32;CDKN2D
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),-0.7436671673693949,-1.2476007659131845,0.175,0.9724013076114337,1.0,2/8,12.44%,PCGF1;PCGF6
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.5898497438736319,1.2472134679217495,0.18461538461538463,1.0,1.0,12/67,10.23%,TUBB1;GYPB;NR1I3;UROD;CD300LF;KCNN4;GMFG;CA1;ARG1;HEMGN;MYO1F;RHD
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),-0.7990731523496114,-1.2468555106607957,0.2391304347826087,0.9740588817427105,1.0,2/6,15.06%,LIN28B;PNPT1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.6972209084995646,1.246776779353834,0.1875,1.0,1.0,2/17,2.72%,CAV3;PDGFRB
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.59519558094616,1.246653436023366,0.1791044776119403,1.0,1.0,8/44,9.35%,ALDH1A1;BTN2A2;IL18R1;NOTCH1;IL15;TLE3;ARRDC3;ACOT13
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.7290588175761706,-1.2465673738982062,0.3125,0.973389207489891,1.0,4/8,20.94%,APOE;SIN3A;DNM2;NRCAM
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.8364399499076256,-1.24480342970706,0.275,0.9782147309209188,1.0,1/5,1.89%,CA2
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.596874501963923,1.244602558844803,0.14492753623188406,1.0,1.0,11/53,7.95%,C3AR1;CCL5;HCK;CD300LF;PIK3R5;PTPRC;ARHGAP9;GMFG;TAGAP;WAS;ARHGAP25
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7993295830783639,1.2445362901790569,0.24561403508771928,1.0,1.0,1/6,6.67%,PPARGC1A
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),0.752257421036935,1.2443594283378971,0.208955223880597,1.0,1.0,3/7,15.92%,ATP5IF1;DNAJA1;PINK1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6627618371100531,-1.2443223985826346,0.20512820512820512,0.9784930998679928,1.0,4/15,17.21%,PNKP;SHLD1;KMT5B;DTX3L
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.7831989483553342,1.2437259028597583,0.25,1.0,1.0,1/6,3.39%,POLE3
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.8119348443332524,-1.2435246251173406,0.2,0.9796268503117924,1.0,2/5,16.87%,XRCC6;ATM
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.7212569941901692,-1.2435100422566758,0.20408163265306123,0.9778119315029694,1.0,5/12,14.33%,PRKG2;GCH1;GCHFR;PTS;MTHFD1L
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),-0.7469937417815549,-1.2433316145438447,0.22448979591836735,0.9767622930500306,1.0,4/6,24.90%,MACROH2A2;LRWD1;MACROH2A1;RUVBL2
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.5308087238748531,-1.243249745405463,0.18604651162790697,0.9752908425991152,1.0,14/35,22.18%,IARS1;VARS1;RARS1;SARS1;WARS2;FARS2;QRSL1;FARSB;RARS2;YARS2;MARS1;HARS2;LARS2;FARSA
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),-0.6769985636365526,-1.2431586084925073,0.19444444444444445,0.9738249552879008,1.0,2/10,12.56%,ZMIZ2;SERTAD2
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.8410841922667637,1.2429107927294951,0.15789473684210525,1.0,1.0,2/5,12.08%,CD4;NPR2
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.8410841922667637,1.2429107927294951,0.15789473684210525,1.0,1.0,2/5,12.08%,CD4;NPR2
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.8530043280033622,1.2429010053458622,0.18181818181818182,1.0,1.0,2/5,7.73%,ADRB1;SOD2
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.5349002428095441,-1.2427592446697482,0.20588235294117646,0.9735193149917015,1.0,13/86,4.53%,GPC4;NPNT;RIMBP2;BMP7;PTPRT;TPPP3;FREM1;PCDH19;TNFRSF19;EPHB2;MYH14;ZBTB7C;ID4
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.7205793374717867,1.2427440719358365,0.24528301886792453,1.0,1.0,4/12,13.49%,SLC13A4;SLC26A4;SLC26A7;RACGAP1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.6591794032801599,1.242671399921115,0.2153846153846154,1.0,1.0,4/21,10.21%,NOTCH1;TWIST1;NOTUM;TGFB1
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.7276215661011541,-1.2420452803934203,0.23076923076923078,0.975073003842377,1.0,2/12,4.14%,EPHB2;NFIB
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),-0.776275712301939,-1.2420302584556107,0.17142857142857143,0.9732636368773262,1.0,2/9,7.09%,NRG1;TGFB2
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),0.8034362839893945,1.241752001760817,0.27586206896551724,1.0,1.0,3/5,18.14%,P2RY12;GPR183;CX3CR1
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),-0.8150909675526171,-1.241341451087678,0.1794871794871795,0.9744839137248444,1.0,1/5,0.36%,GLYATL2
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.7955280947372234,1.2409747487040417,0.22033898305084745,1.0,1.0,1/7,1.54%,AGER
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.756857327441206,1.2408654671986614,0.15873015873015872,1.0,1.0,8/10,21.24%,PLA2G10;GPER1;CD74;PLSCR1;PJA2;GPR137B;CD200;LYN
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.7172157273592397,-1.2408154186370273,0.19047619047619047,0.9747640563193443,1.0,2/8,11.07%,MYL5;TNNC2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.7185782697292712,1.2406945509501024,0.24193548387096775,1.0,1.0,1/11,3.33%,ELANE
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.4795506636905554,-1.240679234962953,0.07142857142857142,0.9733622842735837,1.0,18/80,13.53%,STAC;CACNG4;CACNG3;CACNG5;GSG1L;CRH;CNIH3;SHANK1;FGF13;GRIA4;KCNE1;GRIA1;SELENON;FGF14;GRIN2A;CNIH2;KCNS2;GRIA2
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.7845973475205907,1.24035540335483,0.16666666666666666,1.0,1.0,3/9,14.20%,PTPRC;STAP1;SPHK1
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.763854605807406,1.2402242942958248,0.2222222222222222,1.0,1.0,2/9,7.39%,TWIST1;RPS6KA4
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.7235146048296959,1.2401504735943532,0.16981132075471697,1.0,1.0,5/11,15.85%,LPCAT3;VAPB;VCPIP1;ATL1;TRDN
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),0.8341027226154785,1.240081851165792,0.18518518518518517,1.0,1.0,2/5,8.81%,IGSF3;FGFR2
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.7092118299885559,-1.23990079056311,0.21951219512195122,0.9748318672495551,1.0,2/6,19.31%,SRM;HDAC10
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.6656171491211539,-1.2397866133851594,0.30303030303030304,0.9733421559475927,1.0,4/14,5.59%,KDR;F2RL1;CDH13;AZU1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.4659657201410177,-1.2393126316920857,0.13636363636363635,0.973831274737851,1.0,18/109,14.17%,ROR2;EPHA3;FBXW8;AMIGO1;ITGA6;ARSB;TOX;PLXNA1;APOE;NGF;PLXNA2;STMN2;MDK;P3H1;PLPPR5;GPC2;CARMIL2;PLXNC1
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.6750432776449473,-1.2391520924986428,0.2857142857142857,0.9726965294686288,1.0,3/13,9.83%,AASS;CHTOP;TET1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.5502638269385582,-1.2390253577821013,0.21428571428571427,0.9713346947664147,1.0,5/36,7.08%,KIT;INHA;ALAS1;LYAR;ID2
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5816735219648345,-1.2389885591962266,0.16666666666666666,0.9697701163737859,1.0,8/24,18.86%,ERCC2;GTF2H2;ERCC1;CUL4A;DDB2;GTF2H5;XPC;ERCC3
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.6168609850606794,1.238838747864955,0.15517241379310345,1.0,1.0,10/29,24.70%,LDLRAP1;HIP1R;LRPAP1;B2M;TF;PIK3CB;RAB21;HNRNPK;SERPINE1;FLOT1
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.8192110417246286,1.2387775761451174,0.21052631578947367,1.0,1.0,2/6,5.66%,NOTCH1;ZFPM1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.41845311496494525,-1.2386772454399297,0.0,0.9691330661992419,1.0,13/151,5.55%,ROR2;EPHA3;PTPN9;MYLIP;LZTS3;PRAG1;NTNG1;ITGA6;MARK1;ARSB;KNDC1;RTN4R;TOX
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.6844890736847182,1.2384248982236457,0.25,1.0,1.0,3/19,14.30%,WFS1;MYO5B;RAB11A
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.833434331921122,1.238281988743996,0.19642857142857142,1.0,1.0,2/5,12.90%,ANLN;KANK2
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.7283583285728303,-1.2378529462752716,0.2564102564102564,0.971304537331273,1.0,1/11,0.63%,KDR
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.7464048216078093,-1.2376509996406344,0.2727272727272727,0.9704603762623776,1.0,1/7,2.13%,ARL13B
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.7879210002015596,1.2375185076690751,0.15384615384615385,1.0,1.0,1/7,3.56%,DOCK2
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),0.7872799096532987,1.2373322301604455,0.1875,1.0,1.0,1/6,7.41%,MPV17L2
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.789078968999315,1.2372945093687233,0.2807017543859649,1.0,1.0,3/6,20.49%,SLC38A2;SLC38A5;SLC38A3
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.7887069021402211,-1.2372171331542579,0.2926829268292683,0.9688499557760879,1.0,4/7,19.72%,EEFSEC;SECISBP2;DIO2;TRNAU1AP
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.7887069021402211,-1.2372171331542579,0.2926829268292683,0.9688499557760879,1.0,4/7,19.72%,EEFSEC;SECISBP2;DIO2;TRNAU1AP
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.5339766380845767,-1.2367095326053272,0.1794871794871795,0.9694077390386777,1.0,4/40,6.01%,SHC3;BTC;EREG;DGKD
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.6560511589655149,-1.2365904902891354,0.1794871794871795,0.9680262034444506,1.0,5/15,13.50%,KDR;MAPK7;IL11;SCG2;ANGPT1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.6530360861257628,-1.236366017352014,0.21428571428571427,0.9672184520616512,1.0,3/9,16.33%,APOBEC3H;HMGA2;SETDB1
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.46904020279801245,-1.2363435986687599,0.125,0.9655052904340314,1.0,16/131,8.75%,KIT;LTBP1;RUNX1;RND3;FHL2;MT1E;NFIB;BCKDHB;GRK5;MGMT;CACNA1A;VLDLR;RASA2;SLC7A1;SFMBT1;COL11A1
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),0.7700084050262367,1.2359584732809104,0.20689655172413793,1.0,1.0,1/6,1.60%,CFAP54
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.7873214821849845,1.2357747760772835,0.22580645161290322,1.0,1.0,2/6,8.03%,DNAH11;CCDC39
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.733393685740368,1.2356448912225595,0.15384615384615385,1.0,1.0,4/11,13.86%,ALDH4A1;ARG1;GAD1;DAO
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.8146001326123387,-1.2355477571574849,0.21621621621621623,0.9673571406714139,1.0,1/6,4.14%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),-0.7741351379006707,-1.2353301475484808,0.1875,0.96662287054265,1.0,2/6,12.31%,ADAMTS3;SMOC2
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.8530835633284518,1.234787615743209,0.140625,1.0,1.0,1/5,1.54%,AGER
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6296069881722851,1.2344528501518643,0.208955223880597,1.0,1.0,3/18,7.34%,TRPV6;WFS1;FAM20A
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5987407321625141,-1.2344328587756073,0.2571428571428571,0.9688951267650044,1.0,4/15,9.95%,CACNG4;CACNG3;CACNG5;DRD1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.673543108318666,-1.234354900425111,0.2222222222222222,0.9675294789430497,1.0,4/12,15.06%,PRR5L;KHSRP;ZC3HAV1;PNPT1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.591679601250325,-1.2341451416145452,0.09090909090909091,0.9668213714278898,1.0,5/16,16.89%,LYAR;UBTF;POLR2L;SIRT7;WDR75
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.7650178141482117,-1.2340976388405107,0.3157894736842105,0.9651948022206043,1.0,2/5,15.88%,CROCC;ENTR1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.6409105222767415,-1.2340490363934242,0.2222222222222222,0.9637310365814739,1.0,9/21,22.69%,SHANK1;DLG5;LRP8;APOE;DBNL;FOXO6;NEURL1;RELN;PSEN1
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.7252976686964114,1.2339939155613193,0.21568627450980393,1.0,1.0,1/9,4.67%,AHR
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.7252976686964114,1.2339939155613193,0.21568627450980393,1.0,1.0,1/9,4.67%,AHR
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.6671746128013109,1.233969418579158,0.19298245614035087,1.0,1.0,5/20,16.02%,WNT8A;TBX1;ATP6AP2;ACVR2B;PCSK5
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.7305440359579297,-1.2338679087517797,0.2222222222222222,0.9629887771093897,1.0,5/8,17.67%,STAT3;CFAP20;NR4A3;EIF2AK4;SGIP1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.6407297422546795,-1.2338265656775265,0.2558139534883721,0.96135545034129,1.0,2/13,11.82%,ARFIP2;CSF1R
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.6573963637165581,-1.2337065864583876,0.2,0.9603078394532923,1.0,5/11,18.49%,ERCC1;INO80;POLD3;DDB2;XPC
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.7720665478267733,1.2335201190422644,0.25925925925925924,1.0,1.0,1/8,1.45%,TDG
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.6113487547036359,1.233502774691296,0.14705882352941177,1.0,1.0,3/30,5.59%,PPP1R1B;PDGFRB;FKBP1B
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.5716782433532975,-1.2330582297361674,0.15,0.9615348321699091,1.0,5/23,14.52%,PRR5L;EIF4EBP1;SYAP1;MEAK7;RPTOR
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.5520413437159741,-1.2330040054509888,0.14285714285714285,0.9600239303438395,1.0,8/47,14.27%,MDGA1;SH3RF1;MARK1;FGF13;SPOCK1;NRP1;LRP12;DNER
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.8368781971230176,-1.232957619374722,0.2558139534883721,0.9586515018290748,1.0,1/5,3.48%,XRCC4
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.6726360682559152,-1.232240725711207,0.21951219512195122,0.9600520647353329,1.0,3/12,7.81%,SRPK3;PTCD2;IWS1
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.7101596330104508,1.2315833467447266,0.2222222222222222,1.0,1.0,2/9,6.55%,TRIM5;CIITA
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.667298719268392,1.2313565142859217,0.20967741935483872,1.0,1.0,3/19,9.70%,CAV3;MYBPC3;SMAD7
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.8422692704396949,1.2305945401631433,0.18333333333333332,1.0,1.0,1/5,1.33%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.7530631639731555,1.2304769643104034,0.1774193548387097,1.0,1.0,5/11,17.80%,ELANE;WAS;SPOCK3;FBLN1;FRMD5
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.7248577624022788,-1.230108560640771,0.2,0.9682341512767437,1.0,3/10,6.81%,F2RL1;SPHK2;APOA1
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.7098217916668733,-1.2298839964092927,0.2708333333333333,0.9676268275497016,1.0,1/6,0.85%,BCL2L11
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),-0.7955467082484627,-1.22977712665615,0.2564102564102564,0.9664048668760323,1.0,1/5,1.57%,TSPAN12
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.7243738208929409,1.2297223323273263,0.26229508196721313,1.0,1.0,1/9,1.54%,AGER
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.755970499626646,1.229447179998864,0.24561403508771928,1.0,1.0,3/7,13.40%,GM2A;GBA3;NEU1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.4726621046739415,-1.2293335275817774,0.05,0.9662206940682294,1.0,8/86,6.85%,STAC;EPHA3;PTPN9;EPHB2;ZDHHC5;BCL2;TFDP1;RANGRF
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),0.7780048771593362,1.2293131576826686,0.27586206896551724,1.0,1.0,1/6,6.67%,PPARGC1A
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.6249440568213599,1.2293093994441053,0.22413793103448276,1.0,1.0,10/27,26.88%,CD4;CCL5;IL4I1;SPINK5;TNFSF18;CCDC88B;LAPTM5;FGL1;CD47;TNFSF9
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.5442148142950225,1.2291733487058583,0.1643835616438356,1.0,1.0,9/66,19.47%,CA9;NOTCH1;PSMB6;EPAS1;PSMA3;PSMB8;HIF3A;CUL2;ARNT
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.7131810017147193,1.2291282837977462,0.25396825396825395,1.0,1.0,4/11,11.25%,ZNF703;ALOX12;PRKG1;ADAMTS18
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.6282319060362552,1.2288927034400823,0.171875,1.0,1.0,7/16,25.11%,CHMP4B;CHMP2B;CHMP1A;CHMP2A;VPS4A;MITD1;KLHDC8B
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.697264710996256,-1.2287161984834625,0.2571428571428571,0.967507845514888,1.0,1/10,3.08%,NTNG1
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.6994938143887417,1.2285294261410422,0.2833333333333333,1.0,1.0,2/10,7.67%,NCBP1;NCBP2
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),-0.7863735536161012,-1.2285103041758718,0.28205128205128205,0.9666869390094527,1.0,2/7,2.20%,F2RL1;EPHB2
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.695418267525737,1.2284826162135658,0.24242424242424243,1.0,1.0,2/13,7.53%,CD8A;HLA-A
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),0.7881850243822888,1.2281633256943867,0.19696969696969696,1.0,1.0,3/6,5.16%,PLA2G10;PLA2G7;AGT
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.6279119197446668,-1.2278962439578338,0.23255813953488372,0.9674656746034858,1.0,3/13,14.36%,PARP2;HDAC1;SIRT7
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.7387749508197384,1.2278731861628758,0.21052631578947367,1.0,1.0,4/11,11.98%,PTGES;HPGDS;PTGR1;ACOX1
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.7415594686287257,-1.2272251690636,0.18421052631578946,0.9687657339934315,1.0,3/10,18.07%,PRMT8;PRMT5;ART4
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.5338299440974081,-1.2270520736895587,0.16666666666666666,0.9680123216700974,1.0,8/45,12.11%,KDR;EPHB2;SFRP1;CLSTN2;ACE2;DLG5;NRP1;SYNDIG1
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),0.6119800806771102,1.226791853265508,0.2,1.0,1.0,10/26,22.74%,ACKR3;TRIM32;CDKN2D;TWIST1;THOC5;CD74;BCL2L1;KDM1A;SNAI2;SFRP2
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.521176828510562,1.2262868039798898,0.14666666666666667,1.0,1.0,15/124,13.33%,ITK;BTN2A2;CD4;THEMIS2;PTPRC;FYB1;HHLA2;HLA-A;WAS;PSMB6;PLCG2;EIF2B5;RIPK2;PSMA3;PSMB8
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.8199979767121608,1.2259909472982111,0.20408163265306123,1.0,1.0,1/5,6.29%,NCEH1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.7607180000962436,-1.2256084564439915,0.15384615384615385,0.9723749455087324,1.0,1/6,5.01%,GSTM3
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.7792995573074536,-1.225399425250303,0.2619047619047619,0.971574434152808,1.0,4/5,11.80%,SLC22A2;SLC22A3;SLC29A4;SLC22A1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.7178248885859723,-1.225326516373316,0.2391304347826087,0.9702346112722765,1.0,2/8,9.28%,SFRP1;AKR1C3
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.4523802562865151,1.225104293725055,0.047058823529411764,1.0,1.0,88/394,19.70%,TRIM22;IL21R;IL18R1;CD4;TRIM5;CCL5;XAF1;TCP1;HCK;CD300LF;PRLR;PLP2;CRLF1;ACKR3;IL15;ISG20;JUNB;FLT3;TWIST1;OSMR;PTPRZ1;CA1;CIITA;PELI3;IFNLR1;CDKN1B;ADIPOR2;STAT4;TRAF3IP2;RPS6KA4;CSF2RA;HLA-A;SOD2;IFIT3;HGF;IL20RA;IL7;TOLLIP;PSMB6;STAT1;CTF1;NANOG;TGFB1;IRF1;IL17RE;IL20RB;STAT6;TXLNA;RHOU;STAT5A;CD27;RIPK2;PSMA3;HSPA8;TNFRSF11B;CAMK2D;INPPL1;PSMB8;OPRD1;FN1;PTAFR;TXNDC17;TNFSF13B;IFI27;PDCD4;TAB2;PIM1;IL3RA;MSN;BCL2L1;TNFSF18;NDN;TRIM25;IL18BP;CXCL13;B2M;IL18;IFIT1;IRAK4;IL5;IFI35;CD80;MAOA;IFITM3;LBP;PIK3CB;SP100;SHC1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.6938788652347403,1.2249906054492794,0.21311475409836064,1.0,1.0,4/15,10.17%,SLC23A1;ABCC2;ABCB1;ABCG2
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.7825769102713834,1.224976563290748,0.21153846153846154,1.0,1.0,3/8,10.18%,CHAC2;ALDH4A1;CHAC1
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.7315366063413921,-1.224803749718215,0.2222222222222222,0.9706744096698481,1.0,4/12,17.52%,BEND3;PRDM7;WDR82;TET2
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),-0.7463362815653134,-1.2247320320117345,0.3181818181818182,0.9691895196979605,1.0,1/5,2.18%,RBP4
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.7315228994845889,1.2246559786572384,0.17307692307692307,1.0,1.0,2/8,11.99%,CNTN2;MTCH1
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.7880200105077482,1.224567566780184,0.25,1.0,1.0,2/8,6.36%,BTN2A2;PDCD1LG2
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.6978666081714273,1.224315433425371,0.25,1.0,1.0,4/13,23.69%,PPARGC1A;SLC25A18;ETFB;ETFA
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.6446299983354473,-1.2240649042548886,0.21951219512195122,0.970298313995838,1.0,3/15,6.80%,MELTF;RUNX1;PDPN
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),-0.8000656344437252,-1.224029159123325,0.23529411764705882,0.968862260976517,1.0,2/5,6.61%,F2RL1;TLR1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.7302627732122811,1.224024819267033,0.1896551724137931,1.0,1.0,2/7,25.44%,BCL2L1;RNF213
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.5989837202513274,-1.223914927090242,0.17647058823529413,0.9677106128207054,1.0,5/20,10.88%,TPPP3;MAP7D3;FGF13;KATNB1;STMN2
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),0.7575754385714246,1.2236188834280721,0.23880597014925373,1.0,1.0,2/6,12.26%,SCTR;AQP9
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.7780809529089286,-1.2236131202948173,0.20930232558139536,0.9677003075401326,1.0,1/7,1.38%,F2RL1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.6437185852002698,-1.2235166234514003,0.2571428571428571,0.9665546032089318,1.0,3/14,8.68%,IGBP1;MTMR9;SMG6
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.6948372688119797,1.2234567421915137,0.23333333333333334,1.0,1.0,3/13,13.40%,GM2A;GBA3;NEU1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.7689655459521508,1.22339296769126,0.27450980392156865,1.0,1.0,1/7,1.72%,CD4
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),0.8580572106645831,1.2231525173213267,0.18518518518518517,1.0,1.0,1/5,6.04%,UFM1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),0.8580572106645831,1.2231525173213267,0.18518518518518517,1.0,1.0,1/5,6.04%,UFM1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),0.8580572106645831,1.2231525173213267,0.18518518518518517,1.0,1.0,1/5,6.04%,UFM1
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.6754094889116479,-1.223151173803671,0.175,0.9664393796543791,1.0,6/14,17.39%,SFSWAP;RBMX;U2AF2;SRSF7;PTBP1;PCBP4
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.6373649168000585,1.2229267704443165,0.21428571428571427,1.0,1.0,3/18,7.87%,CCL5;RARRES2;CMKLR1
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7413927772602863,1.2227073890886249,0.2631578947368421,1.0,1.0,3/9,20.17%,FKBP1B;TRDN;CALM3
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7413927772602863,1.2227073890886249,0.2631578947368421,1.0,1.0,3/9,20.17%,FKBP1B;TRDN;CALM3
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.7307984218533072,1.2226267625981266,0.203125,1.0,1.0,4/11,16.58%,HSPA5;GPAA1;INSIG2;INSIG1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.6697504682520514,1.2225963312730308,0.2631578947368421,1.0,1.0,1/18,1.49%,SHCBP1L
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),0.847661084136362,1.2225834127588295,0.1896551724137931,1.0,1.0,2/6,3.05%,CALCR;GOT1
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.769541329176187,1.2223814735625826,0.25396825396825395,1.0,1.0,2/8,7.05%,FADD;TBX1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.5831846412456534,1.2221882626291316,0.1791044776119403,1.0,1.0,7/36,15.76%,MARVELD2;MARVELD3;F11R;CLDN10;ECT2;CLDN20;MPP7
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.8278330765467452,1.2216628447335576,0.14285714285714285,1.0,1.0,1/5,5.45%,SLC39A12
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.505716810979861,-1.2215457305896946,0.13793103448275862,0.972153113296371,1.0,3/58,7.30%,MYB;RUNX1;CBFB
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.580255307269735,1.2212667947068387,0.14285714285714285,1.0,1.0,13/45,16.26%,TIMP3;A2ML1;TIMP2;SERPINF1;AGT;SERPINA10;KNG1;SERPINI2;SPOCK3;PSMA3;PSMB8;FURIN;SERPIND1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.4110895466755545,-1.2210083532042406,0.1,0.9730091555183558,1.0,21/331,4.05%,SPRED2;SHC3;KIT;ALK;ROR2;UBASH3B;KDR;SPRED1;SULF2;PTPRT;ATP6V0D2;NRG1;EPHA3;FGFR4;RGS14;EPHB2;PDGFD;SHC4;IGF1;ARPC3;EFS
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.8054013440077326,1.220959249380235,0.23333333333333334,1.0,1.0,1/6,6.95%,IFNLR1
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.6223478681747673,-1.220826555602227,0.21428571428571427,0.9720749873944815,1.0,5/11,17.76%,PORCN;ATG10;APOE;WDR45;WIPI2
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.7595405914841666,-1.2207023601436713,0.23255813953488372,0.9709315855153245,1.0,1/6,6.58%,MAPK7
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.5761579032493828,-1.2205521128615917,0.16666666666666666,0.9700465268364785,1.0,5/25,10.57%,NUMA1;NSFL1C;CDK5RAP2;KIF25;LLGL2
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.7883969417450866,1.2197499015703428,0.23214285714285715,1.0,1.0,2/6,4.74%,PLP1;SOX10
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.6928404887940638,1.2194970605317155,0.23076923076923078,1.0,1.0,4/12,11.89%,AHR;FADD;IRF1;IL4I1
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.5795233336135157,1.2193958255179882,0.21666666666666667,1.0,1.0,15/51,15.56%,NR1I3;MYLK;HCK;CD300LF;ELANE;DOCK8;TAGAP;CD14;MYO1F;AQP9;IGSF6;ARG2;TBXAS1;PTAFR;LY86
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.499637709775188,-1.2193355553159435,0.17857142857142858,0.9734194606709835,1.0,16/85,6.61%,KIT;TAGLN;COL15A1;ABI3BP;ITGA4;ADAMTS2;LAMA4;SVEP1;COL6A2;FNDC1;PCDH18;SGCD;PRRX1;ADAMTS5;RHOJ;TLR1
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),0.8167432445982792,1.2191172174151925,0.1864406779661017,1.0,1.0,2/6,15.97%,SCTR;CGAS
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.5642846611409779,1.2189936646419701,0.15384615384615385,1.0,1.0,5/55,3.92%,PLA2G10;CAV3;LDLRAP1;TMEM97;FABP3
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6612938029213513,1.2189418471613371,0.24561403508771928,1.0,1.0,4/12,21.38%,TWIST1;CD74;KDM1A;SNAI2
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.7371227142703929,-1.2187569364002135,0.2972972972972973,0.9743717843374565,1.0,2/7,6.66%,BCL6;FOXP1
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.5333541174048337,1.2186023437948201,0.16923076923076924,1.0,1.0,15/64,12.26%,GNLY;IL21R;SPON2;HCK;CD300LF;ALOX12;ARHGAP9;GMFG;TAGAP;WAS;VWF;MYO1F;TGFB1;PDE6B;AQP9
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.548675521956703,1.2178961821289207,0.19047619047619047,1.0,1.0,22/58,24.30%,EPHA1;ZBTB7B;DENND1C;TNK1;TJP3;CAPN1;SYNGR2;SLC14A1;TMEM79;NBEAL2;TMC4;TMEM238;TMEM184A;TRIM25;MROH6;RPS6KB2;MPZL3;ELMO3;IL4R;TMCO4;ANXA11;IRF3
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.7616768458265262,1.2178576008122506,0.265625,1.0,1.0,2/7,8.03%,DNAH11;CCDC39
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),-0.648759465277638,-1.2178488107051992,0.23333333333333334,0.9764179658270863,1.0,1/8,0.63%,KDR
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.6642636655113019,1.2177074548727347,0.1875,1.0,1.0,7/16,19.53%,XAF1;STAT1;IRF1;PYHIN1;PLSCR1;IKBKE;IFITM3
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.5706647985665428,-1.217285911826114,0.14285714285714285,0.9768775946259309,1.0,4/36,3.65%,PER2;G6PC3;RBP4;SLC37A4
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.7346303252785931,1.2167355584554116,0.25,1.0,1.0,4/8,21.39%,CHAC1;GAS1;LRRK2;PRNP
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.6125538423011505,1.2162053892783713,0.22413793103448276,1.0,1.0,8/33,18.75%,H3-3A;SPTY2D1;NAP1L2;H2BC18;H2BC5;CHAF1A;HAT1;GRWD1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.48921090463363304,1.2161732324093975,0.10810810810810811,1.0,1.0,39/147,19.86%,TRIM58;TRIM22;TRIML2;AGER;TRIM5;HCK;TRIM32;TNK1;ZDHHC11;RARRES2;CIITA;CORO1A;IFNLR1;PLCG2;MASP2;RIPK2;TRIM14;SIGLEC15;IFI27;CD74;PGLYRP1;TLR2;PJA2;TRIM25;SFTPD;NCF2;B2M;SERINC3;CX3CR1;IFIT1;YES1;IRAK4;PPARG;RNF187;IFITM3;LBP;SP100;STYK1;CYLD
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.7462263408522649,1.2160582940620814,0.2698412698412698,1.0,1.0,2/9,17.33%,SULT2A1;TPST2
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.6832480657608575,-1.2159166919502469,0.23809523809523808,0.9807840321887672,1.0,3/9,7.61%,RUBCNL;PPP1R3B;PPP1R3E
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.7873099619661386,1.2158145708539223,0.2222222222222222,1.0,1.0,3/6,19.54%,CD14;TLR2;LBP
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.7873099619661386,1.2158145708539223,0.2222222222222222,1.0,1.0,3/6,19.54%,CD14;TLR2;LBP
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.5950428186369785,1.2156743993810084,0.203125,1.0,1.0,7/33,15.76%,MARVELD2;MARVELD3;F11R;CLDN10;ECT2;CLDN20;MPP7
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.600174223077234,1.2156656743574865,0.18571428571428572,1.0,1.0,8/36,14.22%,TBX19;NOTCH1;ZFPM1;ACTC1;TBX1;MYBPC3;HTR2B;TTN
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),-0.6591572119023439,-1.2153584754090052,0.21153846153846154,0.9817595586967314,1.0,4/10,20.65%,VCAN;CHST12;IDUA;DSEL
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.5551497695466271,-1.2153374955206366,0.175,0.9802170911354567,1.0,5/17,19.70%,TPR;ANO6;PLEKHA7;NUP107;TSPAN33
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.6921651467363276,-1.2152983816665421,0.25,0.9788262372830104,1.0,3/10,9.86%,APOA1;APOE;SCARB1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.6883541628125204,-1.2148316868529594,0.23529411764705882,0.9791526803192084,1.0,2/11,2.36%,KIT;INHA
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.7597302034882962,1.2145233200033918,0.26229508196721313,1.0,1.0,2/6,6.05%,CAV3;MYOF
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.5564431128611868,1.2143910678064704,0.2077922077922078,1.0,1.0,15/46,20.00%,LDLRAP1;NSDHL;SULT2A1;CYP1B1;HMGCR;CYP19A1;SQLE;MSMO1;INSIG2;DHCR7;FAXDC2;INSIG1;ANGPTL3;SOAT1;PRKAG2
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),-0.7391886747757435,-1.2141725405938364,0.3617021276595745,0.9787198544968395,1.0,3/5,24.29%,MAPRE1;GAS2L2;GAS2L1
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),-0.7391886747757435,-1.2141725405938364,0.3617021276595745,0.9787198544968395,1.0,3/5,24.29%,MAPRE1;GAS2L2;GAS2L1
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.7137732717677778,-1.2139168633949702,0.2926829268292683,0.9783174868981587,1.0,1/6,20.80%,BSN
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.5488438673141651,-1.21387402809341,0.18421052631578946,0.9770035818975493,1.0,6/26,11.39%,UBASH3B;FIBP;HSPB1;TYRO3;PDGFRA;TLN1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.5032195841585203,1.2135798384401257,0.16901408450704225,1.0,1.0,21/106,10.44%,C3AR1;MS4A6A;ALDH1A1;FGL2;STAB1;HCK;CD300LF;MGST1;NOTCH1;FCGRT;PTPRC;FLT3;CDCP1;CD14;ABCB1;CMKLR1;SIGLEC1;HGF;VWF;ABCG2;C1QA
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.555837532812386,1.2134218739175067,0.13636363636363635,1.0,1.0,15/55,17.53%,LDLRAP1;NSDHL;SULT2A1;HMGCR;G6PD;HMGCS1;SQLE;MSMO1;INSIG2;DHCR7;SNX17;DHCR24;INSIG1;ANGPTL3;ACAA2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.5609982904774907,-1.21327263209309,0.18181818181818182,0.9782417010388268,1.0,1/19,1.38%,F2RL1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5172745712500607,-1.2131013120267253,0.15151515151515152,0.9771390566014867,1.0,14/39,22.18%,IARS1;VARS1;RARS1;SARS1;EARS2;WARS2;FARS2;FARSB;RARS2;YARS2;MARS1;HARS2;LARS2;FARSA
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.5929528517269448,1.212999688532365,0.22857142857142856,1.0,1.0,7/27,13.45%,PIGC;PGAP4;PIGH;PIGV;PGAP3;MPPE1;GPAA1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.4949576889260572,-1.2129537116132723,0.16666666666666666,0.9759781244840946,1.0,25/148,8.02%,GEM;DUSP4;BCL2A1;DUSP5;F2RL1;LAMB3;IFIH1;CEBPD;FOS;SDC4;PMEPA1;GCH1;SGK1;MARCKS;DUSP2;BCL6;CFLAR;IER3;PLK2;ATF3;ID2;IL15RA;BTG1;MAP2K3;SERPINB8
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.7406014473967123,-1.2128547795002034,0.3333333333333333,0.9747385830440838,1.0,2/6,5.78%,ARL13B;ZDHHC3
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6713628824560545,1.2125057684355067,0.2413793103448276,1.0,1.0,3/16,9.67%,HCK;NTF3;STAP1
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.48680616577425306,-1.2124280221384571,0.2,0.9752521062661663,1.0,8/67,6.99%,STAC;EPHA3;PTPN9;PID1;EPHB2;ZDHHC5;RANGRF;NUMB
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.6300612538051013,-1.2122086164732677,0.23255813953488372,0.9744081419501208,1.0,9/14,20.29%,NCL;MACROH2A2;SMARCA4;SMARCB1;SIRT7;DDX11;MACROH2A1;MTOR;MARS1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.6169641090587785,1.2115474545711666,0.2727272727272727,1.0,1.0,5/18,17.07%,AGER;PLCG2;SCIMP;RIPK2;TLR2
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.6846327183037639,1.2112806484213048,0.13432835820895522,1.0,1.0,6/20,16.12%,NOTCH1;DNAH11;ODAD3;TBX1;ARL6;DNAI1
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.7622081710979973,-1.2112011036927366,0.21951219512195122,0.9768278273875461,1.0,1/5,6.10%,PRKCD
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.7853895766341501,1.2111442284881209,0.18181818181818182,1.0,1.0,3/6,17.07%,PRDX4;DAB2IP;TLR2
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.8081753415298614,1.2110655562484152,0.20408163265306123,1.0,1.0,3/7,16.81%,CCL5;MSMP;MSN
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.6565280671112049,1.2106390947095331,0.2727272727272727,1.0,1.0,3/17,7.81%,BORA;PSRC1;TPX2
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.477488940483058,-1.2103202067165908,0.15789473684210525,0.9791781542902483,1.0,19/93,9.65%,KIT;ALK;ROR2;KDR;EPHA3;FGFR4;RASSF2;EPHB2;EREG;DRD4;AZU1;EPHA5;MAP2K3;TYRO3;MMD2;PDGFRA;XRCC6;LCP2;LMO4
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.5853956008650066,-1.2102656591905958,0.2564102564102564,0.977759545209444,1.0,6/29,9.21%,BMP7;BMP3;INHA;BMP6;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.6170484081312843,1.2098207602139788,0.2222222222222222,1.0,1.0,5/29,10.24%,LRP4;NOTCH1;OMG;REST;YWHAH
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),0.7541265747593692,1.209799717360801,0.2698412698412698,1.0,1.0,1/10,4.38%,ISG20
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.6201781764437212,-1.209743374268855,0.225,0.9787537320004388,1.0,7/19,18.32%,KHSRP;DGCR8;LIN28B;TRIM71;DIS3L2;XPO5;TARBP2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.6403835554972839,-1.2096492358018485,0.21428571428571427,0.9776664411829592,1.0,6/13,13.65%,GCH1;S100A1;DHFR;APOE;SCARB1;NOS1AP
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5282467980634551,1.2090747140854727,0.2028985507246377,1.0,1.0,15/70,12.80%,CALCR;MC4R;RXFP1;GPR26;TBXA2R;CALCB;ADGRB1;CNR2;PTGER3;TSHR;ADRB1;GPER1;DRD3;ADGRE1;ADGRG2
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.6461988408841786,1.2090475975422674,0.22058823529411764,1.0,1.0,6/18,16.55%,POLE3;GINS2;GINS1;MCMDC2;PCNA;GINS4
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.5145839496471929,-1.2089807828180983,0.21875,0.9790033494134435,1.0,7/48,6.56%,PTPRT;IGSF11;CDH13;AMIGO1;CNTN6;SDK1;DSCAML1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.7805262195353742,1.2089749294625076,0.22413793103448276,1.0,1.0,1/7,7.73%,SOD2
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.7766411930846167,1.2089227342410247,0.24193548387096775,1.0,1.0,1/6,1.69%,NDP
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.7671800194298003,1.2085141383229312,0.23076923076923078,1.0,1.0,1/8,1.83%,WFS1
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.6910813071983397,1.208398036381763,0.2807017543859649,1.0,1.0,3/9,19.06%,BNIP3;VPS35;ATG3
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),-0.706561188813018,-1.208282698818512,0.24489795918367346,0.9799297383184493,1.0,1/6,0.36%,GLYATL2
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.7442053268150973,-1.2080239675869646,0.2549019607843137,0.977765442443464,1.0,5/7,7.68%,RTP5;TAS2R7;TAS2R9;CA6;GNAT3
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.7442053268150973,-1.2080239675869646,0.2549019607843137,0.977765442443464,1.0,5/7,7.68%,RTP5;TAS2R7;TAS2R9;CA6;GNAT3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.631055849346846,1.2078377255619854,0.22950819672131148,1.0,1.0,3/24,12.15%,RFC5;RPA3;PCNA
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.6341124780135521,-1.2075741290314184,0.17391304347826086,0.9783255574462326,1.0,1/12,1.80%,CDH13
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.6723801013190909,1.207192562068417,0.22727272727272727,1.0,1.0,2/10,5.66%,NOTCH1;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.6430325267467554,1.2071053671560386,0.2698412698412698,1.0,1.0,1/19,0.65%,NES
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.7952108233949606,1.2069726745405016,0.15789473684210525,1.0,1.0,1/7,1.31%,PLA2G10
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.6658085174674255,1.2066602800595276,0.1875,1.0,1.0,1/18,0.26%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.44891660236300107,-1.2062978898290764,0.15384615384615385,0.9814060312122028,1.0,11/72,13.50%,KDR;ATOH8;RIN2;FOXP1;ETS1;MAP2K3;HSPB1;SCARB1;NRP1;SMOC2;ANGPT1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.7175718874176502,1.2061335244657223,0.18032786885245902,1.0,1.0,1/8,3.61%,ITGA5
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.5789919213529865,1.205755030937547,0.17391304347826086,1.0,1.0,12/38,19.65%,XAF1;ISG20;HLA-A;IFIT3;STAT1;IRF1;PSMB8;IFI27;IFIT1;IFI35;IFITM3;SP100
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.5789919213529865,1.205755030937547,0.17391304347826086,1.0,1.0,12/38,19.65%,XAF1;ISG20;HLA-A;IFIT3;STAT1;IRF1;PSMB8;IFI27;IFIT1;IFI35;IFITM3;SP100
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.8361971259531511,1.2056636332620674,0.16071428571428573,1.0,1.0,2/5,13.37%,VEGFC;RIN3
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.6500907345073638,1.2054896296714936,0.21052631578947367,1.0,1.0,3/15,12.89%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.6518229866319412,1.2052973274152228,0.2608695652173913,1.0,1.0,5/20,9.70%,ADAMTS9;PDGFRB;NOTCH1;TBX1;SMAD7
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.7541963067967741,-1.205269736840449,0.25,0.9838923686521102,1.0,1/5,4.05%,FABP5
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.5718045181815423,-1.2052149451448402,0.2,0.9825895740135332,1.0,11/29,16.12%,CHST8;IGF1;B3GAT2;HS3ST3B1;EXT1;B3GAT3;GAL3ST4;EXT2;CHST9;XYLT2;CHST12
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.6325450418245696,1.2049281560461256,0.23076923076923078,1.0,1.0,11/26,24.44%,RARRES2;HLA-A;LYG1;LYG2;PGLYRP1;TLR2;GBP6;LBP;ROMO1;ADAM17;PPP1R11
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.7772843513969679,1.2046058559614916,0.2857142857142857,1.0,1.0,1/5,1.71%,TYR
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.5641995397944229,1.2045639860975281,0.16901408450704225,1.0,1.0,5/53,4.89%,TRIM22;TRIML2;TRIM5;BORA;SLC26A4
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.672325799194714,-1.2039555092999406,0.25,0.9856099152817226,1.0,2/11,6.57%,BLOC1S4;AP3B2
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.672325799194714,-1.2039555092999406,0.25,0.9856099152817226,1.0,2/11,6.57%,BLOC1S4;AP3B2
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.6678265123334481,-1.203859167267625,0.28888888888888886,0.9843906942826134,1.0,4/11,14.10%,PID1;NR1H4;AKR1C3;IRS1
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.8182592933431753,1.2036504378398856,0.26229508196721313,1.0,1.0,3/5,18.00%,IL15;TMBIM1;IL18
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.7655197637330926,-1.2036478883190962,0.16279069767441862,0.9835750477006348,1.0,2/5,13.49%,FRMPD4;CTNNA2
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.565034939640023,1.2035516857787045,0.1864406779661017,1.0,1.0,13/38,23.10%,PLP1;ZNF430;HSPA5;G6PD;CKB;YWHAH;CNP;SUDS3;BASP1;CALM3;RAD1;MAOB;CDC42
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.7823196254677174,-1.20353945652561,0.4,0.9824627311771746,1.0,2/5,8.59%,ENPP3;CTPS2
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.5180350962232466,-1.203465481113087,0.20588235294117646,0.9811746835965028,1.0,5/51,6.32%,PER2;GLP1R;ITPR2;CELA2A;CACNA1A
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.6600710141812032,-1.2034513968005793,0.21621621621621623,0.9796918562559696,1.0,4/9,16.47%,ASCL1;ID2;PAX6;TGFBR1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.6558908484489498,-1.2033739208294973,0.23809523809523808,0.9784520225496274,1.0,6/15,11.83%,RUNX1;SOX12;BCL6;CBFB;DUSP10;MDK
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.5500053441122956,-1.202937789504336,0.12,0.9787030032084743,1.0,6/45,9.64%,KDR;VASH1;ETS1;MAP2K3;HSPB1;APOE
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.7176712770321331,-1.2022932171386156,0.2857142857142857,0.9797053461798856,1.0,1/8,0.87%,PAH
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),-0.8223639095144677,-1.202026232616733,0.22916666666666666,0.9791037702601392,1.0,2/5,11.83%,SIGLEC10;MDK
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.5845308978303083,-1.2020013698927559,0.2553191489361702,0.9777345826387467,1.0,6/16,11.80%,SLC22A2;SLC25A29;SLC22A3;SLC29A4;SLC25A26;SLC22A1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5686414825788719,-1.2017994419047981,0.24390243902439024,0.9769804131667877,1.0,3/16,19.34%,RIPOR2;LLGL2;TEK
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.6921759424277985,-1.2017738502461555,0.27906976744186046,0.975540206047119,1.0,2/10,5.82%,F2RL1;SPHK2
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.7620585505941047,1.201327688234715,0.2535211267605634,1.0,1.0,2/8,1.82%,RREB1;ZNF703
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),0.7357960780331132,1.2013170804904632,0.3,1.0,1.0,1/5,5.60%,TCAF2
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.7226336763096741,1.2012260081346242,0.25,1.0,1.0,2/9,20.00%,PHKA1;PRKAG2
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.7536443862994948,1.2011269528690287,0.25396825396825395,1.0,1.0,2/8,18.37%,STRC;ADGRV1
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.6203415805318722,1.2009439158922182,0.25,1.0,1.0,1/16,1.38%,LDLRAP1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.6983724732079242,1.2009404738331533,0.30158730158730157,1.0,1.0,4/13,18.37%,GRM3;DRD3;AKAP5;ADGRV1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.6601887556767627,-1.2008001731288507,0.2631578947368421,0.9776000948012614,1.0,3/9,19.49%,LRP8;DBNL;RELN
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.7462289709583664,-1.2007817723558576,0.3023255813953488,0.9761046151498793,1.0,3/5,15.06%,APOBEC3H;EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.6666660311876301,1.2006893049310787,0.3548387096774194,1.0,1.0,4/13,9.29%,TRPV6;TRPV3;SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.6666660311876301,1.2006893049310787,0.3548387096774194,1.0,1.0,4/13,9.29%,TRPV6;TRPV3;SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.6000843682028854,1.2006012276005953,0.24285714285714285,1.0,1.0,3/20,7.68%,ZACN;SLC30A8;KHK
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.6847878879134681,1.200567661317557,0.25806451612903225,1.0,1.0,1/12,2.31%,RP1
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.6534159882179728,-1.2000070953589044,0.2631578947368421,0.9777460563589514,1.0,3/8,13.71%,NSFL1C;KIF25;CEP85
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),-0.7549299409860535,-1.1998954902455041,0.2631578947368421,0.9766850369944617,1.0,1/6,0.87%,PAH
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.6600045404243041,-1.198945029433496,0.32608695652173914,0.9791010529428371,1.0,1/7,3.10%,PNP
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.6805358702142987,-1.1988968162923284,0.35,0.97774895770567,1.0,1/8,0.84%,BMP7
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.5028994690171026,-1.198788041309119,0.2,0.9767901642740837,1.0,8/63,3.53%,KIT;ROR2;KDR;SELP;UNC5B;F2RL1;PDGFD;IGF1
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),-0.7466255227809186,-1.1982085102910254,0.3404255319148936,0.9773882913116989,1.0,1/7,9.28%,AKR1C3
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),-0.7200388462534673,-1.1980572781103123,0.2926829268292683,0.9748223658850735,1.0,3/5,19.31%,APOA1;APOE;LCAT
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),-0.7200388462534673,-1.1980572781103123,0.2926829268292683,0.9748223658850735,1.0,3/5,19.31%,APOA1;APOE;LCAT
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.7343686668000193,1.1978867594112537,0.25,1.0,1.0,3/6,11.87%,NOTCH1;DRD3;DAAM2
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.663193997700456,1.1975700141680716,0.2727272727272727,1.0,1.0,3/17,8.80%,SYT2;SYT4;CPNE5
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-0.7982986729903985,-1.1974609534589362,0.30612244897959184,0.975923445951477,1.0,2/6,15.14%,RPUSD1;RPUSD4
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.5598414451243151,-1.197196943295338,0.23076923076923078,0.9753030539299586,1.0,3/22,3.82%,APRT;PNP;GMPR
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.5481227967767508,-1.196918924240152,0.21428571428571427,0.9750315149885033,1.0,7/48,7.37%,SPRED2;SPRED3;SPRED1;EYA4;BRCC3;PRKCD;ERCC8
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5043813411973608,1.1969032092245226,0.15714285714285714,1.0,1.0,9/117,6.64%,NPY;LRP4;P2RY1;TMEM35A;ASXL3;SLC26A4;SYT4;RGS4;CPE
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.5531526307983556,1.1968927704831134,0.203125,1.0,1.0,5/56,3.92%,PLA2G10;CAV3;LDLRAP1;TMEM97;FABP3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.7219054926525351,1.1965061827023191,0.2542372881355932,1.0,1.0,2/10,15.47%,GLRX;ATP1B1
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.5489356557775454,1.1959354205041592,0.22727272727272727,1.0,1.0,18/59,18.63%,DNAH3;FAM81B;ECT2L;C11ORF16;CCDC60;TEX26;ANKUB1;CCDC39;CFAP126;EFHB;APOBEC4;TTC29;CFAP65;DNAI1;ATP5MK;DRC3;ARMC3;MAP3K19
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.6114259755366478,1.1954168880709435,0.22033898305084745,1.0,1.0,9/22,22.77%,KCNE2;ATP12A;KCNQ1;ATP1B1;SLC40A1;KCNE4;ATP1A1;ATP2B4;SLC9A1
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.7800196781237693,1.1951416033159983,0.3230769230769231,1.0,1.0,1/5,3.99%,IL15
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.6797569438997979,-1.1949510801912977,0.2608695652173913,0.9809960797311138,1.0,4/10,17.93%,BUD23;SIRT7;WDR75;RIOK1
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.7327377869173768,1.1948770687871653,0.29508196721311475,1.0,1.0,4/8,22.77%,ATP12A;ATP1B1;ATP1A1;SLC9A1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),0.7383078389776384,1.1948449639948837,0.32786885245901637,1.0,1.0,1/6,2.72%,PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.6577011784470613,-1.1945007827380452,0.27906976744186046,0.9810432735365564,1.0,5/13,14.41%,SDC4;RAB7A;SMPD3;SNF8;TSG101
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5386871595630873,1.1942231671062467,0.21875,1.0,1.0,19/68,24.58%,WFS1;FANCI;ARRDC3;PHF23;SMAD7;BRCA1;FANCM;RIPK2;DERL1;SPHK1;PINK1;DCUN1D1;LRRK2;KDM1A;RCHY1;UBE2D1;LAPTM5;UBQLN1;UBE3A
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.5564483738312762,1.1940590200482886,0.25,1.0,1.0,14/42,20.49%,POLQ;PPP4C;FIGNL1;WAS;KLHL15;HELB;ACTR2;CGAS;RMI2;MAGEF1;RAD51AP1;OOEP;TERF2IP;KDM1A
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.7752841361473961,1.1939394780716972,0.2962962962962963,1.0,1.0,1/5,6.34%,HIP1R
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.8072006666725101,1.1934671621104982,0.21818181818181817,1.0,1.0,2/5,10.83%,ALDH1A1;GAD1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.5969438850022676,1.193391635254317,0.2,1.0,1.0,8/29,15.85%,CSRP3;SCN4B;ACTC1;MYBPC3;KCNQ1;TTN;ATP1B1;TRDN
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.6793247029746796,1.1933208414629324,0.23636363636363636,1.0,1.0,3/17,5.89%,CSRP3;PDGFRB;ACTC1
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),0.8061590183184661,1.1927884833670932,0.2727272727272727,1.0,1.0,1/5,5.12%,FLT3
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.493291830616776,-1.1927630396294122,0.23333333333333334,0.9863663424297556,1.0,5/57,4.14%,CCL28;EPHA3;CDH13;UTRN;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.49422479193631796,-1.192726439238767,0.14814814814814814,0.9850450716351613,1.0,15/40,26.68%,AMIGO1;PLXNA1;LIMK1;NGF;PLXNA2;PLXNC1;CHODL;DBNL;TIAM1;SLITRK1;GOLGA4;MAP6;L1CAM;PLXND1;MAP3K13
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7128148890239151,1.19265837492454,0.30612244897959184,1.0,1.0,2/11,4.08%,PTGIS;BOK
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),0.8012261862364645,1.1925603294285056,0.2833333333333333,1.0,1.0,2/5,7.05%,NOTCH1;TBX1
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.734627054865282,-1.19224243367109,0.22727272727272727,0.9853344959863011,1.0,3/8,15.46%,NR1H4;PRMT5;PRMT6
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.5745730187467769,1.1922334065658016,0.2,1.0,1.0,13/41,15.67%,GLRX;PRDX4;MGST1;NQO1;JUNB;CDKN2D;SOD2;G6PD;IPCEF1;NDUFB4;GLRX2;PRDX6;TXNRD2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.5914917648210786,1.191945779144149,0.2807017543859649,1.0,1.0,5/26,15.92%,ARIH2;HSPA1L;RHOU;UBL5;PINK1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.7407991141719737,1.1919357493281186,0.3137254901960784,1.0,1.0,1/7,4.40%,CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.7332582855501906,-1.1918328724546414,0.3055555555555556,0.9852601823573561,1.0,2/7,11.11%,GRIN3A;PTPRS
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),-0.709686423918747,-1.1916129906186865,0.2978723404255319,0.9847475232677142,1.0,2/5,9.98%,SAMHD1;RRM2
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.7571138354806222,1.191481345914778,0.288135593220339,1.0,1.0,3/8,11.58%,BCAP31;USP14;HERPUD1
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),-0.8011458635838526,-1.1910979140836049,0.28205128205128205,0.9854168635396198,1.0,3/5,11.39%,SLC22A2;SLC7A1;SLC7A2
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.4568843319774373,-1.1903044923490225,0.1388888888888889,0.9870346821086747,1.0,17/77,11.03%,COL15A1;ADAMTS2;ADAMTS3;GREM1;COL6A2;LAMB3;LOXL1;COL11A2;ITGA6;COL4A3;SERPINF2;TGFB2;COL11A1;COL18A1;COL4A2;LAMA3;COL28A1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.5677811112898912,-1.189573830769176,0.2857142857142857,0.9882110104936072,1.0,5/18,17.95%,PTCH1;APOA1;APOE;EEPD1;NR1H2
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.7609588314254009,1.1893318406420883,0.25,1.0,1.0,2/8,6.86%,LOXL2;SOX6
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6806906335711334,1.1892613891322945,0.3050847457627119,1.0,1.0,5/9,20.72%,CCL5;PODXL;DPP4;CXCL13;SKAP1
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.7170836936567759,1.1891228858033662,0.2727272727272727,1.0,1.0,3/9,22.17%,HSPA5;CALR;HSP90B1
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),0.7820453199304087,1.1887039668757928,0.24561403508771928,1.0,1.0,2/5,3.71%,PDGFRB;NOTCH1
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),-0.7821516539289446,-1.188689923974965,0.35555555555555557,0.9900092053908292,1.0,3/5,11.39%,SLC7A1;SLC25A29;SLC7A2
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.6011645033003868,-1.188509124449318,0.24390243902439024,0.9892282998986397,1.0,3/17,3.32%,UNC13B;GRIK4;UNC13C
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.6465728938235236,-1.1883589010729554,0.2727272727272727,0.9885064430392654,1.0,6/10,20.29%,NCL;SMARCA4;SMARCB1;DDX11;MTOR;MARS1
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),0.695312887680365,1.1882726763849518,0.19642857142857142,1.0,1.0,1/15,0.16%,WEE2
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),0.7444247836688074,1.1882053704025244,0.2835820895522388,1.0,1.0,5/8,20.88%,TWIST1;NLRC3;TSC2;DAB2IP;NOP53
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.7539979224419734,1.1877618741562739,0.22950819672131148,1.0,1.0,1/9,3.26%,H3-3A
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.7539979224419734,1.1877618741562739,0.22950819672131148,1.0,1.0,1/9,3.26%,H3-3A
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),0.7480307206652393,1.1875462281956657,0.3220338983050847,1.0,1.0,4/5,18.82%,DRD3;GHRL;ABCB4;SLC51A
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.6895551326042324,1.187278258198606,0.3,1.0,1.0,1/9,2.24%,SDS
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.5937809033880056,1.186706597043885,0.25757575757575757,1.0,1.0,4/20,15.27%,LDLRAP1;LPCAT3;ACADL;FMO5
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.6369699537681127,-1.1864722927538227,0.30952380952380953,0.994276923786391,1.0,1/10,1.85%,GREM1
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),0.7608921058840402,1.1864135804936955,0.24561403508771928,1.0,1.0,3/7,19.54%,PLSCR1;ITIH4;LBP
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.7148565691710471,-1.1863792640194069,0.27906976744186046,0.9931917023712973,1.0,2/7,12.10%,GALE;PGM2
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.6225171731129986,1.1863180753668556,0.22033898305084745,1.0,1.0,4/19,11.52%,STAT4;STAT1;STAT6;STAT5A
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.6671820316146801,1.1861440334907236,0.30357142857142855,1.0,1.0,1/13,7.37%,YBX3
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.7927038740095008,1.1857966524303096,0.18181818181818182,1.0,1.0,1/5,7.34%,OTUD4
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.6040131642532426,-1.1856330828695159,0.30952380952380953,0.9945550376420991,1.0,3/20,9.22%,PNP;ITPA;DNPH1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5646580267555878,-1.1852122407906696,0.17857142857142858,0.9949564099493701,1.0,4/30,8.65%,SELP;AMIGO1;ADGRL1;TENM4
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.6554160462498481,-1.1851023126623672,0.2926829268292683,0.9936875224587931,1.0,2/14,7.10%,BRCA2;TPP1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.5301211722119643,1.1843738929905834,0.25806451612903225,1.0,1.0,3/35,10.04%,SYT4;MYO5B;MYO1F
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),-0.6933775136418644,-1.184257861819231,0.3611111111111111,0.992405309852881,1.0,2/8,14.13%,HSPB1;RAB27B
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),-0.6933775136418644,-1.184257861819231,0.3611111111111111,0.992405309852881,1.0,2/8,14.13%,HSPB1;RAB27B
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),-0.6933775136418644,-1.184257861819231,0.3611111111111111,0.992405309852881,1.0,2/8,14.13%,HSPB1;RAB27B
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.6406984448767433,-1.1841501743437457,0.2564102564102564,0.9914833517084181,1.0,9/17,18.15%,MOB3B;WTIP;SHANK2;MAP2K3;DLG5;WWC3;VGLL4;WWC1;MARK3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.7495522699785121,1.1838146626222288,0.25806451612903225,1.0,1.0,1/7,1.54%,AGER
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5155082813357539,1.1837782545671187,0.2318840579710145,1.0,1.0,10/71,11.79%,ENPP2;ITGA5;NTF3;IL15;PTPRC;AGT;HGF;PLCG2;TGFB1;RIPK2
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.4509098962046196,-1.1837323420442787,0.22857142857142856,0.991476211834632,1.0,10/77,10.58%,PM20D1;UNC5B;NRBP2;BCL2;TYRO3;TGFB3;APOE;EIF4G1;SORL1;NGF
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.48623414515097624,-1.1833266381298688,0.14285714285714285,0.9919337427058358,1.0,8/78,5.40%,BMP7;PID1;PRR5L;EPHB2;INHA;PRKRIP1;WWTR1;ZBED3
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.7448348329043138,1.1833133173098154,0.265625,1.0,1.0,1/6,4.90%,TJP3
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.5689945622111191,-1.1831214776252226,0.24324324324324326,0.9914248790148047,1.0,5/23,12.05%,MYB;CHTOP;TET1;DNMT1;PHF1
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.5613627731985977,-1.1829201765012727,0.2631578947368421,0.9906395628769644,1.0,9/27,14.57%,OSTN;RTN4R;PTCH1;FGF13;SLC6A4;PTPRS;DUSP10;WWC3;FGFR3
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.6894378801417892,-1.1828975235838224,0.3333333333333333,0.9893384790888783,1.0,5/11,19.31%,APOA1;APOE;SCARB1;CLU;LCAT
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.5923608498115337,1.1826778952417547,0.24242424242424243,1.0,1.0,6/37,16.81%,TCP1;CA1;STAT4;SOD2;PDCD4;MSN
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.6477764057879607,-1.1825407796376526,0.3,0.9890759008628625,1.0,4/10,14.01%,CLDN4;SGK1;AKR1C3;HNF1A
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.5274120995306906,-1.1822699610625809,0.125,0.9887956496353941,1.0,5/40,9.37%,KIT;RUNX1;INHA;IL11;IFI16
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.6849155861055501,-1.182142455281116,0.2857142857142857,0.9878162080272607,1.0,3/12,8.64%,STING1;IFIH1;COLEC12
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.6624904517334319,-1.1820299365044837,0.2558139534883721,0.986858045744093,1.0,1/12,1.28%,LEF1
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.5135999680445299,-1.1817021166635635,0.22857142857142856,0.9866373944344298,1.0,5/20,10.18%,APOA1;NR1H4;APOE;SCARB1;RORA
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.7936208224369541,1.1812416671841384,0.22580645161290322,1.0,1.0,1/5,2.85%,RABGGTB
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.7035892646716058,1.1811352975241,0.36666666666666664,1.0,1.0,2/8,7.08%,PTGIS;LMO3
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),0.8063180615860734,1.1808622152502297,0.26229508196721313,1.0,1.0,3/5,14.22%,CSRP3;HTR2B;TTN
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.6550560157003218,-1.180862112250464,0.2826086956521739,0.9883614682595295,1.0,5/12,27.08%,TTC21A;WDR35;DYNC2I1;DYNC2I2;IFT43
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.5269183114707328,-1.1805224087217154,0.2,0.9881209461311984,1.0,8/26,18.86%,ERCC2;GTF2H2;CCNH;CUL4A;DDB2;GTF2H5;XPC;ERCC3
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.7897706836270527,1.1801812892547516,0.23529411764705882,1.0,1.0,1/5,3.56%,DOCK2
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.6425431670519688,1.179956562157922,0.28125,1.0,1.0,2/18,6.39%,SLC12A7;ATP12A
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.7237555187393769,1.1799314785869048,0.296875,1.0,1.0,1/9,2.07%,ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.7237555187393769,1.1799314785869048,0.296875,1.0,1.0,1/9,2.07%,ZBTB7B
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.7692802575021014,1.179684885907217,0.29310344827586204,1.0,1.0,2/7,12.32%,WAS;BRK1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.7237498759991765,1.1795342447929635,0.2641509433962264,1.0,1.0,2/8,9.21%,CD300LF;GPER1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.6298995867753604,-1.179431595351236,0.21951219512195122,0.9904961185277892,1.0,2/17,3.53%,PER2;IGF1
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),0.7439871011027899,1.1792029950681824,0.27450980392156865,1.0,1.0,1/6,4.47%,SCN4B
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.7849457785801573,1.1791554098833286,0.3269230769230769,1.0,1.0,1/5,9.36%,STAT1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.7211601643569205,1.1788957497574295,0.3225806451612903,1.0,1.0,2/11,6.87%,IGFBP5;PRKG1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.5754032184709386,-1.1788491037883377,0.2894736842105263,0.991622672096307,1.0,5/16,11.35%,SULF2;RBP4;DSCAML1;PDGFRA;NOG
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.7455557251841373,-1.178547291737362,0.35,0.991451375480808,1.0,1/6,0.76%,PDE10A
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.5540355494117971,-1.1783733855971408,0.30303030303030304,0.9906615513528113,1.0,8/26,13.50%,KDR;ITGA4;MAPK7;IL11;ANO6;AKR1C3;SCG2;ANGPT1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.5322881878335733,1.178314619126987,0.20270270270270271,1.0,1.0,8/69,11.10%,MARVELD2;LRP4;MARVELD3;TJP3;PPFIBP2;TGFB1;C1QA;MYOT
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.7884588890632548,-1.1781773219117784,0.25,0.9898922067396492,1.0,2/5,15.40%,ETS1;PML
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.7264193657000676,1.1778854945512247,0.2833333333333333,1.0,1.0,2/9,8.29%,YBX3;CASP8
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.7430931827437086,1.1778105084565902,0.23728813559322035,1.0,1.0,2/8,7.05%,GLI3;TBX1
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.7224166483985164,-1.1773735840038522,0.3953488372093023,0.9912853945727681,1.0,2/6,10.18%,PRR5L;SYAP1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.7593242540049623,1.1772918989728025,0.3269230769230769,1.0,1.0,2/8,10.39%,BNIP3;RNF122
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.5670047439271217,1.1772658162195273,0.22388059701492538,1.0,1.0,10/31,20.62%,POLQ;TWIST1;KLHL15;OTUB1;HELB;UBR5;CGAS;RMI2;MAGEF1;RNF169
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.6336725476828623,1.1769486306883221,0.24615384615384617,1.0,1.0,7/17,25.70%,PAICS;AMPD2;AK4;IMPDH1;GMPS;PPAT;GMPR2
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.706103066966485,-1.1769366813736886,0.22727272727272727,0.9915143847345762,1.0,4/6,20.85%,PDCD2;ACE;KAT7;EIF2AK2
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),0.7641627021907079,1.176796931219759,0.3114754098360656,1.0,1.0,5/7,21.77%,F8;F10;A2M;F3;SERPING1
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.4719898958782034,1.1766005909787198,0.2077922077922078,1.0,1.0,38/181,16.58%,SLC7A11;MCM2;TMEM97;FGL2;GLRX;GOT1;HSPA5;UFM1;IGFBP5;NFIL3;CORO1A;NAMPT;ADIPOR2;SLC2A1;CDC25A;HMGCR;G6PD;SCD;DDX39A;HMGCS1;TUBA4A;SQLE;CCT6A;PSMA3;FADS2;UCHL5;POLR3G;LGMN;PLOD2;DHCR7;PPA1;STARD4;AK4;ACTR2;DHCR24;EPRS1;PSMG1;INSIG1
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),0.7933241432417032,1.1765969982257551,0.2909090909090909,1.0,1.0,2/5,18.14%,P2RY12;CX3CR1
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.7418842399053738,1.176323811778681,0.2112676056338028,1.0,1.0,1/8,1.47%,RREB1
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.7613043091374097,1.176081670285637,0.288135593220339,1.0,1.0,1/7,3.63%,TMEM204
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.6816918921653187,-1.175977325233077,0.3333333333333333,0.9936252284861815,1.0,5/8,30.80%,RPTOR;MTOR;LARP1;CARD11;CLEC16A
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),-0.5276541527181775,-1.1759560808800398,0.2564102564102564,0.9922595756428463,1.0,6/37,7.69%,NPNT;BMP7;IGF1;WWTR1;BMP6;ZHX3
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.5465989013592009,-1.1758953840020334,0.2222222222222222,0.9910783579007263,1.0,7/29,19.10%,ARSB;CLN6;TPP1;GNPTAB;CLVS1;HOOK3;MTOR
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.650918873421205,1.1758554862915456,0.1896551724137931,1.0,1.0,6/13,23.29%,CHMP4B;CHMP2B;CHMP1A;CHMP2A;VPS4A;MITD1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.4861476395872397,1.1757579455675646,0.17142857142857143,1.0,1.0,8/110,6.34%,AMBP;LDLRAP1;STAB1;HSPG2;ACKR3;WASF1;AMN;HIP1R
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.6196654853774594,1.1752582891310157,0.22413793103448276,1.0,1.0,6/19,17.15%,TRIM5;TRIM32;VPS37B;CHMP2B;CHMP2A;TRIM25
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.5915562671029673,-1.1752253004337432,0.21621621621621623,0.9922615318043846,1.0,4/19,9.09%,SPRY4;EPHB2;TGFB2;SPRY3
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5306654561004172,-1.1752079031611584,0.17647058823529413,0.9908857505414189,1.0,11/56,13.12%,METTL8;BUD23;MTERF4;LCMT2;TRDMT1;TRMT10C;THADA;FBLL1;ALKBH8;TRMT61A;TARBP1
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.7153477429712497,1.1750915119577154,0.288135593220339,1.0,1.0,3/7,19.18%,LPCAT3;MTTP;SOAT1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.6852280595255424,1.174885408570314,0.3157894736842105,1.0,1.0,1/10,3.26%,H3-3A
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.6873296564233697,1.1748801760546848,0.375,1.0,1.0,5/12,20.68%,CHMP4B;PHF23;PINK1;LRRK2;SEC22B
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.6836145519727386,1.1748256222808127,0.2830188679245283,1.0,1.0,2/6,21.25%,TGFB1;CLTC
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.5689533239577573,1.174721305262539,0.21052631578947367,1.0,1.0,9/41,17.56%,SLC7A11;SLC38A11;SLC38A8;SLC36A1;SLC38A2;SLC7A7;SLC38A5;SLC38A4;SLC7A14
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.7562800192392731,1.1745196506300857,0.2857142857142857,1.0,1.0,2/8,6.64%,NOTCH1;CPE
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.49168371531622906,-1.1744881948262098,0.2,0.9920478258567555,1.0,2/45,2.70%,PER2;SVBP
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.5111193301467216,-1.1743663152641404,0.2564102564102564,0.9910890419680546,1.0,6/26,10.57%,MLYCD;NR1H4;FOXK1;APOE;RORA;ACADVL
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.6398616445260209,-1.173766912680913,0.15789473684210525,0.991978701044383,1.0,1/10,0.87%,PAH
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.7800150271823141,1.1735638590165616,0.2545454545454545,1.0,1.0,3/6,13.46%,EID2;TGFB1;SMAD1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6070651613655147,1.1734279540193833,0.3142857142857143,1.0,1.0,2/24,2.22%,CAV3;KCNE2
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.5403357380512721,1.173159512661365,0.21212121212121213,1.0,1.0,9/56,9.44%,SPDYA;INHBA;CDKN2D;MAP3K11;CCNE1;CDKN1B;CCNE2;CDC25A;CRLF3
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6563347281510543,-1.1731194572347357,0.4,0.9926868743005013,1.0,3/9,13.65%,CACNA2D1;NIPSNAP2;NOS1AP
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.6522340602120886,1.1730948041601632,0.3275862068965517,1.0,1.0,2/11,7.67%,NCBP1;NCBP2
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.477824475724325,-1.1729651461220518,0.2,0.9916598188659931,1.0,9/57,6.90%,TPD52L1;F2RL1;RASSF2;TNFRSF19;SH3RF1;RASGRP1;TRAF3;SERPINF2;SH3RF3
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.7509224140970651,1.1722137971172517,0.2807017543859649,1.0,1.0,2/6,12.52%,SMAD7;DACH1
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.6763593527071254,-1.1720944668111444,0.3793103448275862,0.9937046148625721,1.0,3/9,16.05%,ALDH1A2;ALDH1A3;CYP3A5
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.5709388914499521,1.1719744152342186,0.2647058823529412,1.0,1.0,6/39,16.81%,TCP1;CA1;STAT4;SOD2;PDCD4;MSN
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.6912743919195047,1.171960378384504,0.23333333333333334,1.0,1.0,1/12,3.26%,H3-3A
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.75174771379817,1.1718826065585743,0.25396825396825395,1.0,1.0,4/8,16.77%,CSRP3;HTR2B;TTN;INPP5F
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.5385298180403044,-1.1717707747962156,0.26666666666666666,0.9937302460157909,1.0,2/27,3.53%,PID1;IGF1
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.667474020741027,-1.1716086186419283,0.3695652173913043,0.9929018022014791,1.0,1/5,1.28%,LEF1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.730196839238538,1.1712867581712187,0.25,1.0,1.0,4/7,20.62%,TWIST1;OTUB1;UBR5;RNF169
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.5521858101991441,1.1710932614886427,0.2,1.0,1.0,7/41,2.55%,ALDH1A1;RDH10;GPC6;RLBP1;GPC5;HSPG2;BCO1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.5626687569209887,1.1709293038779438,0.23076923076923078,1.0,1.0,8/39,12.20%,ALDH1A1;IL18R1;NOTCH1;IL15;TLE3;ARRDC3;ACOT13;PLCL1
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.6217507759414356,-1.1705475208120415,0.22580645161290322,0.9951670686793316,1.0,2/14,4.14%,ARID5A;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),0.7280082203036324,1.170399267210114,0.25,1.0,1.0,3/7,15.63%,GMFG;CORO1A;DNAI3
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.7633978912889366,1.1703947916056523,0.2857142857142857,1.0,1.0,3/6,17.99%,LMAN1;DNAJA1;LRRK2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.48185580081152346,1.170215576886189,0.14473684210526316,1.0,1.0,43/151,17.21%,APOLD1;MYLK;TIMP3;ELK3;SEMA3D;STAB1;HSPG2;CD82;PDGFRB;RASIP1;POSTN;CHST1;CYP1B1;F8;PLAC8;ANGPTL2;RND1;PLSCR4;SRPX;USHBP1;TBX1;SLC2A1;VEGFC;CASZ1;VWF;EPAS1;ABCG2;A2M;SLC38A5;NOTCH4;RGS5;PODXL;ADGRF5;LDB2;RASGRP3;IFI27;PROCR;RGCC;SPARCL1;CRHBP;MMRN2;SHROOM4;DPP4
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.4773442161825885,-1.1701236774138704,0.125,0.9955275953481704,1.0,14/88,14.27%,PKP2;CDH6;ITGA6;SDK1;SHANK2;CDHR3;DRD1;PCDHB4;CDH1;TLN1;CDH20;FARP1;NLGN3;DNER
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),0.7812705433079462,1.169812753594674,0.25396825396825395,1.0,1.0,2/5,10.65%,GLI3;IRF1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.6140964841769069,1.1696634525838547,0.29508196721311475,1.0,1.0,3/22,12.15%,RFC5;RPA3;PCNA
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.6147339966753113,1.1696235458738635,0.24242424242424243,1.0,1.0,4/15,14.56%,AHR;THEMIS2;IL4I1;BANK1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.6941173948549413,1.1694298909139156,0.23076923076923078,1.0,1.0,2/10,6.55%,TRIM5;CIITA
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),-0.7410046266718762,-1.169390876861439,0.35555555555555557,0.99666660314867,1.0,1/5,1.85%,GREM1
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),0.7231714204986578,1.1690595076994785,0.30158730158730157,1.0,1.0,3/7,12.24%,CNGB1;CNGA1;PDE6B
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.5865094898522357,-1.1689598594652115,0.2558139534883721,0.9968293845617063,1.0,2/19,2.20%,F2RL1;EPHB2
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.5769092146286365,1.1686245401944035,0.2535211267605634,1.0,1.0,9/29,20.00%,ASXL3;HSD17B13;PRKAB2;ADIPOR2;GPER1;THRSP;PDK4;CREBL2;PRKAG2
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.6866171206967655,-1.1684972282746293,0.27906976744186046,0.9970977007806638,1.0,4/11,10.30%,ALK;TYSND1;CIDEA;ABCD1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.5954866496111496,-1.1684327830750032,0.3,0.9959539846447184,1.0,3/21,2.80%,BTC;VPS25;EREG
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.6803568610922064,1.168398221752428,0.375,1.0,1.0,2/8,10.18%,ATP6AP1;FAS
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.5565122959160634,1.168227211706635,0.23076923076923078,1.0,1.0,8/33,16.81%,NOTCH1;AGT;SPTY2D1;GFAP;HSPA8;DAB2IP;PINK1;MSN
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.5802683297856119,-1.1681733131069647,0.2727272727272727,0.9958176095568559,1.0,6/20,18.34%,RILP;PTPN23;RAB7A;SNF8;STX8;HOOK3
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.8019940108428251,-1.168116286130318,0.3103448275862069,0.9946965093391235,1.0,3/5,19.04%,FBLL1;SIRT7;CREBBP
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.6967816795939483,1.1675295301784434,0.2982456140350877,1.0,1.0,2/9,10.18%,CHAC2;CHAC1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.561056586367237,1.167363818137795,0.2698412698412698,1.0,1.0,5/25,8.78%,ACSBG1;FASN;ACSL5;ELOVL2;SCD
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),0.8133424603269285,1.1665337677957726,0.3064516129032258,1.0,1.0,1/5,11.70%,STRC
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),0.8133424603269285,1.1665337677957726,0.3064516129032258,1.0,1.0,1/5,11.70%,STRC
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5718381893200326,1.1665100326649063,0.22641509433962265,1.0,1.0,8/27,20.75%,ERAP2;BCAP31;HLA-A;TAPBPL;B2M;ERAP1;CALR;SEC23A
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.7890201952406681,1.1662727105757236,0.23076923076923078,1.0,1.0,3/5,20.14%,LMO3;CRY2;PER1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.6914417222790444,1.166259951501619,0.32142857142857145,1.0,1.0,5/10,18.00%,ZBTB7B;IL15;TGFB1;SPHK1;IL18
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.724536356679317,1.1660854252451358,0.3442622950819672,1.0,1.0,1/5,6.09%,TMEM30A
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.7719252694524892,1.1660523538325602,0.3709677419354839,1.0,1.0,1/5,1.56%,GLI3
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.7239567941359258,1.165994249795013,0.2857142857142857,1.0,1.0,3/8,15.96%,BOK;HSPA5;TMEM33
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),-0.6725647186682928,-1.1656990733846522,0.2631578947368421,1.0,1.0,4/8,23.44%,SIRT2;HDAC10;HDAC9;HDAC4
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.6950791357529493,-1.1656250502613112,0.2564102564102564,1.0,1.0,2/7,6.90%,NMB;IL11
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.46801724201685935,-1.1655784471336321,0.28,1.0,1.0,17/77,9.85%,SV2C;PDE10A;SVOP;RNFT2;UNC13C;PMEPA1;CATSPER2;DRD4;TNR;KCNJ14;CACNA1A;SAMD7;AP3B2;ROM1;SLC2A11;SAG;TPH1
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.7905729128347029,1.1653896064458007,0.34545454545454546,1.0,1.0,1/6,7.73%,SOD2
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.7560645058192311,1.1653690777488435,0.2982456140350877,1.0,1.0,2/7,14.06%,TBX19;SCX
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.46322553619467444,-1.1652258682055343,0.18181818181818182,1.0,1.0,12/72,17.00%,SAMD4A;SPHK2;PRKCD;SMPD3;ELAVL1;UPF3A;LRRTM3;CLU;CIRBP;RBM3;NSMAF;PLD1
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.5678395086475377,1.1651689575482282,0.2318840579710145,1.0,1.0,5/25,3.38%,CHIT1;GPC6;GPC5;HSPG2;CTBS
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.7205430744167908,-1.1651001292251573,0.32432432432432434,0.9993569570494145,1.0,1/7,7.16%,RAB7A
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.6843155306298678,-1.1648240519507422,0.40540540540540543,0.9992171624827956,1.0,5/7,27.98%,EARS2;WARS2;YARS2;GARS1;TARS2
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.7218618478541985,1.164806067348061,0.2708333333333333,1.0,1.0,2/6,20.49%,SLC36A1;SLC38A3
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.6516258416295556,-1.1647237510071609,0.2926829268292683,0.9980848466028075,1.0,1/9,1.77%,SLC25A37
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.5264151617674202,1.1643977098966865,0.25806451612903225,1.0,1.0,15/56,12.38%,C3AR1;MS4A6A;CHIT1;CD4;FGL2;HCK;CD300LF;CD14;SIGLEC1;G6PD;MYO1F;C1QA;AQP9;ADGRE1;IGSF6
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.459195871699198,1.1641870861787598,0.16176470588235295,1.0,1.0,22/129,12.36%,RIBC2;CHRNG;KCNE2;CALCB;HSD11B2;NTF3;SOX10;TFCP2L1;SERPINA10;ACTC1;PROP1;IRS4;NRIP2;TCF7L1;STAG3;MYOT;EFHD1;KCNMB1;SNN;ZC2HC1C;PDE6B;SKIL
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.7424171519271194,1.1636960818069697,0.2898550724637681,1.0,1.0,1/8,2.77%,GLRX
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.767314746818662,1.1634203026441459,0.2545454545454545,1.0,1.0,1/6,9.21%,GPER1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6342770256283123,1.163322790167734,0.36666666666666664,1.0,1.0,3/15,4.47%,CAV3;KCNE2;SCN4B
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.7200123860138063,1.1632249471204854,0.39344262295081966,1.0,1.0,3/7,23.32%,PLCG2;CD74;LAPTM5
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.6682337315406095,-1.1631998119973204,0.2727272727272727,1.0,1.0,5/6,29.16%,PLK3;VRK1;PLK5;GOLGA2;GBF1
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.7250233674512081,1.163195380512894,0.22413793103448276,1.0,1.0,3/9,11.89%,IDO1;ACMSD;IL4I1
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.7250233674512081,1.163195380512894,0.22413793103448276,1.0,1.0,3/9,11.89%,IDO1;ACMSD;IL4I1
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.6503162897759168,-1.1631790594964142,0.2608695652173913,1.0,1.0,6/13,16.94%,NCSTN;IDE;MME;APEH;BACE2;ACE
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.6180783072253373,1.163145190005297,0.22727272727272727,1.0,1.0,1/19,0.55%,MYLK
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.5886408471893738,1.1630631904788977,0.23943661971830985,1.0,1.0,2/28,2.49%,CAV3;CTNNA1
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.7127408567234017,1.1629156432130925,0.27692307692307694,1.0,1.0,8/9,28.25%,SLC26A4;ATP6AP1;CLCN3;PDK4;SLC9A7;SLC9A1;ATP6V0A4;PDK2
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.6637572340370961,1.1624215592440694,0.265625,1.0,1.0,1/12,1.38%,LDLRAP1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),-0.6731901286020022,-1.1617752685311211,0.3018867924528302,1.0,1.0,1/6,10.37%,SORL1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.7574411701173197,1.161598759069717,0.36507936507936506,1.0,1.0,2/6,16.60%,NOTCH1;RGCC
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.5559138692269223,1.161131280775666,0.2982456140350877,1.0,1.0,5/28,10.18%,PRELP;TST;CHAC2;OGN;CHAC1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.570341710381845,-1.160735563187004,0.20512820512820512,1.0,1.0,4/19,7.12%,SLC16A2;SLC22A2;SLC6A1;SLC7A1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.720030246517771,-1.1606299566974108,0.28888888888888886,1.0,1.0,2/5,10.76%,DPY19L1;DPM3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.720030246517771,-1.1606299566974108,0.28888888888888886,1.0,1.0,2/5,10.76%,DPY19L1;DPM3
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.5409627899514208,-1.1606005312174545,0.3333333333333333,1.0,1.0,3/20,7.77%,NUMA1;NSFL1C;CDK5RAP2
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.6335921585595454,-1.1603883294723913,0.2894736842105263,1.0,1.0,3/8,24.58%,CCNH;GTF2H5;GTF2H1
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.6895196316386623,1.1602830293867414,0.3333333333333333,1.0,1.0,2/10,10.18%,CHAC2;CHAC1
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.6647488695038555,-1.1601530861034528,0.3333333333333333,1.0,1.0,2/7,10.50%,ZDHHC5;XIAP
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.6368447582825866,1.160107460437146,0.34328358208955223,1.0,1.0,5/13,19.65%,WAS;SPOCK3;FBLN1;FRMD5;SP100
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.7257984319632292,-1.1600915934962939,0.43902439024390244,1.0,1.0,1/6,11.83%,MDK
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.5876051776449693,1.1597382229377626,0.22727272727272727,1.0,1.0,6/24,16.94%,MSX1;POSTN;CCND2;LRPAP1;SPP1;PGLYRP1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.602090209582515,1.1594956075920135,0.23333333333333334,1.0,1.0,5/18,19.47%,ITGA5;TMEM204;DAB2IP;MMRN2;ARNT
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5152381554318619,1.1593043316818796,0.2,1.0,1.0,41/85,36.96%,RPL15;RPS7;RPL36;RPL9;RPS21;RPL38;SRP9;RPL21;RPL22;SRP19;RPS5;RPLP2;SRP68;RPS13;RPL27;RPL35A;RPL35;RPL3;RPS20;RPL27A;RPS27A;RPL13A;RPL5;RPS29;RPS12;RPL7;RPL32;RPS4X;RPL37A;RPL24;RPS9;RPL28;SRP14;RPL8;SEC61B;RPS24;RPS3;RPL37;RPSA;RPS19;RPL4
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.5957986454031732,1.1592689910445464,0.2571428571428571,1.0,1.0,1/18,1.33%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.6721430976807754,1.1591987369715444,0.3283582089552239,1.0,1.0,4/13,19.94%,SHCBP1L;MRE11;GNL3;RAD50
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.6901073325565655,-1.1588704591366283,0.2894736842105263,1.0,1.0,9/13,28.61%,FHDC1;PRMT5;STX6;TMED5;GCC2;VTI1A;MYO18A;TRIP11;GOLGA2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.7092319371646586,-1.1585572388428207,0.34782608695652173,1.0,1.0,4/7,12.68%,BCL2L11;SFRP1;BTG1;PRDM11
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),-0.7842351556750318,-1.1582665974790032,0.375,1.0,1.0,1/5,2.16%,UNC13B
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.7884654097009111,1.1581592221065988,0.3225806451612903,1.0,1.0,3/6,18.53%,PLA2G10;GLRA1;CACNA1H
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.5449969347943383,-1.1578966504061123,0.2777777777777778,1.0,1.0,10/28,21.27%,CACNA2D1;MCUB;SLC35G1;MICU1;MICU2;MCUR1;MCU;SLC25A23;JPH4;JPH2
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.6743584656447782,-1.1578517848823304,0.34210526315789475,1.0,1.0,3/11,0.69%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.6118263892678435,-1.157631506712058,0.275,1.0,1.0,2/8,11.02%,IGF1;CHP1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.5799905748600638,1.1573637480753496,0.3064516129032258,1.0,1.0,9/30,19.06%,BIK;BOK;NAIF1;BNIP3;SOD2;VPS35;BCL2L1;BAD;ATG3
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.5334844364764708,1.157331306295289,0.21428571428571427,1.0,1.0,10/44,17.74%,FUT2;GM2A;GBA3;ST8SIA6;B3GNT5;PGAP3;NEU1;B3GALNT1;PSAP;UGT8
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.6231276012590965,1.1572704256872164,0.2708333333333333,1.0,1.0,4/14,12.54%,ZNF16;PLCG2;STXBP4;ATAD5
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.5085390554879433,-1.1570652251150397,0.1935483870967742,1.0,1.0,6/31,13.63%,IGF1;APOE;SORL1;LRRTM3;CLU;BIN1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.690024456412742,1.1570170040112175,0.3548387096774194,1.0,1.0,5/10,26.37%,ATP12A;ATP1B1;ATP1A1;SLC9A1;SLC12A2
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.7302985801716135,1.1569517483628173,0.3333333333333333,1.0,1.0,2/5,22.07%,ACVR2B;CCBE1
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.7080248055744982,-1.156928585725207,0.29545454545454547,1.0,1.0,4/8,12.68%,BCL2L11;SFRP1;BTG1;PRDM11
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.7485562178694865,1.1569213454692953,0.29508196721311475,1.0,1.0,2/5,21.47%,CARNS1;FTCD
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.7485562178694865,1.1569213454692953,0.29508196721311475,1.0,1.0,2/5,21.47%,CARNS1;FTCD
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.5198813451320812,-1.156818900197821,0.2972972972972973,1.0,1.0,9/35,12.19%,LEF1;IGF1;TFAP4;ZBTB7A;IFI16;NGF;HMGB2;SIRT2;HMGA2
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.6533494738188685,-1.1563265210994547,0.3541666666666667,1.0,1.0,1/7,3.48%,XRCC4
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.7831049597651158,1.1562984471769195,0.23529411764705882,1.0,1.0,3/7,17.49%,FADD;FAS;PPP2R3C
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.5849323811659727,-1.1562161931874257,0.3023255813953488,1.0,1.0,6/16,17.87%,SIGLEC10;RTN4R;PTPRS;MDK;AJAP1;CASK
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.6184772204462973,-1.156189138534432,0.2777777777777778,0.9996047977846652,1.0,3/10,9.85%,PAH;SRM;TPH1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.628895143098232,1.1560653390436746,0.23809523809523808,1.0,1.0,3/18,4.47%,CAV3;KCNE2;SCN4B
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.5208359141014502,-1.155644767472741,0.25,1.0,1.0,6/34,7.66%,MDGA1;SULF2;NTNG1;CROCC;GSTM3;HSPB1
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.6220427981835589,1.155624434934882,0.2857142857142857,1.0,1.0,6/15,16.17%,CHRNB1;NQO1;CHRNE;CHRNB4;CHRNA7;CHRNA2
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.7475517397976684,1.155603687798502,0.3548387096774194,1.0,1.0,1/5,4.92%,PTPRC
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.726578307404149,-1.1554454148204045,0.3695652173913043,0.9983238129734181,1.0,1/5,0.64%,PAPSS2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.726578307404149,-1.1554454148204045,0.3695652173913043,0.9983238129734181,1.0,1/5,0.64%,PAPSS2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.6281308100873471,-1.1554039492253536,0.3111111111111111,0.9971314633003971,1.0,1/13,0.83%,MYB
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.5051503308547135,-1.1552618551544604,0.2571428571428571,0.9963620022836011,1.0,9/30,18.27%,LYAR;TRAFD1;SAMHD1;TYRO3;IFI16;CACTIN;IRAK3;FAM3A;SUSD4
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.739596796403782,1.1551544120203017,0.3103448275862069,1.0,1.0,1/7,2.31%,RP1
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.6572640272847958,1.1546764772626004,0.3230769230769231,1.0,1.0,2/10,4.82%,RASIP1;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),-0.7266943946989259,-1.154538891628733,0.35555555555555557,0.9976399129327848,1.0,2/6,4.42%,KIT;TICAM1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.6082087695051621,-1.1544184802573105,0.3333333333333333,0.9965872136304649,1.0,2/16,9.28%,BMP7;AKR1C3
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.5954991286771716,1.1539979881186164,0.2676056338028169,1.0,1.0,7/26,17.62%,CALB1;AGER;SCGN;AKAP5;LGMN;CHRNA7;NSG1
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.6697709533603039,-1.1536049407067568,0.34285714285714286,0.9979115610971332,1.0,4/7,22.77%,MX1;DNM2;AP3D1;SNAP91
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),-0.7437297367357512,-1.153549892338626,0.3333333333333333,0.9967611279443155,1.0,1/5,10.37%,SORL1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.5644957964751969,-1.1533572615161334,0.2926829268292683,0.9959639474129259,1.0,4/16,13.72%,APOA1;APOE;SCARB1;ABCG4
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.6087301247404259,-1.1533193269036,0.24242424242424243,0.994802525862181,1.0,5/20,11.39%,SLC16A2;SLC22A2;SLC7A1;SLC6A9;SLC7A2
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.7439977595344447,1.1531874681820675,0.3269230769230769,1.0,1.0,3/7,13.40%,GBA3;MANBA;NEU1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.5516632570876625,1.1530224460001277,0.2571428571428571,1.0,1.0,12/32,23.03%,CAV3;CHMP4B;PHF23;BRCA1;CCP110;MDM1;TCHP;PINK1;LRRK2;SEC22B;KAT2B;YAP1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.7229470293236819,1.1530218281206372,0.3793103448275862,1.0,1.0,2/6,7.57%,TCAF2;ABCB1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),-0.643957258716864,-1.152835220746395,0.28,0.9951908676104978,1.0,3/9,20.65%,VCAN;CHST12;DSEL
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.45841835509353807,-1.152832078127267,0.2,0.9938674754993136,1.0,13/74,8.04%,F11;NOX4;PAH;SLC16A9;SLC9A8;RBP4;AOAH;CACNG5;SLC22A13;SERPINF2;NME4;SORD;NR1H4
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.6861475332397123,1.1526100399847694,0.2459016393442623,1.0,1.0,4/7,27.93%,KCNJ11;CACNA1H;ABCC9;ASIC2
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.6904684779203125,-1.1524053602124846,0.2727272727272727,0.993924293739208,1.0,2/8,7.66%,KDR;HSPB1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5638344638120195,-1.1523315230242364,0.20512820512820512,0.9928876915371696,1.0,4/19,6.58%,UNC5B;EYA4;BCL2;MAPK7
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),-0.6411164313657276,-1.1523081956996752,0.38461538461538464,0.9916387795135992,1.0,3/8,14.17%,PLXNA1;PLXNA2;PLXNC1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.6799034470921408,1.1522027577380378,0.3333333333333333,1.0,1.0,4/8,26.82%,HLA-A;PGLYRP1;NOD1;NLRC4
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),-0.7500775338693639,-1.1520992073755412,0.32432432432432434,0.9898603133856986,1.0,2/5,23.40%,CSF1R;IL34
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),-0.7500775338693639,-1.1520992073755412,0.32432432432432434,0.9898603133856986,1.0,2/5,23.40%,CSF1R;IL34
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.7375387069494554,1.151922568226242,0.3114754098360656,1.0,1.0,2/8,11.10%,SMIM22;SQLE
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.7301986321921242,1.151825856047202,0.2982456140350877,1.0,1.0,3/6,23.87%,RCN3;SFTPD;CTSH
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.7301986321921242,1.151825856047202,0.2982456140350877,1.0,1.0,3/6,23.87%,RCN3;SFTPD;CTSH
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),0.7250660858607201,1.151540244883981,0.26,1.0,1.0,2/6,14.63%,TCP1;VBP1
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.6332983074388259,-1.1511645406486264,0.3111111111111111,0.9916521577557157,1.0,5/13,12.00%,STAC;MYH14;MYH3;TNNC2;CCDC78
prerank,GO_Biological_Process_2021__negative regulation of muscle cell differentiation (GO:0051148),-0.7397413594580057,-1.151160906429997,0.3673469387755102,0.9903785443158148,1.0,3/5,14.28%,EREG;ID2;PTBP1
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.7621477968950249,1.1510966939659597,0.3275862068965517,1.0,1.0,2/6,2.55%,RLBP1;BCO1
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.6986264028139146,-1.1506996631372595,0.32432432432432434,0.9908502779035904,1.0,3/7,23.03%,NR1H2;PRKN;PPARA
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5659439119347435,-1.1505378214954987,0.2894736842105263,0.9901226720788021,1.0,8/19,13.93%,SULF2;SPRY4;APLN;SPRY3;CREB3L1;NOG;SMOC2;SPRY1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.6499601518020535,-1.1504663790313974,0.21621621621621623,0.9890199879175765,1.0,3/12,19.21%,NOP9;NMD3;SDAD1
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.6716468547833783,1.150225775697644,0.3333333333333333,1.0,1.0,1/14,2.18%,BORA
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.7161355225158375,-1.14997671333025,0.4,0.9891151532899136,1.0,1/5,3.48%,XRCC4
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.7378589892623912,1.14997655708525,0.33962264150943394,1.0,1.0,5/8,21.76%,C17ORF99;GPR183;RNF168;EXOSC6;MSH6
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.727153984251954,1.1498008689721797,0.35714285714285715,1.0,1.0,5/6,25.34%,CD300LF;PLSCR1;LYN;CRLF2;CD226
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.6414528398750071,1.1495100550428292,0.3230769230769231,1.0,1.0,4/16,15.98%,ODAD4;CCDC39;CABYR;NEK10
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.5411948248420846,-1.1493130650935452,0.21621621621621623,0.9900928549250358,1.0,8/32,9.61%,ATOH8;FOS;APLN;NFIB;ETS1;TGFB2;STAT3;SMARCA4
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.4523027583168325,-1.1492984647768014,0.1891891891891892,0.9888475954222661,1.0,4/62,7.18%,FRMPD1;RTP5;ZDHHC3;RAB3IP
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.7237366889794096,1.149293409169047,0.32142857142857145,1.0,1.0,2/8,11.58%,HSPA5;HERPUD1
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.5905647465517909,1.1492756587991642,0.2916666666666667,1.0,1.0,7/24,12.03%,ZNF703;SSTR1;GPER1;CYP19A1;TGFB1;LOC400499;ESR1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.6650977831074834,-1.1492495142251342,0.30952380952380953,0.9877034184124704,1.0,1/10,1.38%,F2RL1
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),0.7783291916447339,1.1490222398663634,0.2553191489361702,1.0,1.0,3/5,20.49%,SLC36A1;SLC38A5;SLC38A3
prerank,MSigDB_Hallmark_2020__Complement,0.467562399681494,1.1488442432192367,0.23529411764705882,1.0,1.0,30/147,14.65%,C4BPB;CCL5;MMP15;PLA2G7;ERAP2;CP;TIMP2;PPP4C;F8;PIK3R5;LAMP2;HSPA5;CPM;F10;WAS;RABIF;C1QA;PRSS3;PLAUR;IRF1;L3MBTL4;DOCK4;USP14;CDK5R1;VCPIP1;LGMN;FN1;CD59;NOTCH4;DYRK2
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),0.76940933596398,1.1488398168783849,0.2916666666666667,1.0,1.0,1/5,4.68%,TST
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.6300537582391625,-1.1484051486988258,0.34146341463414637,0.9893630618002129,1.0,2/7,13.10%,CSK;PKDCC
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5757716565470541,1.148379643959317,0.3064516129032258,1.0,1.0,6/24,17.99%,WFS1;LPCAT3;SYVN1;HERPUD1;BCL2L1;LRRK2
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.640249416951051,-1.1483662655957236,0.3541666666666667,0.9881724050408537,1.0,3/9,14.03%,PARP2;PARP10;ZC3HAV1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),-0.4859033804322135,-1.1483484979724483,0.1388888888888889,0.98698484491806,1.0,5/49,2.20%,KIT;KDR;EPHA3;FGFR4;EPHB2
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.6230243441209073,1.1478713269029783,0.3484848484848485,1.0,1.0,4/17,10.09%,ACTA2;EXPH5;BFSP1;TMEM79
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.6120826343459339,1.147830131156992,0.323943661971831,1.0,1.0,6/24,18.81%,ENO4;HKDC1;ALDOB;PGAM1;PKLR;HK3
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.6058912581724375,-1.147639875406833,0.32432432432432434,0.9885091914432673,1.0,2/16,2.36%,KIT;INHA
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.7001763430732839,1.147639281334867,0.203125,1.0,1.0,6/13,15.41%,HSD17B10;CYP19A1;UGT2B7;HSD17B6;SPP1;HSD17B11
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.492431281974727,1.147410855794579,0.22058823529411764,1.0,1.0,22/117,18.56%,MCM2;RFC5;POLE2;GMNN;POLE3;GINS2;MGME1;GINS1;MCMDC2;PSMB6;CDC6;HELB;RPA3;PSMA3;CDK2AP1;PSMB8;ORC4;RECQL;GINS4;RECQL4;PURA;MCM6
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.5685159076416063,-1.1473214021690759,0.2777777777777778,0.9884744362527146,1.0,8/19,22.04%,MCUB;MICU1;MICU2;MCUR1;SLC8A3;MCU;SLC25A23;PMPCA
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.43636055553921077,-1.1469588550609218,0.15384615384615385,0.9883103433457084,1.0,13/101,9.40%,ITGB5;BMP7;FOS;ZMIZ2;HIVEP1;AMH;RGMB;GCNT2;APOA1;BMP6;TGFB2;TGFB3;DLX5
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.6805389656078243,-1.146872679724633,0.325,0.9874034281589931,1.0,1/7,0.84%,BMP7
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.43939982091995916,-1.1468555734600654,0.19444444444444445,0.986208396458758,1.0,7/69,9.21%,ITGB5;FOS;ZMIZ2;GCNT2;APOA1;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.5124249608154101,-1.1467924627465436,0.2857142857142857,0.9852259546721499,1.0,7/35,13.57%,HOMER2;GRIK4;GRIN3A;GRIA4;GRIN2A;GRIA2;GRIN2C
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.6251216799553663,1.1466486629779227,0.32727272727272727,1.0,1.0,6/17,18.96%,POLQ;KLHL15;HELB;CGAS;RMI2;MAGEF1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),-0.8229135211148816,-1.146539883541329,0.35,0.9848415627382273,1.0,3/5,13.81%,BMP7;MDK;BAG3
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.6116912614004953,1.1463197932312235,0.2753623188405797,1.0,1.0,5/28,9.76%,LRP4;NOTCH1;TWIST1;NOTUM;SOX11
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.7598784690216109,1.1462413971922325,0.36538461538461536,1.0,1.0,3/5,23.63%,CD27;PPP2R3C;SYK
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.7069051040701649,-1.146058617590496,0.3684210526315789,0.9851815064715652,1.0,2/7,16.29%,PRKCD;DDX11
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),0.7279855771517894,1.1454251039936005,0.328125,1.0,1.0,3/7,18.93%,HCK;KIF9;IL5
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.5118283615241395,1.145382197465214,0.24285714285714285,1.0,1.0,26/72,17.50%,CD4;BLNK;CLEC4C;HCK;CD300LF;CD8A;PIK3R5;DOCK8;SERPINF1;PTPRC;CARD6;ARHGAP9;GMFG;TAGAP;WAS;ARHGAP25;MYO1F;GPR183;ETV6;LY86;TNFSF13B;CD83;IL3RA;WDFY4;ERN1;CD37
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.6985397718067414,1.1445050792086866,0.38596491228070173,1.0,1.0,4/11,18.37%,GRM3;DRD3;AKAP5;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.6985397718067414,1.1445050792086866,0.38596491228070173,1.0,1.0,4/11,18.37%,GRM3;DRD3;AKAP5;ADGRV1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.5593139848885841,1.144255183496824,0.23529411764705882,1.0,1.0,8/30,26.43%,NDUFA2;NDUFB9;NDUFB3;NDUFB2;NDUFB4;NDUFB11;NDUFV1;NDUFB6
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.6889128216340006,1.144030655693411,0.25,1.0,1.0,2/11,9.20%,GMNN;CDC6
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.636524655499777,-1.1438168522240388,0.34210526315789475,0.9921186469266137,1.0,1/9,3.55%,BDH1
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),0.7645994738055679,1.1437893027752817,0.3728813559322034,1.0,1.0,2/6,13.25%,PTGER3;HTR2B
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5164237619002268,1.1437201185066028,0.22077922077922077,1.0,1.0,16/63,17.88%,SLC12A7;TRPV6;KCNE2;SLC39A12;TRPV3;ATP12A;SLC24A2;SLC24A1;KCNJ9;SLC5A2;KCNJ11;ATP1B1;SLC9A6;ATP1A1;SLC9A2;SLC9A7
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.612778803568784,1.143646051801286,0.2711864406779661,1.0,1.0,2/21,5.00%,NTF3;WASF1
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.6593001286146205,1.143436489056503,0.2857142857142857,1.0,1.0,1/14,1.38%,LDLRAP1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.6040696495722806,-1.1433824119582232,0.30952380952380953,0.992336144677021,1.0,3/10,22.04%,IMMP2L;MIPEP;PMPCA
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.715571770023651,1.142988053104565,0.2807017543859649,1.0,1.0,3/10,11.89%,IDO1;ACMSD;IL4I1
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.6309506047954867,1.142915058631217,0.29508196721311475,1.0,1.0,5/12,17.47%,KCNE2;KCNQ1;ATP1B1;KCNE4;ATP1A1
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.6055652623354103,1.1423175393270983,0.25757575757575757,1.0,1.0,3/19,7.87%,CCL5;RARRES2;CMKLR1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.5899438780534598,1.1422400247304534,0.3333333333333333,1.0,1.0,6/24,12.47%,PIGC;PGAP4;PIGH;PIGV;PGAP3;MPPE1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.5818582150047925,1.1421438767078196,0.2903225806451613,1.0,1.0,10/29,21.00%,GADD45B;AGER;SPHK1;DAB2IP;GADD45G;PJA2;DLG1;CYLD;PER1;RELL1
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),0.7426431615917716,1.1420829983013399,0.29850746268656714,1.0,1.0,1/5,5.91%,HSPA5
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.5221185622993366,-1.142056785064006,0.275,0.9958036296413891,1.0,8/23,17.82%,MCUB;CACNA1I;CACNA1A;MICU1;MICU2;MCUR1;CACNA1B;MCU
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.5641398316775745,-1.1420167684310334,0.2682926829268293,0.9946405372206547,1.0,4/22,6.58%,GLP1R;PDE3A;EPHA5;MAPK7
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),0.7684372316743695,1.142011686790519,0.3,1.0,1.0,2/5,10.56%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),0.7684372316743695,1.142011686790519,0.3,1.0,1.0,2/5,10.56%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.7582859259934763,1.1416857058635956,0.3508771929824561,1.0,1.0,1/5,3.21%,PRLR
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.7179072734772014,1.1413936782619467,0.3103448275862069,1.0,1.0,1/8,1.31%,PLA2G10
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.7453597740086425,-1.1408728595042366,0.38095238095238093,0.9970740257881696,1.0,2/6,6.61%,F2RL1;TLR1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5874642297112858,1.1407313788836317,0.27419354838709675,1.0,1.0,5/16,21.38%,TWIST1;CD74;KDM1A;ARMC10;SNAI2
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5486126423519321,1.140712564231474,0.2876712328767123,1.0,1.0,11/36,20.45%,LRRC19;AGER;CD14;CD27;SPHK1;PDCD4;TLR2;IFI35;RTKN2;TERF2IP;C1QTNF4
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.6577387145950384,1.140678726473099,0.3387096774193548,1.0,1.0,2/9,4.82%,CCL5;P2RY12
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),-0.6949275873038581,-1.140573506980538,0.30612244897959184,0.9968534017153081,1.0,3/5,22.04%,IMMP2L;MIPEP;PMPCA
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.649825534198806,1.1404320387348583,0.2786885245901639,1.0,1.0,5/12,23.80%,BCAP31;HERPUD1;USP13;RNF185;UBQLN1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5736736930519737,1.1404029973220633,0.2857142857142857,1.0,1.0,11/42,23.69%,PLCH1;PLCG2;PLCD3;IMPA2;INPPL1;ITPKB;IPMK;PLCD1;IPPK;INPP4B;NUDT4
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.5966960185067605,-1.1402699564629355,0.3181818181818182,0.9967767180175291,1.0,5/17,14.41%,SDC4;RAB7A;SMPD3;SNF8;TSG101
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.6233623520232833,1.1400630007886672,0.3181818181818182,1.0,1.0,2/15,5.66%,NOTCH1;ZFPM1
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.6082431821607599,1.13993461311559,0.3484848484848485,1.0,1.0,5/14,15.93%,IDO1;FAH;ACMSD;IL4I1;HPD
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.5165658237457615,1.1399256340145654,0.27941176470588236,1.0,1.0,18/63,21.24%,CCL5;HCK;PDCD1LG2;CD14;STAP1;CD6;TGFB1;DAB2IP;PDCD4;CXCL13;IL18;CX3CR1;PLAA;CD80;LBP;CD274;GSTP1;LYN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.5469688651676557,-1.1397795190841962,0.25,0.9971457249740011,1.0,2/12,7.89%,F2RL1;STAT3
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.45294537004144386,-1.139742093422243,0.1724137931034483,0.9960201044662973,1.0,12/117,4.05%,SHC3;KIT;ALK;ROR2;KDR;PTPRT;EPHA3;FGFR4;GUCY2C;EPHB2;SHC4;EFS
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.7065921698926239,-1.13970775058184,0.25,0.9948338640440748,1.0,2/7,2.80%,BTC;EREG
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.7695255763214385,1.1396861306970338,0.3090909090909091,1.0,1.0,2/6,20.14%,TRPV3;PER1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.5181101106816011,-1.1396425158994128,0.30303030303030304,0.9937774341654153,1.0,9/45,12.11%,MDGA1;GPC4;EPHB2;LRFN4;CLSTN2;DLG5;EIF4G1;LHFPL4;SYNDIG1
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.6847772700993662,-1.139058485336584,0.3076923076923077,0.9947499073279359,1.0,3/7,11.56%,SOX12;BCL6;DUSP10
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.7183286349050789,1.1390057431375953,0.3469387755102041,1.0,1.0,1/7,3.05%,GOT1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),-0.7029952094044253,-1.1389329936990666,0.3076923076923077,0.9940440748442798,1.0,3/8,20.16%,CHRM5;OPRM1;HRH4
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.5065199909492533,1.138889722889626,0.24615384615384617,1.0,1.0,17/65,24.58%,WFS1;FANCI;PHF23;SMAD7;BRCA1;RIPK2;DERL1;SPHK1;GNL3;PINK1;DCUN1D1;LRRK2;RCHY1;UBE2D1;LAPTM5;UBQLN1;UBE3A
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.6289366047936576,1.1383036256903343,0.34328358208955223,1.0,1.0,5/14,17.47%,KCNE2;KCNQ1;ATP1B1;KCNE4;ATP1A1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5846200586988749,1.1380767165797798,0.2786885245901639,1.0,1.0,4/24,13.98%,CAV3;FKBP1B;CAMK2D;PLN
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.5285371792001817,-1.1380484365370243,0.3783783783783784,0.9961979914905582,1.0,10/23,19.82%,SMYD2;FBLL1;SUV39H2;PRMT8;PRMT5;EHMT2;SIRT7;PRMT6;CREBBP;EHMT1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.5047862506708649,1.1379750943761,0.2328767123287671,1.0,1.0,36/97,32.89%,CHMP4B;RPL15;RPS7;RPL36;MAN1A1;RPL9;RPS21;RPL38;SRP9;RPL21;RPL22;SPCS3;SRP19;RPS5;RPLP2;SRP68;RPS13;RPL27;RPL35A;RPL35;RPL3;RPS20;RPL27A;RPS27A;RPL13A;RPL5;RPS29;RPS12;SEC62;RPL7;RPL32;RPS4X;RPL37A;RPL24;RPS9;RPL28
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),0.7227301806988207,1.1376724408774184,0.4,1.0,1.0,3/6,23.63%,TWIST1;GSTP1;SYK
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.6008126401774059,1.1374665133127226,0.21052631578947367,1.0,1.0,3/19,11.79%,P2RY12;STAP1;EPS8
prerank,GO_Biological_Process_2021__photoreceptor cell outer segment organization (GO:0035845),0.7329211581018295,1.137465959975715,0.3230769230769231,1.0,1.0,1/5,2.31%,RP1
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),0.7722887457278109,1.1367556033856943,0.4,1.0,1.0,4/5,22.26%,NODAL;CALR;ACVR1C;GJA1
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.4211646775081521,-1.1366487943517816,0.2,0.9996869123460767,1.0,25/109,14.86%,PTPRT;KCNIP1;SPHKAP;NTSR2;SLC6A1;SST;KCNC1;ZNF536;MAPK4;ADGRA1;UBE2QL1;TMEM196;VIP;MMD2;CBLN4;GAD2;STMN2;LRRTM3;ELAVL3;SYN2;RGS7BP;GRIA2;GABBR2;BRINP2;BRINP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.7010519076603599,1.136529963169043,0.28846153846153844,1.0,1.0,3/11,10.92%,IGFBP5;PRKG1;DOCK4
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.7526444384725393,1.136168059231211,0.3541666666666667,1.0,1.0,1/6,10.77%,DRD3
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.6502109413866104,1.1361414039995632,0.25396825396825395,1.0,1.0,3/12,10.48%,ZNF703;CCL5;PLAUR
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.7135756946818108,1.1360306192259544,0.359375,1.0,1.0,2/7,3.21%,ZBTB7B;PRLR
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.5133153503082054,1.1356818291316433,0.23880597014925373,1.0,1.0,8/59,13.76%,LIPH;PRLR;ACSL5;HMGCR;SCD;CYP19A1;LIPI;ACSM4
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.687729112434728,1.1354093449432148,0.375,1.0,1.0,2/9,9.70%,ZNF703;SMAD7
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),-0.6223045193451984,-1.135357200754292,0.4,1.0,1.0,3/8,22.16%,WNT9B;NR4A2;LRP6
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.6515743838974123,1.1351405779517003,0.27586206896551724,1.0,1.0,5/13,22.77%,GPR68;PKD1L3;HVCN1;MCOLN1;SLC9A1
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.6864578832891677,1.1351120983005845,0.34615384615384615,1.0,1.0,4/7,26.69%,B2M;ATP2A2;ATP2A3;PTPRF
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5453331469610609,-1.135102834163559,0.29545454545454547,1.0,1.0,7/18,18.86%,ERCC2;GTF2H2;ERCC1;CUL4A;DDB2;GTF2H5;ERCC3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5453331469610609,-1.135102834163559,0.29545454545454547,1.0,1.0,7/18,18.86%,ERCC2;GTF2H2;ERCC1;CUL4A;DDB2;GTF2H5;ERCC3
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.7441749055993556,1.134773698600343,0.35294117647058826,1.0,1.0,1/5,5.47%,GBA3
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.5398032069250343,-1.1346921905666072,0.3142857142857143,1.0,1.0,2/17,9.66%,EIF2B3;EIF4G1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.5104049579618518,-1.1344976202942432,0.2777777777777778,1.0,1.0,4/33,11.37%,SRPK3;PTCD2;IWS1;SON
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.49806855609754846,1.134308933966998,0.25333333333333335,1.0,1.0,12/126,5.16%,CASP12;PTGES;LRRC19;PTGIS;CCL5;HCK;PLA2G7;MMP26;ELANE;LPCAT3;IL15;AGT
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.6770845309070068,1.1342023539910044,0.36363636363636365,1.0,1.0,1/10,1.33%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.6775833977659628,1.1338610985695508,0.3114754098360656,1.0,1.0,4/10,21.77%,TGFB1;GSTP1;CLTC;TAF7
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.6443579249412005,-1.1337437644774608,0.425,1.0,1.0,1/8,4.54%,LTC4S
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.51754043206702,-1.1332874743785546,0.2,1.0,1.0,3/32,5.18%,LEF1;NFATC1;GNAO1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",0.6505792672680011,1.1332317484898222,0.36585365853658536,1.0,1.0,1/13,3.54%,KNL1
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.5574373964181234,-1.132993610858577,0.2765957446808511,1.0,1.0,5/22,16.84%,ZC3H12B;RNASE1;POP1;ZC3H12C;LACTB2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.7273906698811563,1.1328566387167451,0.3620689655172414,1.0,1.0,2/5,24.70%,TGFB1;FLOT1
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.6764505607144058,-1.1327656550024474,0.4146341463414634,1.0,1.0,2/5,13.67%,EIF4G1;COL5A1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.7204758568007552,-1.1324694978412997,0.3888888888888889,1.0,1.0,4/6,26.61%,DPH5;DPH1;DPH7;DPH6
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.7204758568007552,-1.1324694978412997,0.3888888888888889,1.0,1.0,4/6,26.61%,DPH5;DPH1;DPH7;DPH6
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.6029421367736881,-1.1323287304892646,0.3023255813953488,0.9993531548867555,1.0,2/13,2.32%,PID1;MYH14
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.7774441639448965,1.1322344592211517,0.3888888888888889,1.0,1.0,2/6,11.58%,BCAP31;HERPUD1
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.7287994066057794,-1.1318330152041898,0.2702702702702703,0.9996322171622638,1.0,3/11,9.22%,PNP;ITPA;DNPH1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.4740047922125129,-1.1316875784311953,0.22857142857142856,0.9988413627670591,1.0,9/50,6.90%,KIT;ITGA4;EPHB2;RABL3;HDAC5;RASGRP1;AKAP17A;BCL2;IL11
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.6122086784246017,-1.131649854656911,0.3111111111111111,0.9977429323372594,1.0,2/11,2.32%,PID1;MYH14
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.6522667354598715,-1.1310578179373454,0.3055555555555556,0.9984403077977669,1.0,3/6,22.77%,MX1;DNM2;SNAP91
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.5408672170801785,1.1307905730119978,0.26865671641791045,1.0,1.0,4/43,13.33%,NQO1;PSMB6;PSMA3;PSMB8
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.6669009709288677,1.1306418676523873,0.3157894736842105,1.0,1.0,4/9,20.77%,CHMP2B;CHMP1A;CHMP2A;VPS4A
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.6669009709288677,1.1306418676523873,0.3157894736842105,1.0,1.0,4/9,20.77%,CHMP2B;CHMP1A;CHMP2A;VPS4A
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.5187897703701956,1.1301450647397921,0.24285714285714285,1.0,1.0,13/34,27.37%,AHR;IGFBP5;STAT1;AQP9;KCNQ1;CRHBP;DMTN;HCN4;SLC5A5;PDE2A;SLC26A6;DUOX1;INPP5K
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6189272955495805,1.1300419231247685,0.29411764705882354,1.0,1.0,3/19,8.42%,SLC12A7;SLC26A4;CLCN3
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.5035748011319741,-1.1298731478169692,0.21621621621621623,1.0,1.0,1/37,0.23%,NOX4
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.7329332408025724,1.1294344964572498,0.3050847457627119,1.0,1.0,1/5,17.07%,SLC9A6
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.401019620389104,-1.1292756674835291,0.1875,1.0,1.0,30/286,8.88%,CD38;BCL2A1;KDR;HMGN5;LEF1;MIEN1;GREM1;SH3RF1;FHL2;ASCL1;APIP;IGF1;NTSR1;TRIAP1;SFRP1;GRK5;MGMT;TCIM;HDAC1;CFLAR;AZU1;BCL2;PLK2;PDPN;RAB7A;HSPB1;DCPS;NR1H4;VIP;PTMA
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.5621908228588728,1.1292137525372734,0.3684210526315789,1.0,1.0,3/35,3.92%,LIPH;CAV3;FABP3
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.6812168619376191,-1.1290299375001527,0.4186046511627907,1.0,1.0,2/8,8.84%,F2RL1;ANO6
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.6085579397840966,1.1289471377337454,0.3114754098360656,1.0,1.0,2/21,7.95%,DOCK1;ARHGAP25
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.7096901238633531,-1.1284823087315223,0.3333333333333333,1.0,1.0,2/5,20.30%,BAG3;PRKN
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.6717521643166272,-1.1276264845313693,0.425,1.0,1.0,1/10,6.58%,MAPK7
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7389542137590414,1.1274053012770666,0.2711864406779661,1.0,1.0,3/5,26.06%,CNTN2;CNTNAP1;EPB41L3
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),-0.6635927443747207,-1.1272685509788516,0.38461538461538464,1.0,1.0,2/7,7.36%,BCL2;ACE2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.49925914544740724,-1.1272562487957694,0.3,1.0,1.0,13/66,14.85%,LAMB2;ITGA4;ARL13B;LAMB3;NTNG1;SIPA1L3;TYRO3;NRP1;ITGA8;PARVA;RILPL1;VAMP3;TBCD
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.5073170718175746,-1.1272007925378213,0.2647058823529412,1.0,1.0,3/35,2.80%,NOX4;BTC;EREG
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.7168305630680158,1.1269945439117817,0.3269230769230769,1.0,1.0,2/6,11.52%,BAAT;STAT5A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.714936955126233,1.126701822153349,0.39622641509433965,1.0,1.0,1/6,2.70%,ATF5
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.6661192645033327,1.1265890795979205,0.375,1.0,1.0,3/10,15.62%,KCNE2;KCNQ1;KCNE4
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.7139155190050674,-1.1264319341099116,0.38095238095238093,1.0,1.0,2/5,9.05%,CELA2A;IDE
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.6991830937526079,-1.1252505792963259,0.3617021276595745,1.0,1.0,5/8,7.68%,RTP5;TAS2R7;TAS2R9;CA6;GNAT3
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),-0.7078624798738115,-1.1251992866968072,0.41304347826086957,1.0,1.0,1/5,10.27%,MTR
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),-0.7078624798738115,-1.1251992866968072,0.41304347826086957,1.0,1.0,1/5,10.27%,MTR
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5976036275695477,1.1251528819746737,0.30985915492957744,1.0,1.0,1/19,1.54%,AGER
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.6608218286032511,1.1248010827985482,0.25,1.0,1.0,5/14,18.37%,CALCR;AKAP5;PJA2;LRRK2;ADGRV1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.6079594158915094,1.124585508401872,0.3333333333333333,1.0,1.0,9/20,19.88%,B3GALT1;B3GNT4;B3GNT3;NDST4;CSGALNACT1;B3GALNT1;B4GAT1;HAS3;NDST3
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.7077074628967726,-1.1241569054785656,0.3103448275862069,1.0,1.0,3/6,11.35%,GREM1;PMEPA1;NOG
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.6646100319845334,-1.1241543576904343,0.2702702702702703,1.0,1.0,3/6,15.06%,EXOSC10;EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.6393151678841095,-1.124128987747281,0.3469387755102041,1.0,1.0,1/6,1.87%,SH3RF1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.473628204680498,-1.123731294062724,0.175,1.0,1.0,7/76,4.15%,UBASH3B;SPRED1;TRIB2;PTPRT;PTPRB;PRKRIP1;WWTR1
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.7700962137042735,1.1234373753424394,0.375,1.0,1.0,1/5,6.23%,MGME1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.6206843567548772,1.1232692803055826,0.36363636363636365,1.0,1.0,8/14,24.23%,CCL5;P2RY12;PODXL;CXCL13;SKAP1;SFRP2;SYK;ADAM9
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.6918600379038812,-1.123196476480272,0.3111111111111111,1.0,1.0,1/5,10.76%,NRP1
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.43336720212034907,-1.1231960793700755,0.2727272727272727,1.0,1.0,23/167,5.66%,ITGB5;NPNT;KDR;COL15A1;LAMB2;ITGA4;ADAM19;ADAMTS2;ADAMTS3;LAMA4;ADAM12;COL6A2;ADAMTS15;LAMB3;LOXL1;ADAMTS8;COL11A2;ITGA6;PAPLN;VCAN;TNR;COL4A3;ADAMTS5
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.5062122100165917,-1.1231174819440641,0.17857142857142858,1.0,1.0,4/55,8.66%,STING1;ARL13B;RAB7A;PCNT
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.5319396961645848,1.1230609151600863,0.21875,1.0,1.0,10/43,16.12%,CFAP54;ODAD4;DNAH11;ODAD3;CCDC39;CABYR;DNAH7;TTC29;DNAI3;DNAI1
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.6378485621405533,1.1229607239025328,0.36666666666666664,1.0,1.0,3/15,10.78%,HENMT1;MRPL44;CLP1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.7210772958407097,1.1226078268410542,0.3898305084745763,1.0,1.0,1/7,6.44%,PEX16
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5143148811867037,1.1224822183509262,0.27692307692307694,1.0,1.0,18/55,22.74%,ACKR3;TRIM32;SYVN1;CDKN2D;YBX3;SOD2;BCL2L2;PLAUR;HERPUD1;DNAJA1;PINK1;BCL2L1;LRRK2;RTKN2;ARMC10;SNAI2;CREB3;SFRP2
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.52216293074887,-1.1218294087621425,0.2857142857142857,1.0,1.0,4/49,3.65%,PER2;G6PC3;RBP4;SLC37A4
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.6660960340860046,1.1217151725125512,0.3148148148148148,1.0,1.0,1/14,1.11%,C17ORF99
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.6911282634088137,1.1214044592956898,0.34328358208955223,1.0,1.0,3/9,28.32%,RPS7;MAD2L1;RPL5
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.6703991026849512,1.1213485192249908,0.328125,1.0,1.0,4/10,24.71%,HLA-A;SFTPD;TF;WFDC2
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.5265596961801335,1.1212394348018182,0.2714285714285714,1.0,1.0,8/45,25.81%,NQO1;PSMB6;PSMA3;PSMB8;PSMA5;PPM1K;AZIN1;PSMC6
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.6699057378028712,-1.1212332903960698,0.4186046511627907,1.0,1.0,3/8,11.80%,SLC25A29;SLC22A3;SLC22A1
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.5066475336036824,-1.1212111511243115,0.23333333333333334,1.0,1.0,4/15,10.18%,APOA1;APOE;SCARB1;RORA
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.6586453189764251,1.1208732946187574,0.3103448275862069,1.0,1.0,1/15,1.45%,TDG
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.573764343255861,1.1208628785100356,0.3050847457627119,1.0,1.0,11/41,23.69%,PLCH1;PLCG2;PLCD3;IMPA2;INPPL1;ITPKB;IPMK;PLCD1;IPPK;INPP4B;NUDT4
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.6051589431714863,1.1207415167952193,0.32786885245901637,1.0,1.0,3/22,7.63%,ITK;P2RY12;AVPR1A
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.6677037253491926,-1.1206515803492545,0.34782608695652173,1.0,1.0,2/6,13.27%,TPR;XRCC3
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.6677037253491926,-1.1206515803492545,0.34782608695652173,1.0,1.0,2/6,13.27%,TPR;XRCC3
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.7151299169949279,1.1206266276320005,0.41509433962264153,1.0,1.0,2/5,13.98%,CAMK2D;PLN
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.604066608349716,1.1204310729230356,0.3684210526315789,1.0,1.0,4/11,18.64%,ERAP2;HLA-A;B2M;ERAP1
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.5760296546124497,1.1196380021795203,0.3508771929824561,1.0,1.0,8/35,14.83%,HNF4G;BCO1;HSD11B2;GPX2;B3GNT3;PIEZO2;EPCAM;CD99
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.7323368036270538,1.1196037467119189,0.35714285714285715,1.0,1.0,3/5,21.88%,ATP6AP1;SIGLEC15;NOTCH2
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.6700646301370221,1.1193758561979343,0.3728813559322034,1.0,1.0,1/9,3.94%,NTF3
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.5933245386382797,1.1186774924458047,0.3380281690140845,1.0,1.0,2/25,4.65%,LRP4;OMG
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.46133706119044404,-1.1185410232356776,0.20588235294117646,1.0,1.0,15/79,10.96%,KIT;TPD52L1;TRIB2;BMP7;SPRY4;RGS14;PDGFD;RASGRP1;PIK3R6;PRKCD;SPRY3;APOE;PDGFC;SORL1;RGS2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.7011329149208704,1.118373091993815,0.37735849056603776,1.0,1.0,3/9,15.92%,STK26;REST;PINK1
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),-0.7060717993844681,-1.118333895858198,0.33962264150943394,1.0,1.0,3/5,24.43%,SIRT2;RCC2;CCNB1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.4477405572747718,-1.1180058835830966,0.2608695652173913,1.0,1.0,24/153,8.33%,ETV1;ETV5;TRIB2;BTC;F2RL1;CA2;RBP4;EPHB2;ZNF277;PTCD2;PRKG2;EREG;IL1RL2;PRRX1;ANO1;ETS1;CIDEA;ID2;ALDH1A2;ATG10;ALDH1A3;NR1H4;CROT;IL10RA
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.6399435122489092,1.1179867483142256,0.35,1.0,1.0,4/14,14.06%,LOXL2;BMP1;SOX6;SCX
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.6244437978982694,-1.1176313749732925,0.37142857142857144,1.0,1.0,1/9,0.91%,PTPRT
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.6625484857419137,-1.117620974168465,0.30303030303030304,1.0,1.0,5/7,31.42%,STAT3;PXN;JAK2;PIK3R1;GHR
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.6182621939784017,1.1174920929273304,0.30357142857142855,1.0,1.0,3/18,10.56%,PPARGC1A;RPS6KA4;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.5698137155326765,1.1173765614338478,0.3235294117647059,1.0,1.0,3/24,5.59%,PPP1R1B;SH2D4A;FKBP1B
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.5284074339171418,1.1171590985766704,0.22058823529411764,1.0,1.0,8/41,22.03%,RFC5;POLE2;RPA3;PCNA;TRIM25;POLN;RCHY1;POLD1
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),0.757176386951701,1.117004058382667,0.37037037037037035,1.0,1.0,3/5,24.13%,HLA-A;CTSH;EMP2
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.6729775925203231,1.116907653578017,0.4166666666666667,1.0,1.0,4/7,11.89%,AHR;PTPRC;SMAD7;IL4I1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.6453732347946879,1.1168142349706562,0.3333333333333333,1.0,1.0,5/13,23.59%,PAICS;AMPD2;IMPDH1;GMPS;PPAT
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.5847787641163078,1.116347312876796,0.2857142857142857,1.0,1.0,3/16,10.55%,CTNNA1;UFM1;RAB23
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.5167162922054457,-1.1158331513139859,0.24390243902439024,1.0,1.0,4/23,14.10%,PID1;PRKCD;PTPN1;IRS1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.6044014780577779,1.1157388866188516,0.35384615384615387,1.0,1.0,7/24,11.52%,CALCR;AGER;STAT4;STAT1;EIF2B5;STAT6;STAT5A
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.4527602662549806,-1.1156460367472032,0.23333333333333334,1.0,1.0,3/80,1.44%,FBXL7;CDK2AP2;GFI1B
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.5308086663851864,1.1155107195793401,0.2786885245901639,1.0,1.0,8/44,11.79%,ROPN1B;PLEKHG7;RIPOR1;WAS;RHOB;CELSR1;RHOU;EPS8
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.5183432327373879,1.1149075856448722,0.30985915492957744,1.0,1.0,22/56,14.35%,C4BPB;HSD17B2;ANKS4B;TPO;PRLR;SLC23A1;ITIH2;SULT2A1;SERPINA10;UPB1;KNG1;TSHR;ALDOB;SLC26A7;LECT2;UGT2B7;ASGR1;SLC10A1;ABCC6;DIO1;PIK3C2G;PDZK1
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),0.758467112461143,1.114726681325061,0.3148148148148148,1.0,1.0,2/6,7.83%,MCM2;MCMDC2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),0.758467112461143,1.114726681325061,0.3148148148148148,1.0,1.0,2/6,7.83%,MCM2;MCMDC2
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.771701797072581,1.1145269633712998,0.40625,1.0,1.0,2/6,9.96%,SLC25A18;LRRC8D
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.7221023145058467,1.1144725987024604,0.4,1.0,1.0,1/5,16.54%,CD74
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.6672137513955173,-1.1143897775326965,0.425,1.0,1.0,4/8,26.61%,DPH5;DPH1;DPH7;DPH6
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.4899442165808124,-1.1143763090931664,0.2777777777777778,1.0,1.0,3/35,6.85%,ALK;RILP;CIDEA
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.5585374899162159,-1.1143696063333322,0.25,1.0,1.0,3/22,4.14%,KIT;KDR;SFRP1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.6362219822232947,-1.1142077750812034,0.37777777777777777,1.0,1.0,3/6,19.00%,SH3GLB1;PLEKHM2;DNM2
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),0.7344226339729032,1.1141811073954349,0.3548387096774194,1.0,1.0,2/5,15.92%,ATP5IF1;PINK1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.6071058758649946,-1.1141794341414542,0.275,1.0,1.0,5/13,10.25%,SULF2;SPRY4;APLN;SPRY3;CREB3L1
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.6128419693833113,-1.113812314218097,0.27450980392156865,1.0,1.0,1/16,1.29%,BUD23
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.617718909447778,-1.1137868372350384,0.325,1.0,1.0,4/15,7.62%,GCH1;SPHK2;SPTLC1;DHFR
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),-0.7185028001730515,-1.113690771692155,0.4418604651162791,1.0,1.0,4/5,25.44%,CARMIL2;MTPN;CRACD;CARMIL1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),-0.5703999357654921,-1.1134740640125806,0.32558139534883723,1.0,1.0,4/12,15.54%,PLIN5;CIDEA;PNPLA2;OSBPL11
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6161038822145684,1.1133719700537215,0.3064516129032258,1.0,1.0,4/14,15.56%,TRIM5;CARD8;SCIMP;LY86
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.5671448862675802,-1.1132076739555041,0.34782608695652173,1.0,1.0,1/17,0.83%,MYB
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.4350164495663677,-1.11275723617853,0.3333333333333333,1.0,1.0,23/167,5.66%,ITGB5;NPNT;KDR;COL15A1;LAMB2;ITGA4;ADAM19;ADAMTS2;ADAMTS3;LAMA4;ADAM12;COL6A2;ADAMTS15;LAMB3;LOXL1;ADAMTS8;COL11A2;ITGA6;PAPLN;VCAN;TNR;COL4A3;ADAMTS5
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.526230254480445,1.112625932495183,0.24285714285714285,1.0,1.0,13/45,16.58%,BAAT;PRLR;HSD11B2;HSD17B10;HMGCR;ACOX2;CYP19A1;SQLE;MSMO1;INSIG2;DHCR7;FAXDC2;INSIG1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.47774768232565484,1.1125268827277932,0.2777777777777778,1.0,1.0,26/99,18.66%,LAMA2;CSRP3;PDE1A;CAV3;TRIM54;NOTCH1;FABP3;MYOM1;ACTC1;PRKG1;ADIPOR2;CASQ1;MYBPC3;CKB;MITF;NEXN;PLN;TTN;RRAD;TRDN;MYH7B;FLNC;ZFPM2;MTTP;SGCG;CTNNA3
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.5040389058121572,-1.1121887842580391,0.3157894736842105,1.0,1.0,2/28,1.06%,ATP6V0D2;RAB32
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.5705913261498115,1.1121457247633793,0.288135593220339,1.0,1.0,1/21,1.33%,CAV3
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.5354466046600701,-1.1120096255024403,0.32432432432432434,1.0,1.0,1/24,1.40%,CPSF1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.5354466046600701,-1.1120096255024403,0.32432432432432434,1.0,1.0,1/24,1.40%,CPSF1
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.6276860500230155,-1.111957922548327,0.34210526315789475,1.0,1.0,2/8,12.64%,BMP6;SCAP
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.7830315472052286,1.1112505242514807,0.48214285714285715,1.0,1.0,2/5,16.78%,EIF2B5;CDK6
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.7131997736235692,1.1108224538419156,0.375,1.0,1.0,3/5,24.34%,NCBP1;EIF3E;FMR1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.6192436148311866,1.1106017910091641,0.3484848484848485,1.0,1.0,3/14,5.17%,MSX1;GLI3;TWIST1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.6047254612373625,-1.1105157344973366,0.35135135135135137,1.0,1.0,7/10,23.91%,CACNG5;NPTXR;NPTX2;DLGAP4;DLGAP2;DLGAP3;AKAP9
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.7240819644511913,-1.110469420936857,0.42105263157894735,1.0,1.0,2/5,8.45%,GREM1;ENPP3
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.6912246559081389,-1.1104133939796994,0.38095238095238093,1.0,1.0,1/7,3.40%,ZNHIT6
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.5391190046723774,1.1102821069505162,0.296875,1.0,1.0,4/39,4.47%,MYLK;WFS1;CCL5;SCN4B
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.4622623949416079,-1.1102542733994487,0.30303030303030304,1.0,1.0,13/61,19.02%,WDR24;EPM2A;FAM83D;GNA12;TTI1;TELO2;RPTOR;LEP;ITFG2;TBC1D7;LAMTOR4;RHEB;NPRL2
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.5743910251769069,1.1100889619973349,0.3787878787878788,1.0,1.0,7/32,13.73%,SEMA3D;SOX10;TBX1;SEMA3F;SEMA3A;HTR2B;FN1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.7383443880027907,-1.1099373812590192,0.4,1.0,1.0,1/5,3.63%,SFSWAP
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.6556170775808894,1.1098001302103675,0.46774193548387094,1.0,1.0,5/14,10.21%,CCL5;HCK;CD14;CD6;TGFB1
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.6884081401063006,-1.1096034197513802,0.3617021276595745,1.0,1.0,1/7,0.56%,UBASH3B
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.5813966519687833,1.1093069932543618,0.3220338983050847,1.0,1.0,9/31,16.87%,BORA;CHMP4B;PSRC1;TPX2;CHMP2B;CHMP1A;EML3;CHMP2A;GPSM2
prerank,PanglaoDB_Augmented_2021__Neurons,0.4201986739498848,1.1091657350486839,0.2857142857142857,1.0,1.0,18/265,10.83%,NPY;CALB1;PPP1R1B;PDE1A;SHISA2;ZDHHC22;GRM3;SYT4;ZCCHC12;SCRG1;IFIT3;CNTN2;SPOCK3;NEFM;RIT2;KCNJ9;C11ORF87;GAD1
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.6550094610642763,-1.1090343057340244,0.4418604651162791,1.0,1.0,2/6,15.70%,TICAM1;IRAK3
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.6439235545383384,1.1089713239141703,0.26666666666666666,1.0,1.0,6/15,21.39%,ZBTB7B;IL15;TGFB1;SPHK1;IL18;PRNP
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.7285337017132516,1.108940977179384,0.36538461538461536,1.0,1.0,3/9,7.83%,MCM2;GINS1;MCMDC2
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.6245148290382236,1.1088611800572616,0.36923076923076925,1.0,1.0,2/11,1.31%,SLCO6A1;SLCO2B1
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),-0.5828027193099756,-1.1088363917580388,0.3142857142857143,1.0,1.0,3/11,14.24%,C5AR1;LRRTM3;NLGN3
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),-0.5935006239190075,-1.1084239912885405,0.2777777777777778,1.0,1.0,2/17,0.41%,MDGA1;GPC4
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),-0.5935006239190075,-1.1084239912885405,0.2777777777777778,1.0,1.0,2/17,0.41%,MDGA1;GPC4
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),0.7321731308318498,1.1083218689688905,0.4307692307692308,1.0,1.0,3/5,18.14%,RARRES2;PLCG2;CX3CR1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.6199855101307131,-1.1079152712641887,0.38461538461538464,1.0,1.0,3/12,13.27%,TPR;CDK5RAP2;XRCC3
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.4415104030158601,-1.1079047291532453,0.25,1.0,1.0,11/49,14.42%,DECR2;EHHADH;ACOT8;CROT;MECR;ABCD1;ACADVL;HADHA;SLC27A2;SLC25A17;ACOX3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.6981107204569347,-1.10777702080754,0.36585365853658536,1.0,1.0,1/7,0.35%,KIT
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.4383243000816316,-1.1076340566278018,0.27586206896551724,1.0,1.0,8/89,3.53%,KIT;ROR2;KDR;SELP;UNC5B;F2RL1;PDGFD;IGF1
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.7268988054256074,-1.107500574086293,0.3902439024390244,1.0,1.0,2/5,20.95%,MME;STK11
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.5321167411104352,-1.1074573824366134,0.32432432432432434,1.0,1.0,10/19,23.91%,CACNG5;NPTXR;NPTX2;HTR2C;DLGAP4;SLC8A3;DLGAP2;TYMP;DLGAP3;AKAP9
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),0.7565664717043132,1.1069197561784236,0.39344262295081966,1.0,1.0,2/5,14.22%,ACTC1;TTN
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.5527213062538177,-1.106896768350419,0.36363636363636365,1.0,1.0,1/9,1.38%,F2RL1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.4231190093929546,-1.1068666034084111,0.23529411764705882,1.0,1.0,25/86,20.89%,GEM;HDAC5;HDAC1;RFWD3;ZBTB7A;SMARCA4;HMGB2;PHF1;HMGA2;CUL4A;COPS6;LRWD1;MTHFR;HMGN1;DDB2;LATS1;HMGN2;PWWP3A;XPC;LDB1;HDAC10;EHMT1;SAFB;HDAC11;MSH3
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.6899937067782932,1.1066828945897813,0.41379310344827586,1.0,1.0,2/8,6.47%,H3-3A;SUV39H1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.5830610851058761,1.1064753871641237,0.2857142857142857,1.0,1.0,3/25,7.72%,PREX1;WASF1;WAS
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.5671491569284208,1.106379822109361,0.3880597014925373,1.0,1.0,2/23,3.87%,GLI3;HHIP
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.4464020842449036,-1.1062844968537235,0.23809523809523808,1.0,1.0,11/103,9.50%,ETV5;NOX4;PRR5L;FOS;GPX7;PRKCD;VKORC1L1;RBM11;PDGFRA;AKR1C3;ANKRD2
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.5047255332745613,-1.1062547126328128,0.3225806451612903,1.0,1.0,2/27,3.53%,NRG1;IGF1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.6800189575608376,-1.1061137230647984,0.4146341463414634,1.0,1.0,3/9,19.10%,RPTOR;ICE1;MTOR
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.48459015970492536,-1.106060904033836,0.3448275862068966,1.0,1.0,7/37,10.58%,CARD18;SH3RF1;TRIAP1;IGBP1;IFI16;XIAP;NGF
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.6811982242876738,-1.105966221248827,0.3488372093023256,1.0,1.0,2/7,8.45%,SPHK2;ENPP3
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),0.7556421519767471,1.105895676190263,0.3508771929824561,1.0,1.0,2/5,13.46%,OPRK1;OPRD1
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.6617306165995808,-1.105679536357494,0.3695652173913043,1.0,1.0,3/8,11.11%,FGF13;NGF;PTPRS
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.611167729945554,1.1056232317841213,0.3548387096774194,1.0,1.0,4/21,5.57%,NTF3;ADGRB1;SOX10;ARTN
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.4820684978515838,-1.105490516658043,0.2564102564102564,1.0,1.0,4/48,7.50%,KDR;STING1;EPM2A;SPTLC1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.5313852295527113,1.1054408859254021,0.3582089552238806,1.0,1.0,5/46,9.82%,ENPP2;RREB1;MARVELD3;DOCK1;PLCG2
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),-0.6895107637069612,-1.1051751811547927,0.42857142857142855,1.0,1.0,4/6,24.60%,MTR;MTHFR;CTH;MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),-0.7177015892364302,-1.104501128304002,0.45454545454545453,1.0,1.0,1/5,9.86%,SCARB1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.4697012375681572,-1.1041594732125144,0.35714285714285715,1.0,1.0,8/43,12.51%,SULF2;BMP7;RBP4;PTCH1;ALDH1A2;TGFB3;NOG;TRIM71
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.5168270753579158,-1.1039802047986207,0.28125,1.0,1.0,10/42,20.92%,PRR5L;KHSRP;POLR2G;MEX3D;BTG2;ZC3HAV1;PNPT1;RC3H1;NANOS3;CELF1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.4420967541182742,1.1038576221490846,0.26666666666666666,1.0,1.0,33/184,17.62%,CASP12;NOX5;MCM2;BIK;BOK;AHR;DAPK2;FADD;BNIP3;TBX1;CD14;CASP8;RNF152;RHOB;SIAH1;FAS;IRF1;BCL2L14;KREMEN1;TSC2;GLRX2;RFK;PAWR;DHCR24;TCHP;IFI27;TNFAIP1;PDCD4;FXR1;PLSCR1;BCL2L1;TLR2;NSG1
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.6254323794037122,1.103756590632377,0.3448275862068966,1.0,1.0,5/19,14.22%,CSRP3;MYPN;CASQ1;SIX4;TTN
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.645498521281089,-1.1034835229838411,0.3902439024390244,1.0,1.0,3/9,23.90%,RANGRF;HSPA1A;CKAP5
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.558205686404045,1.1034513010176832,0.4262295081967213,1.0,1.0,6/28,17.17%,SYT2;SYT4;DRD3;SYT9;SYT15;SYT13
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.5039783862079126,1.1034056661172806,0.38666666666666666,1.0,1.0,5/39,8.68%,TRIM5;ARIH2;PELI3;TRAF3IP2;RNF152
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.4352036962262989,-1.1033637596930668,0.21212121212121213,1.0,1.0,14/74,14.69%,SPRED2;SPRED1;FGFR4;SFRP1;FIBP;POLR2G;FGFRL1;GTF2F1;TRIM71;POLR2C;POLR2L;PTBP1;FGFR3;FLRT2
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.6757704927860739,-1.103243356174112,0.4146341463414634,1.0,1.0,1/5,4.42%,TICAM1
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.7008155366266492,1.1028289472932156,0.36923076923076925,1.0,1.0,2/11,7.05%,MSX1;TBX1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.596443458457424,-1.1028243397575956,0.2894736842105263,1.0,1.0,1/11,0.85%,BCL2L11
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.7176702913168937,1.1027091172850771,0.37254901960784315,1.0,1.0,2/6,16.00%,FN1;FURIN
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.6289685730559125,-1.102502028220404,0.32608695652173914,1.0,1.0,3/11,13.70%,SLC37A4;SLC20A2;SLC25A10
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.6289685730559125,-1.102502028220404,0.32608695652173914,1.0,1.0,3/11,13.70%,SLC37A4;SLC20A2;SLC25A10
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.5540625082776505,1.102290664142814,0.3333333333333333,1.0,1.0,8/32,14.22%,CSRP3;PDGFRB;ACTC1;MYPN;CASQ1;SIX4;PGM5;TTN
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),-0.6854119026812615,-1.102188670335012,0.3617021276595745,0.9989720092033088,1.0,2/6,16.74%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),-0.6854119026812615,-1.102188670335012,0.3617021276595745,0.9989720092033088,1.0,2/6,16.74%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.5820149899900073,1.1021554921953942,0.391304347826087,1.0,1.0,3/23,1.66%,LRP4;GLI3;RSPO2
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.7107465643274178,-1.1018607998696286,0.38636363636363635,0.998804221001969,1.0,2/5,14.36%,DDX21;SIRT7
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.523738965657262,1.1017937040334462,0.3230769230769231,1.0,1.0,16/35,27.89%,CCL5;CIITA;STAT1;EPRS1;CD74;TLR2;GBP6;IFITM3;SP100;GBP5;PDE12;SLC11A1;SYNCRIP;CD47;SLC26A6;RPL13A
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.557856073677592,1.1013796422593223,0.30303030303030304,1.0,1.0,8/33,18.81%,ENO4;HKDC1;ALDOB;MANBA;PGAM1;NEU1;PKLR;HK3
prerank,PanglaoDB_Augmented_2021__Myocytes,0.4617468765273107,1.101240866119288,0.2875,1.0,1.0,14/88,10.37%,LAMA2;CSRP3;CAV3;TRIM54;FABP3;ANGPTL2;NID2;ACTC1;PRKG1;DOCK1;CMKLR1;CASQ1;NOTCH3;SIX4
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.6030096988197975,-1.101179778804135,0.375,1.0,1.0,5/14,10.30%,DECR2;EHHADH;ACOT8;CROT;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.6834738643372226,-1.1010051445688804,0.4523809523809524,0.998428701609498,1.0,2/7,8.84%,F2RL1;ANO6
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.6834738643372226,-1.1010051445688804,0.4523809523809524,0.998428701609498,1.0,2/7,8.84%,F2RL1;ANO6
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.5331735226702369,-1.1008800223602895,0.2619047619047619,0.9977883263474385,1.0,1/27,0.10%,F11
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.560508705373905,-1.100753042653802,0.29411764705882354,0.9972329225693666,1.0,3/23,5.82%,KIT;F2RL1;SPHK2
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.5957870582822147,1.1005334685773516,0.39285714285714285,1.0,1.0,1/15,1.31%,PLA2G10
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.5903661459117469,1.1002921504816954,0.3728813559322034,1.0,1.0,9/21,25.13%,MYBPC2;ACTC1;MYBPC3;TTN;ACTN2;TMOD1;MYH7;MYL6B;MYBPC1
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.5903661459117469,1.1002921504816954,0.3728813559322034,1.0,1.0,9/21,25.13%,MYBPC2;ACTC1;MYBPC3;TTN;ACTN2;TMOD1;MYH7;MYL6B;MYBPC1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.6079781352810603,-1.1000494042670665,0.41304347826086957,0.998013965937571,1.0,3/13,6.85%,ALK;SLC22A13;CIDEA
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.6202800098234498,1.0997481961195295,0.328125,1.0,1.0,2/12,9.20%,TICRR;CDC6
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.4336579659674525,-1.0997446945348603,0.26666666666666666,0.9978763358202649,1.0,16/77,12.70%,TPD52L1;F2RL1;RASSF2;TNFRSF19;SH3RF1;RASGRP1;TRAF3;SERPINF2;SH3RF3;TGFB2;SEMA4C;KLHDC10;ANKRD6;DUSP15;SH3RF2;MAP3K10
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.6634503183397313,-1.0995987549937696,0.39473684210526316,0.9972671754734369,1.0,3/11,14.20%,SPHK2;DGKD;GPD1L
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.5087326533693834,-1.0995361335700538,0.3611111111111111,0.9964652975046309,1.0,4/22,14.36%,TPR;EMD;BAG3;SIRT7
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.6153781853726532,1.0994545094437373,0.4225352112676056,1.0,1.0,6/22,12.40%,MSX1;SSUH2;INHBA;TBX1;FGFR2;TUFT1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.5731732404885655,1.0993423154142787,0.3787878787878788,1.0,1.0,1/19,1.79%,TMEM35A
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.606821076668073,1.0987916017311372,0.36507936507936506,1.0,1.0,6/15,20.85%,PLP1;SOX10;EIF2B5;ZNF488;CNTNAP1;B4GALT6
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.7135603430369342,-1.0986857072546607,0.36585365853658536,0.9982960821285823,1.0,3/7,8.79%,IGF1;RYR1;SELENON
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.5184063542862873,1.0985657353405447,0.35714285714285715,1.0,1.0,4/58,2.75%,CASP12;PTGES;LRRC19;HCK
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.5154573338823656,1.0984867760276136,0.26229508196721313,1.0,1.0,6/42,18.36%,RFC5;CDKN2D;RPA3;PCNA;TRIM25;POLN
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),0.7089241108761741,1.0984063732299332,0.3793103448275862,1.0,1.0,3/6,19.87%,STAT1;SIX4;BASP1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.4859248403289622,1.0983444967209592,0.28,1.0,1.0,33/88,32.89%,RPL15;RPS7;RPL36;RPL9;RPS21;RPL38;SRP9;RPL21;RPL22;SRP19;RPS5;RPLP2;SRP68;RPS13;RPL27;RPL35A;RPL35;RPL3;RPS20;RPL27A;RPS27A;RPL13A;RPL5;RPS29;RPS12;SEC62;RPL7;RPL32;RPS4X;RPL37A;RPL24;RPS9;RPL28
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),0.7404076795569243,1.0982708564352874,0.4444444444444444,1.0,1.0,3/6,20.66%,ALOX12;ALOXE3;GSTP1
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),0.7404076795569243,1.0982708564352874,0.4444444444444444,1.0,1.0,3/6,20.66%,ALOX12;ALOXE3;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.6271235357582807,1.0982427725213593,0.4098360655737705,1.0,1.0,5/12,22.15%,ADRB1;KCNQ1;ADRA1D;ATP2A2;RYR2
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),-0.6968112709749796,-1.0982007934249927,0.3939393939393939,0.9985598606257894,1.0,1/5,3.33%,LHFPL2
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.6704673598284256,1.098118542117811,0.3559322033898305,1.0,1.0,2/10,2.91%,CCL5;PLA2G7
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.7351980179950355,1.0979531438255228,0.3584905660377358,1.0,1.0,3/5,18.60%,SOD2;PDCD4;PPARG
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.6706249721249466,-1.0979236379830772,0.3958333333333333,0.9982704104787362,1.0,1/6,4.55%,DDX60
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.7609376311323537,1.0978893116455537,0.3793103448275862,1.0,1.0,3/5,19.48%,SPP1;MSN;NCOA4
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.7609376311323537,1.0978893116455537,0.3793103448275862,1.0,1.0,3/5,19.48%,SPP1;MSN;NCOA4
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.7104682854806101,-1.0975566303415332,0.41304347826086957,0.9982576172035091,1.0,2/5,13.66%,COX10;COA6
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6871228580060774,1.0973845473162736,0.36923076923076925,1.0,1.0,2/8,10.37%,AGT;SIX4
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.6871228580060774,1.0973845473162736,0.36923076923076925,1.0,1.0,2/8,10.37%,AGT;SIX4
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.6485452395510805,-1.0973770205927822,0.3902439024390244,0.9979002114842034,1.0,2/9,4.42%,F2RL1;TICAM1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.4134057455046821,-1.0973184108656442,0.25806451612903225,0.9971304810222034,1.0,10/136,4.28%,NRK;KIT;ROR2;KDR;SPRED1;GREM1;APIP;PRDM15;IGF1;RASGRP1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.6367132349123407,-1.097046584275841,0.40476190476190477,0.9969539222932946,1.0,1/8,3.55%,BDH1
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.565025530619313,1.097046204785161,0.3728813559322034,1.0,1.0,3/24,6.05%,CHRNB1;CAV3;MYOF
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.5305488691773579,1.0968744715265466,0.2857142857142857,1.0,1.0,11/39,15.92%,SLC7A11;SLC38A11;SLC38A8;SFXN3;SLC25A18;SLC36A1;LRRC8D;SLC38A2;SLC7A7;SLC38A5;SLC38A4
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.6076477206066798,-1.0967427567755585,0.39473684210526316,0.9946031464060593,1.0,3/10,13.27%,ERCC1;SMARCAL1;XRCC3
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.6076477206066798,-1.0967427567755585,0.39473684210526316,0.9946031464060593,1.0,3/10,13.27%,ERCC1;SMARCAL1;XRCC3
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.6076477206066798,-1.0967427567755585,0.39473684210526316,0.9946031464060593,1.0,3/10,13.27%,ERCC1;SMARCAL1;XRCC3
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.567811457844699,1.0967114962110367,0.36923076923076925,1.0,1.0,8/23,15.93%,ALDH4A1;IDO1;FAH;HSD17B10;ACMSD;IL4I1;DAO;HPD
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5111095596685336,-1.096116154483158,0.34146341463414637,0.9955120329248806,1.0,10/38,14.59%,STING1;IFIH1;POLR3D;TRAF3;RNF216;PTPRS;YY1;REL;CACTIN;MAVS
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5581570378341765,1.0960326773009816,0.3898305084745763,1.0,1.0,5/24,10.56%,FADD;CASP8;TMBIM1;FAS;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),-0.7189153991938824,-1.095588523204376,0.425,0.996227409398649,1.0,1/5,0.83%,MYB
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.6948496167006963,1.0950431803769114,0.3770491803278688,1.0,1.0,3/7,10.48%,CCL5;F11R;PLAUR
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.5720660467877432,1.0947503428457912,0.38461538461538464,1.0,1.0,2/23,4.31%,ENPP2;CYP1B1
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.6611528554242564,1.094601008683617,0.3333333333333333,1.0,1.0,5/9,28.81%,FAAH;DGAT2L6;PLA2G4A;DGAT2;DGAT1
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.6692932110461559,-1.0945753701703629,0.4634146341463415,0.998307717043746,1.0,5/6,29.08%,GMDS;PMM1;PMM2;GFUS;GMPPB
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.7394295012651975,1.0941728915170477,0.46808510638297873,1.0,1.0,1/5,14.43%,AMPD2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.6444549714468786,-1.0940202169221422,0.35135135135135137,0.9988683241187645,1.0,1/9,5.55%,TOX
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5470363558145599,-1.0939652202251888,0.3333333333333333,0.9980369239726444,1.0,5/19,13.63%,IGF1;APOE;SORL1;CLU;BIN1
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.41883415490919934,-1.0939356606558372,0.19230769230769232,0.9970575142709114,1.0,24/164,10.96%,FRMPD1;GNG4;UBASH3B;TSPAN12;RUNX1;RGS14;DOK5;PRAG1;DTX1;WWTR1;GRK5;PTCH1;ZDHHC3;TSPEAR;RGS8;CBFB;CSK;UBTF;AKR1C3;RORA;RGS20;LLGL2;GIT2;RGS2
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.4247545800255575,-1.0937247948355544,0.2857142857142857,0.9968965637473142,1.0,14/96,11.12%,PER2;GLP1R;UNC13B;ITPR2;IGF1;CELA2A;DRD4;CACNA1A;BMP6;TGFB2;TGFB3;APOE;LLGL2;DNAJC1
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.6144190979744283,1.093464108543577,0.328125,1.0,1.0,3/15,9.85%,PIGC;PIGH;PIGV
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.6505108076941296,1.0932512083152193,0.37142857142857144,1.0,1.0,5/10,23.98%,NLRP2B;NLRC3;USP50;GBP5;DDX3X
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.43134348799268746,1.0932145445338965,0.2839506172839506,1.0,1.0,31/180,19.28%,ENPP2;MYLK;RREB1;CCNG2;NKIRAS1;CD302;LPCAT3;MRAP;TST;PTGER3;ADIPOR2;FAH;YWHAG;STAT5A;STOM;ACOX1;ALDH2;ACADL;DHCR7;MTARC2;DECR1;PDCD4;SPARCL1;G3BP2;IDH3A;ACAA2;DBT;ARL4A;PPARG;ANGPTL4;RETSAT
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.7061521935706174,1.0930116155498844,0.36666666666666664,1.0,1.0,4/10,17.81%,CCL5;GPR183;MSMP;CXCL13
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5525179503812363,1.0929317219371935,0.3188405797101449,1.0,1.0,4/23,13.58%,LMAN1;SYVN1;HERPUD1;DERL1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.7218529036005192,1.0925089641332457,0.4444444444444444,1.0,1.0,2/6,6.44%,SERINC1;PEX16
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.4899263991333231,1.0923468861032295,0.2647058823529412,1.0,1.0,4/46,13.39%,LDLRAP1;ACKR3;TGFB1;LGMN
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.5185703496266056,-1.0923222533678456,0.38235294117647056,1.0,1.0,2/18,6.61%,F2RL1;TLR1
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),-0.5052205645723933,-1.0919396405060915,0.2619047619047619,1.0,1.0,3/24,7.64%,EPHB2;DOCK10;SHANK1
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),-0.7127188514681797,-1.091378707254795,0.3673469387755102,1.0,1.0,2/6,11.85%,APOE;LHFPL4
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.5738456658567026,1.0912868874905441,0.3939393939393939,1.0,1.0,6/17,23.98%,CCL5;EIF2B5;POLR2D;RPS6KB2;YTHDF1;DDX3X
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.7268050066494787,-1.0908332961546108,0.41304347826086957,1.0,1.0,2/5,20.03%,TPRKB;OSGEP
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5933525837913964,1.0907826569382708,0.36507936507936506,1.0,1.0,3/10,11.52%,PRLR;STAT6;STAT5A
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.6238970870046022,-1.0904227865569456,0.4444444444444444,1.0,1.0,2/9,10.69%,KDM8;KDM4B
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.6508334721000039,-1.0896203049943958,0.4,1.0,1.0,3/10,9.95%,PAH;DRD4;DRD1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.6983697930481854,-1.0892347115891872,0.4878048780487805,1.0,1.0,3/6,23.65%,PLEKHA7;CDHR2;MMP24
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.5102915814352433,-1.0891398693217649,0.36585365853658536,1.0,1.0,4/28,11.75%,LAMB3;ITGA6;LAMA3;TRIP6
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.4943187791603429,-1.0890188089995787,0.29411764705882354,1.0,1.0,7/43,11.71%,SELP;TNFRSF11A;GCH1;FOXP1;HMGB2;OTUD5;SIRT2
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),-0.6835991557534747,-1.0889743089465451,0.45,1.0,1.0,1/5,0.75%,PKP2
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.598559606154169,1.0888646926454546,0.3939393939393939,1.0,1.0,4/17,15.17%,ITGA5;NOTCH1;ZNF304;PDK4
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.6552939785290903,1.0887392379298504,0.3684210526315789,1.0,1.0,4/10,27.62%,KCNMB1;CALM3;RYR2;KCNMB2
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.5835143222987668,-1.0886416849426834,0.35135135135135137,1.0,1.0,2/14,2.20%,RBP4;EPHB2
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.5732897896720441,1.0884615540240112,0.3787878787878788,1.0,1.0,5/24,13.91%,RASA1;WAS;ABITRAM;BRK1;ARHGAP28
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.4279257290454781,-1.0881793021458113,0.2631578947368421,1.0,1.0,16/124,7.77%,ALK;EPHA3;SINHCAF;GREM1;RUNX1;CEBPD;KLK6;BCL6;TRPS1;PTHLH;ZFHX3;SERPINF2;ID2;CBFB;PDCD2;CDK5RAP2
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.5486348093486005,1.0872840422402654,0.36065573770491804,1.0,1.0,5/29,10.56%,ZBTB7B;ING2;PPARGC1A;RPS6KA4;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.4826519805915806,1.087256860718662,0.2903225806451613,1.0,1.0,11/57,18.81%,SPDYA;TRIM32;CCND2;PSRC1;CDKN1B;FGFR2;LGMN;SPHK1;RGCC;CDK4;CALR
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.5078227791021065,1.0867485294993158,0.3387096774193548,1.0,1.0,6/35,19.94%,RAD54L;MRE11;RECQL;RECQL4;RAD51C;RAD50
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.6069238853435132,1.086730735781812,0.38596491228070173,1.0,1.0,6/14,29.43%,ATP5F1E;ATP5F1C;ATP5MC3;ATP5ME;ATP5PB;ATP5PD
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.6966749039735967,1.0864647834565662,0.39655172413793105,1.0,1.0,1/6,25.44%,RNF213
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.4418248413809736,1.086029115356709,0.2702702702702703,1.0,1.0,21/136,17.62%,ANKS4B;TMEM35A;TCP1;PRLR;CHMP4B;EID2;HIP1R;CCDC39;CASQ1;ANLN;HIGD1C;TGFB1;ARL6;STXBP6;SMAD1;VBP1;PSMG1;COX7A2L;CHMP2A;RPL38;NSG1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.6430198616077178,1.0859102189410794,0.42857142857142855,1.0,1.0,2/9,9.20%,TICRR;CDC6
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.4046359298741844,-1.0858621812466889,0.3225806451612903,1.0,1.0,24/150,13.53%,SHC3;RIMBP2;KCNIP1;LIX1;CACNA2D1;FILIP1;TOX;RGMB;GCNT2;KCNC1;ZNF536;MAPK4;ADGRA1;NMU;TMEM196;VIP;FSTL5;STMN2;IGF2BP3;SCG2;PARVA;ELAVL3;RGS7BP;GRIA2
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5337665745758517,1.0857426260742529,0.373134328358209,1.0,1.0,7/26,23.32%,CD300LF;FADD;IL7;CD74;C1QTNF4;ADAM17;LAPTM5
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.6119867373545018,1.085725611986991,0.4,1.0,1.0,3/13,10.56%,NR5A2;SCEL;BRCA1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.5932128079402696,-1.085665948764869,0.39215686274509803,1.0,1.0,2/14,3.53%,NRG1;IGF1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.6486915029638073,-1.0854695973622932,0.43243243243243246,1.0,1.0,1/6,7.09%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.502308460016036,-1.085405238483847,0.34146341463414637,1.0,1.0,2/21,5.59%,BMP7;AZU1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.7522882969489779,1.0850213191985993,0.4098360655737705,1.0,1.0,1/5,8.10%,PHF23
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.6180768999407764,1.0848892950759006,0.38596491228070173,1.0,1.0,4/12,21.82%,CHST1;CHST6;EXTL2;OGA
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.5441047418616796,1.0847565475713727,0.3968253968253968,1.0,1.0,8/34,12.47%,PIGC;ST8SIA6;B3GNT5;PGAP4;PIGH;PIGV;PGAP3;MPPE1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.614486636668499,-1.0841844021488776,0.36585365853658536,1.0,1.0,1/13,0.92%,STING1
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),0.6865066742455114,1.0841766369603836,0.41379310344827586,1.0,1.0,1/5,3.71%,NOTCH1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.5626280036610214,-1.083744261747613,0.32075471698113206,1.0,1.0,5/16,16.87%,MAP3K20;XRCC6;HSF1;TLK2;ATM
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.6753541298089103,1.083660784554553,0.36363636363636365,1.0,1.0,3/9,18.99%,P2RY12;CX3CR1;CD200
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.6239608053328577,1.0827237683209765,0.44776119402985076,1.0,1.0,1/12,4.86%,PATL2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.45743986660532604,1.0824570138419085,0.3181818181818182,1.0,1.0,18/121,14.88%,ROPN1B;CSRP3;MSX1;LAMP2;TMEM30A;RIPOR1;TOLLIP;FSIP2;SIX4;ARL1;TRAM2;ARL6;TUB;RAB11A;DNAJA1;VPS35;OTOF;CCDC47
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.6223998062000538,1.082453328048425,0.359375,1.0,1.0,3/12,7.28%,AGER;FADD;HHLA2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.6620900831805365,-1.0823849960335088,0.35714285714285715,1.0,1.0,1/7,0.63%,KDR
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.5750257090049528,1.0823729798318231,0.42105263157894735,1.0,1.0,6/23,17.17%,SYT2;SYT4;DRD3;SYT9;SYT15;SYT13
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.5981982212720952,-1.0822760022588154,0.4146341463414634,1.0,1.0,3/13,8.08%,SPHK2;PRKCD;SMPD3
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.6728405560353565,1.0822478419328163,0.41379310344827586,1.0,1.0,1/6,7.53%,HLA-A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.6728405560353565,1.0822478419328163,0.41379310344827586,1.0,1.0,1/6,7.53%,HLA-A
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),0.6817190511573162,1.0820955959258645,0.36507936507936506,1.0,1.0,4/7,25.46%,ARG1;ARG2;CPS1;SLC25A15
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.6696753098127453,1.0820767613739726,0.4576271186440678,1.0,1.0,1/10,0.41%,STEAP4
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.6374670268492626,-1.0816511628167595,0.4090909090909091,1.0,1.0,2/6,19.03%,APEH;ETF1
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.6652086278933799,1.0810679331208044,0.4230769230769231,1.0,1.0,1/7,4.68%,TST
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.37061064993455367,-1.0810056340796608,0.14285714285714285,1.0,1.0,38/367,9.61%,CD38;PER2;SOX13;MYB;BMP7;NRG1;LEF1;ARID5A;TLE2;KDM8;EREG;ASCL1;ATOH8;PRDM5;ZNF256;HDAC5;SFRP1;ID4;RING1;BCL6;HDAC1;TIMELESS;TFAP4;SAMD7;FOXP1;SBNO2;PHC2;ID2;ZHX3;SFMBT1;SAMD13;SUV39H2;ZBTB7A;FOXK1;LBH;XRCC6;IFI16;SMARCA4
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.5629912991306553,1.0809885882124337,0.3548387096774194,1.0,1.0,4/27,10.13%,CCL5;NR5A2;VAPB;PPID
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.4378471068897128,-1.080912563164759,0.28,1.0,1.0,12/80,8.21%,F11;PAH;ITGA4;EYA4;HRH2;RBP4;SPTSSB;AFF3;APOA1;XYLB;NR1H4;ARX
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5876446514532101,-1.0808617083411292,0.38636363636363635,1.0,1.0,6/9,29.25%,NPLOC4;TSPAN6;DHX58;SEC14L1;RIOK3;TKFC
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.6137953049796527,-1.0807687308967584,0.34375,1.0,1.0,2/11,6.31%,GREM1;PTHLH
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.628922440262403,1.0804370521941953,0.42105263157894735,1.0,1.0,2/10,18.99%,PTPRC;CD200
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.5006113726565553,-1.0804016122450824,0.3333333333333333,1.0,1.0,4/39,4.14%,SULF2;RUNX1;COL11A2;NFIB
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.627346125995521,1.0800793235540653,0.3770491803278688,1.0,1.0,3/9,11.25%,ALOX12;PRKG1;ADAMTS18
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.5410667979981147,1.0799616191491688,0.43283582089552236,1.0,1.0,2/34,4.40%,LRP4;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.6330856649882184,-1.0798293339278429,0.47368421052631576,1.0,1.0,1/10,1.97%,CDC14B
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.5687019920183538,-1.0797090519386807,0.40625,1.0,1.0,4/9,19.81%,STAT3;LEP;NR4A3;GCK
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.6743532335785196,1.0795893207386547,0.4406779661016949,1.0,1.0,3/9,22.24%,HSPA5;ERN1;COPS5
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.7154460387838105,1.0795460383677975,0.375,1.0,1.0,2/6,7.12%,SOX6;REST
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),-0.5656947284901822,-1.0794518289146926,0.425,1.0,1.0,2/12,12.56%,ZMIZ2;SERTAD2
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.4920216933778873,-1.0793432126287377,0.29545454545454547,1.0,1.0,2/30,1.44%,CDK2AP2;GFI1B
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.7146022481625596,1.0792832055189487,0.45614035087719296,1.0,1.0,5/5,28.56%,CIITA;HSPH1;TAF7;NLRP12;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.6215810537448767,-1.0788994838495052,0.3888888888888889,1.0,1.0,1/9,0.39%,RAB7B
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.45744312110041413,1.0788038190519607,0.32432432432432434,1.0,1.0,22/89,14.26%,C3AR1;AGER;OSCAR;STAB1;HCK;SERPINF1;FCGRT;CD14;SLC2A1;CMKLR1;TCN2;SIGLEC1;VWF;MAFB;C1QA;CTSK;SLC7A7;ESR1;AQP9;TNFRSF11B;SPP1;CTSZ
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.6668401702912032,1.078730077502958,0.3870967741935484,1.0,1.0,3/10,14.65%,TMEM30A;TOLLIP;VPS35
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.6454180679568654,1.078531355245121,0.42592592592592593,1.0,1.0,1/13,2.38%,DDX20
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6334991975174508,1.0782181477579387,0.4126984126984127,1.0,1.0,4/10,23.59%,PAICS;IMPDH1;GMPS;PPAT
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.5991882500167873,-1.0779991175275236,0.42105263157894735,1.0,1.0,4/9,11.35%,BMP7;PTCH1;TGFB2;NOG
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.5375063794437817,-1.0778873685710824,0.3409090909090909,1.0,1.0,6/20,18.69%,DGKB;DGKD;DGKH;PNPLA2;MOGAT1;PGS1
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),-0.5284561002647408,-1.0778395846879536,0.4,1.0,1.0,3/20,7.61%,IGF1;PPP1R3B;PPP1R3E
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.4707311792112934,-1.077642470612449,0.32727272727272727,1.0,1.0,3/32,7.10%,LEMD2;XRCC4;TPP1
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.55522759499064,1.07762632627371,0.34782608695652173,1.0,1.0,7/25,16.12%,ODAD4;ODAD3;CCDC39;DNAH8;DNAH7;DNAI3;DNAI1
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.5580969738321507,1.0773853599160226,0.39436619718309857,1.0,1.0,6/23,18.16%,SOX10;SOX11;EIF2B5;CDK6;TLR2;ZNF488
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),0.7125063065478237,1.0773635669748898,0.42105263157894735,1.0,1.0,2/6,13.49%,ARTN;RACGAP1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.49190895085891695,-1.0772320934237205,0.425,1.0,1.0,4/28,10.94%,TPPP3;MAP7D3;FGF13;TUBG1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.43438253951800365,1.0771196256998128,0.2857142857142857,1.0,1.0,28/108,15.89%,CALB1;CSRP3;CAV3;WFS1;GCM2;CCL5;CALCB;ELANE;VAPB;TMEM203;FKBP1B;SLC24A4;SLC24A2;GPER1;TMEM178A;SLC24A1;SCGN;DRD3;HERPUD1;CAMK2D;HTR2B;PLN;CCDC47;TRPC4;ATP1B1;NPTN;TRDN;CHRNA7
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.5395590807951605,-1.077049650953868,0.25,1.0,1.0,3/22,11.77%,METTL8;TRMT10C;TRMT61A
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.5238803208878499,1.076850191741461,0.36231884057971014,1.0,1.0,3/44,2.58%,TDG;RFC5;POLQ
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),-0.6476824106193048,-1.076774859917956,0.4634146341463415,1.0,1.0,4/9,11.80%,SLC22A2;SLC22A3;SLC29A4;SLC22A1
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,0.5276542561520876,1.0764235857041444,0.36507936507936506,1.0,1.0,8/34,8.64%,VWA2;FUT2;CP;EXPH5;CLCA4;MUC4;ZNF750;IL20RA
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.6616483700834795,1.0764146175637526,0.38333333333333336,1.0,1.0,3/9,14.84%,PDGFRB;NOTCH4;ACVR2B
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.4668864512117046,1.0763911836719824,0.3333333333333333,1.0,1.0,17/70,13.94%,CA12;SLCO6A1;SLCO2B1;SLC23A1;MGST1;CA9;SLC22A25;CA1;SLC52A2;SLC26A7;LRRC8D;ABCG2;CA7;SLCO4C1;AQP9;ABCC6;SLC52A1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.4951324395993822,-1.0762139170626022,0.36585365853658536,1.0,1.0,1/24,0.08%,CD38
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.5103061747564925,-1.0761221145177315,0.42105263157894735,1.0,1.0,1/14,0.64%,PAPSS2
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.40108382732333014,-1.0760945540326146,0.25,1.0,1.0,11/139,8.07%,PER2;MDGA1;SH3RF1;RUNX1;ASCL1;ATOH8;NRBP2;MARK1;TGFB2;FGF13;SPOCK1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6731924223164978,1.0760074500483563,0.45901639344262296,1.0,1.0,2/7,9.82%,ADGRB1;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.6254306496382687,-1.0756456522031355,0.4,1.0,1.0,3/5,7.08%,INHA;SFRP1;ID2
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),0.7198301754970997,1.075543621077343,0.47058823529411764,1.0,1.0,2/5,19.19%,SLC19A3;SLC25A19
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.7144322192890835,1.075482633678446,0.40625,1.0,1.0,1/5,4.24%,SULT2A1
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.6907397975342693,-1.075347143781014,0.475,1.0,1.0,2/6,17.50%,UXT;MAP1S
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.5790358572543173,1.0753437162452288,0.41935483870967744,1.0,1.0,3/17,11.99%,RND1;C1QA;MTCH1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),0.6504169007504103,1.0753181735236015,0.39285714285714285,1.0,1.0,4/6,22.77%,PLN;TRDN;ATP2A2;SLC9A1
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.6473262052177289,1.074692422753495,0.4166666666666667,1.0,1.0,3/9,18.53%,TSPOAP1;AKR1B1;CACNA1H
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.7005892130586472,1.0746192427382404,0.375,1.0,1.0,4/7,26.01%,CHRNA7;ATP2B4;CHRNB2;LYPD1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.40022863004302234,-1.0745223188723103,0.23333333333333334,1.0,1.0,15/163,4.28%,DUSP4;SPRED2;ROR2;SPRED3;NPNT;KDR;SPRED1;FGFR4;F2RL1;RGS14;EPHB2;PDGFD;APIP;C5AR1;RASGRP1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.6748287245391966,-1.0745127929777043,0.5,1.0,1.0,2/7,17.05%,DHX8;VCP
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.46828050983002834,-1.07450209835036,0.2777777777777778,1.0,1.0,7/47,6.92%,KIT;LEF1;F2RL1;RUNX1;TNFRSF11A;FOXP1;SBNO2
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.5191571527124215,-1.074306131798752,0.3,1.0,1.0,4/22,14.10%,PID1;PRKCD;PTPN1;IRS1
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),0.6886454559640482,1.0740640051209045,0.423728813559322,1.0,1.0,2/8,14.16%,ARG1;ARG2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.7077393776790023,1.0736873701762837,0.4444444444444444,1.0,1.0,3/7,18.60%,SOD2;PDCD4;PPARG
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.5785116078081949,1.0735063828105473,0.39705882352941174,1.0,1.0,4/17,11.10%,SMIM22;HSD17B13;PPID;SQLE
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.476983734559175,1.0733204249627162,0.375,1.0,1.0,17/60,19.04%,NEUROD2;SYT2;SYT4;CPNE5;PLCG2;CAMK2D;ECT2;LGMN;SYT9;SYT15;ITPKB;CRHBP;SYT13;DMTN;MCOLN1;ADGRV1;MEF2A
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.6477113518013201,-1.0733188969958087,0.41025641025641024,1.0,1.0,2/7,25.48%,IKBKB;VCL
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),0.6369630624639642,1.073015500884919,0.38461538461538464,1.0,1.0,4/15,12.32%,LIPH;FABP3;LIPI;PNPLA1
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.6638704569364748,-1.0728286362437796,0.38095238095238093,1.0,1.0,3/6,29.02%,YY1;WRN;POLH
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.6272292023854809,1.0727990599983204,0.463768115942029,1.0,1.0,3/10,8.81%,TWIST1;TBX1;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.4792453739396797,-1.0727873790025875,0.3333333333333333,1.0,1.0,7/37,18.47%,WDR24;TELO2;RPTOR;PIP4P1;LEP;LAMTOR4;RHEB
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),0.6523810157037225,1.0726942861374158,0.42592592592592593,1.0,1.0,1/6,8.33%,SIGLEC1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.6682849447133334,-1.072505409028295,0.3611111111111111,1.0,1.0,3/7,23.15%,CTPS2;AK5;UMPS
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.44775349009523346,-1.0723283881461736,0.3611111111111111,1.0,1.0,3/33,1.80%,KDR;F2RL1;CDH13
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.6311924118326946,1.072072157932674,0.4576271186440678,1.0,1.0,3/12,5.89%,GLI3;PTPRC;FADD
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.6017671838243726,-1.0719648141442157,0.3902439024390244,1.0,1.0,1/10,5.82%,SRM
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.4609494996059704,1.0719193365102118,0.3582089552238806,1.0,1.0,13/87,10.18%,PRELP;HPGDS;GGTA1;MGST1;CHST1;CHAC2;MAT2B;SLC35B3;B3GNT4;B3GNT3;OGN;CSGALNACT1;CHAC1
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.6401228386290696,-1.0719154181626125,0.42105263157894735,1.0,1.0,2/9,6.10%,F2RL1;PRKCD
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.4467555324939367,1.0719048843455015,0.31343283582089554,1.0,1.0,15/82,14.30%,NCAPH2;NCAPG;CENPK;CHMP4B;PSRC1;KIF14;TEX14;CHMP2B;PHF13;SMC2;CHMP1A;PDS5B;EML3;TTN;RAB11A
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.5522788357468779,-1.0717556909550616,0.3409090909090909,1.0,1.0,7/17,22.22%,LEMD2;EMD;SUN3;DMPK;SUN2;NEMP1;TOR1B
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.48338117558960325,-1.0717494011191082,0.35135135135135137,1.0,1.0,12/35,19.82%,CAMKMT;EEF1AKMT1;PRMT8;SNRPB;PRMT5;EHMT2;PRMT6;ICMT;FAM98A;METTL22;ETF1;EHMT1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.5991373641902126,1.0716461390661443,0.4375,1.0,1.0,6/14,26.37%,ATP12A;ATP6AP1;ATP1B1;ATP1A1;SLC9A1;SLC12A2
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.5256674620551757,-1.0715207949956158,0.3111111111111111,1.0,1.0,6/20,6.23%,BMP7;RBP4;MYH14;SGCD;CFLAR;SVIL
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",0.6840444273023353,1.0713637805120688,0.3898305084745763,1.0,1.0,1/6,3.61%,ITGA5
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.6965488873936256,1.0712995516782438,0.4126984126984127,1.0,1.0,2/8,15.43%,CMPK2;AK4
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.7112255051019367,1.0710700866321492,0.42857142857142855,1.0,1.0,2/6,20.60%,RSPO3;MLLT3
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.5229300877409875,1.071058492776988,0.4262295081967213,1.0,1.0,2/39,1.31%,LIPH;PLA2G10
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.6794911559310103,1.0707630868108309,0.4406779661016949,1.0,1.0,1/7,6.23%,MGME1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.45141703718704607,1.0706389499899707,0.38461538461538464,1.0,1.0,17/80,16.40%,SLC7A11;SLCO2B1;SLC23A1;ABCC2;SLC26A7;SLC36A1;LRRC8D;ABCG2;SLC38A2;SLC7A7;SLC10A1;SLC38A5;SLC16A1;SLC10A5;SLC16A8;SLC38A4;SLCO1A2
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5342032763553918,-1.0706331895682892,0.325,1.0,1.0,4/17,8.32%,KDR;SELP;AZU1;ADGRL1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.45229458328518024,1.070405006286031,0.3150684931506849,1.0,1.0,14/94,13.84%,TICRR;MCM2;RFC5;POLE2;POLE3;RAD9B;CDC6;DONSON;BRCA1;HELB;MRE11;RPA3;CDK2AP1;ORC4
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.5706942376476641,-1.0703121219347695,0.38095238095238093,1.0,1.0,6/15,22.34%,CDH13;WDR54;EGFR;MVB12B;PTPN12;ERBB2
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6815197268816775,1.0701389116922186,0.4915254237288136,1.0,1.0,2/8,10.98%,EEF1A1;GFAP
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.7181736483526896,1.070127796821515,0.42105263157894735,1.0,1.0,1/6,1.82%,ZNF703
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.6985441100246702,1.0700940856253727,0.5,1.0,1.0,1/6,1.54%,AGER
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.45057771321130424,-1.0700881920797614,0.3023255813953488,1.0,1.0,12/46,23.66%,TRIAP1;MAP3K20;HUS1;USP10;CDC5L;ATM;TP53BP1;BRIP1;CASP9;CHEK2;NDRG1;ATRIP
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.6674455849181197,1.0699647133341392,0.42105263157894735,1.0,1.0,3/9,16.03%,COPS9;EPAS1;DCUN1D1
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.5362478367029101,-1.0698163574736839,0.37142857142857144,1.0,1.0,1/9,0.76%,NMB
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.43448803908229,-1.0698118857273453,0.2682926829268293,1.0,1.0,9/56,7.57%,FGFR4;BTC;RUNX1;LAMB3;CEBPD;CLDN4;ANKRD30A;SPDEF;BTG1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.4816830100262922,1.0696533080508839,0.3235294117647059,1.0,1.0,4/45,2.38%,PRELP;GPC6;GPC5;HSPG2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.6185945219870522,1.0696078421362314,0.4426229508196721,1.0,1.0,4/10,19.90%,REST;PINK1;FBXO7;NONO
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.6420079953410485,1.0694933250497614,0.4262295081967213,1.0,1.0,1/12,7.33%,F11R
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.5525444954028397,1.069491690594246,0.44642857142857145,1.0,1.0,3/22,13.91%,F11R;WAS;ARHGAP28
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.593432205870682,1.069465508744472,0.3870967741935484,1.0,1.0,5/16,21.52%,TCP1;CCT6A;CCT8;CORO2B;CCT7
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.6520279994171505,1.069392849332855,0.4444444444444444,1.0,1.0,3/8,20.17%,CAMK2D;TRDN;CALM3
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6519565999293473,1.0693867424670351,0.3620689655172414,1.0,1.0,5/9,33.26%,HLA-A;IL18;SYK;TNFSF4;CD81
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.6393681438375074,-1.0686897955396164,0.45714285714285713,1.0,1.0,1/7,2.50%,IFIH1
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.6853697297294143,1.0685482560154447,0.4583333333333333,1.0,1.0,2/5,27.31%,LTN1;MTRES1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.5178797442066525,-1.0683490581985102,0.2777777777777778,1.0,1.0,4/14,20.34%,PDPN;CARMIL2;MRTFA;LCP1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.621105985883365,-1.0681609372631282,0.375,1.0,1.0,1/10,2.60%,NEK6
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.511250601154419,-1.0680087961640743,0.45,1.0,1.0,8/29,17.39%,BMP7;BMP6;ANO6;TGFB3;PKDCC;ODAPH;ACVR1;NELL1
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.5169614087412076,-1.0679939589250496,0.3684210526315789,1.0,1.0,3/18,3.22%,BMP7;INHA;PRKRIP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.6898294423824683,1.0677984185263891,0.47368421052631576,1.0,1.0,3/6,25.94%,NAIF1;ACAA2;ATF2
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.7215717497853174,1.0675267976937954,0.40384615384615385,1.0,1.0,1/5,7.39%,RPS6KA4
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.6855907522267416,-1.067421559970725,0.45,1.0,1.0,3/7,20.62%,TRMT10C;PNPT1;ELAC2
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.5488833081666051,1.0674093930369017,0.3939393939393939,1.0,1.0,5/27,8.94%,PRELP;CHST1;B3GNT4;B3GNT3;OGN
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.5903519337889102,1.0671935307213116,0.32786885245901637,1.0,1.0,3/13,15.07%,SMAD7;ACVR2B;NODAL
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.6670237958013564,1.0671276896912218,0.4067796610169492,1.0,1.0,3/7,12.63%,C17ORF99;DOCK11;GPR183
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.6546482547588133,-1.067064884450149,0.45,1.0,1.0,2/6,20.30%,UBE2D4;PRKN
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.5000530026897646,1.0664718378380036,0.34782608695652173,1.0,1.0,11/29,27.37%,AHR;IGFBP5;AQP9;KCNQ1;CRHBP;DMTN;HCN4;SLC5A5;PDE2A;SLC26A6;INPP5K
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.5952746132365656,-1.0663450466831783,0.40540540540540543,1.0,1.0,1/7,3.85%,TPR
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.5038578000260864,-1.0663011859701799,0.35555555555555557,1.0,1.0,7/26,17.39%,BMP7;BMP6;ANO6;TGFB3;PKDCC;ACVR1;NELL1
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.6578107109979412,1.0659053897238535,0.4444444444444444,1.0,1.0,5/11,20.04%,RHOH;SEMA3A;CHN1;NTN1;SLIT1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.675121395121964,-1.0658770176695513,0.5434782608695652,1.0,1.0,2/7,11.33%,NFATC1;DNMT1
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.575616033078913,1.0658604724169334,0.42424242424242425,1.0,1.0,1/14,1.75%,TBX19
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.7535228606090911,-1.0658393851071215,0.43478260869565216,1.0,1.0,3/5,17.20%,SLC6A4;WWC3;WWC1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.4357144975340658,-1.0656014045312787,0.3103448275862069,1.0,1.0,9/83,2.30%,GEM;TAGLN;FBXL7;COL15A1;ADAMTS2;LAMA4;COL6A2;FNDC1;PCDH18
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.5151260897737437,-1.0653880122910766,0.35714285714285715,1.0,1.0,2/27,1.44%,CDK2AP2;GFI1B
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.5573606332521511,1.0651896386945936,0.44776119402985076,1.0,1.0,5/23,8.94%,PRELP;CHST1;B3GNT4;B3GNT3;OGN
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.676933591089213,1.0651618296746976,0.3877551020408163,1.0,1.0,1/6,7.12%,REST
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.405289564658863,-1.065097977144013,0.28125,1.0,1.0,10/68,11.94%,KDR;CDH13;VASH1;ATOH8;VASH2;VIP;APOE;NRP1;HMGB2;SCG2
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.4875580814734921,-1.0650459204409046,0.4,1.0,1.0,10/33,26.24%,BLOC1S4;AP3B2;HSPB1;RAB27B;AP3S2;KIF1A;AP3D1;MGARP;TRAK1;KIF5C
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.47711287586697615,-1.0647844840174543,0.3333333333333333,1.0,1.0,8/59,6.58%,UNC5B;EYA4;SH3RF1;IGF1;ITGA6;CFLAR;BCL2;MAPK7
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.5385710513898414,1.0645879679150017,0.36065573770491804,1.0,1.0,2/23,7.53%,FADD;HLA-A
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5912664698886184,-1.0641880617412467,0.41935483870967744,1.0,1.0,3/14,19.36%,KHSRP;TRIM71;RC3H1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.50719158158889,1.0639682427995556,0.3972602739726027,1.0,1.0,5/32,9.07%,MSX1;BOK;BCAP31;RPS7;SIAH1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.7135113053523495,1.063961070567064,0.4642857142857143,1.0,1.0,3/5,18.49%,REST;PINK1;FBXO7
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.6004937308708652,1.063807608772275,0.46551724137931033,1.0,1.0,2/15,6.31%,ABT1;ERAL1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.5099375576744319,1.0633577034696948,0.36363636363636365,1.0,1.0,22/45,33.40%,CP;FRRS1;ATP6AP1;ABCG2;HJV;NUBP1;SLC40A1;B2M;TF;SLC11A2;CUL1;TFR2;SLC11A1;SMAD4;HEPH;CAND1;ATP6V1A;TFRC;ATP6V1G1;GLRX3;SKP1;CYBRD1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.6082331125173379,1.0629690518674755,0.4444444444444444,1.0,1.0,1/13,1.45%,TDG
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.5554189663920882,-1.062930824137507,0.41025641025641024,1.0,1.0,3/12,10.96%,APLN;TGFB2;RGS2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.5959130334203862,1.06267192672349,0.4067796610169492,1.0,1.0,3/16,6.45%,CCL5;PDGFRB;IGFBP5
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.46743053590839373,-1.0620245329331315,0.34210526315789475,1.0,1.0,9/50,9.40%,BMP7;SFRP1;HIVEP1;AMH;RGMB;BMP6;TGFB2;TGFB3;DLX5
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.5916665606337276,1.0619367213424347,0.3620689655172414,1.0,1.0,2/10,5.66%,NOTCH1;ZFPM1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.5081605261481983,1.0618693956211782,0.4696969696969697,1.0,1.0,9/38,11.89%,CCL5;IL15;HLA-DMB;PTPRC;PDCD1LG2;IDO1;ARG1;CD6;IL4I1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.615706352949112,-1.061733534515548,0.43243243243243246,1.0,1.0,3/9,25.68%,PLK2;RAPGEF1;RAP2B
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.6461704246152834,-1.0617071617901155,0.40476190476190477,1.0,1.0,1/7,3.42%,AGBL1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.6328151673984437,-1.061693106266876,0.5116279069767442,1.0,1.0,2/7,13.65%,LRRC55;NOS1AP
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.6225427795903115,-1.061596929162706,0.425,1.0,1.0,2/9,13.23%,ZNHIT6;NAF1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5185501613208165,1.0614908634876241,0.3333333333333333,1.0,1.0,4/25,8.29%,CD300LF;FADD;CD14;CASP8
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5185501613208165,1.0614908634876241,0.3333333333333333,1.0,1.0,4/25,8.29%,CD300LF;FADD;CD14;CASP8
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.535815145195555,1.0614141275814877,0.36231884057971014,1.0,1.0,7/26,12.63%,PDGFRB;ELANE;P2RY12;RARRES2;TGFB1;USP14;GPR183
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.6439756442274209,1.061338252357395,0.4444444444444444,1.0,1.0,3/11,11.52%,CD4;IL15;STAT5A
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.6439756442274209,1.061338252357395,0.4444444444444444,1.0,1.0,3/11,11.52%,CD4;IL15;STAT5A
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.42784503302619686,-1.0611744895014867,0.3225806451612903,1.0,1.0,10/62,10.64%,GOLGA8M;NEK6;GOLGA8H;NUMA1;SMC1A;GOLGA8B;INO80;MAPRE1;GOLGA8A;GOLGA8N
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.46612020554476535,1.0609281844594265,0.4,1.0,1.0,12/91,8.95%,NOX5;ITK;LRRC19;BTN2A2;IL15;TRIM32;PTPRC;AGT;HHLA2;RPS6KA4;CASP8;RNF26
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.4507338542022403,-1.060061998290306,0.34210526315789475,1.0,1.0,8/42,11.29%,PER2;RGS14;ASCL1;NUMB;MME;PCM1;SORL1;HMGB2
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.46682494016268994,-1.060046372196637,0.3157894736842105,1.0,1.0,7/41,9.21%,BMP7;GREM1;SRGN;BMP6;SGMS2;ANO6;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.571162477503789,-1.0598541938010815,0.40540540540540543,1.0,1.0,5/14,23.44%,PGP;GCK;NUPR1;PPARA;HDAC4
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.4213153110494109,-1.0598447639742168,0.3181818181818182,1.0,1.0,5/109,5.18%,ROR2;LEF1;NFATC1;SFRP1;GNAO1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.5977255660830056,1.059827640579938,0.43548387096774194,1.0,1.0,4/15,13.27%,ALOX12;ELOVL2;FADS2;ALOXE3
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.34482123714185364,-1.0597323906205092,0.2,1.0,1.0,65/559,9.28%,NOX4;KIT;ALK;ROR2;KDR;TBX6;NRG1;FGFR4;HMGN5;LEF1;BTC;MELTF;SINHCAF;CDH13;GREM1;RUNX1;INHA;RNF126;PDGFD;TNFRSF11A;EREG;ZBTB7C;KITLG;ADAMTS8;SMYD2;IGF1;ECRG4;SFRP1;WWTR1;SGK1;DBF4B;GRK5;CDCA7;COL4A3;SLC25A33;BCL6;CHTOP;HDAC1;TIMELESS;TFAP4;P3H3;CHRNA10;PTHLH;BCL2;SST;ETS1;PDPN;GCNT2;BMP6;IL11;ID2;TGFB2;ALDH1A2;SHANK2;ACE2;BTG1;STAT3;VIP;DLG5;JAG2;COL18A1;PDGFRA;TGFB3;XRCC6;AKR1C3
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.6271275940263915,-1.0595334486677477,0.42105263157894735,1.0,1.0,2/11,11.29%,XRCC4;HMGB2
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.6048667924986033,1.0587034843980585,0.4444444444444444,1.0,1.0,2/12,8.68%,SESN3;RNF152
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.5212855050981534,-1.0586897735482093,0.3404255319148936,1.0,1.0,7/18,15.99%,SLC19A1;MTHFD2;DHFR;MTHFS;MTHFD2L;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.6859621011974382,1.0581314486056244,0.4444444444444444,1.0,1.0,4/6,25.19%,RNF168;EXOSC6;MSH6;MSH2
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.522123629679013,1.057629897115188,0.45901639344262296,1.0,1.0,4/26,8.78%,GGTA1;FASN;ALOX12;SCD
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.7203409052410523,1.0576146518909744,0.48333333333333334,1.0,1.0,1/5,7.08%,LMO3
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.48771479135475526,-1.057521849332255,0.4090909090909091,1.0,1.0,3/24,7.77%,NUMA1;NSFL1C;CDK5RAP2
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.429472158575368,1.0575069105998454,0.38235294117647056,1.0,1.0,21/97,14.17%,LIPH;MSX1;AGER;PRG4;KNL1;ITGA5;BOK;GPX2;KLF5;SCEL;AP1M2;B3GNT3;ANLN;MYO5B;EMILIN2;BRCA1;PAQR5;TMC4;ECT2;THRSP;EPCAM
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.6395798957622507,1.0574352091199863,0.41935483870967744,1.0,1.0,1/12,4.28%,KCNN4
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.5443528105358462,1.0572284311229634,0.375,1.0,1.0,7/22,13.94%,SLC23A1;AMN;CBLIF;TCN2;SLC52A2;ABCG2;SLC52A1
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.6591355735482303,1.0571098010127258,0.49122807017543857,1.0,1.0,1/7,1.26%,P2RY1
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),0.6952176275858821,1.057104241823977,0.4482758620689655,1.0,1.0,2/5,10.37%,TBX1;SIX4
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.5084844050515992,-1.0569173234704108,0.3448275862068966,1.0,1.0,3/26,4.14%,SULF2;RUNX1;NFIB
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),0.550664208813934,1.056701758229483,0.3333333333333333,1.0,1.0,4/24,12.32%,LIPH;FABP3;LIPI;PNPLA1
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.4295504561948835,-1.0566958763561576,0.16666666666666666,1.0,1.0,14/64,10.77%,CACNG4;RGS14;EPHB2;CACNG3;CACNG5;CRHR2;ZDHHC3;CLSTN2;PLK2;SHANK2;KCTD13;NMU;DRD1;GRIN2A
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.48133374338243884,1.0565253817159301,0.35294117647058826,1.0,1.0,19/48,26.82%,CARD8;FADD;BCAP31;REST;CASP8;GPER1;RIPK2;LGMN;NODAL;CYCS;BAD;USP50;ACVR1C;SYK;NLRP2;DDX3X;ARL6IP5;NOD1;NLRC4
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.4784849474725924,1.0563250451278066,0.3880597014925373,1.0,1.0,7/44,9.61%,H3-3A;POLE3;SPTY2D1;H1-2;NAP1L2;H2BC18;M1AP
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.5235130262552097,1.0562118940110472,0.45,1.0,1.0,2/38,1.31%,LIPH;PLA2G10
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.6165523037493602,-1.0561065293720169,0.5151515151515151,1.0,1.0,2/13,4.14%,GREM1;SFRP1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.48981951298944143,1.0557345162239111,0.3561643835616438,1.0,1.0,10/46,18.81%,SDS;ENO4;LDHB;HKDC1;ALDOB;PGAM1;SLC16A1;SLC16A8;PKLR;HK3
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.6479928287909995,1.0555893281468314,0.4482758620689655,1.0,1.0,3/7,15.32%,SDS;DAO;GLDC
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),-0.6619071074510856,-1.0550494901521748,0.4772727272727273,1.0,1.0,2/5,20.30%,UBE2D4;PRKN
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.48934550100837376,1.0549684683585407,0.38596491228070173,1.0,1.0,6/35,15.31%,SLC13A4;SLC26A4;SLC26A7;TTYH1;RACGAP1;GLRA1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),-0.42763398668009506,-1.054716043360593,0.24,1.0,1.0,15/103,12.88%,EYA4;PRDM5;HDAC5;PARP2;HDAC1;PRKCD;TAF10;INCENP;BAZ1B;TBL1Y;SIN3B;USP51;SIRT2;PRMT8;EHMT2
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),0.665472157355034,1.0542011375099025,0.5098039215686274,1.0,1.0,2/6,15.63%,GMFG;DNAI3
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.6096438916999023,1.0540848575668367,0.43283582089552236,1.0,1.0,4/13,15.17%,ITGA5;NOTCH1;ZNF304;PDK4
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.6801165677552755,1.054041095711417,0.515625,1.0,1.0,5/8,27.76%,SLC23A1;AQP9;SLC2A5;SLC26A6;AQP11
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.6246576446006593,-1.053878324307613,0.4897959183673469,1.0,1.0,2/11,16.74%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.6246576446006593,-1.053878324307613,0.4897959183673469,1.0,1.0,2/11,16.74%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.6246576446006593,-1.053878324307613,0.4897959183673469,1.0,1.0,2/11,16.74%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.6827485420331305,-1.0537696215444714,0.5227272727272727,1.0,1.0,1/5,12.79%,CLU
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.530954846059889,-1.0536603377102411,0.38235294117647056,1.0,1.0,3/28,5.04%,STING1;IFIH1;POLR3D
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.656290977934236,1.0531994284818014,0.46551724137931033,1.0,1.0,3/10,18.24%,PRAF2;SLC25A18;SLC1A3
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.5483602464465281,-1.0529490384143538,0.40476190476190477,1.0,1.0,1/17,0.84%,BMP7
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.48353936566097266,1.0524073785711665,0.3698630136986301,1.0,1.0,10/59,20.52%,CALCR;NTF3;TGFB1;RIPK2;OPRD1;PINK1;MTCP1;CREBL2;TERF2IP;ATP2B4
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.49033486607518767,1.052156505501279,0.34328358208955223,1.0,1.0,9/42,16.81%,HESX1;GCM2;FADD;TBX1;IGSF3;FGFR2;GFER;NOTCH4;MSN
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.5860434111360093,1.0520308454427696,0.4375,1.0,1.0,3/15,13.58%,SYVN1;HERPUD1;DERL1
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.6520785977388783,1.0519934867844734,0.453125,1.0,1.0,2/7,21.64%,ADGRV1;LRTOMT
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.6592925032092501,1.0518340027216022,0.42105263157894735,1.0,1.0,3/7,21.88%,NOTCH1;SNAI2;NOTCH2
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.6166421286436568,-1.0518147923389665,0.425,1.0,1.0,1/7,0.51%,DECR2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.5435786426195492,1.051800558424787,0.43636363636363634,1.0,1.0,7/28,20.88%,POLR3K;TBP;GTF3C4;POLR3G;SNAPC2;SNAPC1;POLR2K
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.4146917069386495,-1.0516116318850242,0.34285714285714286,1.0,1.0,14/91,9.62%,UBASH3B;SPRED1;TRIB2;RASSF2;EREG;PRKRIP1;C5AR1;WWTR1;AZU1;MAP2K3;HSPB1;MMD2;XRCC6;LCP2
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.5115382373098837,1.051489290597901,0.3787878787878788,1.0,1.0,21/42,33.40%,CP;FRRS1;ATP6AP1;ABCG2;HJV;NUBP1;SLC40A1;TF;SLC11A2;CUL1;TFR2;SLC11A1;SMAD4;HEPH;CAND1;ATP6V1A;TFRC;ATP6V1G1;GLRX3;SKP1;CYBRD1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6263509537256833,1.051334671050849,0.45614035087719296,1.0,1.0,3/11,16.98%,TGFB1;ESR1;MYCN
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.6496028104798434,1.051317158369905,0.4838709677419355,1.0,1.0,3/8,13.71%,TPO;CTSK;DIO1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.4950359965537769,1.051312791748694,0.40625,1.0,1.0,12/50,14.50%,PTGES;KLRG2;SH2D4A;AP1M2;IGSF3;SERTAD4;SIX4;CELSR1;SEMA3F;TUFT1;ALOXE3;SHROOM3
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),0.6796199652684031,1.0509735872521513,0.4642857142857143,1.0,1.0,2/6,18.32%,DOLK;DOLPP1
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),0.6796199652684031,1.0509735872521513,0.4642857142857143,1.0,1.0,2/6,18.32%,DOLK;DOLPP1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5931192359322656,1.0509186561504749,0.45454545454545453,1.0,1.0,5/12,23.59%,PAICS;RFK;IMPDH1;GMPS;PPAT
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.5280743576084064,1.0507281149369763,0.36231884057971014,1.0,1.0,4/26,9.76%,NOTCH1;ZFPM1;SMAD7;SOX11
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.6787683610101365,-1.050648103142393,0.5405405405405406,1.0,1.0,4/6,28.75%,SYAP1;MARS1;HAS1;MTSS2
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.4988570710846212,1.0505999613848627,0.36764705882352944,1.0,1.0,10/45,22.37%,EXPH5;ATP6AP1;RAB9A;RAB8A;STXBP6;SYTL4;SEPTIN1;CADPS2;LGI3;RAB21
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.48259496307189204,-1.0505641159914314,0.43478260869565216,1.0,1.0,4/19,10.57%,NR1H4;APOE;RORA;ACADVL
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),-0.6717161182219662,-1.050530450749435,0.45652173913043476,1.0,1.0,1/6,6.31%,PTHLH
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.5233371548364177,-1.0503717597027726,0.4146341463414634,1.0,1.0,1/25,1.23%,CHCHD6
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.5094102063884284,1.0502863018702844,0.41935483870967744,1.0,1.0,12/50,12.63%,C3AR1;MS4A6A;FGL2;HCK;PTPRC;CARD6;CIITA;CSF2RA;IRF1;MITF;IGSF6;GPR183
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.5560988985145894,-1.0502158414630998,0.43243243243243246,1.0,1.0,5/17,13.63%,IGF1;APOE;SORL1;CLU;BIN1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5403719903895733,1.0499403441477317,0.3793103448275862,1.0,1.0,3/25,7.33%,MARVELD2;TJP3;F11R
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.439565864943701,-1.0499024319134131,0.3103448275862069,1.0,1.0,7/81,2.20%,KIT;ALK;ROR2;KDR;EPHA3;FGFR4;EPHB2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.6507294728902928,1.0498194391491005,0.45614035087719296,1.0,1.0,4/7,18.64%,ERAP2;HLA-A;B2M;ERAP1
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.6580449981487622,1.049725751517394,0.5490196078431373,1.0,1.0,2/7,13.06%,TAS1R1;PKD1L3
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.6520286673683169,-1.049536205415055,0.475,1.0,1.0,3/5,26.15%,SMC1A;MUS81;SLX4
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.7181341515795541,1.0493707116457727,0.49056603773584906,1.0,1.0,2/5,16.53%,BOK;CYCS
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.6024962233079492,-1.049207408140697,0.37209302325581395,1.0,1.0,1/11,5.78%,ZDHHC3
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.6391467011013542,1.0488349209290042,0.4576271186440678,1.0,1.0,1/9,5.96%,DNAJB1
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.47161843337261855,1.0487358444450074,0.36363636363636365,1.0,1.0,7/67,7.91%,GNLY;STAB1;ELANE;ADGRB1;RARRES2;HLA-A;LYG1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.47530632406607454,-1.048708807996563,0.32432432432432434,1.0,1.0,6/30,14.36%,RUBCNL;MLYCD;FOXK1;RORA;IRS1;SIRT7
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5319451568698086,-1.0481809918964184,0.4318181818181818,1.0,1.0,4/14,6.81%,BMP7;MAPK7;GCNT2;APOA1
prerank,PanglaoDB_Augmented_2021__NK Cells,0.4878766316875028,1.0478349292296867,0.4142857142857143,1.0,1.0,17/64,10.21%,GNLY;ITK;IL18R1;SPON2;KLRG1;CCL5;CD8A;DOCK2;AHR;PTPRC;ARHGAP9;GMFG;TAGAP;ARHGAP25;CD6;MYO1F;TGFB1
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.42543719863911894,-1.0474632908673218,0.37037037037037035,1.0,1.0,7/61,6.20%,NPNT;PID1;TNFRSF11A;SFRP1;GCH1;IGBP1;AFF3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.6238422658369877,1.0472123390741075,0.5,1.0,1.0,2/8,10.92%,IGFBP5;DOCK4
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.5667815538528895,1.0470319359746163,0.4482758620689655,1.0,1.0,4/19,10.13%,FKBP4;FKBP1B;FKBP5;PPID
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.5359211182028176,1.0468844397481045,0.43103448275862066,1.0,1.0,1/19,3.94%,NTF3
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.5403936446531441,-1.0468637755705439,0.47368421052631576,1.0,1.0,4/15,12.51%,ARL13B;PTCH1;ALDH1A2;TRIM71
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.45602358845395546,-1.0467645742298928,0.34285714285714286,1.0,1.0,7/40,6.09%,HRH1;F2RL1;ST6GALNAC2;LAMB3;CEBPD;CLDN4;CRH
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.6774611227172659,1.046513380431214,0.45454545454545453,1.0,1.0,2/6,18.14%,C1QA;CX3CR1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.47131171794886917,-1.0465118630198502,0.4411764705882353,1.0,1.0,7/35,8.73%,LEF1;HDAC5;MAML1;PTCH1;NUMB;NCSTN;JAG2
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.5287540773841479,1.0460498671285237,0.4507042253521127,1.0,1.0,3/20,6.47%,H3-3A;POLE3;SUV39H1
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.6196175744050086,1.0458231337538286,0.42857142857142855,1.0,1.0,1/8,8.03%,CCDC39
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.6066451721611941,1.0454508641125893,0.5,1.0,1.0,3/11,16.52%,CHMP4B;EPS8;CHMP2A
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.7137881467109588,1.045187649092182,0.4461538461538462,1.0,1.0,2/7,14.22%,MYOM1;TTN
prerank,GO_Biological_Process_2021__vascular wound healing (GO:0061042),-0.6609231208162567,-1.0450407890363318,0.4666666666666667,1.0,1.0,1/5,0.63%,KDR
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.5289059156553376,1.0449444151714304,0.4915254237288136,1.0,1.0,2/17,10.04%,MYO5B;MYO1F
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.7278378810304271,1.0448834967047063,0.5192307692307693,1.0,1.0,1/5,7.13%,ADIPOR2
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.4917723058039701,-1.0447438780102798,0.3888888888888889,1.0,1.0,5/24,13.39%,MIEN1;TGFB3;RIPOR2;NRP1;PLPPR5
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.45261725648189377,-1.0447010236392638,0.37037037037037035,1.0,1.0,4/34,11.02%,RASSF2;PDGFD;PDGFC;CHP1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),-0.5294493947334944,-1.0445645743955398,0.3888888888888889,1.0,1.0,1/15,4.38%,INTS11
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),-0.5132810439257347,-1.0444960060130057,0.4,1.0,1.0,2/14,4.26%,NRG1;TCOF1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.5616828809291483,-1.044286265768793,0.45454545454545453,1.0,1.0,5/8,16.47%,TGFB2;TGFB3;NOG;ACVR1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.6241693500886931,-1.0442366486820949,0.4411764705882353,1.0,1.0,2/10,6.10%,F2RL1;PRKCD
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.5463803890715309,-1.0442144963388351,0.45454545454545453,1.0,1.0,3/14,10.18%,MLYCD;FOXK1;RORA
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.42135943495334227,-1.0441580981275462,0.34375,1.0,1.0,6/30,21.47%,LZTS3;LRP8;DBNL;ARHGAP44;RELN;KIF1A
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.6642971062407432,1.0441324529314313,0.5102040816326531,1.0,1.0,3/7,25.96%,STAT1;IFIT1;HACD3
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.5400512793608631,-1.043240976891877,0.45,1.0,1.0,4/17,5.66%,ADAM12;ADAMTS15;IGF1;ADAMTS5
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.6428223782779579,1.0429709026014695,0.45161290322580644,1.0,1.0,5/8,24.33%,CYP1B1;PDE3B;JAM3;SNAI2;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.4958002521295697,1.042910707700175,0.4426229508196721,1.0,1.0,7/33,9.36%,LDLRAP1;CCL5;PDGFRB;ELANE;NOX1;IGFBP5;STAT1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.6238895610003188,1.0427504649539465,0.4375,1.0,1.0,2/10,18.60%,TBX1;PPARG
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.663931422740218,1.0426353591045854,0.42857142857142855,1.0,1.0,1/10,2.44%,STK26
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.6521513046702367,1.0424345777692232,0.39622641509433965,1.0,1.0,2/8,8.81%,SFRP4;FGFR2
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.5696927622130209,1.0423504497197358,0.4032258064516129,1.0,1.0,4/18,18.37%,GRM3;DRD3;AKAP5;ADGRV1
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.4608104635031174,-1.0416907444621883,0.34285714285714286,1.0,1.0,6/37,10.55%,ST6GAL2;ST3GAL3;ST8SIA2;ST3GAL2;GAL3ST4;MPDU1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.4360030403464558,-1.041675271410658,0.3793103448275862,1.0,1.0,8/62,8.46%,RAB7B;F2RL1;IFIH1;EREG;SPHK2;TLR1;STAT3;POU2F2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.5522505063892895,1.04158448434211,0.4117647058823529,1.0,1.0,3/14,11.52%,PRLR;STAT6;STAT5A
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.5583450932155366,-1.0415680238823835,0.35714285714285715,1.0,1.0,3/8,22.08%,KYNU;AADAT;ACAA1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.5478767008928126,1.0414549977421195,0.4406779661016949,1.0,1.0,6/21,10.21%,PDGFRB;TRIM32;P2RY12;TWIST1;RARRES2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5339495991464442,1.041388308048232,0.4727272727272727,1.0,1.0,2/16,6.45%,LDLRAP1;IGFBP5
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.44431743061770457,-1.0413327076230163,0.34615384615384615,1.0,1.0,14/66,14.39%,KDR;VASH1;SVBP;ATOH8;RIN2;RHOJ;FOXP1;ETS1;APOE;SCARB1;NRP1;SMOC2;ANGPT1;BMPER
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.575333291118607,1.0408200632871167,0.4307692307692308,1.0,1.0,3/16,7.12%,CALCR;GOT1;REST
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.6103668858794356,1.040786231480255,0.4576271186440678,1.0,1.0,6/14,20.99%,ELANE;CD6;PLSCR1;ITIH4;LBP;F3
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.671853641728934,-1.0405940627459604,0.45,1.0,1.0,1/5,1.85%,GREM1
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.524038557032541,-1.0405329239457612,0.38461538461538464,1.0,1.0,3/16,10.55%,ALG8;ALG12;MPDU1
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.5968079803722763,1.0394815509330193,0.5230769230769231,1.0,1.0,3/14,9.20%,TICRR;RAD9B;CDC6
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.4813351752803998,-1.039409576387342,0.3333333333333333,1.0,1.0,3/19,10.92%,BRCC3;TAF10;USP51
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.574617014252136,-1.0393828002508416,0.47619047619047616,1.0,1.0,4/11,21.74%,CARD10;CHI3L1;MALT1;MAP3K7
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.5450358607933085,1.0391630303228783,0.4375,1.0,1.0,4/24,2.72%,MYLK;WFS1;CCL5;PDGFRB
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.4064311504030252,-1.0387992796301466,0.24242424242424243,1.0,1.0,13/68,10.96%,FRMPD1;GNG4;RGS14;KLK6;GRK5;ZDHHC3;PPEF1;FNTB;SAG;CAMKMT;RGS20;GIT2;RGS2
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.4287576170313073,-1.0385438054239233,0.2962962962962963,1.0,1.0,13/66,11.14%,PRAG1;MAML3;DTX1;MAML1;TCIM;RITA1;TSPEAR;TGFB2;STAT3;JAG2;ZBTB7A;LLGL2;BEND6
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.5444537753870996,1.0377931473077875,0.4411764705882353,1.0,1.0,4/22,9.76%,NOTCH1;ZFPM1;SMAD7;SOX11
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.6899734402075788,1.0376410011672972,0.4222222222222222,1.0,1.0,1/5,4.68%,TST
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.5938039924868627,-1.0375878665255964,0.5238095238095238,1.0,1.0,5/10,23.83%,NME4;UPP2;MACROD2;TYMP;NT5C3A
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),0.6478436974446076,1.0375339463326887,0.5178571428571429,1.0,1.0,2/5,20.84%,CACNA1G;HCN4
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.6057382589553568,1.037470213529732,0.484375,1.0,1.0,1/11,8.76%,BTBD18
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.5481418309110434,1.0373490000490975,0.39705882352941174,1.0,1.0,6/21,9.21%,IGFBP5;PRKG1;CDKN1B;SOD2;OGN;GPER1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.5341566523694559,1.0370483749314492,0.4142857142857143,1.0,1.0,3/25,11.23%,CAV3;PSRC1;CDK5R1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.6266726264910315,1.0367770640448108,0.4426229508196721,1.0,1.0,3/9,10.21%,FADD;CASP8;TGFB1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.4467217385477815,1.0366008867456395,0.4142857142857143,1.0,1.0,16/99,15.96%,ANKS4B;WFS1;ITPR1;RCN3;SYVN1;HSPA5;BCAP31;UFM1;CHAC1;EIF2B5;RNF139;HERPUD1;DERL1;CCDC47;DAB2IP;TMEM33
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.577408073832436,1.0363166276982334,0.4696969696969697,1.0,1.0,5/16,10.03%,NEUROD2;ITPR1;CMKLR1;PLCG2;RIT2
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.609102067930204,-1.0359599461635174,0.39473684210526316,1.0,1.0,1/12,2.60%,NEK6
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.4542660761521486,-1.0350842035205665,0.325,1.0,1.0,6/32,11.39%,UBASH3B;FIBP;HSPB1;TYRO3;PDGFRA;TLN1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.5171578849059434,1.0350508736324897,0.390625,1.0,1.0,5/25,10.60%,CA12;CA9;CA1;SLC26A7;CA7
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.562408402731683,-1.0347789962158027,0.3783783783783784,1.0,1.0,1/14,1.28%,LEF1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.48027398417133726,-1.0346871281017531,0.3611111111111111,1.0,1.0,6/30,13.28%,TRDMT1;TENT5A;VIP;ELAVL1;NAF1;CIRBP
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.34896159852424463,-1.0346642245434856,0.29411764705882354,1.0,1.0,36/424,9.48%,STK32B;NRK;KIT;ALK;CAMK1G;KDR;TRIB2;EPHA3;FGFR4;LMTK3;EPHB2;MYO3A;PRAG1;PRKG2;NEK6;NRBP2;SGK1;MAML1;GRK5;MAP3K20;MARK1;PRKCD;CDC42BPB;PLK2;AURKA;TGFB2;CSK;TYRO3;INCENP;LIMK1;BAZ1B;PDGFRA;PEAK3;TAF1;CDKL1;CDK14
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),0.5856556537990663,1.0345878751662068,0.44642857142857145,1.0,1.0,6/15,29.43%,ATP5F1E;ATP5F1C;ATP5MC3;ATP5ME;ATP5PB;ATP5PD
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.5890525375312907,-1.0345395459758424,0.47368421052631576,1.0,1.0,3/10,9.22%,APIP;NLRP1;GSDMB
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4247301942207489,1.0345129249241867,0.3611111111111111,1.0,1.0,14/104,6.88%,CALCR;MC4R;RXFP1;GPR26;TBXA2R;CALCB;OPRK1;GNAT2;ADGRB1;SCTR;CNR2;P2RY12;PTGER3;TSHR
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.6215374414325308,-1.0342252541914856,0.4318181818181818,1.0,1.0,3/8,16.29%,TIMELESS;SPIDR;DDX11
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.33244917069677477,-1.0342209974971528,0.2222222222222222,1.0,1.0,85/904,9.64%,ETV1;CD38;ETV5;MYRFL;MYB;BMP7;STING1;H1-4;HMGN5;LEF1;TOX2;F2RL1;SSBP3;CREB5;PID1;CDH13;GREM1;RUNX1;ZNF496;CREB3L4;E2F5;NFATC1;KDM8;MAML3;SOX12;ASCL1;GABPB2;ATOH8;FOS;ZNF462;TEAD2;BRCA2;HDAC5;PRDM15;IGF1;NRL;ZMIZ2;TRIAP1;SFRP1;NFIB;WWTR1;FIZ1;ADIRF;MAML1;ITGA6;RRP1B;LYAR;MED30;HIVEP1;WBP2NL;HDAC1;ZBED3;TFAP4;RGMB;ZNF300;ZFHX3;TFDP1;MAPK7;ATF3;SERPINF2;ETS1;BMP6;IL11;SBNO2;ID2;NFIX;MAP2K3;E4F1;CDK5RAP2;INO80;STAT3;NR1H4;POU2F2;THOC1;FOXK1;LBH;UBTF;TGFB3;XRCC6;IFI16;DLX5;RBMX;PBX4;SMARCA4;APOE
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.5125250796072,1.0341963949152373,0.4117647058823529,1.0,1.0,3/26,2.36%,LDLRAP1;GPC6;GPC5
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.6231422275558014,1.0340422122537427,0.4146341463414634,1.0,1.0,2/11,11.79%,P2RY12;EPS8
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.6128850194655805,1.0337816917304465,0.5079365079365079,1.0,1.0,1/10,1.54%,AGER
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.6246211082440473,1.033780250954409,0.42105263157894735,1.0,1.0,2/7,20.17%,TRDN;CALM3
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.4541729450404265,1.0336431289896542,0.42857142857142855,1.0,1.0,9/80,7.50%,PLA2G10;CCL5;PDGFRB;NTF3;FASN;INHBA;AGT;IFNLR1;SFRP4
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),0.6819975035864808,1.0335431983473846,0.5272727272727272,1.0,1.0,1/5,11.99%,PBXIP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.7153518741280933,1.0331166248584798,0.49206349206349204,1.0,1.0,2/5,22.72%,DOCK4;DOCK5
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.5254325401189637,1.032460844767534,0.38235294117647056,1.0,1.0,14/35,19.01%,HCK;CD300LF;PIK3R5;PTPRC;TAGAP;MYO1F;AQP9;ADGRE1;IGSF6;PTAFR;LY86;NCF2;HK3;CD80
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.6381069648344976,1.0324544337185697,0.4406779661016949,1.0,1.0,4/9,26.82%,NKD2;CCBE1;TFR2;NLRC4
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.6549553887763224,1.03228427887928,0.43137254901960786,1.0,1.0,3/6,20.17%,CAMK2D;TRDN;CALM3
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.41518405494372906,-1.032203789080112,0.29411764705882354,1.0,1.0,12/89,10.37%,SPRED2;SPRED3;SPRED1;GREM1;LEMD2;PMEPA1;CIDEA;CILP;ZBTB7A;CRIM1;VWC2;SORL1
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),0.6440663281564827,1.0319764704730754,0.45,1.0,1.0,2/6,21.98%,G6PD;TKT
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.35566212623142734,-1.031742830715259,0.34782608695652173,1.0,1.0,24/232,5.66%,ITGB5;NPNT;KDR;COL15A1;LAMB2;ITGA4;ADAM19;ADAMTS2;ADAMTS3;LAMA4;GREM1;ADAM12;COL6A2;ADAMTS15;LAMB3;LOXL1;ADAMTS8;COL11A2;ITGA6;PAPLN;VCAN;TNR;COL4A3;ADAMTS5
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.6483863379808151,-1.0317379004057634,0.5365853658536586,1.0,1.0,3/9,18.15%,NUMA1;MACROH2A2;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.6002594603704812,-1.0315822756157709,0.5121951219512195,1.0,1.0,1/10,4.28%,SGK1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.46634362079396025,-1.031535259021418,0.34375,1.0,1.0,3/30,10.70%,FBXW8;KNDC1;NSMF
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.5566509163462744,1.0314637164314888,0.4666666666666667,1.0,1.0,8/17,30.73%,FASN;SCD;ACSL4;DGAT2;CBR4;DGAT1;ACSL3;ACLY
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.45677457218711376,-1.031458915976323,0.45454545454545453,1.0,1.0,6/57,6.01%,PTPN3;BTC;CDH13;RNF126;EREG;DGKD
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5456172533580221,1.0314412189902278,0.4576271186440678,1.0,1.0,4/21,5.11%,ACKR3;TRIM32;ING2;CDKN2D
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.6417924409999453,-1.031291903589552,0.42105263157894735,1.0,1.0,2/7,7.46%,PUM3;PNKP
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.4785420950899615,-1.0311689199214182,0.4166666666666667,1.0,1.0,5/21,14.24%,DRD4;INSYN2A;GRIN2A;GRIN2C;NLGN3
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),-0.5781266817023211,-1.0310977551364655,0.5,1.0,1.0,3/14,5.69%,GPC4;NTNG1;LRFN4
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.6946959205004233,1.0310711836921276,0.5094339622641509,1.0,1.0,1/5,9.21%,GPER1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.42302377601573,-1.0308702047586238,0.3448275862068966,1.0,1.0,8/85,6.32%,PER2;GLP1R;RBP4;ITPR2;CELA2A;SFRP1;EPHA5;CACNA1A
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.6571160614485362,-1.030815611512066,0.52,1.0,1.0,1/6,2.63%,ERCC2
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.5917417669731778,-1.0308010297940466,0.4883720930232558,1.0,1.0,5/6,38.78%,KMT2B;SETD1B;KMT2D;SETD1A;SETD4
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5480312764393371,-1.0306060101025047,0.4,1.0,1.0,1/12,0.75%,PKP2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.5304910583917393,-1.0305246368985752,0.43243243243243246,1.0,1.0,3/22,4.58%,RNF126;VPS25;PTPN23
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.540072092112005,1.0303943953599661,0.4166666666666667,1.0,1.0,2/27,6.59%,KCNN4;CD160
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.6534485636177925,1.0303670251944634,0.5211267605633803,1.0,1.0,4/7,27.00%,BFSP1;WNT5B;ABI2;WNT7A
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5553783480091163,1.0301806369838458,0.4393939393939394,1.0,1.0,3/21,13.46%,NOTCH1;RUNX2;SMAD1
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.637571570843155,1.0301419904268643,0.4807692307692308,1.0,1.0,3/9,20.10%,ITPKB;IPMK;IPPK
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.5195517985592765,1.030140266455662,0.453125,1.0,1.0,5/35,5.28%,PTGIS;PLA2G10;CYP1B1;ALOX12;EPHX1
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5613127914385504,1.0300319842844832,0.4264705882352941,1.0,1.0,4/17,23.32%,CD160;GPS2;PRNP;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.5788765482506055,1.0298507419851102,0.38095238095238093,1.0,1.0,5/15,14.17%,PTPRC;CCNE1;SOX11;NANOG;EPCAM
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.440427963290483,1.0298446314976584,0.375,1.0,1.0,1/78,0.23%,RAB6C
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.5855361315780151,1.029796862551608,0.453125,1.0,1.0,4/13,11.87%,NOTCH1;PTPRZ1;DRD3;DAAM2
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.4892787185735339,-1.0294782349637939,0.41025641025641024,1.0,1.0,3/21,4.39%,NMNAT3;NAXE;SLC22A13
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.5219318390161514,1.0294038954915317,0.46875,1.0,1.0,7/31,13.84%,MCM2;POLE2;GMNN;POLE3;CDC6;RPA3;ORC4
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.5881921153674228,-1.0290724155970286,0.41025641025641024,1.0,1.0,5/7,38.78%,KMT2B;SETD1B;KMT2D;SETD1A;SETD4
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.546629806146493,1.0290389253793146,0.44,1.0,1.0,6/19,23.54%,DNASE2;DNASE2B;GPER1;H1-0;ACVR1C;DFFB
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.5176123650988348,1.0289331936928137,0.4444444444444444,1.0,1.0,11/29,21.79%,TRPV6;SYT2;SYT4;REST;DOC2A;SYT9;SYT15;SYT13;CACNA1H;CACNA1G;DOC2B
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),0.7074623472415738,1.0286731586301638,0.5517241379310345,1.0,1.0,3/5,25.73%,TLR2;GBP5;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.6665565241972427,-1.0286663567555463,0.45,1.0,1.0,2/7,7.06%,CHTOP;GTF2H2
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.6506932087807517,1.0286330314012604,0.53125,1.0,1.0,2/8,15.43%,CMPK2;AK4
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.4720815309190342,1.0283414309784773,0.4225352112676056,1.0,1.0,6/43,18.36%,RFC5;BRCA1;RPA3;PCNA;TRIM25;POLN
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.6599923799227901,1.0283146648409416,0.5,1.0,1.0,1/6,9.67%,STAP1
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.6652767536935175,-1.028007455536099,0.55,1.0,1.0,2/5,4.61%,ABCC4;SLC19A1
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),-0.6197740938112598,-1.0279944765315627,0.43137254901960786,1.0,1.0,1/6,4.60%,DRD4
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.5468238228128107,-1.0273523433901746,0.36363636363636365,1.0,1.0,2/13,6.31%,GREM1;PTHLH
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.4624699783534071,1.0272529321773942,0.4393939393939394,1.0,1.0,27/72,17.50%,ADAM28;RCSD1;DOCK8;PTPRC;ARHGAP9;GMFG;TAGAP;WAS;ARHGAP25;MAP4K1;STAG3;P2RY14;LINC00926;STAP1;MYO1F;RHOH;MITF;TMC8;ABCB4;BANK1;CD72;LY86;BTLA;PYHIN1;CD74;WDFY4;CD37
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.4377715022166564,1.0272004353194464,0.4027777777777778,1.0,1.0,9/65,9.91%,PTER;ZNF703;OVOL3;TST;TBX1;CNN3;TOLLIP;FGFR2;DEUP1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.45898816138897675,-1.0269273645954,0.375,1.0,1.0,2/32,6.57%,BLOC1S4;AP3B2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.4132466296224448,-1.026236692852277,0.3333333333333333,1.0,1.0,1/75,0.45%,ROR2
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.4715066305554238,1.0262335250117978,0.4153846153846154,1.0,1.0,6/48,11.78%,TYR;ELANE;TRIM32;CDKN2D;SLC24A1;OPN3
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.49014608031128576,1.0258953309975911,0.4,1.0,1.0,7/61,9.85%,PLA2G10;PDGFRB;PLA2G7;SERINC1;PIGC;PIGH;PIGV
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.5728084030345018,-1.0256243051718763,0.5,1.0,1.0,3/12,6.80%,SLC16A12;SLC19A1;PDPN
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.6305392974545122,-1.0254537730742777,0.5641025641025641,1.0,1.0,4/9,10.30%,BMP7;GCH1;DHFR;ABCD1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.4517198298772382,1.025374478867078,0.43283582089552236,1.0,1.0,15/78,16.52%,CALCR;CCL5;CHMP4B;CDKN1B;BNIP3;ACOX2;SOX11;LRPAP1;RIPK2;HTR2B;CTSZ;VPS35;DHCR24;CHRNA7;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.5881564080441332,1.0253654088922388,0.4642857142857143,1.0,1.0,3/9,13.69%,MC4R;ATP6AP1;SPP1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.504465298379607,-1.0249804951002182,0.39473684210526316,1.0,1.0,4/12,27.27%,ATG10;DESI2;DESI1;ATG7
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.4479230571977488,-1.0249694966920657,0.3953488372093023,1.0,1.0,19/38,31.00%,MTMR8;MTMR9;PLPPR5;SGPP2;PIP4P1;PLPP4;MTMR7;MTM1;EPHX2;INPP5B;INPP5J;SYNJ2;PLPPR4;MTMR4;MTMR10;PLPPR2;MTMR6;PTEN;PLPP3
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.44644163405258,1.0248416611800384,0.42857142857142855,1.0,1.0,11/69,11.56%,MMP15;PRDX4;HSD11B2;FASN;FKBP4;TEAD4;MBNL3;DUSP9;AP1M2;SLC52A2;CCDC86
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.3532956936248505,-1.0248119542451468,0.38461538461538464,1.0,1.0,43/436,9.61%,CD38;PER2;SOX13;MYB;BMP7;NRG1;LEF1;SAMD4A;ARID5A;TLE2;KDM8;EREG;ASCL1;TYMS;ATOH8;PRDM5;ZNF256;HDAC5;SFRP1;ID4;RING1;BCL6;HDAC1;TIMELESS;TFAP4;SAMD7;FOXP1;SBNO2;NCL;PHC2;ID2;DHFR;ZHX3;SFMBT1;SAMD13;SUV39H2;ZBTB7A;FOXK1;LBH;XRCC6;IFI16;SLFN11;SMARCA4
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.6397362068375398,1.0247257893045252,0.5490196078431373,1.0,1.0,3/7,27.68%,TLR2;B2M;RPS27A
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.6397362068375398,1.0247257893045252,0.5490196078431373,1.0,1.0,3/7,27.68%,TLR2;B2M;RPS27A
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.5656956612635023,1.0247102392371943,0.47692307692307695,1.0,1.0,4/11,22.26%,NODAL;CALR;ACVR1C;GJA1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.6890684655944446,1.024637537360629,0.4482758620689655,1.0,1.0,1/5,22.43%,PDE12
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.6242753688839127,1.0246299490581452,0.43859649122807015,1.0,1.0,4/7,29.79%,CKB;CKMT1A;CKMT2;GATM
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5594981207302747,1.024628814636756,0.5,1.0,1.0,3/19,9.67%,KCNN4;PTPRC;STAP1
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.6157251378484865,1.024492288070764,0.4642857142857143,1.0,1.0,5/14,21.82%,CHST1;GNPDA1;CHST6;EXTL2;OGA
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.6456598977858107,1.0244218837508898,0.45901639344262296,1.0,1.0,5/8,31.98%,LRRC8D;LETM1;MAT2A;LRRC8A;UGDH
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),0.6331835467616804,1.024408830492218,0.5074626865671642,1.0,1.0,4/6,27.76%,SLC5A11;AQP9;SLC26A6;AQP11
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),-0.6338028408098489,-1.0242715429082676,0.46511627906976744,1.0,1.0,3/6,14.24%,DRD4;INSYN2A;NLGN3
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.44125563443763044,-1.0242691789174339,0.3939393939393939,1.0,1.0,12/43,21.64%,PRDM5;HDAC5;HDAC1;TBL1Y;SIN3B;SIRT2;SIRT7;SIN3A;HDAC10;HDAC9;HDAC11;HDAC7
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.508497656252418,1.0237323342689646,0.42857142857142855,1.0,1.0,6/29,17.99%,SLC30A8;CLDN10;RAB11A;DNAJA1;PINK1;LRRK2
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.48475429454611185,-1.0236929878493284,0.4,1.0,1.0,5/23,5.78%,KRT16P6;IL1RL2;ADIRF;MYH11;ANO1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.4475116745076242,-1.0236787145909139,0.3673469387755102,1.0,1.0,4/24,10.86%,KDM8;HR;KDM4B;KDM3B
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.30460427216397334,-1.0235856710750504,0.5,1.0,1.0,178/1645,10.89%,ETV1;ETV5;PER2;ZNF534;KIT;ZNF485;ZNF707;SOX13;MYB;ZNF442;POU6F2;STING1;TBX6;RFX8;LEF1;AASS;TOX2;F2RL1;GFI1B;SSBP3;TCF24;CREB5;PID1;CDH13;GREM1;ARID5A;RUNX1;FHL2;ZNF496;CREB3L4;ZNF606;ARID3B;ZNF572;E2F5;NFATC1;CEBPD;MAML3;SOX12;ZNF449;ASCL1;ZNF132;GABPB2;BACH2;ATOH8;ZBTB7C;FOS;ZNF462;ZNF347;TEAD2;PRDM5;ZNF256;ZNF239;BRD3;ZNF18;SMYD2;HDAC5;PRDM15;IGF1;NRL;TPR;ZMIZ2;ZNF155;TRIAP1;NFIB;WWTR1;FIZ1;ADIRF;MAML1;ITGA6;RRP1B;ID4;PRRX1;LYAR;RITA1;MED30;ZNF354B;HIVEP1;RFX1;BCL6;ZNF25;HDAC1;ZBED3;ZNF608;PTCH1;TOX;ZNF48;TFAP4;ZNF334;MED15;IGBP1;POU3F4;ZNF596;ZNF300;TRPS1;ZNF846;ZBTB39;HR;ZNF558;ZFHX3;TFDP1;MAPK7;ATF3;HDX;ZNF441;FOXP1;SERPINF2;E2F6;ETS1;BMP6;IL11;SBNO2;ZNF446;GTF2H2;ID2;CBFB;NFIX;SPDEF;ZNF536;E4F1;GTF2H2C;ZHX3;ZNF771;ZNF264;INO80;STAT3;MACROH2A2;ZNF397;WIZ;NR1H4;ZNF99;ARX;BAZ1B;SUV39H2;POU2F2;BRD9;ZSCAN16;ZNF429;ZBTB7A;TBL1Y;SMARCAL1;KLF16;ZNF416;FOXK1;TGFB3;XRCC6;TAF1;SIN3B;IFI16;DLX5;ZNF184;VGLL3;RBMX;ANKRD2;PBX4;SMARCA4;APOE;ZNF26;TET1;ZNF514;SARS1;RORA;ZMYM5;MAFK;CREB3L1;MXI1;NFX1;ZBTB47;POU3F1;ZNF275;ZGLP1;NACC1;PCGF1;LCORL;IKZF3;DACH2;MAMLD1;KDM3B;CCNH
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.5442713565470302,1.0235755610057635,0.44642857142857145,1.0,1.0,4/17,14.43%,ASXL3;GPER1;BRCA1;ACADL
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.4798195784748828,1.023463796467444,0.47619047619047616,1.0,1.0,7/41,14.90%,ADAMTS9;ISG20;NCBP1;RNASEH2C;MANBA;NGLY1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.5521989194279936,-1.0234402463893646,0.37142857142857144,1.0,1.0,8/13,28.54%,SHLD1;KMT5B;HMCES;TP53BP1;SUPT6H;SLC15A4;PARP3;SHLD2
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.5294557266890099,1.0234374110359814,0.45588235294117646,1.0,1.0,7/21,19.65%,LMAN1;UFM1;RAB23;INSIG1;DMTN;LRRK2;SP100
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.606202364532923,1.0232618636990116,0.4576271186440678,1.0,1.0,3/10,13.17%,ZBTB7B;ING2;CAMK2D
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.5950284719035686,-1.0231003154806124,0.5,1.0,1.0,1/12,0.84%,BMP7
prerank,PanglaoDB_Augmented_2021__Pericytes,0.43228666854421677,1.0230489566954089,0.42028985507246375,1.0,1.0,15/107,6.45%,STEAP4;LAMA2;ALPL;TIMP3;MSX1;SLC38A11;ACTA2;PDGFRB;POSTN;ECM2;ANGPTL2;MFGE8;PLSCR4;RARRES2;IGFBP5
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6238296437572516,1.022845471500015,0.45614035087719296,1.0,1.0,5/9,29.53%,BRCA1;TAF7;KLF15;SET;CTBP1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.5803553681042727,1.0226547144636282,0.4411764705882353,1.0,1.0,6/15,19.30%,ZNF703;SSTR1;GPER1;ESR1;CRHBP;H2AZ1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.42462744374032046,-1.022428365468053,0.3225806451612903,1.0,1.0,1/60,0.31%,ITGB5
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.5884466548111726,1.022188722344778,0.4666666666666667,1.0,1.0,3/12,17.89%,HLA-A;SMAD7;B2M
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.3485448305562548,-1.022061228283858,0.3125,1.0,1.0,36/358,9.21%,CD38;BCL2A1;KDR;UNC5B;HMGN5;LEF1;MIEN1;GREM1;SH3RF1;FHL2;ASCL1;APIP;IGF1;NTSR1;TRIAP1;SFRP1;NRBP2;GRK5;MGMT;TCIM;HDAC1;CFLAR;AZU1;IGBP1;POU3F4;PRKCD;BCL2;PLK2;PDPN;CIDEA;HSPB1;TYRO3;NR1H4;VIP;PTMA;TGFB3
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.6511370590269747,-1.0212086863834455,0.5555555555555556,1.0,1.0,1/5,6.58%,MAPK7
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.4382269591232657,1.0211403495508526,0.4166666666666667,1.0,1.0,11/81,10.81%,TICRR;ALPL;TRIM32;DEPDC1B;FANCI;GINS1;BUB1B;PAICS;CDC6;NANOG;PHF6
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.4082407998042868,-1.0207480368992046,0.46153846153846156,1.0,1.0,4/81,4.30%,ETV5;NOX4;PRR5L;GPX7
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.6822516844421812,1.020483110054659,0.5344827586206896,1.0,1.0,3/5,26.62%,KHK;SLC2A5;SLC26A6
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.4111003954945922,-1.0202763777440769,0.37037037037037035,1.0,1.0,1/76,0.45%,ROR2
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.5087613373639469,1.0202536967265659,0.4406779661016949,1.0,1.0,8/23,27.68%,SYVN1;RNF139;MAN1A1;UGGT1;MAN1B1;RNF185;MARCHF6;RPS27A
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.5993992915554313,1.020217506856578,0.4225352112676056,1.0,1.0,3/9,21.44%,AMPD2;AK4;NT5E
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.6015546283657064,1.020108972162112,0.4827586206896552,1.0,1.0,1/13,1.82%,ZNF703
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.46018213108678263,-1.0199598642242118,0.4358974358974359,1.0,1.0,6/18,20.36%,SMYD2;SUV39H2;EHMT2;KMT2B;EHMT1;SETD2
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.6298363649107653,1.019882746095061,0.46774193548387094,1.0,1.0,1/9,4.14%,NOX1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.3829911496327827,-1.0197381096852023,0.44,1.0,1.0,10/127,8.10%,NRK;BMP7;EPHB2;NTNG1;NYAP2;SGK1;DOCK10;DSCAML1;SHANK1;NYAP1
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.4733478451763497,1.0196613496160183,0.4411764705882353,1.0,1.0,9/52,17.18%,NDUFA2;NDUFB9;NDUFB3;NDUFB2;NDUFB4;COX4I1;COX7A2L;CYCS;UQCRB
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6363859388245582,1.0195566704419405,0.5079365079365079,1.0,1.0,1/7,2.22%,KCNE2
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),0.6363859388245582,1.0195566704419405,0.5079365079365079,1.0,1.0,1/7,2.22%,KCNE2
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.3933934869760078,-1.0195185463031384,0.45714285714285713,1.0,1.0,30/105,17.63%,SPHKAP;CACNG3;TNR;SLC6A1;KCNC1;RGS8;ADGRA1;GRIA4;TMEM196;GRIA1;MMD2;GAD2;GRIN2A;STMN2;LRRTM3;TMEM132B;FRRS1L;ELAVL3;SRRM4;CTNNA2;GRIA2;CNTNAP5;BRINP2;UNC13A;DIRAS2;SLC1A6;CACNA1B;UNC79;CELF5;CELF4
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.48779809588132284,1.019467101619547,0.4090909090909091,1.0,1.0,6/33,20.68%,CHMP4B;PHF23;PINK1;PIP4K2C;LRRK2;SEC22B
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.549104155142441,-1.0194599395052888,0.5,1.0,1.0,2/19,1.08%,SELP;ITGA4
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.5345571107173973,1.0193872120005247,0.49230769230769234,1.0,1.0,8/20,21.39%,BTN2A2;PDCD1LG2;ARG1;IL4I1;SFTPD;CD80;CD274;PRNP
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5087300368014949,1.0192435449608226,0.45161290322580644,1.0,1.0,5/28,11.79%,AGER;CMKLR1;PLCG2;SCIMP;RIPK2
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.48104265679487,-1.0188982734586691,0.4,1.0,1.0,4/23,7.89%,PTPRT;PID1;SBNO2;STAT3
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.5437282030721562,1.018783509146024,0.5087719298245614,1.0,1.0,4/18,18.27%,CNGB1;SLC28A2;B2M;TF
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.5697703196756151,-1.0187241818189985,0.47058823529411764,1.0,1.0,2/9,5.82%,SLC25A33;SPHK2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.47642237698179385,1.0186927961311605,0.39655172413793105,1.0,1.0,11/51,8.78%,STEAP4;ALDH1A1;SLCO2B1;CLIC6;AGER;CRLF1;TFCP2L1;CD14;SCEL;SIGLEC1;SCD
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),0.6427148289642611,1.0186766876664737,0.49206349206349204,1.0,1.0,4/6,26.35%,SLC28A2;AQP9;SLC29A2;VDAC3
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.4902955391386267,-1.0183154307134614,0.4444444444444444,1.0,1.0,4/22,10.42%,PNP;MLYCD;NUDT7;PRTFDC1
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5217528630516959,1.0183039447603592,0.3958333333333333,1.0,1.0,3/22,8.08%,ZDHHC22;ZDHHC11;ZDHHC6
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5217528630516959,1.0183039447603592,0.3958333333333333,1.0,1.0,3/22,8.08%,ZDHHC22;ZDHHC11;ZDHHC6
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.4671003962596666,-1.0180003662003514,0.4418604651162791,1.0,1.0,6/25,11.48%,ITGA4;IGF1;CACNA2D1;CACNA1A;GRIN2A;ABCC1
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.5550041281763752,-1.0179884590994313,0.41025641025641024,1.0,1.0,4/13,16.72%,SLC25A33;EARS2;PNPT1;TEFM
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4257213688629135,1.0179390137787716,0.375,1.0,1.0,14/142,8.81%,STK16;ITK;EPHA1;STK26;PDGFRB;HCK;TNK1;MAK;FLT3;DAPK2;MAP3K11;MEX3B;MAP4K1;FGFR2
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.37435291356941525,-1.017872741277721,0.41935483870967744,1.0,1.0,19/144,11.33%,KDR;RUNX1;ATOH8;IGF1;APLN;SFRP1;HDAC1;FOXP1;AURKA;ID2;TGFB2;CILP;TAF1;APOE;TET1;CREB3L1;PARP10;WDR54;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.6653684173656421,1.017667899872991,0.47761194029850745,1.0,1.0,1/5,7.67%,NCBP2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.6653684173656421,1.017667899872991,0.47761194029850745,1.0,1.0,1/5,7.67%,NCBP2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4779038444642087,1.0173313687405947,0.41935483870967744,1.0,1.0,10/45,18.80%,ARIH2;HSPA1L;CASP8;YWHAH;YWHAG;RHOU;UBL5;PINK1;TP63;BAD
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.5898901046484629,-1.0170030502325986,0.5121951219512195,1.0,1.0,1/10,0.83%,MYB
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.5235425606836408,1.0169774141679768,0.5396825396825397,1.0,1.0,6/26,18.27%,CP;TMC8;HJV;SLC40A1;B2M;TF
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.4019599719399807,-1.0169547635289347,0.41379310344827586,1.0,1.0,23/106,17.00%,KDR;FGFR4;SAMD4A;SLC25A37;EREG;IGF1;AZU1;TGFB2;SLC6A9;PPP1R3E;ELAVL1;UPF3A;SMOC2;ABCB10;CIRBP;FAF1;IRS1;RBM3;EGFR;NMD3;TMEM106A;MTPN;PLD1
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.5361106198727037,1.0169225789161964,0.48214285714285715,1.0,1.0,6/20,12.07%,ERAP2;CHAC2;LVRN;ENPEP;CHAC1;NAALADL1
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.5624000452445821,-1.016795815917884,0.45161290322580644,1.0,1.0,4/9,12.80%,ALAS1;LYAR;ZBTB7A;ABCB10
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.5813941279452807,1.016772220291354,0.5714285714285714,1.0,1.0,4/14,23.22%,SLC30A8;GHRL;RAB1A;CDK16
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4975503741463515,-1.0165031054271685,0.5625,1.0,1.0,1/22,0.25%,STAC
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.4079789617246983,-1.0164039995964849,0.3181818181818182,1.0,1.0,11/74,10.58%,SPRY4;EPHB2;RABL3;IGF1;RASGRP1;RASGRF1;TGFB2;MMD2;SPRY3;RALGPS1;NGF
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.39564782563616113,1.0163982790987698,0.42857142857142855,1.0,1.0,27/235,10.64%,PNMA5;GADD45B;NLRP2B;DDX20;PREX1;BOK;CYP1B1;MOAP1;DAPK2;MAP3K11;PNMA2;KNG1;PXT1;FADD;HIP1R;BNIP3;REST;DUSP9;SFRP4;CASP8;RHOB;SIAH1;GPER1;PPID;FAS;RNF122;TFPT
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5099539292739266,1.0161195302925061,0.41935483870967744,1.0,1.0,9/21,32.49%,CASP8;RIPK2;TAB2;CYLD;NOD1;RPS27A;RNF34;ITCH;AAMP
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.481747945729227,-1.0158577617221802,0.45,1.0,1.0,3/21,14.65%,PRR5L;GNA12;PRKCE
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),0.6498144398472998,1.0158312920167583,0.4827586206896552,1.0,1.0,2/7,14.16%,ARG1;ARG2
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.5706298973554609,1.0157423491158482,0.48484848484848486,1.0,1.0,3/14,8.54%,ODAD4;ODAD3;DNAH8
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.480191611817809,1.0156194069089117,0.5074626865671642,1.0,1.0,7/44,9.67%,NLRP2B;PTPRC;CARD8;PELI3;ARG1;OTUD4;STAP1
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.46823876005875453,-1.0155079638706368,0.4634146341463415,1.0,1.0,7/24,15.06%,POP1;LIN28B;EXOSC10;EXOSC7;EXOSC5;DIS3L2;EXOSC4
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.49719443348656245,1.015470235961868,0.4090909090909091,1.0,1.0,5/36,9.36%,C3AR1;ACTC1;MYOF;AVPR1A;STAT1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.629632484107574,1.0152089599514151,0.5161290322580645,1.0,1.0,3/6,24.86%,DDX1;DDX3X;SSB
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.5310423946677074,-1.0149229712469388,0.45454545454545453,1.0,1.0,1/16,1.77%,PID1
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.5084790171358351,-1.014679979697739,0.45,1.0,1.0,1/16,0.81%,SLC39A11
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.44522835446982273,1.0145200743211713,0.4383561643835616,1.0,1.0,12/91,11.99%,CASP12;BOK;CARD8;FADD;BCAP31;HIP1R;REST;CASP8;KHDC1;GPER1;FAS;MTCH1
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.6773320284256549,-1.0144968961365626,0.5,1.0,1.0,2/6,3.53%,BMP7;IGF1
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.5937606954876748,1.0142829183281747,0.5454545454545454,1.0,1.0,5/9,30.67%,CELSR1;SHROOM3;JAM3;ATP8B1;SHROOM2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.4655446707956347,-1.0139744599984066,0.42424242424242425,1.0,1.0,5/25,12.39%,CATSPER2;TGFB2;TGFB3;PAQR7;CATSPERG
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.5939512640320759,-1.0139617609553082,0.45454545454545453,1.0,1.0,3/7,18.73%,CCDC22;FAF1;NFKBIB
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.43820985869075496,1.0136326956247865,0.4225352112676056,1.0,1.0,22/105,11.50%,LAMA2;ALDH1A1;TIMP3;ACSBG1;PRLR;POSTN;HSD11B2;NR5A2;INHBA;ANGPTL2;PLSCR4;RARRES2;IGFBP5;CPE;F10;EFEMP1;CYP19A1;MAFB;EPAS1;PLAUR;ADAM21;KIAA1217
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.5410643692867158,-1.013625952789026,0.5,1.0,1.0,2/11,7.92%,SLC22A13;PGP
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.5530416145539506,-1.0134861440252616,0.4864864864864865,1.0,1.0,3/16,8.68%,SPTSSB;FEM1A;SMG6
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.6562789749920563,1.013458865668497,0.532258064516129,1.0,1.0,2/5,26.50%,TMEM167B;TRAPPC11
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.4443871702689083,1.013292261833885,0.463768115942029,1.0,1.0,13/92,12.24%,CASP12;PTGES;LRRC19;TRIM5;HCK;CNGB1;P2RY12;CASP8;GUCY2F;CNGA1;IRF1;USP14;PDE6B
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.36557677476504,-1.0132553750293676,0.45,1.0,1.0,22/106,15.69%,SHC3;LEF1;TNFRSF19;SEZ6L2;ID4;SLC19A1;CDC42BPB;TYRO3;NYAP1;NCS1;TBC1D16;GPR37;FAT1;FARP1;FNDC4;ARNT2;FGFR3;KAZN;SRRM3;CAP2;EGFR;EPN2
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),-0.6344939664153246,-1.0129468690322867,0.4528301886792453,1.0,1.0,1/5,8.00%,GDE1
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),-0.6344939664153246,-1.0129468690322867,0.4528301886792453,1.0,1.0,1/5,8.00%,GDE1
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),-0.5814870128176446,-1.0129327037939537,0.43902439024390244,1.0,1.0,1/10,0.84%,BMP7
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.42057088476457116,1.0127673904596577,0.4696969696969697,1.0,1.0,19/104,15.47%,SLC13A4;CLIC6;GPC6;WFS1;MMP15;PRLR;AGT;RARRES2;IGFBP5;CPE;TMEM178A;NOTCH3;SLC31A1;KIAA1217;CHMP1A;SHROOM3;FLRT3;DAB2IP;ATP1B1
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.4496781358782105,1.0127362938303117,0.4189189189189189,1.0,1.0,42/87,36.96%,RPL15;RPS7;RPL36;RPL9;RPS21;RPL26L1;RPL38;RPL21;RPL22;RPS5;RPL22L1;RPS13;RPL27;RPL35A;RPL35;RPL3;RPS20;RPL27A;FTSJ1;RPS27A;RPL13A;RPL5;EIF3I;RPS29;RPS12;RPL7;RPL32;RPS4X;RPL37A;RPL24;RPS9;RPL28;ZC3H15;RPL8;RPS24;RPS3;EIF4A2;RPL37;RPSA;GSPT2;RPS19;RPL4
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.4216857451040133,1.0124915694711614,0.4473684210526316,1.0,1.0,19/102,12.12%,C3AR1;CALB1;CALCR;P2RY1;CAV3;TBXA2R;CALCB;ACKR3;FKBP1B;KNG1;BCAP31;PTGER3;CMKLR1;GPER1;TMEM178A;SCGN;DRD3;ESR1;GHRL
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),-0.5648931558776222,-1.0120923583515493,0.4418604651162791,1.0,1.0,1/10,0.56%,UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.594920318054986,1.011783965220081,0.5576923076923077,1.0,1.0,4/14,10.92%,CCL5;PDGFRB;IGFBP5;DOCK4
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),0.6106445801963674,1.0116764012984925,0.5178571428571429,1.0,1.0,2/5,20.84%,CACNA1G;HCN4
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.47290413737456005,-1.0112582656074494,0.40625,1.0,1.0,7/29,13.53%,EPHB2;CRH;SLC6A9;GRIA4;GRIA1;GRIN2A;GRIA2
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),0.5605170528232618,1.0112536280912385,0.48333333333333334,1.0,1.0,1/9,3.05%,GOT1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.6544525158454457,1.0108690818579051,0.5384615384615384,1.0,1.0,2/5,27.05%,PLSCR1;UHRF1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.6544525158454457,1.0108690818579051,0.5384615384615384,1.0,1.0,2/5,27.05%,PLSCR1;UHRF1
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6245968308870562,1.0108328718453226,0.5,1.0,1.0,2/10,6.09%,BCAP31;TMEM30A
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.4619672783512533,-1.0106347030301002,0.425,1.0,1.0,4/30,12.37%,ADAM19;NCSTN;RBMX;HM13
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5670760275145748,1.0105475605021992,0.5352112676056338,1.0,1.0,4/14,9.76%,GLI3;RARRES2;FGFR2;SOX11
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.5738440862778668,1.0102379748130637,0.46153846153846156,1.0,1.0,5/11,19.86%,ABCB1;MLC1;SLC38A2;CRHBP;CORO2B
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.5120090726851614,-1.0098569759323186,0.4090909090909091,1.0,1.0,1/11,1.38%,F2RL1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.559808663237034,1.0097612531098445,0.4393939393939394,1.0,1.0,4/11,25.85%,CSGALNACT1;GFPT2;EXTL2;PARG
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",0.5094511207347798,1.009610684095497,0.4444444444444444,1.0,1.0,4/33,12.15%,TDG;RFC5;RPA3;PCNA
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.5785523701428962,1.0094913653257322,0.45,1.0,1.0,4/11,20.77%,VPS37B;CHMP2B;CHMP2A;VPS4A
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.6121666082024673,1.0094128626496277,0.5094339622641509,1.0,1.0,3/8,15.63%,CCDC39;DNAH7;DNAI3
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.466032555407344,1.0093636072503414,0.4027777777777778,1.0,1.0,4/47,7.05%,HSD17B2;WNT8A;CDKN2D;TBX1
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.5877932536577115,1.0092285761673647,0.5272727272727272,1.0,1.0,6/12,25.32%,INHBA;HJV;ACVR2B;ACVR1C;ACVR2A;INHBB
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.6202398214629218,-1.0091019681083186,0.5227272727272727,1.0,1.0,1/9,0.35%,KIT
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.5374623019086358,-1.0090663904638957,0.4791666666666667,1.0,1.0,2/13,5.46%,IGF1;PTCH1
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.6585156647693942,1.0087166013852717,0.5333333333333333,1.0,1.0,1/6,6.47%,TSHZ3
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.43973862402186525,-1.008622286443238,0.5128205128205128,1.0,1.0,3/29,8.11%,TPD52L1;BCL2;CRADD
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.6839108679030954,1.0084726722349735,0.5272727272727272,1.0,1.0,2/5,5.16%,LDLRAP1;AGT
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.6248885349420596,1.0083759468008495,0.5,1.0,1.0,2/9,13.21%,DAPK2;TSC2
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.6518024768847056,1.0082373340493338,0.5517241379310345,1.0,1.0,2/9,7.55%,CLEC2A;TUBB
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.593796230079032,1.0082166051464936,0.4727272727272727,1.0,1.0,2/9,9.06%,ADAMTS9;EPN1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.44605424415217915,-1.0080361712351023,0.36363636363636365,1.0,1.0,3/40,3.79%,PAPSS2;GUCY2C;DCAKD
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.45287332377768835,-1.0079537815182746,0.4,1.0,1.0,5/26,10.58%,IGF1;RASGRP1;RASGRF1;MMD2;NGF
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5854361277371112,1.0078501663098154,0.4411764705882353,1.0,1.0,4/11,24.42%,WASF1;BRK1;CYFIP1;ABI2
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.5271594320982718,1.007774785041703,0.5,1.0,1.0,1/23,1.54%,AGER
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.5952281401581923,1.0077175225035577,0.5084745762711864,1.0,1.0,1/8,7.04%,BNIP3
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.5160142700878023,-1.0076132778466589,0.5384615384615384,1.0,1.0,2/15,14.43%,SAMHD1;CACTIN
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.5783361386831508,1.007263718198268,0.46875,1.0,1.0,4/11,28.44%,NAMPT;PGRMC2;DGAT2;LRP5
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),-0.674387700101683,-1.0070636229939252,0.4772727272727273,1.0,1.0,1/5,4.52%,RYR1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),-0.674387700101683,-1.0070636229939252,0.4772727272727273,1.0,1.0,1/5,4.52%,RYR1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.6480956792328225,1.0070520742054434,0.5,1.0,1.0,1/6,1.29%,PTGIS
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.6480956792328225,1.0070520742054434,0.5,1.0,1.0,1/6,1.29%,PTGIS
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.5966836368330355,1.0069572785919567,0.515625,1.0,1.0,8/14,31.67%,RAB23;AK4;LRRK2;IMPDH1;RHOQ;MFN1;GTPBP1;ENTPD7
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.49368046893222817,-1.006735492885515,0.41025641025641024,1.0,1.0,3/16,5.61%,RASGRP1;KLRD1;PIK3R6
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.4504340139400323,-1.0065741670943475,0.34375,1.0,1.0,5/46,7.12%,CD38;EPHB2;PNP;BCL2;SLC7A1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.4134727165903967,-1.0063004836460865,0.37037037037037035,1.0,1.0,15/93,13.95%,BCL2L11;NRG1;TPPP3;UNC13B;ERCC2;TRABD2A;GTF2H2;ERCC1;FERMT1;EIF4G1;CLU;CUL4A;SPIDR;SH3GLB1;FAF1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.5713264335158021,-1.006207142781004,0.45714285714285713,1.0,1.0,1/12,2.20%,EPHB2
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.5515601521840136,-1.006170502055948,0.4090909090909091,1.0,1.0,4/13,10.25%,RUNX1;SERPINF2;TGFB3;CREB3L1
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.5515601521840136,-1.006170502055948,0.4090909090909091,1.0,1.0,4/13,10.25%,RUNX1;SERPINF2;TGFB3;CREB3L1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.6203533745153796,-1.0061604197234126,0.5581395348837209,1.0,1.0,1/6,5.82%,SPHK2
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),0.6858685088939233,1.0060677692633875,0.49122807017543857,1.0,1.0,4/5,27.26%,TSC2;SLC25A4;VDAC1;SLC25A5
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4630138913781942,1.0059494011725167,0.4861111111111111,1.0,1.0,9/62,11.99%,CASP12;BOK;CARD8;FADD;HIP1R;CASP8;KHDC1;FAS;MTCH1
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5745101634629969,1.0058857573948388,0.4897959183673469,1.0,1.0,4/18,15.19%,TCP1;CCT6A;CCT8;DCP2
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.4199004294878821,-1.0058511633147693,0.37142857142857144,1.0,1.0,4/79,1.70%,ITGB5;NPNT;ITGA4;CD96
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.4276944738890658,1.005401069635917,0.5138888888888888,1.0,1.0,20/108,19.47%,PTGIS;CA9;TWIST1;SUV39H1;BNIP3;PSMB6;NDNF;EPAS1;PSMA3;PSMB8;OPRD1;TBL2;AK4;PINK1;HIF3A;RGCC;CUL2;ACAA2;BAD;ARNT
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.5270991204773895,1.0053270825971905,0.4126984126984127,1.0,1.0,1/23,3.50%,SYT2
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),0.6574865691805469,1.0052814958834861,0.46,1.0,1.0,1/5,14.30%,RAB11A
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.4340332353342842,1.0052672600334955,0.4444444444444444,1.0,1.0,6/70,12.18%,LRP4;ADGRB1;ABITRAM;FGFR2;RAB8A;ATL1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.587736499235662,1.0052076978329891,0.45161290322580644,1.0,1.0,2/13,6.34%,BOK;HIP1R
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.4490990267645628,1.0051563999071194,0.4722222222222222,1.0,1.0,18/72,19.74%,SDS;GOT1;ACAD8;ALDH4A1;IDO1;ARG1;FAH;HSD17B10;ACMSD;GAD1;IL4I1;ASPA;DAO;GLDC;PIPOX;DBT;CARNS1;ACAT1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.4411853431375416,-1.005129775890165,0.3684210526315789,1.0,1.0,18/75,11.71%,BTC;CDC14B;EREG;IGF1;TPR;DBF4B;MAP3K20;SVIL;NUMA1;NSFL1C;ANKRD31;AURKA;INO80;WIZ;KIF23;MAP10;CXCR5;SIRT2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),0.6797593190591504,1.0051223147476283,0.5,1.0,1.0,2/7,13.92%,KCNE2;KCNQ1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.5758905655254964,1.0050069318448034,0.5283018867924528,1.0,1.0,6/14,20.00%,FABP3;PRKAB2;ADIPOR2;PDK4;PPARG;PRKAG2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.5613542655146964,-1.0049437251640152,0.4166666666666667,1.0,1.0,2/7,7.13%,EREG;OLFM2
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.5207530994815724,1.004819101005812,0.47540983606557374,1.0,1.0,7/24,20.84%,SCN4B;SCN9A;SCN7A;YWHAH;CACNA1H;CACNA1G;HCN4
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),-0.5324705707748917,-1.0044048617400243,0.42857142857142855,1.0,1.0,1/15,4.38%,INTS11
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.4525319139930634,1.0044032138235628,0.47058823529411764,1.0,1.0,10/56,10.37%,WFS1;RASA1;CRLF1;NTF3;PTPRZ1;PPARGC1A;SOD2;KIF14;NDNF;SIX4
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.5523077298315068,-1.0043908530527084,0.4883720930232558,1.0,1.0,3/9,6.92%,PTPRT;PID1;SBNO2
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.5225208008382286,1.0041472502164854,0.45454545454545453,1.0,1.0,2/21,7.81%,TRIM54;TPX2
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.4528673543525106,-1.004086803716283,0.3611111111111111,1.0,1.0,6/56,5.61%,KIT;TPD52L1;PDGFD;TNFRSF11A;RASGRP1;PIK3R6
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.5833085204183037,-1.0040570295820952,0.45652173913043476,1.0,1.0,3/9,17.45%,IRS1;PRKCE;SLC45A3
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.3802459902121642,-1.0039747268844383,0.3333333333333333,1.0,1.0,11/94,10.29%,IQGAP2;CDK2AP2;EPHA3;RND3;RHOBTB1;TRIM36;EPHA5;PRKCD;RHOBTB2;PEAK3;TRAF3IP1
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.44686390228601564,-1.0039722733832488,0.4,1.0,1.0,4/30,8.04%,TCOF1;PRKCD;PUM3;NR1H4
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.5560489720999644,1.0037759378110398,0.4576271186440678,1.0,1.0,4/15,27.91%,LRRK2;CX3CR1;KDM1A;DCT
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.510092183469121,1.003544388577104,0.45,1.0,1.0,6/29,9.21%,LDLRAP1;IGFBP5;PRKG1;CDKN1B;SOD2;GPER1
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),-0.6934398213330901,-1.0034642016581585,0.6190476190476191,1.0,1.0,2/5,15.31%,TCIM;EGFR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),-0.6934398213330901,-1.0034642016581585,0.6190476190476191,1.0,1.0,2/5,15.31%,TCIM;EGFR
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.518548361170764,1.0033934363916703,0.5396825396825397,1.0,1.0,4/22,12.78%,HSPA5;DNAJB1;HSPA1L;HSPA8
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),-0.6752182756674726,-1.003181985609813,0.5319148936170213,1.0,1.0,1/5,3.53%,IGF1
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.6273881078029476,1.0030466458169705,0.5636363636363636,1.0,1.0,1/5,13.45%,GPAA1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.4446749618830331,1.0030200932668465,0.4492753623188406,1.0,1.0,3/62,3.94%,NES;HCK;NTF3
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.6979136794554501,-1.0030094301281527,0.5,1.0,1.0,2/6,19.21%,NMD3;SDAD1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.4580155176278027,-1.0028241274758456,0.3783783783783784,1.0,1.0,5/46,8.75%,RUBCNL;NUP210;TPR;NUP37;ZBTB7A
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.4792039561069416,1.0026876137894167,0.5,1.0,1.0,6/49,11.79%,CALCR;CDKN1B;BNIP3;ACOX2;C1QA;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.49953848501666254,-1.0026177666096936,0.5,1.0,1.0,2/19,9.23%,TICAM1;XRCC6
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.47937658444834946,-1.0025289441464469,0.45454545454545453,1.0,1.0,8/45,12.07%,LAMB2;ITGA4;LAMB3;NTNG1;TYRO3;NRP1;ITGA8;PARVA
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4772778486397469,1.0024717648573398,0.48333333333333334,1.0,1.0,8/52,17.07%,NKIRAS1;PRDX4;CD14;RIPK2;NLRC3;DAB2IP;TAB2;TLR2
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.36724235748366657,-1.0022046949296353,0.30434782608695654,1.0,1.0,23/138,11.82%,CNGA3;KCNJ16;SLC22A2;SGK1;SLC12A3;KCNK7;ANO1;KCNF1;KCNC1;SLC7A1;SLC25A29;SLC6A9;FGF13;SLC22A3;SLC29A4;ANO6;KCNQ4;KCNN2;SLC38A7;CHP1;SCNN1G;SLC22A1;KCNB2
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.41842033763357495,1.001833515172365,0.48148148148148145,1.0,1.0,11/107,9.38%,CALCR;NES;TIMP3;HSPG2;TRIM32;CDCP1;IGFBP5;SRPX;DOCK1;EFEMP1;NOTCH3
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.47650804151215315,-1.0018206475067901,0.4146341463414634,1.0,1.0,2/21,6.74%,MYLIP;VLDLR
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.5562832795567487,-1.0018036440194884,0.38095238095238093,1.0,1.0,2/6,6.66%,LEF1;FOXP1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.4370243394823352,-1.00156364782426,0.45714285714285713,1.0,1.0,9/75,11.02%,PID1;PRR5L;EPHB2;WWTR1;ZBED3;PNKP;TRAF3IP1;PPP1R8;CHP1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.5827427257159787,-1.0014508824760937,0.5777777777777777,1.0,1.0,1/9,5.14%,DCLRE1B
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.3090965270692507,-1.0009836102023,0.75,1.0,1.0,181/1686,10.89%,ETV1;CD38;ETV5;PER2;ZNF534;KIT;ZNF485;ZNF707;MYRFL;SOX13;MYB;BMP7;ZNF442;POU6F2;TBX6;RFX8;NRG1;HMGN5;LEF1;TOX2;GFI1B;TCF24;CREB5;ARID5A;RUNX1;ZNF496;CREB3L4;RGS14;ZNF606;ARID3B;ZNF628;ZNF572;TLE2;E2F5;NFATC1;KDM8;CEBPD;OR7D2;SOX12;ZNF449;EREG;ASCL1;ZNF132;TYMS;BACH2;ATOH8;ZBTB7C;FOS;ZNF347;TEAD2;PRDM5;BRCA2;ZNF256;ZNF239;BRD3;ZNF18;HDAC5;PRDM15;IGF1;NRL;ATXN1L;ZMIZ2;ZNF117;ZNF155;SFRP1;NFIB;WWTR1;WTIP;ID4;PRRX1;TCIM;MED30;ZNF354B;HIVEP1;RING1;ZNF562;RFX1;BCL6;ORC1;WBP2NL;ZNF25;HDAC1;ZNF608;TOX;ZNF48;AKAP17A;TIMELESS;TFAP4;RGMB;ZNF334;POU3F4;ZNF596;ZNF273;ZNF300;TRPS1;ZNF846;ZBTB39;HR;ZNF558;SAMD7;ZFHX3;TFDP1;ATF3;HDX;ZNF441;FOXP1;E2F6;ETS1;SBNO2;ZNF446;PHC2;GTF2H2;ID2;CBFB;NFIX;SPDEF;ZNF536;BTG1;MAP2K3;DHFR;E4F1;GTF2H2C;ZHX3;ZNF771;CDK5RAP2;SFMBT1;ZNF264;SAMD13;STAT3;ZNF397;WIZ;NR1H4;ZNF99;ARX;BAZ1B;SUV39H2;POU2F2;BRD9;ZSCAN16;ZNF429;ZBTB7A;TBL1Y;SMARCAL1;THOC1;KLF16;ZNF416;FOXK1;LBH;TGFB3;XRCC6;IFI16;DLX5;ZNF184;VGLL3;CDK14;ANKRD2;PBX4;SMARCA4;APOE;ZNF26;TSFM;ZNF514;RRM2;RORA;MAFK;CREB3L1;MXI1;NFX1;ZBTB47;POU3F1;ZNF275;ZGLP1;NACC1;PCGF1;LCORL;IKZF3;DACH2;MAMLD1;DAP;KDM3B;CCNH
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.4294456555734569,1.00088633298927,0.4025974025974026,1.0,1.0,25/111,18.38%,SLC7A11;SLC23A1;ABCC2;RCN3;AMN;TMEM30A;CBLIF;ARRDC3;TCN2;SLC52A2;CHMP2B;SLC36A1;LRRC8D;ABCG2;SLC38A2;SLC7A7;CHMP1A;AQP9;SLC52A1;SLC38A5;SLC38A4;CHMP2A;SLC7A14;SLC18A2;SNX4
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.46065531300531115,-1.000397165413831,0.45714285714285713,1.0,1.0,2/19,7.04%,KDR;AURKA
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5688402474292913,0.9998850322820496,0.515625,1.0,1.0,4/21,9.21%,INHBA;AGT;FADD;GPER1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.7035781914999586,0.9997833903057618,0.5686274509803921,1.0,1.0,1/5,5.89%,FADD
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.6277978432320723,-0.9997621634432182,0.5227272727272727,1.0,1.0,4/8,22.31%,FAM83D;MAPRE1;MID1;MID2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.6734004875295718,0.9996254053434357,0.5660377358490566,1.0,1.0,2/5,18.14%,PLCG2;CX3CR1
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.6344891765614731,0.9994010358565258,0.5384615384615384,1.0,1.0,3/7,18.14%,RARRES2;PLCG2;CX3CR1
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.5360727107314804,0.9993955584415279,0.4745762711864407,1.0,1.0,6/21,14.20%,FUT2;CYP1B1;SERINC1;CERKL;ALOXE3;SPHK1
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.6474317372579186,0.999257252261951,0.5967741935483871,1.0,1.0,1/7,13.45%,GPAA1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.464437380319804,0.9992186666058579,0.44642857142857145,1.0,1.0,4/34,14.38%,HSPA5;SESN3;NUAK2;TBL2
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.676142967280688,0.9990547673195255,0.46296296296296297,1.0,1.0,1/5,17.03%,FAAH
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.35351804006350146,-0.9984988663890316,0.34782608695652173,1.0,1.0,29/284,9.21%,PER2;NOX4;ROR2;SLC16A2;CDH13;GREM1;RBP4;EREG;ZBTB7C;ADAMTS8;SMYD2;SFRP1;COL4A3;EMD;TFAP4;P3H3;PTHLH;TFDP1;SST;ETS1;PDPN;TGFB2;ALDH1A2;BTG1;VIP;DLG5;MCC;COL18A1;TGFB3
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.6082497692976324,-0.9983150911624192,0.4883720930232558,1.0,1.0,4/9,19.42%,TIMELESS;SPIDR;DDX11;KAT7
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.36389306880337063,-0.9982558846488659,0.4230769230769231,1.0,1.0,15/168,8.45%,DUSP4;ALK;DUSP5;PTPRB;G6PC3;EPHB2;SPHK2;THNSL2;XYLB;PNKP;DUSP12;STAT3;PGP;GDE1;ENPP3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.6032661604278582,-0.9982066838600187,0.525,1.0,1.0,1/10,0.75%,PKP2
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.6038725679802881,0.9977714471363452,0.5636363636363636,1.0,1.0,2/7,6.14%,PLSCR5;PLSCR4
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.6046834992872412,0.9975503132125675,0.5901639344262295,1.0,1.0,3/7,24.47%,PIK3C2G;PIK3CB;PIK3CD
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.39572648530009547,0.9973268504743269,0.46153846153846156,1.0,1.0,15/140,12.46%,TRIM58;TRIM22;TRIML2;TRIM5;RASA1;AHR;PTPRC;REST;YBX3;PCBP2;PRDM6;NANOG;PRDM1;CGGBP1;AFF1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5676808559725631,-0.9972771855724721,0.46511627906976744,1.0,1.0,1/10,1.85%,GREM1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.420685481621742,-0.9971696441520761,0.46875,1.0,1.0,25/96,17.45%,ITGA4;HNRNPL;ZDHHC5;ORC1;TIMELESS;URB2;GTF3C2;DDX21;INCENP;RFWD3;POLG;UCP3;EIF4G1;TTI1;NOP14;SSRP1;MCM3;ABCB10;CUL4A;CEP85;PTBP1;DDX11;NEU3;NUP107;XPO5
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.5610398003436535,-0.996915276227026,0.4864864864864865,1.0,1.0,1/8,4.05%,EFS
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.634971498267989,0.9969080417788629,0.5918367346938775,1.0,1.0,3/6,22.34%,FADD;SKAP1;IL6ST
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.5815591944041153,0.9968594383309092,0.5961538461538461,1.0,1.0,4/13,20.10%,CYP2R1;ITPKB;IPMK;IPPK
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.6007607270611561,0.9968065034754677,0.48148148148148145,1.0,1.0,3/9,16.78%,CD4;CD74;CDK6
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.5303346364017664,0.9967705540416013,0.5,1.0,1.0,5/13,15.71%,EMB;MYPN;CNTN2;NEXN;NPTN
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.42574841239980793,-0.9964440374870537,0.4166666666666667,1.0,1.0,3/57,2.57%,CD38;ITGA4;IL1R1
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.6523018037075133,-0.9964244941784174,0.5128205128205128,1.0,1.0,1/6,6.10%,PRKCD
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.5507231215039488,-0.9962711255651765,0.4782608695652174,1.0,1.0,3/14,9.14%,ST3GAL1;ST8SIA2;ST3GAL2
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.6269430270763591,0.9961935338272844,0.515625,1.0,1.0,2/8,13.06%,NOX1;PKD1L3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.5202191041268132,0.9960507316257643,0.4838709677419355,1.0,1.0,10/20,28.73%,NLRP2B;OTUD4;IRF1;TLR2;GPS2;FLOT1;LRRC14;CD36;NFKBIL1;TLR5
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),-0.6377416907138928,-0.9958882606519095,0.54,1.0,1.0,1/5,5.78%,ANO1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.47558049641518835,-0.9957880741362568,0.4722222222222222,1.0,1.0,5/31,9.21%,BMP7;BMP6;TGFB2;ANO6;TGFB3
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.5464948689721782,-0.9954954109739642,0.45,1.0,1.0,2/10,16.94%,ACE2;ACE
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.5464948689721782,-0.9954954109739642,0.45,1.0,1.0,2/10,16.94%,ACE2;ACE
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.4210074410702429,0.9954344158246698,0.49333333333333335,1.0,1.0,17/98,17.90%,ENPP2;GM2A;VAPB;SERINC1;GBA3;CERKL;ELOVL2;HACD4;DEGS2;ALOXE3;NEU1;SPHK1;B3GALNT1;PSAP;SPTLC3;UGT8;PRKD3
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.5426923990682133,0.9954088810819726,0.47619047619047616,1.0,1.0,1/15,1.83%,WFS1
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.49561819527776735,0.9953036115292638,0.5245901639344263,1.0,1.0,7/28,7.72%,LIPH;SMIM22;ANXA10;GPX2;GCNT3;GPRC5A;B3GNT3
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.6106620679104404,-0.9952485405516491,0.5454545454545454,1.0,1.0,2/6,12.10%,GALE;PGM2
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.3782370825723532,0.9946802913005774,0.5054945054945055,1.0,1.0,50/358,15.79%,C3AR1;CHIT1;OSCAR;FGL2;CLEC4C;PRDX4;ELANE;MGST1;DOCK2;TIMP2;PLAC8;GM2A;PTPRC;ARHGAP9;GMFG;LAMP2;TMEM30A;CAPN1;ARG1;CD14;EEF1A1;TUBB;OSTF1;TOLLIP;TMBIM1;MANBA;PRSS3;PLAUR;NBEAL2;PGAM1;TMC6;GGH;CHRNB4;SLCO4C1;ATP6AP2;STOM;C6ORF120;AGL;HSPA8;CCT8;TMEM63A;NEU1;CD59;CTSZ;PRDX6;COPB1;PTAFR;CYSTM1;ACTR2;PSAP
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.6491386605418152,-0.994651529621044,0.4878048780487805,1.0,1.0,1/5,8.59%,CTPS2
prerank,GO_Biological_Process_2021__regulation of system process (GO:0044057),-0.6814855816120522,-0.9945162830208454,0.4883720930232558,1.0,1.0,3/5,28.93%,HTR2C;MTG2;NOS3
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.5983606731367828,0.9944085563598266,0.5,1.0,1.0,5/9,27.49%,F11R;KCNQ1;SLC2A5;SLC26A6;CD36
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.4176769808664655,-0.994217014241819,0.39285714285714285,1.0,1.0,5/45,7.37%,EYA4;MGMT;TIMELESS;BRCC3;ERCC8
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.5002398334730968,-0.9940623903179789,0.46153846153846156,1.0,1.0,3/18,7.30%,RUNX1;FOXP1;CBFB
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.31734113342165166,-0.9939722979721725,0.5,1.0,1.0,87/752,11.35%,CD38;ETV5;PER2;SOX13;MYB;BMP7;TBX6;NRG1;LEF1;AASS;GFI1B;ARID5A;RUNX1;FHL2;TLE2;KDM8;EREG;ASCL1;ATOH8;PRDM5;ZNF256;ZNF239;SMYD2;HDAC5;TPR;SFRP1;ID4;LYAR;RITA1;HIVEP1;RING1;BCL6;ZNF25;HDAC1;ZNF608;PTCH1;TIMELESS;TFAP4;IGBP1;ZNF596;TRPS1;ZNF846;ZNF558;SAMD7;ZFHX3;ATF3;FOXP1;E2F6;BMP6;SBNO2;PHC2;ID2;CBFB;NFIX;SPDEF;ZNF536;E4F1;ZHX3;SFMBT1;SAMD13;STAT3;MACROH2A2;NR1H4;SUV39H2;ZBTB7A;FOXK1;LBH;XRCC6;TAF1;SIN3B;IFI16;ANKRD2;SMARCA4;SARS1;ZMYM5;MAFK;CREB3L1;MXI1;NFX1;ZGLP1;NACC1;PCGF1;DAP;DMAP1;BEND3;HMGB2;NOG
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.6114173275659243,0.9939059126003639,0.5423728813559322,1.0,1.0,3/7,32.61%,ESR1;PSMC6;PSMC3
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.3764856870576316,0.9938404871302057,0.4142857142857143,1.0,1.0,21/174,13.54%,RAD54L;MCM2;POLQ;ATF5;KNL1;GINS2;SUV39H1;CDKN1B;TLE3;CDC25A;TPX2;DDX39A;CDC6;TGFB1;SQLE;SMC2;DR1;CHMP1A;HSPA8;RACGAP1;PDS5B
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.4751791931329427,-0.9937140050672642,0.45714285714285713,1.0,1.0,5/27,14.24%,EPHB2;CLSTN2;DLG5;SYNDIG1;NLGN3
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),-0.5763677789323851,-0.9936540607116211,0.55,1.0,1.0,2/8,10.57%,PLIN5;ACADVL
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.3858299460168086,-0.9934492681968341,0.5238095238095238,1.0,1.0,29/163,9.11%,NOX4;TAGLN;COL15A1;ABI3BP;PENK;ADAMTS2;LAMA4;GREM1;SVEP1;RUNX1;COL6A2;FNDC1;PCDH18;IL1R1;NFATC1;SGCD;IGF1;PRRX1;TNXB;COL4A3;PTCH1;ADAMTS5;PRKCD;ERCC1;STAT3;FKBP7;PDGFRA;FBLN7;ADGRL4
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.4874945166400229,0.9931473384310512,0.5689655172413793,1.0,1.0,7/47,6.52%,GNLY;ITK;CD4;CCL5;CNGB1;PTPRC;TAGAP
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.40378263203049947,-0.9930105560453488,0.34375,1.0,1.0,8/59,9.66%,CDK2AP2;GFI1B;LSM10;TFDP1;ID2;INO80;SLFN11;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.6263048697752108,0.9927422502529829,0.49206349206349204,1.0,1.0,4/8,24.42%,WASF1;BRK1;CYFIP1;ABI2
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.439906684452426,0.9927278310978249,0.45454545454545453,1.0,1.0,22/64,22.15%,CAV3;ITPR1;AGT;FKBP1B;CASQ1;SMAD7;NPR2;KCNJ11;CAMK2D;KCNQ1;PLN;CORIN;ATP1B1;TRDN;ATP1A1;CACNA1H;ABCC9;CALM3;ATP2B4;HCN4;ATP2A2;RYR2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.42974236490765305,-0.9924610686332779,0.4090909090909091,1.0,1.0,4/32,3.51%,KIT;ITGA4;RABL3;HDAC5
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.5522689954792426,-0.9924412605430112,0.4883720930232558,1.0,1.0,1/9,3.84%,MLYCD
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),0.5268029636779727,0.9924372841153808,0.4782608695652174,1.0,1.0,2/17,3.49%,HPGDS;MGST1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),0.5268029636779727,0.9924372841153808,0.4782608695652174,1.0,1.0,2/17,3.49%,HPGDS;MGST1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.5939233812245979,0.9923383478951273,0.5098039215686274,1.0,1.0,1/8,8.41%,ATP6AP1
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.5841849074380849,0.9923209736471266,0.484375,1.0,1.0,2/11,11.58%,HSPA5;HERPUD1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.4794065509721419,-0.9922846675038407,0.4634146341463415,1.0,1.0,1/14,10.10%,RIPOR2
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.4196743567647213,0.9922834188447759,0.5142857142857142,1.0,1.0,5/75,7.95%,EPHA1;GRTP1;NTF3;RUNDC1;ARHGAP25
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.5405777889638631,0.9922657808503262,0.46774193548387094,1.0,1.0,1/13,0.29%,CALB1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.5296576530138104,0.9922592208840505,0.49206349206349204,1.0,1.0,5/16,16.52%,CHMP4B;CHMP2B;CHMP1A;EML3;CHMP2A
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.609577566771905,-0.9921648706418988,0.4883720930232558,1.0,1.0,2/7,12.19%,ITGA8;HMGA2
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.4209779222907853,-0.9920261024195396,0.5,1.0,1.0,11/33,20.88%,GRIK4;FABP5;CACNA1A;LRP8;NGF;BTBD9;NLGN3;CACNA1B;GRID1;RELN;GRIK1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.6591581840995544,0.9919933084866276,0.5818181818181818,1.0,1.0,3/7,30.76%,RNF122;ARL6IP5;BAX
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),0.5912622925747795,0.9918910763181223,0.5409836065573771,1.0,1.0,2/10,4.58%,FABP3;RCN3
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.4441688137132614,0.9918770466262355,0.4520547945205479,1.0,1.0,15/58,23.91%,SLC12A7;GABRA2;CLCN3;SLC26A7;TTYH1;GLRA3;GLRA1;GABRR1;GABRA4;SLC1A3;GABRD;GABRA6;ANO2;GLRB;BEST1
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.5953563244359862,0.9918404574913164,0.603448275862069,1.0,1.0,4/8,17.74%,B3GALT1;GBA3;B4GALT3;UGT8
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.5046497546223703,-0.9918131382100521,0.5128205128205128,1.0,1.0,6/17,16.29%,TIMELESS;NR1H4;SPIDR;HSF1;EPG5;DDX11
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.5001699614225701,0.9916375196750439,0.4915254237288136,1.0,1.0,9/40,11.52%,ZBTB7B;IGFBP5;STAT4;KHK;GPER1;STAT1;EIF2B5;STAT6;STAT5A
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.464038844732869,-0.9915088657662534,0.4411764705882353,1.0,1.0,1/37,0.38%,MDGA1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.4966481561086074,0.9913121804040927,0.5285714285714286,1.0,1.0,5/34,12.15%,SLC12A7;KCNE2;ATP12A;KCNJ9;KCNJ11
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.521220554729337,-0.9911008628895168,0.4864864864864865,1.0,1.0,2/9,16.28%,STAT3;LEP
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.496010000550856,-0.9910309216201842,0.42857142857142855,1.0,1.0,13/33,20.95%,PRR5L;TPR;NUMA1;PCNT;B3GAT3;PCM1;SORL1;ICE1;PLK3;EIPR1;PGAP1;STX18;STK11
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.5755894048197057,-0.9910094102087508,0.4864864864864865,1.0,1.0,4/6,39.04%,MERTK;HCLS1;AXL;GAS6
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),0.6858408792731813,0.9909866417173275,0.5344827586206896,1.0,1.0,1/5,0.79%,TIMP3
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.5546321228284093,-0.9909782273256434,0.4666666666666667,1.0,1.0,2/10,2.60%,VASH1;NEK6
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.49292534612621913,0.9909592442028066,0.46774193548387094,1.0,1.0,6/39,20.55%,TICRR;HELB;SUB1;TOM1L1;TERF2IP;ALYREF
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.5261514222998547,-0.9909380890267108,0.5416666666666666,1.0,1.0,1/11,2.25%,ARFIP2
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),-0.6411621752883696,-0.9908518532322882,0.5652173913043478,1.0,1.0,2/5,8.45%,ITPA;ENPP3
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.6200164463497897,0.99083597832067,0.5283018867924528,1.0,1.0,2/10,4.74%,PLP1;SOX10
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.4668180530254537,-0.9903194688949001,0.41379310344827586,1.0,1.0,6/21,16.86%,PID1;COX10;ACADVL;SDHAF4;LEP;NR4A3
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.6728528666327822,0.9901856916555417,0.5254237288135594,1.0,1.0,5/6,26.37%,GPR183;CD99;MSN;PIK3CD;SLC12A2
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.4848362566936939,-0.9900853332996872,0.5151515151515151,1.0,1.0,5/18,14.04%,SFRP1;TEDC2;DLG5;TTC23;KIF7
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.45377336830688847,0.9899624480443606,0.5070422535211268,1.0,1.0,16/57,19.81%,ACOT4;BAAT;SULT2A1;HINT1;ACOT13;RAB23;ACSM4;AMPD2;ACOT12;AK4;TPST2;LRRK2;ACSM3;BAD;ACAT1;ACSM6
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.3950498197460758,0.9897793879648284,0.47560975609756095,1.0,1.0,32/243,10.37%,NOX5;ITK;RREB1;ZNF703;ZBTB7B;TBXA2R;PRLR;IL15;INHBA;PLAC8;PRKAB2;LOXL2;AGT;TWIST1;KDM3A;BMP1;PPARGC1A;SOX6;TSHR;ADRB1;REST;ADIPOR2;HHLA2;AVPR1A;CMKLR1;SCD;SMTNL1;SOX11;EPAS1;TGFB1;LRPAP1;SIX4
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.5011974137320344,0.9896279386200262,0.4411764705882353,1.0,1.0,7/32,8.00%,PLA2G10;SMIM22;HSD11B2;TJP3;GPX2;B3GNT3;MUC4
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.4839166715984545,0.9896162213339001,0.40625,1.0,1.0,3/33,7.10%,ISG20;NCBP1;RNASEH2C
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.377263735565693,0.989195639966508,0.5054945054945055,1.0,1.0,50/360,15.79%,C3AR1;CHIT1;OSCAR;FGL2;CLEC4C;PRDX4;ELANE;MGST1;DOCK2;TIMP2;PLAC8;GM2A;PTPRC;ARHGAP9;GMFG;LAMP2;TMEM30A;CAPN1;ARG1;CD14;EEF1A1;TUBB;OSTF1;TOLLIP;TMBIM1;MANBA;PRSS3;PLAUR;NBEAL2;PGAM1;TMC6;GGH;CHRNB4;SLCO4C1;ATP6AP2;STOM;C6ORF120;AGL;HSPA8;CCT8;TMEM63A;NEU1;CD59;CTSZ;PRDX6;COPB1;PTAFR;CYSTM1;ACTR2;PSAP
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.6128506870753387,-0.9890597772455361,0.4523809523809524,1.0,1.0,4/7,28.31%,CTPS2;UMPS;PRPS1;TPK1
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.4934189511506588,0.9889978411324841,0.4262295081967213,1.0,1.0,4/26,6.99%,CALCR;RXFP1;TSHR;ADRB1
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.3990551713489751,-0.988699989000842,0.5,1.0,1.0,12/124,5.86%,KIT;ALK;ROR2;KDR;EPHA3;FGFR4;GREM1;EPHB2;DSCC1;DRD4;EPHA5;NVL
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.6518215999950074,0.9885496049860721,0.5178571428571429,1.0,1.0,2/5,29.76%,CNST;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.42534061666471457,-0.9883477117797693,0.36363636363636365,1.0,1.0,11/39,14.00%,BMP7;SPRY4;RGS14;PRKCD;SPRY3;APOE;SORL1;RGS2;DUSP10;SPRY1;PTPN1
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.426487240803664,-0.9883123842359288,0.4375,1.0,1.0,16/46,14.11%,GPC4;HS3ST3A1;SDC4;B3GAT2;HS3ST3B1;CLN6;GCNT2;HS3ST2;GUSB;EXT1;B3GAT3;HS3ST5;EXT2;SGSH;CHST9;GPC2
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.44012142638371465,-0.9881092834368781,0.42424242424242425,1.0,1.0,12/41,18.16%,BUD23;LIN28B;U2AF2;ZC3H18;SIRT7;PNPT1;EGFR;NMD3;SETX;WDR75;RIOK1;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.5889278991672173,-0.9879817527417001,0.5,1.0,1.0,4/10,21.72%,PDE3A;ANGPT1;PTPRJ;DDAH1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5726378566475866,0.9876417821208765,0.5344827586206896,1.0,1.0,3/10,32.61%,ESR1;PSMC6;PSMC3
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.5944886765447874,0.9873046536774484,0.5625,1.0,1.0,3/9,17.47%,ATP12A;ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),-0.5232780578853193,-0.987273457403456,0.425,1.0,1.0,2/6,19.49%,FGF13;RELN
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.644219766004675,0.9870876308151594,0.5740740740740741,1.0,1.0,1/7,4.27%,ADGRB1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.5476092584981885,0.9870048195842371,0.44680851063829785,1.0,1.0,6/8,40.05%,RIPK2;NOD1;LDOC1;CHMP5;VIM;ARHGEF2
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.40357364386975836,-0.9867967388367913,0.375,1.0,1.0,4/71,9.07%,MYB;RUNX1;CBFB;PDGFRA
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),-0.5630755194377001,-0.986702861759082,0.5098039215686274,1.0,1.0,7/11,29.86%,PTHLH;ADCY7;PDE4D;ADCY2;ADCY5;ADCY8;ADCY9
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.6396124212998753,0.9865185906131163,0.5576923076923077,1.0,1.0,3/5,20.89%,SIX4;EPHB1;MSTN
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.483395923035974,0.9864881284681958,0.46551724137931033,1.0,1.0,4/19,22.05%,MYO5B;MYO1F;MYO1B;SYNE2
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),-0.6706496705105757,-0.9864858394851153,0.5238095238095238,1.0,1.0,1/5,5.46%,PTCH1
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.5586339435172812,-0.9864755609978016,0.475,1.0,1.0,1/11,1.32%,PEX7
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.6026628095821384,-0.9864055131493316,0.5348837209302325,1.0,1.0,1/10,7.89%,STAT3
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.33865115155671854,-0.9862151717616736,0.5384615384615384,1.0,1.0,33/347,9.89%,NRK;ALK;TRIB2;LMTK3;EPHB2;PRAG1;PRKG2;NEK6;DGKB;NRBP2;SGK1;MAML1;FGGY;GRK5;MAP3K20;MARK1;SPHK2;DGKD;PRKCD;CDC42BPB;PLK2;AURKA;XYLB;TGFB2;PNKP;CSK;STAT3;LIMK1;PEAK3;TAF1;CDKL1;CDK14;DGKH
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.67974966535402,0.9861185940683651,0.5,1.0,1.0,2/5,16.52%,CCP110;CHMP2A
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.5712432568981703,-0.9860847453662468,0.6,1.0,1.0,3/6,26.33%,PHF1;MACROH2A1;SUPT6H
prerank,MSigDB_Hallmark_2020__Myogenesis,0.4126204628256234,0.9859717620884694,0.5625,1.0,1.0,25/151,9.38%,LAMA2;MYLK;CSRP3;GADD45B;CHRNB1;PTGIS;CAV3;CHRNG;NOTCH1;FABP3;MYOM1;NQO1;DAPK2;KLF5;FKBP1B;ACTC1;TEAD4;SYNGR2;CNN3;CASQ1;ATP6AP1;SCD;MYBPC3;CKB;CTF1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.49812598363226673,0.9859221267219503,0.5303030303030303,1.0,1.0,3/24,12.97%,PLA2G10;PLAAT5;SELENOI
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),-0.6232769625297744,-0.9858453847360573,0.5,1.0,1.0,1/5,0.81%,SULF2
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.5604249921260848,0.9857659166719142,0.5263157894736842,1.0,1.0,8/15,23.03%,PTPRC;SOX11;NANOG;EPCAM;FBLN1;KDM1A;GJA1;YAP1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.43368500585540554,0.9855811559750703,0.48484848484848486,1.0,1.0,8/68,13.26%,RGPD3;RGPD4;RANBP6;NXT1;RGPD1;RGPD2;TSC2;SPRN
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.6075114702644742,0.9855022605556534,0.5081967213114754,1.0,1.0,2/9,15.92%,IFNLR1;PINK1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.5495649288604489,-0.985349429428386,0.5116279069767442,1.0,1.0,6/9,25.86%,ABCD1;TRAP1;SLC30A10;ABCD2;PPARA;FYN
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),-0.5087675545585528,-0.9853085628529933,0.43243243243243246,1.0,1.0,4/17,17.28%,RING1;PCGF1;PCGF6;DDB2
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.4722995577770487,0.9852571207946946,0.5,1.0,1.0,7/35,9.82%,TRPV6;ITPR1;PTPRC;TRPV3;SLC24A2;SLC24A1;PLCG2
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.38988799664911883,0.9852338325055,0.4523809523809524,1.0,1.0,40/206,20.23%,TRIM22;TRIML2;TRIM5;DEPP1;RASIP1;ITPR1;BOK;DAPL1;PRKAB2;DAPK2;CAPN1;BNIP3;EEF1A1;ATP6V1B2;HGF;RNF152;GFAP;RAB8A;CDK5R1;WDR6;USP13;HTR2B;ATP6V1C1;TRIM14;VPS35;PSAP;PINK1;TAB2;ULK1;ERN1;PIP4K2C;LRRK2;GPR137B;BAD;ATP6V1C2;ATG101;RAB39B;PIK3CB;PRKAG2;ATP6V0B
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.6409577854241197,0.984871795404787,0.5517241379310345,1.0,1.0,2/7,17.89%,HLA-A;B2M
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.6197896055140591,0.9846694796126082,0.5970149253731343,1.0,1.0,1/8,6.43%,IDO1
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.6182688058936122,0.9846510283368414,0.509090909090909,1.0,1.0,3/7,31.65%,SPHK1;DOC2B;C2CD5
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.5944296343684135,-0.9845993724715252,0.48,1.0,1.0,3/10,15.14%,RPUSD1;NAF1;RPUSD4
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4887197018556144,0.9845385273736565,0.5076923076923077,1.0,1.0,6/27,16.09%,CAV3;KCNE2;ATP5IF1;RNF139;DAB2IP;PYHIN1
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.46359585141862325,0.9843736993590413,0.5230769230769231,1.0,1.0,11/49,14.17%,ALPL;SMIM22;SCTR;TJP3;GPX2;AP1M2;B3GNT3;MYO5B;TMC4;SPP1;EPCAM
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.49280830155437844,0.9842538773890467,0.5538461538461539,1.0,1.0,7/27,22.98%,HSPA5;DNAJB1;HSPA1L;HSPA8;UGGT1;HSPA14;ERO1A
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.42215888219862385,-0.9839028605780734,0.43333333333333335,1.0,1.0,1/62,0.31%,ITGB5
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.46980469825415433,0.9837319731815701,0.4805194805194805,1.0,1.0,15/39,23.98%,NLRP2B;HSPA5;KIF14;NLRC3;TMC8;OPRD1;ULK1;ANKRD27;JAM3;NOP53;PPM1A;PEX5;AIDA;CDC42;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.6721504565808285,0.9836376268401877,0.5714285714285714,1.0,1.0,3/5,24.94%,ACVR2B;NODAL;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.5562278690712043,0.9835944841033892,0.5208333333333334,1.0,1.0,3/13,17.07%,CD300LF;PLSCR1;TLR2
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.41700069759080005,0.9834796880034329,0.4675324675324675,1.0,1.0,10/100,11.35%,TMEM200C;TMEM35A;ASXL3;PLP1;ZDHHC22;PNMA2;RUNX1T1;CNTN2;NEFM;CPT1C
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.36620715198900167,-0.9834175225155904,0.42857142857142855,1.0,1.0,3/98,2.98%,KIT;NFATC1;FOS
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.3736953761915689,0.9821666166452551,0.5384615384615384,1.0,1.0,50/363,15.79%,C3AR1;CHIT1;OSCAR;FGL2;CLEC4C;PRDX4;ELANE;MGST1;DOCK2;TIMP2;PLAC8;GM2A;PTPRC;ARHGAP9;GMFG;LAMP2;TMEM30A;CAPN1;ARG1;CD14;EEF1A1;TUBB;OSTF1;TOLLIP;TMBIM1;MANBA;PRSS3;PLAUR;NBEAL2;PGAM1;TMC6;GGH;CHRNB4;SLCO4C1;ATP6AP2;STOM;C6ORF120;AGL;HSPA8;CCT8;TMEM63A;NEU1;CD59;CTSZ;PRDX6;COPB1;PTAFR;CYSTM1;ACTR2;PSAP
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.533056523896334,-0.9819477870124732,0.4864864864864865,1.0,1.0,1/13,3.85%,TPR
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.5242527508895901,0.981854081198122,0.5098039215686274,1.0,1.0,2/14,8.18%,DNASE2;DNASE2B
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.5439948338915456,0.9817252127591646,0.5344827586206896,1.0,1.0,1/13,1.33%,CAV3
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.6447268344841828,-0.9815047962892074,0.5641025641025641,1.0,1.0,2/6,7.30%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.41011849236018366,0.9812014619844959,0.5454545454545454,1.0,1.0,13/108,18.50%,PTGIS;CCL5;PELI3;RPS6KA4;TOLLIP;PSMB6;RIPK2;PSMA3;PSMB8;DAB2IP;TAB2;MAPK13;IRAK4
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.6084433572946547,0.98106618886018,0.5333333333333333,1.0,1.0,1/6,16.52%,CHMP2A
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.5761097800360774,-0.9808786450416312,0.525,1.0,1.0,2/9,4.60%,ABCC4;DRD4
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),-0.5279391348596094,-0.9804594645007528,0.5,1.0,1.0,2/13,11.56%,ALKBH8;ADAT2
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),-0.6594728604638376,-0.9802758971227906,0.6382978723404256,1.0,1.0,3/6,7.62%,BMP7;GCH1;DHFR
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.35543395030171165,-0.9798825624011307,0.47619047619047616,1.0,1.0,13/171,8.53%,FRMPD1;PKP2;RAB32;ITGA4;EHD4;PRAM1;PTCH1;ZDHHC3;RAB40A;FGF13;TMEM150A;HPS6;RAB3C
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5898254033124483,0.9798758409184201,0.5555555555555556,1.0,1.0,7/12,31.67%,RAB23;AK4;LRRK2;RHOQ;MFN1;GTPBP1;ENTPD7
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.4890870795060366,0.9793543383021955,0.5373134328358209,1.0,1.0,3/31,7.81%,TRIM54;FKBP4;TPX2
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.5114829839771232,0.9790218216585059,0.5178571428571429,1.0,1.0,7/18,27.68%,SYVN1;RNF139;UGGT1;MAN1B1;RNF185;MARCHF6;RPS27A
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.6616062281283454,0.9790135277986974,0.5652173913043478,1.0,1.0,2/5,26.64%,KDM7A;PHF8
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.41998875064102437,0.9788792107644604,0.5512820512820513,1.0,1.0,8/70,16.81%,LMAN1;F11R;NEXN;MIEF2;VPS35;PINK1;TMEM33;MSN
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.39583393506220327,0.9787709143111145,0.5694444444444444,1.0,1.0,23/187,11.79%,NES;CCNG2;BORA;SPDYA;CHMP4B;INHBA;CCND2;CDKN2D;CCNE1;CCNB3;CDKN1B;CCNE2;TUBB;ABCB1;CDC25A;CEP72;FBXL6;CRLF3;YWHAG;TUBA4A;FBXL3;CEP70;EPS8
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.4117798530134318,-0.97867016573484,0.46875,1.0,1.0,6/68,3.53%,B3GALT9;CHST8;ST6GALNAC2;ST3GAL3;ST8SIA2;IGF1
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.5041026095369676,-0.978492002176219,0.5319148936170213,1.0,1.0,5/21,16.87%,MAP3K20;XRCC6;HSF1;TLK2;ATM
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.44193410143765693,0.9784899410420984,0.5070422535211268,1.0,1.0,10/42,19.62%,BTN2A2;FASN;CYP1B1;VPS35;PDK4;PINK1;ARF4;STK17A;RNF41;FOXM1
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.4288412714251378,-0.9784444102178964,0.5526315789473685,1.0,1.0,9/47,11.35%,BMP7;HIVEP1;AMH;RGMB;BMP6;TGFB2;TGFB3;DLX5;NOG
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.41854422005739916,0.9783046660820924,0.4794520547945205,1.0,1.0,10/91,10.98%,NES;LRP4;GPC6;GLI3;FJX1;EYA1;CNN3;SERTAD4;SIX4;CDR2L
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.4802745022499699,-0.9782378428908789,0.3939393939393939,1.0,1.0,4/27,9.61%,LEF1;TLE2;HDAC1;SMARCA4
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.5943440459504059,0.9781299719887572,0.5535714285714286,1.0,1.0,4/8,30.57%,PFN4;TWF2;TWF1;TMSB10
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.3678740243868858,-0.9779768389291106,0.4642857142857143,1.0,1.0,22/94,14.61%,PRELID2;ABCC4;FABP5;TRIAP1;ABCA13;PITPNC1;CHKA;APOA1;SLC27A3;NME4;NR1H4;APOE;SCARB1;ABCD1;PITPNA;GOT2;PITPNM1;SLC25A17;SLCO3A1;SLCO1C1;ABCG4;OSBP
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5183506735924885,0.9779289831524203,0.5072463768115942,1.0,1.0,3/23,6.63%,LRP4;DOK7;PPFIBP2
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.5351585418281686,0.9778737918168874,0.5074626865671642,1.0,1.0,2/18,11.23%,RGS10;CDK5R1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.6051518586291375,0.9776835040621841,0.5,1.0,1.0,2/8,16.60%,TGFB1;RGCC
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.6396838508208408,0.977622272766949,0.5471698113207547,1.0,1.0,1/5,8.41%,ATP6AP1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.420894073508038,-0.9774671115129687,0.42857142857142855,1.0,1.0,11/55,11.02%,PRR5L;UNC13B;IGF1;TPR;BMP6;TGFB2;PCNT;TGFB3;B3GAT3;PCM1;CHP1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.44764668439667643,0.9773520588444814,0.5076923076923077,1.0,1.0,14/37,15.32%,ALPL;CCL5;CYP1B1;CDKN2D;IGFBP5;CYP19A1;TGFB1;DRD3;LOC400499;ESR1;ABCB4;SPP1;TIPARP;GLDC
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.473531275068496,-0.9771564698562636,0.5277777777777778,1.0,1.0,3/24,10.99%,NEK6;CDK5RAP2;CDC23
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.4363448276150144,0.9767418120069206,0.4782608695652174,1.0,1.0,11/78,17.79%,CALCR;NLRP2B;NTF3;SMAD7;TGFB1;RIPK2;OPRD1;PINK1;MTCP1;DMTN;CREBL2
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.5454538762569912,-0.9767079162052529,0.53125,1.0,1.0,2/14,4.52%,TRPC3;RYR1
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.5924154015659269,0.9764399040284774,0.5471698113207547,1.0,1.0,4/10,20.89%,NOTCH1;TGFB1;EID2B;MSTN
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),-0.5863355348741668,-0.9763288284332129,0.53125,1.0,1.0,2/5,17.44%,EIF4G1;EIF2AK4
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.566086803870474,-0.9762431430463494,0.5348837209302325,1.0,1.0,4/6,24.73%,SLC25A33;EPG5;ABCC5;ABCC11
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.4717127977489402,-0.9761175067341272,0.4473684210526316,1.0,1.0,6/33,17.32%,NUP210;TPR;NUP37;NUP42;NUP107;NUP43
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.4717127977489402,-0.9761175067341272,0.4473684210526316,1.0,1.0,6/33,17.32%,NUP210;TPR;NUP37;NUP42;NUP107;NUP43
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.4697643934989105,-0.9759787059838688,0.46153846153846156,1.0,1.0,3/18,15.98%,IGF1;IRS1;CLTCL1
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.589574923985317,0.975974582519972,0.6,1.0,1.0,1/10,6.94%,SESN3
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.5907294428077423,-0.97564388143858,0.5609756097560976,1.0,1.0,1/5,15.61%,ACVR1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.5571450985195906,0.9754961193102124,0.6,1.0,1.0,6/14,27.61%,HSPA5;BCAP31;LRRK2;RYR2;TAPT1;GABARAPL2
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5030634452592014,-0.9752862512978341,0.5757575757575758,1.0,1.0,1/13,0.85%,BCL2L11
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.6075399939112276,-0.9751880220258573,0.5208333333333334,1.0,1.0,2/5,11.11%,FGF13;PTPRS
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.44609915331640243,0.9750811854372274,0.5142857142857142,1.0,1.0,6/64,8.22%,EPHA1;TDG;RASIP1;ARHGAP9;PRKG1;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.4842222462328439,-0.975016882738402,0.5384615384615384,1.0,1.0,10/28,17.18%,PRR5L;TPR;PCNT;B3GAT3;PCM1;PTPN1;SIRT7;ICE1;PLK3;GCC2
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.49481131466353223,0.9747564655184533,0.4925373134328358,1.0,1.0,2/25,7.81%,TRIM54;TPX2
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.5423319056834486,-0.9747270668449871,0.41025641025641024,1.0,1.0,2/13,4.28%,NRG1;SGK1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.40582093347450526,0.9746108896363697,0.4794520547945205,1.0,1.0,19/87,15.09%,RSPO2;ZNF703;SHISA2;HIC1;DEPDC1B;NOTUM;SFRP4;TCF7L1;NKD2;FGFR2;RSPO3;ATP6AP2;DAAM2;ESR1;KREMEN1;TSC2;NLK;AMER2;LGR6
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.5284118695514644,-0.9744885294365222,0.5238095238095238,1.0,1.0,2/9,10.30%,APOE;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.602169161185427,-0.9742653162227144,0.6216216216216216,1.0,1.0,2/7,11.11%,RTN4R;PTPRS
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.39612795117654487,0.9741488512243658,0.48484848484848486,1.0,1.0,15/149,10.83%,CALB1;PDE1A;SYT2;PLP1;ADGRB1;ZDHHC22;GRM3;SYT4;PRKG1;SLC24A2;CNTN2;RIT2;KCNJ9;C11ORF87;GAD1
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.3688780972268046,0.9740882417380143,0.5180722891566265,1.0,1.0,54/286,20.17%,ENPP2;CALCR;P2RY1;AGER;CD4;SPDYA;ITGA5;NTF3;IL15;INHBA;CCND2;PTPRC;AGT;RARRES2;TBX1;FAM20A;RPS6KA4;VEGFC;HGF;GPER1;PLCG2;FAS;TGFB1;PLAUR;MRE11;RIPK2;CDK2AP1;OPRD1;SPHK1;BANK1;FAXDC2;NODAL;LIMCH1;NPTN;CHRNA7;PINK1;NEK10;TAB2;FXR1;CD74;TOM1L1;TNIK;MTCP1;MUSK;CREBL2;LRRK2;CX3CR1;IL5;CD80;RAD50;PRKAG2;TERF2IP;FGF5;CALM3
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.408590368049319,0.9740220086666217,0.5,1.0,1.0,29/134,19.30%,ALDH1A1;UROD;NCAPH2;NSDHL;FASN;ACSL5;SERINC1;EPHX1;ADIPOR2;HSD17B10;ECI2;HMGCS1;YWHAH;IL4I1;MDH1;ACOX1;PRDX6;ACADL;HSPH1;DECR1;HSD17B11;DHCR24;METAP1;CPOX;ACAA2;ACSM3;MAOA;RETSAT;H2AZ1
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.6532528400427376,0.973978281267641,0.6181818181818182,1.0,1.0,1/5,7.50%,SFRP4
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.6333632639334482,-0.9737932343168048,0.5483870967741935,1.0,1.0,2/5,27.63%,CAP2;MAPK8
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.5216228053573856,-0.9734820896161828,0.53125,1.0,1.0,2/22,1.08%,PKP2;ITGA4
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.5478921133760029,-0.9730627400448892,0.45454545454545453,1.0,1.0,3/9,19.68%,ABCD1;CLU;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.6022492811729897,-0.9730205331815721,0.55,1.0,1.0,2/6,11.11%,RTN4R;PTPRS
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.5879481093058863,0.9730078555743205,0.5,1.0,1.0,1/7,1.97%,CCL5
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.4746618335967982,-0.9728648209667876,0.475,1.0,1.0,7/20,19.03%,CAMKMT;EEF1AKMT1;PRMT8;SNRPB;FAM98A;METTL22;ETF1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.3906828191757241,-0.9727844208427261,0.4827586206896552,1.0,1.0,10/102,2.30%,TAGLN;FBXL7;MYB;LAMB2;ADAMTS2;LAMA4;SVEP1;COL6A2;FNDC1;PCDH18
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.6642022666165018,0.9726922981349125,0.6190476190476191,1.0,1.0,2/5,17.99%,BCAP31;LRRK2
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.5505634458522866,-0.9726284445502088,0.5454545454545454,1.0,1.0,2/10,11.11%,RTN4R;PTPRS
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.6435655743534077,0.9725579035738259,0.5614035087719298,1.0,1.0,1/5,12.92%,PCMT1
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),-0.5086415139214933,-0.9725536240402358,0.45,1.0,1.0,2/14,7.30%,RUNX1;CBFB
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.45242534341786345,0.972515528281043,0.5211267605633803,1.0,1.0,12/50,10.82%,PTGES;CD4;ERVFRD-1;INHBA;KLF5;CDCP1;GPRC5A;SCEL;B3GNT3;TMEM40;PLAUR;FOSL2
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.5959868809694142,0.9723813297573732,0.5789473684210527,1.0,1.0,3/8,28.85%,PAICS;GMPS;DPYD
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.3641746008896227,-0.9723291748676826,0.5,1.0,1.0,22/136,14.41%,ZNF707;APRT;ERCC2;TYMS;PNP;ITPA;POLL;TAF10;NME4;ERCC8;ERCC1;DGCR8;POLR2G;NFX1;SSRP1;GTF2F1;BRF2;ADA;TAF12;POLR2C;POLD3;TSG101
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),-0.5100523620712756,-0.972321490711541,0.5,1.0,1.0,2/12,4.26%,NRG1;TCOF1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.41400184694357023,-0.9722296165336817,0.4411764705882353,1.0,1.0,10/41,14.10%,KCNJ16;AMIGO1;KCNN3;KCNE1;ANO6;KCNN2;NOS1AP;KCNJ6;GABBR2;KCNJ2
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.4171398424952913,-0.9720979669147417,0.4857142857142857,1.0,1.0,4/46,7.30%,RAB7B;RUNX1;HDAC1;CBFB
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.47711480448861376,0.9719277445318742,0.5,1.0,1.0,6/43,13.49%,RASA1;CHMP4B;ANLN;RHOB;ECT2;RACGAP1
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.6261824510742987,0.9719021020119891,0.6129032258064516,1.0,1.0,4/6,33.25%,NUP54;TOR1AIP2;PLK1;NUP155
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.4572766200856821,0.9716634844263001,0.5352112676056338,1.0,1.0,5/48,5.17%,AMBP;WFS1;LPCAT3;HHIP;TWIST1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.5514239252568441,0.9715136080537463,0.5555555555555556,1.0,1.0,2/17,10.32%,HENMT1;MRPL44
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5359195261867432,0.9712331273850285,0.5142857142857142,1.0,1.0,5/18,22.77%,ARG1;STAT1;PPARG;IFNGR2;SUMO1
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.492739791830114,0.9711328593948327,0.576271186440678,1.0,1.0,6/28,11.98%,ACSBG1;ACOT4;ELOVL2;ACOX2;HACD4;ACOX1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5598462648145064,-0.9709469087531531,0.4523809523809524,1.0,1.0,3/11,14.10%,IGF1;GIGYF1;IRS1
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.517524569442025,0.9707697094630824,0.48484848484848486,1.0,1.0,3/19,12.53%,SEMA3D;SEMA3F;SEMA3A
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",-0.5908274202190656,-0.9706839406883693,0.5625,1.0,1.0,3/6,18.83%,HS3ST3B1;HS3ST5;HS6ST2
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.6073374403879216,0.9706529575721763,0.5303030303030303,1.0,1.0,4/6,33.26%,C1QA;C1S;C1QB;CD81
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.6017793246251861,0.9704563168062248,0.5319148936170213,1.0,1.0,4/9,29.43%,ATP5F1C;ATP5MC3;ATP5PB;ATP5PD
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.4490893178926169,0.9703706342252382,0.5384615384615384,1.0,1.0,15/43,24.09%,HSPA5;DNAJB1;HSPA1L;HERPUD1;HSPA4L;HSPA8;DERL1;DNAJA1;HSPH1;DAB2IP;ERN1;HSPA14;HSPB3;HSPA4;PACRG
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.5749721330935169,-0.9702030117171405,0.5319148936170213,1.0,1.0,2/5,20.30%,EIF2AK4;PRKN
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.4865588759007299,0.9699092882491039,0.5333333333333333,1.0,1.0,5/22,13.39%,ELANE;SIAH1;TGFB1;CLPX;LGMN
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.37202194134043337,0.9698288207508305,0.5584415584415584,1.0,1.0,29/253,11.23%,PNMA5;GADD45B;PTGIS;NLRP2B;DDX20;PREX1;BOK;CYP1B1;MOAP1;DAPK2;MAP3K11;PNMA2;KNG1;PXT1;FADD;HIP1R;BNIP3;REST;DUSP9;SFRP4;CASP8;RHOB;SIAH1;GPER1;PPID;FAS;RNF122;TFPT;CDK5R1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.4152734982651387,0.969580189631378,0.5797101449275363,1.0,1.0,11/88,8.29%,AMBP;C17ORF99;OSCAR;CD300LF;CD8A;IL15;AHR;CD160;PIANP;HLA-A;CASP8
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.5135881415565933,0.9695750072629655,0.5538461538461539,1.0,1.0,8/22,21.43%,SLCO2B1;ABCC2;SLC10A1;SLC10A5;SLCO1A2;SLC51A;NCOA2;STARD5
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.6031366536523894,0.9694363675734168,0.5254237288135594,1.0,1.0,2/8,12.90%,BRCA1;KANK2
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5706479881941324,-0.9693339219080677,0.5555555555555556,1.0,1.0,2/10,4.55%,ZDHHC5;DDX60
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),-0.6102962389948857,-0.9692408550524932,0.5625,1.0,1.0,1/5,0.85%,BCL2L11
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.53542209019278,0.969196214866933,0.5517241379310345,1.0,1.0,2/10,7.12%,CCL5;REST
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),-0.46442354419978726,-0.969026507275802,0.43333333333333335,1.0,1.0,4/14,17.11%,CHKA;CEPT1;PCYT2;PHOSPHO1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.6266633607910119,0.9689766350541306,0.532258064516129,1.0,1.0,2/6,13.64%,GOT1;PLOD2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.39497670732443024,0.9686752284923464,0.5066666666666667,1.0,1.0,21/133,17.40%,TRIM22;ROR1;TRIML2;CD4;TRIM5;TRIM32;CXXC5;FADD;TRAF3IP2;CASP8;LITAF;RIPK2;HTR2B;ECT2;TRIM14;TMEM101;PINK1;TAB2;CD74;TRIM25;IKBKE
prerank,PanglaoDB_Augmented_2021__T Cells Naive,0.48849608922528276,0.9686463922669948,0.5294117647058824,1.0,1.0,10/37,9.82%,GNLY;CD4;PIK3R5;PTPRC;ARHGAP9;GMFG;TAGAP;WAS;ARHGAP25;CD6
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.49030275578448046,-0.9684885355000487,0.6052631578947368,1.0,1.0,3/20,7.36%,PER2;ECE1;ACE2
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.5467601272154389,-0.968003435243739,0.5277777777777778,1.0,1.0,1/9,0.87%,PAH
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.49607260324954894,0.9677617760125014,0.5423728813559322,1.0,1.0,4/24,10.13%,FKBP4;FKBP1B;FKBP5;PPID
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.48741931179889775,0.967733671208567,0.5614035087719298,1.0,1.0,5/23,21.57%,SLC30A8;CAMK2D;SLC4A9;HCN4;SLC30A4
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.6240112676582996,-0.967518149373172,0.5,1.0,1.0,1/6,10.57%,LLGL2
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4741713995359248,0.9674630459421837,0.5428571428571428,1.0,1.0,5/33,6.88%,NPY;SSTR1;CNR2;AGT;TSHR
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.4795626409080511,0.9673249774271547,0.5142857142857142,1.0,1.0,5/37,13.99%,STK26;CYP1B1;RHOB;ECT2;GLRX2
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.5693552224809018,-0.9671935107569822,0.5384615384615384,1.0,1.0,5/10,15.62%,B3GAT2;CLN6;B3GAT3;CHST9;XYLT2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.45605322567809503,0.9670675750461184,0.5571428571428572,1.0,1.0,7/34,16.60%,ZNF703;NOTCH1;TGFB1;EPCAM;NOTCH4;PODXL;RGCC
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.6077611220721943,-0.966963179954735,0.5416666666666666,1.0,1.0,2/5,26.33%,SETD2;SUPT6H
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5490023485916514,-0.9669239333306979,0.5,1.0,1.0,1/14,0.83%,HOMER2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.6664978798739888,-0.966870102356178,0.5217391304347826,1.0,1.0,1/5,14.80%,BDP1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.3138401968160166,-0.966656595335609,0.5555555555555556,1.0,1.0,68/864,9.64%,DUSP4;NRK;DUSP5;B3GALT9;PTPN3;FBXL7;TRIB2;LTBP1;PTPRT;LAMB2;LMTK3;MELTF;PENK;ASB9;PTPRB;PTPN9;FBXW8;CDC14B;ST6GALNAC2;ST3GAL3;PRAG1;PRKG2;NEK6;PPP2R3B;ST3GAL1;LOXL1;ST8SIA2;CCDC22;FBXO27;NRBP2;SGK1;MAML1;GRK5;MAP3K20;VCAN;FEM1A;MARK1;DUSP2;PARP2;PORCN;CD247;PRKCD;PPEF1;CDC42BPB;PLK2;TGM1;GCNT2;APOA1;AURKA;TGFB2;ATG10;SENP8;PPM1G;ERCC8;SEPHS1;CSK;DUSP12;FNTB;PTPRH;LIMK1;FBXO15;PARP6;PEAK3;ST3GAL2;TAF1;CDKL1;CDK14;APOE
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.4467962242837402,0.9665343760400689,0.5507246376811594,1.0,1.0,9/53,17.18%,NDUFA2;NDUFB9;NDUFB3;NDUFB2;NDUFB4;COX4I1;COX7A2L;CYCS;UQCRB
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.35642624987772303,-0.9664657272821717,0.42105263157894735,1.0,1.0,8/124,5.77%,ETV1;ALK;GPRIN2;RUNX1;ASCL1;BLOC1S4;RASGRF1;EPHA5
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.3592828935755087,-0.9664205104981188,0.45161290322580644,1.0,1.0,6/94,7.28%,NRK;NRG1;IGF1;PRKCD;TGFB2;CARD10
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),-0.5901066095084873,-0.9663407728275714,0.5,1.0,1.0,2/5,35.69%,HTT;SHANK3
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),-0.5901066095084873,-0.9663407728275714,0.5,1.0,1.0,2/5,35.69%,HTT;SHANK3
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.6433992897189114,0.9663094928159272,0.5094339622641509,1.0,1.0,2/5,33.26%,CD274;CD81
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.42383976213794633,0.9662870444253463,0.5142857142857142,1.0,1.0,14/83,13.67%,PTER;RCN3;TST;SOX10;TBX1;CNN3;TOLLIP;FGFR2;STAT1;SOX11;TGFB1;PCNA;KANK2;PPP2R3A
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.643903042638938,0.9661802946686696,0.5849056603773585,1.0,1.0,1/5,1.72%,CD4
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.643903042638938,0.9661802946686696,0.5849056603773585,1.0,1.0,1/5,1.72%,CD4
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.4231514987496554,0.965609385699841,0.5070422535211268,1.0,1.0,11/74,11.23%,WFS1;RASA1;CRLF1;NTF3;PTPRZ1;PPARGC1A;SOD2;KIF14;NDNF;SIX4;CDK5R1
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.45175789437558556,-0.9654655315458011,0.55,1.0,1.0,6/35,17.32%,NUP210;TPR;NUP37;NUP42;NUP107;NUP43
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.4491208512088425,0.9654399524342455,0.4927536231884058,1.0,1.0,14/39,21.94%,PPP4C;TWIST1;FIGNL1;WAS;OTUB1;ACTR2;UBR5;RAD51AP1;OOEP;FOXM1;TERF2IP;KDM1A;RNF169;SLF1
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),-0.5973431010372342,-0.9653984692789298,0.5476190476190477,1.0,1.0,1/6,10.27%,MTR
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.4868156743046892,-0.9653263735100401,0.4411764705882353,1.0,1.0,2/21,7.30%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.5608242648361595,-0.9649747968974265,0.47058823529411764,1.0,1.0,1/11,0.63%,KDR
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.5289819432310001,-0.9649194501874807,0.5526315789473685,1.0,1.0,2/13,8.45%,ITPA;ENPP3
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5342558374482711,0.9647027421197791,0.5471698113207547,1.0,1.0,5/14,22.23%,SYVN1;HERPUD1;BCL2L1;LRRK2;CREB3
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.5552741985522278,-0.9644854339878834,0.5106382978723404,1.0,1.0,1/7,11.00%,CDH1
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),0.5593982591108739,0.9643985631631912,0.48484848484848486,1.0,1.0,3/14,23.32%,CD160;PRNP;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.4702053486422681,-0.9643347949143127,0.46153846153846156,1.0,1.0,6/15,14.35%,PRKCD;PLIN5;APOA1;ABCD1;IRS1;PNPLA2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.6525416782857905,0.9642993859753061,0.631578947368421,1.0,1.0,3/5,31.78%,TMEM33;RAB3GAP1;RAB3GAP2
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.42648707586583623,0.9640733408791992,0.4861111111111111,1.0,1.0,4/59,7.99%,HCK;RASA1;HIP1R;ABITRAM
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.3782390253905949,-0.9637476873767374,0.41379310344827586,1.0,1.0,15/115,11.18%,B3GALT9;ALG8;ST6GALNAC2;ST3GAL3;ST3GAL1;ST8SIA2;GALNT10;GAL3ST1;GCNT2;ALG12;ST3GAL2;TET1;MOGS;DPM3;GCNT4
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.587806775054255,0.963734069956159,0.5483870967741935,1.0,1.0,1/8,5.96%,DNAJB1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.5201627175765384,0.9636608345471891,0.5166666666666667,1.0,1.0,5/18,14.88%,WFS1;BCAP31;HERPUD1;CAMK2D;CCDC47
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),-0.39821704307535066,-0.9635291573939923,0.4,1.0,1.0,11/70,11.35%,NPNT;BMP7;GREM1;IGF1;WWTR1;PTCH1;BMP6;ZHX3;CRIM1;SMOC1;NOG
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.40759013205562733,0.9634480104180057,0.5211267605633803,1.0,1.0,8/110,10.50%,CENPO;CENPI;KNL1;CENPK;WDR62;SPC24;BUB1B;CENPU
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),-0.5829922635185056,-0.963277118350308,0.4,1.0,1.0,2/5,16.34%,STAT3;GPR157
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.47623863170464065,0.9630910027617648,0.45454545454545453,1.0,1.0,5/32,10.02%,ZNF16;INHBA;ZFPM1;STAT1;MAFB
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.5332933144897576,0.9627865371836617,0.5882352941176471,1.0,1.0,9/18,34.32%,BRCA1;MRE11;RNF138;RAD50;BLM;NBN;BARD1;KAT5;RBBP8
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),0.666286296817914,0.9626603014353923,0.6779661016949152,1.0,1.0,1/5,13.92%,KCNQ1
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),-0.5806585387697919,-0.9624119420434406,0.5135135135135135,1.0,1.0,2/5,9.47%,DUSP12;MIDN
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.5678323903277145,0.9623859281701285,0.578125,1.0,1.0,3/10,20.48%,GABRA2;GABRA4;GABRA6
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.3613671978685347,-0.9619739007026656,0.46875,1.0,1.0,30/152,15.75%,POU6F2;TOX2;NKAIN3;DTX1;CPNE4;IGLON5;KCNC1;FBLL1;RGS8;MAPK4;ADGRA1;NYAP1;TMEM196;SLC29A4;MMD2;CDK14;NGF;STMN2;ELAVL3;MTUS2;PLPPR5;GRIA2;ABCG4;FBXO44;DNER;BRINP1;FXYD7;SRRM3;KCTD8;GALNT14
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.41476875074589875,-0.9616877463747254,0.475,1.0,1.0,7/37,11.02%,TPPP3;CFAP46;JHY;NUMA1;CDK5RAP2;RSPH1;CHP1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.6548946870581085,0.9616727416548084,0.5714285714285714,1.0,1.0,2/5,2.07%,GLI3;ZBTB7B
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.511829938311385,0.9616032551316464,0.5285714285714286,1.0,1.0,12/26,24.33%,CYP1B1;P2RY12;TESC;DPP4;PDE3B;JAM3;LYN;SNAI2;SFRP2;SYK;ADAM9;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.43441338005849317,-0.9615951839819893,0.4838709677419355,1.0,1.0,5/23,20.86%,IGF1;IRS1;CLTCL1;NR4A3;CLIP3
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.5914938879791646,0.9613017191294227,0.5535714285714286,1.0,1.0,4/6,18.37%,CAPN1;CASP8;LGMN;ADGRV1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.37588171551064914,-0.9612884490972555,0.47058823529411764,1.0,1.0,8/64,10.62%,FBXW8;RGS14;AMIGO1;NUMB;PLXNA1;MME;NGF;PLXNA2
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.40735536545961476,0.9610032280337255,0.5616438356164384,1.0,1.0,8/116,5.16%,TRIM22;ROR1;TRIML2;AGER;IL18R1;TRIM5;TRIM32;AGT
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.44043746814284346,-0.9609765766606138,0.42857142857142855,1.0,1.0,2/31,3.88%,SULF2;COL11A2
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.5728673657086085,0.9609347692794685,0.5833333333333334,1.0,1.0,2/9,8.05%,NTF3;VEGFC
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.3980288421509737,0.9608423420378491,0.55,1.0,1.0,7/89,6.99%,C4BPB;PLA2G10;WFS1;TRIM32;INHBA;AGT;CDKN1B
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.34182488053240895,-0.9606447523818059,0.5,1.0,1.0,25/162,10.25%,STK32B;KIT;KDR;PAPSS2;SPRED1;COL15A1;PID1;UNC13B;IL1R1;SGCD;HS3ST3A1;LTC4S;CPA1;CRH;RIN2;LRRC66;RNASE1;SSPN;ENPP3;PDGFRA;ADGRL4;EXT1;TPH1;SLC6A4;CREB3L1
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),-0.5417631264051189,-0.9604530685971756,0.5277777777777778,1.0,1.0,3/9,13.86%,NRG1;SPX;VAMP3
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.602442733113163,0.9602766518202528,0.5833333333333334,1.0,1.0,2/5,25.95%,GRM7;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.47789122416462704,-0.9601803961509313,0.5,1.0,1.0,3/18,3.84%,UBASH3B;CBARP;CACNA2D1
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.547141576058572,0.9600283860382779,0.6111111111111112,1.0,1.0,4/13,9.76%,TWIST1;TBX1;FGFR2;SOX11
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.3462823864150022,-0.9598919931527258,0.53125,1.0,1.0,13/131,5.87%,ITGB5;LMCD1;KDR;LAMB2;GXYLT2;LAMA4;SVEP1;FNDC1;PXDC1;WWTR1;PDE3A;COL4A3;P3H3
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.32086415800735374,-0.9596220691171904,0.5,1.0,1.0,86/358,20.67%,STING1;RAB32;UBXN10;CDC14B;GOLGA8M;ARL13B;RILP;VPS25;NEK6;ABCC4;CFAP221;B9D1;EHD4;PTPN23;GOLGA8H;PDE6D;TMOD4;CFAP52;EXOC7;NSFL1C;RAB7A;RAB3IP;GOLGA8B;INO80;MAPRE1;SNAP29;PCNT;GOLGA8A;CEP83;UBXN2A;PCM1;FHDC1;TRAF3IP1;GOLGA8N;MAP1LC3A;PTPDC1;TTC39C;CNGA4;PARVA;TTC36;ATG9B;RILPL1;TRAPPC14;MKS1;SCLT1;CIRBP;SNF8;ATAT1;TSG101;PIBF1;CFAP44;KIF24;CFAP70;EMC6;CFAP20;PACS2;RCC1;BBIP1;WDR45;DBNL;DZIP1L;TCTN1;WDR35;NUDCD3;CYS1;RAB11FIP3;WIPI2;RFX2;TMEM250;CLUAP1;NEK1;INTU;WDPCP;TP53INP2;KIAA0586;EXOC2;RC3H1;ZFYVE1;DYNC2I1;PLA2G4C;VPS37C;FBF1;EHD3;OGFOD1;HAUS8;DNAH5
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.586206525645944,0.9593487968915813,0.6065573770491803,1.0,1.0,2/9,8.95%,PCBP2;RNF26
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.40804222586891636,-0.9591930788158356,0.5151515151515151,1.0,1.0,13/34,23.74%,PRKCD;PPP6R1;NSMF;PPP1R8;PTBP1;PPP1R7;SYMPK;ENSA;PPP1R16B;PPP6R2;PIN1;PPIA;PTPA
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.5096000054447327,0.9589313310458548,0.52,1.0,1.0,3/18,15.89%,RGS10;CDK5R1;CHRNA7
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.6290393746906365,-0.958743787432838,0.6190476190476191,1.0,1.0,1/5,4.08%,TRIAP1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.42079112528189555,-0.9583523572987591,0.5862068965517241,1.0,1.0,1/33,0.23%,NOX4
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.47466385162616337,0.9583500394683075,0.5757575757575758,1.0,1.0,10/42,10.04%,GNLY;CD4;PIK3R5;PTPRC;ARHGAP9;GMFG;TAGAP;ARHGAP25;CD6;MYO1F
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.5756921137601463,0.9582755953984101,0.5,1.0,1.0,2/10,21.11%,PSMG1;POMP
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.4855415443275237,0.9582679249969086,0.5862068965517241,1.0,1.0,5/29,13.33%,TIMP3;TIMP2;KNG1;CHAC1;GAS1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4990791559544717,0.9581869683172588,0.5147058823529411,1.0,1.0,5/27,10.56%,BOK;HIP1R;CASP8;YWHAH;YWHAG
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),-0.5378439135288321,-0.9579433780265214,0.6046511627906976,1.0,1.0,3/8,18.86%,HMGB2;TOP3B;ERCC3
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.634907967845271,-0.9578321943149256,0.5918367346938775,1.0,1.0,2/5,25.48%,NOL8;WRN
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.5108793476630884,-0.9577753809093528,0.4222222222222222,1.0,1.0,2/12,6.90%,UBASH3B;IL11
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.49698228005101164,0.957703819995502,0.532258064516129,1.0,1.0,2/25,5.13%,SKA3;FKBP4
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.5553226003355247,-0.9576439507449054,0.5789473684210527,1.0,1.0,3/8,22.64%,MAPK12;ATM;CHEK2
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.44066175641318706,0.9576096090151665,0.5483870967741935,1.0,1.0,23/77,19.53%,TRIM5;IL15;ISG20;IFIT3;CASP8;IL7;CMPK2;LPAR6;IRF1;RIPK2;PSMA3;PSMB8;CNP;TRIM14;IFI27;PROCR;CD74;PLSCR1;IFI44;TRIM25;B2M;IFI35;IFITM3
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.4695148845531573,0.9574290786466533,0.463768115942029,1.0,1.0,12/42,22.88%,SLC12A7;GABRA2;CLCN3;GLRA3;GLRA1;GABRR1;GABRA4;SLC1A3;GABRD;GABRA6;ANO2;GLRB
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.5168866847243307,0.957314614799081,0.5806451612903226,1.0,1.0,3/20,13.44%,FABP3;PRKAB2;THRSP
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.47049400048376167,-0.9572991804931936,0.6111111111111112,1.0,1.0,2/20,7.16%,ATP6V0D2;RAB7A
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),-0.501918136936348,-0.9572246476389251,0.4358974358974359,1.0,1.0,2/15,4.28%,KIT;RASGRP1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.39187763009416726,0.9568761597426737,0.5135135135135135,1.0,1.0,10/122,10.98%,NPY;PPP1R1B;PLP1;GRM3;SYT4;CNTN2;RIT2;KCNJ9;C11ORF87;GFAP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.4593621066558865,0.956652841723425,0.5066666666666667,1.0,1.0,5/35,8.05%,CCL5;PLA2G7;RARRES2;CMKLR1;VEGFC
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.5193269711927666,0.9564964598800585,0.5081967213114754,1.0,1.0,2/13,13.39%,NOTCH1;LGMN
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.4594377506603452,-0.956058055576597,0.5833333333333334,1.0,1.0,3/27,2.45%,ITGB5;ITGA4;LAMB3
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.5609377704907166,0.955872564648133,0.5862068965517241,1.0,1.0,3/11,27.91%,CX3CR1;KDM1A;DCT
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.5602451028090777,-0.9557855194036976,0.5555555555555556,1.0,1.0,2/5,18.15%,MACROH2A2;MACROH2A1
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.5467479288815783,-0.9557532134737182,0.5806451612903226,1.0,1.0,1/11,2.23%,MT1E
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.43288299987337686,-0.9556068595143261,0.5,1.0,1.0,7/27,15.81%,KCNJ16;KCNJ14;BCL2;ACE2;KCNJ6;KCNJ2;CTTNBP2NL
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.4409132057192883,-0.9555315557549319,0.42857142857142855,1.0,1.0,7/39,12.19%,BMP7;LEF1;TGFB2;FAM83D;DLG5;NOG;HMGA2
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),-0.6159435685951089,-0.9554973024372417,0.6382978723404256,1.0,1.0,4/6,29.42%,CDK5RAP2;LCMT1;CCNB1;ANAPC15
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),-0.6159435685951089,-0.9554973024372417,0.6382978723404256,1.0,1.0,4/6,29.42%,CDK5RAP2;LCMT1;CCNB1;ANAPC15
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.45695272790352337,-0.9554717736509748,0.5,1.0,1.0,4/25,7.04%,BTC;EREG;IGF1;AURKA
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.5950107255762533,0.9554055098852727,0.5714285714285714,1.0,1.0,2/7,22.26%,KCNQ1;GJA1
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.4275296544025702,-0.9549415285194349,0.6333333333333333,1.0,1.0,5/56,4.15%,UBASH3B;SPRED1;TRIB2;PRKRIP1;WWTR1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.5594341873358811,0.9548609923205754,0.5254237288135594,1.0,1.0,4/16,17.18%,TBX1;SMAD7;ACVR2B;ANGPTL3
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.35853445655739247,-0.9547741064357775,0.6,1.0,1.0,19/85,20.02%,MRPL17;MRPL58;MRPL33;MRPS18A;MRPL21;MRPL39;MRPL55;DAP3;MRPL48;MRPL4;AURKAIP1;APEH;MRPL9;MRPS7;MTRF1L;ETF1;MRPL37;MRPS27;MRPL40
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.4131006637400103,-0.9546382226248352,0.5277777777777778,1.0,1.0,5/27,12.10%,KCNIP1;RANGRF;KCNE1;KCNN2;DPP6
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),0.5831317197178117,0.9541580418242621,0.6190476190476191,1.0,1.0,1/10,1.79%,TMEM35A
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.5930295544727295,-0.9539765496289322,0.5897435897435898,1.0,1.0,3/7,24.60%,MTR;MTHFR;MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),-0.592860140234257,-0.9538752292849583,0.5714285714285714,1.0,1.0,3/5,20.94%,IL11;RAB11FIP3;RAB11FIP1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.5420945782578805,0.9537546061010156,0.5666666666666667,1.0,1.0,4/19,10.48%,AGT;HIP1R;GPER1;PLAUR
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.5382440013750939,0.9535079038089534,0.5714285714285714,1.0,1.0,4/12,17.47%,CAMK2D;PLN;ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.5013196389434714,-0.9534820881090953,0.4722222222222222,1.0,1.0,4/11,15.04%,IFIH1;TRIM44;MAVS;AGPAT2
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.60788646487932,0.9534669363509289,0.5818181818181818,1.0,1.0,5/6,36.33%,ATPAF2;ATPAF1;TMEM70;OXA1L;ATP23
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.4411092557558123,-0.9532245802874197,0.45714285714285713,1.0,1.0,2/22,1.08%,PKP2;NRG1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),0.5757256458381754,0.9531674725594439,0.5625,1.0,1.0,1/11,1.33%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.5522140919822719,-0.9530712008910582,0.6060606060606061,1.0,1.0,4/6,8.80%,GLP1R;TAC3;ID2;SPX
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5321321061855746,0.952832309525291,0.5333333333333333,1.0,1.0,4/10,16.60%,NOTCH1;EPCAM;NOTCH4;RGCC
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.5358910545945075,0.9527503899260779,0.5522388059701493,1.0,1.0,2/12,7.53%,GLI3;HLA-A
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),0.6346583014684574,0.9524381615370012,0.5,1.0,1.0,1/6,10.67%,CELSR1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.34348824238951303,-0.9520418592513893,0.5454545454545454,1.0,1.0,57/243,18.67%,KIT;UBXN10;CDH13;CDC14B;ARL13B;ARFIP2;RILP;ABCC4;CFAP221;B9D1;EHD4;PTPN23;PDE6D;CFAP52;EXOC7;RAB3IP;SNAP29;PCNT;ANO6;CEP83;PCM1;FHDC1;TRAF3IP1;NRP1;PTPDC1;TTC39C;CNGA4;PARVA;TTC36;RILPL1;ABLIM2;FGD5;TRAPPC14;MKS1;SCLT1;ATAT1;PIBF1;CFAP44;PTPRO;KIF24;CFAP70;CFAP20;PPP1R9B;BBIP1;DZIP1L;TCTN1;WDR35;NUDCD3;CYS1;RAB11FIP3;RFX2;TMEM250;CLUAP1;NEK1;INTU;VSTM5;WDPCP
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.49767738746993045,0.9518631156519699,0.5,1.0,1.0,4/18,16.74%,CHAC2;CHAC1;PLOD2;PLSCR1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.5184045589832134,-0.9517626561961166,0.6511627906976745,1.0,1.0,1/11,0.85%,BCL2L11
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.5352798399423857,0.9515252327992607,0.5409836065573771,1.0,1.0,1/10,6.94%,SESN3
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.5352798399423857,0.9515252327992607,0.5409836065573771,1.0,1.0,1/10,6.94%,SESN3
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.46210108744373557,-0.9514283352845653,0.4857142857142857,1.0,1.0,4/28,11.16%,PEX7;TOMM40L;TIMM50;TOMM40
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.4090301023949448,-0.951366708601787,0.5,1.0,1.0,15/50,13.38%,BTC;MYH14;LAMB3;SDC4;CLDN4;ANO1;ACE2;ALDH1A3;GPR39;AKR1C3;LAMA3;CDH1;TSPAN1;PERP;PDLIM3
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.5708391164495414,0.9513292767384961,0.5573770491803278,1.0,1.0,3/7,34.32%,MMUT;PCK2;MMAA
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),-0.5990679480389097,-0.9512797643583903,0.5106382978723404,1.0,1.0,1/5,19.36%,RC3H1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5082675759629749,-0.9512732864946748,0.4782608695652174,1.0,1.0,6/16,14.00%,RGS14;PDGFD;PDGFRA;PDGFC;NRP1;PTPN1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5195627018494636,-0.9511586731181997,0.55,1.0,1.0,2/11,3.32%,UNC13B;UNC13C
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.48929797127527874,-0.9508761965294561,0.48484848484848486,1.0,1.0,4/21,7.59%,EPHB2;CBARP;DRD4;SLC6A9
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.4884010821731996,0.9507970524198883,0.5901639344262295,1.0,1.0,5/17,16.54%,CD4;VPS37B;CHMP2B;CHMP2A;CD74
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.5866881982523389,0.9503715842651623,0.5384615384615384,1.0,1.0,1/7,1.97%,CCL5
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.44172835625015333,-0.9503530614486931,0.6666666666666666,1.0,1.0,2/19,1.38%,TRIB2;F2RL1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.4358050193715869,0.9503189670227298,0.6029411764705882,1.0,1.0,7/57,13.84%,MCM2;GMNN;PSMB6;CDC6;PSMA3;PSMB8;ORC4
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.4365731257289619,-0.9502795636551065,0.4,1.0,1.0,3/23,10.30%,PEX7;ACOT8;ABCD1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.45297619131650224,0.9502788467629328,0.5151515151515151,1.0,1.0,5/40,7.80%,NPY;SSTR1;OPRK1;CPE;GALR1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.4263748085098794,-0.9502337339228187,0.5294117647058824,1.0,1.0,10/37,14.10%,KCNJ16;AMIGO1;KCNN3;KCNE1;KCNN2;DRD1;NOS1AP;KCNJ6;GABBR2;KCNJ2
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.381715145147074,-0.9496434341105935,0.4,1.0,1.0,7/103,6.30%,KDR;STING1;ATP6V0D2;NRBP2;EPM2A;MTMR8;EXOC7
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.4410400658161865,-0.9492150508200268,0.5769230769230769,1.0,1.0,3/32,7.09%,KIT;SFRP1;TGFB2
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.6238361845532521,0.9492103306358405,0.5471698113207547,1.0,1.0,4/7,25.19%,RNF168;EXOSC6;MSH6;MSH2
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.528876281317756,0.9489915438303631,0.578125,1.0,1.0,4/13,17.47%,CAMK2D;PLN;ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),0.6458421187560651,0.9489426561966232,0.5666666666666667,1.0,1.0,2/5,19.60%,SLC28A2;SLC29A2
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),0.6458421187560651,0.9489426561966232,0.5666666666666667,1.0,1.0,2/5,19.60%,SLC28A2;SLC29A2
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),0.6458421187560651,0.9489426561966232,0.5666666666666667,1.0,1.0,2/5,19.60%,SLC28A2;SLC29A2
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.3983004425442907,0.9489054530327851,0.5135135135135135,1.0,1.0,12/86,16.33%,C4BPB;ADGRB1;TRIM32;CDKN1B;EEF1A1;HMGCR;GFAP;HECW1;TIPARP;DAB2IP;FURIN;PRKCG
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.6241631086951425,0.9486157368794077,0.5517241379310345,1.0,1.0,4/6,26.30%,MOCS2;MOCOS;MOCS1;NFS1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.532670276802633,0.9484053038790231,0.5882352941176471,1.0,1.0,7/17,16.29%,CSRP3;CAV3;PKD2L2;PIEZO2;PKD1L3;TTN;LHFPL5
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.40979567474955403,-0.9482266113036624,0.45714285714285713,1.0,1.0,6/44,11.25%,SPTSSB;CLN6;CERS4;SPTLC1;SGMS2;SMPD4
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.36573478546900884,-0.9476567486727225,0.6153846153846154,1.0,1.0,28/133,13.78%,SVOP;SPHKAP;PCBP3;NTNG1;CACNG3;NRL;TNR;ADAMTS5;AP3B2;KCNC1;RGS8;ZNF536;GRIA4;TMEM196;GRIA1;RAB3C;MMD2;ROM1;SAG;GAD2;STMN2;FRRS1L;ELAVL3;SRRM4;CDH20;CTNNA2;GRIA2;CNTNAP5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.540213814822064,-0.9476448946208373,0.5128205128205128,1.0,1.0,1/13,0.83%,HOMER2
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.5462303481689608,0.9476234948050244,0.5862068965517241,1.0,1.0,3/13,9.21%,ASXL3;CIITA;GPER1
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.6134770462343363,0.9471458697928121,0.576271186440678,1.0,1.0,1/7,9.41%,CHMP2B
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.5008504817737472,0.9469990124529121,0.5,1.0,1.0,3/26,9.38%,NOTCH1;MAML2;NOTCH3
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.4972403066056288,-0.9466086995352507,0.5476190476190477,1.0,1.0,4/15,9.24%,TRPC3;CIB2;P2RY11;TAF1
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.6030871292648643,0.9459262093309385,0.5645161290322581,1.0,1.0,1/5,14.04%,APLF
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.6502441408275839,0.945836004807437,0.603448275862069,1.0,1.0,2/5,24.47%,PIK3CB;PIK3CD
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.44730486636940003,-0.945832554799624,0.48484848484848486,1.0,1.0,2/15,2.18%,RUNX1;RBP4
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.6116833009775666,-0.9453909993966881,0.5277777777777778,1.0,1.0,1/9,1.09%,H1-4
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.4805175200020206,0.9453429712322926,0.5254237288135594,1.0,1.0,4/22,9.76%,HHIP;SFRP4;FGFR2;SOX11
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.4805689897228279,-0.9452467107448189,0.4666666666666667,1.0,1.0,8/19,25.10%,CYGB;NOS1AP;EGFR;LEP;DNM2;DDAH1;NOSIP;VDR
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.45680102438085607,0.9451629839924991,0.5294117647058824,1.0,1.0,7/29,26.24%,TCP1;CCT6A;CCT8;CCT7;PKIB;TNKS2;MAPKAPK5
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.4345986472273139,-0.9451315284840676,0.4523809523809524,1.0,1.0,6/26,11.32%,SFRP1;HDAC1;FOXP1;ZBTB7A;SMARCA4;TRIM68
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.5898625934339937,-0.9450200643975462,0.575,1.0,1.0,1/6,5.43%,CFLAR
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.4126835635765982,-0.9449461609205362,0.48484848484848486,1.0,1.0,13/46,14.33%,DGLUCY;IDH2;SLC19A1;OGDH;MTHFD2;ACOT8;DHFR;MTHFS;MDH1B;NIT2;GOT2;MTHFD2L;MTHFD1L
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.44664141912869687,-0.9443234318404085,0.5675675675675675,1.0,1.0,6/25,14.59%,TPR;PRKCD;CDH1;DMAP1;BAG3;MAVS
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.5891946894625474,0.9440896559305266,0.5846153846153846,1.0,1.0,1/7,17.39%,ULK1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.5891946894625474,0.9440896559305266,0.5846153846153846,1.0,1.0,1/7,17.39%,ULK1
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4873953261137097,0.9440071748708659,0.5645161290322581,1.0,1.0,4/22,20.17%,CASQ1;GPER1;TRDN;CALM3
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.4451646164698728,-0.9438179269136999,0.4634146341463415,1.0,1.0,8/18,14.94%,RGS14;CRHR2;PLK2;SHANK2;GRIN2A;GRIN2C;STX4;SLC8A3
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.5264636183962809,-0.9437850406113006,0.4857142857142857,1.0,1.0,3/7,16.28%,TICAM1;PIBF1;LEP
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.5530126884257204,0.9437300268390387,0.5070422535211268,1.0,1.0,3/12,16.99%,AHR;SOX11;TNFSF18
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.518355715397456,0.9436320338217243,0.5833333333333334,1.0,1.0,5/21,7.73%,NOX5;PREX1;NOX1;ALOX12;SOD2
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.364555168043869,0.9433930091476433,0.6133333333333333,1.0,1.0,31/282,12.79%,SERF1A;CALB1;TLL1;HSPG2;H3-3A;CYP1B1;LOXL2;FBLN5;RND1;COL8A1;MFGE8;FIGNL1;ACTC1;HIP1R;BMP1;CORO1A;KIF14;ARHGAP25;MYO5B;RHOB;SIAH1;BFSP1;MYO1F;RHOH;COL9A1;GFAP;COL10A1;PGM5;TUBGCP4;TLE6;WDR73
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4147515651790658,0.9433730420424356,0.5857142857142857,1.0,1.0,14/90,10.21%,ENPP2;CCL5;DOK7;CRLF1;ITGA5;NTF3;IL15;PTPRC;FLT3;AGT;HGF;CTF1;PLCG2;TGFB1
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.5449293392158723,-0.9433241501487284,0.45454545454545453,1.0,1.0,2/8,5.75%,RBP4;VSIG1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.4126839593901648,0.9427315630870323,0.582089552238806,1.0,1.0,15/84,17.99%,HCK;SLC30A8;PTPRC;HIP1R;RIT2;RNF139;RAB8A;TSC2;GAS1;SEPTIN1;SPHK1;RAB11A;SNX17;INPP5F;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.44704249637566873,-0.9426366273048605,0.5405405405405406,1.0,1.0,6/24,14.59%,TPR;PRKCD;CDH1;DMAP1;BAG3;MAVS
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.36561091063198115,0.9423555077069743,0.6235294117647059,1.0,1.0,29/371,10.67%,SERF1A;NES;RAPGEF5;NDP;NEUROD2;NTF3;WDR62;ADGRB1;INHBA;SOX10;IRF2BPL;NHEJ1;ARTN;PROP1;PTPRZ1;PAFAH1B3;SOX6;SCRG1;SLC2A1;IL1RAPL2;ACTL6A;HMGCR;B3GNT5;SIAH1;NAB1;CHAC1;TGFB1;NPAS1;CELSR1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.628319115153557,0.9422425222533121,0.6451612903225806,1.0,1.0,4/7,30.04%,RIPOR1;CDC42;PDCD10;YWHAZ
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5050961842182181,0.942155692571012,0.5535714285714286,1.0,1.0,3/16,7.70%,ACSBG1;ACSL5;ELOVL2
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.3863724744707079,0.9420884327015967,0.5352112676056338,1.0,1.0,18/120,15.92%,TMEM97;ANGPTL7;ATF5;AGT;HIP1R;KIF14;RIT2;PAPPA2;GFAP;HSPA8;TMC8;CAMK2D;TSC2;SPHK1;DAB2IP;NUBP1;SNX17;PINK1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.512258963571028,0.9420814506677978,0.5671641791044776,1.0,1.0,7/17,10.21%,NOTCH1;ZFPM1;ACTC1;FGFR2;MYBPC3;SMAD7;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),-0.5310706185707842,-0.941742860454241,0.574468085106383,1.0,1.0,2/9,15.76%,ACVR1;NOMO3
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.4020525326284966,0.9416815356454062,0.5733333333333334,1.0,1.0,17/85,25.92%,CLEC4C;MUC4;PSMB6;PLCG2;MUCL1;PSMA3;PSMB8;MUC20;TAB2;LYN;PSMA5;SYK;MUC6;CUL1;KRAS;PSMC6;NRAS
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4020525326284966,0.9416815356454062,0.5733333333333334,1.0,1.0,17/85,25.92%,CLEC4C;MUC4;PSMB6;PLCG2;MUCL1;PSMA3;PSMB8;MUC20;TAB2;LYN;PSMA5;SYK;MUC6;CUL1;KRAS;PSMC6;NRAS
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.4020525326284966,0.9416815356454062,0.5733333333333334,1.0,1.0,17/85,25.92%,CLEC4C;MUC4;PSMB6;PLCG2;MUCL1;PSMA3;PSMB8;MUC20;TAB2;LYN;PSMA5;SYK;MUC6;CUL1;KRAS;PSMC6;NRAS
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.4261379798975938,-0.941596864548469,0.5277777777777778,1.0,1.0,2/25,7.04%,KDR;AURKA
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3181282491622315,-0.9415289518195901,0.7333333333333333,1.0,1.0,38/394,9.64%,CD38;MYRFL;MYB;BMP7;HMGN5;LEF1;CREB5;RUNX1;ZNF496;NFATC1;KDM8;ATOH8;FOS;TEAD2;BRCA2;IGF1;SFRP1;NFIB;MED30;WBP2NL;HDAC1;TFAP4;RGMB;ZFHX3;ETS1;ID2;MAP2K3;CDK5RAP2;STAT3;NR1H4;FOXK1;LBH;TGFB3;XRCC6;DLX5;PBX4;SMARCA4;APOE
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.6223013696074724,-0.9412681292666192,0.6428571428571429,1.0,1.0,2/5,18.66%,PRKCB;VRK1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4473492035854597,0.9412673127977409,0.5492957746478874,1.0,1.0,7/31,26.24%,TCP1;CCT6A;CCT8;CCT7;PKIB;TNKS2;MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.48401774466689884,-0.941258884150863,0.6060606060606061,1.0,1.0,1/18,0.14%,TRPC3
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.4938967521963021,0.9410218877533898,0.5423728813559322,1.0,1.0,2/21,8.18%,DNASE2;DNASE2B
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.4533056854004531,0.9410043893148842,0.5657894736842105,1.0,1.0,6/33,11.23%,RASA1;AMOT;ETS2;TLE3;CELSR1;CDK5R1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5566809337322344,0.9409311238691275,0.6060606060606061,1.0,1.0,2/12,3.71%,TBXA2R;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.5868906154057292,0.940905284526589,0.6129032258064516,1.0,1.0,2/8,14.90%,NEUROD2;DAB2IP
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.33309239411875635,-0.9408863005980391,0.6,1.0,1.0,23/220,8.07%,MDGA1;KLHL17;POU6F2;TBX6;CHST8;PCDH18;SOX12;AMIGO1;KLK6;CNTN6;ECRG4;NFIB;VCAN;MARCKS;PTCH1;JHY;ZFHX3;DSCAML1;TPP1;CDK5RAP2;STAT3;MACROH2A2;SPOCK1
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.5954386739116471,0.9407700896710867,0.5645161290322581,1.0,1.0,2/9,7.22%,OMG;NREP
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.5224656688525843,0.9407613585024036,0.6721311475409836,1.0,1.0,7/26,20.49%,PRAF2;SLC25A18;SLC36A1;SLC38A2;SLC38A5;SLC1A3;SLC38A3
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.5639952122051928,0.9404871721997567,0.5735294117647058,1.0,1.0,2/11,9.98%,RIPOR1;ARCN1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.48229083087087005,0.9403736711528662,0.59375,1.0,1.0,5/22,15.92%,ATP5IF1;USP14;UCHL5;TMF1;PINK1
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.43077975199373675,-0.9403275784565085,0.5555555555555556,1.0,1.0,7/47,7.59%,SLC16A2;SLC16A9;SLC16A12;SLC6A11;SLC7A1;SLC25A29;SLC6A9
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,0.41142481114736185,0.940205879480911,0.5671641791044776,1.0,1.0,10/64,11.12%,ZBTB7B;DENND1C;ISG20;JUNB;OSTF1;CTDSP1;LITAF;IRF1;NBEAL2;TMC6
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),-0.5806063060615556,-0.9400478576409087,0.5909090909090909,1.0,1.0,1/6,1.38%,F2RL1
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.3746374780203942,-0.9398923501784663,0.55,1.0,1.0,8/90,4.15%,KIT;LAMB2;TSPAN12;RND3;ADAMTS15;KITLG;CACNA2D1;WWTR1
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.606049895762301,-0.9398831890136762,0.6,1.0,1.0,3/6,25.31%,CTCF;DIRAS3;DNMT3A
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.6295156350179552,0.9398487682684863,0.6833333333333333,1.0,1.0,2/6,18.60%,ARG1;PPARG
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.6295156350179552,0.9398487682684863,0.6833333333333333,1.0,1.0,2/6,18.60%,ARG1;PPARG
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.5038664291387707,0.9397990449238977,0.6065573770491803,1.0,1.0,6/19,23.98%,CSDE1;UBAP2L;G3BP1;YTHDF1;DDX6;DDX3X
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.4927397005419284,0.9393969722423111,0.6119402985074627,1.0,1.0,7/23,20.00%,PRKAB2;ADIPOR2;BRCA1;ACADL;PDK4;ERLIN1;PRKAG2
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.46234311652835597,-0.9391684939007157,0.5625,1.0,1.0,3/18,12.35%,RUNX1;CBFB;MAFG
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),-0.6230239837645734,-0.9391425044860638,0.6122448979591837,1.0,1.0,1/5,5.03%,PDE3A
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),-0.6230239837645734,-0.9391425044860638,0.6122448979591837,1.0,1.0,1/5,5.03%,PDE3A
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.581721744003788,-0.9390400199136376,0.6388888888888888,1.0,1.0,2/6,3.61%,SVBP;CLDN4
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.4075807748505414,-0.9389746434808364,0.4473684210526316,1.0,1.0,11/42,21.52%,TCOF1;PUM3;GCNT2;TRIM71;MEX3D;RBM3;MTPN;RC3H1;NANOS3;EIF2B4;TDRD7
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.414580964204841,0.9388838115744853,0.5333333333333333,1.0,1.0,14/79,7.58%,LAMA2;MYLK;SEMA3D;ACTA2;PDGFRB;POSTN;ECM2;ANGPTL2;NID2;RUNX1T1;IGFBP5;PRKG1;SFRP4;ITGA11
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.5525195570334656,-0.9386021029859845,0.5454545454545454,1.0,1.0,3/11,13.46%,HDAC5;SPHK2;SMARCB1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.4989279919386427,-0.938332795995835,0.5,1.0,1.0,1/10,4.42%,TICAM1
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.37012679946158666,0.9381944088879484,0.5657894736842105,1.0,1.0,20/155,10.26%,ALDH1A1;LRP4;VASN;BTN2A2;AGER;IL18R1;NOTCH1;IL15;MARVELD3;LOXL2;TRPV3;TLE3;RPS6KA4;ARRDC3;HMGCR;ZNF750;ACOT13;SMAD7;TGFB1;LRPAP1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.4406875041538831,-0.9381298532330202,0.4444444444444444,1.0,1.0,9/30,17.09%,LSM6;DCPS;POLR2G;EXOSC1;EXOSC7;EXOSC5;DIS3L2;EXOSC4;LSM7
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.5754281723608199,0.9379655019287867,0.65,1.0,1.0,2/14,15.43%,CMPK2;AK4
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.5925789308837963,0.9378569302306544,0.6140350877192983,1.0,1.0,3/8,3.99%,CCL5;PREX1;IL15
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.44740640533648557,0.9378131053413372,0.5846153846153846,1.0,1.0,8/41,9.38%,LAMA2;MKX;CAV3;TEAD4;SOX6;TBX1;ITGA11;CTF1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.3584683092635827,-0.9378117558387385,0.52,1.0,1.0,21/94,20.02%,MRPL17;MRPL58;MRPL33;MRPS18A;MRPL21;MRPL39;MRPL55;DAP3;TSFM;MRPL48;EARS2;MRPL4;AURKAIP1;QRSL1;MRPL9;MRPS7;RARS2;MTRF1L;MRPL37;MRPS27;MRPL40
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.3852279729450221,0.9377766590748045,0.5609756097560976,1.0,1.0,48/142,32.90%,GGTA1;ASMT;EEF1A1;RPL15;RPS7;RPL36;RHD;RPL9;RPS21;FURIN;PCSK5;MRPS14;RPL38;MRPL34;RPL21;RPL22;CARNS1;RPS5;RSL24D1;RPS6KB2;RPLP2;COPS5;RPS13;MRPL35;RPL27;RPL35A;RPL35;MRPL43;RPL3;RPS20;RPL27A;EIF4EBP2;RPS27A;RPL13A;RPL5;MRPL42;RPS29;RPS12;MRPL28;MRPS18C;RPL7;RPL32;RPS4X;RPL37A;RPL24;RPS9;RPL28;MRPL51
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.565605053455777,-0.9376661367356347,0.6428571428571429,1.0,1.0,3/8,7.30%,SH3RF1;RUNX1;CBFB
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.38493645608664456,-0.9376134240942098,0.5,1.0,1.0,14/70,16.88%,AHNAK2;HNRNPL;RRP1B;AKAP17A;PTBP3;U2AF2;SON;SRRM4;FASTK;PTBP1;RPS26;KHDRBS3;SETX;PTBP2
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.3734237254116486,0.9375753969404595,0.5714285714285714,1.0,1.0,10/149,7.95%,EPHA1;RGS10;CCL5;GRTP1;NTF3;DOCK8;RUNDC1;ADRB1;F11R;ARHGAP25
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.5135077249882083,-0.937156351049759,0.5151515151515151,1.0,1.0,4/15,12.39%,CATSPER2;TGFB2;TGFB3;CATSPERG
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.5092003067591313,0.9366753432363499,0.5689655172413793,1.0,1.0,3/18,10.21%,NOTCH1;TWIST1;TGFB1
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.37436696979049505,-0.9364983660535916,0.5,1.0,1.0,13/67,12.69%,PKP2;F2RL1;CDH13;CDH6;SDK1;TGFB2;CSK;CDHR3;TGFB3;CDH1;TLN1;CSF1R;CDH20
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.3254522278964236,-0.9364329136996501,0.5882352941176471,1.0,1.0,52/360,15.23%,GEM;RAB32;PEX7;FBXW8;GOLGA8M;PTCD2;SPTSSB;ALAS1;WTIP;PI4K2A;GOLGA8H;MARK1;TMEM11;SLC25A33;TMED3;CFAP61;PLIN5;MTX1;CDC42BPB;SIPA1L3;NUMA1;NSFL1C;CIDEA;RAB7A;GOLGA8B;ZMYM6;ATP8B4;KIF25;HPS6;PLD2;GOLGA8A;APOE;UBXN2A;ODF2;ABCD1;GOLGA8N;SMPD4;MDK;SEMA6A;FGD5;ARAP3;FAM161B;NIPSNAP2;PLEKHM2;BIN1;MAST2;POLG2;STX4;ATL2;ADCK1;DOP1B;CAPZB
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.5876497739361999,-0.9364028403308319,0.5681818181818182,1.0,1.0,2/5,25.49%,MCCC2;HMGCL
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.5546033028055638,0.9362458403189898,0.6307692307692307,1.0,1.0,1/11,4.69%,DOCK8
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.38982127396387917,-0.9359304196763157,0.4583333333333333,1.0,1.0,13/65,17.39%,TRIAP1;TFAP4;TFDP1;PLK2;AURKA;CRADD;USP10;PIDD1;BTG2;PML;PLK3;ATM;PCBP4
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.5740880743463705,0.9359265395514401,0.6363636363636364,1.0,1.0,2/7,10.55%,UFM1;RAB23
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.5740880743463705,0.9359265395514401,0.6363636363636364,1.0,1.0,2/7,10.55%,UFM1;RAB23
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.4957727824338523,0.9359099898046359,0.6111111111111112,1.0,1.0,1/19,1.97%,CCL5
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.4873556342986845,0.9357597829801154,0.546875,1.0,1.0,4/23,12.57%,ING2;TDRD5;SYCP3;MEIOC
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.5961598119313709,-0.9352195949146341,0.574468085106383,1.0,1.0,3/6,21.41%,NUP107;LDB1;RAE1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.467962669074526,0.9352075788616503,0.5645161290322581,1.0,1.0,8/32,14.22%,NCAPH2;NCAPG;H1-2;GPER1;PHF13;SMC2;CHMP1A;TTN
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.4234794956862957,-0.9350233266411782,0.5128205128205128,1.0,1.0,10/29,19.71%,RUBCNL;LIX1;SNAP29;MAP1LC3A;TSG101;EPG5;VCP;WIPI2;VPS16;VAMP8
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.3478793348262854,-0.9349768592623451,0.6333333333333333,1.0,1.0,11/93,10.30%,EEFSEC;MRPL17;MRPL58;MRPL33;MRPS18A;MRPL21;MRPL39;MRPL55;DAP3;TSFM;MRPL48
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,0.4358086673156949,0.9348768018920929,0.6029411764705882,1.0,1.0,13/41,14.48%,LIPH;SMIM22;FUT2;TJP3;GPX2;KLF5;AP1M2;B3GNT3;MUC4;GGH;TMC4;EPCAM;MUC20
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.36519756057643477,-0.9344968434650884,0.6551724137931034,1.0,1.0,10/79,10.30%,MRPL17;MRPL58;MRPL33;MRPS18A;MRPL21;MRPL39;MRPL55;DAP3;TSFM;MRPL48
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4897858728269059,0.9344646852392342,0.5737704918032787,1.0,1.0,8/23,32.49%,CASP8;RIPK2;TAB2;CYLD;NOD1;RPS27A;ITCH;AAMP
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.5057497431017999,-0.9343608236946732,0.5609756097560976,1.0,1.0,1/21,1.43%,SAMD4A
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.4999535943943566,-0.9343162330458413,0.4864864864864865,1.0,1.0,4/14,14.10%,TYSND1;PLIN5;ABCD1;IRS1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.4725106493997047,-0.9343032491503634,0.5128205128205128,1.0,1.0,3/17,5.40%,HDAC5;MAML1;HDAC1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.46913889392589864,0.9332684084874487,0.5967741935483871,1.0,1.0,8/36,11.59%,RASIP1;RASA1;CYP1B1;LAMA1;TBX1;SMAD7;TGFB1;AGGF1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.3686259566604695,0.9332506348595053,0.5822784810126582,1.0,1.0,26/204,16.52%,CHRNB1;CAV3;LDLRAP1;CD4;SYT2;LPCAT3;CHMP4B;VAPB;TGFA;MYOF;HIP1R;SYNGR2;CNTN2;RABIF;EPN1;CHMP2B;MTCH1;CHMP1A;HSPA8;SYT9;OTOF;ACTR2;TRDN;TMEM33;SPAG4;CHMP2A
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.5791484129547966,0.933215446868551,0.58,1.0,1.0,1/7,11.72%,LGSN
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.5775019873252879,0.9332076213592543,0.576271186440678,1.0,1.0,2/11,4.82%,P2RY1;P2RY12
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4017226518202908,0.9331581143938434,0.5789473684210527,1.0,1.0,8/72,6.99%,CALCR;MC4R;RXFP1;CALCB;HCK;SCTR;TSHR;ADRB1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.3760385418674537,-0.9331544317550468,0.5666666666666667,1.0,1.0,5/44,3.34%,KIT;KDR;RBP4;TEAD2;KITLG
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.44084894998851215,0.9327024461127182,0.546875,1.0,1.0,10/46,6.52%,GNLY;ITK;IL18R1;CD4;CCL5;HPGDS;AHR;PTPRC;GMFG;TAGAP
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.4460495233293072,-0.9326221733167374,0.5217391304347826,1.0,1.0,3/30,3.10%,HOMER2;RUNX1;PNP
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.58715252764535,-0.932406547621346,0.5909090909090909,1.0,1.0,3/6,17.21%,APOE;PTPN1;DTX3L
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,0.49895349106205544,0.9321681990700992,0.5538461538461539,1.0,1.0,5/25,6.52%,GNLY;ITK;CD8A;PTPRC;TAGAP
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.3635134992968,0.9321055942801285,0.5733333333333334,1.0,1.0,23/168,12.33%,AEN;SLC7A11;CD82;NOTCH1;CSRNP2;CCND2;GM2A;EPHX1;GPX2;LDHB;TGFA;HINT1;MXD1;H1-2;TCN2;CGRRF1;RPL36;FAS;TGFB1;CDK5R1;STOM;PCNA;HSPA4L
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.5348888453597535,0.932100134041168,0.5230769230769231,1.0,1.0,2/8,17.98%,DAB2IP;PIP4K2C
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.47943991752646925,0.9320996864444429,0.5757575757575758,1.0,1.0,3/21,7.70%,ACSBG1;ACSL5;ELOVL2
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.4561616146413642,0.9319759416691102,0.6176470588235294,1.0,1.0,18/51,26.27%,PLA2G7;IL15;AGT;OSMR;PDCD4;TLR2;IL18;SNX4;MAPK13;IFI35;NFKBIZ;LBP;IL6ST;SERPINE1;NLRP12;PDE2A;CD47;NAPEPLD
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.4440234042934257,-0.931881540177315,0.46511627906976744,1.0,1.0,5/23,9.61%,SFRP1;HDAC1;FOXP1;ZBTB7A;SMARCA4
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.4132728741436898,0.9317175892074173,0.5522388059701493,1.0,1.0,13/65,14.63%,PPP1R1B;VWA2;HSD11B2;TJP3;AP1M2;B3GNT3;IL20RA;FGFR2;PLEKHG3;ALDH2;TMC4;KCNQ1;PCDH1
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.4639930872399015,-0.9316542538713439,0.48484848484848486,1.0,1.0,11/22,23.74%,PRKCD;MTMR9;NSMF;PTBP1;PPP1R7;SYMPK;PPP1R16B;BMP2;PIN1;PPIA;PTPA
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.6662108128063545,0.931646409121471,0.6307692307692307,1.0,1.0,2/5,28.75%,BBOX1;ACADM
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.6662108128063545,0.931646409121471,0.6307692307692307,1.0,1.0,2/5,28.75%,BBOX1;ACADM
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.4726501314116926,0.9314902933781726,0.578125,1.0,1.0,5/24,17.17%,SYT2;SYT4;SYT9;SYT15;SYT13
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.39370817214031595,0.9313467500557463,0.5774647887323944,1.0,1.0,13/95,6.45%,LAMA2;MYLK;TIMP3;HSPG2;ACTA2;PDGFRB;POSTN;CYP1B1;ANGPTL2;EPHX1;PLSCR4;RARRES2;IGFBP5
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.48117624142573323,-0.9312765757500716,0.5853658536585366,1.0,1.0,2/16,3.64%,GREM1;SRGN
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.3120230705782059,-0.930859313449159,0.7894736842105263,1.0,1.0,75/275,21.89%,UBXN10;CDC14B;CFAP46;ARL13B;RILP;ABCC4;CFAP221;B9D1;EHD4;PTPN23;PDE6D;CFAP52;EXOC7;JHY;RAB3IP;CDK5RAP2;MAPRE1;NEDD1;SNAP29;PCNT;CEP83;RSPH1;ODF2;PCM1;FHDC1;TRAF3IP1;TUBG1;PTPDC1;TTC39C;CNGA4;PARVA;TTC36;RILPL1;TRAPPC14;MKS1;SCLT1;ATAT1;RPGRIP1L;PIBF1;CFAP44;KIF24;CFAP70;TUBB4A;CFAP20;BBIP1;DZIP1L;TCTN1;WDR35;TBC1D32;NUDCD3;CYS1;RAB11FIP3;RFX2;TMEM250;CLUAP1;NEK1;INTU;WDPCP;KIAA0586;SSNA1;EXOC2;DYNC2I1;CEP135;FBF1;IFT27;EHD3;HAUS8;DNAH5;RSPH4A;TMEM216;IFT52;KIFAP3;CCDC40;TEKT3;CEP89
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.3830779470647054,0.9306303547133389,0.589041095890411,1.0,1.0,11/135,12.71%,CENPO;CENPI;KNL1;CENPK;WDR62;SPC24;TPX2;BUB1B;CENPU;MZT1;CENPL
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),-0.5652164664282444,-0.9305302938000906,0.5945945945945946,1.0,1.0,2/7,7.09%,NRG1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.5163110796362805,0.9304212595953824,0.5538461538461539,1.0,1.0,4/13,18.08%,NOTCH1;FGFR2;PIM1;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),-0.49360376849121823,-0.9302791021482278,0.5454545454545454,1.0,1.0,3/12,14.10%,IGF1;PPP1R3E;IRS1
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.43232356320715426,0.9297088708730666,0.5909090909090909,1.0,1.0,7/65,9.96%,CAV3;WFS1;SLC30A8;HKDC1;PPARGC1A;ADIPOR2;LRRC8D
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),0.6068545654598878,0.9296469638797882,0.6379310344827587,1.0,1.0,3/6,3.99%,CCL5;PREX1;IL15
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.4649877469714727,0.9295239124839141,0.5671641791044776,1.0,1.0,3/30,4.24%,LDLRAP1;NSDHL;SULT2A1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.36055075169346396,0.9293341051967731,0.6164383561643836,1.0,1.0,23/246,13.99%,RAD54L;TICRR;MCM2;TDG;RFC5;POLE2;GMNN;POLQ;POLE3;DNASE2;RAD9B;UHRF2;INIP;CDC6;BRCA1;HELB;MRE11;RPA3;PCNA;DCTPP1;PDS5B;ORC4;GLRX2
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,0.45819019612454076,0.9291204952962885,0.6567164179104478,1.0,1.0,10/51,10.04%,GNLY;ITK;PIK3R5;PTPRC;ARHGAP9;GMFG;TAGAP;ARHGAP25;CD6;MYO1F
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.5368302483215621,-0.9290736606273573,0.575,1.0,1.0,3/13,5.66%,ADAM12;ADAMTS15;ADAMTS5
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.39583668822731677,-0.9289828886611861,0.48,1.0,1.0,11/57,11.94%,VASH1;EREG;ATOH8;BRCA2;SFRP1;NFIB;TGFB2;MCC;APOE;DUSP10;SCG2
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.44390836632066405,-0.9289552053732971,0.5,1.0,1.0,2/26,2.02%,CA2;SLC9A8
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.43241534911031804,0.9288969548194533,0.5238095238095238,1.0,1.0,8/33,21.38%,PTGIS;ACMSD;BRCA1;OPN3;ACADL;ERLIN1;ATP2B4;SNAI2
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.4956974768779425,0.9288869730849317,0.5423728813559322,1.0,1.0,3/21,10.21%,NOTCH1;TWIST1;TGFB1
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.6196709205792859,-0.9288819407709014,0.6829268292682927,1.0,1.0,3/5,25.79%,HMGB2;NEIL1;OAS2
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.3822800286869743,-0.9288003490157551,0.6538461538461539,1.0,1.0,18/105,9.11%,GEM;KDR;LAMB2;RNF182;ARID5A;PXDC1;NEK6;CDH6;IGF1;SLC12A3;ADAMTS5;ANO1;RIN2;LRRC66;RNASE1;SSPN;PDGFRA;ADGRL4
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.43773297131057265,-0.9285565119546568,0.4888888888888889,1.0,1.0,6/26,10.83%,KIT;LHFPL2;KITLG;TGFB2;AKR1C3;MAMLD1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.4812847484546313,-0.9284183079059325,0.5151515151515151,1.0,1.0,1/10,5.85%,TFAP4
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),0.6024503733543681,0.928413454409675,0.5357142857142857,1.0,1.0,1/5,1.38%,LDLRAP1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4859037587789433,-0.9282902277129994,0.4594594594594595,1.0,1.0,3/11,9.28%,ITGA4;ANO6;AKR1C3
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.6095296941463836,0.9282698596816147,0.6037735849056604,1.0,1.0,2/6,18.60%,ALOXE3;PPARG
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5582840590518878,-0.9282394944401907,0.6585365853658537,1.0,1.0,3/8,26.32%,WNT9B;LRP6;WNT3
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.43784406221542566,0.9281090369848803,0.546875,1.0,1.0,7/35,9.36%,CCL5;PDGFRB;ELANE;NOX1;IGFBP5;OGN;STAT1
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.463368453487423,0.9279638005132999,0.5217391304347826,1.0,1.0,7/30,23.51%,RREB1;DOCK1;DMTN;CALR;DOCK5;CDC42;LIMS2
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.4216970496728385,-0.9279259431232538,0.5862068965517241,1.0,1.0,6/40,7.77%,BMP7;BTC;EREG;IGF1;AURKA;CDK5RAP2
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.5388126294398983,0.9276514911171726,0.5689655172413793,1.0,1.0,3/11,16.09%,STAT1;IRF1;PYHIN1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.5598146203751867,0.927570329478474,0.5882352941176471,1.0,1.0,1/7,1.33%,CAV3
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.5482117158674624,-0.9274572214672425,0.5869565217391305,1.0,1.0,1/5,7.75%,NCSTN
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.4320677976502715,-0.9272569517378202,0.5319148936170213,1.0,1.0,5/25,16.74%,CDC26;UBE2D4;CDC23;FZR1;ANAPC7
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.5954150006946239,-0.9272072391141031,0.6444444444444445,1.0,1.0,1/7,5.14%,DCLRE1B
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.5988541129689839,0.92680915611307,0.5254237288135594,1.0,1.0,5/6,28.73%,RMI2;MSH6;AXIN2;MSH2;TCF7L2
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.6019968139829646,-0.9267099875515992,0.5869565217391305,1.0,1.0,2/6,8.79%,RYR1;SELENON
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.3971358881310203,-0.9266152045263848,0.5,1.0,1.0,10/39,13.46%,RBP4;ASCL1;ECE1;SIPA1L3;TGFB2;PBX4;SMG9;SMOC1;CHRDL1;PAX6
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.4317433523755426,0.9264811590935871,0.5614035087719298,1.0,1.0,14/40,22.15%,ITPR1;AGT;FKBP1B;CASQ1;NPR2;KCNJ11;CORIN;ATP1B1;TRDN;ATP1A1;ABCC9;ATP2B4;ATP2A2;RYR2
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.4920687559759267,0.926455055982284,0.5909090909090909,1.0,1.0,8/20,34.29%,ENO4;ENO2;RAB5A;SCARB2;RAB1B;LAPTM4B;PIKFYVE;TBC1D14
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.43786691233133146,0.9263239556844732,0.5211267605633803,1.0,1.0,16/44,28.89%,PREX1;WASF1;WAS;GHRL;DIAPH3;ENAH;TWF2;TWF1;CFL2;VILL;ABI2;WDR1;WASL;ARHGAP6;CORO7;CFL1
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.38748963410555276,0.9262144222269456,0.6486486486486487,1.0,1.0,19/112,14.81%,TIMP3;GLI3;TYR;HSPG2;POSTN;AHR;LOXL2;ANGPTL2;OSMR;SRPX;DOCK1;SYNC;EPAS1;MITF;EPS8;MLANA;FN1;SRPX2;FILIP1L
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.5849690962060692,0.9261699662634852,0.6851851851851852,1.0,1.0,1/10,6.00%,SLC24A4
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.494496041460772,-0.926155182130217,0.5454545454545454,1.0,1.0,2/14,6.90%,UBASH3B;IL11
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.5779534199648018,-0.926090632556051,0.56,1.0,1.0,2/8,9.92%,LYPLA2;ABHD17A
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.5779534199648018,-0.926090632556051,0.56,1.0,1.0,2/8,9.92%,LYPLA2;ABHD17A
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.45739372259359934,-0.9260223524975495,0.5675675675675675,1.0,1.0,3/25,4.78%,SULF2;LRRC17;SLC10A7
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.46963487850216334,0.9260007394742646,0.5633802816901409,1.0,1.0,4/21,14.06%,TDG;DUSP9;RACGAP1;SCX
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.5617516599491512,0.9257519990396553,0.5849056603773585,1.0,1.0,3/5,35.52%,DOC2B;C2CD5;SNCA
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.5665712626670782,-0.9257364575318224,0.5348837209302325,1.0,1.0,3/9,12.03%,CBARP;DRD4;GPR35
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.41325721282219174,-0.925681326447352,0.4827586206896552,1.0,1.0,1/23,1.05%,TBX6
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.5397105845889008,-0.9255771601163079,0.59375,1.0,1.0,1/8,9.24%,TAF1
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),0.5654141650197271,0.9253522061218257,0.5645161290322581,1.0,1.0,1/6,11.04%,PLAAT5
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.6043402987878944,0.9252873027586274,0.6491228070175439,1.0,1.0,1/6,9.67%,STAP1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.5594164095623263,0.9251743695023196,0.6290322580645161,1.0,1.0,1/11,8.10%,PHF23
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.4501546316238444,-0.9249836307151823,0.625,1.0,1.0,7/23,20.36%,SMYD2;SUV39H2;EEF1AKMT1;EHMT2;KMT5A;EHMT1;SETD2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.4425297215802986,-0.9248759906847162,0.525,1.0,1.0,2/18,6.35%,BCL2A1;BCL2
prerank,MSigDB_Hallmark_2020__Hypoxia,0.3724467350443417,0.9245745525646434,0.6891891891891891,1.0,1.0,19/165,10.82%,CA12;CCNG2;GLRX;ACKR3;CP;ISG20;PLAC8;PHKG1;KDM3A;HSPA5;PPARGC1A;NFIL3;SRPX;CDKN1B;SLC2A1;ALDOB;LXN;PLAUR;FOSL2
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.6247135721151539,0.9242932010801942,0.6538461538461539,1.0,1.0,2/6,18.14%,PLCG2;CX3CR1
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.5724953043710607,-0.9242796427324826,0.5909090909090909,1.0,1.0,2/5,16.06%,BEND3;KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.5724953043710607,-0.9242796427324826,0.5909090909090909,1.0,1.0,2/5,16.06%,BEND3;KMT5B
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.5293314276931433,0.9242375015394215,0.609375,1.0,1.0,5/13,28.06%,PPARGC1A;CYB561;ETFB;ETFA;ENOX2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.5717635068292928,0.9241721747487587,0.5689655172413793,1.0,1.0,1/9,7.04%,BNIP3
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.556879727205936,-0.9241151713597616,0.6,1.0,1.0,1/7,4.14%,SFRP1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.4364765272543251,-0.9238599653547794,0.48717948717948717,1.0,1.0,6/20,19.10%,BRF2;ZNF76;RPTOR;ZNF345;ICE1;MTOR
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.5924682388424755,0.9238302129684247,0.6212121212121212,1.0,1.0,1/6,4.14%,NOX1
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.4413381242036137,0.923763224924958,0.5245901639344263,1.0,1.0,10/34,18.81%,HCK;DOCK2;IL15;PTPRC;TUB;SPHK1;PLSCR1;TLR2;SFTPD;CALR
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.314087919763565,-0.9236693823011122,0.6923076923076923,1.0,1.0,56/684,8.04%,ETV1;ETV5;MYB;STING1;LEF1;TOX2;F2RL1;SSBP3;PID1;CDH13;GREM1;RUNX1;CREB3L4;E2F5;NFATC1;MAML3;SOX12;ASCL1;GABPB2;ATOH8;FOS;ZNF462;HDAC5;PRDM15;IGF1;NRL;ZMIZ2;TRIAP1;APLN;NFIB;WWTR1;FIZ1;ADIRF;MAML1;ITGA6;RRP1B;MED30;HIVEP1;HDAC1;ZBED3;ZNF300;ZFHX3;TFDP1;MAPK7;ATF3;SERPINF2;ETS1;BMP6;IL11;SBNO2;TGFB2;NFIX;E4F1;INO80;STAT3;NR1H4
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.4327421812335146,-0.9235752488073632,0.5128205128205128,1.0,1.0,4/27,5.26%,LEF1;SOX12;PNP;BCL6
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.5144056256409086,0.923498755308909,0.6612903225806451,1.0,1.0,2/16,13.52%,GOT1;ASPA
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.562092452835515,-0.923464670238244,0.5348837209302325,1.0,1.0,3/11,9.89%,AZU1;DGKD;DGKH
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.39430027510121524,0.9231613952146211,0.6197183098591549,1.0,1.0,15/125,6.64%,NES;RDH10;TIMP3;LRP4;RLBP1;POSTN;PLP1;SCN4B;CNR2;DAPL1;ANGPTL2;AGT;PLSCR4;IGFBP5;CPE
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.40451376053602267,0.9229371599257202,0.6567164179104478,1.0,1.0,9/56,12.47%,ZDHHC22;HHAT;PIGC;ZDHHC6;PGAP4;PIGH;PIGV;PGAP3;MPPE1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.37659924864183353,-0.9228666941362339,0.5,1.0,1.0,15/64,14.39%,SULF2;SPRY4;GREM1;LEMD2;APLN;CRIM1;SPRY3;CREB3L1;VWC2;SORL1;NOG;NBL1;SPRY1;PTPN1;BMPER
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.5693645654067657,-0.922827723079226,0.6060606060606061,1.0,1.0,3/9,10.76%,ASCL1;UNC5C;NRP1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.40302149856896546,-0.9228230623012122,0.7027027027027027,1.0,1.0,11/54,15.03%,BMP7;RING1;TFDP1;E2F6;KIF25;RRM2;PCGF6;EHMT2;TOM1L2;UXT;AURKAIP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.5718625203333423,-0.922763660597802,0.627906976744186,1.0,1.0,1/6,5.82%,SPHK2
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.5325407772725052,-0.9227601363290051,0.6052631578947368,1.0,1.0,4/8,33.44%,ETF1;OGFOD1;JMJD4;SHFL
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.40862544612064744,-0.9225939288166939,0.5769230769230769,1.0,1.0,1/25,1.05%,TBX6
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.5368861939185006,-0.9225719658758,0.6511627906976745,1.0,1.0,1/8,0.83%,HOMER2
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.35063599862308836,-0.922476568592775,0.6666666666666666,1.0,1.0,17/79,20.02%,MRPL17;MRPL58;MRPL33;MRPS18A;MRPL21;MRPL39;MRPL55;DAP3;MRPL48;MRPL4;AURKAIP1;MRPL9;MRPS7;MTRF1L;MRPL37;MRPS27;MRPL40
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.36183175985565985,-0.922293084879581,0.5925925925925926,1.0,1.0,20/135,11.00%,KIT;ADGRA3;ITGA4;LEF1;SPRY4;RND3;TEAD2;PRDM5;KITLG;SFRP1;ITGA6;LRIG3;STAT3;FRAS1;FBXO15;ANO6;COL4A2;FAT1;NACC1;CDH1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.5683510823715172,-0.922091743635431,0.5813953488372093,1.0,1.0,2/7,15.00%,HMGA2;HSF1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.48595611718130743,-0.9218008958886847,0.6285714285714286,1.0,1.0,1/12,2.73%,SOX12
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.3951647908031949,0.9215488937325683,0.6266666666666667,1.0,1.0,10/68,15.55%,SLC30A8;CP;SLC39A12;FRRS1;ATP6AP1;SLC31A1;ABCG2;HJV;NUBP1;SLC40A1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.3589190885323084,0.9215224453239377,0.65,1.0,1.0,29/227,11.79%,NOX5;ITK;POLR3K;AGER;IL18R1;CD4;ZBTB7B;ELANE;IL15;NOX1;CYP1B1;PTPRC;AGT;TWIST1;ZFPM1;FADD;CD14;HHLA2;HLA-A;IL7;PLCG2;CD6;SCIMP;TGFB1;BRCA1;IRF1;STAT6;MRE11;RIPK2
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.47675913012194204,0.9214594243625986,0.5666666666666667,1.0,1.0,4/23,9.27%,ABCC2;PRAF2;SLC25A18;SLC26A7
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),-0.5813289365105869,-0.9214337202774102,0.6530612244897959,1.0,1.0,2/6,7.09%,IL11;TGFB2
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.3516531100947558,-0.9212323142839088,0.6666666666666666,1.0,1.0,13/97,8.04%,STING1;LEF1;PTPN9;PID1;IL1RL2;KHSRP;SFRP1;PTPN23;EMD;MAPK7;DCPS;STAT3;NR1H4
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.5021009178983576,0.9207066702774862,0.6140350877192983,1.0,1.0,3/18,7.12%,CAV3;NOTCH1;REST
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.4495244158602188,-0.9206642378262033,0.6,1.0,1.0,4/25,7.28%,KDR;HDAC5;RHOJ;CARD10
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.4436681363953756,0.920453373943522,0.589041095890411,1.0,1.0,2/27,8.81%,CTNNA1;FGFR2
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.5943011483258258,-0.9202412837532342,0.5869565217391305,1.0,1.0,1/5,2.93%,TYMS
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.39436406536985585,0.9200463225257021,0.6351351351351351,1.0,1.0,20/129,6.87%,LAMA2;MYLK;TIMP3;VASN;SLC38A11;SPON2;ACTA2;PDGFRB;IRAG1;POSTN;ACKR3;HHIP;FBLN5;ANGPTL2;NID2;ACTC1;PLSCR4;IGFBP5;PRXL2C;PRKG1
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.5136097420207452,0.919998412847681,0.5740740740740741,1.0,1.0,1/16,1.31%,PLA2G10
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.5222903146295732,-0.9199945170531884,0.6097560975609756,1.0,1.0,3/13,16.33%,TPR;DNMT1;SETDB1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.3925249337117809,-0.9198907359684346,0.6071428571428571,1.0,1.0,5/56,4.14%,CCL28;NPNT;CDH13;UTRN;SFRP1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.35475731969603175,-0.919711893085774,0.5555555555555556,1.0,1.0,9/88,6.90%,TPD52L1;F2RL1;RASSF2;TNFRSF19;SH3RF1;RASGRP1;TRAF3;SERPINF2;SH3RF3
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.4714245077569789,0.9195987759244518,0.6351351351351351,1.0,1.0,2/27,9.21%,AGER;GPER1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.34661727909221984,0.9193630158724858,0.6708860759493671,1.0,1.0,51/347,19.43%,TRIM58;TRIM22;TRIML2;TRIM54;TRIM5;ENC1;NEUROD2;ARIH2;RNF212B;C10ORF90;TRIM32;SYVN1;UFM1;EYA1;KLHL21;HLA-A;UHRF2;RNF152;RNF26;EPAS1;KIAA1586;BRCA1;RNF139;FBXL3;VCPIP1;PCNA;TRIM50;FBXO32;RNF138;HECW1;KLHL13;DERL1;RNF220;TRIM14;SPSB1;PINK1;DCUN1D1;TNFAIP1;HIF3A;NUP54;CUL2;PJA2;H2BC5;FBXO7;UBE2E1;MAGEF1;ATG3;RNF41;RNF187;RNF181;SPSB2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),-0.5844469082153788,-0.9191521036584627,0.5526315789473685,1.0,1.0,5/6,38.70%,PARD6A;APC;BICD1;CEP250;MARK4
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.5043071178369409,0.9189410949365848,0.5967741935483871,1.0,1.0,7/25,27.38%,RASIP1;RHOB;PODXL;RYR2;MESP1;SLIT2;SHH
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),-0.49816257073705317,-0.9187172341058434,0.6216216216216216,1.0,1.0,2/15,0.84%,SOX13;BMP7
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.6198332339687432,0.9181543005259947,0.65,1.0,1.0,2/5,8.29%,FADD;CASP8
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),-0.49663854046034817,-0.9172588606424474,0.5454545454545454,1.0,1.0,3/11,14.10%,IGF1;PPP1R3E;IRS1
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),-0.5902761929275632,-0.9171216619977559,0.6666666666666666,1.0,1.0,3/5,37.38%,PTEN;SHANK3;NLGN2
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),0.5982378130498092,0.9169319158027263,0.6481481481481481,1.0,1.0,2/5,16.33%,DRD3;PRKCG
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.4926348916765687,-0.9168989773294918,0.5789473684210527,1.0,1.0,5/14,17.59%,CCDC22;XIAP;COX19;ATP7B;COMMD1
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),0.5943771746035112,0.9168306316613809,0.6226415094339622,1.0,1.0,3/5,17.99%,DRD3;VPS35;LRRK2
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.38538435574548324,-0.9167659083194911,0.5555555555555556,1.0,1.0,11/51,12.29%,PRELID2;TRIAP1;PITPNC1;APOA1;ATP11C;ATP8B4;APOE;SCARB1;PITPNA;ABCC1;PITPNM1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.4483111991073694,-0.9164491188182403,0.6333333333333333,1.0,1.0,1/19,1.97%,CDC14B
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.4745459805313232,-0.9163643434632577,0.6511627906976745,1.0,1.0,2/17,4.55%,MYB;DDX60
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.6155195880962802,0.9160525003381024,0.6739130434782609,1.0,1.0,1/5,13.74%,CHDH
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.6407533773043714,0.9160462880496945,0.7037037037037037,1.0,1.0,2/5,24.70%,EMP2;FLOT1
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.4675930205426669,0.9157423093055386,0.6323529411764706,1.0,1.0,5/35,9.86%,PTGES;TRPA1;OPRK1;SCN9A;TMEM150C
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.45696582765386634,0.9156591766204386,0.5857142857142857,1.0,1.0,3/37,11.23%,CAV3;PSRC1;CDK5R1
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.3413557272800007,-0.9153013829922356,0.6,1.0,1.0,11/181,7.54%,RNF150;FBXL7;MYLIP;RNF126;PTTG1;CDC26;FEM1A;UBE2D4;AURKA;TRPC4AP;UBE2R2
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.3637252308282893,-0.9151833226725641,0.5,1.0,1.0,6/43,7.09%,MYB;F2RL1;EREG;POLR3D;SPHK2;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.4998705932165249,-0.9150770912376771,0.5813953488372093,1.0,1.0,1/10,1.38%,F2RL1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.5703656930776972,0.914520414953677,0.6,1.0,1.0,2/6,11.52%,STAT1;STAT5A
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.5703656930776972,0.914520414953677,0.6,1.0,1.0,2/6,11.52%,STAT1;STAT5A
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.5660588807749268,0.9141500453352015,0.6515151515151515,1.0,1.0,2/9,14.90%,NEUROD2;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4029984299045129,0.9140943978332369,0.589041095890411,1.0,1.0,8/71,6.99%,CALCR;MC4R;RXFP1;CALCB;HCK;SCTR;TSHR;ADRB1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3739726717410791,0.9139799046108142,0.68,1.0,1.0,29/174,17.40%,TRIM22;ROR1;TRIML2;CD4;TRIM5;TRIM32;CXXC5;CARD8;FADD;TRAF3IP2;CASP8;LITAF;STAT1;PLCG2;CARD19;RHOH;RIPK2;ESR1;NLRC3;HTR2B;ECT2;TRIM14;DAB2IP;TMEM101;PINK1;TAB2;CD74;TRIM25;IKBKE
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4404467879675286,-0.9136529732093776,0.5142857142857142,1.0,1.0,3/17,6.86%,ADAM19;SERPINF2;BMP6
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.39097524519597343,-0.9135809171612506,0.5714285714285714,1.0,1.0,12/56,17.39%,TRIAP1;TFDP1;PLK2;AURKA;CRADD;RFWD3;PIDD1;BTG2;PML;PLK3;ATM;PCBP4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.5654380333483505,0.912946917813232,0.6229508196721312,1.0,1.0,3/8,24.47%,PIK3CB;LYN;PIK3CD
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),-0.5339012939504822,-0.912849638342182,0.6046511627906976,1.0,1.0,4/8,34.28%,GALNT1;GALNT16;GALNT2;EOGT
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.520759443310228,0.9125878666459535,0.6,1.0,1.0,2/12,14.40%,YBX3;HNRNPA0
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.37204779159773127,-0.9125375071924995,0.5,1.0,1.0,10/68,10.96%,BMP7;SPRY4;RGS14;HEG1;TFAP4;PRKCD;SPRY3;APOE;SORL1;RGS2
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.39160856492705837,0.9124376592649004,0.5932203389830508,1.0,1.0,11/94,11.23%,CCNG2;CCND2;CDKN2D;CCNE1;CCNB3;CDKN1B;CCNE2;PPEF2;CDC25A;CDC6;CDK5R1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.4497299207816311,0.9121397509362789,0.5737704918032787,1.0,1.0,4/25,9.67%,FADD;CD160;HLA-A;STAP1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.4436374619556413,0.911896399596366,0.5909090909090909,1.0,1.0,5/28,16.30%,ADAMTS9;ITGA5;EPN1;SMAD1;CEMIP2
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.5227143705862749,-0.9117021136668636,0.5428571428571428,1.0,1.0,2/7,10.99%,NEK6;CDC23
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.5560782761043066,0.9115825041841067,0.6666666666666666,1.0,1.0,3/10,27.68%,TLR2;B2M;RPS27A
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.5516074948386851,-0.9113448603363213,0.5833333333333334,1.0,1.0,3/5,36.55%,WDR70;RNF20;CDK9
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.3861561244069149,-0.9113083561055799,0.6,1.0,1.0,3/43,4.15%,ATP6V0D2;MELTF;STEAP3
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),0.5960927629327084,0.9112350884173901,0.5892857142857143,1.0,1.0,2/5,30.47%,CACNA1G;CACNA1C
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.42345379819258155,-0.9111845099999673,0.4482758620689655,1.0,1.0,7/31,18.16%,TPR;TCIM;ANO1;BAG3;HSF1;VCP;HSPA1A
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.501066508562476,0.9110281977239574,0.5846153846153846,1.0,1.0,3/17,13.58%,SYVN1;HERPUD1;DERL1
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.4921215796633307,-0.910959122722256,0.6041666666666666,1.0,1.0,1/12,1.96%,RAD21L1
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.4921215796633307,-0.910959122722256,0.6041666666666666,1.0,1.0,1/12,1.96%,RAD21L1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.41757633115538784,-0.9109082817594983,0.5588235294117647,1.0,1.0,3/27,5.01%,ARID5A;SFRP1;GSTM3
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.375153959599996,0.9108491948991094,0.6901408450704225,1.0,1.0,12/152,7.70%,CA12;CALCR;PTGES;WFS1;FASN;TJP3;FKBP4;NXT1;MYOF;FKBP5;SLC2A1;ELOVL2
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.43641179966231264,0.9106993704464229,0.5970149253731343,1.0,1.0,4/47,5.91%,WFS1;SYVN1;VAPB;HSPA5
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.42386054565535436,0.9106437065256945,0.59375,1.0,1.0,4/53,6.14%,CAV3;PLSCR5;MYOF;PLSCR4
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.5117750805659458,0.9105312706058315,0.5555555555555556,1.0,1.0,6/12,24.33%,CHAC1;GAS1;CTSZ;LRRK2;PRNP;SERPINE1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.4414868814126926,-0.910516163499768,0.5,1.0,1.0,12/24,30.53%,MTMR8;MTMR9;PIP4P1;MTMR7;MTM1;INPP5B;INPP5J;SYNJ2;MTMR4;MTMR10;MTMR6;PTEN
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.486877514728162,0.9103681905434137,0.6166666666666667,1.0,1.0,2/23,5.91%,NOTCH1;HSPA5
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.3558560352602254,-0.9102458764778124,0.7142857142857143,1.0,1.0,4/81,3.33%,SPRED2;SPRED3;SPRED1;PMEPA1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.48029513233127435,0.9094376435377299,0.5833333333333334,1.0,1.0,2/19,4.03%,CCL5;MRAP
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.41231107212736956,-0.9094056846221109,0.6285714285714286,1.0,1.0,5/48,10.15%,HTR1F;DRD4;CHRM5;GNAT3;GPR37
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.37956819068102116,-0.9092893906342759,0.53125,1.0,1.0,7/69,7.09%,KIT;KDR;RUNX1;KITLG;SFRP1;TOX;TGFB2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.4402075857251133,0.9091921804356945,0.6470588235294118,1.0,1.0,13/32,21.43%,SLCO2B1;ABCC2;SLC10A1;GHRL;AQP9;SLC16A1;SLC10A5;SLC16A8;SLCO1A2;SLC51A;ABCG5;NCOA2;STARD5
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.6357046210777977,0.9090712588250285,0.6730769230769231,1.0,1.0,1/5,8.07%,ALDOB
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.44645313214602567,0.9090144714182178,0.6056338028169014,1.0,1.0,6/29,16.74%,PLSCR5;TMEM30A;PLSCR4;ABCB1;ABCB4;PLSCR1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.4212428997446573,0.9089206022243048,0.625,1.0,1.0,4/52,7.13%,CAV3;WFS1;SLC30A8;ADIPOR2
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.3796980696346141,0.9086044471236712,0.7571428571428571,1.0,1.0,12/110,13.84%,MCM2;GMNN;H3-3A;SPTY2D1;NAP1L2;PSMB6;H2BC18;CDC6;RPA3;PSMA3;PSMB8;ORC4
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.35638291496680946,0.9085025551523441,0.6582278481012658,1.0,1.0,24/170,17.99%,P2RY1;AGER;CD4;CCND2;RARRES2;TBX1;FAM20A;VEGFC;HGF;GPER1;FAS;TGFB1;PLAUR;CDK2AP1;FAXDC2;LIMCH1;NPTN;CHRNA7;PINK1;FXR1;CD74;TNIK;MUSK;LRRK2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.3702338953916048,0.9084821842368973,0.6835443037974683,1.0,1.0,6/150,4.73%,NPY;AGER;NTF3;PLP1;OMG;UNC5A
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.6078288368899392,0.9083167889037111,0.5636363636363636,1.0,1.0,1/6,0.46%,TEX101
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.4543222902766757,0.9081239062313871,0.5806451612903226,1.0,1.0,2/22,9.88%,PPARGC1A;SDHAF3
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.3680510376751431,0.9077476051715851,0.6103896103896104,1.0,1.0,32/146,18.75%,TIMP3;SYT2;F8;SYT4;KNG1;LAMP2;RARRES2;GTPBP2;CDC37L1;SYNGR2;FAM3C;VEGFC;HGF;VWF;TMEM79;TGFB1;TUBA4A;SYTL4;A2M;SYT9;PCDH7;FN1;SYT15;TTN;OTOF;PSAP;CRHBP;STEAP2;SYT13;TF;CD109;ITIH4
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.3848501415653497,0.9077273260955024,0.6533333333333333,1.0,1.0,12/99,9.82%,CALCR;AMBP;MC4R;RXFP1;CALCB;HCK;SCTR;TSHR;ADRB1;PCBP2;RNF26;PLCG2
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.5427248509328155,0.9075094043821662,0.543859649122807,1.0,1.0,3/8,23.63%,STAT5A;SHC1;SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.5427248509328155,0.9075094043821662,0.543859649122807,1.0,1.0,3/8,23.63%,STAT5A;SHC1;SYK
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),0.6256805787151068,0.9072525301402298,0.6551724137931034,1.0,1.0,1/5,19.13%,SLBP
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.4480352156051875,-0.907232200404227,0.6571428571428571,1.0,1.0,8/25,21.29%,POLR2G;GTF2F1;POLR2C;POLR2L;NELFA;MDFIC;CCNT1;NELFE
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.382608639068172,-0.9072068255868692,0.5925925925925926,1.0,1.0,2/44,0.85%,TPD52L1;BCL2L11
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.5102070086619293,-0.9070353477186058,0.5897435897435898,1.0,1.0,1/12,2.80%,IDH2
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),-0.5903723381226462,-0.9069381070356249,0.6326530612244898,1.0,1.0,2/5,2.53%,ALKBH2;ALKBH3
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5093124717775873,0.9068961137953563,0.6129032258064516,1.0,1.0,4/12,21.88%,NOTCH1;TGFB1;SNAI2;NOTCH2
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.4512111833601154,0.9065229793101948,0.6031746031746031,1.0,1.0,15/28,31.54%,WAS;BRK1;ACTR2;DMTN;ACTR3;MSTN;TWF2;TWF1;CYFIP1;CDC42;ABI2;SLIT2;ABI3;NCKAP1;RAC1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.4236733804382116,-0.9063660809953228,0.5476190476190477,1.0,1.0,1/32,0.92%,STING1
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.5547900572479797,0.9061820193232627,0.6268656716417911,1.0,1.0,1/11,2.31%,RP1
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.4377579981909362,-0.9060948598588795,0.5555555555555556,1.0,1.0,3/19,13.52%,WTIP;MOV10L1;NRDE2
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.37454768680629147,-0.9060734757408744,0.45714285714285713,1.0,1.0,8/33,19.15%,UNC13B;UNC13C;SNAP29;PIP5K1C;STX4;UNC13A;RIMS1;SNPH
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,0.44554912837572463,0.9060603812918268,0.5636363636363636,1.0,1.0,3/25,1.97%,GNLY;SPON2;CCL5
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.49373994107614605,0.9060214847087111,0.5689655172413793,1.0,1.0,6/16,22.11%,NAIF1;BNIP3;SLC25A31;BCL2L1;BAD;SLC25A4
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.5879055931811925,0.9058997272108003,0.6129032258064516,1.0,1.0,1/8,8.03%,CCDC39
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.39429255030827337,0.9058647948886097,0.6666666666666666,1.0,1.0,13/61,19.83%,H3-3A;POLE3;SPTY2D1;SMARCE1;H1-2;NAP1L2;H2BC18;ACTR6;SRCAP;H2BC5;CHAF1A;GRWD1;H1-0
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.5051908049409081,0.90546879984881,0.6363636363636364,1.0,1.0,5/14,18.80%,FADD;CASP8;RIPK2;LGMN;BAD
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.45143553853535057,0.9054250676611452,0.640625,1.0,1.0,12/31,24.33%,FADD;CASP8;TMBIM1;FAS;BRCA1;TMC8;BCL2L1;SP100;MADD;FEM1B;DDX3X;SERPINE1
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.5793346418901291,0.9052483141032022,0.5967741935483871,1.0,1.0,3/7,24.58%,UBR5;YAP1;UBE3A
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.5833451128230999,0.9047198591856975,0.6229508196721312,1.0,1.0,1/7,4.82%,P2RY12
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.478128574655161,0.9045949211152211,0.6153846153846154,1.0,1.0,2/15,2.22%,CAV3;KCNE2
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4861414068397272,-0.9042987017195675,0.5918367346938775,1.0,1.0,2/14,4.08%,IGF1;TRIAP1
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.5253473937312145,-0.9042011403583509,0.6097560975609756,1.0,1.0,1/6,0.87%,PAH
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.5439700111650722,0.9041808262302101,0.6716417910447762,1.0,1.0,6/12,22.26%,MSX1;SMAD1;CACNA1G;HCN4;NOTCH2;GJA1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.5199693383651774,0.9041208721587926,0.5932203389830508,1.0,1.0,4/14,17.49%,IL7;RHOH;CD27;PPP2R3C
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.4218595619414193,0.9040739876909595,0.676056338028169,1.0,1.0,7/50,7.53%,IL18R1;INHBA;ZFPM1;FADD;PDCD1LG2;CD14;HLA-A
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.3477543892870686,-0.9038236423926197,0.6428571428571429,1.0,1.0,12/105,8.53%,CNGA3;RIMBP2;PTPRT;KCNIP1;GLP1R;CACNA2D1;ID4;POU3F4;SST;ARX;TMEM196;RAB3C
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.5074012386097962,0.9037703550107143,0.6071428571428571,1.0,1.0,5/14,20.04%,NOTCH1;REST;TLR2;B2M;SLIT1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.3461883778787116,-0.9035192488382887,0.6451612903225806,1.0,1.0,8/59,9.08%,IQGAP2;EPHA3;RND3;RHOBTB1;EPHA5;PRKCD;RHOBTB2;PEAK3
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.5593277877652778,0.903138593370443,0.6349206349206349,1.0,1.0,3/8,18.44%,SLC2A1;SLC5A2;SORT1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.6044268215586573,0.903031220645859,0.7457627118644068,1.0,1.0,1/7,8.10%,PHF23
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),-0.554264937261479,-0.9029541311600027,0.6046511627906976,1.0,1.0,2/8,12.43%,SPX;SLC27A2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.5274984457169274,0.9027117789471097,0.6825396825396826,1.0,1.0,1/14,1.33%,CAV3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.42624716260626855,0.9025432406720187,0.6764705882352942,1.0,1.0,12/40,19.86%,BOK;DAPK2;BCAP31;SIAH1;BCL2L2;PLAUR;HERPUD1;PINK1;BCL2L1;BAD;RTKN2;CYLD
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.35192220075451613,-0.9021953145941758,0.6785714285714286,1.0,1.0,8/105,6.33%,NPNT;LAMB2;UNC5B;UNC13B;MYH14;SDC4;OGDH;CDC42BPB
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.5655503075696221,0.9021551526010436,0.7,1.0,1.0,1/10,4.27%,ADGRB1
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.37526150902869715,0.9018817107822003,0.6470588235294118,1.0,1.0,26/102,19.41%,NEUROD2;SYT2;SYT4;CDKN1B;BNIP3;CPNE5;PLCG2;CAMK2D;ECT2;LGMN;SYT9;SYT15;GLRA1;ITPKB;HVCN1;CRHBP;SYT13;DMTN;B2M;LRRK2;MCOLN1;TF;ADGRV1;CACNA1H;MEF2A;MT1M
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.542193237676391,0.9014787657601592,0.5909090909090909,1.0,1.0,5/10,24.02%,DNAJA1;PDCD4;GSTP1;AIDA;DUSP19
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.5086399078500858,0.9014719772708999,0.6333333333333333,1.0,1.0,2/13,13.46%,ITGA5;SMAD1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.4889375688909475,0.9014009950784095,0.7285714285714285,1.0,1.0,3/24,11.23%,CAV3;PSRC1;CDK5R1
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.48064696906961,0.9012578293198622,0.6363636363636364,1.0,1.0,2/18,7.67%,NCBP1;NCBP2
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.3907713514309643,0.9011741198150858,0.65625,1.0,1.0,25/121,18.00%,P2RY1;ZNF703;CCL5;CTNNA1;SSTR1;CYP1B1;AHR;P2RY12;IGFBP5;GPER1;TGFB1;BRCA1;ESR1;AQP9;ABCB4;SPP1;KCNQ1;TIPARP;INSIG1;CRHBP;MSN;ATP1A1;DMTN;LRRK2;IL18
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.4293882169698365,0.9011419053884784,0.5714285714285714,1.0,1.0,9/46,19.57%,PDGFRB;PLCH1;PLCD3;PLCL1;PIK3C2G;PTAFR;INPP5F;PLCD1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.5037256102321541,0.9010775937975695,0.5833333333333334,1.0,1.0,1/14,2.72%,PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3769796094802979,0.9009942935403314,0.6617647058823529,1.0,1.0,16/111,10.21%,CALCR;P2RY1;ROR1;AGER;CD4;CCL5;PDGFRB;ACKR3;NOTCH1;PTPRC;PRXL2C;ATP6AP1;FGFR2;GPER1;SCIMP;TGFB1
prerank,PanglaoDB_Augmented_2021__Decidual Cells,0.49540880400493303,0.9007395192829967,0.5454545454545454,1.0,1.0,3/16,3.32%,GNLY;CCL5;CD8A
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.4119517050596724,-0.9007336694354563,0.6410256410256411,1.0,1.0,8/28,17.21%,PNKP;SHLD1;USP51;HMGA2;SIRT7;HSF1;KMT5B;DTX3L
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.39585278164308324,-0.9004819036431929,0.6060606060606061,1.0,1.0,8/41,14.59%,TPR;EMD;PRKCD;CDH1;DMAP1;NRDE2;BAG3;MAVS
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.4484011924237036,0.900370167067029,0.6451612903225806,1.0,1.0,7/33,13.25%,ITK;PDGFRB;NTF3;P2RY12;AVPR1A;ESR1;HTR2B
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.5221455532822775,0.9003475709917353,0.6721311475409836,1.0,1.0,3/11,23.03%,CCP110;TCHP;YAP1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.38300895870852897,0.9001096812002314,0.6052631578947368,1.0,1.0,7/116,6.64%,NES;LRP4;GPC6;CHST1;ANGPTL2;IGFBP5;CPE
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.483365765244391,-0.8998489092844911,0.5454545454545454,1.0,1.0,3/12,13.52%,TPR;IWS1;NRDE2
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),-0.5156636311708952,-0.8998138788981882,0.6170212765957447,1.0,1.0,1/6,11.83%,MDK
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.42593861004607975,-0.8997458509375298,0.6216216216216216,1.0,1.0,3/29,7.46%,GREM1;NVL;PNKP
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.4811574842364239,0.8997163983248334,0.6567164179104478,1.0,1.0,3/29,13.49%,TDG;TLE6;RACGAP1
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5358288431153021,0.8997129085782566,0.711864406779661,1.0,1.0,4/14,17.47%,KCNE2;KCNQ1;ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.5218080741493798,0.8997089093367996,0.5806451612903226,1.0,1.0,3/12,10.21%,NOTCH1;PTPRZ1;TGFB1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),-0.5556234610287304,-0.8996948855954655,0.6153846153846154,1.0,1.0,4/8,28.94%,CPNE7;CPNE6;CPNE1;AGK
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.6065477240098899,0.8996877888014608,0.6785714285714286,1.0,1.0,1/5,17.99%,LRRK2
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.41041868656868474,0.8996386565304391,0.6805555555555556,1.0,1.0,13/53,18.80%,PTGIS;TWIST1;SUV39H1;BNIP3;NDNF;EPAS1;OPRD1;TBL2;AK4;PINK1;RGCC;ACAA2;BAD
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.4120835211513011,-0.8996374901909654,0.6153846153846154,1.0,1.0,2/35,1.80%,KIT;CDH13
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.47507615136470227,-0.8996005928136174,0.5365853658536586,1.0,1.0,2/12,4.61%,ABCC4;SLC19A1
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.4732144786310458,0.8995089805840342,0.6607142857142857,1.0,1.0,1/17,0.62%,CSRP3
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.5377951213383093,0.8993583301040406,0.6527777777777778,1.0,1.0,1/9,0.65%,NES
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.4205719348039002,-0.899045058155055,0.4864864864864865,1.0,1.0,7/28,9.98%,TYMS;ORC1;TFDP1;ID2;DHFR;CDK14;RRM2
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.486851164093537,-0.8990403455122575,0.6190476190476191,1.0,1.0,1/15,0.85%,BCL2L11
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.39873278468381224,0.8986148523819565,0.6301369863013698,1.0,1.0,9/68,6.45%,LAMA2;MYLK;TIMP3;ACTA2;PDGFRB;POSTN;ANGPTL2;RARRES2;IGFBP5
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.39057498621630315,-0.8984362760140937,0.4583333333333333,1.0,1.0,5/46,11.27%,LEF1;BRCA2;JADE2;DMAP1;BEND3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.4896952447341578,0.898406847019731,0.6307692307692307,1.0,1.0,1/14,0.86%,ITK
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.5657598117689404,-0.8983453249991565,0.66,1.0,1.0,3/5,23.11%,FOXP1;FGF1;RNF207
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.4839840639736666,-0.898201047891317,0.5434782608695652,1.0,1.0,3/12,18.73%,CCDC22;FAF1;NFKBIB
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.5279341040058596,0.8981460820078631,0.5970149253731343,1.0,1.0,4/15,8.29%,IL21R;PTPRC;NFIL3;CASP8
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.4027337531945416,-0.8980794441821215,0.5675675675675675,1.0,1.0,7/42,11.48%,ITGA4;IGF1;CACNA2D1;TIMELESS;CACNA1A;GRIN2A;ABCC1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.4129153643333544,0.8979336267922522,0.6111111111111112,1.0,1.0,9/53,18.60%,EIF5A2;ACOX2;ACOX1;AQP9;PNPLA1;ABCB4;ANGPTL3;SLC4A9;PPARG
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.37666221534964645,-0.8978374232222377,0.5769230769230769,1.0,1.0,19/67,12.13%,LAMB2;CA3;RND3;FHL2;LAMB3;AHNAK2;SDC4;WWTR1;MYH11;ANO1;LRIG3;CARD10;ALDH1A3;FERMT1;MME;COL4A2;LAMA3;PARVA;SH3RF2
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.4491355669488014,0.8977613117960994,0.6533333333333333,1.0,1.0,4/27,11.65%,TICRR;DONSON;BRCA1;MRE11
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.5087527082184352,0.8976493152039084,0.6153846153846154,1.0,1.0,1/10,1.97%,CCL5
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.3781996798719956,0.8974595267359563,0.6818181818181818,1.0,1.0,8/114,6.64%,NPY;ENPP2;MC4R;TRPA1;ASXL3;SYT4;SOWAHA;CPE
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.38218852571772743,0.8972839649337983,0.6521739130434783,1.0,1.0,19/93,18.15%,TEX101;DNAH3;TSKS;PHF13;GSG1;TAF7L;TSSK3;BRCA1;PLAAT5;BCL2L14;MRPL14;ACYP1;MEIOC;SPATA24;MEIG1;SLC25A31;GGNBP1;SMC1B;TSACC
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.4783986243704886,0.8970957403234701,0.5753424657534246,1.0,1.0,1/15,1.56%,GLI3
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.43064430539488574,0.8969406611979072,0.6119402985074627,1.0,1.0,1/36,2.75%,HCK
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.30610201205172594,-0.8966041985492236,0.9166666666666666,1.0,1.0,59/539,10.62%,ETV5;PER2;SOX13;MYB;TBX6;AASS;GFI1B;ARID5A;RUNX1;FHL2;ASCL1;PRDM5;ZNF239;SMYD2;HDAC5;TPR;NFIB;ID4;LYAR;RITA1;HIVEP1;BCL6;ZNF25;HDAC1;ZNF608;PTCH1;IGBP1;ZNF596;TRPS1;ZNF846;ZNF558;ZFHX3;ATF3;FOXP1;E2F6;BMP6;ID2;CBFB;NFIX;SPDEF;ZNF536;E4F1;STAT3;MACROH2A2;NR1H4;SUV39H2;ZBTB7A;TAF1;SIN3B;IFI16;ANKRD2;SMARCA4;SARS1;ZMYM5;MAFK;MXI1;NFX1;ZGLP1;PCGF1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.3714088165008496,-0.8964610274198396,0.5,1.0,1.0,10/71,5.66%,TAGLN;COL15A1;ADAMTS2;LAMA4;SVEP1;COL6A2;PCDH18;SGCD;PRRX1;ADAMTS5
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.45465051156879965,-0.8964317750177384,0.627906976744186,1.0,1.0,4/17,7.04%,BTC;EREG;IGF1;AURKA
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.5130718502758125,-0.8963089646343148,0.6666666666666666,1.0,1.0,2/10,16.72%,SLC25A33;TEFM
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.47252656661818937,-0.8962180987862883,0.5789473684210527,1.0,1.0,8/25,18.13%,KHSRP;SF3B4;PRPF4;TXNL4A;SRRM1;SCAF11;PRPF6;PRPF3
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.5088887218107937,0.896191741456122,0.625,1.0,1.0,3/13,8.95%,IFNLR1;PCBP2;RNF26
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.5949692296963563,0.8958026704478078,0.6730769230769231,1.0,1.0,2/6,31.76%,P4HA3;P4HA1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.4090469871815336,-0.8957813039272804,0.5365853658536586,1.0,1.0,7/41,17.32%,NUP210;TPR;NUP37;ZBTB7A;NUP42;NUP107;NUP43
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.6033311177402957,-0.8956833023014801,0.6666666666666666,1.0,1.0,3/5,34.17%,PRUNE2;BNIPL;PRUNE1
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.5053307620327312,-0.8956129757268131,0.5609756097560976,1.0,1.0,1/7,1.77%,PID1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.4049547635585439,0.8955896549990949,0.6172839506172839,1.0,1.0,13/56,20.15%,CCL5;PLA2G7;IL15;AGT;POLR3G;PDCD4;PLSCR1;TLR2;IL18;MAPK13;IFI35;NFKBIZ;GBP5
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.6183685887336545,0.8955723453043833,0.6896551724137931,1.0,1.0,1/5,12.12%,GHRL
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.5913460622881547,-0.8954274473043004,0.6744186046511628,1.0,1.0,1/5,4.58%,PTPN23
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5067349483444857,-0.8954184807606798,0.55,1.0,1.0,3/10,13.65%,CACNA2D1;BIN1;NOS1AP
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.3696831085096413,-0.8951530268696928,0.5681818181818182,1.0,1.0,11/49,17.50%,CCDC22;VPS53;EHD4;PTPN23;RAB7A;STX6;SNF8;ENTR1;DENND1A;RAB11FIP3;EIPR1
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.4044956932450136,0.8951105105094609,0.6617647058823529,1.0,1.0,18/67,16.12%,DNAH3;VWA2;FUT2;EXPH5;CCDC60;TFCP2L1;TEX26;ATP12A;MUC4;MYO5B;IL20RA;APOBEC4;DNAH7;MROH9;SHROOM3;CFAP65;ATP1B1;DNAI1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5814582143882254,0.8948108461251314,0.6666666666666666,1.0,1.0,2/8,13.17%,HECW1;CAMK2D
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.3379142826218664,-0.8947613342646354,0.7037037037037037,1.0,1.0,15/109,8.01%,SHC3;FBXL7;KCNIP1;PCDH19;DOK5;PDGFD;CACNA2D1;EFS;NTM;ID4;MARK1;SLC6A1;ZNF536;MAPK4;ADGRA1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.33915765038444856,-0.894454747448446,0.59375,1.0,1.0,15/125,10.18%,NRK;NOX4;RASSF2;EREG;AZU1;PRKCD;TGFB2;MAP2K3;INCENP;MMD2;XRCC6;LRP8;LCP2;TELO2;SYAP1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.50860249026398,-0.8943682524142093,0.6857142857142857,1.0,1.0,3/8,37.38%,PTEN;SHANK3;NLGN2
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.3710618370048516,-0.8943680612462225,0.6666666666666666,1.0,1.0,16/80,15.11%,TRPC3;TRPC7;CACNA2D1;MCUB;CACNA1A;TRPC4AP;ANO6;GRIN2A;SLC35G1;TRPC5;GRIN2C;MICU1;MICU2;MCUR1;SLC8A3;SLC24A3
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.3945334261471297,-0.8942825191283779,0.5714285714285714,1.0,1.0,5/40,10.58%,SH3RF1;TRIAP1;IGBP1;XIAP;NGF
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.43405884758049196,-0.8942193221378466,0.6410256410256411,1.0,1.0,5/23,7.68%,RAB7B;F2RL1;TICAM1;GRAMD4;TYRO3
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.5094250122938623,-0.8940469732245787,0.5909090909090909,1.0,1.0,1/9,1.91%,GUCY2C
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.49133236863863355,-0.8939558843474866,0.6097560975609756,1.0,1.0,2/12,15.40%,ETS1;PML
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.4667729168159139,-0.893910205902259,0.6304347826086957,1.0,1.0,8/23,19.31%,HDAC5;HDAC1;LYPLA2;ABHD17A;SIRT2;SIRT7;SIN3A;HDAC10
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.5626206103330816,0.8938487359750269,0.676923076923077,1.0,1.0,4/6,27.49%,USP50;GBP5;DDX3X;CD36
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.6063039033621318,0.8938054097765108,0.6349206349206349,1.0,1.0,1/5,27.37%,INPP5K
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.6063039033621318,0.8938054097765108,0.6349206349206349,1.0,1.0,1/5,27.37%,INPP5K
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.4103594632330075,0.8937748319597019,0.647887323943662,1.0,1.0,4/48,4.38%,TRIM5;CCL5;TRIM32;ISG20
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.5485425715266592,0.8936765830301128,0.6296296296296297,1.0,1.0,3/7,40.43%,FMR1;CPEB3;CPEB1
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),-0.5610556921090835,-0.8935666325275818,0.6744186046511628,1.0,1.0,1/5,8.04%,NR1H4
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.5212288405901351,0.8935512402684229,0.5967741935483871,1.0,1.0,6/11,34.38%,SORT1;LAMP1;LAPTM5;AP1G1;AP4M1;ANKFY1
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.49524862413548,0.8932710065068815,0.6666666666666666,1.0,1.0,2/13,10.00%,AGT;NDNF
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.37346480682706457,-0.8924831169741438,0.6756756756756757,1.0,1.0,8/48,8.75%,KIT;ITGA4;RABL3;HDAC5;TOX;IL11;JAG2;ZBTB7A
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.4703512151302566,0.8924157085922294,0.6346153846153846,1.0,1.0,3/14,11.25%,ALOX12;PRKG1;ADAMTS18
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.3944409310838814,0.8923599829516283,0.647887323943662,1.0,1.0,33/95,18.14%,MS4A6A;GPR68;FGL2;HCK;CD300LF;CD8A;HLA-DMA;PIK3R5;PLAC8;HLA-DMB;PTPRC;FLT3;PDCD1LG2;TAGAP;ARG1;CD14;HLA-A;MYO1F;SCIMP;AQP9;ADGRE1;IGSF6;CAMK2D;ETV6;PTAFR;LY86;BTLA;CD83;CD74;WDFY4;DPP4;NCF2;CX3CR1
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.4256538576746552,-0.8922147701296166,0.5128205128205128,1.0,1.0,7/31,15.56%,KRT16P6;LAMB3;TGM1;PERP;REL;SIRT7;MST1R
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.32061071230759997,-0.8920957922896877,0.782608695652174,1.0,1.0,19/166,11.71%,CDC14B;NEK6;ERCC2;KCNH5;CDC26;TFAP4;AURKA;ID2;HMMR;CDK5RAP2;INO80;MAPRE1;NEDD1;PCNT;ODF2;PCM1;TUBG1;CDC23;SIRT2
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.4385978614535383,-0.8920383326200653,0.65,1.0,1.0,2/16,5.83%,TYMS;POLL
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4783534655960835,0.8920343181584635,0.5535714285714286,1.0,1.0,2/15,7.53%,FADD;HLA-A
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),0.5373204071150881,0.8920006159602275,0.6349206349206349,1.0,1.0,3/10,22.24%,COPS2;COPS8;COPS5
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.5850303750873136,0.8918765196257534,0.6557377049180327,1.0,1.0,1/5,3.45%,ABCC2
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.3656265256943831,-0.8917459184256552,0.6086956521739131,1.0,1.0,15/112,15.06%,SAMD4A;PRR5L;KHSRP;PRKCD;HSPB1;ELAVL1;EIF4G1;IGF2BP3;EXOSC1;EXOSC7;EXOSC5;ZC3HAV1;SAMD4B;PNPT1;EXOSC4
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.5851707738867271,0.8917401832253758,0.6724137931034483,1.0,1.0,5/5,41.50%,MVD;MVK;IDI1;PMVK;IDI2
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.5693385349819023,0.8917097205865567,0.6607142857142857,1.0,1.0,2/6,22.71%,PAICS;GMPS
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.4498957821315715,-0.8916268559058143,0.5714285714285714,1.0,1.0,4/22,8.82%,COL15A1;F2RL1;GSTM3;COL18A1
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.48032123690458356,0.8915820440187149,0.7058823529411765,1.0,1.0,3/17,7.45%,FUT2;B3GALT1;ST8SIA6
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.5255911483009258,-0.8914961511705087,0.5714285714285714,1.0,1.0,2/7,9.66%,STAT3;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.5255911483009258,-0.8914961511705087,0.5714285714285714,1.0,1.0,2/7,9.66%,STAT3;EIF4G1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.3738651348599844,0.8911311621395209,0.6716417910447762,1.0,1.0,15/110,8.33%,C3AR1;KLRG1;BLNK;CCL5;GPR68;HSPG2;TBXA2R;NOX1;PTGER3;CIITA;CD14;TRAF3IP2;F11R;CMKLR1;SIGLEC1
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.5910481049533101,0.8911047387986128,0.625,1.0,1.0,2/6,20.44%,ADRB1;ADRA1D
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5608076417593841,0.8910729873003831,0.6785714285714286,1.0,1.0,2/8,16.98%,TGFB1;MYCN
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.393582706810847,-0.8910142599911459,0.5652173913043478,1.0,1.0,6/36,11.25%,SPTSSB;ST8SIA2;CERS4;SPTLC1;SGMS2;SMPD4
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.518388811190582,0.89094720026404,0.6885245901639344,1.0,1.0,3/13,15.62%,KCNE2;KCNG1;KCNE4
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.491586505710736,0.8906917301874906,0.65,1.0,1.0,3/17,10.17%,UROD;ATP5IF1;ABCG2
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.4479103322332751,0.8906418333655495,0.6818181818181818,1.0,1.0,1/26,1.29%,PTGIS
prerank,PanglaoDB_Augmented_2021__T Cells,0.39471071091337506,0.8905514496468084,0.6266666666666667,1.0,1.0,17/73,10.41%,GNLY;ITK;IL18R1;CD4;CCL5;CD8A;JUNB;PTPRC;FMNL1;ARHGAP9;GMFG;TAGAP;CD160;IFIT3;NOTCH3;CD6;RHOH
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.5159464508242173,-0.8905436534186585,0.6818181818181818,1.0,1.0,5/10,20.30%,PTPN23;SORL1;EIPR1;VPS11;PRKN
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.3806911255440613,0.8905124710692887,0.6857142857142857,1.0,1.0,14/69,17.88%,SCN4B;SCN9A;SLC24A4;ATP12A;SLC24A2;SLC24A1;SCN7A;SLC5A2;ATP1B1;SLC9A6;ATP1A1;KCNK1;SLC9A2;SLC9A7
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.4686855869081109,0.8904798776688226,0.5797101449275363,1.0,1.0,3/23,12.53%,SEMA3D;SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.44076533782914695,0.8903499573928784,0.6515151515151515,1.0,1.0,5/26,9.44%,CCL5;NOTCH1;CYP1B1;PTPRC;CRLF3
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.3680218105577248,0.8901988534280164,0.7435897435897436,1.0,1.0,15/142,12.04%,ITK;BTN2A2;CD4;BLNK;THEMIS2;PTPRC;FYB1;HHLA2;HLA-A;WAS;PSMB6;PLCG2;EIF2B5;RIPK2;PSMA3
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.5800269025081582,0.8901241411147439,0.7307692307692307,1.0,1.0,3/6,25.19%,CD27;CD74;MSH2
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.34081288759398554,-0.8901198328900979,0.6,1.0,1.0,12/115,9.57%,ALK;RUNX1;ERCC2;ASCL1;ATOH8;NRBP2;EPHA5;ID2;TGFB2;SPOCK1;TENM4;PBX4
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.5312197149722382,0.8900392998731136,0.6551724137931034,1.0,1.0,3/8,18.60%,TGFB1;ESR1;PPARG
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.5171391354964393,-0.8899246282217544,0.6470588235294118,1.0,1.0,3/13,13.86%,ECE1;TBC1D16;VAMP3
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.3656139763719078,-0.8896292718885409,0.6666666666666666,1.0,1.0,8/52,11.11%,PTPN9;MYLIP;PRAG1;RTN4R;SPOCK1;APOE;STMN2;PTPRS
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.3566161876365579,-0.88956332132586,0.52,1.0,1.0,13/106,7.20%,NPNT;LAMB2;BTC;RND3;PXDC1;SDC4;CLDN4;WWTR1;COL4A3;EGFL6;ANO1;PDPN;LRIG3
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.5634866654569516,0.889458333314422,0.6875,1.0,1.0,1/6,3.71%,NOTCH1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.4520226327077073,0.8892244555860659,0.640625,1.0,1.0,5/30,12.15%,CHST1;KHK;ALDOB;GHRL;KCNJ11
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),0.6128331396460718,0.8891714011009217,0.6792452830188679,1.0,1.0,3/5,15.93%,FAH;IL4I1;HPD
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.4756165509922191,0.8890014238194502,0.6363636363636364,1.0,1.0,4/27,10.41%,ADGRB1;DOCK1;ARHGAP25;RHOH
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.41985165755676773,0.8887491417525091,0.4727272727272727,1.0,1.0,4/30,8.08%,ZDHHC22;ZDHHC11;HHAT;ZDHHC6
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.40512045199068475,0.8887451398731008,0.6911764705882353,1.0,1.0,6/77,9.82%,ENPP2;RREB1;AGT;DOCK1;RHOB;PLCG2
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.5452461572820136,0.8887291034291978,0.6610169491525424,1.0,1.0,1/8,4.08%,BOK
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.6202261343738741,0.8886388818507511,0.6935483870967742,1.0,1.0,3/5,32.62%,TAF7;CTBP1;SPI1
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.5086289695431414,-0.888610477406342,0.6222222222222222,1.0,1.0,2/14,14.29%,ZNHIT6;BOP1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.4598934501722626,-0.8884124130987474,0.6190476190476191,1.0,1.0,6/16,12.85%,FABP5;SLC27A3;SLC22A9;APOE;GOT2;SLC25A17
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.48008341317189285,0.888246394154867,0.6507936507936508,1.0,1.0,3/12,19.53%,TRIM32;TRIM14;IFITM3
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.3981108995631698,-0.8880734173245868,0.5,1.0,1.0,8/27,11.35%,MAP3K20;HDAC1;PTCH1;ECE1;AFF3;TGFB2;MYH3;NOG
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),0.5564855319491888,0.8880323374188894,0.6666666666666666,1.0,1.0,1/7,10.16%,NANOG
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3686419590762408,0.8877811373855813,0.6455696202531646,1.0,1.0,22/114,24.64%,GPC5;SCEL;SFRP4;FGFR2;PSMB6;TGFB1;ATP6AP2;DAAM2;PSMA3;PSMB8;RNF220;LGR6;UBR5;LRRK2;DKK2;PPM1A;GPC3;PSMA5;SFRP2;DDX3X;TNKS2;AXIN2
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.4817285227407453,-0.8874452757268261,0.5227272727272727,1.0,1.0,1/11,0.85%,BCL2L11
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.36214608648244867,0.8874028807603409,0.7215189873417721,1.0,1.0,21/133,19.67%,RSPO2;GPC5;DEPDC1B;SCEL;SFRP4;FGFR2;PSMB6;RSPO3;TGFB1;ATP6AP2;DAAM2;PSMA3;PSMB8;RNF220;LGR6;UBR5;TLR2;LRRK2;DKK2;ATP6V1C2;WNT5B
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.4188592749392822,0.8873935729824081,0.5428571428571428,1.0,1.0,12/35,27.61%,DNAJB1;ALDOB;MYBPC3;ATP1B1;PLSCR1;MSH6;RYR2;VMP1;AHSA1;MSH2;UHRF1;GABARAPL2
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.5379028047936831,-0.8872759178509882,0.6363636363636364,1.0,1.0,4/10,18.34%,PCM1;CCDC68;CCDC120;HOOK3
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.43613225231680564,0.8871300711108027,0.5967741935483871,1.0,1.0,6/25,20.68%,CHMP4B;PHF23;TSC2;PINK1;LRRK2;SEC22B
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.3540823927233452,0.8867678323575116,0.6,1.0,1.0,16/135,12.39%,TMEM35A;CALCB;ASXL3;PLP1;SYT4;FKBP1B;CLGN;SCN9A;NKAIN2;CNTN2;NEFM;SCN7A;C11ORF87;PIEZO2;ATL1;CA10
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.39437710361618966,-0.8867583600888593,0.7037037037037037,1.0,1.0,6/32,16.87%,EPHA3;WNT9B;BRINP2;BRINP1;SETX;ATM
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.3833630133792221,-0.8864799670982116,0.4827586206896552,1.0,1.0,13/39,21.38%,MIEN1;PRKCD;TGFB3;RIPOR2;NRP1;MYO10;PLPPR5;CAPZB;ARHGAP44;NEURL1;TRPM2;PPP1R16B;FSCN1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4659373073760291,0.8863501752337446,0.6206896551724138,1.0,1.0,7/23,26.05%,KLHL15;DERL1;NGLY1;UGGT1;RNF185;CLPP;LONP1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.5304824061398067,0.8860887085024824,0.6363636363636364,1.0,1.0,6/13,18.60%,PRKG1;CDKN1B;SOD2;GPER1;PDCD4;PPARG
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.6012256954458866,0.8858413778661587,0.6379310344827587,1.0,1.0,3/5,35.82%,SLC11A2;SLC11A1;SLC39A8
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.6012256954458866,0.8858413778661587,0.6379310344827587,1.0,1.0,3/5,35.82%,SLC11A2;SLC11A1;SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.5356964233418327,0.8857893009121317,0.660377358490566,1.0,1.0,1/7,3.71%,NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.45907197320485793,0.8856579947226749,0.5882352941176471,1.0,1.0,9/19,29.75%,NOTCH1;SOX11;ACVR2B;ACVR2A;ZNF423;SMAD4;BMPR1B;SULF1;CRB2
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.4720938758341175,0.8855759369489515,0.6206896551724138,1.0,1.0,7/24,10.21%,NOTCH1;CPE;FGFR2;MYBPC3;SMAD7;SOX11;TGFB1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.4637907626194225,-0.8855554554983215,0.6136363636363636,1.0,1.0,5/18,19.87%,LEMD2;MACROH2A2;LRWD1;MACROH2A1;MCM9
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.4556166624697223,-0.8854801211274106,0.5294117647058824,1.0,1.0,5/13,22.72%,ATF3;HSF1;VCP;MKNK2;GSTO2
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.2966162739166855,-0.8852027551764058,1.0,1.0,1.0,52/441,10.04%,TRPC3;KDR;TBX6;NRG1;FGFR4;HMGN5;LEF1;BTC;SINHCAF;GREM1;PDGFD;TNFRSF11A;EREG;KITLG;IGF1;SFRP1;WWTR1;DBF4B;GRK5;LYAR;SLC25A33;CHTOP;HDAC1;AZU1;PRKCD;PTHLH;BCL2;ZFHX3;SERPINF2;NUMA1;TGM1;ETS1;PDPN;GCNT2;APOA1;BMP6;IL11;TGFB2;SHANK2;IL15RA;INO80;VIP;COLEC12;TENM4;PDGFRA;TGFB3;DNPH1;AKR1C3;SLFN11;EIF4G1;TET1;PDGFC
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.32568135854677,-0.8851741646804836,0.6521739130434783,1.0,1.0,24/146,15.31%,FGFR4;SAMD4A;SLC25A37;EREG;IGF1;PLIN5;APOA1;SLC6A9;PPP1R3E;ELAVL1;UPF3A;SCARB1;CHP1;SMOC2;ZEB2;CLU;ABCB10;CIRBP;NOS1AP;FAF1;IRS1;ZNF205;RBM3;EGFR
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.4068802531596538,-0.8850954861889248,0.7419354838709677,1.0,1.0,5/30,12.80%,RAB7B;ETS1;STAT3;HMGB2;ABCB10
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.4191709080853385,0.8850615531212404,0.6716417910447762,1.0,1.0,17/52,27.26%,BCAP31;BNIP3;TOMM22;MTX2;SLC25A31;BCL2L1;DNAJC19;FBXO7;BAD;TMEM14C;SLC25A4;TMEM14A;TOMM7;TOMM20;TIMM8B;TIMM22;SLC25A5
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.4540373857982242,-0.8849349576266096,0.5714285714285714,1.0,1.0,5/25,11.94%,VASH1;ATOH8;COL4A3;APOE;SCG2
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.41601110455253293,0.8849030090146651,0.684931506849315,1.0,1.0,6/44,16.44%,PLA2G10;INHBA;AGT;TGFB1;VPS35;METAP1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),0.5123547827838149,0.8847865734555115,0.6031746031746031,1.0,1.0,3/9,25.32%,STAP1;LBP;TNIP2
prerank,PanglaoDB_Augmented_2021__Nuocytes,0.4579445013842907,0.884397729544144,0.6153846153846154,1.0,1.0,5/28,6.97%,GNLY;ITK;PTPRC;TAGAP;ARG1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.5358175745661978,-0.8843833815786393,0.6,1.0,1.0,1/8,6.66%,FOXP1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.598971653725753,0.8840437129216857,0.7222222222222222,1.0,1.0,2/5,29.75%,PRNP;TNFSF4
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.5414340388327525,-0.8838668929651445,0.625,1.0,1.0,2/5,23.71%,NOXO1;NOXA1
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.36982349090480515,-0.8837210009359002,0.5862068965517241,1.0,1.0,2/57,7.04%,FBXL7;AURKA
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.5835026109173287,0.8836540135519753,0.6491228070175439,1.0,1.0,2/6,4.00%,TIMP3;TIMP2
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),-0.5077655663511079,-0.8836459637531239,0.6052631578947368,1.0,1.0,2/12,0.84%,SOX13;BMP7
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.6282751205570503,0.8834617618307326,0.7,1.0,1.0,1/5,9.70%,SMAD7
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.3753822718986742,-0.8827994177225723,0.6538461538461539,1.0,1.0,12/62,16.38%,SDK1;SHANK2;FGF13;CBLN4;DRD1;PCDHB4;CDH1;LRRTM3;FARP1;NLGN3;DNER;DBNL
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),-0.5546131385402139,-0.8826274970211913,0.6346153846153846,1.0,1.0,2/5,13.46%,BMP6;PAX6
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.4505450481951906,0.8826161310233664,0.6428571428571429,1.0,1.0,7/31,11.42%,ODAD4;NOTCH1;DNAH11;ODAD3;TBX1;CCDC39;ARL6
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.36829587111330225,0.8825656014055936,0.7142857142857143,1.0,1.0,11/105,12.66%,PTGIS;PLA2G10;WFS1;NLRP2B;CYP1B1;CARD8;SFRP4;CMKLR1;SMAD7;ESR1;NLRC3
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.36308877108246573,-0.8825142538338037,0.6363636363636364,1.0,1.0,8/55,9.21%,F2RL1;UNC13B;RBP4;IGF1;PTPN23;BMP6;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.3861725185464823,-0.8824114431272374,0.6111111111111112,1.0,1.0,5/41,4.48%,GXYLT2;ST6GALNAC2;ST3GAL3;ST3GAL1;GALNT10
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.33307068099473613,-0.8823751518533621,0.8,1.0,1.0,12/98,7.78%,KDR;PTPRT;KCNIP1;FREM1;EFS;SORCS1;NTM;ID4;SLC6A1;ZNF536;ALDH1A3;MAPK4
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.5837774092360609,0.8821769644829849,0.7068965517241379,1.0,1.0,2/5,19.90%,PINK1;NONO
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.5021576884193517,0.8821519265187394,0.7017543859649122,1.0,1.0,2/12,12.23%,UPB1;DPYS
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.40535032761242235,0.8820165936781392,0.7681159420289855,1.0,1.0,10/76,6.87%,LAMA2;MYLK;TIMP3;ACTA2;PDGFRB;POSTN;ANGPTL2;PLSCR4;IGFBP5;PRKG1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),0.5258788382278952,0.8817837929906318,0.6619718309859155,1.0,1.0,3/11,22.77%,STAT1;IFNGR2;SUMO1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.38608528205299997,-0.8815800802814351,0.6296296296296297,1.0,1.0,1/26,1.05%,TBX6
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4420153209132629,-0.8813877711641207,0.625,1.0,1.0,2/15,13.64%,POLR2G;BTG2
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),-0.5546551834724489,-0.8812252272847423,0.6904761904761905,1.0,1.0,1/5,8.56%,VIP
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.561276736012987,0.8811602294768495,0.6825396825396826,1.0,1.0,1/8,2.87%,GGTA1
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),0.5977396563952442,0.8811059271623471,0.6785714285714286,1.0,1.0,1/5,2.77%,ACOT4
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.3968753517137857,-0.8806661178611663,0.6818181818181818,1.0,1.0,7/27,18.96%,ERCC2;TIMELESS;SHLD1;PRDM7;KMT5B;HMCES;TP53BP1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.5028501801778337,0.8806658481878112,0.7068965517241379,1.0,1.0,2/11,12.23%,UPB1;DPYS
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.39189605495806223,-0.8804730503204944,0.5789473684210527,1.0,1.0,12/53,17.32%,NUP210;TPR;SLC25A33;SPHK2;NUP37;ZBTB7A;ABCD1;BEND3;NUP42;COX7A1;NUP107;NUP43
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.36789763000393527,-0.8799359375949757,0.6388888888888888,1.0,1.0,10/36,20.48%,DTX1;PTMA;POLR2G;POLR2C;POLR2L;FUBP3;POLR3A;NFKBIB;NR4A2;PPP5C
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.5525195288093576,0.8799057146157859,0.6461538461538462,1.0,1.0,3/7,21.38%,FGFR2;KLF9;SNAI2
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.5198333136897264,-0.8798229351622351,0.5454545454545454,1.0,1.0,2/9,5.75%,RBP4;VSIG1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.3900073359920398,-0.8796855285179161,0.6578947368421053,1.0,1.0,2/30,4.15%,ATP6V0D2;STEAP3
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.41657570785624914,-0.8796719380401004,0.5588235294117647,1.0,1.0,5/14,17.95%,MLYCD;APOA1;NR4A3;SLC45A3;NR1H2
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.5411072264066843,0.8791693771367527,0.6875,1.0,1.0,3/10,17.97%,ACOT4;IL4I1;GNPDA1
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),0.5744804636159697,0.8791145765084444,0.6923076923076923,1.0,1.0,4/6,28.91%,HIGD1C;COX7A2L;COX7A2;RAB5IF
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.37707711408347555,0.8791122136031823,0.647887323943662,1.0,1.0,26/95,18.24%,SLC12A7;CHRNB1;TRPA1;PLP2;CNGB1;KCNN4;SLC26A4;CNGB3;SLC24A4;SLC17A8;SLC24A2;SLC25A18;SLC26A7;SLC24A1;SLC36A1;CHRNB4;PIEZO2;PKD1L3;GLRA1;CHRNA7;CHRNA2;SLC9A6;SLC9A2;SLC9A7;MCOLN1;SLC1A3
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.3732537206730624,-0.8790997811728152,0.5789473684210527,1.0,1.0,12/62,14.06%,NUP210;TPR;WTIP;NUP37;STAT3;ELAVL1;POLR2G;EIF4G1;TRIM71;NUP42;POLR2C;POLR2L
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),0.5516752374493017,0.8789988926241028,0.7346938775510204,1.0,1.0,1/6,5.24%,SYT4
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.4557501958053261,0.8788547899063636,0.676923076923077,1.0,1.0,6/32,5.89%,CSRP3;MSX1;ADAMTS9;NOTCH1;ZFPM1;ACTC1
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.4055665721709953,-0.8788257302538282,0.6341463414634146,1.0,1.0,7/26,15.73%,NTNG1;NSMF;MDK;SEMA6A;PHACTR1;CTNNA2;NEXMIF
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5327769110749623,0.8783463597204685,0.75,1.0,1.0,2/10,2.07%,GLI3;ZBTB7B
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.4674302837868096,0.8783388136010464,0.6724137931034483,1.0,1.0,6/21,16.87%,CHMP4B;CHMP2B;CHMP1A;EML3;CHMP2A;GPSM2
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.3591079763955949,0.8782828897762853,0.7051282051282052,1.0,1.0,24/215,10.21%,ENPP2;MYLK;EPHA1;RREB1;ZNF703;SEMA3D;CCL5;SMIM22;PDGFRB;NOTCH1;NTF3;TRIM32;PTPRC;TCAF2;HSPA5;GAB1;RIPOR1;F10;SOD2;DOCK1;HGF;GPER1;PLCG2;TGFB1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.4298150116844216,-0.8782800423537956,0.6111111111111112,1.0,1.0,12/33,18.86%,ERCC2;TCOF1;GTF2H2;UBTF;TAF1;CCNH;POLR2L;POLR1A;TAF1D;POLR1G;GTF2H5;ERCC3
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.3726568934577505,0.8778982622656948,0.6282051282051282,1.0,1.0,16/119,10.18%,TIMP3;VASN;HSPG2;PRLR;BOK;MRO;AGT;EPHX1;PLSCR4;RARRES2;IGFBP5;F10;ACOX2;MAFB;EPAS1;FAS
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.3577401303476448,0.8778964671752543,0.7142857142857143,1.0,1.0,26/159,10.48%,LAMA2;MYLK;TIMP3;GADD45B;MSX1;ACTA2;PDGFRB;CTHRC1;POSTN;CRLF1;ITGA5;IL15;INHBA;LOXL2;FBLN5;ECM2;NID2;LAMA1;RGS4;BMP1;SFRP4;VEGFC;RHOB;FAS;TGFB1;PLAUR
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.4596665774195138,-0.8775175168874109,0.5853658536585366,1.0,1.0,2/13,4.61%,ABCC4;SLC19A1
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.4298835439262032,-0.8771952134359425,0.6571428571428571,1.0,1.0,1/12,3.85%,TPR
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.39493056604720633,-0.8770307454674421,0.71875,1.0,1.0,8/55,16.13%,LEF1;MED30;MED15;CBFB;CSF1R;HNF1A;MED27;CDK8
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.47177098151135066,0.8768511544392972,0.6612903225806451,1.0,1.0,5/17,9.44%,CCL5;PRLR;NOTCH1;CYP1B1;CRLF3
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.5995012613543051,-0.87680574698959,0.7954545454545454,1.0,1.0,3/5,39.19%,KIF5C;KIF3B;KIF17
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.5995012613543051,-0.87680574698959,0.7954545454545454,1.0,1.0,3/5,39.19%,KIF5C;KIF3B;KIF17
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.45533037036136587,-0.8763027935043151,0.6857142857142857,1.0,1.0,4/15,9.95%,GCH1;DRD4;TGFB2;DRD1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.5064542978117872,0.8761619179575778,0.603448275862069,1.0,1.0,2/12,10.77%,ADRB1;DRD3
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.4227844108689448,0.8757572920771008,0.6101694915254238,1.0,1.0,3/34,7.50%,LDLRAP1;NTF3;SFRP4
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.4168432651985029,-0.8757199669181518,0.6274509803921569,1.0,1.0,3/23,8.04%,EPHA5;ANO1;NR1H4
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.31765555238085647,-0.875501198724267,0.7692307692307693,1.0,1.0,52/199,18.92%,UBXN10;CDC14B;ARL13B;RILP;ABCC4;CFAP221;B9D1;EHD4;PTPN23;PDE6D;CFAP61;CFAP52;EXOC7;RAB3IP;SNAP29;PCNT;CEP83;ODF2;PCM1;FHDC1;TRAF3IP1;PTPDC1;TTC39C;CNGA4;PARVA;TTC36;RILPL1;TRAPPC14;MKS1;SCLT1;FAM161B;ATAT1;PIBF1;CFAP44;KIF24;CFAP70;TTC17;CFAP20;BBIP1;DZIP1L;TCTN1;WDR35;NUDCD3;CYS1;RAB11FIP3;RFX2;TMEM250;CLUAP1;NEK1;INTU;WDPCP;KIAA0586
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.5601310323132955,0.8754973473361707,0.6774193548387096,1.0,1.0,2/7,19.73%,ATP1B1;DLG1
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.4828560596698047,-0.8754681334479191,0.625,1.0,1.0,3/14,6.03%,EPHB2;MYO3A;POU3F4
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.36234719572244617,0.8752611255713892,0.6857142857142857,1.0,1.0,14/125,12.77%,NR1I3;HNF4G;NR2E3;NOTCH1;NR5A2;TEAD4;TBP;PPARGC1A;MAML2;NOTCH3;TAF7L;ESR1;DR1;MED7
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.3699361661937639,0.8752029693508036,0.676056338028169,1.0,1.0,18/84,15.71%,ZBTB7B;PRLR;FASN;PLAC8;PRKAB2;KDM3A;PPARGC1A;TSHR;ADRB1;ADIPOR2;CMKLR1;SCD;EPAS1;STAT6;GHRL;ACADL;DECR1;GADD45G
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.4059969576559244,-0.8751566646356566,0.6129032258064516,1.0,1.0,1/18,3.67%,CROCC
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.3512666183151969,0.8748802874356735,0.726027397260274,1.0,1.0,26/163,15.01%,ENPP2;PPP1R1B;ADAMTS4;PLP1;FASN;OMG;SOX10;GRM3;SLC39A12;SOWAHA;CNTN2;ANLN;FGFR2;TMEM235;TMEM178A;KCNJ9;OLIG2;GFAP;CA10;MOBP;TMEM63A;TTYH1;ASPA;NFE2L3;AMER2;ENPP6
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.39210018463612,0.8747812405413433,0.6617647058823529,1.0,1.0,3/50,6.99%,C4BPB;TRIM32;CDKN1B
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.4996136437053821,-0.8747032785362142,0.6,1.0,1.0,4/7,15.62%,FGGY;XYLB;DCXR;RPEL1
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.48665105803846137,0.8746425027154126,0.6567164179104478,1.0,1.0,4/17,10.47%,AMN;CBLIF;TCN2;PRSS3
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.48665105803846137,0.8746425027154126,0.6567164179104478,1.0,1.0,4/17,10.47%,AMN;CBLIF;TCN2;PRSS3
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.44456365029560296,0.8745037125858451,0.7076923076923077,1.0,1.0,7/23,28.07%,TCAF2;MIEF2;PDZK1;PRNP;MIEF1;CEMIP;TCAF1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.46439407671461025,0.8743592581287573,0.6481481481481481,1.0,1.0,1/21,1.97%,CCL5
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.37239607554013193,0.8740772892587343,0.7162162162162162,1.0,1.0,4/119,5.24%,NPY;SLC30A8;ASXL3;SYT4
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.491254403482163,0.8740438945434681,0.7192982456140351,1.0,1.0,3/18,15.07%,LOXL2;REST;NODAL
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.3732259997758028,0.873953212876962,0.6376811594202898,1.0,1.0,22/84,25.87%,WFS1;RCN3;SYVN1;HSPA5;RNF139;MAN1A1;HERPUD1;USP13;DERL1;CCDC47;TRIM25;UGGT1;MAN1B1;ERLIN1;JKAMP;HSP90B1;RNF185;UBQLN1;YOD1;TMUB1;PSMC6;MARCHF6
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.4080645410388829,-0.8738509626970384,0.6097560975609756,1.0,1.0,3/30,6.85%,PKP2;NKAIN3;RANGRF
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.3545648949196336,-0.8738391652528732,0.72,1.0,1.0,11/72,8.75%,KIT;HOMER2;MYH14;MYO3A;COL11A2;COL4A3;POU3F4;TSPEAR;LHFPL3;KCNE1;COL11A1
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),0.557987622681234,0.8737144887888587,0.6379310344827587,1.0,1.0,1/6,7.05%,TBX1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4465320380451512,0.8735369628842714,0.696969696969697,1.0,1.0,5/21,10.48%,BIK;MOAP1;BNIP3;GPER1;PLAUR
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.35123670332797063,-0.8735203606087935,0.6785714285714286,1.0,1.0,22/105,15.11%,SVOP;CACNG3;UNC13C;CATSPER2;TNR;RPH3A;CACNA1A;AP3B2;GNAT3;FGF13;GRIA4;GAD2;FRRS1L;DPP6;CABP1;SRRM4;CTNNA2;GRIA2;CNTNAP5;KCNJ6;CPNE6;XKR4
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.33008222042798896,-0.8734443365249279,0.7058823529411765,1.0,1.0,29/118,20.99%,MYB;HDAC5;HDAC1;HIRIP3;INO80;BAZ1B;SUV39H2;ZBTB7A;SMARCA4;KDM4B;HMGB2;PHF1;HMGA2;SMARCB1;BPTF;LRWD1;HMGN1;DDX11;SETDB1;PBRM1;HMGN2;PWWP3A;HDAC10;NPM2;EHMT1;SETD2;SAFB;HDAC11;TADA2A
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.4034521861345224,0.8733907091608818,0.6417910447761194,1.0,1.0,9/50,14.90%,ADAMTS9;ELANE;LAMP2;SIAH1;MANBA;CLPX;HSPA8;NGLY1;DAB2IP
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.5259744232976503,0.8732350039574065,0.6440677966101694,1.0,1.0,3/11,7.83%,MCM2;GINS2;MCMDC2
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.42706626673490017,-0.8727145423583011,0.6052631578947368,1.0,1.0,4/16,9.64%,ADAM19;KLK6;NCSTN;APOE
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.3481717586574332,-0.8726861407063018,0.6666666666666666,1.0,1.0,14/113,4.84%,FBXL7;PENK;SLC16A2;VAT1L;PCDH19;DOK5;PCDH18;CACNA2D1;EFS;SFRP1;NTM;ID4;VCAN;MARK1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.5360830847213941,0.8725457326953137,0.6764705882352942,1.0,1.0,3/11,26.99%,CYCS;UQCRB;UQCRHL
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.4548824479992233,0.8723945174669334,0.6774193548387096,1.0,1.0,1/25,5.29%,AMN
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.39767085099174754,0.8722049296193283,0.7424242424242424,1.0,1.0,12/75,12.78%,SPDYA;INHBA;CDKN2D;CCNE1;CDKN1B;CCNE2;CDK18;CDC25A;CDC6;CRLF3;PCNA;KLF11
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.41643828698786134,0.8721204107856207,0.6268656716417911,1.0,1.0,4/35,8.11%,TIMP3;TIMP2;ADGRB1;HMGCR
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.47669590600501616,-0.8720891989756728,0.6842105263157895,1.0,1.0,3/14,10.57%,ZBED3;KIF25;LLGL2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.38069978198977733,-0.8719674970949328,0.7307692307692307,1.0,1.0,7/62,9.21%,BMP7;BMP3;INHA;NUMA1;BMP6;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.3998454535088548,0.8719201868224454,0.6621621621621622,1.0,1.0,3/54,5.20%,CAV3;HCK;PSRC1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.36744987769135107,-0.8718683672646599,0.6410256410256411,1.0,1.0,6/52,7.79%,MCM5;TCOF1;SLC19A1;DUSP2;SRM;SORD
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.34758338802934946,0.8713945551954946,0.7564102564102564,1.0,1.0,20/153,9.23%,CA12;CALCR;PTGES;WFS1;PLAC1;PRLR;ISG20;TST;TJP3;GINS2;FKBP4;NXT1;MYOF;FKBP5;PTGER3;CPE;ACOX2;CDC6;GPER1;CKB
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.34857053381925335,-0.8709320539415863,0.6896551724137931,1.0,1.0,23/98,18.86%,ERCC2;BRCA2;POLL;HUS1;GTF2H2;ERCC8;ERCC1;PNKP;GTF2H2C;POLR2G;CCNH;CUL4A;POLR2C;POLD3;POLR2L;COPS6;RAD23A;HMGN1;DDB2;COMMD1;GTF2H5;XPC;ERCC3
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.5333275140617229,0.8709130231287312,0.6333333333333333,1.0,1.0,3/10,20.00%,PRKAB2;THRSP;PRKAG2
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.36097486011399893,-0.8708278735173813,0.6666666666666666,1.0,1.0,16/62,21.29%,ERCC2;GTF2H2;IWS1;POLR2G;CCNH;SSRP1;GTF2F1;POLR2C;POLR2L;NELFA;RTF1;GTF2H5;ERCC3;CCNT1;SETD2;NELFE
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.5540413755814357,0.8706158409128524,0.711864406779661,1.0,1.0,4/7,35.52%,RYR3;SLC41A1;FBP1;SNCA
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.350419182485012,0.8705121613624269,0.8055555555555556,1.0,1.0,20/170,13.17%,MSX1;TMEM97;H3-3A;TRIM32;INHBA;CDKN2D;AGT;PSRC1;OSGIN2;NCBP1;NAIF1;CDKN1B;KIF14;CGRRF1;CRLF3;TGFB1;PAPPA2;TP53TG5;TMC8;CAMK2D
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.4169270116107524,-0.870470204050362,0.65625,1.0,1.0,2/20,0.69%,KDR;SPRED1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.402097151225668,-0.8704289137258739,0.6341463414634146,1.0,1.0,5/26,11.39%,SLC22A2;SLC7A1;SLC25A29;SLC6A9;SLC7A2
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.5387370174296877,-0.8701951698514585,0.6857142857142857,1.0,1.0,3/11,9.22%,PNP;ITPA;DNPH1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.4130200988248833,0.870116511403563,0.6,1.0,1.0,6/27,16.52%,CHMP4B;VPS37B;CHMP2B;CHMP1A;RAB11A;CHMP2A
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.5917142161648714,0.8700908646121918,0.7222222222222222,1.0,1.0,3/6,26.37%,CRHBP;CACNA1H;SLC12A2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.5917142161648714,0.8700908646121918,0.7222222222222222,1.0,1.0,3/6,26.37%,CRHBP;CACNA1H;SLC12A2
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.3726737220051757,0.8699283431120524,0.7611940298507462,1.0,1.0,8/107,8.60%,NES;LRP4;GPC6;PLP1;RUNX1T1;IGFBP5;CPE;TSPAN11
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.4715085037228882,0.8698462824148944,0.6142857142857143,1.0,1.0,2/15,9.70%,RPS7;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.559998333434387,0.8698035115277513,0.640625,1.0,1.0,2/6,13.98%,FKBP1B;PLN
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.39863072390918064,-0.869667318534248,0.6538461538461539,1.0,1.0,11/48,17.39%,TRIAP1;TFDP1;PLK2;AURKA;CRADD;PIDD1;BTG2;PML;PLK3;ATM;PCBP4
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5022085456408182,0.869553376105207,0.6666666666666666,1.0,1.0,3/13,6.58%,NLRP2B;CARD8;PELI3
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.5961289293313682,0.8692682942074588,0.6779661016949152,1.0,1.0,3/7,23.86%,CYP2R1;LGMN;LRP2
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.4643245571218316,0.8691024592439173,0.6521739130434783,1.0,1.0,4/24,10.64%,SOX10;PTPRZ1;SOX11;EIF2B5
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.32494738558193326,-0.8688716520522806,0.85,1.0,1.0,15/114,7.89%,SELP;LEF1;PTPN9;PID1;IL1R1;TNFRSF11A;IL1RL2;KHSRP;GCH1;PTPN23;IGBP1;AFF3;BCL2;ALDH1A2;STAT3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.47930988517101336,0.8687637347734153,0.65625,1.0,1.0,3/13,5.16%,ANGPTL7;NOTCH1;AGT
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.4107757016900617,-0.8686117854458664,0.6363636363636364,1.0,1.0,2/25,5.00%,DSCC1;NAT9
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.537587787225507,0.8685797088311459,0.703125,1.0,1.0,2/10,15.19%,PATL2;DCP2
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.5011951521250364,-0.8683847150180898,0.6666666666666666,1.0,1.0,3/8,22.56%,ACOT8;BACE2;AGO2
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.5278040289440177,0.8683781830969182,0.625,1.0,1.0,2/6,15.87%,UHRF2;HELLS
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.47423832656064324,0.8682759100186747,0.6271186440677966,1.0,1.0,3/19,10.17%,UROD;ATP5IF1;ABCG2
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.517738552276819,0.8681488993050893,0.6229508196721312,1.0,1.0,6/9,38.35%,BOD1;KIF2C;CHAMP1;MIS12;SEH1L;NUF2
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.41515141773233,0.8680718587001407,0.6666666666666666,1.0,1.0,11/33,26.47%,MYBPC3;MLC1;RNF139;GAS1;NEFH;INPP5F;LRRK2;LAMP1;REEP5;RINT1;ANTKMT
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.5420208199331552,-0.8680570063613346,0.5945945945945946,1.0,1.0,3/6,27.35%,NPLOC4;DHX58;SEC14L1
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.3683570200447206,0.8680142503642002,0.6710526315789473,1.0,1.0,23/91,28.43%,LMAN1;LAMP2;BNIP3;CLCN3;RAB9A;ARCN1;COPB1;TOM1L1;ATP1A1;YIPF6;NAPA;SEC22B;CLTC;SCAMP1;RAB5A;ARFGEF2;SNAP23;TMED10;SNX2;TSPAN8;AP1G1;GALC;ERGIC3
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.35984862519365385,-0.8680032479146598,0.7096774193548387,1.0,1.0,11/61,11.14%,ALK;BMP7;ASCL1;DTX1;ZFHX3;ID2;CDK5RAP2;MMD2;VWC2;NGF;BEND6
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.5574537410762357,0.8677340665499583,0.7142857142857143,1.0,1.0,1/8,2.85%,RABGGTB
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5018388789256828,-0.8674618952175633,0.725,1.0,1.0,1/9,3.32%,LRRC55
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.4836171250136992,0.8674109178847581,0.6440677966101694,1.0,1.0,2/18,5.45%,SLC30A8;SLC39A12
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.36246452950978525,-0.8673050852040577,0.6206896551724138,1.0,1.0,10/47,9.37%,F2RL1;CARD18;IGF1;AZU1;NLRP1;FOXP1;APOA1;HSPB1;STAT3;IFI16
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),0.5694742201235936,0.8669910852968283,0.7,1.0,1.0,1/5,14.20%,SPHK1
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.5801786544691594,0.8667773259488245,0.7014925373134329,1.0,1.0,3/6,27.00%,BFSP1;WNT5B;WNT7A
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.5661754881888054,0.8667612100575839,0.6530612244897959,1.0,1.0,3/6,12.48%,VAPB;GRAMD2A;TLE6
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.4407492844964269,-0.866574054802331,0.7567567567567568,1.0,1.0,7/20,22.69%,CACNA2D1;GRIN2A;GRIN2C;TRPM2;JPH4;JPH2;GRIN1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.4566731135977987,0.8664061544752065,0.6428571428571429,1.0,1.0,1/21,1.97%,CCL5
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.5001326852065928,0.8662513468916601,0.7014925373134329,1.0,1.0,2/15,3.71%,LRP4;NOTCH1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.40633535968384693,-0.8662276841731188,0.6666666666666666,1.0,1.0,7/28,16.68%,PRDM5;SMYD2;SUV39H2;WDR82;EHMT2;SETDB1;KMT2B
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.5606811504996623,0.8660544949791223,0.7142857142857143,1.0,1.0,4/7,19.04%,OTUB1;UBR5;PLAA;GPS2
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.2988331967539438,-0.8659550383223504,0.8928571428571429,1.0,1.0,30/189,19.59%,TRPT1;INTS11;RRP1B;LYAR;NVL;DGCR8;RRP7A;TBL3;POP1;LIN28B;WDR46;EXOSC10;SARS1;DDX27;NOP14;EXOSC1;EXOSC7;FARS2;EXOSC5;NOC4L;BOP1;EXOSC4;RPL12;NOL8;WDR75;SRRT;TARBP2;ADAT1;BYSL;RRP36
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.49674352725373994,0.8659277194979564,0.6721311475409836,1.0,1.0,2/16,4.00%,TIMP3;TIMP2
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.3657877895567,0.8658764470540421,0.6901408450704225,1.0,1.0,17/98,17.17%,PPP1R1B;RAPGEF5;KCNE2;CP;HIP1R;SOWAHA;MYO5B;FGFR2;PAIP2B;CHDH;KCNQ1;PCDH1;EBF4;PODXL;SPARCL1;FAAH;SYT13
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.42723123568421456,0.8656910993943984,0.6363636363636364,1.0,1.0,11/31,24.73%,SEMA3D;SEMA3F;SEMA3A;LRTM1;LGR6;NTN1;SLIT1;LRTM2;SEMA4A;SEMA3C;SEMA4B
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.3992174037517315,-0.8656578031081618,0.6470588235294118,1.0,1.0,4/40,8.68%,GREM1;NVL;PNKP;SMG6
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),0.5865996862281128,0.8656052212702303,0.6530612244897959,1.0,1.0,2/5,16.54%,CD27;CD74
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.5189529807412412,0.8655787350279323,0.6779661016949152,1.0,1.0,5/12,16.92%,ACOT4;GOT1;GAD1;ASPA;QPRT
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.5707729028030535,0.8655631346588892,0.6607142857142857,1.0,1.0,1/6,12.78%,HSPA8
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.3762206170251135,0.8655569960442238,0.6716417910447762,1.0,1.0,9/65,19.86%,HCK;C10ORF90;ODAD3;KIF9;TBC1D13;MSN;CEP76;ATG3;CYLD
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.47744879689789627,0.8654957190476343,0.5555555555555556,1.0,1.0,5/12,22.99%,SHOC1;FANCM;MEIOB;TOP2B;ERCC4
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.5205309006143524,0.8654948251178877,0.6842105263157895,1.0,1.0,1/12,6.67%,PPARGC1A
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.32582860443369227,0.8654536779115762,0.8205128205128205,1.0,1.0,30/272,18.17%,RAB6C;CSRP3;GRTP1;AMOT;FBLN5;SLU7;SEPTIN14;RUNDC1;CPE;RAB19;RABL2B;CNTN2;ARCN1;YWHAH;RAB23;CELSR1;ARL1;ARL6;STX19;SEPTIN1;SNX31;VPS35;SNX17;TBC1D13;ARF4;CD74;STX17;LRRK2;WIPI1;ARL4A
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.36440734121914825,0.8654387026969913,0.7083333333333334,1.0,1.0,14/109,7.79%,LAMA2;TIMP3;GADD45B;AGER;GLI3;PRG4;PDGFRB;POSTN;ANGPTL2;NID2;IGFBP5;SOX6;SCRG1;RUNX2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.4815160514764386,-0.8654260740424935,0.6176470588235294,1.0,1.0,1/9,5.85%,TFAP4
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),-0.5470787896416461,-0.8653831689070977,0.6808510638297872,1.0,1.0,2/5,26.73%,SETD2;ASH1L
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.5160210545983908,-0.8650299887594027,0.6,1.0,1.0,1/5,1.85%,GREM1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4785568277829798,-0.8649287109398154,0.6590909090909091,1.0,1.0,1/10,1.77%,PID1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.4906766504650927,-0.8648686998472879,0.6470588235294118,1.0,1.0,2/11,13.49%,SLC6A4;CTNNA2
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.4135900005344717,0.8645042418624777,0.671875,1.0,1.0,10/42,28.32%,ERAL1;MPV17L2;RPS5;RSL24D1;NOP53;DDX3X;RPL3;MTERF3;EIF6;RPL5
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.5335631895356302,-0.864147188781945,0.5945945945945946,1.0,1.0,2/8,7.09%,GREM1;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.4189717708597102,0.8640736150656569,0.7301587301587301,1.0,1.0,5/29,15.92%,BTN2A2;LRPAP1;BRCA1;RIN3;PINK1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.6208886526676355,0.8636988558437199,0.7666666666666667,1.0,1.0,2/5,27.29%,WNT7A;DVL1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.3038641578800256,-0.8635786921016979,0.7142857142857143,1.0,1.0,44/321,11.83%,KIT;ROR2;KDR;PTPRT;LEF1;F2RL1;SRGAP1;SINHCAF;MIEN1;CDH13;PRR5L;EPHB2;PDGFD;NTNG1;IGF1;CLDN4;SFRP1;SGK1;ITGA6;ARSB;DOCK10;SST;PDPN;GCNT2;NUMB;MCTP1;PLXNA1;STAT3;MAPRE1;DLG5;PDGFRA;GNA12;LMO4;DRD1;PDGFC;SORL1;PLXNA2;CDH1;SEMA4C;NOG;DUSP10;TRIP6;CSF1R;MDK
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.5231205273690789,-0.8635217369336099,0.6530612244897959,1.0,1.0,4/7,14.43%,PTPRS;YY1;REL;CACTIN
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.5005518050191887,0.8633897562346997,0.6229508196721312,1.0,1.0,6/16,25.84%,AGT;SIX4;WNT5B;GJA1;PIK3CD;ITGAX
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.5374921595679074,0.8632817270419885,0.6779661016949152,1.0,1.0,1/8,6.44%,PEX16
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.3891015766227453,-0.8632618328912047,0.6111111111111112,1.0,1.0,3/28,3.61%,F2RL1;EPHB2;CLDN4
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.46085345792533305,0.8629994470568697,0.7076923076923077,1.0,1.0,3/23,9.36%,ZNF16;INHBA;STAT1
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),0.5228840613036008,0.8629639081825777,0.6440677966101694,1.0,1.0,1/9,5.67%,KNG1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.37055990868129407,0.8627614541739874,0.6756756756756757,1.0,1.0,37/104,32.89%,NCBP1;NCBP2;RPL15;RPS7;RPL36;RPL9;RPS21;DHX34;RPL38;RPL21;RPL22;RPS5;EIF3E;RPLP2;EIF4A3;SMG7;RNPS1;RPS13;RPL27;RPL35A;RPL35;RPL3;RPS20;RPL27A;RPS27A;RPL13A;RPL5;PPP2R2A;RPS29;RPS12;RPL7;RPL32;RPS4X;RPL37A;RPL24;RPS9;RPL28
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.47214236003791815,-0.8627429628683193,0.6666666666666666,1.0,1.0,2/10,6.14%,LMF1;PLIN5
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.3608863990775845,0.8626713818139679,0.7,1.0,1.0,12/93,11.38%,MSX1;NOTCH1;INHBA;CDKN2D;PSRC1;OSGIN2;NAIF1;CDKN1B;CGRRF1;CRLF3;TGFB1;TP53TG5
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4693278227788939,-0.8626550823015746,0.717391304347826,1.0,1.0,1/11,2.47%,VPS25
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.4051459728973966,-0.8625949581927278,0.6904761904761905,1.0,1.0,10/26,23.90%,PARP2;PARP6;PARP10;SIRT2;ZC3HAV1;ART4;PARP4;PARP16;PARP1;PARP14
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.5492851874562082,0.8618675516284203,0.7,1.0,1.0,1/7,2.07%,ZBTB7B
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.41388633935428554,0.8618241619485053,0.7014925373134329,1.0,1.0,9/30,20.66%,AMBP;MARVELD3;DNAJA1;PINK1;PDCD4;GPS2;CYLD;PER1;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.4737646330402624,0.8617669190874814,0.6461538461538462,1.0,1.0,2/17,7.53%,IL18R1;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3642507448341158,0.861724958451239,0.7435897435897436,1.0,1.0,15/93,12.12%,C3AR1;CALCR;P2RY1;CAV3;TBXA2R;ACKR3;KNG1;BCAP31;PTGER3;CMKLR1;GPER1;LPAR6;DRD3;ESR1;GHRL
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.42525063953736114,0.8614262729287403,0.6521739130434783,1.0,1.0,6/30,13.99%,HPGDS;CHAC2;G6PD;CHAC1;GSTT2;GLRX2
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.3760332766534608,-0.8609579518962082,0.48484848484848486,1.0,1.0,11/57,14.28%,PCBP3;AHNAK2;HNRNPL;RRP1B;AKAP17A;PTBP3;IGF2BP3;SON;SRRM4;FASTK;PTBP1
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),-0.515545630864546,-0.860808223174463,0.5833333333333334,1.0,1.0,2/9,5.46%,OSBPL7;PTCH1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.4745929500516518,-0.8606237353287048,0.6666666666666666,1.0,1.0,1/14,2.06%,RGS14
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),-0.5317909742824034,-0.8606157453250117,0.6511627906976745,1.0,1.0,1/7,1.91%,GUCY2C
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.3945992429956847,-0.8605322206618661,0.7209302325581395,1.0,1.0,8/30,15.20%,GLP1R;PDE3A;EPHA5;MAPK7;APOE;HTR2C;PDE7A;CAP2
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.44473619997838876,0.8605300222820259,0.6666666666666666,1.0,1.0,3/21,8.40%,BAAT;HSD17B10;ACOX2
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.4085274707557357,0.8604547325143838,0.7049180327868853,1.0,1.0,2/33,2.86%,ZBTB7B;VWA2
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.36598302590042486,-0.8600403717051642,0.6774193548387096,1.0,1.0,9/87,4.64%,LMCD1;FBXL7;LAMB2;FGFR4;RND3;ADAM12;CACNA2D1;WWTR1;PRRX1
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.5700101695936547,-0.8600186366672665,0.717391304347826,1.0,1.0,1/5,2.80%,IDH2
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.4526759491641969,-0.8600185533915188,0.5945945945945946,1.0,1.0,2/10,6.81%,LOXL1;APOA1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.31952322819043083,-0.8597663610566955,0.8518518518518519,1.0,1.0,19/136,10.44%,PAH;INHA;SPTSSB;ELOVL6;GSTT2B;LCMT2;GCH1;ALAS1;GSTM3;CHKA;SPHK2;CERS4;APOA1;SPTLC1;SGMS2;ST3GAL2;APOE;GAL3ST4;CEPT1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.4909628269595624,0.8597024411480875,0.6379310344827587,1.0,1.0,1/15,7.04%,BNIP3
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.37924764751688894,-0.8594882058610236,0.6923076923076923,1.0,1.0,12/35,26.68%,RTN4R;LIMK1;APOE;PTPRS;DBNL;SIN3A;DNM2;NRCAM;GOLGA4;L1CAM;DIP2B;MAP3K13
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.39972379045147227,-0.8593649922465515,0.6578947368421053,1.0,1.0,7/41,17.32%,NUP210;TPR;NUP37;ZBTB7A;NUP42;NUP107;NUP43
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.471288352587468,0.8592249263026427,0.6461538461538462,1.0,1.0,3/18,8.80%,SYT2;SYT4;CPNE5
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.3761942731699782,-0.8592192234909298,0.7142857142857143,1.0,1.0,11/58,11.29%,XRCC4;DCLRE1B;POLL;BRCC3;ERCC8;ERCC1;POLM;ZBTB7A;SMARCAL1;XRCC6;HMGB2
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.38839353838810586,-0.8592077213050954,0.5666666666666667,1.0,1.0,5/32,9.28%,ERCC2;EREG;HDAC1;TGM1;AKR1C3
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),0.5892007323361614,0.8590388583282617,0.78125,1.0,1.0,3/5,18.47%,KHK;ALDOB;AKR1B1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.38309142089439674,-0.8590049223974586,0.6486486486486487,1.0,1.0,2/22,3.53%,LMCD1;IGF1
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.35691371370573755,0.8589648117293147,0.7164179104477612,1.0,1.0,21/116,12.90%,PRELP;ALPL;TLL1;ADAMTS4;HHIP;ETS2;NOTUM;TEAD4;BMP1;SOX6;CMKLR1;MEPE;FGFR2;XYLT1;LECT2;SOX11;COL10A1;KIAA1217;GHRL;ALX4;TNFRSF11B
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.5088813704520385,0.8587227481152838,0.6417910447761194,1.0,1.0,2/9,13.98%,FKBP1B;PLN
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.4590695871571615,0.8584471767218097,0.6779661016949152,1.0,1.0,2/17,6.21%,NES;PTPRZ1
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),-0.506401629200321,-0.8581829080630818,0.5555555555555556,1.0,1.0,2/6,6.03%,MYO3A;POU3F4
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.432904281522133,-0.8580887681479271,0.625,1.0,1.0,1/21,0.85%,BCL2L11
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.4056329198061065,-0.8580700143781358,0.6388888888888888,1.0,1.0,5/46,9.64%,STING1;NVL;IDE;TAF1;APOE
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.39045732364075264,0.8578991224410857,0.7352941176470589,1.0,1.0,13/50,20.41%,ALOX12;PPARGC1A;ADIPOR2;HSD17B10;ECI2;PECR;ACOX1;ADH5;ACADL;DECR1;ACAA2;ACAT1;ALDH3A2
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.486806671064437,0.8577627516025957,0.7288135593220338,1.0,1.0,4/15,21.57%,ADRB1;DRD3;ADRA1D;LMBRD2
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.46763244723248765,0.8577353219432082,0.6818181818181818,1.0,1.0,4/22,11.79%,KCNN4;ACSL5;GPX2;RIPK2
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.5316826609411556,0.8575965631114056,0.6842105263157895,1.0,1.0,2/12,9.96%,SLC25A18;LRRC8D
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.3864382150965933,0.8573524959162964,0.7012987012987013,1.0,1.0,4/55,5.68%,WFS1;H3-3A;TRIM32;NCBP1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.4773265713035579,0.8573461430994599,0.6805555555555556,1.0,1.0,6/17,19.94%,GINS2;GINS1;MCMDC2;MRE11;GINS4;RAD50
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.4358229007419282,0.8569710790595233,0.6923076923076923,1.0,1.0,8/33,20.89%,GPER1;DRD3;TSC2;BANK1;PPP2R5B;PIK3CB;NOP53;MSTN
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.5303545976448735,-0.8568850564137221,0.5813953488372093,1.0,1.0,1/5,2.06%,LRRC17
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.38038467153115374,0.856842627340421,0.7534246575342466,1.0,1.0,23/113,18.47%,SLC12A7;KCNA3;KCNG3;KCNE2;KCNN4;SLC24A4;ATP12A;SLC24A2;SLC24A1;KCNJ9;KCNK10;KCNG1;KCNJ11;KCNQ1;ATP1B1;KCNE4;SLC9A6;ATP1A1;KCNK1;SLC9A2;SLC9A7;SLC1A3;LRRC38
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.3183523940466983,-0.8568191034963355,0.7857142857142857,1.0,1.0,26/190,11.14%,NPNT;KDR;BMP7;LEF1;ASCL1;KITLG;IGF1;SFRP1;WWTR1;ADIRF;RIN2;SERPINF2;PDPN;GCNT2;BMP6;ID2;TGFB2;BTG1;ZHX3;MMD2;TGFB3;RIPOR2;SYAP1;VWC2;NGF;BEND6
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),0.5233751928253917,0.8567289325677373,0.6612903225806451,1.0,1.0,2/8,12.15%,RFC5;PCNA
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.5233751928253917,0.8567289325677373,0.6612903225806451,1.0,1.0,2/8,12.15%,RFC5;PCNA
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.5046474342957996,-0.8563843857021854,0.6190476190476191,1.0,1.0,2/5,9.36%,VLDLR;LRP8
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.5384184226542263,0.8562005045679204,0.7166666666666667,1.0,1.0,2/8,17.50%,TGFB1;DMTN
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.5161208098407957,-0.8560165823337741,0.6756756756756757,1.0,1.0,3/7,16.87%,ERCC1;SMG6;ATM
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.45551868258624917,0.8557665886687652,0.7068965517241379,1.0,1.0,5/27,12.27%,NOTCH1;SYT4;HMGCR;DRD3;STXBP6
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.44219738265158615,-0.8555963376204974,0.5833333333333334,1.0,1.0,2/13,13.64%,POLR2G;BTG2
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.35510052904937434,0.8555300700161294,0.7972972972972973,1.0,1.0,12/125,6.99%,CALCR;MC4R;PTGIS;RXFP1;CALCB;HCK;MMP26;ELANE;LPCAT3;SCTR;TSHR;ADRB1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),0.5634724970862477,0.855435944721037,0.7833333333333333,1.0,1.0,3/6,24.06%,ATP5IF1;PINK1;TOMM7
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.361187628137879,-0.855395933189751,0.6756756756756757,1.0,1.0,5/33,8.90%,BRCA2;SAMHD1;RFWD3;SMARCAL1;THOC1
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),0.5622100429166531,0.8548500399067893,0.7358490566037735,1.0,1.0,4/5,36.33%,ATPAF1;TMEM70;OXA1L;ATP23
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4955175824685478,0.8547899335029617,0.7142857142857143,1.0,1.0,4/13,32.77%,MAGEF1;CIAO2A;GLRX5;GLRX3
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.42515663732981956,0.8546357214540699,0.7540983606557377,1.0,1.0,7/25,20.15%,CCL5;FADD;POLR3G;PLSCR1;IFI35;LBP;GBP5
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.3839103722836079,-0.8546291203439866,0.6666666666666666,1.0,1.0,11/42,17.63%,SRPK3;SF3A2;TXNL4A;SF3A1;SMN1;ZRSR2;SCAF11;PRPF6;SETX;CELF5;CELF4
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.39491710149042475,-0.8544966433717589,0.6363636363636364,1.0,1.0,2/36,7.54%,RNF126;UBE2R2
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.525415752022432,0.8541249936682628,0.7115384615384616,1.0,1.0,2/11,13.37%,LRPAP1;RIN3
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.5376761954953019,0.8540814153414524,0.6428571428571429,1.0,1.0,2/7,20.10%,IMPA2;IPPK
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4914657620074759,-0.8538073521673554,0.6774193548387096,1.0,1.0,4/11,21.54%,RFWD3;PLK3;PLK5;FBXO31
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.48312596000075514,-0.8537691035056922,0.6818181818181818,1.0,1.0,3/5,35.10%,SLC6A6;SLC6A13;MT3
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.3795245408893861,-0.8533301308585148,0.6774193548387096,1.0,1.0,3/44,6.24%,CHCHD6;TMEM11;MTX1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.4292565103147927,0.8529929374239288,0.6615384615384615,1.0,1.0,5/21,22.68%,FKBP1B;CAMK2D;TRDN;CALM3;JPH1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.5040100652089315,0.8526755669317064,0.6811594202898551,1.0,1.0,3/9,22.77%,PKD1L3;LGMN;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.4952022229382017,0.852658012323368,0.6896551724137931,1.0,1.0,3/9,17.89%,ARG2;CGAS;B2M
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.3432153378909804,0.852472009297536,0.8117647058823529,1.0,1.0,28/218,15.71%,LAMA2;EPHA1;PLA2G10;SEMA3D;EMB;NOTCH1;SPTBN5;ADGRB1;UNC5A;ARTN;LAMA1;GAB1;MYPN;CNTN2;FGFR2;SIAH1;NOTCH3;RAB8A;CDK5R1;SEMA3F;ATL1;SEMA3A;NEXN;LRTM1;LGR6;EPHA6;NEFH;NPTN
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.4934519473113846,0.8523673899463189,0.7090909090909091,1.0,1.0,4/8,22.77%,KCNQ1;ATP2B4;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.4934519473113846,0.8523673899463189,0.7090909090909091,1.0,1.0,4/8,22.77%,KCNQ1;ATP2B4;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.3214824246018563,-0.8523093810527551,0.8518518518518519,1.0,1.0,6/119,3.34%,KIT;NRG1;FGFR4;BTC;EREG;KITLG
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.431572116761786,-0.8518804095518476,0.7073170731707317,1.0,1.0,4/17,17.28%,RING1;PCGF1;DTX3L;DDB2
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.46790604770437644,0.8513429053049356,0.6774193548387096,1.0,1.0,1/17,1.31%,PLA2G10
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.40311590962675015,-0.8509862305350984,0.6923076923076923,1.0,1.0,6/29,12.10%,KCNIP1;KCNE1;VIP;KCNN2;DRD1;DPP6
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.4305713193124777,0.8508778928306238,0.6551724137931034,1.0,1.0,3/25,13.91%,F11R;WAS;ARHGAP28
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3579514020828093,-0.8508703977733116,0.7037037037037037,1.0,1.0,3/42,3.92%,CACNG4;CACNG3;CACNG5
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.5084046971954161,-0.8508434149930844,0.6818181818181818,1.0,1.0,3/8,8.27%,PRKCD;INCENP;BAZ1B
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),0.5696475372854128,0.8508060483227948,0.7,1.0,1.0,2/5,11.89%,FAH;IL4I1
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),0.5696475372854128,0.8508060483227948,0.7,1.0,1.0,2/5,11.89%,FAH;IL4I1
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),0.5531029683425682,0.8507890631572897,0.7037037037037037,1.0,1.0,3/6,17.72%,PPID;OPN3;OPN1SW
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.4864760968398566,0.8506520464532251,0.6857142857142857,1.0,1.0,3/12,26.93%,KLF9;CTSH;RDX
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.5724437896199879,0.8506496731587645,0.7735849056603774,1.0,1.0,4/5,29.72%,MAFB;HSPA9;ZFP36;ZFP36L1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.4760079687289874,0.8506128974428403,0.6818181818181818,1.0,1.0,4/16,17.02%,RLBP1;CYP2R1;LGMN;RBP2
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.5278691403812009,-0.8503812436816521,0.627906976744186,1.0,1.0,2/5,5.01%,MYH11;TNXB
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.5636347560099549,0.8502040921798273,0.7272727272727273,1.0,1.0,2/7,15.19%,PATL2;DCP2
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.43670856893804433,0.8501496956283127,0.6825396825396826,1.0,1.0,2/28,1.54%,CALCR;AGER
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.4175686895405729,0.8500547435839402,0.6923076923076923,1.0,1.0,3/29,4.47%,CAV3;KCNE2;SCN4B
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.5216094731986991,-0.8492733480960134,0.65,1.0,1.0,1/6,1.87%,SH3RF1
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.302089071456815,-0.8491106797398261,0.8695652173913043,1.0,1.0,32/274,9.75%,ETV1;GNG4;TMEM132D;PTPN3;NMB;TACR1;SRGAP1;PCBP3;NTNG1;CACNA1I;TIMELESS;CRH;PRKCD;SST;VLDLR;KCNC1;RGS8;MAPK4;ADGRA1;FAM81A;ARX;GRIA4;TMEM196;POU2F2;RAB3C;VIP;MMD2;CALN1;DLX5;CDHR1;GAD2;NPTXR
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.43859881080208296,0.8488035980885358,0.7076923076923077,1.0,1.0,10/25,20.52%,ADAMTS9;NOTCH1;ADGRB1;TGFB1;ANGPT2;DAB2IP;RGCC;PPARG;SP100;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.4444441617054331,0.8488031174928494,0.7121212121212122,1.0,1.0,5/33,7.53%,IL18R1;ZFPM1;FADD;CD14;HLA-A
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.5285520145040978,0.8486061439974242,0.6727272727272727,1.0,1.0,1/7,12.23%,DPYS
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.4339690099378422,0.848426556939831,0.7,1.0,1.0,8/18,21.24%,PDCD1LG2;ARG1;SOX11;IL4I1;SFTPD;CD80;CD274;LYN
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.4044431917483634,0.8483261007388383,0.6885245901639344,1.0,1.0,6/28,16.52%,CHMP4B;VPS37B;CHMP2B;CHMP1A;RAB11A;CHMP2A
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.3172597549265298,-0.8479001230667844,0.7272727272727273,1.0,1.0,6/126,6.02%,NPNT;PID1;TNFRSF11A;SFRP1;TRAF3;EDARADD
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.34320015367296475,0.8478973252060072,0.7361111111111112,1.0,1.0,18/122,16.89%,ROPN1B;RREB1;PLEKHG7;WASF1;RIPOR1;WAS;RHOB;RIT2;RHOH;CELSR1;ZNF304;EPS8;BRK1;RASGRP3;MRAS;G3BP1;GPSM2;G3BP2
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.46231563079053956,0.847846094795391,0.7301587301587301,1.0,1.0,6/15,16.00%,A2ML1;RCN3;PSMA3;PSMB8;PINK1;FURIN
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.3742497125165783,-0.8477508256988475,0.7272727272727273,1.0,1.0,6/47,4.58%,SLC16A2;SLC16A9;SLC16A12;ABCC4;SLC22A13;SLC6A11
prerank,MSigDB_Hallmark_2020__UV Response Up,0.3393474351059967,0.8477459293849027,0.8072289156626506,1.0,1.0,24/137,15.00%,C4BPB;MSX1;UROD;POLE3;JUNB;TST;FKBP4;EPHX1;CCNE1;DNAJB1;ABCB1;SOD2;GRINA;RHOB;SELENOW;IRF1;TUBA4A;GGH;PLCL1;ATP6V1C1;EPCAM;DNAJA1;CNP;RRAD
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.5671445362614933,-0.8475923776896059,0.7105263157894737,1.0,1.0,1/5,2.44%,CDH26
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.46872045129566314,0.8475011223964835,0.6551724137931034,1.0,1.0,1/12,3.71%,NOTCH1
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.40053746865508466,-0.8474956119534687,0.7105263157894737,1.0,1.0,4/38,9.72%,LEF1;BRCA2;TAF10;JADE2
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.43212477065185645,-0.8474504537791739,0.6285714285714286,1.0,1.0,5/21,12.13%,PPP1R35;PPP6R1;MTMR9;CHP1;SH3RF2
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.4103282422679004,0.8473926727310394,0.6811594202898551,1.0,1.0,10/40,13.27%,PLA2G10;CYP1B1;ALOX12;EPHX1;ELOVL2;SCD;PTGR1;ACOX1;FADS2;ALOXE3
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.37025083032883965,0.8473005234703289,0.7536231884057971,1.0,1.0,15/97,19.08%,STEAP4;TRPA1;POLQ;UPB1;SOD2;HSD17B10;ACOT13;ATL1;ECT2;GLRA3;CHMP2A;G3BP2;B2M;MCOLN1;LETM1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.3617458568733768,0.847299525403559,0.7183098591549296,1.0,1.0,6/76,8.68%,TRIM22;TRIML2;TRIM5;SESN3;BNIP3;RNF152
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.5037288988128829,0.8472510516830514,0.7142857142857143,1.0,1.0,1/11,3.32%,CD8A
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4169647062499365,0.8469616544555386,0.704225352112676,1.0,1.0,12/31,21.30%,CARD8;CASP8;STAT1;CARD19;RHOH;ESR1;NLRC3;DAB2IP;PER1;GSTP1;PPM1A;TRIM59
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.33784529956202,-0.8469124349508446,0.7878787878787878,1.0,1.0,18/95,13.06%,NPNT;BMP7;TSPAN12;CACNG4;MYH14;SEZ6L2;ID4;MARK1;CKMT1B;LRIG3;MAPK4;ARX;PHF21B;SLC7A2;FAM222A;DUSP15;COBL;PRR36
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.4314968287238808,0.8468975862607887,0.6774193548387096,1.0,1.0,2/19,6.26%,CALCR;GPRC5A
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.35992859553154943,0.846888567607557,0.746268656716418,1.0,1.0,13/90,11.10%,MYLK;CHRNB1;CAV3;MYBPC2;CHRNG;ACTA2;MYOM1;ACTC1;MYOF;CHRNE;MYBPC3;MYH13;MYOT
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.38821526215389296,-0.8464089923650665,0.6551724137931034,1.0,1.0,9/39,14.61%,PER2;PNPO;OSBPL7;ACOT8;AKR1C3;PSAT1;SLC27A2;TM7SF2;OSBP
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.39862901468853795,0.8463909596044349,0.7014925373134329,1.0,1.0,7/48,16.33%,KCNE2;USP14;UCHL5;TMF1;DAB2IP;PINK1;PRKCG
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.5423953791975011,0.8462652424969683,0.7049180327868853,1.0,1.0,1/6,7.87%,CMKLR1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.3756188471716252,0.8461097793943156,0.5967741935483871,1.0,1.0,6/58,9.96%,SLC13A4;SLC23A1;PRAF2;SFXN3;SLC25A18;LRRC8D
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.4315969989101845,0.8460469468685236,0.6851851851851852,1.0,1.0,3/24,12.15%,TDG;RPA3;PCNA
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.3862088829402621,0.8459548606030216,0.704225352112676,1.0,1.0,11/60,14.22%,PLA2G10;EXPH5;MYOM1;ATP6AP1;RAB9A;GPER1;SOX11;PPID;TGFB1;SYTL4;TTN
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.3611321808975978,0.8458420904130172,0.7761194029850746,1.0,1.0,4/64,5.88%,LMAN1;F8;VAPB;TGFA
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.3364580848495802,-0.845605929617155,0.7575757575757576,1.0,1.0,4/82,5.58%,GPC4;LEF1;SFRP1;PORCN
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.497972103588898,0.8455793869454628,0.6491228070175439,1.0,1.0,5/12,21.98%,G6PD;PGD;RPE;RBKS;TKT
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.36654330184287515,0.8454437098081238,0.7183098591549296,1.0,1.0,8/76,16.90%,CA9;DNAJB1;PSMB6;EPAS1;PSMA3;PSMB8;HIF3A;CUL2
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.4959573915986207,0.8453343652326408,0.7966101694915254,1.0,1.0,2/12,16.78%,TWIST1;CDK6
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.494162919878698,-0.8452503850636451,0.6756756756756757,1.0,1.0,2/8,20.95%,MME;STK11
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.4855992836724825,-0.8451016768983115,0.7027027027027027,1.0,1.0,2/7,15.85%,CHP1;FKTN
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.47724582718384945,0.8449962757567964,0.6851851851851852,1.0,1.0,1/10,5.96%,DNAJB1
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.42516857252236756,-0.8448942660792884,0.6756756756756757,1.0,1.0,1/16,0.81%,SLC39A11
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.49775829376187053,0.8448786257943174,0.7115384615384616,1.0,1.0,3/11,16.53%,COX4I1;COX7A2L;CYCS
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),0.5651113579325445,0.8446142307272477,0.7407407407407407,1.0,1.0,2/7,20.70%,RHOH;JAM3
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.5709926931553255,0.8445668316216138,0.6666666666666666,1.0,1.0,2/6,32.54%,LRP2;LAPTM4B
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.37974819796669906,0.8445581800187159,0.6666666666666666,1.0,1.0,9/47,19.96%,MCM2;MCMDC2;MRE11;RECQL;RECQL4;PURA;MCM6;RAD50;DDX1
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.35839389007389844,0.8443779285321418,0.7272727272727273,1.0,1.0,11/75,9.38%,TIMP3;GLI3;EGFLAM;STAB1;PDGFRL;TWIST1;IGFBP5;SRPX;TCF7L1;EFEMP1;NOTCH3
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.5358402000407476,0.8443431801088189,0.7121212121212122,1.0,1.0,2/6,20.50%,LRRK2;NLGN4X
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.40614248175990375,0.8443303323723932,0.6625,1.0,1.0,4/46,12.12%,SYT2;SYT4;CPNE5;GHRL
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.46920820222869897,0.8440960438744209,0.6440677966101694,1.0,1.0,3/10,17.89%,ARG2;CGAS;B2M
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.33479985058798106,0.8440072392139896,0.8472222222222222,1.0,1.0,24/154,18.84%,MSX1;WFS1;TCP1;C10ORF90;SYVN1;GBA3;LAMP2;HIP1R;PPARGC1A;CDC37L1;RPS7;SMAD7;STXBP4;CCT6A;USP13;CCT8;NLK;ATP1B1;PINK1;PYHIN1;TESC;CREBL2;CALR;CAMLG
prerank,MSigDB_Hallmark_2020__Apoptosis,0.34703046300324314,0.8439055464719053,0.72,1.0,1.0,20/126,10.65%,TIMP3;GADD45B;PDGFRB;BIK;TIMP2;ISG20;CCND2;BCAP31;CDKN1B;CD14;AVPR1A;SOD2;CASP8;HGF;RHOB;BCL2L2;SMAD7;FAS;BRCA1;IRF1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.43331543404016226,0.843698823991434,0.6515151515151515,1.0,1.0,3/25,8.40%,BAAT;HSD17B10;ACOX2
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.4022725858597978,-0.8436426267425887,0.7142857142857143,1.0,1.0,5/36,13.13%,KHSRP;DCPS;TRIM71;MEX3D;DIS3L2
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.35320453670734586,-0.8436067262257035,0.7,1.0,1.0,12/62,16.34%,ALG8;ST3GAL1;GAL3ST1;ALG12;MOGS;MPDU1;DPM3;OST4;RPN2;UGGT2;DERL3;RPN1
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),-0.5292542576046023,-0.8434918579381764,0.6666666666666666,1.0,1.0,1/6,1.91%,GUCY2C
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.3608679819009617,-0.8431845291811596,0.8235294117647058,1.0,1.0,4/36,10.30%,PID1;SLC25A33;BCL2;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),-0.551278512529963,-0.8431481292059981,0.75,1.0,1.0,1/5,6.69%,SERPINF2
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.49446819491059973,0.8430346834955071,0.7068965517241379,1.0,1.0,8/14,23.05%,NQO1;CYP1B1;ARG2;MTARC2;CPS1;DDAH2;CYB5B;CYB5R3
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),-0.5290788280894652,-0.8429254286020126,0.6222222222222222,1.0,1.0,1/5,4.56%,HCRT
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),0.5579037163288612,0.842797608619689,0.7368421052631579,1.0,1.0,2/5,21.24%,CD274;LYN
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.41893479851754273,0.842658760977338,0.711864406779661,1.0,1.0,3/36,5.24%,PLA2G7;LPCAT3;ALOX12
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.46124809498654695,0.8424501613936913,0.7384615384615385,1.0,1.0,2/13,6.29%,PLA2G7;NCEH1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.2859352239005254,-0.8422233847205454,0.9230769230769231,1.0,1.0,51/572,9.36%,CD38;BCL2A1;ALK;KDR;BCL2L11;HMGN5;LEF1;MIEN1;RASSF2;GREM1;SH3RF1;FHL2;UNC13B;USP27X;ASCL1;APIP;IGF1;NTSR1;TRIAP1;SFRP1;STEAP3;SGK1;ITGA6;RRP1B;GRK5;MAP3K20;MGMT;TCIM;BCL6;HDAC1;CFLAR;AZU1;SPHK2;TFAP4;BCL2;PLK2;PDPN;CIDEA;SPDEF;PDCD2;SPTLC1;HSPB1;NCSTN;NR1H4;CRADD;VIP;ZBTB7A;ANO6;PTMA;TGFB3;LRP8
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.39695893205671146,0.8420520273488615,0.746268656716418,1.0,1.0,5/52,7.68%,ZACN;TRPV6;SLC30A8;LOXL2;KHK
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.4386179431893392,0.8417946425652786,0.6349206349206349,1.0,1.0,2/18,13.37%,LRPAP1;RIN3
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.3384220884291019,0.841765949573604,0.7941176470588235,1.0,1.0,12/153,9.38%,NR1I3;HNF4G;NR2E3;NOTCH1;NR5A2;TEAD4;TBP;PPARGC1A;MAML2;TBPL1;POLR1H;NOTCH3
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.3600070040095887,0.8417365725456952,0.7183098591549296,1.0,1.0,34/138,22.18%,ZNF703;MGST1;SSTR1;AHR;PDCD1LG2;TBX1;CD14;MAP4K1;GPER1;STAP1;ESR1;ABCB4;SPP1;DAB2IP;PDK4;PDCD4;INSIG1;CRHBP;MSN;TESC;ATP1A1;CXCL13;CX3CR1;PLAA;CD80;H2AZ1;NCOA4;LBP;WNT5B;CD274;GSTP1;LYN;ZNF35;TWF2
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.49970479797711,0.8415728045525461,0.6984126984126984,1.0,1.0,2/11,3.21%,ZBTB7B;PRLR
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.45813744816315227,0.8415647297012001,0.7017543859649122,1.0,1.0,3/18,23.75%,PINK1;FBXO7;VDAC1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.4412272455108362,-0.8415249165132768,0.6571428571428571,1.0,1.0,2/13,4.93%,RASGRP1;KLRD1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.4412272455108362,-0.8415249165132768,0.6571428571428571,1.0,1.0,2/13,4.93%,RASGRP1;KLRD1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.34324160409502685,-0.8415138963712185,0.6818181818181818,1.0,1.0,23/98,19.44%,RND3;RHOBTB1;WTIP;MARK1;CDC42BPB;SIPA1L3;ZMYM6;PLD2;RHOBTB2;APOE;MDK;SEMA6A;FGD5;ARAP3;BIN1;MAST2;CAPZB;ANK1;KLHL20;MAST4;WDPCP;WASF3;PAK5
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.3403904527356791,-0.8414900494347827,0.7307692307692307,1.0,1.0,22/82,21.18%,CCDC22;BLOC1S4;SORCS1;AP4E1;ACBD3;AP1S1;SORL1;AP1S3;STX4;DOP1B;AP1S2;KLHL20;COMMD1;CLVS1;EXOC6B;DNM2;EXOC2;VAMP8;GOLGB1;RABEP1;EPS15;GOPC
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.4712574685267582,0.8411682843192985,0.6557377049180327,1.0,1.0,5/16,22.26%,PRAF2;SLC25A18;LRRC8D;SLC1A3;GJA1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.4306304231648236,-0.841082248645357,0.6470588235294118,1.0,1.0,2/18,4.11%,GREM1;APLN
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.48809548812608883,0.8408046721429258,0.6865671641791045,1.0,1.0,3/11,26.93%,KLF9;CTSH;RDX
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.4769749564797145,-0.8406078919982704,0.6764705882352942,1.0,1.0,3/12,10.54%,PARP2;PARP6;PARP10
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),0.5595398529788466,0.8403505632727881,0.7368421052631579,1.0,1.0,2/5,32.29%,PTK2B;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.4922247703510318,-0.8401423136694404,0.7777777777777778,1.0,1.0,2/10,7.89%,WTIP;STAT3
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.5517616255192784,0.8399828391781237,0.7192982456140351,1.0,1.0,4/8,31.51%,TERF2IP;MPG;OGG1;TINF2
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.3789824600634441,-0.8399484098987798,0.7096774193548387,1.0,1.0,12/50,18.85%,STING1;NSFL1C;RAB7A;UBXN2A;MAP1LC3A;ATG9B;EMC6;PACS2;WDR45;WIPI2;ULK3;TP53INP2
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.2955813384396413,-0.8399428008014787,0.896551724137931,1.0,1.0,16/163,9.09%,SPRED1;PDE10A;BMP7;CCDC22;PRDM15;WTIP;PDE3A;OTUD3;EPM2A;DGKD;BCL2;SHANK2;MAP2K3;NR1H4;DLG5;SPRY3
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.4331755444196991,-0.8398880022573495,0.5897435897435898,1.0,1.0,4/19,9.21%,WWTR1;BMP6;CILP;TGFB3
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.4036154176241592,-0.8397748196267173,0.6410256410256411,1.0,1.0,3/21,6.80%,SLC19A1;ABCA13;PDPN
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),-0.5230886367306877,-0.8395746595755351,0.675,1.0,1.0,3/6,19.84%,CFLAR;ANGPT1;AKIRIN1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.4055142752663025,0.83941473316937,0.726027397260274,1.0,1.0,7/39,15.62%,KCNE2;SCN9A;GPER1;SCN7A;YWHAH;KCNQ1;KCNE4
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),0.5704879376162908,0.839365423201949,0.75,1.0,1.0,1/5,12.90%,KANK2
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.3320435285995329,0.8393335389301636,0.7368421052631579,1.0,1.0,23/190,10.21%,CALCR;P2RY1;ROR1;AGER;CD4;TRIM5;CCL5;PDGFRB;ELANE;ACKR3;NOTCH1;PIK3R5;PTPRC;FLT3;PRXL2C;TBX1;ATP6AP1;FGFR2;GPER1;PLCG2;RIT2;SCIMP;TGFB1
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),0.5270161671407451,0.8392951545148267,0.7407407407407407,1.0,1.0,2/7,20.84%,CACNA1G;HCN4
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.3736473259633384,-0.8392025935416791,0.625,1.0,1.0,12/48,19.71%,HCRT;MCTP1;RAB3C;LLGL2;DNAJC1;P3H1;VAMP3;MCTP2;STX4;RIMS1;SNCAIP;VAMP8
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),-0.5409425007488845,-0.8388450250051123,0.76,1.0,1.0,2/7,9.95%,DRD4;DRD1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.3675665846969451,-0.8388209208679263,0.6764705882352942,1.0,1.0,8/38,17.21%,MGMT;TIMELESS;PNKP;SHLD1;SPIDR;KMT5B;DDX11;DTX3L
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.33201833543021175,-0.8385644056198297,0.8064516129032258,1.0,1.0,11/92,13.46%,MYB;HDAC5;HDAC1;INO80;BAZ1B;SUV39H2;ZBTB7A;SMARCA4;KDM4B;HMGA2;SMARCB1
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.5199428194052034,0.8384357285123537,0.6909090909090909,1.0,1.0,2/8,7.12%,SYT4;REST
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.5018672818584172,-0.8383453392752838,0.6097560975609756,1.0,1.0,2/9,7.64%,SLC6A1;SHANK1
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.5055423227103353,0.8383296029626264,0.6933333333333334,1.0,1.0,3/11,17.63%,KCNN4;KCNK10;KCNK1
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.4587754062969553,-0.8383292637981034,0.6764705882352942,1.0,1.0,3/13,7.08%,INHA;SFRP1;ID2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.5255812126116153,0.8382850957294007,0.68,1.0,1.0,3/8,28.85%,DPYS;ALDH6A1;DPYD
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.37236549434831195,-0.8381624326780337,0.7631578947368421,1.0,1.0,7/38,10.54%,EREG;IGF1;SFRP1;EMD;PDGFRA;PDGFC;PARP10
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.3585187751324798,0.837847199977799,0.6891891891891891,1.0,1.0,17/74,15.71%,ZBTB7B;PRLR;PLAC8;PRKAB2;KDM3A;PPARGC1A;TSHR;ADRB1;ADIPOR2;CMKLR1;SCD;EPAS1;STAT6;GHRL;ACADL;DECR1;GADD45G
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),-0.48066924699500496,-0.8376191871215068,0.6222222222222222,1.0,1.0,1/5,8.84%,ANO6
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.401006288410044,0.8372455599107717,0.7627118644067796,1.0,1.0,10/39,25.78%,ISG20;NCBP1;RNASEH2C;DCP2;ERN1;SIDT2;AGO4;RIDA;NUDT16L1;DXO
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.4449847755015558,-0.8370215020676983,0.6511627906976745,1.0,1.0,1/15,1.09%,H1-4
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.4071917466320642,0.8369371886671373,0.7205882352941176,1.0,1.0,13/45,7.95%,GNLY;CD4;CD8A;NOTCH1;PIK3R5;PTPRC;ARHGAP9;GMFG;TAGAP;CORO1A;TSHR;WAS;ARHGAP25
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.5111771589648306,-0.8368935632201315,0.7272727272727273,1.0,1.0,1/7,5.82%,SPHK2
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.34714997829688093,-0.836806190230325,0.7083333333333334,1.0,1.0,7/72,7.62%,EPHB2;SVBP;AMIGO1;NTNG1;DSCAML1;VASH2;DHFR
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4410473337811925,0.836461307925609,0.7846153846153846,1.0,1.0,4/25,17.48%,ITPR1;CHAC1;DAB2IP;ERN1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.46759780444188437,-0.836444262405926,0.625,1.0,1.0,2/13,5.82%,PID1;SPHK2
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.47949821513649526,-0.8363620241640038,0.7674418604651163,1.0,1.0,1/11,0.85%,BCL2L11
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.33709442135841744,-0.8363338371280882,0.6923076923076923,1.0,1.0,9/89,11.55%,SELP;TNFRSF11A;GCH1;TICAM1;FOXP1;SBNO2;SCARB1;HMGB2;OTUD5
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.47568290547381753,-0.8363215296241967,0.6216216216216216,1.0,1.0,3/7,23.03%,SPX;LEP;PPARA
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.5117484409998984,0.8362459743489894,0.66,1.0,1.0,2/6,29.41%,SLC6A15;SLC6A7
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),-0.5123263463364168,-0.8361710801365181,0.6808510638297872,1.0,1.0,1/8,5.82%,SPHK2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.44634541619246937,-0.8361300785900907,0.6904761904761905,1.0,1.0,5/14,19.62%,HCRT;MCTP1;MCTP2;RIMS1;SNCAIP
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.3921445834894429,-0.835724360615527,0.6129032258064516,1.0,1.0,7/42,12.19%,BMP7;LEF1;TGFB2;FAM83D;DLG5;NOG;HMGA2
prerank,MSigDB_Hallmark_2020__Coagulation,0.36757340516153586,0.8355684560420469,0.7313432835820896,1.0,1.0,17/89,13.80%,TIMP3;P2RY1;MMP15;F8;LAMP2;BMP1;F10;ACOX2;RABIF;VWF;C1QA;MASP2;CTSK;A2M;LGMN;FN1;CPB2
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.3626237109685634,-0.8352592118661675,0.7941176470588235,1.0,1.0,4/50,6.55%,IFIH1;NUP210;TPR;NUP37
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),-0.5504433628741419,-0.8349950190372692,0.7254901960784313,1.0,1.0,1/5,24.88%,LARP4B
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.3969347734460803,0.834922015141219,0.746268656716418,1.0,1.0,4/49,4.93%,CCL5;NR5A2;ISG20;VAPB
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.3255731669642767,-0.8348074147489974,0.6578947368421053,1.0,1.0,17/71,13.68%,NPNT;BTC;MYH14;ZBTB7C;CLDN4;SLC2A9;ANO1;ACE2;KCNE1;TMEM229A;PELI2;CDH1;SCNN1G;COBL;TSPAN1;PHACTR1;CAPN13
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.522396484978261,-0.8344994097756671,0.6904761904761905,1.0,1.0,1/6,3.05%,ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.522396484978261,-0.8344994097756671,0.6904761904761905,1.0,1.0,1/6,3.05%,ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.522396484978261,-0.8344994097756671,0.6904761904761905,1.0,1.0,1/6,3.05%,ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.522396484978261,-0.8344994097756671,0.6904761904761905,1.0,1.0,1/6,3.05%,ELOVL6
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.3378439246818201,0.8344547463654127,0.8,1.0,1.0,10/202,5.92%,NPY;SLC12A7;ZACN;CHRNB1;CHRNG;OPRK1;PLP1;GRM3;GABRA2;HTR3E
prerank,MSigDB_Hallmark_2020__E2F Targets,0.33040949574482376,0.8342528416671803,0.821917808219178,1.0,1.0,38/178,19.94%,MCM2;PRDX4;CCNE1;SPC24;SUV39H1;GINS1;CDKN1B;PSMC3IP;TUBB;CDC25A;CDCA3;BUB1B;PAICS;ATAD2;DDX39A;EXOSC8;DONSON;BRCA1;MRE11;RPA3;PCNA;DCTPP1;RACGAP1;PDS5B;CCP110;HELLS;NAA38;GINS4;CDK4;MMS22L;RAD51C;MCM6;DIAPH3;RAD51AP1;SLBP;H2AZ1;EZH2;RAD50
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.5489470279978286,-0.8340702259618391,0.6666666666666666,1.0,1.0,3/5,21.56%,APOE;SCAP;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.5489470279978286,-0.8340702259618391,0.6666666666666666,1.0,1.0,3/5,21.56%,APOE;SCAP;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.5489470279978286,-0.8340702259618391,0.6666666666666666,1.0,1.0,3/5,21.56%,APOE;SCAP;ERLIN2
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),-0.527036280647229,-0.8340678545550045,0.7021276595744681,1.0,1.0,1/5,6.86%,BMP6
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.4519631794583327,0.8339154714522945,0.6615384615384615,1.0,1.0,7/16,34.05%,MAFB;CDK6;HSPA9;ZFP36;ZFP36L1;PTK2B;PAF1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.45366009247630057,-0.8338438123708634,0.6756756756756757,1.0,1.0,2/12,7.57%,ATOH8;BTG1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.37030938766986243,0.8336601568527385,0.7903225806451613,1.0,1.0,10/81,9.47%,PRELP;GPC6;GPC5;HSPG2;CHST1;B3GNT4;B3GNT3;OGN;CSGALNACT1;XYLT1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.4019048745035073,-0.8333420411782279,0.5853658536585366,1.0,1.0,3/16,5.68%,AOAH;FBXO27;SAMHD1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.4773100600066366,0.8333028293663309,0.6885245901639344,1.0,1.0,5/11,28.89%,TWF2;TWF1;CFL2;WDR1;CFL1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.48392028262132625,0.8332235034969742,0.676923076923077,1.0,1.0,1/10,2.22%,KCNE2
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.5311291194866437,0.8324920774921711,0.6666666666666666,1.0,1.0,1/7,4.74%,SOX10
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.32124122184787185,-0.8321251913285791,0.875,1.0,1.0,9/77,9.08%,IQGAP2;EPHA3;RND3;RHOBTB1;EPHA5;PRKCD;RHOBTB2;PDGFRA;PEAK3
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.4002807515427364,0.8321017129455832,0.7323943661971831,1.0,1.0,2/49,4.65%,LRP4;OMG
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.3679848640745382,0.8319210342616775,0.7971014492753623,1.0,1.0,20/89,19.01%,RAD54L;MCM2;POLQ;GINS2;MCMDC2;BRCA1;FANCM;MRE11;RPA3;RNF138;MEIOB;MORF4L1;RECQL;GINS4;RECQL4;MMS22L;RAD51C;POLN;MCM6;RAD51AP1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.48947111280735345,-0.8316613203918749,0.6829268292682927,1.0,1.0,2/9,13.36%,PDE3A;PDE11A
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.3419050654889685,-0.8313616230260128,0.75,1.0,1.0,13/62,15.13%,SINHCAF;GREM1;VASH1;SFRP1;NFIB;GRIN3A;SFMBT1;SPRY3;PTPRS;MARCHF5;WNT9B;FGFR3;ADCK1
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.3867310901819136,-0.8313583667863848,0.7222222222222222,1.0,1.0,3/37,6.55%,NUP210;TPR;NUP37
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.3279561748378299,-0.8308639082285837,0.8461538461538461,1.0,1.0,17/92,19.61%,IFIH1;LOXL1;NUP210;TPR;P3H3;NUP37;EEF1AKMT1;SIRT2;NUP42;SIRT7;RNF113A;NUP107;NUP43;CTH;HDAC10;HDAC9;PIAS4
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.547391102616241,0.8305802721922304,0.6811594202898551,1.0,1.0,1/7,13.73%,FN1
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.32152805805423557,0.8305295372332953,0.8461538461538461,1.0,1.0,31/217,17.99%,ROPN1B;P2RY1;AGER;CD4;CCND2;RARRES2;TBX1;FAM20A;VEGFC;HGF;GPER1;FKBP8;FAS;TGFB1;PLAUR;CDK2AP1;ECT2;FN1;TTN;FBLN1;DAB2IP;FAXDC2;LIMCH1;NPTN;CHRNA7;PINK1;FXR1;CD74;TNIK;MUSK;LRRK2
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.3626444399196513,0.8305037895154377,0.782051282051282,1.0,1.0,17/65,23.66%,NCBP1;DNASE2;PCBP2;NCBP2;HNRNPA0;PCBP1;POLR2D;ANKLE1;RAD50;DDX1;POLR2K;NT5E;PDE12;DUSP11;HNRNPK;HNRNPR;METTL14
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),-0.4571475010770868,-0.8304323115062892,0.7111111111111111,1.0,1.0,2/14,5.61%,MLYCD;NUDT7
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.5006966980407493,0.8303154722987536,0.6111111111111112,1.0,1.0,4/6,23.10%,WAS;RHOU;NTN1;CDC42
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.4632661965165153,0.8303012551839222,0.7037037037037037,1.0,1.0,2/16,8.76%,TDRD9;BTBD18
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3906536607124737,0.8301309167361618,0.7536231884057971,1.0,1.0,5/46,8.29%,NLRP2B;CARD8;FADD;PELI3;CASP8
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.46133725767847933,0.829712463249951,0.6833333333333333,1.0,1.0,3/15,14.66%,P2RY12;NREP;FLRT3
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.4860052011453713,-0.8296321530947349,0.6511627906976745,1.0,1.0,2/9,6.86%,BCL2;BMP6
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.4564708925167388,-0.8295413479597932,0.7105263157894737,1.0,1.0,2/17,5.40%,MARK1;ZBED3
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.3667266706079276,0.8294118364579554,0.7741935483870968,1.0,1.0,16/63,19.29%,HPGDS;ERAP2;CPM;CPE;G6PD;LVRN;ENPEP;RHD;NAALADL1;GSTT2;GLRX2;FURIN;PCSK5;ERAP1;SPCS3;TRHDE
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.4515703310690148,-0.829300710473393,0.6744186046511628,1.0,1.0,2/11,19.36%,ENPP3;RC3H1
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.5308685192272462,0.8292625764720029,0.7543859649122807,1.0,1.0,3/7,17.74%,B3GALT1;B4GALT3;UGT8
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.5019008583987095,0.8289195655052123,0.7301587301587301,1.0,1.0,1/8,5.47%,GBA3
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.5192315900390279,-0.8287532231303986,0.7333333333333333,1.0,1.0,1/5,8.73%,JAG2
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.3567390699990416,0.8286424108791632,0.8142857142857143,1.0,1.0,10/97,6.87%,NES;TIMP3;LRP4;ADAMTS9;POSTN;ANGPTL2;RUNX1T1;IGFBP5;CPE;PRKG1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.32604179086981294,0.8286189500418912,0.8461538461538461,1.0,1.0,26/212,16.06%,LRP4;GLI3;ZNF703;GPC5;NOTUM;SCEL;TLE3;SFRP4;NKD2;FGFR2;PSMB6;BICC1;TGFB1;ATP6AP2;DAAM2;PSMA3;TLE6;HECW1;KREMEN1;PSMB8;RNF220;AMER2;DAB2IP;LGR6;UBR5;TMEM170B
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.39433066489596513,-0.8284973132472958,0.6842105263157895,1.0,1.0,5/16,26.15%,SMG6;NAF1;ATM;PARP1;SLX4
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.35989335597386307,-0.8283692289554645,0.7272727272727273,1.0,1.0,6/65,6.35%,SH3RF1;IGF1;TRIAP1;ITGA6;CFLAR;BCL2
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.3438813961505348,0.8280985620155259,0.7631578947368421,1.0,1.0,6/101,6.64%,LRP4;TMEM200C;NOTCH1;ZDHHC22;PTPRZ1;CPE
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.45528773459519856,0.8278710486980628,0.6507936507936508,1.0,1.0,3/14,20.00%,SLC2A1;RTN2;PRKAG2
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5011731702908557,0.8277302857866246,0.7457627118644068,1.0,1.0,2/8,10.77%,ARR3;DRD3
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.3032757855531702,-0.8277235965823805,0.8888888888888888,1.0,1.0,14/120,10.30%,TRIB2;HOMER2;LEF1;F2RL1;INHA;IFIH1;SRGN;APOA1;CIDEA;NR1H4;SARS1;RNF216;TRAF3IP1;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.5379339559405237,0.8274896339159827,0.6896551724137931,1.0,1.0,2/7,24.33%,DMTN;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.5379339559405237,0.8274896339159827,0.6896551724137931,1.0,1.0,2/7,24.33%,DMTN;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.42065295390797924,-0.8271020550610084,0.7368421052631579,1.0,1.0,9/17,23.03%,PLIN5;ABCD1;TRAP1;SIRT2;SLC30A10;ABCD2;PRKN;AATF;PPARA
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.4783751520052421,0.8270731356109976,0.7090909090909091,1.0,1.0,6/11,35.52%,BRCA1;TAF7;SET;CTBP1;SPI1;SNCA
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.39197499166894734,0.8269869207012267,0.7777777777777778,1.0,1.0,6/46,11.42%,PREX1;CHMP4B;WASF1;WAS;CASQ1;ARL6
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.5745867113597039,0.8269821757198706,0.8135593220338984,1.0,1.0,1/8,2.31%,RP1
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.4990174864698041,-0.8269764062083222,0.6363636363636364,1.0,1.0,3/8,29.04%,CCNT1;NELFE;RNF20
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.4209843820517442,-0.8269637767384868,0.5882352941176471,1.0,1.0,4/20,9.86%,RHOBTB1;TYRO3;RHOBTB2;SCARB1
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.48406764033110716,-0.8269495036055322,0.7619047619047619,1.0,1.0,3/8,19.42%,IWS1;SMARCB1;KAT7
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.3744803842091014,-0.8266906133703238,0.6388888888888888,1.0,1.0,5/20,9.07%,RBP4;DSCAML1;ID2;ALDH1A3;PDGFRA
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.4023680113853795,0.8266373224334775,0.7213114754098361,1.0,1.0,7/23,18.88%,RNF212B;IHO1;STAG3;MEIOB;SYCP2;MEI4;MAJIN
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.36197934600076975,0.8265806597538424,0.8260869565217391,1.0,1.0,18/91,19.28%,ALDH1A1;SLC23A1;TFCP2L1;ACSL5;PEX16;PECR;HSD17B6;AQP9;FADS2;BBOX1;DIO1;HSD17B11;DHCR24;SLCO1A2;PEX11A;PIPOX;PXMP2;RETSAT
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.36267375656677014,-0.8260357892821792,0.675,1.0,1.0,5/39,6.31%,SVEP1;LAMB3;FABP5;HDAC1;PTHLH
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.300739224341857,-0.8258555238940795,0.8125,1.0,1.0,20/126,13.53%,FEZF2;EPHA3;ASCL1;BCL2;KCNC1;RGS8;ZNF536;MAPK4;ADGRA1;GRIA4;RAB3C;MMD2;GAD2;STMN2;LRRTM3;ELAVL3;SRRM4;PAX6;CTNNA2;GRIA2
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.3780915294687037,-0.8258525861748504,0.8055555555555556,1.0,1.0,9/28,25.16%,MAP3K20;HUS1;CDC5L;ATM;TP53BP1;BRIP1;CHEK2;ATRIP;ATR
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.5623862431831305,0.8257310853895431,0.7446808510638298,1.0,1.0,1/5,7.39%,RPS6KA4
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.39709193382913727,-0.8257022065381342,0.7567567567567568,1.0,1.0,2/22,7.13%,NRG1;OLFM2
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.3822769573315373,-0.8256851421699337,0.8157894736842105,1.0,1.0,9/27,20.94%,IGF1;APOE;FGFR3;LEP;LATS1;SIN3A;DNM2;LATS2;NRCAM
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.34509747383430184,-0.825615442559505,0.7333333333333333,1.0,1.0,11/51,16.75%,H1-4;ZMIZ2;SPHK2;DDX21;BAZ1B;SERTAD2;ATAD2B;POLR2L;POLR1A;TAF1D;POLR1G
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.4005769418545752,-0.8253556738239142,0.7931034482758621,1.0,1.0,4/23,7.36%,PER2;ECE1;S100A1;ACE2
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.566099622370546,0.8249100084527504,0.7647058823529411,1.0,1.0,1/5,10.56%,BRCA1
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.3528304281706611,-0.8247935200306838,0.7142857142857143,1.0,1.0,11/52,18.85%,STING1;NSFL1C;RAB7A;UBXN2A;MAP1LC3A;ATG9B;EMC6;PACS2;WDR45;WIPI2;TP53INP2
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.48487454281205733,-0.8246451690608438,0.6451612903225806,1.0,1.0,4/12,18.34%,PCM1;CCDC68;CCDC120;HOOK3
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.42281073048671364,-0.824331033014558,0.7608695652173914,1.0,1.0,2/13,5.82%,AASS;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.31540754319720465,-0.8239192137891629,0.8571428571428571,1.0,1.0,14/206,5.77%,KIT;ALK;ROR2;KDR;EPHA3;FGFR4;EPHB2;EREG;IGF1;RASGRP1;ITGA6;DRD4;KNDC1;EPHA5
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.47714287367168445,-0.8237927301607826,0.7446808510638298,1.0,1.0,1/9,1.85%,GREM1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.505868800334351,-0.8237506359523521,0.6808510638297872,1.0,1.0,2/5,15.31%,NOS1AP;EGFR
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.36192052608893627,-0.8234562495013549,0.6176470588235294,1.0,1.0,4/32,10.60%,CYB5A;EMD;EMC8;UBE2J2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.42193241344408877,-0.8233807844785462,0.75,1.0,1.0,6/23,13.50%,KDR;MAPK7;IL11;MDK;SCG2;ANGPT1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.3706784383826548,-0.8231684038255063,0.5666666666666667,1.0,1.0,2/28,3.53%,PID1;IGF1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.33798339294530966,-0.8231363712823264,0.8,1.0,1.0,12/52,19.63%,FOS;PRKCD;MAPK7;PDGFRA;AKR1C3;MPV17;EGFR;ERCC6L2;SETX;PXN;TRPM2;PTPRK
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.48357491080675064,-0.8230286964722314,0.7045454545454546,1.0,1.0,2/10,14.81%,ANO1;STX4
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.5012355872315449,0.8229817832859181,0.6984126984126984,1.0,1.0,5/8,27.49%,UNC119B;PPARG;ZDHHC17;VMP1;CD36
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.33766713081460525,-0.8229283803876956,0.8235294117647058,1.0,1.0,16/64,21.29%,ERCC2;GTF2H2;IWS1;POLR2G;CCNH;SSRP1;GTF2F1;POLR2C;POLR2L;NELFA;RTF1;GTF2H5;ERCC3;CCNT1;SETD2;NELFE
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.36141358385614397,-0.8229150955838902,0.72,1.0,1.0,3/33,6.58%,SFRP1;EMD;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.36129141310390017,-0.822768024131735,0.7297297297297297,1.0,1.0,6/26,15.53%,PRKCD;MAPRE1;STMN2;SSH1;TBCD;TUBB4A
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.34930598117924444,0.8227569890786447,0.8333333333333334,1.0,1.0,15/70,21.18%,CSTF2T;SLU7;NCBP1;U2AF1;NCBP2;DDX39A;CLP1;THOC5;FIP1L1;CDC40;SARNP;POLR2D;SLBP;ALYREF;SRSF3
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.45938983576199993,0.8226985749412867,0.6724137931034483,1.0,1.0,1/12,3.71%,NOTCH1
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),-0.5469891169431279,-0.8226969406548383,0.7368421052631579,1.0,1.0,2/5,28.35%,PXN;SRC
prerank,PanglaoDB_Augmented_2021__B Cells,0.3466424612570816,0.8225157068390386,0.7123287671232876,1.0,1.0,27/88,17.50%,IL21R;BLNK;RCSD1;EBF1;PTPRC;ARHGAP9;GMFG;TAGAP;CORO1A;CD14;WAS;IFIT3;ARHGAP25;SCD;STAP1;RHOH;CD27;TMC8;BANK1;CD72;LY86;RASGRP3;BTLA;CD74;HVCN1;WDFY4;CD37
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.3687575683087153,-0.8224688606129948,0.6857142857142857,1.0,1.0,2/25,6.80%,RBP4;PDPN
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.47936760269748524,-0.8224532740023173,0.6739130434782609,1.0,1.0,1/10,1.09%,H1-4
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.517610039117834,0.8222925992076238,0.711864406779661,1.0,1.0,3/8,21.82%,NGLY1;MAN2A1;OGA
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.3869863331057084,0.822265973117342,0.7540983606557377,1.0,1.0,9/58,9.14%,ITK;EPHA1;PDGFRB;HCK;PRLR;IL15;FLT3;FGFR2;EFEMP1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.44848842088446966,0.8222646671303318,0.6842105263157895,1.0,1.0,2/15,12.23%,UPB1;DPYS
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.44125088046905075,-0.8222135780833328,0.7,1.0,1.0,2/14,8.04%,PID1;NR1H4
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.4403842195441976,0.8221876518076773,0.7377049180327869,1.0,1.0,3/19,10.56%,PPARGC1A;RPS6KA4;BRCA1
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.45869061226884955,0.8220571660221679,0.6818181818181818,1.0,1.0,3/12,12.31%,ELOVL2;ACOX1;FADS2
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.45024894446415076,-0.8219752586373538,0.6578947368421053,1.0,1.0,3/17,7.68%,KDR;IGF1;TYRO3
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.3826565206846016,0.8219100298635741,0.7837837837837838,1.0,1.0,6/44,8.29%,TRIM32;RCN3;FADD;ATP5IF1;NKD2;CASP8
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.4299494065038503,-0.8216426504844884,0.717948717948718,1.0,1.0,1/10,2.06%,LRRC17
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.3796829268390528,0.821615197981503,0.7714285714285715,1.0,1.0,11/34,27.65%,BNIP3;CTSK;PINK1;ULK1;WIPI1;FBXO7;ATG3;MAP1LC3B;GABARAPL1;GABARAPL2;FUNDC1
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.4585685335826,-0.8215721879743619,0.6829268292682927,1.0,1.0,2/12,7.50%,SPHK2;SPTLC1
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.4585685335826,-0.8215721879743619,0.6829268292682927,1.0,1.0,2/12,7.50%,SPHK2;SPTLC1
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.39372290353520367,-0.8215605245025649,0.6551724137931034,1.0,1.0,4/31,6.35%,CHCHD6;TMEM11;MTX1;BCL2
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.30405367987886756,0.821502183028641,0.9565217391304348,1.0,1.0,40/419,10.21%,TRIM22;CALCR;LRRC19;ROR1;TRIML2;AGER;CD4;TRIM5;CCL5;PDGFRB;NEUROD2;NTF3;BOK;TRIM32;PIK3R5;CXXC5;SCTR;P2RY12;PTPRC;FLT3;AGT;TGFA;FADD;BCAP31;GAB1;TBX1;CD14;TRAF3IP2;F10;CASP8;HGF;FGFR2;LITAF;SIAH1;GPER1;VWF;SOX11;PLCG2;RIT2;TGFB1
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.38494311916072765,-0.8215016984016903,0.7777777777777778,1.0,1.0,4/27,10.91%,GREM1;TRIAP1;IFI16;USP10
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.4364469662270629,0.8213148325293119,0.7258064516129032,1.0,1.0,1/23,0.91%,FRMD7
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.36957818346439625,-0.821097209189138,0.6666666666666666,1.0,1.0,6/47,8.04%,PKP2;PAH;FGFR4;CLDN4;CARD10;NR1H4
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.4279565731704465,-0.8210185066228156,0.65625,1.0,1.0,4/17,12.39%,CATSPER2;TGFB2;TGFB3;CATSPERG
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.36774733126823606,-0.8210027765353024,0.7647058823529411,1.0,1.0,3/40,6.72%,SDC4;CROCC;NUMA1
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.5319213418380904,-0.8208169383526495,0.6666666666666666,1.0,1.0,1/5,1.89%,CA2
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.4669363060520982,0.8208090941559975,0.7678571428571429,1.0,1.0,1/12,3.71%,NOTCH1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.4380619048224551,0.8207701925749151,0.7246376811594203,1.0,1.0,2/25,9.31%,LRP4;SAV1
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.4694705318952722,0.8205486885423379,0.7868852459016393,1.0,1.0,1/11,0.62%,CSRP3
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.3563729251444372,-0.8204332023567743,0.6774193548387096,1.0,1.0,10/42,20.71%,EYA4;BRCC3;ERCC8;SIRT7;EGFR;PML;RADX;KAT7;EYA2;BABAM2
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.35249820396301956,0.8204024304396004,0.7692307692307693,1.0,1.0,24/84,19.70%,PLA2G10;TRIM5;OPRK1;ISG20;ZDHHC11;PTPRC;FADD;IFNLR1;BNIP3;IFIT3;STAT1;IRF1;AGBL5;CGAS;IFI27;G3BP1;PLSCR1;BCL2L1;TLR2;NDUFAF4;SERINC3;IFIT1;IFITM3;ABCC9
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.4523537090088561,0.8202211821919704,0.7222222222222222,1.0,1.0,5/19,26.99%,MTFR1L;UQCRB;SLC25A14;MTFR1;UQCRHL
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.3595140189659889,-0.8196756347576721,0.6756756756756757,1.0,1.0,11/51,17.32%,NUP210;TPR;NUP37;POLR2G;EIF4G1;TRIM71;NUP42;POLR2C;POLR2L;NUP107;NUP43
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.3595140189659889,-0.8196756347576721,0.6756756756756757,1.0,1.0,11/51,17.32%,NUP210;TPR;NUP37;POLR2G;EIF4G1;TRIM71;NUP42;POLR2C;POLR2L;NUP107;NUP43
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.46963312622617776,0.819635360640397,0.7761194029850746,1.0,1.0,1/17,3.75%,LPCAT3
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.3307454743075027,0.8196157294986326,0.8795180722891566,1.0,1.0,32/189,23.63%,ENC1;RCN3;SYVN1;KBTBD6;PCBP2;KIF14;PSMB6;SIAH1;RNF122;RNF139;PSMA3;HECW1;PSMB8;DERL1;CCDC47;SPSB1;IFI27;TNFAIP1;PLAA;RNF41;RNF187;SPSB2;SPSB3;KBTBD7;KCTD10;FEM1C;FEM1B;PSMA5;PRAME;CUL4B;RNF185;KCTD2
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.40838740457781575,-0.8194235871769695,0.7837837837837838,1.0,1.0,1/17,4.58%,PTPN23
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.48312395940104286,0.8190814888124862,0.7457627118644068,1.0,1.0,7/13,23.05%,NQO1;CYP1B1;ARG2;MTARC2;DDAH2;CYB5B;CYB5R3
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),-0.4023263230368234,-0.8189731745193906,0.7027027027027027,1.0,1.0,3/9,21.72%,SPX;ACE;DDAH1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.3726098260164425,0.8184054487697272,0.7352941176470589,1.0,1.0,14/61,26.05%,CHMP4B;CASP8;CTSK;CLPX;LGMN;NGLY1;CTSZ;RNF41;VPS4A;CUL4B;CTSH;CLPP;MARCHF6;LONP1
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.47072736064602116,-0.8182248302239029,0.6857142857142857,1.0,1.0,1/10,7.20%,MTMR9
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.3822069047937542,-0.8181404298729235,0.75,1.0,1.0,7/32,19.10%,ARSB;CLN6;TPP1;GNPTAB;CLVS1;HOOK3;MTOR
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.4791359616116465,-0.8179746007178308,0.7272727272727273,1.0,1.0,2/7,20.30%,XIAP;PRKN
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.35528318316769086,0.8179578083484237,0.7777777777777778,1.0,1.0,11/63,15.96%,LMAN1;LPCAT3;VAPB;TRAM2;VCPIP1;ATL1;TLE6;OTOF;CCDC47;TRDN;TMEM33
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.5749294355005217,0.8178858181049761,0.8064516129032258,1.0,1.0,1/6,2.31%,RP1
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.47840772784853425,0.8176596133902255,0.7868852459016393,1.0,1.0,2/11,8.76%,TDRD9;BTBD18
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.472607190417298,0.817563524381267,0.6956521739130435,1.0,1.0,3/19,10.64%,SLC30A8;KHK;EIF2B5
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.5355997581531624,0.8175224801921074,0.6984126984126984,1.0,1.0,2/6,19.54%,SMAD7;NFKBIZ
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.535940715066596,0.8170560424121626,0.7777777777777778,1.0,1.0,1/6,12.18%,AKAP5
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.37201389229979764,-0.816826423126468,0.7037037037037037,1.0,1.0,7/43,11.75%,F2RL1;GREM1;RASGRP1;IGBP1;TGFB2;SEMA4C;KLHDC10
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.46649142669856175,0.8167707304571553,0.6779661016949152,1.0,1.0,1/9,11.78%,OPN3
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.3642777038142831,0.8167385852373518,0.7647058823529411,1.0,1.0,16/59,25.32%,PDCD1LG2;CD14;STAP1;DAB2IP;PDCD4;TLR2;CXCL13;CX3CR1;PLAA;CD80;LBP;CD274;GSTP1;ADAM9;SERPINE1;TNIP2
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),-0.5630714529281515,-0.8166941396577613,0.7435897435897436,1.0,1.0,1/5,16.49%,CFAP100
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.5197952095138244,0.8162063946551003,0.7627118644067796,1.0,1.0,1/6,5.66%,ZFPM1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.44015622526573234,0.8158236258027127,0.7068965517241379,1.0,1.0,4/14,19.74%,FASN;SCD;PPCS;ACAT1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.36863147673109586,0.8156786302780563,0.734375,1.0,1.0,12/79,14.40%,HSD17B2;ALPL;WNT8A;CDKN2D;SCD;CYP19A1;CD6;TGFB1;LOC400499;ESR1;SPP1;HNRNPA0
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.4960040239089943,0.8156369679221163,0.7903225806451613,1.0,1.0,1/7,3.71%,NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.449314841177887,0.8155607242188389,0.7333333333333333,1.0,1.0,5/15,14.59%,NOTCH1;MAML2;STAT1;NOTCH3;NOTCH4
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.35618493047760863,0.815555842564684,0.7671232876712328,1.0,1.0,30/82,26.27%,CCL5;PDGFRB;PLA2G7;IL15;P2RY12;AGT;RARRES2;SCIMP;TGFB1;POLR3G;LY86;PDCD4;PLSCR1;TLR2;IL18;MAPK13;IFI35;NFKBIZ;GBP5;ZCCHC3;PUM1;PLG;SERPINE1;ANKRD17;STX3;NLRP12;SASH1;PDE2A;CD47;NAPEPLD
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.3442346988570634,-0.8154407922767754,0.6666666666666666,1.0,1.0,16/65,23.44%,NUP210;IGF1;TPR;NUP37;ZBTB7A;NUP42;PFKFB3;NUP107;NUP43;ZBTB20;GCK;NUPR1;RAE1;PSEN1;PPARA;HDAC4
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.3863272670633211,0.8153648222898865,0.7681159420289855,1.0,1.0,11/53,21.28%,ARIH2;TRIM32;SYVN1;KBTBD6;RNF152;UBR5;IFI27;UBE2E1;RNF187;KBTBD7;UBE2H
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.4073766472127095,0.8151335390506719,0.75,1.0,1.0,7/25,24.09%,HSPA5;HSPA1L;HSPA8;DAB2IP;ERN1;HSPA14;PACRG
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.47773851316854543,-0.8149495305452896,0.6956521739130435,1.0,1.0,1/7,7.75%,NCSTN
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.40902701273190367,0.8149308888958208,0.7575757575757576,1.0,1.0,8/26,30.72%,USP14;UCHL5;CAMLG;NOP53;SVIP;BAG5;MAP1A;WAC
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),0.4860167774090042,0.8148145744992513,0.671875,1.0,1.0,2/6,13.92%,OPRK1;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.34737525953448395,0.8147604795861463,0.7894736842105263,1.0,1.0,15/87,15.89%,EPHA1;PTGIS;ITGA5;CYP1B1;TWIST1;GAB1;VEGFC;RHOB;BRCA1;AGGF1;ZNF304;SMAD1;SPHK1;NODAL;CHRNA7
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.4115361112663917,0.8147219459875217,0.7058823529411765,1.0,1.0,7/25,29.72%,RIPOR1;ARL1;GBP5;ARL5B;TMED10;BICD2;ARFRP1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.45227520167769164,-0.8145395422557469,0.6222222222222222,1.0,1.0,2/9,12.79%,APOE;CLU
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.3669663622114347,-0.8142804805609757,0.6976744186046512,1.0,1.0,4/29,11.55%,USP27X;BRCC3;USP25;OTUD5
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.5218249135388667,0.8142795022345062,0.7166666666666667,1.0,1.0,1/7,9.67%,STAP1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.33507294307823354,0.81421805167479,0.9024390243902439,1.0,1.0,25/182,15.71%,LAMA2;EPHA1;PLA2G10;SEMA3D;EMB;NOTCH1;SPTBN5;UNC5A;ARTN;LAMA1;GAB1;MYPN;CNTN2;SIAH1;NOTCH3;RHOH;CDK5R1;SEMA3F;SEMA3A;NEXN;CHN1;LRTM1;LGR6;EPHA6;NPTN
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.40212211003685994,-0.8141193834545414,0.6944444444444444,1.0,1.0,9/22,20.75%,TCIM;RITA1;ZBTB7A;BEND6;EGFR;EGFL7;NIBAN2;NEURL1;HEY1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.3157575601973823,-0.8136021205741681,0.8620689655172413,1.0,1.0,19/85,15.06%,PCBP3;EREG;LSM10;SF3B4;SF3A2;LSM6;U2AF2;SON;SNRPB;SF3A1;KIN;SRRM4;DIS3L2;SRSF7;SCAF11;PTBP1;HSF1;AURKAIP1;PNPT1
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.5222243659964725,-0.8135765697625797,0.7368421052631579,1.0,1.0,4/6,16.33%,PRDM5;SUV39H2;BEND3;SETDB1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.42917059704255234,0.8134274575559624,0.7931034482758621,1.0,1.0,2/19,6.26%,PTPRC;GPRC5A
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.3912603965014914,0.813333606642441,0.7837837837837838,1.0,1.0,5/37,11.65%,TICRR;CDC6;DONSON;BRCA1;MRE11
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.36706805882666177,0.8133091103539092,0.75,1.0,1.0,11/66,9.37%,TIMP3;ACTA2;PDGFRB;POSTN;LOXL2;FBLN5;NID2;IGFBP5;SRPX;VEGFC;RSPO3
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.41349688723940803,-0.8132851916626999,0.7916666666666666,1.0,1.0,1/21,2.16%,UNC13B
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.3755793080681171,-0.8129583368449749,0.71875,1.0,1.0,4/27,9.64%,NAXE;PTCH1;APOA1;APOE
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.5167719408365388,-0.8125988776581377,0.7045454545454546,1.0,1.0,2/6,17.44%,DNAJC3;EIF2AK4
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.49689689443930674,0.812522283534017,0.703125,1.0,1.0,1/8,8.11%,HMGCR
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.5079555941858226,0.8124107271598601,0.7846153846153846,1.0,1.0,3/8,19.82%,INSIG2;INSIG1;ERLIN1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.5079555941858226,0.8124107271598601,0.7846153846153846,1.0,1.0,3/8,19.82%,INSIG2;INSIG1;ERLIN1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.3198853203748936,0.812360883356386,0.9154929577464789,1.0,1.0,28/242,12.19%,GADD45B;ZNF703;NLRP2B;GMNN;SMIM22;NOTCH1;TRIM32;INHBA;JUNB;PTPRC;CDKN2D;FIGNL1;CDKN1B;LIN9;CDC25A;UHRF2;FGFR2;RHOB;GPER1;FBXL6;CRLF3;TGFB1;BRCA1;SPATA22;IRF1;FBXL3;WDR6;CHMP1A
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.39996045136226427,0.8123486652474239,0.7192982456140351,1.0,1.0,10/34,24.58%,KDM3A;GPER1;ESR1;TMF1;UBR5;NCOA4;RHOXF1;ESR2;YAP1;UBE3A
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.4015332161891137,0.8123276309034871,0.7702702702702703,1.0,1.0,4/34,9.36%,LRP4;WFS1;AGT;STAT1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.524412981887407,0.8122863230081755,0.7272727272727273,1.0,1.0,1/7,7.04%,BNIP3
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.4750363975355031,-0.8121981071016471,0.7027027027027027,1.0,1.0,2/8,6.35%,RASGRP1;BCL2
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.3783045580859601,-0.8119809147337315,0.7428571428571429,1.0,1.0,9/33,14.59%,IFIH1;RNF216;TRAF3IP1;PTPRS;OTUD5;YY1;REL;CACTIN;MAVS
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.4541084500173289,0.8115579665230396,0.8032786885245902,1.0,1.0,6/18,30.76%,MIEF2;MIGA1;THG1L;MIEF1;MFN1;BAX
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),0.5600164197481408,0.8115084495269765,0.7962962962962963,1.0,1.0,2/5,7.12%,SYT4;REST
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.4544192316615349,-0.8113042203656834,0.675,1.0,1.0,5/12,18.15%,AASS;DNMT1;PHF1;DNMT3B;MACROH2A1
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),-0.44823951620082425,-0.8112235520008505,0.5641025641025641,1.0,1.0,1/13,9.82%,ALKBH8
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.43021747381976316,0.8109302128897858,0.7966101694915254,1.0,1.0,2/17,12.23%,UPB1;DPYS
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.4731584500747712,-0.8109111985767133,0.6511627906976745,1.0,1.0,1/6,6.00%,IGBP1
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.40776374421677253,-0.8103874338605753,0.6862745098039216,1.0,1.0,1/17,1.91%,GUCY2C
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.38669895308719626,-0.8101802694765751,0.7368421052631579,1.0,1.0,7/33,20.14%,LSM6;SRFBP1;WDR46;NOP14;RIOK1;RRP36;BMS1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.4990475423294933,-0.8098503879675244,0.6086956521739131,1.0,1.0,1/6,5.47%,NPHS1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.4990475423294933,-0.8098503879675244,0.6086956521739131,1.0,1.0,1/6,5.47%,NPHS1
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.43975445017001413,-0.8097171934479462,0.7073170731707317,1.0,1.0,1/11,4.11%,APLN
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.3473840904716851,-0.8096489252319431,0.7419354838709677,1.0,1.0,7/51,7.66%,PER2;MLYCD;OSBPL7;ALDH1A2;ACOT8;ALDH1A3;ACSF3
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.4388917914337437,-0.8094450441524024,0.6904761904761905,1.0,1.0,6/10,24.60%,SEPHS1;PSAT1;CTH;PSPH;SRR;MTHFD1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.3399998369784459,-0.809364983606585,0.7307692307692307,1.0,1.0,6/71,6.32%,TRPC3;CACNG3;CACNA2D1;RYR1;GRIN3A;CACNA1A
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.3080019224414283,-0.8093232465693105,0.8888888888888888,1.0,1.0,13/134,10.94%,FBXL7;KCNH5;DBF4B;AURKA;HMMR;CDK5RAP2;MAPRE1;NEDD1;PCNT;ODF2;PCM1;RAD51B;TUBG1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.3480018278562177,0.8092990179887571,0.8082191780821918,1.0,1.0,10/70,17.96%,C4BPB;TRIM32;CDKN1B;HECW1;TIPARP;VPS35;DAB2IP;FURIN;MSN;C4BPA
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.44226874684794226,0.8091254010007519,0.7543859649122807,1.0,1.0,2/19,12.14%,TPX2;TUBGCP4
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.4207936571998139,0.8091067405410829,0.7580645161290323,1.0,1.0,3/18,10.18%,BNIP3;SIAH1;FAS
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.3981751321891084,0.8090869742570188,0.6666666666666666,1.0,1.0,8/32,17.79%,CCL5;HSD17B13;ADGRB1;PLCG2;TGFB1;SCX;RGCC;CREBL2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.4539419183755537,0.8086963604052478,0.6956521739130435,1.0,1.0,5/12,10.21%,ADAMTS9;FGFR2;MYBPC3;SMAD7;TGFB1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.35388941639943355,-0.8086559841511135,0.7837837837837838,1.0,1.0,19/79,17.63%,SFSWAP;HNRNPL;SF3B4;NCL;ZBTB7A;RBM11;RBMX;U2AF2;SON;SRRM4;CIRBP;SRSF7;PTBP1;KHDRBS3;RBM3;RBM25;CELF5;PCBP4;CELF4
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3678753242252268,-0.808427056293763,0.7428571428571429,1.0,1.0,6/43,11.83%,MELTF;SPRY4;PDPN;APOA1;NRP1;MDK
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.5285888924254338,-0.8081087652803962,0.7346938775510204,1.0,1.0,3/8,22.31%,MAPRE1;MID1;MID2
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.40818722422803755,-0.8080977296993455,0.7142857142857143,1.0,1.0,6/20,8.79%,MYH14;LEMD2;RYR1;CFLAR;SVIL;SELENON
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.45770880858443713,0.8079334694779304,0.7288135593220338,1.0,1.0,1/14,5.18%,SLU7
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),0.5678461286678713,0.8078356161729571,0.8363636363636363,1.0,1.0,1/5,1.56%,IL18R1
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.34068947714530873,0.807817414771204,0.8115942028985508,1.0,1.0,23/95,23.35%,ALDH1A1;HSD11B2;ACSL5;ABCB1;SOD2;ECI2;SIAH1;YWHAH;ACOX1;ABCB4;PEX11B;DIO1;HSD17B11;DHCR24;PEX11A;SLC25A19;RETSAT;ESR2;MVP;SLC25A4;PEX5;ACSL4;IDH1
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.4591950421018185,0.8076244804435568,0.7627118644067796,1.0,1.0,1/21,1.45%,TDG
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.46238215490422985,-0.80762327258691,0.6756756756756757,1.0,1.0,1/9,3.05%,ST3GAL1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.4335624878938575,0.8074621255115406,0.8490566037735849,1.0,1.0,6/20,12.03%,CCL5;PDGFRB;NTF3;FGFR2;ARL1;ESR1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4171198297186986,0.8074336751102758,0.7413793103448276,1.0,1.0,5/18,16.44%,CNGB1;GUCY2F;CNGA1;PDE6B;METAP1
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.5548377733222254,0.8072912602581626,0.75,1.0,1.0,1/5,20.49%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.4393406640049667,0.8072704470573197,0.6984126984126984,1.0,1.0,2/12,6.86%,NOTCH1;SOX6
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.4607660171898631,-0.8071287003692975,0.6904761904761905,1.0,1.0,4/14,20.89%,ERCC1;XRCC3;TPRKB;MSH3
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),0.5076125074345035,0.8070593728902745,0.7166666666666667,1.0,1.0,2/7,24.06%,PINK1;TOMM7
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.43581150135999513,-0.8070107733728572,0.6444444444444445,1.0,1.0,2/13,8.84%,CA2;ANO6
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.44507021316420914,0.8068180347136741,0.8214285714285714,1.0,1.0,3/14,12.75%,PHKG1;PHKA1;AGL
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.4435282755647869,-0.8067774509206875,0.6363636363636364,1.0,1.0,1/7,7.42%,ERCC1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.3416470823503079,0.8067202122056223,0.8405797101449275,1.0,1.0,11/120,6.45%,LAMA2;MYLK;TIMP3;HSPG2;ACTA2;PDGFRB;POSTN;ANGPTL2;NID2;PLSCR4;IGFBP5
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.4921274454544641,0.8064856546587559,0.7049180327868853,1.0,1.0,3/14,13.90%,ADAMTS9;MANBA;NGLY1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.3773650509470019,0.8064067299671601,0.75,1.0,1.0,2/44,1.97%,PTGIS;CCL5
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),-0.5162534416626191,-0.8062984124905909,0.75,1.0,1.0,2/8,13.86%,ECE1;VAMP3
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.32933606597479675,-0.8061947658831543,0.7333333333333333,1.0,1.0,11/92,9.49%,TRPC3;TRPC7;CACNG3;CACNA2D1;RYR1;CACNA1I;GRIN3A;CACNA1A;TRPC4AP;ANO6;CRACR2A
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.40308266946716553,-0.8061203360179323,0.723404255319149,1.0,1.0,1/21,0.35%,KIT
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.3837777589936827,-0.806080019331852,0.6944444444444444,1.0,1.0,5/17,24.53%,CLU;NOS1AP;TMEM106A;DDAH1;ASS1
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),0.5083142727482887,0.8060040259391411,0.7547169811320755,1.0,1.0,3/10,10.08%,FADD;CASP8;SCIMP
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.49835502611261273,0.8059926639291115,0.7692307692307693,1.0,1.0,1/5,11.86%,VCPIP1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.3819639071963085,0.8058774189657976,0.8064516129032258,1.0,1.0,7/46,10.41%,ITK;CD4;CD8A;PTPRC;NHEJ1;CASP8;RHOH
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),-0.468475824785568,-0.8058029172846887,0.7058823529411765,1.0,1.0,1/5,10.50%,XIAP
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.38800084802432916,-0.8057593720251189,0.7333333333333333,1.0,1.0,1/12,1.05%,TBX6
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.37787069741458995,0.8055376484524789,0.8142857142857143,1.0,1.0,11/64,17.42%,PDGFRB;PLCH1;PIK3R5;CD160;PLCD3;PLCL1;HTR2B;PIK3C2G;PTAFR;INPP5F;PLCD1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.5227530309670464,-0.8051430884303946,0.8,1.0,1.0,3/7,10.76%,APOA1;APOE;NRP1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.30302382855818116,-0.8050575588042372,0.9,1.0,1.0,17/146,7.66%,KDR;SPRED1;TSPAN12;NAXE;VASH1;RUNX1;ADAM12;SFRP1;COL4A3;GTF2I;PIK3R6;RHOJ;ETS1;VASH2;TGFB2;BTG1;HSPB1
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.4494399223985533,-0.8049481822211226,0.6666666666666666,1.0,1.0,3/11,16.61%,CCDC22;COX19;ATP7B
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.27018056383668637,-0.8048000150126621,1.0,1.0,1.0,50/322,17.32%,NOX4;CPSF1;LMF2;NUP210;DTX1;TPR;HNRNPL;ADARB2;CHTOP;LMF1;MAGOHB;NUP37;DHX8;MRPS18A;SMG6;PTMA;THOC1;POLR2G;RBMS2;MRPL55;EIF4G1;RRBP1;PRPF4;SARS1;SORL1;RBMS1;IGF2BP3;U2AF2;SRRM1;NUP42;DNAJB11;SRSF7;POLR2C;POLR2L;CASC3;RPS26;NXF5;RBM3;TASP1;RPL12;FUBP3;FARSB;MRPL9;ATXN1;SETX;NUP107;TSPAN32;POLR3A;MRPS7;NUP43
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.48644719375220286,0.8046503925645797,0.7636363636363637,1.0,1.0,3/7,33.50%,PLSCR1;UHRF1;ITGAM
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.32498745565377507,0.8046079616846763,0.8953488372093024,1.0,1.0,41/186,27.19%,MCM2;TCP1;PRDX4;POLE3;NCBP1;U2AF1;EIF1AX;NCBP2;PCNA;DHX15;VBP1;GNL3;SNRPD2;EPRS1;G3BP1;PCBP1;RPL22;CDK4;UBE2E1;MCM6;RRM1;H2AZ1;RPS5;SRSF3;CCT7;COPS5;HNRNPR;VDAC1;RNPS1;CBX3;CUL1;DEK;SSB;PSMC6;SYNCRIP;MAD2L1;SRPK1;VDAC3;SLC25A3;IFRD1;ERH
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.36004344214364103,-0.8046026519358158,0.7272727272727273,1.0,1.0,5/37,9.98%,NPNT;PDPN;GCNT2;SPOCK1;RSU1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.29058051666655793,-0.8043648344556913,1.0,1.0,1.0,19/198,7.68%,UBASH3B;SULF2;PTPRT;PID1;SPRY4;RGS14;NFATC1;TRABD2A;APLN;SFRP1;TCIM;RITA1;PTCH1;PRKCD;PLIN5;HMGXB4;BCL2;CILP;TYRO3
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.34526154397930114,0.8041777280496727,0.8181818181818182,1.0,1.0,16/98,13.76%,LIPH;ACSBG1;ACOT4;BAAT;FASN;ACSL5;ALOX12;PPARGC1A;ADIPOR2;ACOX2;CPT1C;LIPI;ACOX1;MSMO1;ALOXE3;ACSM4
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.3388469839641215,-0.803939193271109,0.7352941176470589,1.0,1.0,12/73,8.04%,EPHB2;IFIH1;IGF1;RASGRP1;AZU1;SPHK2;TLR1;FOXP1;CIDEA;HSPB1;STAT3;NR1H4
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.4973563431073829,-0.8038702926550229,0.75,1.0,1.0,1/8,1.09%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.4973563431073829,-0.8038702926550229,0.75,1.0,1.0,1/8,1.09%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.4973563431073829,-0.8038702926550229,0.75,1.0,1.0,1/8,1.09%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.3318827435904012,-0.8032369338364124,0.8235294117647058,1.0,1.0,11/64,15.70%,EPHA3;APOA1;BMP6;MCTP1;NR1H4;TRAF3IP1;SORL1;CLU;CARMIL2;HSF1;IRAK3
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.3388684773991256,0.8031391034263455,0.8787878787878788,1.0,1.0,19/90,17.69%,CALB1;EXPH5;EPB41L4A;TFCP2L1;TRPM6;PPARGC1A;MUC4;MYO5B;TMEM213;BBOX1;PIK3C2G;ALDH1L1;MUC20;ADGRF5;ATP1B1;SPTLC3;CLMN;ATP5MK;SLC22A8
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.45395213723680783,0.8027745694781848,0.7741935483870968,1.0,1.0,2/16,2.91%,CCL5;PLA2G7
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.4827079073088788,-0.802752181549269,0.7441860465116279,1.0,1.0,2/7,25.31%,DIRAS3;DNMT3A
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.347055079757591,-0.8025007694248835,0.7666666666666667,1.0,1.0,9/49,10.50%,EREG;LYAR;TRAFD1;POLR3D;SAMHD1;TYRO3;LRP8;IFI16;XIAP
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.4570332256709736,0.8023352153596974,0.6984126984126984,1.0,1.0,2/13,9.50%,GMNN;DONSON
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.3099582658095202,0.8018223028217505,0.926829268292683,1.0,1.0,64/306,19.70%,PTGIS;LDLRAP1;IL18R1;CD4;CCL5;HCK;PRLR;PLP2;CRLF1;JUNB;DOCK8;FLT3;TWIST1;OSMR;PTPRZ1;IFNLR1;CDKN1B;STAT4;YBX3;CSF2RA;HGF;IL20RA;IL7;GPER1;STAT1;CTF1;NANOG;TGFB1;BRCA1;IRF1;IL20RB;STAT6;TXLNA;RHOU;STAT5A;NPR2;HSPA8;PTPN20;INPPL1;OPRD1;TCF7;FN1;DAB2IP;PTAFR;EPRS1;PYHIN1;PIM1;IL3RA;CRHBP;BCL2L1;NDN;TLR2;IL18BP;IL18;GBP6;IFIT1;MAPK13;IRAK4;IL5;CD80;MAOA;LBP;PIK3CB;SHC1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.39142296118307784,0.80163288136186,0.746268656716418,1.0,1.0,3/28,7.12%,LRRC19;CCL5;REST
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.37679550638740766,-0.8016128348046231,0.7857142857142857,1.0,1.0,7/37,14.90%,RING1;TFDP1;E2F6;RRM2;PCGF6;EHMT2;UXT
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.43092038271808514,0.801472359305146,0.7205882352941176,1.0,1.0,4/25,9.76%,RCN3;CCDC39;FGFR2;SOX11
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.49913482487544963,0.8014070773635624,0.7241379310344828,1.0,1.0,1/6,5.86%,SPTY2D1
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.4409595629826434,-0.8010035712913317,0.7608695652173914,1.0,1.0,4/14,10.25%,RUNX1;SERPINF2;TGFB3;CREB3L1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.46901640799002964,-0.8006105395088428,0.725,1.0,1.0,3/9,9.64%,TRIAP1;APOA1;APOE
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.5311316339208577,0.8005856138284635,0.7818181818181819,1.0,1.0,3/6,17.74%,B3GALT1;B4GALT3;UGT8
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.5311316339208577,0.8005856138284635,0.7818181818181819,1.0,1.0,3/6,17.74%,B3GALT1;B4GALT3;UGT8
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.4569697627292214,0.8005211030635014,0.7241379310344828,1.0,1.0,4/14,20.86%,HSD17B10;TSPOAP1;AKR1B1;AKR1D1
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.48556691989027706,0.8002608371669585,0.8103448275862069,1.0,1.0,1/10,9.88%,SDHAF3
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.37339665059186766,-0.8002478132337203,0.8235294117647058,1.0,1.0,7/29,16.34%,ALG8;DPM3;OST4;RPN2;UGGT2;DERL3;RPN1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.5027038069943899,-0.8002175812906599,0.7027027027027027,1.0,1.0,1/7,0.84%,BMP7
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.40738246424931884,0.7999162871552037,0.7903225806451613,1.0,1.0,7/25,20.00%,CCL5;PRKAB2;ADIPOR2;MITF;PDK4;CX3CR1;PRKAG2
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.34189638075274825,0.7998228013827259,0.8307692307692308,1.0,1.0,12/123,12.39%,CALB1;AGER;KCNN4;GRM3;SYT4;CNTN2;RIT2;KCNJ9;C11ORF87;GFAP;SPINK8;CA10
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.2772094260228062,-0.7997158322007617,1.0,1.0,1.0,26/100,21.15%,GRIK4;CACNG5;HCRT;CACNA1A;CLSTN2;MCTP1;KCTD13;NMU;LRP8;NPTXR;NGF;NPTX2;BTBD9;NLGN3;MCTP2;DLGAP4;SLC8A3;UNC13A;CACNA1B;RIMS1;GRID1;RELN;SNCAIP;HOMER1;GRIK1;DLGAP2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3638348678364068,-0.7996019061735968,0.6666666666666666,1.0,1.0,1/36,0.56%,UBASH3B
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.4260800305752361,0.7994759457236905,0.7313432835820896,1.0,1.0,6/22,18.00%,AGER;ELANE;IL7;CD74;TLR2;IL18
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.5084158626991592,-0.7994260300567086,0.7346938775510204,1.0,1.0,1/7,4.55%,DDX60
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.45243499665641773,0.7993122990072393,0.7419354838709677,1.0,1.0,4/12,16.54%,CUEDC2;PLCG2;TGFB1;CD74
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.35555400497117207,0.7993051269313418,0.8382352941176471,1.0,1.0,8/70,14.14%,MMP15;RABGGTB;LOXL2;CPE;MANBA;PIGH;PLOD2;UBL5
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.3628401390954766,0.7991184838311487,0.8405797101449275,1.0,1.0,7/37,21.81%,LDLRAP1;STARD4;SOAT1;ABCG5;VPS4A;STARD5;SERAC1
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.4908599479830575,0.7990923202907677,0.7796610169491526,1.0,1.0,2/9,7.37%,SLC23A1;SLC2A1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.3322555720582925,-0.7987324400224759,0.7692307692307693,1.0,1.0,15/79,12.75%,BMP7;LEF1;MYO3A;ST8SIA2;SYT6;VASH2;IGLON5;FRAS1;LIN28B;IGDCC3;PHF21B;CDH1;TRIM71;ERAS;SEMA6A
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3764816100726967,-0.7985920992663942,0.7727272727272727,1.0,1.0,1/28,0.35%,KIT
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.3090483501284783,-0.79836167460251,0.8,1.0,1.0,23/127,14.38%,POU6F2;PROS1;ASCL1;NTNG1;ST8SIA2;ITGA6;RHBDL3;MAPK7;VLDLR;KCNC1;FBLL1;MAPK4;NYAP1;IGDCC3;LRP8;PHF21B;STMN2;PHF1;ELAVL3;PRR36;PLPPR5;SEMA5B;DLX2
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),-0.4049786266412462,-0.7980911208955286,0.7804878048780488,1.0,1.0,8/14,22.75%,COQ6;COQ9;COQ2;PDSS2;UBIAD1;COQ7;COQ10B;PDSS1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.3011319156996176,0.798075229106868,1.0,1.0,1.0,64/433,17.07%,MSX1;BTN2A2;TDRD9;WFS1;NLRP2B;GMNN;ATF5;RASA1;SSTR1;NOTCH1;LPCAT3;FABP3;ADGRB1;CYP1B1;CHMP4B;INHBA;CDKN2D;PSRC1;RND1;OSGIN2;KNG1;NAIF1;IFNLR1;CDKN1B;BNIP3;TBX1;REST;SFRP4;SOD2;IFIT3;BTBD18;CGRRF1;RHOB;CDC6;GPER1;CRLF3;SOX11;TGFB1;LRPAP1;IRF1;RNF139;TP53TG5;WDR6;CHMP1A;KLF11;KANK2;TSC2;HTR2B;PDS5B;NOTCH4;VPS35;FBLN1;DAB2IP;PODXL;TCHP;PDCD4;CLMN;NME6;CHMP2A;RGCC;PLSCR1;CDK6;TESC;TLR2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.35198411677797803,-0.7977372478740435,0.7647058823529411,1.0,1.0,8/30,13.46%,RBP4;SIPA1L3;TGFB2;PBX4;SMG9;SMOC1;CHRDL1;PAX6
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.4861780226407116,0.7974786276032371,0.7627118644067796,1.0,1.0,1/10,4.31%,CYP1B1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.3780760636826257,-0.7974607507394023,0.7777777777777778,1.0,1.0,7/28,16.34%,ALG8;DPM3;OST4;RPN2;UGGT2;DERL3;RPN1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.4145244767341981,-0.7972915780050093,0.7,1.0,1.0,1/15,1.32%,MELTF
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.36160464674182635,0.7971540309829741,0.7605633802816901,1.0,1.0,8/39,16.75%,WEE2;CDKN1B;BUB1B;TGFB1;GAS1;NME6;RGCC;TOM1L1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.3458962397615308,0.7971184723179553,0.8382352941176471,1.0,1.0,11/97,17.98%,PLA2G10;PDGFRB;PIK3R5;PLCG2;PGAP3;INPPL1;PIK3C2G;PLEKHA2;INPP5F;PLCD1;PIP4K2C
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.38190334792651903,-0.7969993186097081,0.7317073170731707,1.0,1.0,7/35,14.90%,RING1;TFDP1;E2F6;RRM2;PCGF6;EHMT2;UXT
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.39739927876276027,-0.79699808054684,0.7619047619047619,1.0,1.0,4/21,10.04%,EREG;IGF1;PDGFRA;PDGFC
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.33769804377159773,-0.7969255042978838,0.8571428571428571,1.0,1.0,10/88,10.18%,KIT;TPD52L1;PDGFD;RASGRP1;TCIM;PIK3R6;INCENP;TELO2;PDGFC;SYAP1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.373387575680554,-0.796712468525439,0.631578947368421,1.0,1.0,8/34,15.73%,MELTF;SPRY4;GCNT2;SPOCK1;AJAP1;TBCD;PTPRO;NEXMIF
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.33986737264391026,0.7964449987792613,0.8533333333333334,1.0,1.0,9/82,18.50%,PELI3;RPS6KA4;TOLLIP;PSMB6;RIPK2;PSMA3;PSMB8;TAB2;IRAK4
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.32984673887388605,-0.7963682239174019,0.8846153846153846,1.0,1.0,4/55,12.81%,KDR;HSPB1;NRP1;ELMO2
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.5075433971412681,0.7963570370376034,0.7169811320754716,1.0,1.0,3/7,38.26%,CDC42;ANKFY1;APPL1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.45092395004205427,0.7960929626503516,0.6851851851851852,1.0,1.0,5/14,22.30%,C10ORF90;BRCA1;MDM1;CEP76;KAT2B
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.35440200368186575,0.7960336000904346,0.7837837837837838,1.0,1.0,11/69,14.76%,MARVELD2;ROR1;WFS1;SLC26A4;TBX1;EYA1;MYO3B;PIEZO2;NDUFB9;KCNQ1;CDC14A
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.4930324367194125,-0.7960015200630927,0.7297297297297297,1.0,1.0,2/8,10.76%,ASCL1;NRP1
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.398059454771265,-0.795906010043285,0.7209302325581395,1.0,1.0,1/23,0.35%,KIT
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.30682761413143006,0.7958595997826889,0.9634146341463414,1.0,1.0,20/285,9.55%,NR1I3;HNF4G;RREB1;GCM2;ZBTB7B;NR2E3;NOTCH1;CSTF2T;NR5A2;ABT1;NCBP1;TEAD4;TBP;PPARGC1A;MAML2;NCBP2;COPS2;TBPL1;NOTCH3;GLIS3
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.5167022026706285,0.7958066669057628,0.7741935483870968,1.0,1.0,5/8,27.60%,SEMA3F;SEMA3A;SLIT1;SLIT2;ALCAM
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.5167022026706285,0.7958066669057628,0.7741935483870968,1.0,1.0,5/8,27.60%,SEMA3F;SEMA3A;SLIT1;SLIT2;ALCAM
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.454716355035759,0.7955997693153534,0.7166666666666667,1.0,1.0,4/12,23.89%,NANP;GNPDA1;GFPT2;UAP1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.28923463096458385,-0.795108114045933,0.95,1.0,1.0,60/276,18.30%,CPSF1;SNRNP27;ERCC2;HNRNPL;SF3B4;SF3A2;RBM41;CHTOP;MAGOHB;GTF2H2;LSM6;PPIH;DHX8;ELAVL1;THOC1;POLR2G;RBM10;RBMX;PRPF4;RBM17;TXNL4A;ZCRB1;CCNH;U2AF2;CPSF7;SON;SRRM1;GPATCH1;GTF2F1;SNRPB;SF3A1;KIN;SRRM4;ZRSR2;SNRPN;RBM19;DDX41;SRSF7;POLR2C;SCAF11;PPIL1;POLR2L;PTBP1;CASC3;CACTIN;CDC5L;RSRC1;AURKAIP1;PDCD7;PRPF6;DDX46;RNF113A;SF3B6;CWF19L2;LSM7;SYMPK;PRPF3;GTF2H5;SRRT;WBP4
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.36758997795693393,0.795022336094709,0.7183098591549296,1.0,1.0,8/50,18.06%,NDUFA2;NDUFB9;NDUFB3;NDUFB2;NDUFB4;DMAC1;NDUFAF4;TMEM126B
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.36758997795693393,0.795022336094709,0.7183098591549296,1.0,1.0,8/50,18.06%,NDUFA2;NDUFB9;NDUFB3;NDUFB2;NDUFB4;DMAC1;NDUFAF4;TMEM126B
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.4191096563996746,-0.794916032689003,0.7567567567567568,1.0,1.0,3/18,14.55%,SPHK2;SPTLC1;SGPP2
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),0.5307254016711755,0.7948270000527354,0.7903225806451613,1.0,1.0,3/5,18.34%,IHO1;MRE11;MEI4
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.43237024667709434,0.7946955957136214,0.7833333333333333,1.0,1.0,3/20,13.14%,SLC30A8;SLC39A12;TMC8
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.4671647314548062,-0.7945887157337467,0.7317073170731707,1.0,1.0,3/12,13.73%,GCH1;PYCR3;NOXRED1
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),-0.500395355076468,-0.7943712560530941,0.717948717948718,1.0,1.0,1/6,5.69%,LRFN4
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.44224213632571674,-0.7942870548438771,0.7297297297297297,1.0,1.0,1/7,5.04%,COL4A3
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.3054603878600467,0.7941039717168753,0.9375,1.0,1.0,37/332,10.21%,NES;EPHA1;ZNF703;CCL5;PDGFRB;HCK;SPDYA;PRLR;ELANE;CRLF1;NOTCH1;NTF3;IL15;NOX1;ZNF16;CCND2;PTPRC;FLT3;AGT;OSMR;TGFA;CAPN1;TSHR;NAMPT;TBX1;AVPR1A;KIF14;COPS9;VEGFC;IL7;FGFR2;GPER1;STAT1;CTF1;SOX11;NANOG;TGFB1
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.42891741396629257,0.7940997038680919,0.8059701492537313,1.0,1.0,2/16,5.44%,FUT2;B3GALT1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.47442817218821465,-0.7939504996119884,0.7073170731707317,1.0,1.0,1/8,1.85%,GREM1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.5411107852200121,0.7938514489760883,0.78125,1.0,1.0,1/5,11.73%,ZNF304
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.3447308344459711,0.7936838171759641,0.8115942028985508,1.0,1.0,10/75,13.64%,ATF5;TUBB;TPX2;KIF14;CEP72;YWHAG;TUBA4A;CEP70;ATAD5;CCP110
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.5249392269477303,-0.7936262586948148,0.7111111111111111,1.0,1.0,2/5,29.39%,PPIB;TBC1D20
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.3842584331749423,-0.7933932506873027,0.7297297297297297,1.0,1.0,5/32,6.81%,BMP7;ADAM19;PTPN23;SERPINF2;GCNT2
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.35781792017389114,0.7932643406418287,0.7571428571428571,1.0,1.0,11/61,20.23%,IRS4;RARRES2;GAB1;NAMPT;ATP6V1B2;ATP6AP1;ATP6V1C1;PDK4;ATP6V1C2;SHC1;ATP6V0B
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",-0.5437054137129244,-0.7931160394010995,0.7674418604651163,1.0,1.0,1/5,0.83%,MYB
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.35112370739808313,0.793091939627344,0.8732394366197183,1.0,1.0,12/64,15.18%,AOX1;SLC23A1;SLC19A3;AMN;CBLIF;SLC2A1;TCN2;SLC52A2;PRSS3;SLC52A1;ALDH1L1;RFK
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3646193264476845,0.7927938741055716,0.7638888888888888,1.0,1.0,14/63,22.99%,RFC5;ISG20;IHO1;MRE11;RPA3;PCNA;MEI4;ANKLE1;RAD50;DDX1;POLD1;PDE12;CUL4B;ERCC4
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.41183372073711383,-0.792450516475534,0.7,1.0,1.0,2/19,6.28%,RNF126;DNAJB12
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.4976867813521532,-0.7921748222127306,0.7567567567567568,1.0,1.0,1/5,4.28%,RASGRP1
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.4976867813521532,-0.7921748222127306,0.7567567567567568,1.0,1.0,1/5,4.28%,RASGRP1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.29609747843900636,0.791919184800112,0.9230769230769231,1.0,1.0,29/345,10.75%,TRIM22;RREB1;ZNF703;SNAI3;ATF5;NOTCH1;HIC1;NR5A2;ZNF732;AHR;ING2;ZNF430;SPTY2D1;HINT1;PPARGC1A;NFIL3;SOX6;REST;RPS6KA4;TCF7L1;COPS2;CASZ1;NAB1;EFEMP1;SOX11;MAFB;NANOG;RHOH;ZNF682
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.3515719558572372,-0.7918889196341146,0.8387096774193549,1.0,1.0,7/39,12.13%,PPP1R35;RRP1B;PLIN5;MAPK7;GCHFR;CHP1;SH3RF2
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.49669232901627663,0.7918699145269437,0.7719298245614035,1.0,1.0,1/6,7.27%,STAT4
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.4517783109383246,0.7918115626377011,0.8148148148148148,1.0,1.0,3/13,16.26%,CUEDC2;NLRC3;PDCD4
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.45636593577194484,-0.7917615408045895,0.7105263157894737,1.0,1.0,5/11,29.39%,APOE;PC;ZNF502;PPIB;TBC1D20
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.5214263128048036,0.7916530493668984,0.8333333333333334,1.0,1.0,2/6,5.16%,NTF3;AGT
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.32808063628205797,0.7913742839643904,0.7903225806451613,1.0,1.0,14/74,22.54%,TDG;H3-3A;TBP;POLR1H;CGGBP1;JARID2;POLR1E;SUZ12;EZH2;POLR1F;SF3B1;POLR2K;KAT2B;TAF1A
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),-0.44214164595970273,-0.791314288359031,0.7678571428571429,1.0,1.0,4/11,25.44%,COBL;CARMIL2;LCP1;CARMIL1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.46390487637384914,0.7912693389543362,0.7796610169491526,1.0,1.0,2/12,19.04%,LRRK2;MEF2A
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.33477086418469415,-0.7912650995363352,0.8461538461538461,1.0,1.0,25/111,19.47%,FBXW8;GOLGA8M;PI4K2A;GOLGA8H;TMED3;NSFL1C;GOLGA8B;ATP8B4;GOLGA8A;UBXN2A;FHDC1;GOLGA8N;PRMT5;PLEKHM2;STX6;ATL2;PLK3;TMED5;GCC2;TMED4;RAB2A;VRK1;VTI1A;GORASP1;NPLOC4
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.41863836554255174,0.7910122808496395,0.8095238095238095,1.0,1.0,6/22,21.05%,SLC24A2;SLC24A1;DRD3;LRRK2;NLGN4X;GRIK3
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),-0.4975705377118195,-0.7908660978850572,0.6904761904761905,1.0,1.0,3/6,7.62%,BMP7;GCH1;DHFR
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.382526777793085,0.7907105273396404,0.7857142857142857,1.0,1.0,1/28,3.35%,RASA1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.3199490853675422,-0.7907082923596588,0.75,1.0,1.0,4/93,3.77%,SELP;BCL2L11;NRG1;TRABD2A
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.4832602550194939,-0.7907060416648973,0.7428571428571429,1.0,1.0,1/8,0.69%,SPRED1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),0.34649807634935825,0.790412377187724,0.8,1.0,1.0,23/77,19.70%,PLA2G10;TRIM5;OPRK1;ISG20;PTPRC;FADD;IFNLR1;BNIP3;IFIT3;STAT1;IRF1;AGBL5;CGAS;IFI27;G3BP1;PLSCR1;BCL2L1;TLR2;NDUFAF4;SERINC3;IFIT1;IFITM3;ABCC9
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.30321374421138303,-0.7903614420488145,0.9642857142857143,1.0,1.0,16/87,16.56%,B9D1;RAB3IP;CDK5RAP2;MAPRE1;NEDD1;PCNT;CEP83;ODF2;PCM1;TUBG1;MKS1;SCLT1;RPGRIP1L;KIF24;TUBB4A;TCTN1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.4844690795765769,0.7903600206879089,0.8,1.0,1.0,3/11,8.29%,INHBA;FADD;CASP8
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.36747880142048805,0.7902908386894182,0.828125,1.0,1.0,13/56,23.30%,SLC12A7;GABRA2;CLCN3;GLRA3;GLRA1;GABRR1;GABRA4;SLC1A3;GABRD;GABRA6;ANO2;GLRB;SLC25A14
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.3631657766014818,-0.7901995523518986,0.7666666666666667,1.0,1.0,3/21,7.64%,HEG1;NPHS1;SHANK1
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.4412118903749761,0.7900674895333326,0.6774193548387096,1.0,1.0,3/18,13.44%,PRKAB2;SLC2A1;THRSP
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.38096928708685196,-0.7893795614408237,0.696969696969697,1.0,1.0,7/37,14.36%,SMYD2;IER3;PRKCD;RFWD3;USP51;HMGA2;SIRT7
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.4558855574007876,0.7893192839794477,0.7413793103448276,1.0,1.0,4/15,25.73%,GHRL;NLRC3;CD200;NLRP12
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.447136253696015,0.7890407150089195,0.7272727272727273,1.0,1.0,1/7,10.21%,TGFB1
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.4060606811373093,-0.7889561233962007,0.7674418604651163,1.0,1.0,8/13,22.75%,COQ6;COQ9;COQ2;PDSS2;UBIAD1;COQ7;COQ10B;PDSS1
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.4060606811373093,-0.7889561233962007,0.7674418604651163,1.0,1.0,8/13,22.75%,COQ6;COQ9;COQ2;PDSS2;UBIAD1;COQ7;COQ10B;PDSS1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.368824918803674,0.7888500920659921,0.8082191780821918,1.0,1.0,7/46,16.86%,GLI3;HHIP;FGFR2;UCHL5;GAS1;STK36;TULP3
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.3906390320305188,0.788845207407278,0.7534246575342466,1.0,1.0,3/32,12.53%,SEMA3D;SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.4871879235115596,-0.7887865490443516,0.7391304347826086,1.0,1.0,2/6,15.44%,LETM2;TESMIN
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.46101894887043,-0.7885619365872722,0.7872340425531915,1.0,1.0,2/7,6.81%,BMP7;GCNT2
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),-0.5158769716554048,-0.7884642427836659,0.7346938775510204,1.0,1.0,1/5,1.83%,PNPO
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.38357935729100984,0.7884293708291411,0.7761194029850746,1.0,1.0,7/40,13.25%,SEMA3D;SOX10;TBX1;SOX11;SEMA3F;SEMA3A;HTR2B
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.3891846850090422,-0.7884116164017357,0.6756756756756757,1.0,1.0,4/24,10.07%,ALG8;ST3GAL2;RRM2;GAL3ST4
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.5183605242039131,0.7879949599085673,0.8431372549019608,1.0,1.0,1/6,7.04%,BNIP3
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.2928518382450053,0.7879284560792075,0.974025974025974,1.0,1.0,36/454,13.58%,TRIM58;TRIM22;TRIML2;TRIM54;TRIM5;ENC1;NEUROD2;ARIH2;C10ORF90;TRIM32;SYVN1;PELI3;KLHL21;HLA-A;UHRF2;RNF152;RNF26;PSMB6;SIAH1;EPAS1;RNF122;BRCA1;RNF139;FBXL3;RNF141;VCPIP1;PSMA3;PCNA;TRIM50;FBXO32;RNF138;HECW1;KLHL13;RNF144B;PSMB8;DERL1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.3824924749226502,0.7878841167139401,0.796875,1.0,1.0,3/41,9.46%,GYPB;GMFG;HEMGN
prerank,PanglaoDB_Augmented_2021__T Memory Cells,0.3752033810931471,0.7874159079920114,0.7794117647058824,1.0,1.0,14/55,14.17%,GNLY;ITK;CD4;PTPRC;ARHGAP9;GMFG;TAGAP;ARHGAP25;CD6;RHOH;CD27;TMC8;TCF7;SEPTIN1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.5139587964702426,0.787401947009732,0.7543859649122807,1.0,1.0,1/6,8.95%,RNF26
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.4271860167879553,0.7873383655189533,0.734375,1.0,1.0,4/16,18.48%,ALOX12;TMEM79;ALOXE3;TP63
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.4271860167879553,0.7873383655189533,0.734375,1.0,1.0,4/16,18.48%,ALOX12;TMEM79;ALOXE3;TP63
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.38158864479539334,0.7872137286659003,0.8169014084507042,1.0,1.0,7/47,13.25%,SEMA3D;AMOT;SOX10;TBX1;SEMA3F;SEMA3A;HTR2B
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.4466691347185563,0.7871779419362454,0.7538461538461538,1.0,1.0,5/13,21.48%,SFRP4;RSPO3;DAAM2;WNT5B;GPC3
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.464921085146298,0.787112917406917,0.8032786885245902,1.0,1.0,3/12,18.26%,ATP5IF1;PLN;IFIT1
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.47756231809175326,-0.7868621805616879,0.6739130434782609,1.0,1.0,2/6,9.86%,APOA1;SCARB1
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.47756231809175326,-0.7868621805616879,0.6739130434782609,1.0,1.0,2/6,9.86%,APOA1;SCARB1
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.49908795320009985,-0.7868382041066142,0.7446808510638298,1.0,1.0,2/5,26.69%,RTF1;CDC73
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.438178454343061,0.7867105910935647,0.7758620689655172,1.0,1.0,4/14,19.55%,WAS;ACTR2;RAD51AP1;OOEP
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.3178582371931633,-0.786697623334174,0.9166666666666666,1.0,1.0,8/35,22.13%,SLC25A33;MRPS18A;QRSL1;TEFM;MRPS7;RARS2;MRPS21;LARS2
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),-0.5195205378675052,-0.7865704913364348,0.75,1.0,1.0,1/5,14.00%,PTPN1
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.5219950890330217,0.7863402516584715,0.8333333333333334,1.0,1.0,3/6,10.17%,ABCC2;ABCB1;ABCG2
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.5042763963979974,0.7861916260889316,0.7966101694915254,1.0,1.0,1/7,10.09%,TMEM79
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.36024945832539307,0.7859435807539343,0.8225806451612904,1.0,1.0,10/55,10.17%,BTN2A2;PRLR;KLF5;KDM3A;SCEL;AP1M2;B3GNT3;RUNX2;MYO5B;ABCG2
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.3198001560735189,-0.785907306925504,0.9090909090909091,1.0,1.0,14/92,14.30%,NUP62CL;CPSF1;NUP210;TPR;CHTOP;MAGOHB;NUP37;SMG6;THOC1;U2AF2;SRRM1;NUP42;SRSF7;CASC3
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.38276940260199843,0.7858732153950694,0.8028169014084507,1.0,1.0,2/28,4.09%,FABP3;HSD17B13
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.4203560004633221,-0.7858000612838276,0.8064516129032258,1.0,1.0,1/13,2.20%,EPHB2
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.41361118373589256,-0.7856057698971314,0.6923076923076923,1.0,1.0,2/12,17.18%,PCM1;GCC2
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.48439142468686175,-0.7854269394327881,0.7727272727272727,1.0,1.0,1/7,1.87%,SH3RF1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.45252002302778943,-0.7853470539943495,0.6666666666666666,1.0,1.0,1/7,9.50%,ANKRD2
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.3844687477276717,0.7852441791142949,0.8805970149253731,1.0,1.0,4/29,13.37%,NTF3;SFRP4;LRPAP1;RIN3
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),-0.48738702185177907,-0.7850325734245025,0.6595744680851063,1.0,1.0,1/6,3.33%,LHFPL2
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),0.4998444245549275,0.7847808746635783,0.6949152542372882,1.0,1.0,4/5,40.34%,NUDT4;NUDT11;NUDT3;NUDT10
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),0.4916815388141904,0.7847472907110652,0.7755102040816326,1.0,1.0,2/5,9.30%,AGT;ENPEP
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.3231011840548712,-0.7845955946864058,0.8,1.0,1.0,4/72,7.04%,PTTG1;CDC26;ECRG4;AURKA
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.37589941221250356,-0.7845788739592232,0.8529411764705882,1.0,1.0,7/28,17.09%,LSM6;DCPS;EXOSC1;EXOSC7;EXOSC5;EXOSC4;LSM7
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.3707239027504121,0.7843384575169489,0.7166666666666667,1.0,1.0,4/33,9.67%,HCK;NTF3;F11R;STAP1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.35836602001709245,0.784288053385084,0.8695652173913043,1.0,1.0,12/52,15.92%,BIK;BOK;MOAP1;HIP1R;PPARGC1A;BNIP3;ZDHHC6;GPER1;PLAUR;MIEF2;VPS35;PINK1
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.46806454492422384,0.7841847774894427,0.8214285714285714,1.0,1.0,4/8,16.96%,ENPEP;ATP6AP2;CTSZ;REN
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.46806454492422384,0.7841847774894427,0.8214285714285714,1.0,1.0,4/8,16.96%,ENPEP;ATP6AP2;CTSZ;REN
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4626032017941643,-0.7841616473617852,0.7272727272727273,1.0,1.0,2/10,7.30%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.3273863358851,0.7840342700247345,0.9142857142857143,1.0,1.0,3/98,1.47%,RAB6C;RAPGEF5;RREB1
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.3263043953253979,-0.7840092609740902,0.8709677419354839,1.0,1.0,10/79,6.92%,LAMB3;IFIH1;IL1R1;CEBPD;FABP5;NFIB;EHD4;TICAM1;IER3;SBNO2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3484705816412288,0.7837124426706997,0.8055555555555556,1.0,1.0,12/58,13.46%,C3AR1;P2RY1;OPRK1;P2RY12;AGT;PTGER3;CMKLR1;LPAR6;DRD3;ESR1;HTR2B;OPRD1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.33927315338718333,0.7836702429358909,0.8507462686567164,1.0,1.0,18/96,14.22%,TIMP3;F8;KNG1;LAMP2;RARRES2;GTPBP2;CDC37L1;FAM3C;VEGFC;HGF;VWF;TGFB1;TUBA4A;SYTL4;A2M;PCDH7;FN1;TTN
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.33779576034321174,0.7835295630773701,0.8507462686567164,1.0,1.0,6/61,5.67%,RASA1;NOTCH1;CYP1B1;PTPRC;RND1;KNG1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.29763229326203144,-0.7833777676301847,0.9047619047619048,1.0,1.0,22/147,18.98%,PTPN3;NEK6;ERCC2;CDC26;TFAP4;BTG1;EIF4EBP1;CDC23;SMOC2;PRMT5;BTG2;FZR1;BRINP2;BRINP1;HSF1;RCC1;ANAPC7;XPC;CUL9;ERCC3;HECA;PKN2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.5259700276862038,0.7829523550367602,0.8035714285714286,1.0,1.0,1/6,1.54%,AGER
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.3962974911336402,-0.7825200637041603,0.825,1.0,1.0,1/25,3.40%,ZNHIT6
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.4539226053021815,0.7824061593969883,0.8095238095238095,1.0,1.0,6/13,28.52%,SOX11;IL4I1;BANK1;LAPTM5;FGL1;GPNMB
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.37303479738055595,0.7823930982134509,0.8333333333333334,1.0,1.0,5/36,13.29%,NEUROD2;TRIM32;REST;SOX11;ECT2
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.442973304064593,0.7823583268531329,0.8135593220338984,1.0,1.0,4/14,16.81%,PTPRC;FLT3;HELLS;MSN
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.3166730570161368,0.7823293265650701,0.9295774647887324,1.0,1.0,19/151,10.55%,GADD45B;AGER;IL18R1;FGL2;CCND2;AHR;CDCP1;SCN9A;CCNE1;NFIL3;MXD1;ABCB1;SYNGR2;FAH;PRAF2;RHOB;CDC6;RHOH;COCH
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.3778454243783525,0.7818882235670951,0.7678571428571429,1.0,1.0,8/32,28.16%,SESN3;RNF152;GPR137B;GPR137;RRAGD;SPAAR;LAMTOR5;RRAGA
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.5179986133043422,-0.7818711943421613,0.8181818181818182,1.0,1.0,2/5,16.86%,SPHK2;NR4A3
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.4420994592269366,0.7815500647589966,0.7878787878787878,1.0,1.0,4/14,22.72%,IHO1;CDC6;RMI2;PUM1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.5059498381459151,0.7813798699160431,0.7868852459016393,1.0,1.0,2/8,13.17%,HECW1;CAMK2D
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.5244896723413492,-0.7813778019910301,0.7555555555555555,1.0,1.0,3/5,10.72%,NOP9;TBL3;NOP14
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.5244896723413492,-0.7813778019910301,0.7555555555555555,1.0,1.0,3/5,10.72%,NOP9;TBL3;NOP14
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.5244896723413492,-0.7813778019910301,0.7555555555555555,1.0,1.0,3/5,10.72%,NOP9;TBL3;NOP14
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.3174292219600444,0.7813459520615448,0.9054054054054054,1.0,1.0,51/255,21.14%,NPY;SLC12A7;ZACN;CHRNB1;CHRNG;OPRK1;PLP1;NQO1;GRM3;GABRA2;HTR3E;SLC17A8;SYPL1;CHRNE;RIT2;GAD1;HTR3B;CHRNB4;KCNMB1;AKAP5;HSPA8;DOC2A;PDLIM4;HTR2B;GLRA3;TSPOAP1;CNP;GLRA1;CHRNA7;CHRNA2;CRHBP;GABRR1;PCDHB3;GABRA4;NSG1;SLC1A3;SLC18A2;NPTX1;LIN7C;NPBWR1;GRM7;PCDHB2;GABRD;DLG1;NAPA;GRM1;GABRA6;NLGN4X;HTR6;GRIK3;SLC32A1
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.42684970004864076,-0.7812765875115566,0.7567567567567568,1.0,1.0,6/6,57.33%,SLC6A6;SLC6A13;MT3;HEBP2;RIPK1;ASAH1
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4546920882649731,0.7811004541141008,0.8064516129032258,1.0,1.0,4/11,13.75%,CSTF2T;NCBP1;NCBP2;FIP1L1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.3408947163455046,-0.7810483277403637,0.84375,1.0,1.0,6/46,8.73%,MAML3;ASCL1;DTX1;MAML1;NCSTN;JAG2
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.4239468629213422,-0.7810349047981825,0.7142857142857143,1.0,1.0,4/13,10.70%,INHA;SFRP1;ID2;IKZF3
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.43893700525962454,-0.7810306498560896,0.7714285714285715,1.0,1.0,5/13,25.47%,P3H3;P3H1;OGFOD1;ASPH;HIF1AN
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.4076251592639011,-0.7808458019694975,0.696969696969697,1.0,1.0,4/13,18.35%,ZBED3;TENM4;RBM19;NIBAN2
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.33559207335320707,0.7806995043396648,0.8333333333333334,1.0,1.0,8/69,11.05%,SLC23A1;SCN4B;SCN9A;SLC24A4;SLC24A2;SLC24A1;SCN7A;SLC5A2
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4867889143803394,0.7800181064887722,0.8113207547169812,1.0,1.0,3/7,13.31%,TGFB1;ESR1;BCDIN3D
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.3414157429576158,-0.779850381751351,0.7407407407407407,1.0,1.0,6/51,9.28%,EREG;CLDN4;ITGA6;RYR1;TGM1;AKR1C3
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.3075180148779165,0.7797816987868866,0.92,1.0,1.0,50/180,27.41%,LDHB;HSD17B10;ATP6AP1;TOMM22;NDUFA2;MDH1;NDUFB3;NDUFB2;NDUFB4;ATP6V1C1;COX4I1;PDK4;DECR1;ATP1B1;COX11;MTX2;COX7A2L;CYCS;ATP5F1E;UQCRB;IDH3A;MRPL34;ACAA2;RETSAT;ACAT1;ATP5F1C;ATP6V0B;ATP5MC3;SLC25A4;MAOB;CYB5R3;IDH1;ETFB;ETFA;DLST;VDAC1;ALDH6A1;IDH3B;MRPL35;ATP6V1D;NDUFV1;SLC25A11;ATP5ME;TIMM8B;VDAC3;NDUFB6;NNT;SLC25A3;SLC25A5;HSPA9
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.39110860409956677,0.7797220797506713,0.8904109589041096,1.0,1.0,15/40,18.66%,HSD17B2;ANKS4B;SCTR;GBA3;GIPC2;ALDOB;SCGN;SLC28A2;ABCC6;FMO5;SLC40A1;PBLD;TPH2;SLC18A2;ACSM3
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.3209519906914583,-0.77962503031894,1.0,1.0,1.0,5/62,10.70%,ARID5A;SFRP1;STAT3;AKR1C3;NSMF
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.39864359430915985,-0.7795208801613338,0.7291666666666666,1.0,1.0,4/9,24.53%,MDK;MIA3;PPARA;ASS1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.323858705286662,0.7792499010432762,0.8513513513513513,1.0,1.0,15/103,16.78%,ENPP2;AMOT;TRIM32;TWIST1;WAS;KIF14;SPOCK3;RHOB;TGFB1;NEXN;FBLN1;LDB2;NRG4;INPP5F;CDK6
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.4899923677391614,0.779146423837586,0.8235294117647058,1.0,1.0,3/9,5.24%,NOX5;NOX1;ALOX12
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.35378214476911435,0.779058839119531,0.8142857142857143,1.0,1.0,25/69,17.50%,ADAM28;RCSD1;PTPRC;ARHGAP9;GMFG;TAGAP;CORO1A;WAS;ARHGAP25;MAP4K1;IL7;STAP1;RHOH;CD27;ZBTB32;TMC8;BANK1;CD72;NPIPB15;LY86;BTLA;PYHIN1;HVCN1;WDFY4;CD37
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.31990414556523705,-0.7790505402778389,0.8387096774193549,1.0,1.0,11/54,11.71%,NRBP2;MTMR8;BCL2;MTMR9;STAT3;IL10RA;KIF25;FOXK1;EIF4G1;DAP;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.44503829882793244,0.7787579663710258,0.7592592592592593,1.0,1.0,4/9,27.26%,FBXO7;SLC25A4;VDAC1;SLC25A5
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.3223085843909556,-0.7785098428093907,0.8181818181818182,1.0,1.0,12/52,14.10%,KCNIP1;KCNJ16;AMIGO1;KCNN3;KCNE1;KCNN2;DPP6;BIN1;NOS1AP;KCNJ6;GABBR2;KCNJ2
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.4843388178551882,-0.7784715973937132,0.825,1.0,1.0,1/7,5.87%,P3H3
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.4366047762593004,0.7783352481148434,0.7540983606557377,1.0,1.0,2/16,15.40%,SCO2;COA5
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3494081693789895,0.7780563269462467,0.8115942028985508,1.0,1.0,5/61,7.87%,PTGIS;NLRP2B;CYP1B1;CARD8;CMKLR1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.2966679167007866,-0.7780519709092573,1.0,1.0,1.0,10/111,7.09%,PKP2;BMP7;RBP4;SGCD;HEG1;APLN;PDLIM1;ECE1;ID2;TGFB2
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.4252227438814098,-0.7779279904265656,0.7619047619047619,1.0,1.0,3/8,22.69%,ABCD1;ABCD2;PSEN1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.3327026433519723,0.777875467794965,0.8857142857142857,1.0,1.0,20/88,19.04%,TRPV6;NEUROD2;SYT2;SYT4;CPNE5;PLCG2;KCNMB1;CAMK2D;ECT2;LGMN;SYT9;SYT15;TTN;ITPKB;CRHBP;SYT13;DMTN;MCOLN1;ADGRV1;MEF2A
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.43923578280740416,-0.7775162356678561,0.7804878048780488,1.0,1.0,4/12,12.20%,GRIN3A;SDF4;GRIN2A;GOT2
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.4173661293805785,-0.7774807119671718,0.7058823529411765,1.0,1.0,5/15,19.55%,EREG;FAF1;EGFR;KAT7;NPM2
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.48460561343895914,0.7774482398537221,0.8333333333333334,1.0,1.0,2/12,9.36%,CRLF1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4601456978011028,0.7772560796983611,0.7230769230769231,1.0,1.0,3/11,13.61%,MRAP;GPER1;KLK14
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),0.4465577011982873,0.7769241552074871,0.7627118644067796,1.0,1.0,3/13,15.70%,IL4I1;PRDM1;SPINK5
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.4074205083168949,0.7766370977564736,0.8484848484848485,1.0,1.0,5/20,24.70%,YBX3;CASP8;CYLD;SLC25A4;FLOT1
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),0.5151080942009648,0.7766121579137166,0.8035714285714286,1.0,1.0,2/6,10.77%,ARR3;DRD3
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.38190924815635424,-0.7766107477294616,0.7297297297297297,1.0,1.0,3/15,12.20%,DGLUCY;MTHFS;GOT2
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.3663852389005771,-0.7765887202436712,0.7222222222222222,1.0,1.0,6/29,9.89%,DGKB;DGKD;LMF1;LYPLA2;APOE;DGKH
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.392789771260543,0.7762710757892181,0.7761194029850746,1.0,1.0,6/29,13.17%,CAV3;GLRX;SCN4B;YWHAH;HECW1;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.4847969203519922,0.7762017410596085,0.7758620689655172,1.0,1.0,4/7,28.57%,VPS4A;ZFYVE19;BLM;TXNIP
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.36268320111841396,0.7761048156284951,0.803030303030303,1.0,1.0,8/34,15.31%,RCN3;SYVN1;DRD3;RNF139;DERL1;GLRA3;CCDC47;GLRA1
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.45500187770871187,0.7758091966938176,0.7692307692307693,1.0,1.0,4/13,25.61%,ARL6;RAB11A;MKKS;MREG
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.45500187770871187,0.7758091966938176,0.7692307692307693,1.0,1.0,4/13,25.61%,ARL6;RAB11A;MKKS;MREG
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.2858704571932243,-0.7757165383725135,0.9375,1.0,1.0,56/256,18.30%,SRPK3;CPSF1;SNRNP27;HNRNPL;SF3B4;SF3A2;RBM41;MAGOHB;LSM6;PPIH;DHX8;DCPS;ELAVL1;POLR2G;RBM10;RBMX;PRPF4;RBM17;TXNL4A;ZCRB1;U2AF2;CPSF7;SRRM1;GPATCH1;GTF2F1;SNRPB;SF3A1;PRMT5;SMN1;ZRSR2;SNRPN;RBM19;DDX41;SRSF7;POLR2C;SCAF11;PPIL1;POLR2L;PTBP1;CASC3;CACTIN;CDC5L;RSRC1;PDCD7;PRPF6;DDX46;RNF113A;SF3B6;CWF19L2;LSM7;GEMIN8;CELF4;SYMPK;PRPF3;SRRT;WBP4
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.46299290581427666,0.7756344826967473,0.7903225806451613,1.0,1.0,2/12,16.99%,RHOH;TNFSF18
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.4311669523256374,0.7755528302936491,0.8163265306122449,1.0,1.0,3/18,9.82%,CD4;PTPRC;PLCG2
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.2995989452086197,0.7755214374616938,1.0,1.0,1.0,19/266,12.15%,RAD54L;TICRR;TDG;RFC5;POLE2;POLQ;CDKN2D;MGME1;FANCI;FAAP24;RAD9B;EYA1;INIP;BRCA1;FANCM;MRE11;VCPIP1;RPA3;PCNA
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.29000027536202966,-0.7749081154530908,1.0,1.0,1.0,13/89,11.94%,KDR;CDH13;IGF1;C5AR1;SFRP1;TGM1;VASH2;BMP6;VIP;NRP1;HMGB2;MDK;SCG2
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.30902556244501245,0.7748884902874311,0.9066666666666666,1.0,1.0,19/153,14.90%,LRP4;GLI3;SHISA2;HIC1;NOTUM;TLE3;SFRP4;NKD2;PSMB6;BICC1;PSMA3;TLE6;HECW1;KREMEN1;TSC2;PSMB8;NLK;AMER2;DAB2IP
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.371498483494675,0.774844217715412,0.88,1.0,1.0,5/50,11.65%,TICRR;RAD9B;DONSON;BRCA1;MRE11
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.4973737419928649,0.7744892063340003,0.7704918032786885,1.0,1.0,1/6,15.47%,ATP1B1
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.44781637735074153,0.7744288227199727,0.7586206896551724,1.0,1.0,3/13,15.79%,ABCB1;ABCB4;PSAP
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.41062241115422504,0.7735542493616238,0.8387096774193549,1.0,1.0,8/21,24.42%,BRK1;ACTR2;ACTR3;MSTN;TWF2;CYFIP1;CDC42;ABI2
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.36903144610832717,0.7734955819858716,0.8428571428571429,1.0,1.0,7/40,16.95%,SPTY2D1;SMARCE1;ACTL6A;ACTR6;SRCAP;SMARCA1;ACTR8
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.4660327808221694,0.7734411766395717,0.7457627118644068,1.0,1.0,5/9,33.26%,CD74;IL18;DENND1B;TNFSF4;CD81
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.35798615620222707,-0.7731277779726966,0.85,1.0,1.0,4/24,9.64%,ABCA13;PTCH1;APOA1;APOE
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.37061539787330144,-0.7725575772638464,0.8055555555555556,1.0,1.0,5/21,13.10%,GREM1;TRPS1;PTHLH;MDK;PKDCC
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.3826031319062765,-0.7723832630367379,0.7,1.0,1.0,5/24,8.56%,TACR1;LHFPL2;PDE3A;ANKRD31;VIP
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),0.5361131114424238,0.7722244313110429,0.8214285714285714,1.0,1.0,3/5,22.91%,MAOA;LRTOMT;MAOB
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.4536694923333836,0.7722134275035065,0.7746478873239436,1.0,1.0,3/12,21.81%,STARD4;VPS4A;SERAC1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.44252554715359926,0.7719728932029059,0.8253968253968254,1.0,1.0,5/12,31.53%,ATL1;TMEM33;REEP3;RAB18;RTN4
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.3122833005910193,0.771875678545058,0.9428571428571428,1.0,1.0,41/144,18.96%,CCL5;FGL2;XAF1;IL15;HLA-DMA;ISG20;IDO1;CIITA;NAMPT;STAT4;HLA-A;SOD2;IFIT3;CMKLR1;CASP8;P2RY14;IL7;CMPK2;STAT1;FAS;IRF1;RIPK2;PSMA3;PSMB8;BANK1;TRIM14;IFI27;APOL6;PIM1;CD74;PLSCR1;IFI44;TRIM25;IL18BP;B2M;ARL4A;GBP6;IFIT1;GPR18;ZNFX1;IFI35
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.46196742827525145,0.7714309906845478,0.7222222222222222,1.0,1.0,4/9,24.46%,DAB2IP;PIK3CB;ATP2B4;DCN
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.33023632025226834,-0.7712626881933862,0.8571428571428571,1.0,1.0,4/54,7.30%,LEF1;MED30;MED15;CBFB
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),-0.452247023605959,-0.7712483428601293,0.7142857142857143,1.0,1.0,1/7,7.37%,ERCC8
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.5014783236697593,0.7711110719751091,0.8245614035087719,1.0,1.0,1/7,6.03%,BCAP31
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.4400490214813302,0.7709540049165783,0.7241379310344828,1.0,1.0,8/15,27.48%,SLC5A2;SLC9A6;SLC9A2;SLC9A7;HCN4;SLC9A1;SLC12A2;SLC9A5
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.44535188511554025,-0.7708278793698973,0.7878787878787878,1.0,1.0,3/8,24.33%,TSFM;MTG2;ALKBH1
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.46602728927200654,0.7706423651075318,0.7735849056603774,1.0,1.0,1/6,11.86%,VCPIP1
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),-0.46714365082772924,-0.7705156043146433,0.7073170731707317,1.0,1.0,3/5,18.00%,SLC10A7;ANGPT1;IDUA
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.44113141197430755,0.7705117237989786,0.7761194029850746,1.0,1.0,2/10,10.21%,SMAD7;TGFB1
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.4598001977006982,-0.7704070855008976,0.7755102040816326,1.0,1.0,3/10,18.05%,ERCC1;XRCC3;TPRKB
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.37412275478636997,0.7703674902774524,0.7837837837837838,1.0,1.0,9/25,22.12%,TBXA2R;NOTCH1;TGFB1;ANGPT2;RGCC;MMRN2;PPARG;ATP2B4;MEOX2
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.43824353492090273,0.7703490996595501,0.8392857142857143,1.0,1.0,3/16,23.04%,CDK5R1;NLGN4X;NRXN3
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),0.49365119074784425,0.7700724245358948,0.7924528301886793,1.0,1.0,1/5,10.26%,LRPAP1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.4656065586649214,-0.7699604463842612,0.7142857142857143,1.0,1.0,1/6,16.53%,PPM1F
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.3779839994755448,-0.7698622227165044,0.8222222222222222,1.0,1.0,2/23,7.42%,H1-4;ERCC1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.309973709052687,-0.7693993967528789,0.9230769230769231,1.0,1.0,31/109,23.51%,RIMBP2;KCNC1;MAPK4;ADGRA1;TMEM196;PHF21B;GAD2;STMN2;KCNB2;LHFPL4;ELAVL3;PRR36;GRIA2;KCNJ6;UNC13A;CACNA1B;CELF5;CELF4;SCRT1;PAK5;NR4A2;MSI1;BRSK2;BSN;KIF1A;CASKIN1;PCDH8;SNAP91;SLITRK1;LONRF2;CSRNP3
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.5042710499104961,0.7693163783385263,0.7924528301886793,1.0,1.0,2/5,19.08%,EFHD1;LETM1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.3538716426021225,0.7692729769131856,0.8115942028985508,1.0,1.0,5/43,9.35%,TRPA1;UPB1;SOD2;HSD17B10;ACOT13
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.275488194715001,-0.7692592395621363,1.0,1.0,1.0,39/261,15.33%,KDR;SAMD4A;RUNX1;TYMS;ATOH8;IGF1;SRGN;APLN;SFRP1;HDAC1;PTBP3;FOXP1;CIDEA;NCL;AURKA;ID2;TGFB2;CILP;LSM6;DHFR;MACROH2A2;TAF1;APOE;CREB3L1;PARP10;IGF2BP3;DNMT1;PHF1;TRIM71;YY1;DIS3L2;REL;BTG2;PTBP1;RPS26;SAMD4B;PNPT1;SLC24A3;RBMS3
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.43304938628155937,-0.769255989708681,0.75,1.0,1.0,2/8,13.53%,GRIN3A;GRIA2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.3317502046536538,0.7691741607628727,0.875,1.0,1.0,9/61,13.75%,CSTF2T;SLU7;NCBP1;U2AF1;NCBP2;DDX39A;CLP1;THOC5;FIP1L1
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.3305681282789884,0.7687421838916415,0.8208955223880597,1.0,1.0,13/97,18.12%,CCL5;RASA1;FUT2;RND1;KNG1;KIF14;FBLN1;PODXL;TNFSF18;TESC;FRMD5;IL18;PDE3B
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.4151876126258299,0.7686300304511955,0.8666666666666667,1.0,1.0,2/22,4.92%,C17ORF99;PTPRC
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.3967815579057138,0.7682654635419461,0.8,1.0,1.0,4/23,20.49%,SLC36A1;SLC38A2;SLC38A5;SLC38A3
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.45254371726640186,0.7682484628761439,0.7796610169491526,1.0,1.0,2/10,13.27%,ALOX12;ALOXE3
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.3752747742635021,-0.7681821675289633,0.7619047619047619,1.0,1.0,6/25,12.18%,SMC1A;SGO2;INO80;KIF25;TUBG1;SMC4
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.44618761541941776,-0.7681624914957217,0.7142857142857143,1.0,1.0,2/7,5.43%,MYH11;CFLAR
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.4689094810699891,0.7680345528116558,0.8225806451612904,1.0,1.0,4/10,32.01%,ROMO1;TIMM8B;TIMM22;TIMM8A
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.3818115943904007,-0.7678247877800676,0.7741935483870968,1.0,1.0,5/43,7.08%,SOX13;BMP7;SFRP1;ADIRF;ID2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.36611193991328617,-0.7677451786882972,0.875,1.0,1.0,2/19,5.59%,SELP;AZU1
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.4691464837576642,-0.7675090744688242,0.8235294117647058,1.0,1.0,1/6,5.82%,SPHK2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3308166112430747,0.7674481369458783,0.8676470588235294,1.0,1.0,16/59,27.39%,ODAD3;WAS;ABITRAM;PODXL;TBC1D13;FXR1;DMTN;ATG3;CYLD;TWF2;TWF1;CDC42;FMR1;RAB5A;RDX;ATP8B1
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.5287937852195929,-0.7672903957790934,0.85,1.0,1.0,2/6,4.27%,PNPO;GCH1
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.4693903770008428,0.7671229131078778,0.7647058823529411,1.0,1.0,1/9,6.97%,ARG1
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.3322614346339261,0.7671226375001658,0.8625,1.0,1.0,13/108,12.26%,SLCO2B1;SLC23A1;RCN3;GM2A;AMN;SLC22A25;CBLIF;ARRDC3;TCN2;CHMP2B;ABCG2;CHMP1A;AQP9
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.4975824387905332,0.7670860000369532,0.8135593220338984,1.0,1.0,1/6,0.69%,ALDH1A1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3916514816515029,0.7669522628458347,0.7846153846153846,1.0,1.0,2/24,4.92%,NTF3;PTPRC
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.4223552529858635,-0.7665414578363955,0.7567567567567568,1.0,1.0,3/9,14.57%,RASGRP1;RGS2;FGFR3
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.3114707621174717,0.7664178273098737,0.9342105263157895,1.0,1.0,9/149,8.08%,ENPP2;RREB1;ZNF703;NEUROD2;BMP1;SOX6;BNIP3;REST;ZDHHC6
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.2874613093685123,-0.7663236395281339,0.9166666666666666,1.0,1.0,15/137,11.71%,KDR;BMP7;SFRP1;PDE3A;EMD;MAPK7;BMP6;CILP;MAP2K3;HSPB1;DLX5;SYAP1;NRP1;STMN2;SIRT2
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.4433412760961748,-0.7663061592919493,0.725,1.0,1.0,1/9,5.29%,CHTOP
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.31474696173460565,0.7661447294859438,0.9054054054054054,1.0,1.0,9/143,7.33%,EPHA1;RGS10;CCL5;RASIP1;DOCK8;ARHGAP9;PRKG1;ADRB1;F11R
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.42605428718419747,0.7661430925317045,0.7457627118644068,1.0,1.0,4/17,25.60%,FMNL1;DLG1;FHOD3;RHOQ
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.30089827955946225,-0.766043578592221,0.9473684210526315,1.0,1.0,23/149,13.27%,BRCA2;XRCC4;PARP2;DCLRE1B;SAMHD1;POLL;HUS1;BRCC3;ERCC1;INO80;POLM;BAZ1B;RFWD3;SMARCAL1;XRCC6;RAD51B;KDM4B;SEM1;HMGB2;PALB2;YY1;SPIDR;XRCC3
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.36823060481205744,-0.765866025821554,0.8333333333333334,1.0,1.0,8/30,14.10%,IGF1;NYAP2;TYRO3;NYAP1;SIRT2;HTR2A;MYO16;IRS1
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.45536541886220366,0.7657802732682589,0.7543859649122807,1.0,1.0,3/6,16.81%,FGFR2;TGFB1;MSN
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3707752091088781,0.7654819019428472,0.8309859154929577,1.0,1.0,6/42,10.56%,AEN;HIC1;BOK;MOAP1;BCL2L2;BRCA1
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.3268309581040925,-0.7650307011590737,0.7096774193548387,1.0,1.0,11/49,16.47%,PMEPA1;WWTR1;HDAC1;ID2;XIAP;CDH1;NOG;PPP1CA;ID3;ACVR1;TGFBR1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.36353252691258386,0.7647749340495648,0.8051948051948052,1.0,1.0,3/43,5.16%,LRP4;WFS1;AGT
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.3131251649393789,-0.7647268692844191,0.9333333333333333,1.0,1.0,6/31,9.37%,F2RL1;AZU1;NLRP1;HSPB1;STAT3;IFI16
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.3258112814529437,-0.7647027091760503,0.88,1.0,1.0,15/61,20.03%,LCMT2;PUSL1;TRDMT1;THADA;WDR4;ALKBH8;ADAT2;TRMT61A;TARBP1;QTRT1;TYW3;CDKAL1;TPRKB;DUS2;OSGEP
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.4542154935734747,0.7645909004318914,0.7868852459016393,1.0,1.0,3/9,17.72%,PPID;OPN3;OPN1SW
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.4484277464115956,-0.7642649315805643,0.7209302325581395,1.0,1.0,2/9,5.40%,HDAC5;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.3155074317918462,0.7636312776026665,0.9565217391304348,1.0,1.0,16/86,24.34%,CCL5;EIF5A2;YBX3;MPV17L2;EIF2B5;FXR1;POLR2D;EIF3E;RPS6KB2;YTHDF1;EIF4A3;EEF2;METTL14;FASTKD3;DDX3X;FMR1
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4395396652291513,-0.7634637506199214,0.75,1.0,1.0,2/8,21.64%,PTPRJ;PTPN12
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.36909191394492785,-0.7632708573643634,0.6842105263157895,1.0,1.0,1/18,0.92%,STING1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3775619146118843,-0.7632439145700645,0.8695652173913043,1.0,1.0,7/24,18.77%,VCAN;B3GAT2;B3GAT3;CHST9;XYLT2;CHST12;PXYLP1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.398407895454572,-0.7632105418024289,0.7714285714285715,1.0,1.0,7/15,20.85%,TGFB2;SEMA4C;KLHDC10;MID1;CARD9;TAOK3;EIF2AK2
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.396151436579162,0.763204488651053,0.8333333333333334,1.0,1.0,8/26,19.81%,ACOT4;BAAT;ACOT13;ACSM4;ACOT12;ACSM3;ACAT1;ACSM6
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.396151436579162,0.763204488651053,0.8333333333333334,1.0,1.0,8/26,19.81%,ACOT4;BAAT;ACOT13;ACSM4;ACOT12;ACSM3;ACAT1;ACSM6
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.477685556561676,0.7629979354664509,0.7636363636363637,1.0,1.0,1/6,11.78%,OPN3
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.477685556561676,0.7629979354664509,0.7636363636363637,1.0,1.0,1/6,11.78%,OPN3
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),0.46592976568451655,0.7629796761741351,0.75,1.0,1.0,3/10,9.50%,MCM2;MCMDC2;DONSON
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.3660761559415221,-0.7626190610893505,0.875,1.0,1.0,2/26,9.92%,LZTS3;ABHD17A
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.4315328654348628,-0.7625785748760628,0.7619047619047619,1.0,1.0,1/13,0.65%,SELP
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),-0.4893094401116523,-0.7625055408964987,0.7435897435897436,1.0,1.0,2/5,15.62%,XYLB;RPEL1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.2984095146417851,-0.7624213005410424,0.96,1.0,1.0,6/72,10.76%,F2RL1;MIEN1;CROCC;TGFB3;RIPOR2;NRP1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.38320527675132676,-0.7623939716676462,0.78125,1.0,1.0,5/18,22.69%,SHANK1;NLGN3;RIMS1;RELN;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.3406308983995363,0.7621395748023211,0.8529411764705882,1.0,1.0,9/60,9.36%,STAB1;HSPG2;ADAMTS9;AMOT;ADGRB1;SERPINF1;CD160;EPN1;STAT1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.2883611901459702,-0.7620413466127813,0.9130434782608695,1.0,1.0,43/195,17.03%,ADAM19;TMPRSS7;ADAMTS3;VASH1;CPXM2;TYSND1;SVBP;SRGN;TRABD2A;CELA2A;CPA1;PTCH1;AZU1;NLRP1;ECE1;DPP3;VASH2;TPP1;NCSTN;IDE;LRP8;MME;LAP3;USP25;HTRA1;CTSC;THOP1;HM13;PRSS54;CAPN13;MMP17;PM20D2;METAP2;DPP7;APEH;CPQ;TASP1;EEF1AKMT4-ECE2;MALT1;MIPEP;BACE2;ACE;DESI2
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.3363030351462596,0.7620386890920012,0.8309859154929577,1.0,1.0,13/76,15.89%,EPHA1;PTGIS;CYP1B1;TWIST1;GAB1;VEGFC;RHOB;BRCA1;AGGF1;ZNF304;SPHK1;NODAL;CHRNA7
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.5039278691408944,-0.7620202539270099,0.7837837837837838,1.0,1.0,4/6,31.91%,MACROD2;PRPS1;FHIT;OARD1
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.4750115869268239,-0.7620156986377975,0.6666666666666666,1.0,1.0,1/5,7.09%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.3988693914232333,-0.761958578882489,0.8055555555555556,1.0,1.0,3/15,9.28%,ITGA4;ANO6;AKR1C3
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.4097700892355803,0.7616546680487225,0.8088235294117647,1.0,1.0,4/17,18.60%,HSD17B13;ANGPTL3;CREBL2;PPARG
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.4023334512545894,0.7614380578483821,0.7910447761194029,1.0,1.0,6/22,24.37%,ALDOB;PGAM1;PKLR;HK3;ENO2;ADPGK
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.3023445251875345,-0.7612927091806634,0.96,1.0,1.0,13/115,10.94%,TPD52L1;FBXL7;KDM8;AURKA;CDK5RAP2;MAPRE1;NEDD1;PCNT;CDK14;ODF2;PCM1;CCNH;TUBG1
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.42378727347517126,-0.7610819425191061,0.8,1.0,1.0,6/13,26.90%,FGD5;PPP1R9B;VSTM5;FGD1;FGD6;SPEF1
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.45239591315411004,-0.7608726561315607,0.6944444444444444,1.0,1.0,1/8,6.00%,IGBP1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.30887482180694126,0.7608569628005909,0.9620253164556962,1.0,1.0,18/170,9.21%,MYLK;EPHA1;ZNF703;SEMA3D;CCL5;SMIM22;PDGFRB;NOTCH1;NTF3;TRIM32;TWIST1;TCAF2;HSPA5;RIPOR1;F10;SOD2;HGF;GPER1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.4691167457278609,-0.7607105506950558,0.813953488372093,1.0,1.0,1/7,4.58%,PTPN23
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.32687425147563665,0.7604553208578231,0.8933333333333333,1.0,1.0,11/79,10.98%,NES;ROR1;GLI3;FJX1;SRPX;TCF7L1;CNN3;VEGFC;NOTCH3;SERTAD4;CDR2L
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.35595471580843796,0.7601845983086899,0.8,1.0,1.0,9/34,20.66%,AMBP;MARVELD3;PINK1;GPS2;FOXM1;DLG1;CYLD;PER1;GSTP1
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.4149031084715028,0.7601722725832301,0.7761194029850746,1.0,1.0,4/18,21.24%,FLT3;THOC5;PPARG;LYN
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),-0.4611077218266404,-0.7599960201374472,0.8275862068965517,1.0,1.0,2/6,16.47%,NOG;TGFBR1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3737720116718765,-0.7598233710889931,0.8205128205128205,1.0,1.0,7/24,20.92%,THOC1;TSFM;HMGN1;LDB1;KAT7;CCNT1;ZMYND11
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.38209125808773936,0.759816587287353,0.7857142857142857,1.0,1.0,4/31,10.47%,CYP1B1;LOXL2;STAT1;PRSS3
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.46280901344772774,0.7596930882242621,0.7704918032786885,1.0,1.0,3/6,31.13%,DNAJC19;SHH;PKD1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.4505957439106327,0.7594347600631639,0.7678571428571429,1.0,1.0,3/9,18.69%,FURIN;PCSK5;SPCS3
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.33650534655191544,-0.7593775915000106,0.8780487804878049,1.0,1.0,8/31,14.59%,TPR;PRKCD;CDH1;CHP1;DMAP1;CABP1;BAG3;MAVS
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.3553102937009604,-0.7591694611261858,0.7575757575757576,1.0,1.0,6/25,19.68%,PEX7;ABCD1;SLC25A17;GDAP1;ACBD5;ABCD2
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.43767158228779635,0.7591277083269179,0.8421052631578947,1.0,1.0,2/13,10.08%,CD14;SCIMP
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.36594886752184275,0.7589512033617455,0.90625,1.0,1.0,8/39,20.85%,GM2A;GBA3;NEU1;B3GALNT1;PSAP;UGT8;ST6GALNAC5;B4GALT6
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.4288069814798194,0.7589074172772138,0.8088235294117647,1.0,1.0,1/14,1.72%,CD4
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.29770732969675645,0.7588701713013154,0.9726027397260274,1.0,1.0,21/218,10.25%,NOX5;TRPV6;KCNA3;KCNG3;KCNE2;TRPA1;SLC30A8;KCNN4;SCN4B;SCN9A;TRPM6;SLC24A4;TRPV3;ATP12A;CACNA2D4;SLC24A2;SLC24A1;SCN7A;SLC36A1;RHD;KCNK10
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.37910338148769646,0.7584903852066637,0.8166666666666667,1.0,1.0,8/31,19.81%,ACOT4;BAAT;ACOT13;HMGCS1;ACSM4;ACOT12;ACSM3;ACSM6
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.5105159049921248,0.7582927014227727,0.8064516129032258,1.0,1.0,2/5,24.23%,LRRK2;ADAM9
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.46844094934966307,0.7580853798579642,0.8095238095238095,1.0,1.0,3/11,8.81%,TWIST1;TBX1;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.3182061308116363,0.7580753152140327,0.9285714285714286,1.0,1.0,7/121,8.68%,TRIM22;TRIML2;TRIM5;TWIST1;PRXL2C;BNIP3;RNF152
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.434784699276193,0.7580739451738879,0.7692307692307693,1.0,1.0,3/10,22.30%,BRCA1;MDM1;KAT2B
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.39885893305938147,0.7578040919644474,0.8225806451612904,1.0,1.0,1/29,3.50%,SYT2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3820631195473816,-0.7574587880926203,0.8055555555555556,1.0,1.0,11/31,18.86%,ERCC2;GTF2H2;UBTF;TAF1;CCNH;POLR2L;POLR1A;TAF1D;POLR1G;GTF2H5;ERCC3
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.4141275498980481,0.7574399318214889,0.8,1.0,1.0,5/21,18.44%,CHMP4B;CHMP2B;CHMP1A;CHMP2A;SORT1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.3866791199368341,0.7573329401817834,0.8656716417910447,1.0,1.0,1/33,3.50%,SYT2
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.32337178571455455,-0.7573296318843261,0.8181818181818182,1.0,1.0,5/57,7.37%,EYA4;FGFR4;TOX;BRCC3;ERCC8
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.3053746561947682,-0.7572618880770953,0.896551724137931,1.0,1.0,13/88,13.39%,CACNG4;ST8SIA2;RHBDL3;FBLL1;RGS8;NYAP1;LIN28B;IGDCC3;PHF21B;STMN2;KCNB2;SCG2;PLPPR5
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.29838974531542817,0.7572588734956526,0.9493670886075949,1.0,1.0,41/206,19.47%,PTGIS;RSPO2;ZBTB7B;ITGA5;NOTCH1;NTF3;DEPDC1B;PTPRC;MAML2;LMO3;IL7;FGFR2;GPER1;RSPO3;VWF;SCIMP;FAS;DRD3;ATP6AP2;GHRL;UCHL5;KLK14;MYORG;NOTCH4;STK36;VPS35;DAB2IP;LGR6;LY86;NPTN;CHRNA7;CD74;TLR2;ERN1;DMTN;LRRK2;TP63;CD80;GPS2;ATP6V1C2;ARNT
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.36802822766311727,-0.7571705629913125,0.7941176470588235,1.0,1.0,3/15,20.31%,LRRTM3;CLU;SLC2A13
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),0.48375780990622863,0.7568215296309947,0.8571428571428571,1.0,1.0,4/7,37.82%,GFM2;MTIF2;MCTS1;DENR
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.49623724117113865,0.7567908271598935,0.8035714285714286,1.0,1.0,1/6,26.24%,MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.3734356414270097,-0.7567257498042241,0.782608695652174,1.0,1.0,3/19,16.86%,ETS1;MDK;NR4A3
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.49096988901721705,0.7567249447660415,0.8275862068965517,1.0,1.0,2/6,21.14%,CPS1;DDAH2
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.3802857666474627,0.7562553526764668,0.8,1.0,1.0,1/24,5.06%,FBLN5
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.4033268701536643,0.7562181507273831,0.8870967741935484,1.0,1.0,8/22,16.07%,TDRD9;ING2;SYCP3;BTBD18;MEIOC;MEIOB;HSF2BP;SLC25A31
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.3793927188269031,-0.7561007866462003,0.7777777777777778,1.0,1.0,1/12,2.23%,MT1E
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.32461571403787076,0.7553419865555078,0.927536231884058,1.0,1.0,19/108,20.23%,GOT1;IRS4;RARRES2;GAB1;NAMPT;ATP6V1B2;ATP6AP1;RAB8A;ATP6V1C1;INSIG2;PDK4;EPRS1;INSIG1;PKLR;PDE3B;PPARG;ATP6V1C2;SHC1;ATP6V0B
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.4630827907852246,-0.7552473826339751,0.6976744186046512,1.0,1.0,2/5,29.48%,ZFAND2B;SRP54
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.44383847897879564,0.7552019782401138,0.7586206896551724,1.0,1.0,3/7,24.13%,DMTN;LIMS2;EMP2
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),-0.441298959035051,-0.7551786970734764,0.8888888888888888,1.0,1.0,2/6,3.10%,SH3RF1;PNP
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),0.500168898664043,0.7551139355010756,0.8260869565217391,1.0,1.0,2/5,7.50%,GCM2;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.3692388978921461,-0.7551112466307558,0.7407407407407407,1.0,1.0,7/21,26.68%,LIMK1;NRP1;DBNL;GOLGA4;L1CAM;DSCAM;MAP3K13
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.3138373503083466,0.755017264687593,0.9253731343283582,1.0,1.0,12/88,17.55%,BORA;ATF5;KLHL21;IHO1;GPER1;KLHL13;ECT2;RACGAP1;CCP110;RAB11A;BCL2L1;RMI2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.32373600193489793,-0.7549845643482735,0.9411764705882353,1.0,1.0,4/36,7.28%,TPR;WWTR1;NVL;CARD10
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),0.46431692650771905,0.7549078225051977,0.7962962962962963,1.0,1.0,3/8,17.99%,DRD3;VPS35;LRRK2
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.3748659361009786,0.7548728308599991,0.84,1.0,1.0,8/37,23.69%,PPARGC1A;MTFR1L;CYCS;UQCRB;SLC25A14;MTFR1;ETFB;ETFA
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.42812504190525275,0.7548570927916942,0.8548387096774194,1.0,1.0,3/14,19.62%,TWIST1;CDK6;FOXM1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.2750343922594071,-0.7546811406699919,1.0,1.0,1.0,20/162,13.53%,HOMER2;NRG1;PCDH19;ADAM12;CIB2;RGMB;CLSTN2;KCNC1;ZNF536;MAPK4;INSYN2A;PHF21B;RIPOR2;STMN2;SMOC2;ELAVL3;LINGO2;TRIM44;PLPPR5;GRIA2
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.4946293728332003,0.7544374234698468,0.7843137254901961,1.0,1.0,1/5,18.50%,UBE2E1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.44747157529869946,0.7542191220297699,0.8333333333333334,1.0,1.0,1/11,1.09%,WNT8A
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.4689846782180811,0.7538004112418789,0.8095238095238095,1.0,1.0,4/7,39.78%,ZFP36;ZFP36L1;PNRC2;EDC3
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.4410722268336192,0.7536626551044892,0.8245614035087719,1.0,1.0,2/15,10.44%,AGER;C1QA
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),-0.3690314047593368,-0.753345729065507,0.8108108108108109,1.0,1.0,6/24,16.53%,LLGL2;CHP1;DNAJC1;P3H1;PTPN1;PPM1F
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.3511323522847778,-0.7532253068042378,0.825,1.0,1.0,6/24,11.56%,VASH1;SVBP;PTPN23;MCC;APOE;DUSP10
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.43475435194310486,-0.752939637921162,0.7435897435897436,1.0,1.0,1/7,7.75%,NCSTN
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.4361591384115957,0.7528406958398298,0.8688524590163934,1.0,1.0,5/12,17.48%,CSTF2T;NCBP1;NCBP2;FIP1L1;ERN1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.3961952778901361,0.7527778389100507,0.896551724137931,1.0,1.0,6/31,5.89%,GLI3;CD4;CD8A;PTPRC;NHEJ1;FADD
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.44259210377912306,0.752480984704821,0.8333333333333334,1.0,1.0,2/9,21.64%,CHDH;LRTOMT
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.4212242759060488,0.7523696467854126,0.75,1.0,1.0,1/19,0.11%,C3AR1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.4366074392669421,0.7522029274779366,0.8939393939393939,1.0,1.0,2/17,15.92%,HSPA5;PINK1
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.4355758234249342,0.752169742679059,0.8392857142857143,1.0,1.0,2/14,6.90%,PTGIS;NAMPT
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.3547014290913155,-0.7521594649411997,0.7647058823529411,1.0,1.0,9/33,20.33%,CDC14B;CDC26;CDC23;SIRT2;PPP1R9B;ANAPC7;KNTC1;NPM2;ANAPC16
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.3510465635481503,-0.7520505033881438,0.7058823529411765,1.0,1.0,2/26,2.60%,VASH1;NEK6
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.4552587060445525,0.7518929665841134,0.7586206896551724,1.0,1.0,2/7,9.45%,NDST4;CSGALNACT1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.41813761594054677,0.7517297990173456,0.7704918032786885,1.0,1.0,4/15,9.44%,CCL5;NOTCH1;CYP1B1;CRLF3
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.38901821289106003,-0.7511645606657343,0.8536585365853658,1.0,1.0,3/13,23.03%,SCARB1;NR1H2;PPARA
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.4183895474069963,0.7510514425556207,0.8656716417910447,1.0,1.0,3/14,17.03%,FAH;ACOX1;FAAH
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.2694585033504168,-0.7509257246336702,1.0,1.0,1.0,21/231,9.61%,FBXL7;STING1;LEF1;TLE2;TEAD2;ZNHIT6;TRAPPC1;HDAC1;TFAP4;CD247;DNAJB12;TRAPPC9;PPP6R1;CARD10;CNIH3;SHANK1;PPIH;GRIA1;ANO6;WIPF1;SMARCA4
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.3719120766529475,0.7507863174187903,0.890625,1.0,1.0,6/41,10.88%,TRIM32;KNG1;FADD;CASP8;PLAUR;RNF139
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.40006951324788875,-0.7506465178595422,0.7560975609756098,1.0,1.0,1/13,2.47%,VPS25
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.43017527245640463,0.7506244972820979,0.8208955223880597,1.0,1.0,1/18,4.73%,ING2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.43017527245640463,0.7506244972820979,0.8208955223880597,1.0,1.0,1/18,4.73%,ING2
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.3485864963744943,-0.7505509756409647,0.8205128205128205,1.0,1.0,7/30,14.06%,ERCC2;GTF2H2;POLR2G;CCNH;GTF2F1;POLR2C;POLR2L
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.3485864963744943,-0.7505509756409647,0.8205128205128205,1.0,1.0,7/30,14.06%,ERCC2;GTF2H2;POLR2G;CCNH;GTF2F1;POLR2C;POLR2L
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.34561720199471313,-0.7505078873470183,0.9024390243902439,1.0,1.0,1/25,1.97%,CDC14B
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.3464868522031917,-0.7504379621306825,0.7777777777777778,1.0,1.0,6/27,19.68%,PEX7;ABCD1;SLC25A17;GDAP1;ACBD5;ABCD2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.2991072999638874,-0.7503732749286611,0.9629629629629629,1.0,1.0,6/35,9.37%,F2RL1;AZU1;NLRP1;HSPB1;STAT3;IFI16
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.3024325091652428,-0.7502989456732906,0.96,1.0,1.0,13/116,10.94%,TPD52L1;FBXL7;KDM8;AURKA;CDK5RAP2;MAPRE1;NEDD1;PCNT;CDK14;ODF2;PCM1;CCNH;TUBG1
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.36527155327551036,-0.7500393866011932,0.875,1.0,1.0,7/20,21.61%,DRD4;CSK;APOE;PKDCC;PPM1F;ERP29;RSAD2
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.3748123022239651,-0.7499551910898326,0.8666666666666667,1.0,1.0,2/31,2.02%,CA2;SLC9A8
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.33959746918329775,0.7499175881444008,0.8656716417910447,1.0,1.0,8/54,18.00%,STK26;LAMP2;RIPOR1;HSPA8;PDK4;ULK1;LRRK2;WIPI1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.40034547073563137,0.7497179449201085,0.8620689655172413,1.0,1.0,4/18,11.25%,ALOX12;PRKG1;F11R;ADAMTS18
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),0.4516894823824883,0.7496102038990958,0.8548387096774194,1.0,1.0,2/9,12.81%,EXOSC8;RPS21
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.38609029005359263,0.749591154498473,0.8,1.0,1.0,2/21,5.17%,TRIM32;TWIST1
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.3195022836964782,-0.7495798257232585,0.8055555555555556,1.0,1.0,17/67,12.92%,BMP7;SLC25A37;MT1E;LAMB3;SDC4;CLDN4;ADIRF;BCL2;ALDH1A3;HSPB1;DNPH1;ACADVL;LAMA3;ALKBH7;SH3RF2;TSPAN1;PERP
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.345547066304572,-0.7490364847071879,0.8823529411764706,1.0,1.0,7/53,15.44%,EPHA3;CDH13;MCTP1;APOE;PTPN1;ARFGAP1;RUFY2
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.36349400050774905,0.7486625599528368,0.7878787878787878,1.0,1.0,2/34,7.99%,LRP4;ABITRAM
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.3250670222486221,-0.7486340627389979,0.8,1.0,1.0,6/47,8.56%,SVBP;STEAP3;PORCN;OLFM2;RAB3C;VIP
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.48512123185961453,-0.7483558411006944,0.75,1.0,1.0,1/6,4.52%,RYR1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.3522162358010858,-0.7482405819920683,0.92,1.0,1.0,1/19,0.85%,BCL2L11
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.46268528046549506,-0.7480680270684775,0.7254901960784313,1.0,1.0,3/5,25.72%,SSU72;RPRD1B;RPRD1A
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),-0.4815986950079868,-0.7475880214416132,0.8108108108108109,1.0,1.0,4/5,22.52%,ATM;RC3H1;TNFRSF21;BLK
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.32232655414085126,0.7474565483583638,0.8591549295774648,1.0,1.0,14/88,16.54%,EPHA1;STK26;CYP1B1;IGFBP5;WAS;SPOCK3;RHOB;SMAD7;MITF;DACH1;FBLN1;LIMCH1;DNAI3;CD74
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),-0.4345992661677792,-0.747214264122641,0.725,1.0,1.0,1/7,2.83%,ASCL1
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.30551032668902595,0.7471906119680928,0.9041095890410958,1.0,1.0,7/120,8.27%,P2RY1;CAV3;MRAP;ZDHHC22;FYB1;F11R;NKD2
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.2832543786329865,-0.7471762411494995,0.9629629629629629,1.0,1.0,19/94,15.48%,MYB;PTPRT;CFAP47;CROCC;CFAP221;CFAP61;CFAP52;RSPH1;FAM216B;DNAH2;SCGB1A1;NWD1;TRIM71;MYO16;DNAH6;CFAP44;GAS2L2;C11ORF97;CFAP70
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4337301080047623,0.7471100541413034,0.7727272727272727,1.0,1.0,4/12,21.79%,SYT4;CACNA1H;CACNA1G;DOC2B
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.39761697156112163,0.7467133487144609,0.8,1.0,1.0,5/23,9.76%,TRIM32;SERPINF1;ATP6AP1;GPER1;SOX11
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.43207001604786655,0.7466653340308095,0.8709677419354839,1.0,1.0,3/12,17.99%,DNAJA1;PINK1;LRRK2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.4086401826191084,-0.746466366665557,0.8444444444444444,1.0,1.0,4/12,20.65%,VCAN;B3GAT3;CHST12;DSEL
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.31513567137815435,0.7461056011476783,0.922077922077922,1.0,1.0,12/98,24.56%,ITK;PSMB6;PLCG2;PSMA3;PSMB8;TAB2;PIK3CB;SHC1;LYN;PSMA5;SYK;CUL1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.29374625735029414,-0.7460813139558687,0.967741935483871,1.0,1.0,5/72,7.75%,EPHA3;EPHB2;ARPC3;EPHA5;NCSTN
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3338308786123082,-0.7458882744951854,0.8421052631578947,1.0,1.0,5/33,9.28%,F2RL1;PID1;PRKCD;ACE2;AKR1C3
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.4258471073581265,-0.7457885698159765,0.8260869565217391,1.0,1.0,3/14,8.13%,DCAKD;NUDT7;CROT
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.42325965464524984,-0.7454764428435242,0.8333333333333334,1.0,1.0,2/12,8.84%,SERPINF2;ANO6
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.3611325395781213,-0.74527683644559,0.8611111111111112,1.0,1.0,2/27,7.16%,ATP6V0D2;RAB7A
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.26437096004750327,-0.7452129439557388,1.0,1.0,1.0,12/286,4.60%,FBXL7;LTBP1;LAMB2;MELTF;PENK;ASB9;FBXW8;DSCC1;CCDC22;FBXO27;VCAN;FEM1A
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.35564487884080354,-0.7451336408539986,0.8611111111111112,1.0,1.0,5/35,11.94%,SVBP;STEAP3;OLFM2;RAB3C;SCG2
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.41367917150319955,-0.7449831992594663,0.8055555555555556,1.0,1.0,1/9,1.16%,ADAM19
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.4430638581079957,0.7447223981093873,0.7758620689655172,1.0,1.0,3/9,17.99%,RNF139;GAS1;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.46030053430876294,0.7447215845313193,0.782608695652174,1.0,1.0,4/11,24.47%,IL15;TNFSF18;PIK3CB;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.37299074241934066,0.7439757281770819,0.7903225806451613,1.0,1.0,4/32,5.17%,ZNF703;NOTCH1;LOXL2;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),0.5084484764767336,0.7439329467858646,0.8793103448275862,1.0,1.0,1/5,14.20%,SPHK1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.40054882324453317,0.743691281671058,0.8392857142857143,1.0,1.0,3/16,16.54%,DAPK2;CD99;CD74
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.29404727067473213,0.7436520814360111,0.9647058823529412,1.0,1.0,42/276,20.88%,TICRR;MCM2;RFC5;POLE2;POLE3;INHBA;ASMT;GTPBP2;RAD9B;EEF1A1;RPL15;RPS7;CDC6;DONSON;RPL36;GCNT1;BRCA1;HELB;RPL9;MRE11;RPA3;RPS21;ORC4;SCX;MRPS14;RPL38;MRPL34;RPL21;RPL22;RMI2;RECQL4;CREBL2;MCM6;GRWD1;POLR2D;MEF2A;RPS5;RSL24D1;RAD50;RPS6KB2;RPLP2;POLR2K
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.35238591686507276,0.7433246200383029,0.8412698412698413,1.0,1.0,4/32,10.24%,CAV3;SCN4B;TCAF2;YWHAH
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.2621578386092508,-0.7432767235769009,1.0,1.0,1.0,41/319,17.70%,RNF150;FBXL7;MYLIP;RNF126;PTTG1;CDC26;PTPN23;FEM1A;UBE2D4;NSFL1C;AURKA;TRPC4AP;ERCC8;UBE2R2;KCTD13;TAF1;UBXN2A;RNF216;CDC23;SIRT2;RNF114;ZNRF1;TRIM71;RNF130;CUL4A;RBBP6;FZR1;FAF1;TSG101;FBXO45;RBCK1;PML;FBXL22;RAD23A;ANAPC7;KLHL20;VCP;DTX3L;FBXO22;OTUD7A;RNF215
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.4864785678398335,-0.7430653831782011,0.84,1.0,1.0,2/6,34.78%,LARP4B;METTL16
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),0.5120895007775053,0.7427942853504921,0.8333333333333334,1.0,1.0,2/5,11.83%,ALOX12;PTGR1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.3443392805045009,0.7427175448254929,0.8484848484848485,1.0,1.0,7/54,12.89%,RFC5;TCP1;PDGFRB;HGF;CCT6A;PCNA;CCT8
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.28753835469159833,-0.7426673109022774,1.0,1.0,1.0,11/71,12.65%,LEF1;CARD18;TFAP4;PRKCD;CYP2D6;AURKA;IFI16;SORL1;GTF2F1;HMGA2;PPP1CA
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.27987737141355784,0.7425898896655062,1.0,1.0,1.0,45/352,17.68%,NOX5;CALCR;ITK;ZBTB7B;ACTA2;NOTCH1;IL15;MYOM1;INHBA;RHOXF2;AGT;TWIST1;ACTC1;TBP;PPARGC1A;HHLA2;SFRP4;RPS7;POLR1H;GPER1;STAP1;SOX11;PLCG2;TGFB1;SLC38A2;BRCA1;MITF;HTR2B;SMAD1;FN1;SCX;TTN;VPS35;POLR1E;UBR5;FXR1;CD74;RGCC;PLSCR1;MSN;MYCN;TESC;TLR2;ERN1;MUSK
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.33423952212179386,0.7424904451153043,0.9117647058823529,1.0,1.0,6/91,6.73%,NES;LRP4;FJX1;BOK;TEAD4;SRPX
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.3244057966702234,0.7421730903361209,0.8904109589041096,1.0,1.0,12/76,18.06%,SCO2;SDHAF3;NDUFA2;NDUFB9;NDUFB3;NDUFB2;NDUFB4;COA5;DMAC1;SDHAF1;NDUFAF4;TMEM126B
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.37618125006131986,0.7419685234986927,0.7878787878787878,1.0,1.0,4/19,13.25%,ITPR1;PTPRC;PLCG2;HTR2B
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.4347198581024472,-0.741928867559293,0.8125,1.0,1.0,1/10,3.05%,ST3GAL1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.28114812698666564,-0.7417166211777295,0.9523809523809523,1.0,1.0,14/118,11.95%,GPC4;UNC13B;NTNG1;UNC13C;C5AR1;SDK1;LRFN4;SLC6A1;SHANK2;DRD1;PCDHB4;CDH1;PTPRS;PPFIBP1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.38708528024466626,-0.7415234101430576,0.8666666666666667,1.0,1.0,3/15,11.02%,HMMR;GUSB;CHP1
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.3875985670776442,0.7414436546042835,0.8412698412698413,1.0,1.0,2/27,9.70%,CDKN1B;SMAD7
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.4603652823263805,0.7414327750102503,0.9032258064516129,1.0,1.0,1/10,5.56%,GABRA2
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.33875150984411617,-0.741340135353763,0.8,1.0,1.0,4/40,11.16%,PEX7;TOMM40L;TIMM50;TOMM40
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.3496402218176889,-0.7411978578428298,0.825,1.0,1.0,5/31,10.83%,KIT;KITLG;TGFB2;AKR1C3;MAMLD1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.39433003938238953,0.741115799778147,0.9090909090909091,1.0,1.0,5/21,18.30%,CDC25A;ATAD5;RAB11A;CDK4;RAD51C
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.34372433751989223,0.7409815509817401,0.8615384615384616,1.0,1.0,15/55,21.07%,LRRC19;AGER;CD14;CD27;NLRC3;SPHK1;PDCD4;TLR2;IFI35;RTKN2;DLG1;CYLD;TERF2IP;C1QTNF4;PPM1A
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.37632087836136585,0.7408715197744884,0.8360655737704918,1.0,1.0,6/27,21.86%,EPS8;PAWR;DMTN;RFLNB;BAIAP2L1;MYO1B
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.3833684452917698,0.7405078656268886,0.873015873015873,1.0,1.0,6/26,22.17%,EPS8;PAWR;DMTN;BAIAP2L1;MYO1B;HSP90B1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.43447118962904974,0.7403853592705736,0.85,1.0,1.0,4/16,18.80%,BOK;SOD2;BCL2L1;BAD
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.3839360166872517,-0.7403574591197316,0.8235294117647058,1.0,1.0,3/19,8.43%,PKP2;CACNA2D1;KCNE1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.36263533439957063,0.7403268472536783,0.8787878787878788,1.0,1.0,3/37,4.47%,CSRP3;RCSD1;SCN4B
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.37441288445230925,-0.7402479800098324,0.8333333333333334,1.0,1.0,4/26,11.71%,TRIB2;WWTR1;RORA;SIRT2
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.2936311857199011,-0.7401843207137749,0.9696969696969697,1.0,1.0,3/90,3.85%,NUP62CL;BMP7;TPR
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.41203131830466444,0.7401026125015825,0.84375,1.0,1.0,8/24,27.60%,SEMA3F;SEMA3A;SLC9A6;ULK1;SLIT1;CYFIP1;SLIT2;ALCAM
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),-0.44785047238840514,-0.7400082692249235,0.7755102040816326,1.0,1.0,2/6,9.95%,GNA14;DRD1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.35243567942486304,-0.7396564743765007,0.8387096774193549,1.0,1.0,2/19,8.68%,PNKP;SMG6
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.455399649963688,0.7392598856284981,0.8032786885245902,1.0,1.0,1/9,4.27%,CHST1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.3935481344126869,0.738789355516441,0.8,1.0,1.0,4/21,18.81%,ALDOB;PGAM1;PKLR;HK3
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.3935481344126869,0.738789355516441,0.8,1.0,1.0,4/21,18.81%,ALDOB;PGAM1;PKLR;HK3
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.36794748572485636,0.7387770236354237,0.7916666666666666,1.0,1.0,4/35,9.96%,HKDC1;PPARGC1A;GPER1;LRRC8D
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3422231680441561,0.7386681728024583,0.828125,1.0,1.0,6/48,9.82%,AGER;PTPRC;TWIST1;FADD;CD14;PLCG2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.341100727265558,-0.7383482860962668,0.868421052631579,1.0,1.0,4/25,9.98%,TYMS;NME4;CTPS2;RRM2
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.4093620800079559,0.7381512392330407,0.8461538461538461,1.0,1.0,7/14,33.69%,INTS6;SSB;TRNT1;PTCD1;INTS14;INTS5;INTS2
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.4190028018723685,0.7380553907105332,0.8793103448275862,1.0,1.0,2/9,14.30%,RAB8A;RAB11A
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3188544938899959,0.7378429105551277,0.90625,1.0,1.0,3/57,5.88%,LMAN1;F8;TGFA
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.3188544938899959,0.7378429105551277,0.90625,1.0,1.0,3/57,5.88%,LMAN1;F8;TGFA
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.3188544938899959,0.7378429105551277,0.90625,1.0,1.0,3/57,5.88%,LMAN1;F8;TGFA
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.3434365693501479,-0.7378361035905406,0.9142857142857143,1.0,1.0,5/29,12.20%,DGLUCY;MTHFS;PYCR3;NIT2;GOT2
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.39994153122177445,-0.7378293022511533,0.825,1.0,1.0,4/15,18.30%,SFSWAP;DCPS;CACTIN;WBP4
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.3326886174010106,-0.7377933964282613,0.8285714285714286,1.0,1.0,3/28,5.46%,ARL13B;B9D1;PTCH1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.3277427251897417,0.7376512138944771,0.972972972972973,1.0,1.0,3/73,5.20%,CAV3;HCK;PSRC1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.3549675370459799,0.73746704264164,0.864406779661017,1.0,1.0,8/36,19.70%,TRPM6;SFXN3;KCNJ11;SLC38A5;ATP1B1;CACNA1H;SLC25A19;ABCC9
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.3435794101231314,0.7373497746849561,0.9193548387096774,1.0,1.0,9/61,12.66%,PTGIS;MMP26;ELANE;LPCAT3;PCBP2;RNF26;GPER1;GHRL;NLRC3
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.4452414623103882,0.73728621470865,0.7258064516129032,1.0,1.0,2/8,21.85%,DCUN1D1;UBA3
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.36034174680492737,0.7370965220015057,0.8805970149253731,1.0,1.0,5/28,15.85%,YWHAG;MTCH1;CAMK2D;GLRX2;TRDN
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.30185664582203736,-0.7368528789332165,0.967741935483871,1.0,1.0,6/67,8.32%,KDR;SELP;AZU1;MCTP1;P2RY11;ADGRL1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.332485370051066,0.7368290736826623,0.8676470588235294,1.0,1.0,3/59,4.93%,CCL5;NR5A2;VAPB
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.397609741561603,0.7366851773257005,0.84375,1.0,1.0,7/24,25.20%,MRE11;RECQL;RECQL4;RAD50;DDX1;BLM;MTERF1
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.42037034654791366,0.7366586348655506,0.7878787878787878,1.0,1.0,2/8,16.58%,TGFB1;INSIG1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.4490861243019087,0.736561354673132,0.796875,1.0,1.0,2/9,22.40%,CLP1;AGO4
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.3242406303860238,0.736560368450111,0.9428571428571428,1.0,1.0,15/65,18.27%,SYT2;SYT4;NKAIN2;KCNJ9;YWHAH;DRD3;CLDN10;KCNJ11;SYT9;SYT15;PDZK1;SYT13;ATP1A1;B2M;TF
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.357124262525914,-0.7365093258479877,0.875,1.0,1.0,2/22,6.80%,RBP4;PDPN
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.4655135111111611,0.736499904317014,0.7678571428571429,1.0,1.0,2/7,23.63%,LYN;SYK
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.2985082172914776,-0.7363978252748297,0.96,1.0,1.0,16/135,15.06%,SAMD4A;KHSRP;PRKCD;TENT5A;HSPB1;VIP;ELAVL1;EIF4G1;IGF2BP3;EXOSC1;EXOSC7;EXOSC5;MEX3D;CIRBP;SAMD4B;EXOSC4
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.31646289450669257,-0.7361502224193418,0.896551724137931,1.0,1.0,2/65,1.45%,ATP6V0D2;WDR24
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.25142937880093635,-0.7361205569261633,1.0,1.0,1.0,38/379,13.03%,NRK;SPRED1;F2RL1;ARHGAP31;SRGAP1;RASSF2;MOB3B;SMYD2;SGK1;TRAF3;HDAC1;SPHK2;IER3;HUS1;RHOJ;TAF10;AURKA;FAM83D;HSPB1;TAF11;GNA12;LBH;TAF1;PIP5K1B;TTI1;TELO2;ARHGAP33;XIAP;WDR54;MCF2L;SSRP1;PIP5K1C;PRMT5;PRDM11;ARHGEF1;EHMT2;TAF12;ARAP3
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.434053989566347,-0.7357008976655633,0.8181818181818182,1.0,1.0,2/7,18.36%,CTTNBP2NL;PRKCB
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.3144216810313062,-0.7355686358361355,0.8620689655172413,1.0,1.0,2/66,1.45%,ATP6V0D2;WDR24
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.32789069612253335,-0.7353172641797824,0.8648648648648649,1.0,1.0,8/64,11.71%,TRIB2;SFRP1;WWTR1;ADIRF;ID2;RORA;SYAP1;SIRT2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.3151165393694008,-0.7348954659376038,0.8518518518518519,1.0,1.0,2/52,7.04%,FBXL7;AURKA
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),0.4671752879662544,0.73466680794719,0.8793103448275862,1.0,1.0,2/7,14.08%,SLC36A1;SLC38A5
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.3736024774595327,0.7344988228750872,0.8225806451612904,1.0,1.0,4/30,13.47%,SESN3;RNF152;TSC2;TNFAIP8L1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.39416632996966033,0.7344916496584495,0.8059701492537313,1.0,1.0,2/21,7.82%,PTPRZ1;KIF14
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.4701536934368571,0.7344494860057106,0.7966101694915254,1.0,1.0,2/7,9.29%,SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.4928068792909004,0.7344470901837944,0.8947368421052632,1.0,1.0,3/6,25.53%,CHAF1A;HAT1;CHAF1B
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.4928068792909004,0.7344470901837944,0.8947368421052632,1.0,1.0,3/6,25.53%,CHAF1A;HAT1;CHAF1B
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.319448590419655,0.7344237721774072,0.9041095890410958,1.0,1.0,17/71,25.87%,WFS1;SYVN1;HSPA5;MAN1A1;HERPUD1;DERL1;TRIM25;MAN1B1;ERLIN1;JKAMP;HSP90B1;RNF185;UBQLN1;YOD1;TMUB1;PSMC6;MARCHF6
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.4739201664911734,0.7343925560911236,0.8518518518518519,1.0,1.0,2/7,13.39%,HGF;LGMN
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.4739201664911734,0.7343925560911236,0.8518518518518519,1.0,1.0,2/7,13.39%,HGF;LGMN
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.36904877987877593,-0.7342283207477801,0.8536585365853658,1.0,1.0,4/22,11.55%,USP27X;OTUD3;USP25;OTUD5
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.27281664838466474,0.7342100844047684,1.0,1.0,1.0,29/381,10.75%,TRIM22;RREB1;ZNF703;SNAI3;GMNN;ATF5;NOTCH1;HIC1;NR5A2;ZNF732;AHR;ING2;ZNF430;SPTY2D1;HINT1;PPARGC1A;NFIL3;SOX6;REST;RPS6KA4;TCF7L1;CASZ1;NAB1;EFEMP1;SOX11;MAFB;NANOG;RHOH;ZNF682
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.3683836353960627,-0.7341737148229585,0.825,1.0,1.0,2/15,11.82%,NMU;KCNB2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.3151685791679796,0.7341345884540086,0.9459459459459459,1.0,1.0,15/103,11.50%,TIMP3;HSPG2;AOX1;POSTN;ACKR3;RND1;OSMR;PLSCR4;RARRES2;IGFBP5;DOCK1;EFEMP1;EPAS1;IL17RE;KIAA1217
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.31112321227972106,0.7340073821224988,0.9166666666666666,1.0,1.0,16/66,23.34%,FADD;CD14;CASP8;PLCG2;SCIMP;CTSK;RIPK2;LGMN;TAB2;TLR2;SFTPD;IRAK4;LBP;HSP90B1;UBE2D1;MAPKAPK3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.34263601612315964,0.7338010219363784,0.8032786885245902,1.0,1.0,6/46,9.82%,AGER;PTPRC;TWIST1;FADD;CD14;PLCG2
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.4519484307957623,0.7337404699170013,0.8064516129032258,1.0,1.0,4/6,30.03%,LIN7C;AP4M1;LIN7B;PDZD11
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.3106369433308571,0.7336569960818012,0.9722222222222222,1.0,1.0,11/97,11.38%,MSX1;INHBA;CDKN2D;PSRC1;OSGIN2;NAIF1;CDKN1B;CGRRF1;CRLF3;TGFB1;TP53TG5
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.325419942650613,0.7336093982974418,0.8611111111111112,1.0,1.0,2/82,2.19%,RAB6C;LMAN1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.4085559532320778,0.7333206781610307,0.88,1.0,1.0,2/10,16.37%,BRCA1;YTHDC1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.37727842392279143,0.7332251452438676,0.803030303030303,1.0,1.0,5/31,17.39%,SEMA3F;SEMA3A;FLRT3;SLC9A6;ULK1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.4031817735192478,0.7331536923262912,0.8208955223880597,1.0,1.0,4/19,19.74%,ACAD8;HSD17B10;DBT;ACAT1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.4031817735192478,0.7331536923262912,0.8208955223880597,1.0,1.0,4/19,19.74%,ACAD8;HSD17B10;DBT;ACAT1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.3075302277619715,0.7330944858820261,0.9594594594594594,1.0,1.0,13/120,12.39%,NES;HESX1;HSPG2;SLC23A1;SCTR;UFM1;PAFAH1B3;SOX6;B3GNT5;ZFHX2;POMK;CDK5R1;CA10
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.4853358999755189,-0.7330103073897024,0.7555555555555555,1.0,1.0,1/5,1.83%,PNPO
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.35490957922729705,-0.7329905974822618,0.8205128205128205,1.0,1.0,3/24,6.01%,BTC;EREG;DGKD
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.29378671361265035,0.7329361254948008,0.9864864864864865,1.0,1.0,14/158,16.77%,LIPH;PLA2G10;LPCAT3;PIK3R5;SLC44A5;PLCG2;LIPI;SELENOI;INPPL1;PIK3C2G;DDHD2;PLEKHA2;PLSCR1;INPP5F
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.27120054870789484,-0.732841132725905,1.0,1.0,1.0,49/233,18.30%,CPSF1;SNRNP27;HNRNPL;SF3B4;SF3A2;RBM41;MAGOHB;LSM6;PPIH;DHX8;ELAVL1;POLR2G;RBM10;RBMX;PRPF4;RBM17;TXNL4A;ZCRB1;U2AF2;CPSF7;SRRM1;GPATCH1;GTF2F1;SNRPB;SF3A1;ZRSR2;SNRPN;RBM19;DDX41;SRSF7;POLR2C;PPIL1;POLR2L;PTBP1;CASC3;CACTIN;CDC5L;RSRC1;PDCD7;PRPF6;DDX46;RNF113A;SF3B6;CWF19L2;LSM7;SYMPK;PRPF3;SRRT;WBP4
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.4851746153984444,0.7327475805127466,0.8135593220338984,1.0,1.0,2/7,22.30%,HAT1;KAT2B
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.44071813866625786,-0.732715433912985,0.7608695652173914,1.0,1.0,3/8,21.72%,NRP1;NR4A1;CCN3
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.3228356869903786,0.7324008785719169,0.9166666666666666,1.0,1.0,18/79,15.14%,RP1;EXPH5;CCDC60;EPB41L4A;SLC26A4;FAM227A;AVPR1A;ZNF750;P2RY14;TMEM213;WDR93;TMEM150C;DNAH7;BBOX1;ALDH1L1;MUC20;CFAP65;ADGRF5
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.2908013562795281,-0.7319754476302288,0.90625,1.0,1.0,16/73,16.47%,NUP62CL;TPR;RITA1;CHTOP;MAGOHB;THOC1;RANBP3;CHP1;U2AF2;SRRM1;NUP42;SRSF7;CASC3;RANBP17;ATXN1;MALT1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.37155061513077414,0.7319316842606798,0.8676470588235294,1.0,1.0,6/28,18.00%,AGER;TWIST1;IL7;CD74;TLR2;IL18
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.4418931283136315,-0.7317505070350431,0.8387096774193549,1.0,1.0,4/16,16.27%,TOMM40L;TIMM50;TOMM40;TIMM44
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.4581820368450988,0.7315715497335891,0.8615384615384616,1.0,1.0,1/10,6.86%,SOX6
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),-0.3331112925533136,-0.7315374645950039,0.8,1.0,1.0,9/42,14.39%,GREM1;LEMD2;CRIM1;VWC2;SORL1;NOG;CHRDL1;NBL1;BMPER
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.45897465351841193,0.731492461453416,0.7903225806451613,1.0,1.0,2/7,6.36%,AGER;PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.36832273720626085,0.7312452560802197,0.8805970149253731,1.0,1.0,9/27,28.07%,TCAF2;MIEF2;PDZK1;DMTN;PRNP;MIEF1;CEMIP;INPP5K;TCAF1
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.4894316563208658,0.7312421062046864,0.8360655737704918,1.0,1.0,1/7,8.11%,HMGCR
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.4040173109518952,0.7311351786602841,0.8333333333333334,1.0,1.0,3/15,18.05%,BAAT;DAO;SEPHS2
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),-0.47708234903929037,-0.730794294731206,0.7380952380952381,1.0,1.0,2/6,11.43%,KIF23;MAP10
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),-0.47708234903929037,-0.730794294731206,0.7380952380952381,1.0,1.0,2/6,11.43%,KIF23;MAP10
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.4021854766161481,0.7307919482721836,0.8421052631578947,1.0,1.0,2/16,3.05%,SDS;GOT1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.4299239659669293,-0.7301809046475405,0.7804878048780488,1.0,1.0,2/13,12.98%,RYR1;SPIDR
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.28746612089525214,0.730002956006739,0.972972972972973,1.0,1.0,33/131,24.42%,RND1;ACTC1;HIP1R;CORO1A;WAS;ARHGAP25;MYO5B;RHOB;MYO1F;RHOH;EPS8;GHRL;TLE6;INPPL1;TTN;SHROOM3;SHROOM4;DMTN;RFLNB;RHOF;OOEP;DLG1;GAS2;ELMO3;BAIAP2L1;MYO1B;ENAH;TMOD1;CDC42;FHOD3;EMP2;VILL;ABI2
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.30109253634364463,0.7297466043420522,0.9722222222222222,1.0,1.0,16/111,19.57%,PIK3R5;PIGC;PGAP4;PIGH;PLCG2;PIGV;PGAP3;MPPE1;INPPL1;PIK3C2G;ITPKB;PLEKHA2;INPP5F;PIP4K2C;PIGN;PIK3CB
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.427995516012326,0.72971865494545,0.8070175438596491,1.0,1.0,5/12,17.34%,TBP;TAF7L;DR1;POLR1E;GTF2A2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.38799617093504857,-0.7297052889881058,0.8235294117647058,1.0,1.0,2/17,10.58%,IFI16;NGF
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.33666384631874907,0.7296814006364462,0.819672131147541,1.0,1.0,7/60,16.52%,CENPK;CHMP4B;TPX2;MZT1;EPS8;RAB11A;CHMP2A
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.31480743711555204,0.7295001332085699,0.9594594594594594,1.0,1.0,16/92,13.69%,ENPP2;SLCO2B1;SSTR1;PLP1;SCN4B;P2RY12;SLC39A12;TGFA;CD14;VWF;C1QA;GFAP;ALDH2;CA10;A2M;SPP1
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.40330130969249617,0.7292868295760405,0.8055555555555556,1.0,1.0,2/17,3.21%,ZBTB7B;PRLR
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),-0.4924313713733217,-0.7292432729328734,0.875,1.0,1.0,1/5,4.69%,ABCA13
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4065093533511005,-0.7291822233731814,0.8048780487804879,1.0,1.0,3/12,16.33%,TET1;DNMT1;SETDB1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.28501621157437285,-0.7289820932144004,1.0,1.0,1.0,22/112,19.10%,VASH1;NEK6;NUP210;TPR;IER3;NUP37;ATF3;EIF4G1;ABCD1;USP51;NUP42;BAG3;RPTOR;HSF1;PNPT1;NUP107;ATM;NUP43;HSPA1A;OPRM1;CREBBP;MTOR
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.3199772857851941,-0.7289379644182687,0.8387096774193549,1.0,1.0,8/43,15.31%,DSCC1;EREG;ORC3;SLFN11;EHMT2;RBBP6;FAF1;EGFR
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.26046471760034645,0.7289130904415348,1.0,1.0,1.0,58/800,10.75%,TRIM58;TRIM22;CALCR;LRRC19;BTN2A2;TDG;RREB1;TRIML2;ZNF703;SNAI3;TRIM5;ZBTB7B;ACTA2;ATF5;ABCC2;NOTCH1;HIC1;MYOM1;NR5A2;INHBA;ZNF732;RHOXF2;AHR;ING2;PTPRC;TWIST1;ZNF430;SPTY2D1;ACTC1;HINT1;MBNL3;PPARGC1A;NFIL3;SOX6;REST;HHLA2;YBX3;RPS6KA4;SFRP4;PCBP2;TCF7L1;CASP8;RPS7;CASZ1;NAB1;EFEMP1;GPER1;STAP1;PRDM6;SOX11;PLCG2;MAFB;NANOG;TGFB1;RHOH;SLC38A2;BRCA1;ZNF682
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.4692187724717739,0.7286031221413782,0.7894736842105263,1.0,1.0,1/6,5.66%,ZFPM1
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3989108103129019,0.728539492304229,0.8870967741935484,1.0,1.0,4/17,15.63%,WASF1;GMFG;BRK1;DNAI3
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),-0.47233030696065714,-0.728376899620473,0.7368421052631579,1.0,1.0,5/5,52.79%,NLGN2;NRXN1;NRXN2;NLGN1;LRRC4
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.422149666901148,0.7283355711187691,0.7666666666666667,1.0,1.0,3/10,19.82%,BRCA1;ACADL;ERLIN1
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.35570321085450257,-0.7277713543684007,0.8857142857142857,1.0,1.0,10/29,18.86%,ERCC2;GTF2H2;UBTF;CCNH;POLR2L;POLR1A;TAF1D;POLR1G;GTF2H5;ERCC3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.39713877264936887,0.7277059699907673,0.8225806451612904,1.0,1.0,2/18,9.70%,NLRP2B;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.3552585179256387,-0.7277018308461928,0.9629629629629629,1.0,1.0,3/23,15.40%,QRICH2;TAF1;PML
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.30057534785972695,0.7274460213382465,0.9722222222222222,1.0,1.0,7/123,8.27%,P2RY1;CAV3;MRAP;ZDHHC22;FYB1;F11R;NKD2
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.3833185907152272,-0.7271860490608635,0.7575757575757576,1.0,1.0,4/13,15.06%,EXOSC10;EXOSC7;EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.38751418597542386,-0.7271788829119767,0.813953488372093,1.0,1.0,3/15,11.25%,LYPLA2;GDE1;SMPD4
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.4870801368752201,0.7271202403875091,0.7857142857142857,1.0,1.0,1/6,2.79%,NEUROD2
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.3757672237956641,0.7271036531681987,0.8382352941176471,1.0,1.0,3/29,12.53%,SEMA3D;SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.3344341170749098,-0.7269647736636204,0.8484848484848485,1.0,1.0,5/36,8.73%,MAML3;MAML1;TGFB2;STAT3;JAG2
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.35017388749796463,0.7268646491838545,0.8767123287671232,1.0,1.0,7/41,9.47%,GPC6;GPC5;HSPG2;B3GALT1;B3GNT4;B3GNT3;XYLT1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.347109887714943,-0.7267472078535918,0.9743589743589743,1.0,1.0,3/17,7.55%,PID1;NUMB;CSK
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.416821552117616,0.7266835240570975,0.8870967741935484,1.0,1.0,3/11,16.99%,DOCK8;MSN;TNFSF18
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.46779024708955474,0.7265780894508479,0.7333333333333333,1.0,1.0,3/6,22.30%,BRCA1;MDM1;KAT2B
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),-0.4614867656735025,-0.7265410330710886,0.7777777777777778,1.0,1.0,1/6,7.35%,SLC25A29
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.48221669776210085,0.726447500778899,0.82,1.0,1.0,1/7,2.58%,POLQ
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.4261117061938954,0.7261142188420032,0.8448275862068966,1.0,1.0,2/10,14.22%,NOTCH1;TTN
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.42763808511575163,0.7257986430752438,0.7666666666666667,1.0,1.0,7/11,40.85%,TERF2IP;DDX3X;KAT5;RAPGEF3;CAMK1;TAOK1;PARK7
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),0.39844609177594625,0.7257974228710613,0.8507462686567164,1.0,1.0,6/20,32.32%,RSL24D1;NOP53;RPL3;RPL5;MRPL20;RPL24
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.3881403980578103,-0.7255693755715835,0.7619047619047619,1.0,1.0,1/14,7.61%,ADPRM
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.3941149658737773,-0.7255049224410837,0.8095238095238095,1.0,1.0,3/14,16.87%,EXOSC10;EXOSC4;ATM
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.3990081083752397,0.7254809078174973,0.828125,1.0,1.0,4/11,19.54%,DOCK2;PLCG2;IFI35;LBP
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.35407729055926607,0.7251349712267429,0.8870967741935484,1.0,1.0,4/35,10.37%,GCM2;WDR62;CHAC1;SIX4
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.33245208059447484,-0.7250097111029812,0.8235294117647058,1.0,1.0,3/28,6.32%,CACNG4;CACNA1I;CACNA1A
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.40276990005435254,0.7249387752559626,0.8307692307692308,1.0,1.0,1/16,1.58%,OSCAR
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.43207140983412384,0.7248428263674068,0.8620689655172413,1.0,1.0,3/12,17.00%,GLRX;ATP1B1;TESC
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.36410360814581905,0.7246451543382185,0.8507462686567164,1.0,1.0,5/29,17.48%,HSPA5;HSPA1L;HSPA8;DAB2IP;ERN1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.37615316167839397,0.7245335827396784,0.796875,1.0,1.0,1/13,6.32%,SMARCE1
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.37615316167839397,0.7245335827396784,0.796875,1.0,1.0,1/13,6.32%,SMARCE1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3817060165254184,0.7244029794168021,0.8985507246376812,1.0,1.0,5/20,18.80%,CASP8;YWHAH;YWHAG;TP63;BAD
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3817060165254184,0.7244029794168021,0.8985507246376812,1.0,1.0,5/20,18.80%,CASP8;YWHAH;YWHAG;TP63;BAD
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.39866575269866444,-0.7243533670157429,0.8108108108108109,1.0,1.0,3/12,10.18%,OSBPL7;PTCH1;RORA
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.440653574469981,0.7243505299715632,0.782608695652174,1.0,1.0,2/10,13.46%,MRPL44;SMAD1
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.2401623632764495,-0.7242421155901821,1.0,1.0,1.0,19/223,12.87%,USP27X;IFIH1;MBD6;OTUD3;TRAF3;BRCC3;TAF10;INO80D;SENP8;INO80;USP35;FOXK1;USP25;USP10;USP51;RCE1;OTUD5;YY1;USP4
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.4183087326239267,-0.7242090325674988,0.8333333333333334,1.0,1.0,1/10,1.77%,PID1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.44380178769889056,-0.7239023095660302,0.7096774193548387,1.0,1.0,2/9,7.89%,TICAM1;STAT3
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.3561145639083454,-0.7237769125591669,0.8780487804878049,1.0,1.0,3/22,6.63%,CBARP;DRD4;THADA
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.32364787760643876,0.723726834423509,0.9117647058823529,1.0,1.0,12/72,18.60%,ZBTB7B;GOT1;KHK;RAB8A;INSIG2;EPM2AIP1;EPRS1;INSIG1;PKLR;PDE3B;SORT1;PPARG
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.29995612282467043,-0.7234230155358908,0.8709677419354839,1.0,1.0,9/35,16.33%,IFIH1;APOBEC3H;IFI16;PARP10;HMGA2;MX1;ZC3HAV1;MAVS;SETDB1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.47775660876067055,-0.7233097017164657,0.8260869565217391,1.0,1.0,3/5,31.24%,DDAH1;ENO1;NOL3
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.48910456671930114,0.7230055428376362,0.8,1.0,1.0,1/5,5.47%,GBA3
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.4787696738149825,0.7226780972642025,0.7962962962962963,1.0,1.0,2/6,23.63%,LYN;SYK
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.4387706378309274,-0.7226324514143799,0.7441860465116279,1.0,1.0,4/7,30.30%,MEAF6;KAT7;BRPF1;PHF14
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.37406514188516005,-0.7224500055486002,0.8571428571428571,1.0,1.0,1/12,2.50%,IFIH1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.2941973838067669,0.7220890777862755,0.972972972972973,1.0,1.0,15/142,13.33%,WFS1;STK26;RABGGTB;NTF3;MOAP1;FLT3;AGT;DAPK2;BNIP3;STAT1;FAS;TP53I3;BCL2L14;KANK2;GAS1
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),-0.4008109904797887,-0.7220837669319574,0.8108108108108109,1.0,1.0,7/18,25.76%,SIPA1L3;FERMT1;FBF1;PARD3;MYO18A;MYO9A;CYTH1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.31880716746913873,0.7216425928389776,0.9850746268656716,1.0,1.0,11/83,12.66%,PTGIS;MMP26;ELANE;LPCAT3;CARD8;PCBP2;RNF26;GPER1;DRD3;GHRL;NLRC3
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.3517289699487036,-0.7212506315919578,0.9285714285714286,1.0,1.0,7/31,13.12%,LCMT2;TRDMT1;TRMT10C;THADA;ALKBH8;TRMT61A;TARBP1
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.3534544533885989,0.7211780366147709,0.9,1.0,1.0,11/40,24.55%,H3-3A;MRE11;RPA3;PCNA;RECQL4;SP100;RAD50;TERF2IP;POLD1;ERCC4;BLM
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.34095703167436064,-0.721085534255659,0.8260869565217391,1.0,1.0,4/27,10.72%,NOP9;TBL3;WDR46;NOP14
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.31940413484376595,0.720986393221644,0.8939393939393939,1.0,1.0,15/66,23.37%,GCM2;DNAJC5G;CTAGE14P;COL9A1;KCNJ11;ACVR2B;TRDN;MYH7B;HIF3A;CTNNA3;L2HGDH;ACTN2;RYR2;MYH7;TMEM266
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.4116938926054412,0.7209828183079211,0.8970588235294118,1.0,1.0,1/13,1.07%,CHRNB1
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.4694100147306899,0.7208518544628241,0.819672131147541,1.0,1.0,1/5,6.21%,PTPRZ1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.2542586321697554,-0.7202655966620195,1.0,1.0,1.0,20/163,16.89%,RRP1B;LYAR;NVL;LSM6;RRP7A;TBL3;SRFBP1;WDR46;EXOSC10;DDX27;NOP14;EXOSC1;EXOSC7;EXOSC5;NOC4L;BOP1;EXOSC4;RPL12;NOL8;WDR75
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.40886612966823344,0.7202492273861935,0.8208955223880597,1.0,1.0,1/12,3.71%,NOTCH1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.415127891357429,0.720096735318528,0.8333333333333334,1.0,1.0,2/10,13.25%,IRAG1;HTR2B
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.4126816088429872,0.7200171612657958,0.8305084745762712,1.0,1.0,2/9,30.67%,TENM3;SHROOM2
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.3585876528142552,0.7199630385214094,0.873015873015873,1.0,1.0,4/27,19.69%,H3-3A;JARID2;SUZ12;EZH2
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.41186117875665107,0.7198685209542005,0.835820895522388,1.0,1.0,2/13,18.34%,IHO1;MEI4
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),-0.4158422308295548,-0.7197995204998326,0.7948717948717948,1.0,1.0,2/7,8.80%,VIP;SPX
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),0.4899653057912451,0.7197992678007421,0.8928571428571429,1.0,1.0,1/5,3.75%,LPCAT3
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.3225765992691604,0.7192706474823172,0.9577464788732394,1.0,1.0,9/64,14.79%,HCK;ITGA5;FYB1;ITGA11;DOCK1;ZNF304;ITGBL1;FN1;FBLN1
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.28523314263452887,-0.7190571857661436,0.9696969696969697,1.0,1.0,21/88,22.93%,ITPR2;ARPC3;MAP2K3;GNA14;NGF;PPP1CA;PPP2R1B;RPTOR;EGFR;CAB39L;PRKCB;NFKBIB;FGF22;ATF1;SQSTM1;MKNK2;TIAM1;MAP3K7;PFN1;PIN1;PAK4
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.3439057101028351,-0.7188706539998568,0.8620689655172413,1.0,1.0,6/21,24.62%,DPY19L1;DPM3;FKTN;TMTC2;RXYLT1;DPY19L3
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.41882607629269647,0.718848157794632,0.7818181818181819,1.0,1.0,3/8,23.10%,ECT2;RACGAP1;CDC42
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.299150612389531,-0.7186249232580378,0.9393939393939394,1.0,1.0,5/62,7.57%,PTPN3;BMP7;INHA;TFAP4;BTG1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.3815478508146394,0.718416264175884,0.8805970149253731,1.0,1.0,3/25,10.65%,TRIM5;CASP8;IRF1
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.3888433420427087,0.7182544270331243,0.855072463768116,1.0,1.0,7/18,22.07%,NKD2;CHAC1;RNF139;GAS1;LRRK2;PRNP;CCBE1
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4277891012370573,0.7181741823961324,0.8,1.0,1.0,2/10,7.63%,RASA1;PCBP2
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.3580233391528583,-0.7181342329512822,0.8529411764705882,1.0,1.0,8/20,15.70%,LYAR;TRAFD1;TYRO3;IFI16;TRAF3IP1;SIRT2;CACTIN;IRAK3
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.388687352011938,0.7180896115860517,0.8333333333333334,1.0,1.0,2/16,6.36%,INHBA;PDCD1LG2
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.3759582242683017,-0.7179722240315235,0.7837837837837838,1.0,1.0,3/11,22.16%,WNT9B;NR4A2;LRP6
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.42482350428607474,0.7178445650345072,0.8412698412698413,1.0,1.0,4/14,25.61%,ARL6;RAB11A;MKKS;MREG
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.42482350428607474,0.7178445650345072,0.8412698412698413,1.0,1.0,4/14,25.61%,ARL6;RAB11A;MKKS;MREG
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.4264483354950281,-0.7178347054644145,0.9230769230769231,1.0,1.0,5/5,57.37%,DLD;PDHA1;PDHX;PDHB;DLAT
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.4172667301426754,0.7176908508911095,0.9285714285714286,1.0,1.0,1/11,5.91%,HSPA5
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.2728495464639771,-0.7176727038420365,1.0,1.0,1.0,22/159,16.27%,RAB32;PID1;MYH14;PTCD2;ALAS1;TMEM11;SLC25A33;IMMP2L;MTX1;SPATA18;TIMM50;TOMM40;MX1;NIPSNAP2;MPV17;POLG2;PNPT1;ADCK1;GDAP1;HK2;COX7A1;TIMM44
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.366256915293271,-0.7176689337264681,0.8108108108108109,1.0,1.0,2/13,18.28%,SH3GLB1;LAMTOR4
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.4622917452303482,0.7173943858081965,0.8,1.0,1.0,2/5,29.75%,IL18;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),0.4622917452303482,0.7173943858081965,0.8,1.0,1.0,2/5,29.75%,IL18;TNFSF4
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.2738607067432194,0.717258015796509,1.0,1.0,1.0,46/338,17.53%,WFS1;MMP15;RABGGTB;RCN1;CP;ITIH2;LOXL2;NOTUM;SERPINA10;MFGE8;KNG1;ASMT;IGFBP5;CPE;PAPPA;EEF1A1;CSF2RA;MEPE;RPL15;RPS7;MANBA;RPL36;PIGH;PAPPA2;MGAT4A;EVA1A;RPL9;RPS21;PCMT1;LGMN;PLOD2;SPP1;FN1;UBL5;SFTPC;DAB2IP;FURIN;PCSK5;SERPIND1;SPARCL1;MRPS14;RPL38;MRPL34;SFTPD;RPL21;RPL22
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.45201704570134293,0.7168676275631487,0.864406779661017,1.0,1.0,2/10,9.36%,STAT4;STAT1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.35173650286019575,-0.7167829228542818,0.775,1.0,1.0,3/29,8.43%,PKP2;CACNA2D1;KCNE1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.38178812134916157,-0.7166026095210318,0.8372093023255814,1.0,1.0,3/16,10.10%,HEG1;KCTD13;RIPOR2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.33720348165867503,0.7165300195734836,0.921875,1.0,1.0,5/42,10.56%,CTNNA1;AHR;MAP4K1;MLC1;BRCA1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.34932399536207653,0.7163521024099498,0.8923076923076924,1.0,1.0,2/28,9.29%,LPCAT3;SLC44A5
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.4231639413652766,0.7163494908233838,0.7878787878787878,1.0,1.0,2/9,13.17%,ACTC1;CAMK2D
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),-0.3934543776454462,-0.7159876109637575,0.7560975609756098,1.0,1.0,3/9,20.38%,SORL1;PLEKHJ1;EHD3
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.3438576672341563,-0.7159714017546003,0.8648648648648649,1.0,1.0,3/23,11.83%,RUNX1;CBFB;MDK
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.29581842059690655,-0.7156930050410981,0.9629629629629629,1.0,1.0,10/82,11.18%,GXYLT2;ST6GALNAC2;ST3GAL3;ST3GAL1;GALNT10;ST3GAL2;TET1;DPM3;GALNT12;GCNT4
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.3040619153190608,0.7155283569880369,0.9428571428571428,1.0,1.0,14/94,17.50%,WASF1;PPARGC1A;SLC2A1;WAS;PPID;FAS;MITF;TUBGCP4;GPAA1;TSPAN4;EPRS1;CD74;NUP54;DMTN
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.3507629937914651,-0.7153312622562793,1.0,1.0,1.0,3/24,8.46%,IFIH1;RRP1B;POU2F2
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.37028688812105104,0.7152831156472937,0.8688524590163934,1.0,1.0,2/22,9.61%,IHO1;M1AP
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.42203264018015985,0.7151903346129241,0.8135593220338984,1.0,1.0,2/9,20.29%,LGSN;CPS1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.37248156979918257,0.7151761523455412,0.9056603773584906,1.0,1.0,6/31,12.70%,CD300LF;DOCK2;IL15;PTPRC;STAP1;TUB
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.3064744467992127,0.7151615313903639,0.987012987012987,1.0,1.0,15/114,11.92%,GPC6;WFS1;MMP15;AOX1;PRLR;BOK;ALDH4A1;FKBP5;CPE;F10;SFRP4;PGAM1;CDR2L;KIAA1217;TMEM86A
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.36254367364828294,0.7149214728028739,0.90625,1.0,1.0,9/27,25.80%,MAP3K11;PPEF2;DNAJA1;DAB2IP;PDCD4;GSTP1;AIDA;DUSP19;SASH1
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.4486013665487104,0.7148608133953719,0.8679245283018868,1.0,1.0,2/5,17.07%,CD14;TLR2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.28298414820750206,0.7146718923401574,0.9545454545454546,1.0,1.0,14/129,15.17%,STK26;DAPL1;LAMP2;HSPA5;SESN3;RIPOR1;ATP6V1B2;RNF152;FAS;NUAK2;HSPA8;ATP6V1C1;TBL2;PDK4
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),0.45062100943395006,0.7144921479993102,0.7936507936507936,1.0,1.0,3/8,29.36%,GBP6;SLC11A1;BATF2
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.32841579020677414,0.7141071833911878,0.9076923076923077,1.0,1.0,4/46,7.22%,ELANE;PTPRC;FADD;CD14
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.3961489278931401,-0.7139988316624802,0.8409090909090909,1.0,1.0,5/13,17.05%,SLC25A33;IDE;ABCD1;COX7A1;VCP
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.3402241595882931,-0.7137396284073613,0.8947368421052632,1.0,1.0,7/27,20.36%,SUV39H2;BEND3;PRDM7;WDR82;KMT5B;TET2;SETD2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.30177407161423936,-0.7135446796107111,0.9393939393939394,1.0,1.0,11/53,12.85%,SPRED1;NAXE;VASH1;COL4A3;GTF2I;TGFB2;SARS1;COL4A2;ISM1;SEMA6A;THBS2
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.28294555296151297,-0.7134664530686943,1.0,1.0,1.0,10/109,8.75%,BMP7;INHA;EREG;PRKRIP1;NUP210;TPR;ITGA6;NUP37;HSPB1;ZBTB7A
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.30719049954488914,-0.7133588136818644,0.9629629629629629,1.0,1.0,10/65,11.69%,ITGB5;MYH14;PDLIM1;TMOD4;CDC42BPB;KCTD13;MYOM2;FHDC1;MYH3;CSRP2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.3912289978834778,0.7131707466463818,0.835820895522388,1.0,1.0,6/21,28.17%,TUBB;TUBA1A;CCDC88B;TUBA1B;HOOK2;CCDC88C
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.33386675898322654,0.7128505540651244,0.8870967741935484,1.0,1.0,16/54,25.64%,CNGB1;CDC25A;COPS9;CNGA1;OPN3;PCNA;PDE6B;OPN1SW;MAPK13;KDM1A;POLD1;ERCC4;SDE2;FMR1;OPN5;TMEM161A
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),-0.40474061789001636,-0.7123825671362948,0.8837209302325582,1.0,1.0,2/12,7.09%,NFATC1;TGFB2
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.28608779950326557,-0.7123617071030212,1.0,1.0,1.0,8/90,7.47%,RIMBP2;FGFR4;CACNG4;GAL3ST1;FAM163B;APOA1;FBLL1;CARMIL3
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.3194500562177385,0.7119905389183485,0.9436619718309859,1.0,1.0,4/58,4.65%,TIMP3;RASIP1;TIMP2;DAPL1
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.37189272629794684,0.7119275643023295,0.8714285714285714,1.0,1.0,5/24,10.47%,GPX2;GIPC2;RARRES2;ALDOB;PRSS3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.42408817021398315,0.7118279765182823,0.8703703703703703,1.0,1.0,4/10,25.34%,LBP;CRLF2;TNIP2;CD226
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.375649089885663,-0.7117742035967086,0.85,1.0,1.0,1/15,4.55%,DDX60
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.34522162444131227,0.7115624044255137,0.9295774647887324,1.0,1.0,15/59,19.19%,BOK;INHBA;MOAP1;FADD;CASP8;BCL2L2;FAS;TGFB1;CD27;DAB2IP;IFI27;BCL2L1;SORT1;BAD;RNF41
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.36356318899462403,-0.7114983638640855,0.8409090909090909,1.0,1.0,4/16,14.10%,SFRP1;CRH;MIDN;IRS1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.28858219247926503,0.71110323862399,0.958904109589041,1.0,1.0,15/134,14.90%,LRP4;GLI3;NOTUM;TLE3;SFRP4;NKD2;PSMB6;BICC1;PSMA3;TLE6;HECW1;KREMEN1;PSMB8;AMER2;DAB2IP
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.43271370556997885,0.7109729517594369,0.8405797101449275,1.0,1.0,2/8,9.76%,FGFR2;SOX11
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),-0.44071063640325475,-0.7109018155877836,0.775,1.0,1.0,1/5,6.80%,PDPN
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.49171648579487864,0.7108124197640099,0.8363636363636363,1.0,1.0,2/5,33.26%,LRP2;CD81
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.4449067869000622,0.7107021696817396,0.7555555555555555,1.0,1.0,2/5,36.46%,GRHL2;MECP2
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.4508469801128918,-0.710665608348373,0.7924528301886793,1.0,1.0,2/5,17.21%,PTPN1;DTX3L
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),-0.3789230339236669,-0.7106216893215871,0.8292682926829268,1.0,1.0,1/8,5.13%,OTUD3
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.35540361993907327,0.7105598162651051,0.8714285714285714,1.0,1.0,4/35,7.67%,DDX20;NXT1;NCBP1;NCBP2
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.33205189303598986,-0.7103783767122872,0.9333333333333333,1.0,1.0,7/40,12.11%,RGS14;EPHB2;CLSTN2;NUMB;DLG5;MME;SYNDIG1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.288807159138031,0.7101815665540857,0.9875,1.0,1.0,23/118,21.44%,PREX1;DEPDC1B;ARHGAP9;TAGAP;ARHGAP25;RHOB;RHOH;ARHGAP10;RHOU;A2M;ECT2;RACGAP1;FAM13B;ARHGAP28;CHN1;ABR;ARHGAP23;ARHGAP32;RHOF;FOXM1;ARHGAP18;ARHGEF6;FGD4
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.3276535996361659,0.710131773706521,0.8783783783783784,1.0,1.0,1/41,1.10%,EPHA1
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.40838693917982066,-0.7100232122282731,0.8536585365853658,1.0,1.0,2/14,15.19%,IWS1;NXF5
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.30747349437541566,-0.7097518044361185,0.9333333333333333,1.0,1.0,16/90,13.95%,BMP7;BCL2L11;NRG1;RUNX1;TRABD2A;PTPN23;TGFB2;ADGRL1;TGFB3;APOE;FRMPD4;CLU;SPIDR;SH3GLB1;PLEKHM2;FAF1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.44429691666787796,0.7096757935103172,0.84,1.0,1.0,2/8,7.83%,MCM2;MCMDC2
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.3929348585347681,-0.7093364831235356,0.8478260869565217,1.0,1.0,4/9,17.13%,APOA1;NAA20;METAP2;NAA15
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.3761993551450234,0.7093217288585484,0.828125,1.0,1.0,1/20,3.61%,ITGA5
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.3102735155245927,-0.70928319555505,0.9487179487179487,1.0,1.0,3/32,5.91%,MAP3K20;TIMELESS;HUS1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.45140252353993154,0.7091721251323961,0.8620689655172413,1.0,1.0,1/8,4.27%,ADGRB1
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.401487293032165,-0.709070516826665,0.7241379310344828,1.0,1.0,1/8,4.14%,SFRP1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.38404298105237233,0.7089725231074165,0.8035714285714286,1.0,1.0,4/21,18.97%,SOX10;FGFR2;KLK14;LIN7C
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),-0.423788279165213,-0.7089483941471357,0.7954545454545454,1.0,1.0,1/5,5.26%,DOCK10
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.26237390805434213,0.7088440341752333,1.0,1.0,1.0,29/282,16.75%,RAB6C;LMAN1;GRTP1;RANBP6;SLU7;NXT1;LAMP2;RUNDC1;STRADA;AP1M2;RAB19;RABL2B;ARCN1;TGFB1;YWHAH;RAB23;ARL1;ARL6;STX19;TSC2;SPRN;STRADB;SNX31;VPS35;SNX17;TBC1D13;ARF4;CD74;STX17
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.38817897908508414,-0.7086784919683469,0.8837209302325582,1.0,1.0,2/9,8.80%,VIP;SPX
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.3692972539150793,0.7083717058603599,0.84375,1.0,1.0,2/16,9.34%,BUB1B;TEX14
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.3679117308505875,0.7083321134819074,0.9272727272727272,1.0,1.0,7/26,10.71%,BIK;INHBA;ING2;ADAM29;CSDE1;SIX4;ADAM21
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.3327496825297297,0.7082912969644948,0.8923076923076924,1.0,1.0,6/39,11.25%,SCO2;LAMA1;SALL2;EFEMP1;CPAMD8;ADAMTS18
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.35389796483326286,-0.7082474391513325,0.8837209302325582,1.0,1.0,2/18,4.95%,MYH14;CACNA1I
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.37821303733594586,-0.708147936400204,0.8723404255319149,1.0,1.0,3/12,10.30%,MCTP1;SELENON;ABCD1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.3671677489461027,-0.7080653612182369,0.8421052631578947,1.0,1.0,2/15,5.46%,OSBPL7;PTCH1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.33518713418378915,0.7079627873113248,0.8596491228070176,1.0,1.0,11/49,20.05%,ADAMTS9;ST8SIA6;MANBA;GCNT1;MGAT4A;MAN1A1;NGLY1;MAN2A1;MGAT4B;MAN1B1;GANAB
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.26894907142945,0.7076451520102971,1.0,1.0,1.0,21/306,11.86%,RAD54L;TICRR;RFC5;POLE2;POLQ;SPDYA;POLE3;HIC1;BOK;MOAP1;SUV39H1;RAD9B;INIP;BCL2L2;STXBP4;BRCA1;SUSD6;OTUB1;HELB;MRE11;VCPIP1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.35014864493475867,0.707595809258232,0.8142857142857143,1.0,1.0,4/35,11.85%,SLC12A7;SLC36A1;LRRC8D;NEURL1B
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.4267767482806233,0.7074754443287855,0.8596491228070176,1.0,1.0,2/9,16.00%,DAB2IP;FURIN
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.28080685745544276,-0.7073744200630151,1.0,1.0,1.0,2/96,2.70%,PER2;SVBP
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.44125261818807937,0.7072682844600438,0.864406779661017,1.0,1.0,2/7,24.55%,RECQL4;BLM
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.27939853463398234,0.7072603960205395,1.0,1.0,1.0,30/219,17.85%,ANKS4B;RP1;WASF1;PPARGC1A;SLC2A1;WAS;STAG3;M1AP;PPID;FAS;TGFB1;RHOH;RHOU;MITF;EPS8;VCPIP1;TUBGCP4;GPAA1;TSPAN4;CFAP74;SYCP2;NEFH;LRGUK;PAWR;EPRS1;CD74;CHAF1A;DMTN;HAS3;FLNC
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.3232907639571208,-0.707074883779963,0.9210526315789473,1.0,1.0,8/41,19.36%,NBDY;LSM6;EXOSC10;DIS3L2;PNPT1;EXOSC4;HSPA1A;RC3H1
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.2717802258592273,-0.7070342101687008,0.9333333333333333,1.0,1.0,7/87,7.09%,PKP2;RBP4;HEG1;PDLIM1;ECE1;ID2;TGFB2
prerank,MSigDB_Hallmark_2020__Glycolysis,0.2835125379319572,0.7068849454238855,0.9868421052631579,1.0,1.0,18/174,12.75%,POLR3K;NSDHL;GLRX;GOT1;BIK;CHST1;ISG20;FKBP4;ARTN;TGFA;HSPA5;B3GNT3;ALDOB;G6PD;NANP;PGAM1;MDH1;AGL
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.30278384548693243,0.7068454225148194,0.9545454545454546,1.0,1.0,10/96,14.26%,NES;LDLRAP1;ZFPM1;HIP1R;LRPAP1;EFHB;RIPK2;TMC8;DERL1;CTSZ
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.3376467594533271,-0.706827472744153,0.8947368421052632,1.0,1.0,3/21,6.85%,PTPN3;UTRN;RANGRF
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),-0.3845066523683889,-0.706642566674023,0.8108108108108109,1.0,1.0,5/11,25.23%,CPSF7;FARSB;FARSA;GRIN1;GRIN2B
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.4014957882306128,0.706459418508705,0.8688524590163934,1.0,1.0,3/15,21.25%,HIP1R;NSG1;CLTC
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.29505220212326616,0.7064113846361937,0.9863013698630136,1.0,1.0,31/155,20.99%,CALCR;PDGFRB;PIK3R5;RCN3;P2RY12;FLT3;TGFA;GAB1;F10;HGF;FGFR2;GPER1;TGFB1;DRD3;ESR1;TSC2;MYORG;BANK1;PINK1;NRG4;GFRAL;IL18;CX3CR1;CD80;RNF41;PPP2R5B;PIK3CB;FGF5;NOP53;MSTN;F3
prerank,MSigDB_Hallmark_2020__Androgen Response,0.3040281947769272,0.7062950776115965,0.9420289855072463,1.0,1.0,19/95,19.84%,STEAP4;LMAN1;MAK;FKBP5;HMGCR;SCD;HMGCS1;SLC38A2;HERC3;NGLY1;DHCR24;INSIG1;CDK6;B2M;SPCS3;SRP19;NCOA4;H1-0;TSC22D1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.33774109287150017,0.7059683534578257,0.9322033898305084,1.0,1.0,4/47,15.19%,TCP1;CCT6A;CCT8;DCP2
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.2869077036735511,-0.7057240682329202,0.9090909090909091,1.0,1.0,15/65,17.87%,UNC13B;SLC22A2;SLC22A3;SLC29A4;GAD2;SLC6A4;SLC6A2;SLC22A1;SYN2;UNC13A;SLC1A6;LIN7A;APBA1;RIMS1;CASK
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.285767302488571,-0.7053188350331675,1.0,1.0,1.0,10/46,14.68%,PID1;SLC25A33;SPHK2;PLIN5;ACE2;AKR1C3;SIRT2;DCXR;MPV17;NOXO1
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),-0.4461565792210892,-0.7051960317565956,0.9090909090909091,1.0,1.0,1/7,6.85%,CIDEA
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.4508190995412746,0.7050711501848498,0.8360655737704918,1.0,1.0,2/7,14.93%,AGT;STARD4
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2847543242920095,0.7048827245327546,0.974025974025974,1.0,1.0,11/190,7.39%,TRIM22;ROR1;TRIML2;AGER;IL18R1;TRIM5;NEUROD2;TRIM32;AGT;PPARGC1A;RPS6KA4
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.34165396374429285,0.7047087194327016,0.9473684210526315,1.0,1.0,11/34,20.96%,BIK;MOAP1;BNIP3;HGF;GPER1;PLAUR;PINK1;BCL2L1;BAD;GHITM;HRK
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.33809566782716427,-0.7046600986866259,0.8857142857142857,1.0,1.0,4/25,13.28%,TENT5A;VIP;ELAVL1;CIRBP
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.4620379102508446,0.7044356908581619,0.8421052631578947,1.0,1.0,1/8,6.23%,MGME1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.29203301727115044,0.7044086520910083,0.9857142857142858,1.0,1.0,11/111,11.43%,ZDHHC22;ZDHHC11;LAMP2;BCAP31;PEX16;AP1M2;ZDHHC6;VPS37B;TOMM22;ARL6;MAN1A1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.40201793316629925,0.7043279174490029,0.7966101694915254,1.0,1.0,7/11,33.34%,METAP1;NAA50;NAA40;NAA16;NAA35;AANAT;NTMT1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.36921034217968496,0.7041018195081931,0.8309859154929577,1.0,1.0,3/16,14.06%,BMP1;SOX6;SCX
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),0.47120232961440917,0.7040427728342484,0.8181818181818182,1.0,1.0,1/5,8.07%,ALDOB
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.3556149535095491,-0.704014886036883,0.8780487804878049,1.0,1.0,3/16,11.82%,MYL5;TNNC2;KCNB2
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.3290642956542691,-0.7039878818604532,0.8863636363636364,1.0,1.0,5/19,12.93%,SLC25A33;SPHK2;ABCD1;TRAP1;SLC30A10
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.3003277944214774,-0.7037429431272241,0.972972972972973,1.0,1.0,8/51,15.06%,SAMD4A;LSM6;DCPS;EXOSC1;EXOSC7;EXOSC5;SAMD4B;EXOSC4
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.4064126371081067,0.7036500026644125,0.8208955223880597,1.0,1.0,1/9,6.61%,BMP1
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),-0.46573834667457026,-0.7032477836524912,0.8571428571428571,1.0,1.0,3/5,32.02%,PLEKHA7;KIFC3;FERMT2
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.4613929717926616,0.7031679455484706,0.9016393442622951,1.0,1.0,1/5,9.91%,DEUP1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.27610181385946914,0.7031438977304508,1.0,1.0,1.0,21/286,13.33%,TRIM22;TRIML2;TRIM5;ARIH2;C10ORF90;TRIM32;SYVN1;KBTBD6;PELI3;TRAF3IP2;RNF152;RNF26;PSMB6;SIAH1;BRCA1;FBXL3;PSMA3;FBXO32;HECW1;RNF144B;PSMB8
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.24105500868300073,-0.7028824124228147,1.0,1.0,1.0,27/181,20.14%,RRP1B;LYAR;NVL;URB2;RRP7A;TBL3;WDR46;EXOSC10;DDX27;NOP14;NOM1;EXOSC1;EXOSC7;EXOSC5;CUL4A;NAF1;NOC4L;BOP1;EXOSC4;RPL12;NOL8;WDR75;RIOK1;SDAD1;BYSL;RRP36;BMS1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.35809063045802614,-0.7028315888120629,0.8235294117647058,1.0,1.0,7/19,20.42%,MCUB;MICU1;MICU2;MCUR1;SLC8A3;MCU;SLC25A23
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.4350048112721482,0.7027851325716247,0.8524590163934426,1.0,1.0,5/9,21.77%,TBP;TAF7L;DR1;GTF2A2;TAF7
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.31621629709420984,0.7025813377431858,0.9333333333333333,1.0,1.0,7/62,12.43%,CCL5;NCBP1;NCBP2;CSDE1;PAIP2B;EIF2B5;C8ORF88
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.29476332871314204,-0.7025551875100517,0.925,1.0,1.0,6/77,10.18%,FGFR4;RUBCNL;ELOVL6;ID2;SIN3B;RORA
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.44484307588634575,0.7024613407206204,0.8367346938775511,1.0,1.0,1/6,7.12%,REST
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.2957095916142547,0.702414631655981,1.0,1.0,1.0,7/94,10.21%,PLA2G10;TRIM32;INHBA;AGT;FADD;CASP8;TGFB1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.31672689476965327,-0.7023933151167508,0.9166666666666666,1.0,1.0,2/34,3.84%,PKP2;CACNA2D1
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.38315945460643114,0.7018243325247,0.8888888888888888,1.0,1.0,3/13,29.42%,SHISA8;RAB3GAP1;SHISA6
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.31751540469271095,0.7013374418805653,0.9558823529411765,1.0,1.0,9/75,10.59%,SLCO2B1;AGER;ABCC2;SLC2A1;ABCB1;AVPR1A;ABCG2;SLC38A2;SLC28A2
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.3100411697099733,-0.7011165078276707,0.8974358974358975,1.0,1.0,4/35,5.78%,ZDHHC5;NAT9;PORCN;ZDHHC3
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.38854745004813973,0.7009949048089902,0.8548387096774194,1.0,1.0,2/11,11.05%,SLC23A1;SLC5A2
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.4197666141773355,-0.7008052118277602,0.8055555555555556,1.0,1.0,3/9,26.93%,NRP1;ZSWIM5;MYCBP2
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),0.4497144217436705,0.7001379100085032,0.7924528301886793,1.0,1.0,2/5,25.71%,HAS3;CEMIP
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.4151397530350979,-0.7001318226869814,0.8421052631578947,1.0,1.0,2/5,17.46%,KCNE1;GDI1
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.37396986290393597,0.700111523447694,0.7846153846153846,1.0,1.0,1/14,6.32%,SMARCE1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.450677173872049,0.699975018381253,0.8360655737704918,1.0,1.0,2/8,15.43%,CMPK2;AK4
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.40128848848401577,-0.6998461978857511,0.8125,1.0,1.0,2/11,8.30%,HIRIP3;SUV39H2
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.36674741432627905,0.6997712885500746,0.9428571428571428,1.0,1.0,5/29,9.38%,CCL5;CRLF1;IL15;FLT3;CTF1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.3287775493203192,0.6997710167853772,0.9393939393939394,1.0,1.0,7/47,13.33%,STEAP4;ATF5;TRIM32;PPARGC1A;MAFB;ALOXE3;PSMB8
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),-0.41777427575889653,-0.6992911111185381,0.7894736842105263,1.0,1.0,1/5,6.93%,MRLN
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.3126254224547102,0.6988879885374661,0.9436619718309859,1.0,1.0,9/66,14.94%,POLR3K;CSTF2T;NCBP1;TBP;NCBP2;POLR1H;CLP1;FIP1L1;POLR1E
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.41235810852647087,0.698871166704914,0.828125,1.0,1.0,5/10,31.98%,GPC3;MKKS;MESP1;LRP5;UGDH
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.3551293909727058,-0.6988093809373268,0.9459459459459459,1.0,1.0,3/21,7.88%,PKP2;RANGRF;FGF13
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.2693558440075686,0.698756915474953,1.0,1.0,1.0,41/298,19.37%,RAB6C;GRTP1;RCN3;SLU7;AMN;LAMP2;RUNDC1;ARRDC3;RAB19;RABL2B;ATP6V1B2;ATP6AP1;CHMP2B;ARCN1;TVP23B;YWHAH;RAB23;ARL1;RAB8A;ARL6;NEURL1B;CHMP1A;STX19;ATP6V1C1;SNX31;VPS35;SNX17;TBC1D13;ARF4;CHMP2A;CD74;STX17;UNC119B;MTTP;ARL4A;MCOLN1;TF;SNX4;PPARG;ATP6V1C2;RAB6D
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.4745309112176239,0.6985429232215765,0.8333333333333334,1.0,1.0,2/5,19.73%,MAN1A1;MAN1B1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.4745309112176239,0.6985429232215765,0.8333333333333334,1.0,1.0,2/5,19.73%,MAN1A1;MAN1B1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.4745309112176239,0.6985429232215765,0.8333333333333334,1.0,1.0,2/5,19.73%,MAN1A1;MAN1B1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.38499933648700246,-0.698104226592598,0.7837837837837838,1.0,1.0,1/10,1.92%,RUNX1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.3163904921148267,0.6980990786586733,0.9452054794520548,1.0,1.0,8/53,18.60%,FABP3;RCN3;ACOX2;ACOX1;PNPLA1;ABCB4;ANGPTL3;PPARG
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3863092834787133,0.6978291880591937,0.8360655737704918,1.0,1.0,3/18,16.03%,EPAS1;PINK1;DCUN1D1
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.27738188207724396,-0.6974886535497894,1.0,1.0,1.0,37/162,16.46%,KHSRP;HNRNPL;SF3B4;SF3A2;ADARB2;MAGOHB;LSM6;DHX8;LIN28B;THOC1;RBMS2;PRPF4;RBMS1;ZCRB1;U2AF2;SON;SRRM1;RP9;SNRPB;SF3A1;KIN;SRRM4;ZRSR2;SNRPN;NRDE2;SRSF7;SCAF11;PTBP1;IVNS1ABP;RSRC1;AURKAIP1;RBM3;PDCD7;PRPF6;PPP1R9B;ATXN1;SETX
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.2951691388321772,-0.6974675286558534,0.9411764705882353,1.0,1.0,15/71,18.15%,STING1;IGF1;NVL;IDE;TAF1;APOE;NGF;HMGB2;SIRT2;EDF1;NMD3;DDX11;DTX3L;ADD2;MARK3
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.324894045287096,0.6973867380732096,0.9242424242424242,1.0,1.0,11/38,27.65%,BNIP3;CTSK;PINK1;ULK1;WIPI1;FBXO7;ATG3;MAP1LC3B;GABARAPL1;GABARAPL2;FUNDC1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.3114621261545352,0.6973499190211987,0.971830985915493,1.0,1.0,10/82,10.56%,ITPR1;HIC1;BOK;CYP1B1;MOAP1;HINT1;BNIP3;BCL2L2;CHAC1;BRCA1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.3147151897262456,-0.6972703852077237,0.8888888888888888,1.0,1.0,10/49,18.66%,LEMD2;EMD;NUP37;NSFL1C;UBXN2A;SIRT2;RCC1;NUP107;NUP43;VRK1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.34909817482577815,0.6972585057108464,0.9473684210526315,1.0,1.0,8/31,14.76%,KIF14;FGFR2;CDC6;DRD3;HTR2B;ECT2;RACGAP1;CDC14A
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.44328634415407875,0.6969624716399514,0.8852459016393442,1.0,1.0,2/8,13.98%,MYBPC3;PLN
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.2810856985574424,0.6969116917073781,0.9772727272727273,1.0,1.0,11/140,12.04%,RFC5;ING2;PRKAB2;TBP;RAD9B;TPX2;BRCA1;CDK5R1;MRE11;PRDM1;RPA3
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.4239366693753439,-0.6968897831320742,0.8387096774193549,1.0,1.0,1/9,3.53%,IGF1
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.31639221864382594,0.6965939698957105,0.9428571428571428,1.0,1.0,14/62,22.35%,DEPP1;ITPR1;BOK;DAPK2;RAB8A;USP13;PSAP;PIP4K2C;LRRK2;GPR137B;RAB39B;DCAF12;GPR137;WDR41
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),-0.33737249438585104,-0.6963925643827176,0.8157894736842105,1.0,1.0,3/18,13.66%,LIN28B;MEX3D;ZC3H18
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.3940550973489849,-0.6961127016471877,0.9090909090909091,1.0,1.0,7/13,32.41%,BAG3;APBA1;CLIP3;COPG1;BORCS5;COPG2;DYNC1I2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.38922243201218426,0.6957491601675191,0.8888888888888888,1.0,1.0,4/19,19.74%,TWIST1;MITF;SUB1;MED17
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.3283887540653692,-0.6953758315962381,0.8108108108108109,1.0,1.0,4/16,24.53%,CLU;NOS1AP;DDAH1;ASS1
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),0.4578608501367813,0.6952525081864918,0.8431372549019608,1.0,1.0,1/5,5.18%,SLU7
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.43247319636598636,0.695127492207887,0.8260869565217391,1.0,1.0,1/7,4.92%,PTPRC
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.289938217142916,-0.6950469505286708,0.9696969696969697,1.0,1.0,11/61,17.47%,CDK2AP2;PRDM15;PLK2;AURKA;SIRT2;SH3GLB1;ZFYVE26;ENTR1;ORC6;PLK3;RAB11FIP3
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.4609802318046079,0.6949268432184936,0.9047619047619048,1.0,1.0,2/5,28.76%,TRIM25;RNF135
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.38484655259952405,0.6947718118411228,0.8870967741935484,1.0,1.0,4/19,23.89%,NANS;GNPDA1;GFPT2;UAP1
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.33907304135347605,0.6947490889419984,0.9090909090909091,1.0,1.0,10/35,25.05%,FIGNL1;RAD9B;RHOB;OPN3;ECT2;OPN1SW;RAD51AP1;RAD1;BLM;OPN5
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.3710194293607425,0.694721514735827,0.8833333333333333,1.0,1.0,2/15,9.34%,BUB1B;TEX14
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.3710194293607425,0.694721514735827,0.8833333333333333,1.0,1.0,2/15,9.34%,BUB1B;TEX14
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.3710194293607425,0.694721514735827,0.8833333333333333,1.0,1.0,2/15,9.34%,BUB1B;TEX14
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.39356129773688725,0.6943026312885109,0.819672131147541,1.0,1.0,8/13,31.16%,NAA30;NAA50;KAT2B;NAA40;NAA16;NAA35;AANAT;NAA25
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.2891548660911823,0.6939939646233796,0.987012987012987,1.0,1.0,17/140,12.39%,RLBP1;ACSBG1;PLA2G7;PLP1;SCN4B;AGT;SLC39A12;PTPRZ1;CNTN2;TMEM235;TMEM178A;KCNJ9;C11ORF87;GFAP;CLDN10;DAAM2;CA10
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.40071492695475164,0.6935222232833351,0.8333333333333334,1.0,1.0,8/12,40.44%,TERF2IP;DDX3X;PRKAA1;KAT5;RAPGEF3;CAMK1;DIP2A;TAOK1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.37344053179721687,-0.6934831119448795,0.8421052631578947,1.0,1.0,4/12,14.17%,PLXNA1;PLXNA2;NRP1;PLXNC1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.3513289591287181,0.692979476629895,0.9,1.0,1.0,4/27,18.42%,CYP1B1;RHOB;ECT2;MAPK13
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.43877139354813643,0.6927784689935206,0.9152542372881356,1.0,1.0,5/9,38.85%,MSN;CDC42;CAMSAP3;SYNE4;EZR
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.2871374147013459,-0.6927532027524462,0.96875,1.0,1.0,22/77,20.60%,STING1;ZNHIT6;EHD4;KCNC1;ELAVL1;RBMX;CPSF7;BEND3;PRMT8;KCNC3;WDCP;MICU1;ATL2;PNPT1;HGSNAT;CARD9;MCU;VSTM5;TP53BP1;HOMER1;EHD3;TMEM120B
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.43729267556247137,0.6926005628258868,0.8813559322033898,1.0,1.0,2/7,14.65%,RAB11A;VPS35
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.34443178141540837,-0.6925158249395018,0.9069767441860465,1.0,1.0,3/16,10.54%,SFRP1;EMD;PARP10
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.39342605258448055,0.6922970534788803,0.8148148148148148,1.0,1.0,3/12,16.21%,DEGS2;SPHK1;SPTLC3
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.34672516636721307,-0.6919800255750238,0.8285714285714286,1.0,1.0,6/15,25.23%,CPSF7;FARSB;TMEM120B;FARSA;GRIN1;GRIN2B
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3496898199488973,0.6916463064019951,0.9154929577464789,1.0,1.0,5/35,9.38%,CCL5;CRLF1;IL15;FLT3;CTF1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.4349496941201326,0.6915293725097377,0.8787878787878788,1.0,1.0,3/11,14.43%,CPT1C;BBOX1;ACADL
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.31451598848868917,0.691486501952509,0.9871794871794872,1.0,1.0,7/54,17.99%,HIPK4;CDK5R1;CAMK2D;NLK;DYRK2;ULK1;LRRK2
prerank,MSigDB_Hallmark_2020__Apical Junction,0.27078230143029075,0.6907788580094055,1.0,1.0,1.0,32/158,21.75%,LDLRAP1;CTNNA1;RASA1;PTPRC;FYB1;ACTC1;BMP1;VWF;YWHAH;COL9A1;ITGA9;TNFRSF11B;NEXN;INPPL1;TSPAN4;PCDH1;CD99;INSIG1;MSN;FLNC;MAPK13;RHOF;SGCE;PIK3CB;SHC1;DLG1;CD274;JAM3;CLDN18;ARHGEF6;ACTN2;EPB41L2
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.2968497580528012,0.690627209336616,0.9444444444444444,1.0,1.0,11/75,19.92%,FKBP4;DNAJB1;HSPA1L;DNAJC2;RPA3;HSPA8;CAMK2D;HSPH1;NUP54;CHORDC1;NUP188
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.37584107849368353,-0.6905952879303239,0.9032258064516129,1.0,1.0,3/19,7.08%,LEF1;RUNX1;ID2
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.42523622868460553,0.6903690190148796,0.8604651162790697,1.0,1.0,1/8,20.49%,KDM1A
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.42531949504317274,-0.6901219373847224,0.8444444444444444,1.0,1.0,2/8,8.86%,TIMELESS;SMARCAL1
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.45116977319907736,0.690067817715221,0.9107142857142857,1.0,1.0,2/5,16.11%,OTUD4;STPG4
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.45116977319907736,0.690067817715221,0.9107142857142857,1.0,1.0,2/5,16.11%,OTUD4;STPG4
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),-0.45901130781876864,-0.6898274358168716,0.8333333333333334,1.0,1.0,1/5,17.05%,VCP
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),0.4590178152234435,0.6898055825597657,0.9076923076923077,1.0,1.0,1/5,8.00%,BUB1B
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.3296325343382136,-0.6897608143432171,0.9024390243902439,1.0,1.0,4/24,17.28%,RING1;PCGF1;DTX3L;DDB2
prerank,GO_Biological_Process_2021__negative regulation of SMAD protein signal transduction (GO:0060392),-0.4616065805900683,-0.6894276420920017,0.8333333333333334,1.0,1.0,3/5,21.72%,CILP;FAM89B;CCN3
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.34962929075135996,0.6894186517016345,0.9117647058823529,1.0,1.0,2/25,10.21%,NOTCH1;TGFB1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.355586546466436,0.6890331899272887,0.9166666666666666,1.0,1.0,6/28,17.46%,SCGN;MAFB;SRP9;SYT13;DPP4;PKLR
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.2866963657330688,0.6888345316244908,0.9859154929577465,1.0,1.0,17/127,15.92%,ARIH2;TCAF2;TMEM30A;RIPOR1;HSPA1L;CASP8;TGFB1;YWHAH;YWHAG;RHOU;AKAP5;ECT2;UBL5;MIEF2;PDZK1;UBR5;PINK1
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.40001487115737944,-0.688624057937234,0.9024390243902439,1.0,1.0,1/10,1.38%,F2RL1
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.4112048227688703,-0.6885424313741351,0.8604651162790697,1.0,1.0,2/5,7.09%,AZU1;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.41267345038894543,0.6882350260848787,0.7758620689655172,1.0,1.0,1/7,13.17%,CAMK2D
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.341013122895293,0.6880721083055306,0.8985507246376812,1.0,1.0,16/39,28.73%,CD14;PLCG2;CTSK;LGMN;TAB2;TLR2;SFTPD;IRAK4;LBP;HSP90B1;MAPKAPK3;NOD1;ALPK1;CD36;RPS27A;TLR5
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.29478367645233,0.6880144134389024,0.9726027397260274,1.0,1.0,21/127,18.24%,P2RY1;ACSBG1;PLP1;GRM3;SLC39A12;PTPRZ1;CNTN2;KCNJ9;C11ORF87;GFAP;CA10;A2M;DAO;ALDH1L1;AMER2;RFX4;RFTN2;SPARCL1;NPAS3;PSD2;SLC1A3
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.37501766004745546,0.6874399423494877,0.8688524590163934,1.0,1.0,3/16,13.25%,WNT8A;SOX11;HTR2B
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.30518518019708757,0.6873714426609002,0.9857142857142858,1.0,1.0,13/92,18.42%,P2RY1;CTNNA1;AHR;P2RY12;IGFBP5;TSHR;BRCA1;AQP9;KCNQ1;GLRA1;CRHBP;DMTN;MAPK13
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.4204701987864768,-0.6870820398160697,0.7368421052631579,1.0,1.0,3/5,17.95%,CROT;CPT1A;BHMT2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.2879685643902104,-0.6870328588521962,0.9736842105263158,1.0,1.0,9/51,16.74%,DBF4B;LSM10;TFDP1;EIF4G1;RAD51B;CDC23;RPTOR;EGFR;ANAPC7
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.2719503930009882,-0.686953300457617,1.0,1.0,1.0,2/81,3.91%,FBXL7;FBXO27
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.46609743762136785,0.6867929717426036,0.8870967741935484,1.0,1.0,1/5,11.53%,MITF
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),0.31682187302349846,0.6867877470418052,0.875,1.0,1.0,12/47,21.76%,POLQ;H1-2;KLHL15;HELB;CGAS;RMI2;POLR2D;MAGEF1;H1-0;TERF2IP;POLR2K;MSH6
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.39396754420655083,-0.6866518247259067,0.8333333333333334,1.0,1.0,4/12,14.01%,SLC2A9;SLC2A11;SLC2A14;HNF1A
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),-0.3807474457380254,-0.6865149653260176,0.8085106382978723,1.0,1.0,2/7,11.83%,TGM1;MDK
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.4505536088927229,0.6863834076329004,0.8548387096774194,1.0,1.0,3/5,32.98%,AGO4;MOV10;AGO1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.3983009125637691,0.6862122023693823,0.7903225806451613,1.0,1.0,1/9,8.62%,CEP72
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.3644272586268512,-0.686178051274025,0.9285714285714286,1.0,1.0,3/14,11.71%,IGBP1;SMG6;SIRT2
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.2423745965963933,-0.686025701220681,1.0,1.0,1.0,18/150,16.89%,RRP1B;LYAR;NVL;RRP7A;TBL3;WDR46;EXOSC10;DDX27;NOP14;EXOSC1;EXOSC7;EXOSC5;NOC4L;BOP1;EXOSC4;RPL12;NOL8;WDR75
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.3898911988820647,0.68583992232053,0.9230769230769231,1.0,1.0,3/13,20.19%,KBTBD6;PIK3CB;KBTBD7
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.3692715300743238,-0.6857343777838225,0.8974358974358975,1.0,1.0,4/13,20.19%,PCM1;TMEM201;HOOK3;SUN2
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.3925948802443673,0.6856486637737675,0.8955223880597015,1.0,1.0,1/13,4.52%,SCTR
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.3524643932570975,-0.6853856846086462,0.8918918918918919,1.0,1.0,3/18,6.81%,CARD18;IGF1;APOA1
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.38037377700048314,-0.6853076742665644,0.8974358974358975,1.0,1.0,4/11,17.76%,ATG9B;PACS2;WDR45;WIPI2
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.29854943094909736,0.6851594139098758,0.9625,1.0,1.0,6/86,8.80%,H3-3A;SYT2;TRIM32;SYT4;NCBP1;CPNE5
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.3720370107985729,-0.685029470093285,0.8666666666666667,1.0,1.0,4/13,11.40%,TRMT10C;RPP14;POP1;RPP25
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.374284152289459,0.6850217320314524,0.8928571428571429,1.0,1.0,3/16,13.40%,GM2A;ST8SIA6;NEU1
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.3323077354805027,0.684999850050954,0.9041095890410958,1.0,1.0,1/36,1.10%,EPHA1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),0.2946241538928,0.6849715708682664,0.958904109589041,1.0,1.0,11/65,17.07%,POLR3K;CD14;STAT1;IRF1;STAT6;MRE11;RIPK2;POLR3G;CGAS;G3BP1;TLR2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.3567157098243031,0.6849573734221351,0.8985507246376812,1.0,1.0,4/28,13.92%,KCNE2;KCNJ9;KCNJ11;KCNQ1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.32302430572290153,0.6848505872627566,0.9047619047619048,1.0,1.0,11/32,21.76%,PPP4C;FIGNL1;H1-2;MRE11;RAD51AP1;H1-0;RAD50;TERF2IP;KDM1A;ALYREF;MSH6
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.26997033269395687,0.6848165899458502,1.0,1.0,1.0,41/227,22.18%,P2RY1;ZNF703;SSTR1;AHR;P2RY12;PDCD1LG2;IGFBP5;TSHR;TBX1;CD14;GPER1;STAP1;ESR1;AQP9;ABCB4;KCNQ1;DAB2IP;PDK4;GLRA1;PDCD4;INSIG1;CRHBP;TESC;TLR2;DMTN;CXCL13;CX3CR1;PLAA;CD80;H2AZ1;LBP;ROMO1;WNT5B;CD274;ATP2B4;GSTP1;HCN4;LYN;ZNF35;HSP90B1;TWF2
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.388820367266658,-0.684470366965337,0.7954545454545454,1.0,1.0,2/8,20.30%,DRD1;PRKN
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.388820367266658,-0.684470366965337,0.7954545454545454,1.0,1.0,2/8,20.30%,DRD1;PRKN
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.4246973964447831,-0.6839921803509978,0.7906976744186046,1.0,1.0,1/6,20.97%,IKBKB
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.3474077944564,-0.683466023906131,0.8787878787878788,1.0,1.0,3/22,7.88%,PKP2;RANGRF;FGF13
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.36699686570215395,0.6833761054043703,0.890625,1.0,1.0,4/17,12.32%,WASF1;RHOH;EPS8;BRK1
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.43061946310132404,-0.6833265103590161,0.8,1.0,1.0,1/6,5.94%,CLN6
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.36279821490517994,-0.6832939871509828,0.8529411764705882,1.0,1.0,2/13,10.57%,SLC22A13;ACADVL
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.2987308115972933,0.6828286893921447,0.9615384615384616,1.0,1.0,18/102,18.47%,KCNA3;KCNG3;KCNE2;KCNN4;SLC24A4;SLC24A2;SLC24A1;KCNK10;KCNMB1;KCNG1;KCNJ11;KCNQ1;SLC9A6;KCNK1;SLC9A2;SLC9A7;SLC1A3;LRRC38
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.3344648792413273,-0.6826399949053923,0.9,1.0,1.0,11/29,20.87%,NSFL1C;SNAP29;UBXN2A;DYSF;CHP1;MX1;VAMP3;FER1L5;RIMS1;DNM2;RABEP1
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.35196829290378523,0.6821802769352253,0.9178082191780822,1.0,1.0,4/37,10.64%,SLC30A8;KHK;GPER1;EIF2B5
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.2747934558034236,-0.6820211400028626,0.9565217391304348,1.0,1.0,7/82,10.99%,ERCC2;CDC26;DBF4B;TCIM;TFAP4;TAF1;CDC23
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.27749124373502715,-0.6819646213067762,1.0,1.0,1.0,7/66,13.03%,LEF1;BRCA2;TAF10;JADE2;DMAP1;BEND3;TAF12
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.3540563219306387,-0.6818815847533402,0.9117647058823529,1.0,1.0,4/25,11.35%,GREM1;PTCH1;CRIM1;NOG
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.39361252886608966,-0.6815165491234876,0.8974358974358975,1.0,1.0,2/7,14.44%,PDPN;AQP8
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.45147376329041433,0.6815007715472851,0.8769230769230769,1.0,1.0,1/5,11.73%,ZNF304
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.4204770976133218,-0.6811950301736845,0.8292682926829268,1.0,1.0,2/5,16.29%,PRKCD;DDX11
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.42732526957551337,0.6810232055776758,0.8679245283018868,1.0,1.0,4/7,24.33%,PLAUR;CPB2;PLG;SERPINE1
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.2878451999443324,-0.6809872939140739,1.0,1.0,1.0,8/61,12.51%,SH3RF1;SH3RF3;ERCC8;NFX1;TRIM68;SH3RF2;MARCHF5;TRIM71
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.36089833936475446,-0.6809675420958938,0.926829268292683,1.0,1.0,3/15,6.81%,CARD18;IGF1;APOA1
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.4492259490811795,0.6809424647950225,0.7666666666666667,1.0,1.0,1/6,10.56%,BRCA1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.3512803145880972,0.6806285310754038,0.875,1.0,1.0,3/24,9.31%,AMOT;TEAD4;SAV1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.41159083314540246,0.6805946809360306,0.9,1.0,1.0,2/10,16.58%,TMEM30A;INSIG1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.28785570490342344,-0.6804269085524957,1.0,1.0,1.0,5/50,9.05%,MYLIP;VLDLR;RAB7A;SPATA18;IDE
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.38139671629035654,-0.6802950699359652,0.8888888888888888,1.0,1.0,1/10,5.76%,NLRP1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.34656686568627537,0.6802809241045833,0.9142857142857143,1.0,1.0,2/27,10.21%,PDGFRB;TGFB1
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.41114016723295843,-0.6800170171475276,0.8529411764705882,1.0,1.0,2/10,6.75%,CD247;TGM1
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),0.46211051719085516,0.6799704213061154,0.8867924528301887,1.0,1.0,2/5,14.59%,NOTCH1;NOTCH4
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),0.29427764078341084,0.6799042424039117,0.9859154929577465,1.0,1.0,13/74,17.40%,POLR3K;TRIM32;CD14;PCBP2;RNF26;IRF1;STAT6;MRE11;POLR3G;CGAS;G3BP1;TRIM25;IKBKE
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.4140683398911521,-0.6797422509664343,0.8837209302325582,1.0,1.0,1/6,6.72%,NUMA1
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.34701287866471375,-0.6791539285544682,0.8285714285714286,1.0,1.0,2/11,12.36%,PTCH1;COBL
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.32655216717025604,0.6790534527080094,0.9642857142857143,1.0,1.0,3/29,10.56%,PPARGC1A;RPS6KA4;BRCA1
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.3596075162186141,0.6789103853807438,0.8688524590163934,1.0,1.0,4/20,13.25%,ITPR1;PTPRC;PLCG2;HTR2B
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.4055615716203013,-0.6786928533391273,0.7948717948717948,1.0,1.0,2/7,25.49%,MCCC2;HMGCL
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2933736066114569,0.6785660555384573,0.9393939393939394,1.0,1.0,11/68,21.00%,CAV3;ARIH2;NKD2;SMAD7;RNF139;RNF144B;PYHIN1;LRRK2;MAGEF1;NOP53;RCHY1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.3101768812555019,-0.6778026378572256,0.9024390243902439,1.0,1.0,4/29,6.86%,EREG;DDX60;POLR3D;BMP6
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.34601932873830965,-0.6772980128111666,0.8378378378378378,1.0,1.0,2/14,8.68%,ERCC1;SMG6
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.44286118849659967,0.6770906938451217,0.8461538461538461,1.0,1.0,2/6,9.76%,FGFR2;SOX11
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.3327437081226249,0.6765357922191737,0.9076923076923077,1.0,1.0,3/36,15.35%,DDX20;GEMIN4;SNRPD2
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",0.4395155429465327,0.6764533516468078,0.875,1.0,1.0,3/5,28.79%,RPE;TKT;TALDO1
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.3881117185593784,0.6754270965297614,0.8596491228070176,1.0,1.0,4/15,13.73%,SOX10;SOX11;SEMA3A;FN1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.3955580518462822,-0.6753914202404301,0.8611111111111112,1.0,1.0,2/10,6.35%,TRIAP1;BCL2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.3955580518462822,-0.6753914202404301,0.8611111111111112,1.0,1.0,2/10,6.35%,TRIAP1;BCL2
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),-0.4135435182146716,-0.6752841575470812,0.7741935483870968,1.0,1.0,2/8,5.55%,RABL3;TOX
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.43395111510176587,-0.6750256092729288,0.8478260869565217,1.0,1.0,2/5,13.46%,SPHK2;SMARCB1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.3540015110146102,0.67488689155287,0.8939393939393939,1.0,1.0,3/14,21.39%,LGMN;CHRNA7;PRNP
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),-0.32856227475414934,-0.6748095989711409,0.9333333333333333,1.0,1.0,5/25,18.00%,VCAN;ARSB;CHST9;CHST12;IDUA
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.3423457368684943,-0.6748018589763914,0.9302325581395349,1.0,1.0,6/26,17.63%,SFSWAP;SF3A2;SF3A1;SETX;CELF5;CELF4
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.44609624130599723,-0.6746282117304159,0.9302325581395349,1.0,1.0,1/5,11.02%,CHP1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.35029762416050003,0.6743694349550933,0.8852459016393442,1.0,1.0,1/18,2.81%,SH2D4A
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),0.44208912037366643,0.6741339422310136,0.8269230769230769,1.0,1.0,2/5,18.60%,TGFB1;PPARG
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),0.44208912037366643,0.6741339422310136,0.8269230769230769,1.0,1.0,2/5,18.60%,TGFB1;PPARG
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.40408486622606843,-0.6741189704967978,0.8333333333333334,1.0,1.0,3/8,23.44%,NUPR1;PPARA;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.40408486622606843,-0.6741189704967978,0.8333333333333334,1.0,1.0,3/8,23.44%,NUPR1;PPARA;HDAC4
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.381150800875005,-0.6736953859323124,0.825,1.0,1.0,1/11,3.85%,TPR
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.2667424146972158,0.6736805361384609,1.0,1.0,1.0,38/268,17.07%,CALCR;WFS1;ZBTB7B;ACTA2;NOTCH1;NTF3;MYOM1;INHBA;RHOXF2;TWIST1;ACTC1;PPARGC1A;SFRP4;RPS7;GPER1;STAP1;SOX11;PLCG2;TGFB1;SLC38A2;BRCA1;MITF;ZNF304;SMAD1;FN1;SCX;TTN;VPS35;UBR5;CHRNA7;CD74;RGCC;PLSCR1;INPP5F;MSN;MYCN;TESC;TLR2
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),0.4208710693930723,0.6736529790374703,0.8421052631578947,1.0,1.0,4/9,27.26%,ABCC6;SLC25A4;CD47;SLC25A5
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.3759140279704411,0.6736136183184378,0.8923076923076924,1.0,1.0,1/13,5.01%,TRUB1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.2496821142793728,-0.6734988958350695,1.0,1.0,1.0,28/191,15.82%,HOMER2;NRG1;KLHDC9;B9D1;SEZ6L2;MARK1;CFAP52;CLSTN2;MORN4;SPOCK1;NYAP1;FAM81A;NCS1;FSTL5;RSPH1;TRAF3IP1;WDR54;TTC21A;NRSN2;CNGA4;KIFBP;PRR36;SPA17;DNER;SRRM3;CAP2;EPN2;ARFGEF3
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.3739106771160068,-0.6728465042885678,0.9230769230769231,1.0,1.0,2/15,7.66%,MAPK7;HSPB1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.2891733564626768,0.6721541569702583,0.9538461538461539,1.0,1.0,7/105,7.33%,RGS10;CCL5;RCN3;DOCK8;GBA3;ADRB1;F11R
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.4504888603410156,0.6721451736838754,0.8813559322033898,1.0,1.0,1/5,8.42%,CLCN3
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),-0.3606859570549779,-0.6720352425800923,0.918918918918919,1.0,1.0,3/12,11.48%,LTC4S;CPA1;ABCC1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),0.3786482821519162,0.6719302634711665,0.8928571428571429,1.0,1.0,2/11,10.26%,HMGCR;LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.45119616375131655,-0.6718445879232494,0.8372093023255814,1.0,1.0,2/6,23.90%,HSPA1A;CKAP5
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),-0.4120933653883234,-0.6717736719960046,0.7727272727272727,1.0,1.0,1/5,3.14%,LOXL1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.2928974710196563,0.6707637265322164,0.9733333333333334,1.0,1.0,9/58,18.26%,NES;ZFPM1;LRPAP1;EFHB;TMC8;CTSZ;B2M;LRRK2;IFIT1
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.38247671255929594,0.6702916638824892,0.9482758620689655,1.0,1.0,4/16,21.79%,SYT4;CACNA1H;CACNA1G;DOC2B
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.35176639131201115,0.6702461719271529,0.9152542372881356,1.0,1.0,3/17,17.99%,F11R;DAB2IP;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.38843614560169215,0.6697836012507686,0.873015873015873,1.0,1.0,2/12,17.99%,HGF;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.31325222591232177,-0.669424917580879,0.9666666666666667,1.0,1.0,3/21,8.43%,PID1;NUMB;KCNE1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.22733294860783462,-0.6694023127608427,1.0,1.0,1.0,19/231,12.87%,USP27X;IFIH1;MBD6;OTUD3;TRAF3;BRCC3;TAF10;INO80D;SENP8;INO80;USP35;FOXK1;USP25;USP10;USP51;RCE1;OTUD5;YY1;USP4
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.2718453802546678,0.6692659823234209,1.0,1.0,1.0,9/116,10.78%,DDX20;ISG20;NCBP1;RNASEH2C;PCBP2;NCBP2;M1AP;MRPL44;CLP1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.29499659630417185,0.6686511160094736,0.9264705882352942,1.0,1.0,12/76,19.06%,CHMP4B;ZDHHC22;ZDHHC11;PEX16;ZDHHC6;VPS37B;ARL6;PEX11B;ZDHHC24;PXMP2;SRP19;ATG3
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.39600939439048843,-0.6686074893434555,0.8695652173913043,1.0,1.0,6/15,17.63%,SF3B4;NCL;RBMX;CIRBP;RBM3;CELF4
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),-0.40612107960856664,-0.6683028427783566,0.8823529411764706,1.0,1.0,1/5,7.88%,FGF13
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.26880484872170823,-0.6678468544169961,1.0,1.0,1.0,23/91,16.06%,KHSRP;SF3B4;MAGOHB;LSM6;DHX8;PRPF4;TXNL4A;ZCRB1;SRRM1;RP9;SNRPB;ZRSR2;SNRPN;NRDE2;SRSF7;SCAF11;PTBP1;IVNS1ABP;RSRC1;PDCD7;PRPF6;RNF113A;PPP1R9B
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.3094239680362937,-0.6677511555189909,0.9393939393939394,1.0,1.0,7/27,22.69%,SHANK1;NLGN3;SLC8A3;RIMS1;RELN;TMEM25;GRIN1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.3312247570800794,0.6676227214115433,0.9508196721311475,1.0,1.0,2/42,2.49%,ZNF703;CTNNA1
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.39347257354385623,-0.667456270684196,0.8888888888888888,1.0,1.0,4/9,24.78%,HADHA;PGS1;TAMM41;LCLAT1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.40400665168218536,0.6674523480137704,0.8928571428571429,1.0,1.0,3/9,10.21%,CUEDC2;SMAD7;TGFB1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.36286832979449196,0.6672202093927102,0.9833333333333333,1.0,1.0,5/24,22.30%,MORF4L2;MORF4L1;MSL3;NAA50;KAT2B
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),0.38034959786019884,0.6665909617771879,0.873015873015873,1.0,1.0,4/16,10.02%,INHBA;ZFPM1;TMEM178A;MAFB
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.30096415991368247,0.6663177093016256,0.9852941176470589,1.0,1.0,9/77,10.59%,SLCO2B1;AGER;ABCC2;SLC2A1;ABCB1;AVPR1A;ABCG2;SLC38A2;SLC28A2
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),0.4441601356182042,0.665753277232887,0.8518518518518519,1.0,1.0,1/5,17.81%,CXCL13
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.40408999757483977,-0.6655366429329445,0.9069767441860465,1.0,1.0,3/11,11.40%,RPP14;POP1;RPP25
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3857942036806901,-0.6652264561553337,0.8571428571428571,1.0,1.0,1/9,3.61%,CLDN4
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.2799576910388508,-0.6651438194024345,0.9642857142857143,1.0,1.0,3/66,3.85%,NUP62CL;BACH2;TPR
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.36372523865267486,0.665034955602634,0.9,1.0,1.0,5/12,31.54%,WAS;SLC9A1;CDC42;ACTG1;RAC1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.28593522348667194,0.6649517443992472,1.0,1.0,1.0,6/81,13.49%,HLA-DMA;HLA-DMB;HLA-A;AP1M2;LGMN;RACGAP1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.3505332712636621,-0.6647717429351645,0.9183673469387755,1.0,1.0,6/17,29.86%,CYSLTR2;ADCY7;ADCY2;ADCY5;ADCY8;ADCY9
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.41870136634846294,0.6643517923300433,0.8596491228070176,1.0,1.0,3/10,27.71%,DNAJA1;CORO2B;NDFIP2
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.40770172177041775,-0.6643334039422985,0.8666666666666667,1.0,1.0,2/6,16.94%,NOS1AP;ACE
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.3527816794808853,0.664187762366704,0.9242424242424242,1.0,1.0,5/20,22.55%,PEX16;PEX11B;PXMP2;ALDH3A2;PEX5
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.3924019269004105,0.6641331545998661,0.9152542372881356,1.0,1.0,2/15,13.19%,SYNGR2;STX19
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.4221762025350526,0.6640396917323804,0.9038461538461539,1.0,1.0,2/7,13.25%,FABP3;HTR2B
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.35639236295103327,-0.6639719145748514,0.8857142857142857,1.0,1.0,1/13,7.46%,PNKP
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.43020160117863976,0.6636518273012268,0.8596491228070176,1.0,1.0,1/6,7.51%,GTF3C4
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.3714306561567218,-0.6632807961231593,0.8979591836734694,1.0,1.0,1/14,3.31%,ST8SIA2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.35124021520130916,0.6630968424209557,0.9393939393939394,1.0,1.0,5/24,18.49%,REST;SOD2;PINK1;LRRK2;FBXO7
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.42719546998759117,-0.66295669177526,0.8974358974358975,1.0,1.0,3/6,25.86%,FRRS1L;NECAB2;FYN
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.41503376898014155,0.6628967526630796,0.8392857142857143,1.0,1.0,3/7,24.46%,DAB2IP;PIK3CB;DCN
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.3045086376992162,-0.662760865898975,0.9428571428571428,1.0,1.0,7/31,16.60%,TGFB2;LMO4;SEMA4C;COBL;MTHFD1L;MTHFR;PRICKLE1
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.38423964705612407,0.6625440865696859,0.8970588235294118,1.0,1.0,2/15,13.21%,CORO1A;TSC2
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.35253903069507525,0.662198685428786,0.9464285714285714,1.0,1.0,1/22,1.97%,CCL5
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.357764851834322,0.6621826453170538,0.9178082191780822,1.0,1.0,4/19,10.64%,SOX10;PTPRZ1;SOX6;EIF2B5
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.42855615883614784,-0.6621400864778988,0.8292682926829268,1.0,1.0,1/5,6.69%,SERPINF2
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.3924219369267969,0.6615527438252423,0.9491525423728814,1.0,1.0,1/13,6.03%,BCAP31
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3504899538408211,-0.6607351983951146,0.96,1.0,1.0,5/28,12.75%,KDR;MAP2K3;HSPB1;NRP1;SEMA6A
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.2403972438751984,-0.6605423801040974,1.0,1.0,1.0,17/166,13.64%,SAMD4A;TYMS;MIF4GD;TCOF1;PUM3;NCL;DHFR;HSPB1;ELAVL1;UPF3A;EIF4G1;TSFM;TRAP1;IGF2BP3;TRIM71;CIRBP;BTG2
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.37142422051022167,0.6605244460328096,0.9375,1.0,1.0,4/14,26.98%,ESR1;NCOA4;ESR2;DDX54
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.2677689099621935,-0.6604124503445341,0.9705882352941176,1.0,1.0,16/87,18.33%,TRIB2;GNA12;TAF1;SIRT2;SH3RF2;CLU;TLK2;HSPBP1;RAD23A;PRICKLE1;VCP;FBXO22;COMMD1;ZER1;HSPA1A;N4BP1
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.39338297879308365,0.6603859648257165,0.8983050847457628,1.0,1.0,1/9,4.92%,PTPRC
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2957229125686473,0.6602695389012274,0.9722222222222222,1.0,1.0,9/63,16.53%,CDKN2D;CARD8;BCAP31;REST;HGF;GPER1;NODAL;DHCR24;CYCS
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.3196245910893786,0.659031342592101,0.9193548387096774,1.0,1.0,5/38,16.00%,WFS1;PLAUR;VPS35;CHRNA7;FURIN
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.361913568725589,0.6590309545368257,0.8983050847457628,1.0,1.0,2/13,16.54%,DAPK2;CD74
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.361913568725589,0.6590309545368257,0.8983050847457628,1.0,1.0,2/13,16.54%,DAPK2;CD74
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.3538317074030153,-0.6588544538550183,0.8918918918918919,1.0,1.0,4/16,10.57%,TYSND1;MLYCD;ABCD1;ACADVL
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.3877792967243229,0.6586677302794921,0.9180327868852459,1.0,1.0,3/11,30.47%,AKAP5;NOS1;CACNA1C
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.3480130002409317,0.6585746924661885,0.9538461538461539,1.0,1.0,4/18,20.70%,DAPK2;CD74;DPP4;JAM3
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.37783837551114174,0.6584274013757759,0.875,1.0,1.0,1/12,12.18%,AKAP5
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.275263345611375,0.6583427310271305,0.9871794871794872,1.0,1.0,1/109,0.23%,RAB6C
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.2921078522032224,0.6582025937168424,0.96,1.0,1.0,3/64,7.72%,EPHA1;F11R;WAS
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.35674691139312253,0.6581898069981078,0.9295774647887324,1.0,1.0,3/13,15.43%,CMPK2;DCTPP1;AK4
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.301898415099976,0.658157615401119,0.9846153846153847,1.0,1.0,14/70,18.80%,FUT2;MARVELD3;TGFA;TBX1;FGFR2;TGFB1;SIX4;ZNF304;NLRC3;DAB2IP;NODAL;CDK6;B2M;BAD
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.44320061358147067,-0.6581313775229788,0.8717948717948718,1.0,1.0,1/5,6.72%,NUMA1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.2966701940294265,-0.6580389592383367,0.8857142857142857,1.0,1.0,4/28,18.28%,RAB7A;SORL1;GCC2;LAMTOR4
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.22409412548574528,-0.6579796196315556,1.0,1.0,1.0,35/296,15.96%,FBXL7;RNF126;PTTG1;CDC26;FBXO27;ECRG4;FEM1A;RNF175;DNAJB12;NSFL1C;AURKA;ERCC8;KCTD13;TAF1;UBXN2A;DMAC2;RNF216;UBE2J2;CDC23;SIRT2;ZNRF1;TRIM71;CUL4A;FOXRED2;FZR1;FAF1;FBXO44;FBXO45;RBCK1;PML;FBXL22;UBXN8;DERL3;FBXL15;RAD23A
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),-0.464525854567022,-0.6579411409322945,0.9047619047619048,1.0,1.0,2/5,11.83%,RIPOR2;MDK
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.464525854567022,-0.6579411409322945,0.9047619047619048,1.0,1.0,2/5,11.83%,RIPOR2;MDK
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.3170183375784761,-0.6578198056554753,0.9090909090909091,1.0,1.0,7/28,16.60%,TGFB2;LMO4;SEMA4C;COBL;MTHFD1L;MTHFR;PRICKLE1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.3170183375784761,-0.6578198056554753,0.9090909090909091,1.0,1.0,7/28,16.60%,TGFB2;LMO4;SEMA4C;COBL;MTHFD1L;MTHFR;PRICKLE1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.2711155356730975,0.6577273424521656,1.0,1.0,1.0,19/154,20.80%,LMAN1;SPTBN5;F8;VAPB;TGFA;BCAP31;F10;ARCN1;MPPE1;CD59;CTSZ;COPB1;ARF4;STX17;GOLT1A;NAPA;SEC22B;SEC23A;RAB1A
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.3988500203307394,0.6569940536625478,0.8507462686567164,1.0,1.0,2/7,13.56%,ABCC2;ABCC6
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.27009004802587855,-0.6566865664310365,1.0,1.0,1.0,10/65,15.08%,SPTSSB;ELOVL6;SPHK2;CERS4;SPTLC1;SGMS2;SMPD4;CSNK1G2;SGPP2;HACD1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.37957704472937237,0.6566238206684022,0.8490566037735849,1.0,1.0,3/11,19.74%,COASY;PPCS;ACAT1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.37957704472937237,0.6566238206684022,0.8490566037735849,1.0,1.0,3/11,19.74%,COASY;PPCS;ACAT1
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.37957704472937237,0.6566238206684022,0.8490566037735849,1.0,1.0,3/11,19.74%,COASY;PPCS;ACAT1
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.26644831288991305,0.6564573651702293,1.0,1.0,1.0,15/187,14.37%,RAPGEF5;RASA1;PREX1;DOCK2;WASF1;MAP3K11;TPX2;ANLN;CEP72;TUBA4A;ARHGAP10;DOCK4;ECT2;RACGAP1;GEMIN4
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.31763069141304134,-0.6564152213261516,0.9285714285714286,1.0,1.0,10/25,16.89%,C5AR1;AZU1;TLR1;FOXP1;SBNO2;DYSF;CLU;CRTC3;TMEM106A;FER1L5
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.251996063855223,-0.6564088703916554,1.0,1.0,1.0,34/169,19.47%,FBXW8;GOLGA8M;SPTSSB;LEMD2;SRGN;PI4K2A;GOLGA8H;TMED3;NSFL1C;GOLGA8B;ATP8B4;GOLGA8A;TLCD2;UBXN2A;DYSF;GOLGA8N;SMPD4;RAB22A;PLEKHM2;SUN3;ATL2;DOP1B;PLEKHJ1;TMED5;FER1L5;VPS11;TMED4;MIA3;HOOK3;RAB2A;DMPK;GORASP1;NPLOC4;SQSTM1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.29891734851990504,0.6559653374208205,0.9736842105263158,1.0,1.0,7/60,17.99%,HIPK4;CDK5R1;CAMK2D;NLK;DYRK2;ULK1;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.32191789846038765,-0.6559090888655204,0.9523809523809523,1.0,1.0,6/26,14.65%,CDC14B;SVIL;KIF23;MAP10;CXCR5;PRKCE
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.26740020257021613,0.655881260836063,1.0,1.0,1.0,12/196,9.55%,POLR3K;RREB1;GCM2;ZBTB7B;ABT1;NCBP1;TBP;GTF3C4;NCBP2;COPS2;TBPL1;GLIS3
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.27047118946305804,-0.6558635657109827,1.0,1.0,1.0,13/80,14.74%,SAMD4A;TYMS;IGF1;NCL;DHFR;APOE;SORL1;IGF2BP3;TRIM71;CLU;BIN1;BTG2;SAMD4B
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3130405592607812,0.6558300840203464,0.9565217391304348,1.0,1.0,3/38,10.88%,CAV3;RPS7;RNF139
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.31523683422578774,0.6555641868186505,0.9866666666666667,1.0,1.0,13/52,20.66%,AGT;FADD;PELI3;CASP8;GPER1;FAS;BCL2L14;TMC8;DEPTOR;SP100;CYLD;MADD;GSTP1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),-0.40781925748166764,-0.6549388590755761,0.8461538461538461,1.0,1.0,2/10,7.09%,NFATC1;TGFB2
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.38528177609442277,0.6549290754355109,0.9215686274509803,1.0,1.0,3/9,14.95%,AVPR1A;ENPEP;CORIN
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.36439466792230596,0.6547971067257118,0.875,1.0,1.0,5/14,22.77%,AGT;CAMK2D;MEF2A;IL6ST;SLC9A1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.3359777933207597,-0.6545987016802179,0.9024390243902439,1.0,1.0,5/24,15.70%,IGF1;CIDEA;NR1H4;CACTIN;IRAK3
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),-0.39386106804517584,-0.6545542600609853,0.8181818181818182,1.0,1.0,2/6,10.96%,PLIN5;RGS2
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.37844778350981645,0.6544982930594478,0.9344262295081968,1.0,1.0,3/11,19.86%,CD14;IPMK;CYLD
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.341081929747983,0.6542559466698126,0.9402985074626866,1.0,1.0,4/23,9.36%,ZDHHC11;IFNLR1;TRAF3IP2;STAT1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.26369302314885174,-0.6541503872719605,1.0,1.0,1.0,11/57,19.59%,NVL;URB2;NOP14;NOM1;CUL4A;NAF1;BOP1;RIOK1;SDAD1;BYSL;RRP36
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.3417717891688573,-0.6540712641762478,0.8666666666666667,1.0,1.0,5/11,23.90%,PARP6;PARP10;PARP4;PARP16;PARP14
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.42593528619768495,0.6537324319634479,0.8833333333333333,1.0,1.0,3/7,32.98%,AGO4;DDX3X;AGO1
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),0.4188114607732433,0.6536646515702873,0.84,1.0,1.0,4/6,26.69%,B2M;ATP2A2;ATP2A3;PTPRF
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.37536353803618194,0.6532360996913871,0.9142857142857143,1.0,1.0,2/15,7.50%,TMEM204;SFRP4
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.3874390246651339,0.6525698520572248,0.8793103448275862,1.0,1.0,2/11,16.49%,KNG1;PROCR
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.35907852482371483,-0.6523711686159717,0.8913043478260869,1.0,1.0,6/15,29.86%,CYSLTR2;ADCY7;ADCY2;ADCY5;ADCY8;ADCY9
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.3239520692878701,0.652242695414167,0.9130434782608695,1.0,1.0,7/32,20.77%,EXPH5;ATP6AP1;RAB9A;SYTL4;CHMP2A;CADPS2;VPS4A
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.39430007415454704,0.651958323838998,0.9090909090909091,1.0,1.0,2/11,13.42%,KDM3A;TMF1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.31107607229525847,0.6519205339459033,0.9523809523809523,1.0,1.0,2/44,2.36%,GPC6;GPC5
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.32647822410056215,-0.6518450348012985,0.868421052631579,1.0,1.0,3/23,8.23%,SHANK1;ASAP3;LIMK1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.37934085488793173,0.6516179782380229,0.828125,1.0,1.0,4/9,28.75%,ACADL;ETFB;ETFA;ACADM
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.32350367809543745,-0.6514410909094767,0.918918918918919,1.0,1.0,2/13,6.81%,LMF1;APOA1
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.4226724350271829,0.6513809996898224,0.8888888888888888,1.0,1.0,2/6,25.97%,DLG1;MAD2L1
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),-0.32563575046737164,-0.6508082419107117,0.8863636363636364,1.0,1.0,1/14,1.92%,RUNX1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.306648869170621,-0.6506430718588369,0.9210526315789473,1.0,1.0,11/32,23.87%,SPHK2;SGMS2;CPNE7;CPNE6;PCYT2;GNPAT;SGMS1;FADS1;PIP5K1A;CPNE1;FITM2
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.37845082489361304,-0.6506315810706867,0.8461538461538461,1.0,1.0,2/8,20.06%,DDX11;CTCF
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.33217413920199024,0.6506141795360126,0.9272727272727272,1.0,1.0,5/30,17.01%,EPS8;RIN3;PEX11B;MSN;PEX11A
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.42823129658802234,0.6505717938648443,0.9,1.0,1.0,1/6,21.24%,LYN
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.38033531701002404,0.650563221704877,0.9074074074074074,1.0,1.0,1/13,1.96%,GCM2
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.2772122423227941,-0.6505596766034104,1.0,1.0,1.0,1/40,1.77%,PID1
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.4596473467276427,0.6502376806362008,0.8545454545454545,1.0,1.0,2/5,16.78%,EIF2B5;CDK6
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),0.39074326978323876,0.6499680108091308,0.9464285714285714,1.0,1.0,3/10,13.69%,CYP19A1;ABCB4;SPP1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.29583555541400747,0.6499274155183572,0.9661016949152542,1.0,1.0,16/64,25.20%,DOCK2;IL15;BOK;HIP1R;MLC1;TUB;SFTPD;PLAA;CALR;GPC3;CD151;DOC2B;FMR1;FLOT1;TFR2;SLC11A1
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.4209382076179,-0.6492400590098176,0.8837209302325582,1.0,1.0,1/6,4.60%,DRD4
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.4209382076179,-0.6492400590098176,0.8837209302325582,1.0,1.0,1/6,4.60%,DRD4
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.388026202838168,-0.6492352823787912,0.9148936170212766,1.0,1.0,3/5,20.96%,VAMP3;VAMP8;SNX6
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.35423390201783067,0.6491543255460052,0.9491525423728814,1.0,1.0,8/19,22.34%,NOX1;CYP1B1;TGFB1;BRCA1;NODAL;ARNT;CCBE1;IL6ST
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),0.4124789745461509,0.6490579518049017,0.8541666666666666,1.0,1.0,1/6,10.77%,DRD3
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.3266241620283058,0.6487295383594261,0.9027777777777778,1.0,1.0,3/23,13.41%,TMEM30A;ABCB1;ABCB4
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.33324951676833975,-0.6486168808995264,1.0,1.0,1.0,9/28,18.16%,SF3B4;NCL;RBMX;U2AF2;CIRBP;RBM3;SETX;CELF4;HSPA1A
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.3698033005839547,-0.6483425916094209,0.8611111111111112,1.0,1.0,2/11,5.18%,IDH2;OGDH
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.2981787506169409,0.6483377867017964,1.0,1.0,1.0,5/56,13.63%,WNT8A;SFRP4;TCF7L1;TCF7;FRAT2
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.2707539604138658,0.6483042831887565,0.9855072463768116,1.0,1.0,12/114,15.79%,FASN;NQO1;PRKAB2;HMGCR;SCD;PSMB6;HMGCS1;SQLE;PSMA3;PSMB8;DHCR7;PSAP
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),-0.4152615650670125,-0.6481851845033981,0.8604651162790697,1.0,1.0,5/5,58.49%,ADRA2A;HRH3;STX1A;ADRA2C;KCNB1
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.3953907996444124,0.6480426955108277,0.8928571428571429,1.0,1.0,3/11,17.47%,KCNQ1;ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.3679257707371258,-0.6479958837294609,0.8387096774193549,1.0,1.0,2/5,28.09%,RSAD2;SLC15A4
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.27665147651706445,0.6469006630188865,1.0,1.0,1.0,8/55,14.20%,ACKR3;P2RY12;AGT;PLCG2;NDNF;HTR2B;ACKR4;SPHK1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.3382978986891953,-0.6463043830098802,0.9545454545454546,1.0,1.0,4/17,16.75%,TCOF1;GTF3C2;SIRT7;POLR1G
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.2683129242098876,-0.6461834792850802,1.0,1.0,1.0,3/56,7.60%,TNFRSF19;MAP3K20;MAP2K3
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.3742465928865255,0.6460271768150031,0.927536231884058,1.0,1.0,3/12,12.53%,SOX11;SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.358736572708282,-0.6459280375344623,0.9354838709677419,1.0,1.0,3/15,19.42%,JADE2;MEAF6;KAT7
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.358736572708282,-0.6459280375344623,0.9354838709677419,1.0,1.0,3/15,19.42%,JADE2;MEAF6;KAT7
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3589370388553032,0.6458336919648257,0.9565217391304348,1.0,1.0,3/23,8.29%,MOAP1;FADD;CASP8
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.29915900047857835,-0.6456360288024191,1.0,1.0,1.0,2/31,8.20%,PI4K2A;TMEM150A
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.2596522222687302,0.6455136913020618,1.0,1.0,1.0,36/160,26.60%,PATL2;NCBP1;NCBP2;RPL15;RPS7;EXOSC8;RPL36;CSDE1;RPL9;CNOT11;RPS21;DHX34;DCP2;RPL38;PAN3;RPL21;RPL22;POLR2D;RPS5;EIF3E;RPLP2;EXOSC6;PDE12;EIF4A3;SMG7;RNPS1;RPS13;RPL27;RPL35A;PNLDC1;RPL35;DXO;RPL3;RPS20;RPL27A;CNOT7
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.4176079510876506,0.6452724793872087,0.8620689655172413,1.0,1.0,4/7,25.80%,PLAA;GPS2;DDX3X;SASH1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.40415227216460325,-0.6448446836209952,0.9534883720930233,1.0,1.0,1/8,5.19%,TMOD4
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.3501614040599965,-0.6446991929195403,0.9767441860465116,1.0,1.0,2/8,25.91%,CCN3;PLAT
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.3155258012030511,0.6445441082540024,0.9661016949152542,1.0,1.0,4/26,10.09%,CDKN1B;KIF14;PLCG2;STXBP4
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3836941865242566,0.6442479668270532,0.8333333333333334,1.0,1.0,1/11,12.68%,IMPA2
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.3836941865242566,0.6442479668270532,0.8333333333333334,1.0,1.0,1/11,12.68%,IMPA2
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.3442583333948187,0.6441547487922026,0.9464285714285714,1.0,1.0,6/22,19.83%,TWIST1;TGFB1;PLAUR;PYHIN1;PPARG;H1-0
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.3185632295076535,0.6438446806993051,0.9655172413793104,1.0,1.0,6/30,20.78%,H3-3A;UFM1;ESR1;CALR;KDM1A;NCOA2
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.32128096262231587,0.6437779215752443,0.953125,1.0,1.0,4/23,18.50%,CD14;TAB2;TLR2;IRAK4
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.27732302289459687,-0.6435013724649229,1.0,1.0,1.0,15/57,20.36%,CROCC;WWTR1;NUMA1;RANGRF;CARD10;MEAK7;GPD1L;STX4;TM9SF4;ENTR1;DTX3L;NECAB2;KAT7;PRKN;PARD6A
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.3811664869421312,-0.6434545024336714,0.9047619047619048,1.0,1.0,2/11,7.97%,NUMA1;MACROH2A2
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.38813996924064814,0.6434333144721264,0.864406779661017,1.0,1.0,1/9,17.77%,P4HA3
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.42287151725974714,-0.643182337129295,0.9024390243902439,1.0,1.0,1/5,18.45%,AK5
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.37969398596754556,0.6428985870662175,0.8620689655172413,1.0,1.0,2/11,10.21%,TJP3;TGFB1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.3328187951595954,0.6428527253683523,0.9428571428571428,1.0,1.0,3/24,11.78%,EXPH5;SCEL;OPN3
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.40621615246984794,0.6425522930382589,0.8545454545454545,1.0,1.0,2/6,15.56%,SCIMP;LY86
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),0.3435373231154847,0.6424583893343924,0.8985507246376812,1.0,1.0,4/24,15.37%,RP1;CCDC39;CFAP74;LRGUK
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.31281840651188275,0.6422360960702674,0.9375,1.0,1.0,6/24,19.83%,PDCD1LG2;ARG1;IL4I1;SFTPD;CD80;CD274
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.32726888164086376,0.6420283470086656,0.9696969696969697,1.0,1.0,5/31,13.75%,CSTF2T;NCBP1;NCBP2;CLP1;FIP1L1
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.30381191033641486,-0.6416508708245728,0.9696969696969697,1.0,1.0,9/37,12.92%,LAMB3;CLDN4;HR;CARD10;GPR39;FERMT1;LAMA3;TSPAN1;PERP
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.2846843661689191,0.6414281818112154,1.0,1.0,1.0,5/58,9.35%,TRPA1;UPB1;SOD2;HSD17B10;ACOT13
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.34002918231291945,0.6411445588952434,0.9411764705882353,1.0,1.0,5/23,16.75%,PDGFRB;HGF;DACH1;RGCC;TOM1L1
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.3991010545840137,0.6408518288613302,0.8666666666666667,1.0,1.0,2/12,10.41%,ADGRB1;RHOH
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.3230926125485797,-0.6406445431764969,0.8947368421052632,1.0,1.0,3/17,10.87%,MAPK7;HSPB1;TRAP1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.3468818959408317,-0.6399090000751546,0.8536585365853658,1.0,1.0,2/14,6.35%,TRIAP1;BCL2
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.3533543095464091,-0.6397080576151166,0.8717948717948718,1.0,1.0,2/7,14.44%,PDPN;AQP8
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.33052120022001563,0.6396872591142919,0.8939393939393939,1.0,1.0,2/22,11.96%,CCDC39;GFER
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.34187419590874685,-0.6396833349632749,0.9444444444444444,1.0,1.0,5/14,19.90%,SLC25A33;ABCD1;COX7A1;VCP;NUPR1
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.32887208469164314,0.6393271400743044,0.9672131147540983,1.0,1.0,4/19,20.77%,CHMP4B;GPER1;CHMP2A;VPS4A
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.39566674027986526,0.6386649949796683,0.9104477611940298,1.0,1.0,2/8,17.48%,PINK1;ERN1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.35173222849492203,-0.6385261790653428,0.9736842105263158,1.0,1.0,2/12,10.03%,AHNAK2;DYSF
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.2808119416943129,-0.637843011214753,1.0,1.0,1.0,10/57,14.39%,GREM1;LEMD2;NUMA1;CRIM1;VWC2;SORL1;XIAP;NOG;NBL1;BMPER
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2899777668556647,-0.6376060878346278,1.0,1.0,1.0,6/26,21.38%,SAMHD1;PTPN1;CACTIN;MAVS;CDC37;PTPN6
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.4239440007811939,0.6372484678478751,0.9272727272727272,1.0,1.0,1/5,9.45%,CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.40636148644153314,0.6370938040101914,0.9,1.0,1.0,3/7,32.21%,BEX4;FNTA;PRKAA1
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.4200824226387415,0.636916527812364,0.8363636363636363,1.0,1.0,1/6,6.55%,CIITA
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.30615643604644055,-0.6367870449291307,0.9444444444444444,1.0,1.0,1/20,1.54%,G6PC3
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.3508008735712056,0.6365743084556051,0.875,1.0,1.0,2/12,11.52%,IL7;STAT5A
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.3508008735712056,0.6365743084556051,0.875,1.0,1.0,2/12,11.52%,IL7;STAT5A
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),-0.38527500038996093,-0.6363857565475188,0.9047619047619048,1.0,1.0,2/6,14.57%,PLIN5;FGFR3
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.38297465686225707,-0.636091909051323,0.9047619047619048,1.0,1.0,1/8,4.93%,KLRD1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.37360142551230435,0.6356359341295965,0.9322033898305084,1.0,1.0,3/11,23.12%,DERL1;UGGT1;RNF185
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),0.3900078871769388,0.6350500003235403,0.8923076923076924,1.0,1.0,3/6,22.64%,INPPL1;SCX;COL13A1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.321268713892077,0.6346811694865853,0.967741935483871,1.0,1.0,2/43,7.83%,RREB1;DOCK1
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.4192586098074012,-0.63448629493463,0.8809523809523809,1.0,1.0,1/6,4.52%,RYR1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.3696074714052333,0.6344582957188859,0.8793103448275862,1.0,1.0,2/12,6.67%,TWIST1;PPARGC1A
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.38392394857063367,-0.6344440241523092,0.9545454545454546,1.0,1.0,3/12,10.72%,NOP9;TBL3;NOP14
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.2985569505116976,-0.6343050111153965,0.9411764705882353,1.0,1.0,1/31,1.36%,TPPP3
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.4165862552890056,0.6341172116745634,0.9206349206349206,1.0,1.0,4/7,21.24%,DOCK11;PPP2R3C;CAMLG;LYN
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.2722439293702738,0.6339744213467813,1.0,1.0,1.0,14/112,16.54%,EPHA1;STK26;CYP1B1;MARVELD3;IGFBP5;RHOB;SMAD7;MITF;DACH1;DAB2IP;NODAL;LIMCH1;DNAI3;CD74
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.34740813419215966,-0.6334472962944843,0.8974358974358975,1.0,1.0,3/13,25.74%,UXT;MAP1S;MGARP
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.3502671811070306,0.6333947628769157,0.890625,1.0,1.0,5/16,18.88%,RNF212B;IHO1;MEIOB;MEI4;MAJIN
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.2968008752587863,-0.633375489440845,0.9655172413793104,1.0,1.0,6/30,14.24%,DRD4;INSYN2A;GRIN2A;GABRA3;GRIN2C;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.27634312785826226,-0.6329313509812604,1.0,1.0,1.0,4/41,9.64%,F2RL1;ABCA13;ANO6;APOE
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.34939302004812645,0.632762687020524,0.90625,1.0,1.0,3/16,10.21%,MRAP;TMBIM1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.355347864785705,-0.6326138793164179,0.8372093023255814,1.0,1.0,2/8,17.21%,SORL1;DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.355347864785705,-0.6326138793164179,0.8372093023255814,1.0,1.0,2/8,17.21%,SORL1;DTX3L
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.355347864785705,-0.6326138793164179,0.8372093023255814,1.0,1.0,2/8,17.21%,SORL1;DTX3L
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.2714613579678554,0.6325665999150484,1.0,1.0,1.0,18/81,24.95%,ENC1;PATL2;KNG1;IGFBP5;PAIP2B;RNF139;DAB2IP;EPRS1;FXR1;CALR;EIF4E2;CAMK2N1;RIDA;EIF4A3;DDX6;DDX3X;FMR1;PAIP2
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.3110968850930908,0.6323818093232061,1.0,1.0,1.0,12/43,27.37%,BCAP31;TOMM22;PINK1;DNAJC19;FBXO7;GRPEL2;ROMO1;TOMM7;TOMM20;TIMM8B;TIMM22;TIMM21
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.3733289542830284,0.6319281952465159,0.9076923076923077,1.0,1.0,1/9,14.99%,GNL3
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.3880051154413031,0.6316593311969636,1.0,1.0,1.0,2/11,12.64%,HERPUD1;USP13
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.3213692571757809,-0.631504630981771,0.9375,1.0,1.0,3/18,16.12%,VCAN;CHST9;CHST12
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.33334949390193963,-0.6314515640594167,0.8857142857142857,1.0,1.0,3/15,10.30%,PTPN3;RANGRF;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.4344629644310822,0.6314312704461641,0.9272727272727272,1.0,1.0,1/5,20.24%,SEPTIN9
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.3297055195670025,-0.6313695338381029,0.9743589743589743,1.0,1.0,2/12,10.85%,TRAF3IP1;LAMA3
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.34558935811324165,-0.6311371530756222,0.868421052631579,1.0,1.0,3/8,24.47%,TENM4;PARD3;TPPP
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.38441225819053293,-0.6310878141084405,0.9473684210526315,1.0,1.0,6/10,19.78%,SLC6A4;WWC3;DUSP6;WWC1;LATS1;LATS2
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.40749469953733214,0.631071835671094,0.864406779661017,1.0,1.0,1/7,8.03%,HSD17B10
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.31766409013489416,0.6310544414201791,0.9850746268656716,1.0,1.0,4/26,21.25%,SIGLEC1;INPP5F;DNAJC6;CLTC
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.4039332405485086,-0.6309923935470383,0.9024390243902439,1.0,1.0,3/6,22.97%,PSAT1;PSPH;SRR
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.36336445764314707,-0.6302029821580705,0.9565217391304348,1.0,1.0,1/11,3.87%,GAS2L3
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.3735318064138169,-0.6301669443874848,0.8913043478260869,1.0,1.0,3/9,28.97%,DIS3L2;CHFR;TUT4
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.3721243509996902,0.6301562232346755,0.8970588235294118,1.0,1.0,1/12,12.68%,IMPA2
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),-0.3985880381183191,-0.6300560102391609,0.9111111111111111,1.0,1.0,2/5,26.33%,MTHFR;SUPT6H
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.3293255237819692,0.6295107919684096,0.9516129032258065,1.0,1.0,4/26,15.30%,P2RY12;RHOH;RHOU;NEFH
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.3975568324098363,-0.6292511522432276,0.8823529411764706,1.0,1.0,2/5,24.78%,HADHA;LCLAT1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.29047936807956976,0.629021244932538,0.9830508474576272,1.0,1.0,7/40,16.64%,CHMP4B;CHMP2B;CHMP1A;WDR73;SPAG4;CHMP2A;NUP54
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.404662675611451,-0.6284789551891744,0.8541666666666666,1.0,1.0,3/5,26.57%,RIPOR2;LRCH1;CD200R1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.33609605755828026,0.6280713569510104,0.9642857142857143,1.0,1.0,5/19,28.85%,LRRK2;FMR1;RAB5A;RAB3GAP1;PREPL
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.3563636326163697,0.6280082886472637,0.9166666666666666,1.0,1.0,5/18,21.88%,FGFR2;STXBP4;KLF9;SNAI2;NOTCH2
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.4202266591378985,0.62762100211493,0.9310344827586207,1.0,1.0,1/6,26.69%,PTPRF
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.30864201458228024,-0.6275927413294872,0.9523809523809523,1.0,1.0,1/27,4.54%,MAP3K20
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.3818478202858542,-0.6275659110188521,0.8974358974358975,1.0,1.0,3/6,19.55%,SIRT2;PRDM7;NPM2
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.37170364104406783,0.6273820185545246,0.8813559322033898,1.0,1.0,2/11,22.09%,CABYR;ROPN1L
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.4029939472546477,0.6273183199607609,0.9310344827586207,1.0,1.0,5/5,59.71%,SPIRE1;SNX9;RHOA;SPIRE2;SNX18
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.341486611435409,0.6269435567008842,0.9242424242424242,1.0,1.0,3/18,10.17%,ABCC2;ABCB1;ABCG2
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.3279586835018544,-0.6265671477519129,0.918918918918919,1.0,1.0,3/19,12.07%,QRICH2;RHOJ;PARVA
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.24729250431209665,-0.6263899361184725,1.0,1.0,1.0,11/70,14.22%,ERCC2;GTF2H2;ERCC8;ERCC1;POLR2G;CCNH;CUL4A;POLR2C;POLD3;POLR2L;COPS6
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),-0.38733330799773164,-0.6258064526095145,0.9387755102040817,1.0,1.0,2/8,11.71%,NUMA1;SIRT2
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.3131024402370076,0.6257288129634319,0.9855072463768116,1.0,1.0,4/37,14.30%,TPX2;MZT1;RACGAP1;RAB11A
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.3650474659704109,-0.6256658622798138,0.8863636363636364,1.0,1.0,3/10,9.92%,LYPLA2;APOE;ABHD17A
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.3794628757511832,0.6256605264574298,0.9193548387096774,1.0,1.0,3/11,27.87%,NPTN;RAB5A;NETO1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.2952203681977535,-0.6256280972561609,0.9722222222222222,1.0,1.0,1/22,3.53%,IGF1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.24185414411208364,-0.6251128332205315,1.0,1.0,1.0,16/105,15.07%,IARS1;KHSRP;MTHFD2;ATF3;EIF4EBP1;EIF4G1;EXOSC10;NOP14;EXOSC1;PSAT1;SRPRB;EXOSC5;BAG3;ARFGAP1;EXOSC4;SEC11A
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.38347983966725985,0.6248090698962819,0.8888888888888888,1.0,1.0,1/9,5.14%,NHEJ1
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),0.420267003912126,0.6247364007429235,0.8947368421052632,1.0,1.0,2/5,10.21%,CUEDC2;TGFB1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.25985506843363104,-0.6247073794464774,0.9736842105263158,1.0,1.0,8/56,17.79%,CROCC;CDKL1;TBC1D16;TBC1D10B;TBC1D2B;TBC1D2;ENTR1;TBC1D7
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3039478015839791,-0.624462317530521,0.9375,1.0,1.0,1/19,3.53%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.3039478015839791,-0.624462317530521,0.9375,1.0,1.0,1/19,3.53%,IGF1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.28963667621779166,0.6244163526360114,0.9859154929577465,1.0,1.0,5/45,13.63%,WNT8A;LAMP2;LIX1L;HSPA8;FRAT2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.29662168518644955,0.6240725451650689,0.967741935483871,1.0,1.0,13/35,26.39%,ELANE;FADD;CD14;CD74;TLR2;LBP;RAB1A;F3;AFAP1L2;SYK;SERPINE1;ZNF580;NOD1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.27182375045083385,0.624005870872974,1.0,1.0,1.0,22/89,23.85%,SLU7;NXT1;NCBP1;U2AF1;FYTTD1;NCBP2;DDX39A;THOC5;FIP1L1;YTHDC1;NUP54;CDC40;SARNP;SLBP;NUP188;ALYREF;SRSF3;NUP85;EIF4A3;SMG7;NUP58;RNPS1
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.3189528525382617,0.6237054711631944,0.9666666666666667,1.0,1.0,7/26,29.72%,EEF1A1;DAB2IP;SNAI2;DUSP22;INPP5K;ZFP36;ZFP36L1
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.41356769366657,0.6233795498292983,0.9285714285714286,1.0,1.0,2/5,20.68%,CALR;SEC22B
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.3054916459410166,0.6233531493812413,0.9649122807017544,1.0,1.0,1/30,1.33%,CAV3
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.4094141112473465,0.623289098941947,0.9344262295081968,1.0,1.0,1/6,8.70%,IL7
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.29535432879224016,-0.623220039616717,1.0,1.0,1.0,12/32,21.72%,SFRP1;DRD4;MIDN;APOE;IRS1;RAB11FIP3;OPRM1;PRKN;ERP29;RAB11FIP1;RSAD2;CCN3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.34853029976450467,-0.6230563962249891,0.9761904761904762,1.0,1.0,4/12,23.15%,UPP2;UCK2;TYMP;UMPS
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.2782741978691632,-0.6230138201337487,1.0,1.0,1.0,5/37,10.79%,LSM6;RRP7A;SRFBP1;NOP14;NOM1
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.3587868918760664,0.6227609145407093,0.9142857142857143,1.0,1.0,4/9,27.67%,INPPL1;SCX;COL13A1;BMPR1B
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.32162832457009277,0.6227296741210825,0.9393939393939394,1.0,1.0,4/25,16.03%,ARRDC3;SMAD7;PINK1;DCUN1D1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.3755569293550688,-0.6226106275070076,0.9090909090909091,1.0,1.0,1/8,4.49%,FGGY
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.28167638041772236,0.6223361365782674,0.9855072463768116,1.0,1.0,2/51,5.01%,HENMT1;TRUB1
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.3805258813224169,-0.6220035794423522,0.9512195121951219,1.0,1.0,2/13,7.39%,IGF1;CILP
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.32167629305326645,0.6217082942097616,0.9655172413793104,1.0,1.0,3/22,20.55%,BTBD18;THOC5;ALYREF
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.30791497888434627,-0.6216468261095843,0.9722222222222222,1.0,1.0,3/20,14.06%,POLR2G;POLR2C;POLR2L
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.30791497888434627,-0.6216468261095843,0.9722222222222222,1.0,1.0,3/20,14.06%,POLR2G;POLR2C;POLR2L
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.2755340000980581,0.62120999215127,1.0,1.0,1.0,13/59,23.63%,HCK;WAS;DOCK1;PLCG2;BRK1;ACTR2;YES1;PIK3CB;ACTR3;LYN;CYFIP1;CDC42;SYK
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.2755340000980581,0.62120999215127,1.0,1.0,1.0,13/59,23.63%,HCK;WAS;DOCK1;PLCG2;BRK1;ACTR2;YES1;PIK3CB;ACTR3;LYN;CYFIP1;CDC42;SYK
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.27925332811011533,-0.6207397605528504,1.0,1.0,1.0,5/27,16.87%,ERCC1;PNKP;NAF1;PML;ATM
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.3170161628639821,-0.6204957560197998,0.918918918918919,1.0,1.0,4/19,12.20%,GRIN3A;SDF4;GRIN2A;GOT2
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.34876833020887665,0.6204307937365887,0.94,1.0,1.0,5/13,23.10%,WAS;DMTN;TWF2;TWF1;CDC42
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.3625431208909313,-0.6199829194076886,0.9411764705882353,1.0,1.0,3/9,29.04%,CCNT1;NELFE;RNF20
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.2893741577901374,-0.6199162674342776,0.9666666666666667,1.0,1.0,7/52,9.14%,SPTSSB;ELOVL6;SPHK2;CERS4;SPTLC1;SGMS2;ST3GAL2
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.34529165965551556,0.6196865014743823,0.9344262295081968,1.0,1.0,2/14,14.11%,NOX1;CD59
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.31661419277962743,-0.6193969594097831,0.9411764705882353,1.0,1.0,3/18,11.02%,HMMR;GUSB;CHP1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.2536468430267845,-0.6190522999641708,1.0,1.0,1.0,27/97,22.87%,KCNC1;FBLL1;SLC6A9;ADGRA1;NYAP1;MMD2;STMN2;ELAVL3;CNIH2;PRR36;GRIA2;ABCG4;DNER;BRINP1;SRRM3;SCRT1;TAGLN3;ARHGAP39;BSN;CLIP3;KIF1A;CASKIN1;PCDH8;GRIN1;SCAMP5;SNAP91;SLITRK1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.2803876219948591,-0.6186345520266503,1.0,1.0,1.0,10/44,17.60%,MAP3K20;HUS1;INO80;XRCC6;IFI16;SPIDR;HSF1;TLK2;ATM;EEF1D
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.3074681526979982,0.618426200672946,0.9682539682539683,1.0,1.0,6/26,19.46%,STRADA;TGFB1;STRADB;DUSP16;CALR;ANKLE1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3750597851375188,0.6180119154918493,0.9122807017543859,1.0,1.0,2/11,14.48%,HGF;MUC20
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.3156857546638587,-0.6180081437436804,0.9512195121951219,1.0,1.0,1/17,2.79%,TNFRSF11A
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.3494608519971115,0.6179885092221878,0.9508196721311475,1.0,1.0,3/22,13.76%,PRLR;CYP19A1;MOCS2
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.2944952346527555,0.6178925629592839,1.0,1.0,1.0,4/35,10.41%,FMNL1;RND1;RHOB;RHOH
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3366866707581409,0.6177610827756795,0.9824561403508771,1.0,1.0,4/18,18.30%,CDC25A;RAB11A;CDK4;RAD51C
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.39177891889838556,0.6169125318669482,0.9464285714285714,1.0,1.0,4/9,15.93%,TYR;FAH;IL4I1;HPD
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.34522104488633665,-0.6164381295652573,0.9230769230769231,1.0,1.0,1/8,10.15%,GPR37
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.3559300543815429,-0.6160239305408957,0.8666666666666667,1.0,1.0,1/6,8.84%,ANO6
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.29191332375118795,0.6160005809162565,0.9508196721311475,1.0,1.0,3/34,12.15%,RFC5;RPA3;PCNA
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.3003763596113038,-0.6157870215139369,0.926829268292683,1.0,1.0,3/23,9.66%,WTIP;STAT3;EIF4G1
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.3732861471678187,-0.6152346806835255,0.9230769230769231,1.0,1.0,4/10,15.06%,EXOSC10;EXOSC7;EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.37811963918948555,0.6152011385553436,0.8620689655172413,1.0,1.0,1/9,5.17%,TWIST1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.26639235786296805,0.6149536872687084,1.0,1.0,1.0,24/95,24.10%,SLU7;NXT1;NCBP1;U2AF1;FYTTD1;NCBP2;DDX39A;THOC5;FIP1L1;YTHDC1;NUP54;CDC40;SARNP;POLR2D;SLBP;NUP188;ALYREF;SRSF3;NUP85;EIF4A3;SMG7;NUP58;RNPS1;C12ORF50
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.26463685105756984,0.6147691628249375,1.0,1.0,1.0,23/93,24.34%,SLU7;NXT1;NCBP1;U2AF1;FYTTD1;NCBP2;DDX39A;THOC5;FIP1L1;YTHDC1;NUP54;CDC40;SARNP;SLBP;NUP188;ALYREF;SRSF3;NUP85;EIF4A3;SMG7;NUP58;RNPS1;FMR1
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.39122163992941633,0.6147481290025116,0.8867924528301887,1.0,1.0,1/8,7.22%,NREP
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.31298149269782854,-0.6146540538582058,0.9534883720930233,1.0,1.0,7/22,25.92%,EIF4EBP1;SMOC2;HSF1;PKN2;CCNB1;CCDC57;TTL
prerank,GO_Biological_Process_2021__somite development (GO:0061053),0.3922672769356442,0.6140892768604412,0.9180327868852459,1.0,1.0,5/10,22.74%,SOX11;PPP2R3A;MEOX1;MEOX2;SFRP2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.3591558666334833,-0.6140169245364472,0.9354838709677419,1.0,1.0,2/9,23.40%,CSF1R;IL34
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.2995708079685915,-0.6136093307936128,0.9428571428571428,1.0,1.0,1/23,2.50%,IFIH1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.4019947000350834,0.6134357729133092,0.9180327868852459,1.0,1.0,2/6,15.89%,SEMA3A;CHRNA7
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.3821300928240808,0.6131601207832428,0.9298245614035088,1.0,1.0,1/9,4.92%,PTPRC
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.3600886438570888,-0.6129762808452551,0.8571428571428571,1.0,1.0,8/8,64.01%,MT3;ABL1;HDAC6;ECSIT;SIRT4;SZT2;ABL2;OXA1L
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.3248978106763165,-0.6128787292916522,0.9361702127659575,1.0,1.0,2/19,3.59%,ST8SIA2;GANC
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.3116875254556302,-0.6127821863224301,0.9777777777777777,1.0,1.0,2/13,8.03%,TPR;EIF4EBP1
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),-0.3575538499216072,-0.6122005356832834,0.9230769230769231,1.0,1.0,2/9,8.90%,RFWD3;THOC1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.3677673711518481,-0.6121096861045036,0.9166666666666666,1.0,1.0,1/11,4.14%,NFIB
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.28286180285289775,-0.6120324179057561,1.0,1.0,1.0,10/47,17.63%,HNRNPL;ZBTB7A;RBM11;RBMX;SRRM4;PTBP1;KHDRBS3;RBM25;CELF5;CELF4
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.31230601637265765,0.6119866033981027,0.9852941176470589,1.0,1.0,3/42,4.74%,ACSBG1;PLP1;SOX10
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.34609729134176354,-0.6118240631610696,0.9523809523809523,1.0,1.0,3/12,21.29%,NELFA;TCERG1;NELFE
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.2654666353834261,0.6113563536292176,1.0,1.0,1.0,19/64,24.70%,TST;SLU7;NCBP1;U2AF1;NCBP2;DDX39A;THOC5;CDC40;SARNP;SLBP;NUP188;ALYREF;SRSF3;SIDT2;SIDT1;EIF4A3;RNPS1;FMR1;FLOT1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.39295500883589995,0.6113506494127278,0.9137931034482759,1.0,1.0,1/6,19.90%,NONO
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.3724153234506707,-0.6106679016025758,0.8974358974358975,1.0,1.0,1/5,12.31%,SMOC2
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.2631132693688871,0.6104942263229991,1.0,1.0,1.0,7/74,14.90%,KCNE2;ARIH2;NKD2;SMAD7;USP13;RNF144B;DAB2IP
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3115434056958823,0.6100075451024731,1.0,1.0,1.0,3/20,12.81%,ABT1;EXOSC8;RPS21
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.2976341246138112,0.6099876441425625,0.9666666666666667,1.0,1.0,8/33,28.16%,SESN3;GLRA1;RRAGD;SPAAR;LAMTOR3;LAMTOR2;LAMTOR5;RRAGA
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.34592768060718626,-0.6098095413818463,0.9318181818181818,1.0,1.0,3/10,21.43%,UPP2;UCK2;TYMP
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.3325125937598279,0.6091449085682751,0.9538461538461539,1.0,1.0,3/16,19.06%,ULK1;WIPI1;ATG3
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.3728962694682658,0.6088096086444262,0.9491525423728814,1.0,1.0,2/7,20.55%,THOC5;ALYREF
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.3728962694682658,0.6088096086444262,0.9491525423728814,1.0,1.0,2/7,20.55%,THOC5;ALYREF
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.3696698295246398,-0.607829689094294,0.9333333333333333,1.0,1.0,2/6,16.82%,MALT1;CARD9
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.260203028410155,-0.6076338271177548,1.0,1.0,1.0,14/66,18.16%,TRIB2;TAF1;SIRT2;SH3RF2;CLU;FZR1;HSPBP1;RAD23A;PRICKLE1;PLK3;VCP;FBXO22;ZER1;HSPA1A
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),0.4037076390273404,0.6072329277485518,0.9672131147540983,1.0,1.0,2/5,27.17%,DDX3X;EIF6
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.2787866296164456,0.6066776069883123,1.0,1.0,1.0,13/53,28.61%,FIGNL1;TUBGCP4;WDR73;RAB11A;TRDN;DLG1;CCDC88B;HOOK2;CRIPT;KATNA1;FIGNL2;CCDC88C;CLASP1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.3368290177847451,-0.6052115322814494,0.9512195121951219,1.0,1.0,10/10,66.34%,PACSIN2;PACSIN3;FNBP1L;MICALL1;BIN2;EHD2;SNX9;PACSIN1;BIN3;WHAMM
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.2708960033598657,0.6047059487882145,0.9726027397260274,1.0,1.0,5/53,15.17%,NQO1;PSMB6;PSMA3;PSMB8;PDK4
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.31431258937182693,-0.6045338719876252,0.9743589743589743,1.0,1.0,5/25,15.70%,IGF1;CIDEA;NR1H4;CACTIN;IRAK3
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.28167801549816107,0.6043930938620733,0.9848484848484849,1.0,1.0,12/59,20.57%,CCL5;P2RY12;ECM2;SMAD7;NDNF;NODAL;RNASE10;FBLN2;TNFSF18;FRMD5;VIT;ADGRG1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.30183827937915475,0.6042276982009498,0.9420289855072463,1.0,1.0,2/28,4.75%,FABP3;PRKAB2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.3326329259815221,0.6036898001598003,0.9833333333333333,1.0,1.0,4/20,10.56%,NOX1;CYP1B1;TGFB1;BRCA1
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.27857170724965824,-0.603654053547482,1.0,1.0,1.0,4/30,18.32%,WTIP;TRIM71;XPO5;TARBP2
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.31129341764649876,0.603376873801579,0.9508196721311475,1.0,1.0,4/26,19.13%,NCBP1;NCBP2;DCP2;SLBP
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.3405062971797963,0.6030282902600701,0.9137931034482759,1.0,1.0,1/10,7.37%,SLC2A1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.2543355920043408,-0.6029041604032314,1.0,1.0,1.0,10/66,16.79%,NUP62CL;TPR;STAT3;IL10RA;LAMP5;IPO9;RANBP17;HK2;PRICKLE1;NUP107
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),0.3832466390333499,0.6024010826593602,0.9285714285714286,1.0,1.0,3/6,27.76%,USP14;SVIP;AQP11
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.3964222018051127,-0.6019262523204473,0.9,1.0,1.0,6/6,60.38%,RAB11B;PTPRN2;PTPRN;SELENOT;RAB11FIP2;RAB11FIP5
prerank,GO_Biological_Process_2021__delamination (GO:0060232),0.38575737111475694,0.60165151366978,0.9090909090909091,1.0,1.0,1/6,32.62%,SPI1
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.33417271312228936,-0.6012827847907964,0.9714285714285714,1.0,1.0,2/10,11.82%,IFI16;CSF1R
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.27897512015784076,0.6012147588317373,1.0,1.0,1.0,2/51,2.49%,ZNF703;CTNNA1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.30736465212062364,0.6007649663029705,0.9402985074626866,1.0,1.0,4/26,24.39%,MRE11;RAD50;TERF2IP;GAR1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.2798534252817042,-0.6005520189906838,1.0,1.0,1.0,11/36,23.05%,RILP;PI4K2A;RAB22A;PLEKHJ1;VPS11;HOOK3;SQSTM1;TMEM9;RAB27A;WASHC5;VPS18
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.3608979828662744,0.6003756116242347,0.9375,1.0,1.0,2/9,13.56%,ABCC2;ABCC6
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.2749892964120135,-0.6003180287221196,0.9722222222222222,1.0,1.0,6/30,19.62%,HCRT;MCTP1;MCTP2;PNKD;RIMS1;SNCAIP
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3133558877093047,0.5996433513830407,0.9833333333333333,1.0,1.0,4/25,12.90%,UFM1;BRCA1;ESR1;KANK2
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.3399078757896324,0.5993001006857652,0.9814814814814815,1.0,1.0,1/13,6.34%,HIP1R
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.3334818901014249,0.5990652532124149,0.9607843137254902,1.0,1.0,1/17,4.47%,SCN4B
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.2819391918502261,0.5988837099297079,0.9696969696969697,1.0,1.0,12/62,23.63%,PTPRC;FADD;CASP8;IL7;STAT1;SPHK1;CD74;CYLD;MADD;IFNGR2;SUMO1;SYK
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3385220793867614,0.5987007357400332,0.9393939393939394,1.0,1.0,2/10,9.47%,CSGALNACT1;XYLT1
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.35050455337065234,0.5984561861101786,0.9285714285714286,1.0,1.0,2/11,9.55%,ELOVL2;HACD4
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.35336850315167895,0.5983865246402542,0.9696969696969697,1.0,1.0,4/11,24.17%,TTLL4;TPGS1;TTLL7;TTLL9
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.4001390875534575,0.5977824018325026,1.0,1.0,1.0,1/7,8.58%,PAICS
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.3688098266298001,0.597655302629637,0.9423076923076923,1.0,1.0,2/7,27.49%,ABCG5;CD36
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.3706467420887615,-0.5972641810188212,0.95,1.0,1.0,1/8,11.02%,CHP1
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.3261827721148713,0.5968021367174211,0.9682539682539683,1.0,1.0,4/15,26.84%,STAT1;IL6ST;YAP1;SMAD4
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),0.40427980492235804,0.5964716588508061,0.9,1.0,1.0,3/5,37.85%,EIF6;ABCE1;RAN
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.40248685853510136,0.5964436051875047,0.9180327868852459,1.0,1.0,1/5,9.33%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.40248685853510136,0.5964436051875047,0.9180327868852459,1.0,1.0,1/5,9.33%,EXOSC8
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.40248685853510136,0.5964436051875047,0.9180327868852459,1.0,1.0,1/5,9.33%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.40248685853510136,0.5964436051875047,0.9180327868852459,1.0,1.0,1/5,9.33%,EXOSC8
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.2660194293814252,0.5962159290510313,1.0,1.0,1.0,11/85,18.60%,GOT1;TSHR;GPER1;RAB8A;INSIG2;EPRS1;INSIG1;CRHBP;PKLR;PDE3B;PPARG
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.31985821857008295,0.5957529184736695,0.9571428571428572,1.0,1.0,6/19,24.17%,TTLL4;AGBL5;TPGS1;GGCX;TTLL7;TTLL9
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.24510249751038224,0.5954631204378753,1.0,1.0,1.0,17/120,20.88%,DDX20;ABT1;NCBP1;ERAL1;CLP1;USP39;GEMIN4;SNRPD2;YTHDC1;RPL38;POLR2D;RPS5;RSL24D1;DDX1;SF3B1;CRNKL1;NOP53
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.37374095750752967,0.5953961219365757,0.9508196721311475,1.0,1.0,2/13,11.65%,RAD9B;MRE11
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.3863961732830007,0.5953515904736825,0.9,1.0,1.0,2/6,23.70%,ATP2A2;VMP1
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.33186560188924497,-0.5953147323904621,0.975,1.0,1.0,3/13,20.48%,PPP1CA;PPM1F;PPP5C
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),0.36089002614635857,0.5952982305507146,0.864406779661017,1.0,1.0,4/7,27.39%,PODXL;TWF2;CDHR5;ATP8B1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.32843711757067273,0.5951274192954022,0.95,1.0,1.0,1/11,11.73%,ZNF304
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.3151171398967498,0.594963634260497,0.9710144927536232,1.0,1.0,3/22,18.12%,SCTR;CGAS;PDE3B
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.26488005184869456,0.5944571112671274,1.0,1.0,1.0,13/61,23.63%,HCK;WAS;DOCK1;PLCG2;BRK1;ACTR2;YES1;PIK3CB;ACTR3;LYN;CYFIP1;CDC42;SYK
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.36417697467220406,0.5944335793746205,0.9107142857142857,1.0,1.0,1/8,7.51%,GTF3C4
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.378412881693608,-0.5941298539513814,0.918918918918919,1.0,1.0,4/9,15.06%,EXOSC10;EXOSC7;EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.34805405405405404,-0.5934807596059697,0.9215686274509803,1.0,1.0,9/9,65.22%,WDR81;PIK3R1;WDR91;RBL2;RB1;RBL1;EEF1A2;PPP2R5A;PIK3R3
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),-0.33861032300347094,-0.593283765006086,0.9318181818181818,1.0,1.0,1/6,8.60%,RFWD3
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.32666459545736326,-0.593220324437862,0.9767441860465116,1.0,1.0,3/12,15.08%,ELOVL6;ABCD1;HACD1
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.3288403745261179,-0.5928278849961108,0.9555555555555556,1.0,1.0,3/9,27.50%,MCCC2;PC;HLCS
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.25838107747713784,0.5924142318052814,1.0,1.0,1.0,14/66,21.51%,KLHL21;KIF14;CDC6;DRD3;KLHL13;ECT2;RACGAP1;CCP110;RAB11A;CDC14A;BCL2L1;CALM3;VPS4A;ZFYVE19
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.36760847601424984,0.5918964663277518,0.9423076923076923,1.0,1.0,2/8,27.49%,ABCG5;CD36
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.35809333975938157,0.5915600565936538,0.9152542372881356,1.0,1.0,5/8,37.94%,MSN;WASL;AKT1;SLC8B1;ADTRP
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.3750677793817734,-0.5912390795146524,0.975609756097561,1.0,1.0,3/6,34.17%,PRUNE2;BNIPL;PRUNE1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.35077320591179606,-0.5909380763138766,0.9761904761904762,1.0,1.0,3/9,21.43%,UPP2;UCK2;TYMP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.35077320591179606,-0.5909380763138766,0.9761904761904762,1.0,1.0,3/9,21.43%,UPP2;UCK2;TYMP
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.27413078793188783,-0.5906542497349708,1.0,1.0,1.0,1/33,1.83%,PNPO
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.3241837841852215,0.5906281230384989,0.9672131147540983,1.0,1.0,5/14,26.37%,ATP12A;ATP1B1;ATP1A1;SLC9A1;SLC12A2
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.3442953213937967,-0.5904728632806224,0.8723404255319149,1.0,1.0,2/7,20.30%,PNKD;PRKN
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.3373932059735757,0.5898955755006227,0.9661016949152542,1.0,1.0,3/11,20.42%,ZDHHC11;IFIT1;AKAP1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.33573900425040626,0.5898623224492454,0.9833333333333333,1.0,1.0,4/16,18.35%,ACTL6A;MORF4L2;MORF4L1;MSL3
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.2993280091169031,0.5898579482554878,0.9857142857142858,1.0,1.0,7/31,22.86%,SLC30A8;GPER1;GHRL;C2CD2L;BAD;DOC2B;ACSL4
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.2906905784899,-0.5897652182685065,1.0,1.0,1.0,1/16,5.14%,DCLRE1B
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.3745611381184598,0.5896131606324202,0.9508196721311475,1.0,1.0,1/8,9.70%,SMAD7
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.3461560054410214,-0.5894318858284727,0.9130434782608695,1.0,1.0,2/9,10.09%,NUMB;PCM1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.2529890405871833,0.5893337589133725,1.0,1.0,1.0,5/83,7.92%,ELANE;TRIM32;CDKN2D;CDC25A;COPS9
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),0.3895272418235143,0.5889732927955083,0.9491525423728814,1.0,1.0,2/5,22.18%,BASP1;KLF15
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),0.3895272418235143,0.5889732927955083,0.9491525423728814,1.0,1.0,2/5,22.18%,BASP1;KLF15
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.3960619962849246,0.588828793324384,0.9545454545454546,1.0,1.0,1/5,10.93%,ORAI2
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.34810160807501606,0.5886178681683721,1.0,1.0,1.0,2/13,10.21%,TWIST1;TGFB1
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),-0.38665642654338717,-0.5884863165219024,0.96875,1.0,1.0,1/5,5.54%,TEX15
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.28139054883799575,0.5882651689263209,0.9516129032258065,1.0,1.0,3/36,12.15%,RFC5;RPA3;PCNA
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.253490779909205,-0.5881161528338016,1.0,1.0,1.0,12/71,13.27%,BRCA2;SAMHD1;POLL;HUS1;INO80;RFWD3;RAD51B;SEM1;PALB2;YY1;SPIDR;XRCC3
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.28767978629644003,-0.5877397689502435,1.0,1.0,1.0,5/25,17.52%,BEND3;PRDM7;WDR82;KMT2B;TET2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),0.3689967012212719,0.5877001729110867,1.0,1.0,1.0,1/11,4.72%,SLC19A3
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.33224600656878317,0.5875738995324868,0.9833333333333333,1.0,1.0,6/17,26.84%,TBX1;FGFR2;ZFPM2;LRP2;SEMA3C;SMAD4
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.36948928017391514,0.5872005329300366,0.9574468085106383,1.0,1.0,2/7,12.81%,ABT1;RPS21
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.37217055382599495,0.5867488556752739,1.0,1.0,1.0,2/6,27.27%,GLRA1;TMEM98
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.36780367079685083,0.5867350763920242,0.9122807017543859,1.0,1.0,1/7,7.51%,GTF3C4
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.3522427180443499,-0.5863543622130016,0.9259259259259259,1.0,1.0,5/9,29.86%,ADCY7;ADCY2;ADCY5;ADCY8;ADCY9
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.3396540557655773,-0.5861531335296879,0.9285714285714286,1.0,1.0,1/8,6.66%,FOXP1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.31588621554993107,0.5860801054183311,0.9552238805970149,1.0,1.0,3/17,16.81%,ATP5IF1;VPS35;MSN
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.3167828440626681,-0.5859561170247792,0.972972972972973,1.0,1.0,4/11,25.16%,MME;ATM;CHEK2;ATR
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),-0.34243206311629015,-0.585777550158327,0.9069767441860465,1.0,1.0,2/9,11.71%,HDAC1;SIRT2
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.2565156646156508,0.5856139038052525,1.0,1.0,1.0,17/94,21.03%,CLGN;HSPA1L;MEP1B;GSG1;GAD1;ZC2HC1C;HSPA4L;NEFH;PSMG1;ARL4A;ZPBP;PEBP1;SLC2A5;EZH2;JAM3;CDKN3;ACRV1
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.30824388733684277,0.5855020191382359,0.9864864864864865,1.0,1.0,6/25,27.00%,SLC17A8;OTOF;SLC18A2;SLC32A1;RAB5A;WNT7A
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.37177434606163884,0.5853282907850755,0.9180327868852459,1.0,1.0,2/8,14.20%,GPER1;SPHK1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.2508495282535401,-0.5851936394934849,1.0,1.0,1.0,5/37,9.42%,TIMELESS;RFWD3;SMARCAL1;THOC1;SLFN11
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.3653461600821489,-0.5847441794831785,0.9473684210526315,1.0,1.0,6/6,63.48%,SENP5;SENP1;SENP2;SENP6;SENP7;USPL1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3377030708581461,0.5847359907703589,0.9666666666666667,1.0,1.0,5/10,31.31%,INSIG1;YOD1;SVIP;ERLEC1;UBE2J1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.30047922516736636,-0.5846520274265107,1.0,1.0,1.0,3/18,13.67%,ALDH1A3;STAT3;COL5A1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.3001027797146654,-0.5842617624297498,0.9705882352941176,1.0,1.0,8/18,18.83%,HS3ST3B1;EXT1;B3GAT3;HS3ST5;EXT2;XYLT2;NDST1;HS6ST2
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),-0.3299242113393591,-0.5839054511870118,0.8,1.0,1.0,1/6,15.81%,RNF113A
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.37651318633808917,0.5835615795978183,0.9180327868852459,1.0,1.0,5/5,62.36%,ROBO1;ROBO3;APP;ROBO2;GAP43
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.3577661841971903,-0.5833929410070067,0.9024390243902439,1.0,1.0,1/6,10.19%,RFT1
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.3588128774216209,0.5833399224899992,0.9272727272727272,1.0,1.0,4/7,34.37%,RYR2;MESP1;CITED2;NDRG4
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.3007639875771268,0.5829995789207941,0.9622641509433962,1.0,1.0,4/23,22.79%,HIP1R;PFN4;TWF2;TWF1
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.3806945125467739,0.582852374709489,0.9285714285714286,1.0,1.0,1/5,21.38%,SNAI2
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.3435844773537996,-0.5823119273818367,0.8604651162790697,1.0,1.0,7/7,65.66%,CHCHD10;ERC1;ERC2;RAB3A;CBLN1;DCTN1;CBLN2
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.336361097920287,0.5822982515344144,0.9795918367346939,1.0,1.0,5/9,23.63%,PLCG2;CX3CR1;IFI35;LBP;SYK
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.3545790128976684,-0.5819858426703121,0.8979591836734694,1.0,1.0,1/8,5.59%,AZU1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.3353980226208874,0.5811888925637525,0.9508196721311475,1.0,1.0,1/11,17.99%,LRRK2
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.3213119861406602,0.581156937856984,0.9538461538461539,1.0,1.0,2/13,10.55%,UFM1;RAB23
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.3938674011111756,-0.5809335513615317,0.9411764705882353,1.0,1.0,1/5,17.95%,NR1H2
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.2927161199382867,-0.5807671068195209,0.975609756097561,1.0,1.0,5/20,21.21%,TRMT10C;TSFM;RPUSD4;MRPS27;MTG2
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),0.35770378071048614,0.5802849678523083,0.864406779661017,1.0,1.0,1/6,8.03%,HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.27939630888420913,-0.5801668712583381,0.9722222222222222,1.0,1.0,3/14,23.03%,PNPLA2;NR1H2;PPARA
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.3100572014342761,-0.5800783137420276,0.9230769230769231,1.0,1.0,5/14,16.88%,PTBP3;NRDE2;PTBP1;RPS26;PTBP2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.25616874821286717,-0.5797461483194407,0.975,1.0,1.0,3/46,6.55%,LEMD2;EMD;NUP37
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.25616874821286717,-0.5797461483194407,0.975,1.0,1.0,3/46,6.55%,LEMD2;EMD;NUP37
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3462751050394064,0.5796036842428621,0.9538461538461539,1.0,1.0,5/11,32.98%,NOTCH4;AGO4;EIF6;ZFP36;AGO1
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.3462751050394064,0.5796036842428621,0.9538461538461539,1.0,1.0,5/11,32.98%,NOTCH4;AGO4;EIF6;ZFP36;AGO1
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.3611045710693731,0.5794184619712026,1.0,1.0,1.0,1/8,8.03%,HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.30443939408414084,0.5792076363353333,0.9402985074626866,1.0,1.0,1/20,5.67%,KNG1
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.3108419636906655,-0.5791359204723658,0.9534883720930233,1.0,1.0,3/13,21.29%,NELFA;TCERG1;NELFE
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.31804623403015436,0.5789176372625571,0.9508196721311475,1.0,1.0,6/11,31.57%,KEAP1;NFKBIE;NFKBIA;DBN1;PKD1;YWHAB
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.29056253059450177,0.578507982745187,0.9508196721311475,1.0,1.0,5/21,22.77%,KCNQ1;LRRK2;ATP2B4;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.325068981772746,0.5784016529894627,0.9705882352941176,1.0,1.0,2/12,23.10%,MSN;CDC42
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.35668616617416593,-0.5781052290921724,0.9534883720930233,1.0,1.0,1/7,8.37%,NMU
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.3753361409935892,0.5775841161845725,0.9259259259259259,1.0,1.0,2/7,17.01%,PEX11B;PEX11A
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.316147357597885,-0.5770509693393605,0.9736842105263158,1.0,1.0,3/15,14.10%,SFRP1;MIDN;IRS1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2939674719145259,0.5769102945256569,0.9682539682539683,1.0,1.0,1/26,8.76%,BTBD18
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.38353106667577236,0.5768192070466096,0.9516129032258065,1.0,1.0,2/6,23.86%,CHRNA7;LRP2
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.3016429616723666,-0.5767063464179868,0.9318181818181818,1.0,1.0,3/15,14.59%,IFIH1;PTPRS;MAVS
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),-0.3785081881517741,-0.57655925480459,0.9130434782608695,1.0,1.0,1/5,9.39%,KCNN2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),-0.3785081881517741,-0.57655925480459,0.9130434782608695,1.0,1.0,1/5,9.39%,KCNN2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.315613975632145,-0.5762215408038405,0.9318181818181818,1.0,1.0,2/10,14.81%,SNAP29;STX4
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.3558631870939149,0.5758950020722466,0.9206349206349206,1.0,1.0,1/8,9.33%,EXOSC8
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.3558631870939149,0.5758950020722466,0.9206349206349206,1.0,1.0,1/8,9.33%,EXOSC8
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.33242303416661767,-0.5758296247180067,0.8918918918918919,1.0,1.0,3/8,21.09%,SAMD9;VPS11;VPS41
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.28529713945817337,-0.5756168213213302,0.9473684210526315,1.0,1.0,16/16,71.50%,KIF1A;MGARP;ACTR10;HAP1;PAFAH1B1;DLG2;KIF5B;DST;TMEM108;DYNC1H1;KIF5A;SOD1;KIF1C;FBXW11;MAP1A;NEFL
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.382177482218031,0.5755972125911364,0.9696969696969697,1.0,1.0,2/5,31.50%,ALDH6A1;BCAT2
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3174421026113241,-0.5753060064123668,0.9512195121951219,1.0,1.0,1/13,10.58%,NGF
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.3526677117682037,-0.5752765140376974,0.9565217391304348,1.0,1.0,10/10,64.76%,POGZ;CENPE;CENPF;CENPT;CENPH;CENPC;CENPA;NUF2;MIS12;CENPW
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.2448369046926586,-0.5752641989830486,1.0,1.0,1.0,11/83,14.74%,SAMD4A;TYMS;TPR;NCL;DHFR;EIF4EBP1;IGF2BP3;TRIM71;MEX3D;BTG2;SAMD4B
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.3128749810255451,0.5749837557029256,0.953125,1.0,1.0,2/18,15.40%,SCO2;COA5
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.3787735757173428,-0.5745550944910223,0.9285714285714286,1.0,1.0,1/6,9.24%,TAF1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.25053832677356286,-0.5743686668867646,0.9375,1.0,1.0,5/33,18.33%,QRICH2;TAF1;TLK2;PML;N4BP1
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.23198453876309105,-0.5740588339298933,1.0,1.0,1.0,18/60,22.94%,TRIAP1;PRKCD;ERCC1;INO80;TAF1;MME;YY1;DDB2;EIF2AK4;N4BP1;XPC;CREBBP;PTPRK;RHBDD1;STK11;CASP9;EIF2S1;PARP1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.2572022113121565,-0.5735716488257513,0.9705882352941176,1.0,1.0,5/24,15.31%,LSM10;TFDP1;EIF4G1;RPTOR;EGFR
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.36444447123718277,0.5733632762713995,0.9655172413793104,1.0,1.0,1/6,20.89%,MSTN
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.2755263619484152,0.5731230912762894,0.9841269841269841,1.0,1.0,6/33,19.48%,AHR;MAP4K1;SPP1;KLF9;MSN;NCOA4
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.33650881798002213,0.5727498265517117,0.9344262295081968,1.0,1.0,5/8,30.03%,LIN7C;WDR1;CRB2;LIN7B;PDZD11
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.33650881798002213,0.5727498265517117,0.9344262295081968,1.0,1.0,5/8,30.03%,LIN7C;WDR1;CRB2;LIN7B;PDZD11
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.37429744920017294,-0.5726409007737044,0.9736842105263158,1.0,1.0,5/5,62.59%,MARK2;ABL1;MAP2;PPP2CB;TTBK2
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.3402818767922027,-0.5725840975516207,0.925,1.0,1.0,3/10,20.19%,KIF25;MTOR;SUN2
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.25220807347668694,0.5709494543483772,1.0,1.0,1.0,9/89,16.99%,PSMB6;STAT1;CD27;PSMA3;TNFRSF11B;PSMB8;TXNDC17;TNFSF13B;TNFSF18
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),-0.36802512824897116,-0.5708158652805448,0.8787878787878788,1.0,1.0,1/6,9.66%,EIF4G1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3176661326538745,0.5692177505666692,0.9861111111111112,1.0,1.0,1/14,3.32%,CD8A
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.314978821010977,0.5689654756113778,0.9629629629629629,1.0,1.0,3/12,19.86%,DNAJA1;OOEP;CORO2B
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.2913357665224121,-0.5684376008041521,0.9761904761904762,1.0,1.0,2/16,7.75%,CLDN4;NCSTN
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.30258784572728176,0.5683325736113297,0.953125,1.0,1.0,4/29,16.15%,TBP;TBPL1;HELB;TBPL2
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.2736315065994037,-0.5671758747802546,0.9473684210526315,1.0,1.0,3/17,17.81%,SVIL;CAPZB;ADD2
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.2736315065994037,-0.5671758747802546,0.9473684210526315,1.0,1.0,3/17,17.81%,SVIL;CAPZB;ADD2
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),-0.3329104585448049,-0.5669143811999034,0.9574468085106383,1.0,1.0,2/10,9.64%,PDGFRA;APOE
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.28898444230704584,0.5666661577710203,0.9857142857142858,1.0,1.0,6/36,20.98%,MAP3K11;DUSP9;RIPK2;TAB2;GPS2;ARHGEF6
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.37541852495296923,0.5665650109736448,0.9508196721311475,1.0,1.0,1/6,20.24%,SEPTIN9
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.28593368615098225,-0.5664927300010454,0.9722222222222222,1.0,1.0,5/15,27.33%,GRIN2A;GRIN2C;GRIN1;GRIN2B;DRD2
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.24772479822947813,0.5664510461075454,1.0,1.0,1.0,5/79,13.49%,HLA-DMA;HLA-DMB;AP1M2;LGMN;RACGAP1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.38802421098140943,0.5663147002160429,0.8709677419354839,1.0,1.0,5/5,61.21%,SGTB;PDCL3;PDCD5;DNAJB2;SGTA
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),0.33230274105664054,0.5659693398602615,0.9032258064516129,1.0,1.0,4/8,28.27%,ZCCHC17;SLIRP;FMR1;PKP1
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.32615233392813836,-0.5659275543509169,0.9302325581395349,1.0,1.0,3/7,22.85%,SIRT2;LGI4;PARD3
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.32615233392813836,-0.5659275543509169,0.9302325581395349,1.0,1.0,3/7,22.85%,SIRT2;LGI4;PARD3
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.24559220665721743,0.5656989998239217,1.0,1.0,1.0,9/53,22.73%,H3-3A;ZFPM1;MAFB;CDK6;WDR5;LYN;KAT2B;AGO4;DPY30
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),-0.3336575875486381,-0.5655406674329376,0.8979591836734694,1.0,1.0,5/5,66.65%,DCP1A;DCP1B;EDC4;EDC3;PNRC2
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.29830738025771764,0.56511242274871,1.0,1.0,1.0,3/29,12.12%,SLC30A8;GPER1;GHRL
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.29387329675937446,0.5647423598343205,0.9833333333333333,1.0,1.0,5/20,23.32%,LAMP2;HSPA8;NCOA4;VPS4A;LAPTM5
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.34697076149813544,-0.5645061284151013,0.95,1.0,1.0,6/6,65.32%,PIK3R1;MAP4K4;MAPRE2;ARF6;IQSEC1;DUSP3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.34697076149813544,-0.5645061284151013,0.95,1.0,1.0,6/6,65.32%,PIK3R1;MAP4K4;MAPRE2;ARF6;IQSEC1;DUSP3
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),0.3501699781516504,0.5643901548316527,0.9655172413793104,1.0,1.0,1/5,19.04%,GPS2
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.2680008901387538,0.5641791954007147,1.0,1.0,1.0,9/39,25.97%,ADGRB1;HMGCR;VBP1;PRKCG;EIF2AK1;PRNP;AZIN1;INHBB;MAD2L1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.24794928868780536,0.5640713130009339,1.0,1.0,1.0,5/77,13.49%,HLA-DMA;HLA-DMB;AP1M2;LGMN;RACGAP1
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.3456901204351742,-0.5639847909379092,0.9615384615384616,1.0,1.0,1/8,5.94%,CLN6
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3307843696458813,-0.5638327350530292,0.9411764705882353,1.0,1.0,2/10,14.93%,APOE;NRDC
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.271925381641239,-0.56377037330132,1.0,1.0,1.0,2/31,9.93%,DCLRE1B;TELO2
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.37949997290514426,0.5625558733143242,0.9629629629629629,1.0,1.0,1/5,8.03%,HSD17B10
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.2858527866497296,0.562358383209776,0.9850746268656716,1.0,1.0,4/27,24.39%,MRE11;RAD50;TERF2IP;GAR1
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),-0.29692470876315974,-0.562258054338166,1.0,1.0,1.0,9/18,33.75%,TRIP6;PTPRK;PIP5K1A;RCC2;SRC;ACTN1;FERMT2;CTTN;DLC1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.2354213368477086,-0.562066966106704,1.0,1.0,1.0,8/46,18.07%,DCLRE1B;HUS1;XRCC6;XRCC3;POLD3;ATM;TPRKB;ZBTB48
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.2793843297652208,0.5618627229808751,0.9701492537313433,1.0,1.0,8/31,19.46%,IL15;ACOX2;ARG2;CGAS;FXR1;B2M;CD80;ANKLE1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.331636958854125,-0.5618174809722766,1.0,1.0,1.0,3/11,19.92%,NPHS1;PTPRO;JAG1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.33662481219743207,0.5617815741094941,0.9444444444444444,1.0,1.0,4/11,35.87%,PRNP;CLDN1;IGF1R;SUPV3L1
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.3056205693599959,0.5609436032992475,0.9649122807017544,1.0,1.0,3/13,18.42%,SEMA3A;DAB2IP;PLAA
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.30960973683588255,-0.5608357714828665,0.9487179487179487,1.0,1.0,4/12,18.96%,SHLD1;KMT5B;HMCES;TP53BP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-0.3607903807647984,-0.560703813679278,0.9787234042553191,1.0,1.0,2/7,11.33%,IGF1;DNMT1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.3278250903758642,0.5603330074279175,0.9682539682539683,1.0,1.0,2/12,23.10%,MSN;CDC42
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.286407006375375,0.5603094374037426,1.0,1.0,1.0,9/32,30.72%,UCHL5;PRKCG;CAMLG;NOP53;BAG5;GABARAPL2;AQP11;MAP1A;WAC
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.3050571286766363,-0.5601776790497571,0.9230769230769231,1.0,1.0,3/9,18.36%,ZDHHC3;MIA3;PRKCB
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),-0.37801026486231004,-0.559830428562843,0.9787234042553191,1.0,1.0,1/5,10.96%,RGS2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),0.3706584798867331,0.5592563916270603,0.9298245614035088,1.0,1.0,1/5,13.92%,KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.32358371028729815,-0.5580653642673686,0.9047619047619048,1.0,1.0,4/10,26.57%,RIPOR2;MIA3;LRCH1;CD200R1
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.3703723528764129,-0.557885720075674,0.9512195121951219,1.0,1.0,2/5,13.24%,PARP10;TRIM44
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),0.3526043427457079,0.5572507865216481,0.9807692307692307,1.0,1.0,1/5,17.18%,ANGPTL3
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.33965672220229903,0.5572186854698059,1.0,1.0,1.0,1/8,18.20%,SNAPC1
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.35262958758986,-0.5563366785573519,0.9534883720930233,1.0,1.0,8/8,64.76%,POGZ;CENPE;CENPF;CENPT;CENPC;CENPA;MIS12;CENPW
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.30665735046625814,-0.5561393619326384,0.95,1.0,1.0,2/11,9.21%,BMP6;TGFB3
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.3227673449382211,-0.5559972361083086,0.9183673469387755,1.0,1.0,3/7,23.29%,MDH1B;ME1;FH
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.26365598724053113,0.5557747175120309,1.0,1.0,1.0,7/57,16.09%,TCP1;TGFB1;CCT6A;CCT8;ECT2;UBR5;PYHIN1
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.2701915677967346,0.5554679545017339,1.0,1.0,1.0,1/31,5.29%,AMN
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.33236659654911777,0.5554404109475267,0.9402985074626866,1.0,1.0,2/11,10.77%,FBLN5;DRD3
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),0.35650358570161833,0.5551462963834333,0.9230769230769231,1.0,1.0,3/6,28.81%,DGAT2L6;DGAT2;DGAT1
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.336398854602919,0.5545167177903255,0.9491525423728814,1.0,1.0,2/7,16.44%,TTLL4;METAP1
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.35265842733684977,0.5544378608311158,0.9830508474576272,1.0,1.0,2/7,20.52%,LETM1;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.3226269332218302,0.5538680230077149,0.9846153846153847,1.0,1.0,2/9,31.68%,ERCC4;MEN1
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.34020740721895903,0.553851883627567,0.9245283018867925,1.0,1.0,3/6,41.93%,TMED10;TMED9;TMED2
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.34020740721895903,0.553851883627567,0.9245283018867925,1.0,1.0,3/6,41.93%,TMED10;TMED9;TMED2
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.34020740721895903,0.553851883627567,0.9245283018867925,1.0,1.0,3/6,41.93%,TMED10;TMED9;TMED2
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.31184504524173146,0.5535068720356687,0.9516129032258065,1.0,1.0,5/14,28.81%,DGAT2;GPAM;PCK2;AGMO;DGAT1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.3029485725624122,0.5534901123138354,0.95,1.0,1.0,3/9,35.52%,F3;NDRG4;SNCA
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.2581873402903271,-0.5525806302681996,1.0,1.0,1.0,5/27,18.32%,DGCR8;LIN28B;TRIM71;SRRT;TARBP2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),-0.3949763576100391,-0.5523167840462644,0.9555555555555556,1.0,1.0,2/5,12.74%,HTR2A;HTR2C
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.28672919142275727,0.5522936732784108,0.9811320754716981,1.0,1.0,2/18,16.00%,RARRES2;FURIN
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.35032098365238634,0.5520164707919892,0.9473684210526315,1.0,1.0,2/7,25.72%,RIN3;RAB5A
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.3530115616888863,0.5516929427396781,1.0,1.0,1.0,2/7,20.92%,EFEMP1;FBN2
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.3628371696614934,0.5505403660982032,0.9253731343283582,1.0,1.0,1/6,15.72%,COX11
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.311056112971438,-0.550190079636462,0.8372093023255814,1.0,1.0,1/8,7.16%,RAB7A
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.3297234690260212,-0.549966019575973,0.9285714285714286,1.0,1.0,1/8,6.54%,UBE2D4
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.29787885377516776,0.5497034362723535,1.0,1.0,1.0,3/16,18.99%,RPS6KA4;OPRD1;CD200
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.29284051363917823,-0.5486042024660115,0.9767441860465116,1.0,1.0,4/12,25.28%,ATM;ACBD5;SQSTM1;PIK3C3
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.3620649396529602,0.5477461614995679,0.9245283018867925,1.0,1.0,1/8,6.55%,CIITA
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.3591105059748183,-0.5475198108233341,0.9130434782608695,1.0,1.0,1/5,7.35%,SLC25A29
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.3152932124354317,0.5467707040497118,0.9827586206896551,1.0,1.0,3/13,19.86%,CD14;IPMK;CYLD
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.3508674303108533,0.5466215035481649,1.0,1.0,1.0,1/6,17.39%,ULK1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.26065625696330064,-0.5457278072453523,1.0,1.0,1.0,4/43,8.04%,TRIM67;EPHA5;NUMA1;NR1H4
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.34025756337378343,-0.545647188187946,0.8723404255319149,1.0,1.0,1/5,7.35%,SLC25A29
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.24670689261088521,-0.5456218893405842,1.0,1.0,1.0,1/19,5.43%,CFLAR
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.36635295628783077,0.5454652975516457,0.9433962264150944,1.0,1.0,2/5,32.21%,BEX4;PRKAA1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.24385596058627976,0.5451454642854875,1.0,1.0,1.0,16/77,23.63%,RANBP6;NXT1;LAMP2;PEX16;TOMM22;TSC2;SPRN;PEX11B;TNPO1;PXMP2;NUP188;ALDH3A2;NUP85;PEX5;HSPA4;SYK
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),0.3158488930184706,0.5448756843973901,0.9827586206896551,1.0,1.0,1/13,7.41%,MPV17L2
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.2932052809016144,0.544643430894559,0.9830508474576272,1.0,1.0,5/22,28.19%,TLR2;DMTN;SLIT1;DUSP22;ARHGAP6
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.3017690369478675,0.5436981989916696,0.96875,1.0,1.0,3/17,22.15%,MAN1A1;SPCS3;RYR2
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.33308794010400433,-0.5432419973940227,0.9318181818181818,1.0,1.0,3/6,21.54%,GRIPAP1;ARHGAP44;GRIP2
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),-0.33777040766469657,-0.5415861651493638,0.9772727272727273,1.0,1.0,3/7,19.68%,ABCD1;SLC27A2;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.3096488447072608,0.5415794076444317,0.9655172413793104,1.0,1.0,2/9,17.00%,DAB2IP;MMRN2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.32479481179165287,0.541471613061305,0.9682539682539683,1.0,1.0,2/9,13.98%,FKBP1B;PLN
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.2892765217899954,0.5413610374009254,0.9666666666666667,1.0,1.0,1/16,11.96%,GFER
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.34104130763481216,-0.5408135482832354,0.9523809523809523,1.0,1.0,2/6,19.95%,CDHR2;PTPRJ
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),-0.3538994809434088,-0.5405426908594299,0.9183673469387755,1.0,1.0,2/6,14.93%,PNPLA2;MOGAT1
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.31673963569536784,-0.5405228882472882,0.9459459459459459,1.0,1.0,8/8,68.35%,NUDT5;ENTPD2;ENTPD6;ENTPD3;ENTPD1;ENTPD5;ENTPD4;ENTPD7
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.2903775384588087,0.5402500224828215,0.9682539682539683,1.0,1.0,14/29,37.36%,MSN;LIN7C;DLG1;CRB1;CDC42;WDR1;CRB2;LIN7B;PDZD11;CAMSAP3;ERBIN;PDCD6IP;PRKCI;SYNE4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2797868089027061,0.5387159507190568,0.967741935483871,1.0,1.0,8/23,33.61%,COPS2;COPS8;COPS5;CUL4B;RPS27A;COPS7B;GPS1;RAD23B
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.27965395525263176,-0.5384636181139387,0.975,1.0,1.0,2/26,4.08%,IGF1;TRIAP1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.29552198288111564,0.5381380337652334,1.0,1.0,1.0,3/20,14.36%,NCBP1;NCBP2;PRDX6
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),0.3268903589632951,0.5374000388055964,0.9322033898305084,1.0,1.0,2/8,20.49%,SLC7A7;SLC38A3
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.360707284547489,0.5373858650583996,0.9811320754716981,1.0,1.0,2/5,27.39%,PODXL;ATP8B1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.28166283055068875,0.5368322696924912,1.0,1.0,1.0,2/22,15.89%,HSPA8;CHRNA7
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.24072074927234982,0.5360444409836972,1.0,1.0,1.0,16/51,32.32%,RPL26L1;NIP7;RSL24D1;NOP53;WDR12;RPL35A;ZNF622;RPL3;EIF6;RPL5;PES1;MAK16;MRPL1;RPL7;MRPL20;RPL24
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),-0.3522841480730995,-0.5357275685002929,0.9534883720930233,1.0,1.0,2/6,13.49%,DRD1;CTNNA2
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.28060700714891385,-0.5347961073223971,0.972972972972973,1.0,1.0,5/15,19.75%,SLC2A9;SLC2A11;SLC2A14;SLC45A3;SLC2A8
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.2817786728678092,0.5341436309630024,0.9830508474576272,1.0,1.0,6/18,28.81%,DGAT2L6;PLA2G4A;DGAT2;GPAM;AGMO;DGAT1
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.2768108108108108,-0.5338386492608762,0.9767441860465116,1.0,1.0,9/9,72.34%,EIF2S3;EIF2S2;DHX29;EIF2D;EIF4B;EIF4H;DENR;MCTS1;EIF5
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.3355308123303912,0.5330398526768991,0.95,1.0,1.0,2/7,21.35%,AKAP5;ACTN2
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.3366988694986707,0.5323951639880448,0.9666666666666667,1.0,1.0,1/9,7.12%,REST
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),-0.3346303501945525,-0.5323201238392389,0.8936170212765957,1.0,1.0,5/5,66.55%,DSCAM;SOX8;SOX9;SDK2;PROM1
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.3035506898951062,-0.5321630881586364,0.8947368421052632,1.0,1.0,1/8,15.81%,RNF113A
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.2838946407346014,-0.532027299954767,1.0,1.0,1.0,4/14,17.05%,IDE;TRAP1;PNPT1;VCP
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.31040243127617445,0.5319950869146634,0.9285714285714286,1.0,1.0,5/15,29.57%,WIPI1;SORT1;AP1AR;CORO7;AP4M1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.27312965672338935,0.5309353683769749,1.0,1.0,1.0,3/22,15.85%,STAP1;CCP110;TCHP
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.2559571044831701,0.5299605543186812,1.0,1.0,1.0,3/36,11.23%,REST;C1QA;CDK5R1
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.3457255678831142,0.5296977349187367,0.9636363636363636,1.0,1.0,2/6,22.73%,EZH2;DPY30
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.22588795912279222,-0.5295134318395012,1.0,1.0,1.0,8/36,21.35%,PCM1;TRAF3IP1;WDR35;CLUAP1;DYNC2I1;IFT27;IFT52;KIFAP3
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.32227053567211955,0.52874202023306,0.9473684210526315,1.0,1.0,2/9,18.81%,GFPT2;HK3
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.33647605623514065,0.5269311003599048,0.9666666666666667,1.0,1.0,2/6,19.86%,DLG1;CYLD
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),-0.32237096131241066,-0.5263644800368663,0.9574468085106383,1.0,1.0,1/5,13.08%,GRIPAP1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),-0.3516217174066087,-0.5249983578947439,0.9714285714285714,1.0,1.0,3/5,31.95%,PVR;NECTIN2;IL12A
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),-0.3516217174066087,-0.5249983578947439,0.9714285714285714,1.0,1.0,3/5,31.95%,PVR;NECTIN2;IL12A
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.34228732028969844,-0.524487377572129,0.9512195121951219,1.0,1.0,7/7,65.79%,MYOCD;DDX5;UQCC2;MEF2C;DDX17;GPC1;NR1D2
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.3043382227941469,-0.5244219491891031,0.9111111111111111,1.0,1.0,2/8,20.30%,SQSTM1;PRKN
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.29408383013338546,0.5243885036052844,1.0,1.0,1.0,3/12,24.13%,DMTN;LIMS2;EMP2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.25356853732781665,0.5235791786207371,0.9859154929577465,1.0,1.0,3/29,10.09%,CCND2;PLCG2;STXBP4
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.23707010733475312,-0.5235772637921144,1.0,1.0,1.0,1/18,7.09%,TGFB2
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.30816265519211083,0.5235301223387477,0.9833333333333333,1.0,1.0,3/11,23.89%,GNPDA1;GFPT2;UAP1
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.2222866453458911,-0.5227093959639607,1.0,1.0,1.0,11/38,22.31%,TRIM11;POLR2G;GTF2F1;POLR2C;POLR2L;NELFA;TARBP2;MDFIC;CCNT1;NELFE;MID2
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.27602508948003257,-0.5223224591820906,1.0,1.0,1.0,5/19,22.63%,TGFB3;ARNT2;TGFBR1;CHD7;BMP2
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.265652316986572,0.5221293993476757,1.0,1.0,1.0,6/28,20.15%,CUEDC2;CD6;NLRC3;PDCD4;PER1;GBP5
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.23390029624197348,0.5218375015678514,1.0,1.0,1.0,10/69,23.02%,NCBP1;TBP;NCBP2;SNAPC2;GTF2A2;SNAPC1;POLR2D;POLR2K;NABP1;INTS6
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.302314038595537,0.5218210432614373,0.9672131147540983,1.0,1.0,3/12,23.89%,GNPDA1;GFPT2;UAP1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.2865546163550704,0.5211390428032574,1.0,1.0,1.0,3/17,16.81%,VPS35;DAB2IP;MSN
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.2239590269891255,0.5211135788541101,1.0,1.0,1.0,25/107,25.46%,CHMP4B;PRKAB2;LAMP2;LIX1L;VPS37B;TOMM22;CHMP2B;PINK1;CHMP2A;STX17;ULK1;WIPI1;PLAA;ATG3;ATG101;PRKAG2;VPS4A;VDAC1;UBQLN1;ARL8B;TOMM7;MAP1LC3B;YOD1;TOMM20;GABARAPL1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.23568307477290756,0.5208550062119044,1.0,1.0,1.0,10/68,23.02%,NCBP1;TBP;NCBP2;SNAPC2;GTF2A2;SNAPC1;POLR2D;POLR2K;NABP1;INTS6
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.3015833731372728,0.5205688351363259,0.9824561403508771,1.0,1.0,2/12,15.89%,VBP1;CHRNA7
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.3322477604709346,0.5190519141850852,0.9454545454545454,1.0,1.0,2/7,18.99%,ATP6AP2;CD200
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.31574358714022105,0.5181608370511156,0.9838709677419355,1.0,1.0,1/8,13.17%,CAMK2D
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.29716757515936365,0.5177996068926275,0.9642857142857143,1.0,1.0,1/15,6.00%,SLC24A4
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),-0.31546235745554774,-0.5172111527239383,0.9069767441860465,1.0,1.0,6/6,68.47%,HAS1;MACIR;HYAL2;FGF2;ITGB1BP1;RAC1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.2418867491338696,-0.5166153458291216,1.0,1.0,1.0,4/34,13.28%,TENT5A;VIP;ELAVL1;CIRBP
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.26618004866180045,-0.5162265343196506,1.0,1.0,1.0,14/14,73.41%,NANOS3;AGO2;TNRC6B;DHX36;TOB1;PABPC1;TNRC6C;ZFP36L2;NANOS1;CPEB3;CNOT1;ZFP36L1;ZFP36;CNOT7
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.26618004866180045,-0.5162265343196506,1.0,1.0,1.0,14/14,73.41%,NANOS3;AGO2;TNRC6B;DHX36;TOB1;PABPC1;TNRC6C;ZFP36L2;NANOS1;CPEB3;CNOT1;ZFP36L1;ZFP36;CNOT7
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.27350260897057754,-0.515635885159662,0.9714285714285714,1.0,1.0,2/12,15.10%,SSRP1;TLK2
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.22614390917981425,0.5154017853693634,1.0,1.0,1.0,13/68,24.70%,FJX1;CKB;CDR2L;FAM171A2;IGDCC4;TENM3;ENAH;EFNB3;ADGRB2;FHOD3;NR2F2;NKAIN1;RCOR2
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.3038712579566587,-0.5152424962356036,0.9772727272727273,1.0,1.0,2/9,19.02%,MAP1LC3A;NPRL2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.3038712579566587,-0.5152424962356036,0.9772727272727273,1.0,1.0,2/9,19.02%,MAP1LC3A;NPRL2
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),-0.3593817552961522,-0.5142746724833837,0.9487179487179487,1.0,1.0,5/5,64.08%,CTU1;URM1;TRMU;CTU2;MOCS3
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.3211346778957651,-0.5132027854906354,0.975609756097561,1.0,1.0,1/6,15.81%,CTTNBP2NL
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.28688820578438856,0.5131610034615786,0.9454545454545454,1.0,1.0,2/11,24.34%,IFI27;FMR1
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),0.3461569117085371,0.5131011688728027,0.967741935483871,1.0,1.0,2/5,16.58%,PLN;INSIG1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.3220977571108313,0.5125127293773842,0.9607843137254902,1.0,1.0,3/10,20.49%,KDM3A;KDM7A;KDM1A
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.3274049260084653,0.5116486583922589,0.9682539682539683,1.0,1.0,5/7,42.30%,NOS1;TMX3;PRDX3;PARK7;CHCHD4
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.2997888862287652,-0.5111723397551633,0.925,1.0,1.0,1/8,6.72%,NUMA1
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.3220609695916804,-0.5105964399639927,0.8958333333333334,1.0,1.0,1/6,10.76%,NRP1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.332252485948984,-0.510152473720938,1.0,1.0,1.0,5/5,66.79%,AGO2;VEGFA;ACVR1B;C1QBP;SMURF2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.2863380513258957,-0.5099714040084236,0.9772727272727273,1.0,1.0,2/10,15.50%,EMC8;EMC6
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.29350659065107654,-0.5092572375071783,1.0,1.0,1.0,2/10,16.31%,TENM4;CD9
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.3258321062316209,-0.50752603366348,0.9743589743589743,1.0,1.0,1/5,16.82%,CARD9
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.2582737410775503,0.5064457271817127,0.984375,1.0,1.0,3/24,22.99%,DACH1;DCP2;ERCC4
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2737588630465249,0.5062964612608931,1.0,1.0,1.0,1/18,6.99%,CDKN1B
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.21277714853955626,-0.505885314536244,1.0,1.0,1.0,7/38,21.98%,C5AR1;RP9;DOP1B;FAM107A;MAGT1;CHD7;PTCHD1
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.2689692503494332,-0.50532981695052,1.0,1.0,1.0,2/17,15.06%,EXOSC10;EXOSC4
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.2852200237863553,-0.5049719857602896,1.0,1.0,1.0,11/11,71.50%,MGARP;TRAK1;TRAK2;SPAST;ACTR10;MAPT;OPA1;HAP1;HIF1A;SYBU;NEFL
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.31713448687164836,0.5043842859515321,1.0,1.0,1.0,1/7,9.33%,EXOSC8
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.31713448687164836,0.5043842859515321,1.0,1.0,1.0,1/7,9.33%,EXOSC8
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.2407868799145661,0.5033465950206399,1.0,1.0,1.0,11/39,27.44%,CORO1A;RNF26;CHMP2B;SORT1;USP50;WASHC4;EXOC8;HOOK2;SNX11;ARFGEF2;WASL
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.2989440636905254,0.5027891754732319,1.0,1.0,1.0,2/10,22.09%,CABYR;ROPN1L
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.2382987047381318,-0.501864045960959,0.972972972972973,1.0,1.0,1/21,4.94%,MED30
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.24534058478746978,0.5016598909895557,1.0,1.0,1.0,6/50,20.66%,STK26;SOD2;GLRX2;TXNRD2;ROMO1;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.30416370174565516,0.5014110779978365,0.9692307692307692,1.0,1.0,1/8,18.60%,PPARG
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.2350390230245128,0.501285943438028,1.0,1.0,1.0,9/50,22.99%,FANCI;FAAP24;FANCM;RPA3;POLN;RAD51AP1;RNF168;MSH6;ERCC4
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.31326045269505154,0.5011201248080516,1.0,1.0,1.0,2/7,20.41%,PECR;ALDH3A2
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.28879864514455933,0.5009024287030953,0.9850746268656716,1.0,1.0,1/14,14.99%,GNL3
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),-0.2748108108108108,-0.500457016813587,0.9777777777777777,1.0,1.0,9/9,72.54%,GALNT1;GALNT16;GALNT2;POGLUT3;MGAT5B;GALNT13;GALNT3;POGLUT1;POGLUT2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),-0.3141482922611327,-0.5001213481047596,0.925,1.0,1.0,5/5,68.60%,RFFL;RFPL1;PAK2;RPS3;RNF34
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.26821009144247865,0.4986223400225743,1.0,1.0,1.0,6/21,30.76%,MIEF2;MIGA1;THG1L;MIEF1;MFN1;BAX
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.33051098872367657,-0.4977812207614369,0.9767441860465116,1.0,1.0,2/5,20.48%,PPP1CA;PPP5C
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.27843900569122526,0.49772658658612645,0.9682539682539683,1.0,1.0,4/11,29.34%,NCMAP;CNTNAP1;ADGRG6;PRX
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.22627717225292407,-0.4963311913819957,1.0,1.0,1.0,5/28,19.12%,NSMF;RPTOR;LAMTOR4;MTOR;NEURL1
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.3280946741559856,0.49612059854517976,0.9830508474576272,1.0,1.0,1/8,12.27%,STXBP6
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),-0.33279290964115865,-0.4957596387189062,1.0,1.0,1.0,5/5,66.74%,APC;AMER1;GSK3B;AXIN1;CSNK1A1
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.2989276246793738,-0.4953795568227493,0.926829268292683,1.0,1.0,1/7,12.42%,ATG9B
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.33000054045289956,-0.4940553677989343,0.9473684210526315,1.0,1.0,6/6,67.02%,USP47;USP15;BAP1;USP7;USP1;ATXN3
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.3351728740329287,0.4935377552739366,0.9655172413793104,1.0,1.0,2/5,30.81%,ARL8B;VPS39
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.267545180924134,0.492402011995293,1.0,1.0,1.0,5/23,22.99%,MRE11;GNL3;RAD50;TERF2IP;ERCC4
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.2216069589766163,0.49230695827896886,1.0,1.0,1.0,7/63,25.81%,PSMB6;PSMA3;PSMB8;COPS8;PSMA5;CUL1;PSMC6
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.30697364138034844,0.4916712742362688,1.0,1.0,1.0,4/11,30.47%,CHRNA7;PRNP;TMED10;RANBP9
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.2722791564700314,-0.49165272810290045,1.0,1.0,1.0,4/13,23.58%,HMGB2;TOP3B;ERCC3;KAT6A
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.2840121434888342,0.4914323165326767,0.967741935483871,1.0,1.0,3/11,30.40%,INPP5F;ADIPOR1;NF2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.2871842691653014,0.49099540816563036,0.9365079365079365,1.0,1.0,2/9,19.65%,IFIT1;SP100
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),-0.33036100302637267,-0.4907880376526899,0.9302325581395349,1.0,1.0,5/5,66.98%,COLGALT1;CHADL;RB1;AEBP1;EFEMP2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.22134790725194559,-0.4902912408752625,1.0,1.0,1.0,10/30,31.40%,UXT;TMEM201;MAP1S;TRAK1;COPG1;BORCS5;RAB6A;COPG2;HTT;TRAK2
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.2383756805716849,0.4891436505945476,1.0,1.0,1.0,5/40,21.14%,GAD1;HSPA8;OTOF;LIN7C;SLC32A1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),-0.3015039685669201,-0.48897957525457303,0.972972972972973,1.0,1.0,2/5,18.37%,SMOC2;FGFBP3
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.23876537165885628,0.4885267587450819,1.0,1.0,1.0,5/39,21.14%,GAD1;HSPA8;OTOF;LIN7C;SLC32A1
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.3052018729847963,0.4875137370816071,0.9622641509433962,1.0,1.0,3/8,28.41%,PDK4;PDK2;GSTZ1
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.3052018729847963,0.4875137370816071,0.9622641509433962,1.0,1.0,3/8,28.41%,PDK4;PDK2;GSTZ1
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.3030319407663622,-0.4874202080275852,0.9302325581395349,1.0,1.0,6/6,69.71%,PRKN;MT3;HDAC6;OXA1L;SNCA;ETFBKMT
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),0.31585429704974,0.4873108122753531,1.0,1.0,1.0,2/6,20.49%,BRCA1;KDM1A
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.19653778940960548,0.4872493488097811,1.0,1.0,1.0,58/193,32.90%,ASMT;GTPBP2;EEF1A1;RPL15;RPS7;RPL36;RPL9;RPS21;RPL26L1;PPA1;EPRS1;MRPS14;RPL38;MRPL34;RPL21;RPL22;GFM2;RPS5;RSL24D1;IARS2;RPS6KB2;RPLP2;COPS5;RPL22L1;EEF2;MRPS34;RPS13;MRPL35;RPL27;RPL35A;RPL35;MRPL43;RPL3;RPS20;RPL27A;EIF4EBP2;FTSJ1;RPS27A;RPL13A;RPL5;MRPL42;AIMP2;GTPBP1;EEF2K;RPS29;RPS12;MRPL28;TARS1;MRPS18C;RPL7;RPL32;RPS4X;RPL37A;MRPL57;RPL24;RPS9;RPL28;MRPL51
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.27620098775099894,-0.4855842332347799,1.0,1.0,1.0,2/9,16.18%,DERL3;UBAC2
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.2837458598755027,-0.48537245968375503,1.0,1.0,1.0,3/13,20.29%,SIRT7;POLR1G;MARS1
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.3183539828274342,0.4845603527776341,0.9523809523809523,1.0,1.0,2/6,34.40%,FNTA;C6ORF89
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.322860709323456,-0.4836027662644485,1.0,1.0,1.0,3/6,31.95%,PVR;NECTIN2;IL12A
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.29374518652757176,0.4829302704385662,1.0,1.0,1.0,4/12,26.05%,MGME1;MEF2A;SLC25A4;LONP1
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.28247946389969736,-0.48009268694096796,1.0,1.0,1.0,5/5,71.77%,CDKN2B;USF1;XBP1;LPL;PDK2
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.3025814679664238,0.4791063750078922,1.0,1.0,1.0,1/7,18.80%,BAD
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.2550661787695602,0.47895316513694497,1.0,1.0,1.0,6/21,34.05%,UBE2E1;UHRF1;UBE2B;RAG1;WAC;PAF1
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.29153609702898353,-0.47761445570666217,1.0,1.0,1.0,2/8,17.34%,APOE;CYP46A1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.29153609702898353,-0.47761445570666217,1.0,1.0,1.0,2/8,17.34%,APOE;CYP46A1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.29153609702898353,-0.47761445570666217,1.0,1.0,1.0,2/8,17.34%,APOE;CYP46A1
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.2893840709022806,0.4775105341148312,1.0,1.0,1.0,3/7,23.70%,STX17;ATP2A2;VMP1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),-0.2540017304780446,-0.4773620106439884,1.0,1.0,1.0,17/17,74.63%,STX18;EHD3;AKAP9;MAP2K1;MAP2K2;MYO5A;STX5;ARMH3;MAPK1;MAPK3;RBSN;CAMSAP2;USP6NL;CAMSAP3;PDE4DIP;RAB33B;PDCD10
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.28137035339721617,-0.4764884058304339,0.975609756097561,1.0,1.0,2/7,13.57%,GRIN2A;GRIN2C
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.27295821847467705,-0.47603979167083615,1.0,1.0,1.0,8/8,72.72%,MAP3K13;DVL2;GRIP1;FZD4;WNT5A;DVL3;DLG4;DVL1
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.31033484507850784,0.47547270386954354,1.0,1.0,1.0,2/8,38.77%,WNT7A;PLXNB2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.31468662440885514,0.4743815172943971,0.9848484848484849,1.0,1.0,1/6,18.80%,BAD
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.311499664208258,0.4729538502857143,0.9830508474576272,1.0,1.0,1/7,14.33%,MIEF2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.311499664208258,0.4729538502857143,0.9830508474576272,1.0,1.0,1/7,14.33%,MIEF2
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.3071538407301757,0.4726413131503282,1.0,1.0,1.0,2/7,33.92%,PRNP;IGF1R
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.229633435750726,0.47077646295527364,1.0,1.0,1.0,9/31,28.16%,GLRA3;GLRA1;GLRB;RRAGD;SPAAR;LAMTOR3;LAMTOR2;LAMTOR5;RRAGA
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.32087457267148856,0.47030667936128157,1.0,1.0,1.0,2/5,31.54%,INPP5K;RAC1
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.2930335621250608,-0.47029195830524356,0.9615384615384616,1.0,1.0,6/6,70.71%,NHP2;METTL16;MEPCE;DKC1;NOP10;METTL4
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.27530670702048315,-0.4694645469094362,0.9387755102040817,1.0,1.0,6/6,72.48%,GLTP;CERT1;PLEKHA3;PLEKHA8;CPTP;TTPA
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.2917645185897446,-0.4693522210989857,0.9787234042553191,1.0,1.0,2/5,22.06%,RSAD2;NLRP3
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.2917645185897446,-0.4693522210989857,0.9787234042553191,1.0,1.0,2/5,22.06%,RSAD2;NLRP3
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.2495330883577065,-0.468611941340615,1.0,1.0,1.0,4/17,26.24%,TMEM230;DNM2;RAB27A;KIF5C
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.2976814570610171,-0.46815897418084057,0.9767441860465116,1.0,1.0,6/6,70.25%,ALOX12B;SCIN;XBP1;ABCB11;GPLD1;ACSL3
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),-0.2991785559878945,-0.46702807420835274,0.9791666666666666,1.0,1.0,5/5,70.10%,TRIP11;TBC1D23;C17ORF75;FAM91A1;WDR11
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2476994532320266,0.4662724844356477,1.0,1.0,1.0,1/19,6.99%,CDKN1B
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.26837764383331664,0.4657102974880626,1.0,1.0,1.0,2/9,29.58%,PPARG;NFKBIA
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.25942383751657483,0.4650777102833518,1.0,1.0,1.0,3/18,23.02%,EXOSC8;EXOSC6;INTS6
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.25524820896657474,0.4647331682204887,0.9859154929577465,1.0,1.0,5/21,23.48%,MTFR1L;PEX11B;PEX11A;MIEF1;MTFR1
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.274081109868535,0.4645367218826661,0.967741935483871,1.0,1.0,2/13,17.82%,KIF14;KIF19
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),0.299909152412769,0.4635014287959224,1.0,1.0,1.0,2/6,23.19%,IRAK4;ADAM17
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.2813266989017591,0.46097619899902254,0.9830508474576272,1.0,1.0,1/10,11.86%,VCPIP1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),-0.26959448528556407,-0.4599644208767862,1.0,1.0,1.0,2/9,19.42%,CREBBP;KAT7
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.30531278851839844,0.4599465382504051,0.9607843137254902,1.0,1.0,1/5,23.33%,CHRNB2
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.25513845058452256,-0.4564230294038177,1.0,1.0,1.0,3/8,23.15%,NOS1AP;TMEM106A;JAK2
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.2562452687358062,-0.45624041490818124,1.0,1.0,1.0,15/15,74.40%,ADCY7;ADCY2;ADCY5;ADCY8;ADCY9;PRKACA;PRKAR2B;ADCY6;PRKAR2A;PRKACB;PRKAR1B;ADCY1;PRKAR1A;ADCY3;PRRC1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.2670577584257131,0.4561376093587666,0.9814814814814815,1.0,1.0,1/13,10.32%,MRPL44
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),-0.27688361582938986,-0.4538433715145541,0.9714285714285714,1.0,1.0,1/6,13.71%,SLCO1C1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.2526601862904345,0.45201867095609916,1.0,1.0,1.0,5/15,28.16%,GPR137B;GPR137;RRAGD;LAMTOR5;RRAGA
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.23159921919674695,0.4518261904950482,1.0,1.0,1.0,5/21,27.56%,NUBP1;NFS1;CIAO2A;HSPA9;GLRX5
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.2623398296156817,-0.4509647024605648,0.975609756097561,1.0,1.0,2/7,25.48%,DDX11;WRN
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.26521306917176374,-0.4504307165222651,1.0,1.0,1.0,4/8,26.82%,APOE;PC;ZNF502;PPIB
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.26393480740705,0.4471394678520204,1.0,1.0,1.0,2/9,22.45%,SIDT2;SIDT1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.28615434500648507,-0.44710787897855103,1.0,1.0,1.0,5/5,71.40%,PHLDB2;DAG1;CLASP2;PHLDB1;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.28615434500648507,-0.44710787897855103,1.0,1.0,1.0,5/5,71.40%,PHLDB2;DAG1;CLASP2;PHLDB1;CLASP1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.24403860321973575,0.4468340145990803,1.0,1.0,1.0,4/17,24.23%,TGFB1;APH1B;ADAM17;ADAM9
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.26703092982175314,-0.44621414343373056,1.0,1.0,1.0,4/6,25.86%,APOE;HOMER1;GRIN2B;FYN
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.29859934102671204,-0.44323078787594844,0.972972972972973,1.0,1.0,1/5,14.59%,MAVS
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.21819175338490776,0.44285542251212856,1.0,1.0,1.0,12/49,27.37%,BCAP31;TOMM22;DNAJC19;FBXO7;GRPEL2;ROMO1;HSPA4;TOMM7;TOMM20;TIMM8B;TIMM22;TIMM21
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.23355593679858716,-0.44216658800103803,1.0,1.0,1.0,4/15,20.30%,MX1;GDAP1;DNM2;PRKN
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.25386444708680145,-0.4417655810928678,1.0,1.0,1.0,7/7,74.63%,PPP1R16B;IL12A;THBS1;VEGFA;FGF2;JCAD;PDCD10
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.27796877584289803,0.4416789554711435,1.0,1.0,1.0,2/6,27.09%,GNPDA1;NPL
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.2798868046172373,0.44101808282476723,1.0,1.0,1.0,1/7,9.67%,STAP1
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),0.27791596731601065,0.4408990618880145,1.0,1.0,1.0,2/5,26.41%,NPHP4;TCTN2
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.25992903392409805,0.4408740170384314,1.0,1.0,1.0,3/11,22.65%,CALR;EZH2;PRAME
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.28510115479998255,0.4394172257213862,1.0,1.0,1.0,3/6,29.59%,MADD;DENND4C;DENND4A
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.2723735408560311,-0.43935780365651883,0.9310344827586207,1.0,1.0,5/5,72.78%,MYO9B;RHOA;SLIT3;ROBO1;SLIT2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.2645285751540294,0.4388658078430483,0.9827586206896551,1.0,1.0,2/12,22.26%,KCNQ1;GJA1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),-0.2781454152941668,-0.4379633509271687,0.975609756097561,1.0,1.0,2/5,23.03%,PNPLA2;PPARA
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.2522791623544039,-0.4345544563960024,1.0,1.0,1.0,1/10,8.65%,TENM4
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),-0.2549289642663358,-0.43453337655483565,1.0,1.0,1.0,4/9,25.28%,EPG5;IRAK2;PIK3AP1;PIK3C3
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.2545825052144461,0.43266343212577424,1.0,1.0,1.0,2/12,22.41%,ATP2B4;PKIB
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.22124672839959267,0.4314864285162726,1.0,1.0,1.0,5/23,24.59%,KIF14;TWF2;TWF1;CFL2;WDR1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.20077361313726275,0.43138665321872666,1.0,1.0,1.0,3/43,16.92%,AMN;STXBP6;STEAP2
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.2674061497093098,0.43044393087435323,0.9833333333333333,1.0,1.0,4/9,40.85%,KLF15;PRKAA1;DIP2A;PARK7
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.27844962893991393,0.42989896549797385,1.0,1.0,1.0,3/5,31.16%,NAA30;NAA16;NAA25
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.27291463278895156,-0.4289803545973289,1.0,1.0,1.0,3/6,23.69%,HSPA1A;PRKN;CPNE1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.2554703384256485,0.427994271719376,0.9811320754716981,1.0,1.0,4/11,31.78%,PIP4K2C;RAB3GAP1;GRN;RAB3GAP2
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.22777596998076413,-0.4260490545492306,1.0,1.0,1.0,1/18,9.70%,EXOSC10
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.21295202966268992,0.4259260589809299,1.0,1.0,1.0,5/22,27.56%,NUBP1;NFS1;CIAO2A;HSPA9;GLRX5
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.2748892011674412,0.4256417393807255,1.0,1.0,1.0,7/7,72.52%,EIF6;ABCE1;RAN;XPO1;NPM1;LSG1;TSC1
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.2715629053177691,-0.4250474961422194,0.9772727272727273,1.0,1.0,5/5,72.86%,FITM2;GNB3;C3;PANK2;MBOAT7
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.26816866385462673,-0.4215151499153786,1.0,1.0,1.0,2/8,21.30%,PKIA;PKIG
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),-0.2430279903082221,-0.4214205623779217,1.0,1.0,1.0,2/9,17.50%,SORL1;EIPR1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.2674967462735469,-0.42126007434762797,1.0,1.0,1.0,2/6,22.56%,BACE2;AGO2
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.2333457453914159,-0.42093650795895876,1.0,1.0,1.0,3/19,19.42%,JADE2;MEAF6;KAT7
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.25862255378959886,-0.4191647628633721,1.0,1.0,1.0,11/11,74.16%,MTHFR;MYOCD;CDK9;AKAP8L;AKAP8;SETD5;UBE2N;NNMT;PARK7;HPF1;PARG
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.24360284925111303,-0.4184706430601267,1.0,1.0,1.0,2/7,19.47%,ATM;SQSTM1
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.21360956347703802,0.41709257956623885,1.0,1.0,1.0,22/22,78.66%,RAB1A;KIF3A;NDEL1;FYCO1;FBXW11;KIF1C;KIF5A;DYNC1H1;NDE1;KIF5B;PAFAH1B1;CLN3;BICDL1;HAP1;DYNC1I1;KIF3B;TRAK2;HTT;TRAK1;KIF13A;KIF1A;KIFAP3
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.23154972477331692,0.4158322859680796,1.0,1.0,1.0,3/15,28.19%,DMTN;DUSP22;ARHGAP6
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.23154972477331692,0.4158322859680796,1.0,1.0,1.0,3/15,28.19%,DMTN;DUSP22;ARHGAP6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.23640393556060116,-0.4146051400182715,1.0,1.0,1.0,11/11,76.38%,NLRP3;ZP3;HAVCR2;PRKCQ;PRKCZ;CEBPB;SLC7A5;RARA;HLA-E;TNFSF4;SYK
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.23107154113416953,0.4113141500682181,1.0,1.0,1.0,4/14,28.52%,IL4I1;LAPTM5;FGL1;GPNMB
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.22918492510995997,0.40890698709352613,0.9830508474576272,1.0,1.0,2/10,23.59%,AMPD2;PPAT
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.2608036408367629,0.4025774078585923,0.9836065573770492,1.0,1.0,1/7,16.77%,INPP5F
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.27788897782311517,-0.4008569415718009,0.9767441860465116,1.0,1.0,1/5,13.70%,SLC25A10
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.27788897782311517,-0.4008569415718009,0.9767441860465116,1.0,1.0,1/5,13.70%,SLC25A10
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.2178105703624038,0.40070019679850666,1.0,1.0,1.0,3/17,20.74%,OOEP;DLG1;CRB1
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),-0.24697362732382186,-0.3987030250543779,0.975,1.0,1.0,5/5,75.31%,NIBAN2;MEF2C;DLL1;LMOD3;FLOT1
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.2512565529914068,-0.39727693979317674,1.0,1.0,1.0,6/6,74.89%,COA6;NDUFA12;NDUFV3;NDUFS2;NDUFB6;NDUFV1
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.2439791486830461,0.3969290109600034,1.0,1.0,1.0,2/8,24.55%,RECQL4;BLM
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.19663620139527338,-0.3967598833925575,1.0,1.0,1.0,18/18,80.36%,PML;SUN2;TAF8;CHCHD10;MORC3;SYNE1;ARL2BP;BCL3;BBS4;SUPT7L;PARK7;SUN1;HNRNPU;RANGAP1;TAF3;SKP1;BARD1;SP100
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.24232432432432433,-0.395570228194239,1.0,1.0,1.0,9/9,75.78%,MTOR;FGF10;MAP4K4;FGF7;MAPRE2;EPB41L4B;ARF6;IQSEC1;ADAM9
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.25995774440193103,0.3930221170180871,1.0,1.0,1.0,1/5,21.94%,SLF1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.25995774440193103,0.3930221170180871,1.0,1.0,1.0,1/5,21.94%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.25995774440193103,0.3930221170180871,1.0,1.0,1.0,1/5,21.94%,SLF1
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.23327207869419522,-0.3925884997884824,1.0,1.0,1.0,7/7,76.69%,RBMS3;PLK5;DAPK1;DLEC1;SPI1;ABI3;LAPTM5
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.24168017275820625,-0.39201394076883045,1.0,1.0,1.0,2/6,23.38%,PGS1;TAMM41
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.20873325490878303,0.3918428302675175,0.9850746268656716,1.0,1.0,4/17,28.09%,B4GAT1;POMGNT2;SDF2L1;POMT1
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.24233742364452132,-0.3880063175627415,1.0,1.0,1.0,10/10,75.78%,MTOR;FGF10;PTEN;MAP4K4;FGF7;MAPRE2;EPB41L4B;ARF6;IQSEC1;ADAM9
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.21591385031523025,-0.38282329345249577,0.9743589743589743,1.0,1.0,1/11,8.59%,CTPS2
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.20756961340902946,-0.38169129171756816,1.0,1.0,1.0,14/14,79.26%,SCAP;MIA3;SEC24C;SEC13;TBC1D20;SEC31B;SEC24A;SEC23B;SAR1A;SEC24D;SEC31A;SEC24B;RAB1A;SEC23A
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.23106859088697906,-0.3789874887420625,0.975,1.0,1.0,8/8,76.91%,NR1H2;AXL;PROM2;CLN3;NR1H3;PPT1;ANKFY1;CDC42
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.22402983461247433,-0.37429247736504917,1.0,1.0,1.0,7/7,77.61%,TARBP2;AGO2;ADAR;AGO3;DICER1;AGO1;AGO4
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.21445382813905142,0.37065049465988803,1.0,1.0,1.0,3/15,25.25%,EMC1;CAMLG;EMC3
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.2206568001739375,0.3695005544854485,1.0,1.0,1.0,3/9,31.78%,PIP4K2C;RAB3GAP1;RAB3GAP2
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.23830705546035894,0.36844989580080073,1.0,1.0,1.0,1/6,20.88%,NOP53
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.2323407015078636,-0.3674164805131165,1.0,1.0,1.0,6/6,76.78%,KIFAP3;KIF13A;KIF3B;MAPT;FYCO1;KIF3A
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.20044857813822767,-0.3600498248999934,1.0,1.0,1.0,3/11,22.56%,BACE2;NECAB2;AGO2
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),0.20997151085628907,0.35517088307235745,1.0,1.0,1.0,3/10,34.05%,UBE2E1;WAC;PAF1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.22615637264969612,0.3525835640037973,1.0,1.0,1.0,1/6,17.99%,LRRK2
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.19003081580796888,-0.3493556528367311,1.0,1.0,1.0,12/12,81.01%,CNNM4;MAGT1;NIPAL2;NIPA2;NIPAL4;NIPAL1;NIPA1;MMGT1;MRS2;TUSC3;SLC41A1;NIPAL3
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.22788728673764438,0.348520963003422,1.0,1.0,1.0,2/7,32.03%,JAM3;ICAM1
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.2387648969510161,0.3445477400788041,1.0,1.0,1.0,1/5,20.70%,JAM3
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),-0.23232814526588844,-0.3321612256017641,1.0,0.999965928118064,1.0,5/5,76.78%,KIFAP3;KIF13A;KIF3B;FYCO1;KIF3A
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.16491437658740593,0.31673290767633355,1.0,0.9999766254105162,1.0,3/23,24.42%,DCP2;ERCC4;TNKS2
